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Foreword
With an estimated 17 million to 22 million animals used in laboratories annually in
the United States, public interest in animal welfare has sparked an often emotional de-
bate over such uses of animals. Concerns focus on balancing societal needs for continued
progress in biomedical and behavioral research, for toxicity testing to safeguard the pub-
lic, and for education in the life sciences with desires to replace, reduce, and refine the
use of laboratory animals. In 1985, Congress enacted three laws that dealt with labora-
tory animals, including amendments to the Animal Welfare Act.
In this assessment, OTA analyzes the scientific, regulatory, economic, legal, and ethical
considerations involved in alternative technologies in biomedical and behavioral research,
toxicity testing, and education. Included is a detailed examination of Federal, State, and
institutional regulation of animal use, and a review of recent developments in 10 other
countries. The report was requested by Sen. Orrin Hatch, Chairman of the Senate Com-
mittee on Labor and Human Resources.
The report illustrates a range of options for congressional action in seven principal
areas of public policy regarding animals: using existing alternatives, developing new alter-
natives, disseminating research and testing information, restricting animal use, count-
ing the numbers and kinds of animals used, establishing a uniform policy for animal
use within Federal agencies, and amending the Animal Welfare Act.
OTA was assisted in preparing this study by an advisory panel of individuals and
reviewers selected for their expertise and diverse points of view on the issues covered
in the assessment. Advisory panelists and reviewers were drawn from animal welfare
groups, industrial testing laboratories, medical and veterinary schools, Federal regula-
tory agencies, scientific societies, academia, and the citizenry at large—in short, from
representatives of all parties interested in laboratory-animal use and its alternatives. Written
comments were received from 144 reviewers on the penultimate draft of the assess-
ment. In addition, at the study’s inception, OTA solicited information and opinions from
more than 600 interested groups and individuals.
OTA gratefully acknowledges the contribution of each of these individuals. As with
all OTA reports, responsibility for the content of the assessment is OTA’s alone. The
assessment does not necessarily constitute the consensus or endorsement of the advi-
sory panel or the Technology Assessment Board.
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Summary, Policy Issues, and
Options for Congressional Action
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A former high school teacher in New York organizes demonstrations and advertising campaigns
opposing the use of rabbits and rodents in two product-safety tests. Industry responds by giving
several million dollars in grants to university scientists searching for alternatives to animal testing.
Researchers induce seizures in rats, draw their cerebrospinal fluid, and use it to quell seizures
in other rats; the anticonvulsant substance produced during seizures could bear on the under-
standing and treatment of epilepsy.
Industrial toxicologists in New Jersey adopt refined methods of testing potentially poisonous
chemicals, reducing by 48 percent the number of animals used in acute toxicity studies and
cutting the cost of compliance with government regulations.
A Virginia woman donates $1,250,000 to the University of Pennsylvania to establish the Nation
first endowed professorship in humane ethics and animal welfare. One of the goals of the chair
is to investigate alternatives to animal experiments for medical research.
Members of the Animal Liberation Front break into a biomedical research laboratory in Califor-
nia and remove dogs being used in a cardiac pacemaker experiment.
Veterinary students in Washington study principles of physiology without recourse to the tra-
ditional dog dissection. Instead, they use a computer simulation of canine physiology.
These recent events illustrate the complex po-
litical, ethical, and economic issues raised by the
use of animals in research, testing, and education.
Concern about the continued use of animals has
led to public calls for development of alternatives.
The popular debate over animal use has been
taken up by proponents holding a wide spectrum
of views, ranging from belief in abolition of animal
use on moral and ethical grounds to belief in free
rein on the use of animals in research, testing, and
education. An increasing number of groups are
taking a middle ground. In the mid-1980s, it is
misleading—and often impossible—to character-
ize many vocal groups either as simply “pro-animal”
or “pro-research. ”
In light of requests for “a scientific evaluation
of alternative methods to animal research, experi-
mentation, and testing” from the Chairman of the
Senate Committee on Labor and Human Resources,
Senator  Orrin G. Hatch (R-UT), and from Senator
Alan Cranston (D-CA), this assessment examines
the reasons for seeking such alternatives and the
prospects for developing them. It describes ani-
mal and nonanimal methods used by industry,
academia, and government agencies; explains the
roles and requirements of government regulation
and self-regulation of animal use; and identifies
policy issues and options that the debate over alter-
natives places before Congress.
The report covers three kinds of animal use:
research in the biomedical and behavioral sci-
ences; testing of products for toxicity; and edu-
cation of students at all levels, including the
advanced life sciences, and medical and veteri-
nary training. The use of animals in these three
situations—research, testing, and education-dif-
fers considerably, and each has different prospects
for development of alternatives.
The assessment excludes examination of the use
of animals in food and fiber production; their use
in obtaining organs, antibodies, and other biologi-
cal products; and their use for sport, entertain-
ment, and companionship. Such purposes include
numbers of animals generally estimated to be many
multiples greater than the numbers used for pur-
poses described in this report (see ch. 3). Issues
of animal care, such as feeding and maintenance,
are also beyond the scope of this assessment.
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DEFINITION
In this report, animal is defined as any non-
human member of the five classes of verte-
brates: mammals, birds, reptiles, amphibians,
and fish (see ch. 2). Within this group, two kinds
of animals can be distinguished—warm-blooded
animals (mammals and birds) and cold-blooded ani-
mals (reptiles, amphibians, and fish). Other crea-
tures customarily included in the animal kingdom,
such as invertebrates (e.g., worms, insects, and
crustaceans), are excluded by this definition. The
use of human subjects is not examined in this
assessment.
The concept of alternatives to animal use has
come to mean more than merely a one-to-one
substitution of nonanimal methods for animal tech-
niques. For alternatives, OTA has chosen a def=
inition characterized by the three Rs: replace-
ment, reduction, and refinement.
Scientists may replace methods that use animals
with those that do not. For example, veterinary
students may use a canine cardiopulmonary -resus -
citation simulator, Resusci-Dog, instead of living
dogs. Cell cultures may replace mice and rats that
are fed new products to discover substances poi-
sonous to humans. In addition, using the preced-
ing definition of animal, an invertebrate (e.g., a
horseshoe crab) could replace a vertebrate (e.g.,
a rabbit) in a testing protocol.
Reduction refers to the use of fewer animals.
For instance, changing practices allow toxicolo-
gists to estimate the lethal dose of a chemical with
as few as one-tenth the number of animals used
in traditional tests. In biomedical research, long-
lived animals, such as primates, may be shared,
assuming sequential protocols are not deemed in-
humane or scientifically conflicting. Designing ex-
perimental protocols with appropriate attention
to statistical inference can lead to decreases (or
to increases) in the numbers of animals used. Or
several tissues may be simultaneously taken from
a single animal as a result of coordination among
investigators. Reduction can also refer to the mini-
mization of any unintentionally duplicative exper-
OF TERMS
Resusci-Dog, Canine Cardiopulmonary
Resuscitation Simulator
Photo credit: Charles R. Short,
New York State College of Veterinary Medicine,
Cornell University
Resusci-Dog, a plastic mannequin linked to a computer,
can simulate an arterial pulse, and pressure can be
applied to its rib cage for cardiac massage or cardio-
pulmonary resuscitation. Resusci-Dog has replaced
about 100 dogs per year in the training of veterinary
students at the New York State College
of Veterinary Medicine.
iments, perhaps through improvements in infor-
mation resources.
Existing procedures may be refined so that ani-
mals are subjected to less pain and distress. Refine-
ments include administration of anesthetics to ani-
mals undergoing otherwise painful procedures;
administration of tranquilizers for distress; hu-
mane destruction prior to recovery from surgical
anesthesia; and careful scrutiny of behavioral in-
dices of pain or distress, followed by cessation of
the procedure or the use of appropriate analgesics.
Refinements also include the enhanced use of non-
invasive imaging technologies that allow earlier
detection of tumors, organ deterioration, or meta-
bolic changes and the subsequent early euthana-
sia of test animals.
Pain is defined as discomfort resulting from in-
jury or disease, while distress results from pain,
anxiety, or fear. Pain may also be psychosomatic,
resulting from emotional distress. Although these
are subjective phenomena, pain and distress can
—.
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sometimes be identified and quantified by observ- objectives of procedures. Professional ethics re-
ing an animal’s behavior. Pain is relieved with quire scientists to provide relief to animals in pain
analgesics or anesthetics; distress is eased with or distress, unless administering relief would inter-
tranquilizers. Widely accepted ethical standards fere with the objective of the procedure (e.g., when
require that scientists subject animals to as little the objective is a better understanding of the mech-
pain or distress as is necessary to accomplish the anisms of pain).
HOW MANY ANIMALS ARE USED?
Estimates of the animals used in the United States
each year range from 10 million to upwards of
100 million. OTA scrutinized a variety of surveys
(see ch. 3), including those of the National Research
Council’s Institute for Laboratory Animal Resources
and the Animal and Plant Health Inspection Serv-
ice (APHIS) of the U.S. Department of Agriculture
(USDA). Indirect estimates of animal use were also
based on data such as Federal funds spent on ani-
mal research and sales revenues of the Nation’s
largest commercial breeder of laboratory animals.
All these data are unreliable, No data source ex-
ists, for example, to enumerate how many institu-
tions do not report animal use. In addition, non-
reporting institutions may not be similar enough
to reporting institutions to justify extrapolation.
Thus every estimate of animal use stands as a rough
approximation. With this caveat in mind, the best
data source available--the USDA/APHIS census
—suggests that at least 17 million to 22 million
animals were used in research and testing in
the United States in 1983. The majority of ani-
mals used—between 12 million and 15 million—
were rats and mice. Current data permit no state-
ment about any trends in animal use through re-
cent years. Animal use in medical and veterinary
education amounted to at least 53)000 animals in
the school year 1983-84.
The Animal Welfare Act of 1966 (Public Law 89-
544), as amended and presently enforced, requires
research and testing facilities to report to USDA
their annual use of dogs, cats, hamsters, rabbits,
guinea pigs, and nonhuman primates (see  ch. 13).
(About two-thirds of the reporting institutions also
volunteer the number of rats and mice used ).  For
fiscal year 1983, the USDA reporting forms indicate
the facilities used nearly 1.8 million of these six
kinds of animals (see table 1-1).
Table I-l.—Animal Use Reported to the
U.S. Department of Agriculture, 1983a
Number used
Animal in 1983
Dogs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 182,425
Cats. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 55,346
Hamsters . . . . . . . . . . . . . . . . . . . . , . . . . . 454,479
Rabbits . . . . . . . . . . . . . . . . . . . . . . . . . . . . 509,052
Guinea pigs , . . . . . . . . . . . . . . . . . . . . . . . 521,237
Nonhuman primates . . . . . . . . . . . . . . . . . 59,336
Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,781,875
aTotalS do not include rats or mice, two species that together r@ Present the
majority of animals used.
SOURCE” Office of Technology Assessment.
USDA reports are of limited utility because:
l
l
l
l
the Department counts only six kinds of ani-
mals that together account for an estimated
10 percent of the total animals used (report-
ing of rats, mice, birds, and fish is not re-
quired);
the annual summary report does not tabulate
reports received after December 31st of each
year, resulting in a 10-to 20-percent underes-
timation of laboratory use of regulated species;
ambiguities in the reporting form ask respond-
ents to add figures in a way that can cause
animals to be counted twice; and
terms on the reporting form are undefined
(e.g., the form has room for voluntary infor-
mation about “wild animals, ” but does not
specify what animals might be included).
In the absence of a comprehensive animal census,
the USDA reports will continue to provide the best
data. Imprecise as they are, these reports can iden-
tify major changes in the numbers of dogs, cats,
hamsters, rabbits, guinea pigs, and nonhuman pri-
mates. (It is important to note that any change in
the total number of animals used may reflect not
only the adoption of alternative methods, but
changes in research and testing budgets as well.)
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ETHICAL CONSIDERATIONS
At one end of a broad spectrum of ethical con-
cerns about animal use is the belief that humans
may use animals in any way they wish, without
regard for the animals suffering. At the other ex-
treme is the notion--epitomized by the slogan ‘(ani-
mals are people, too’’ —that each animal has the
right not to be used for any purpose that does not
benefit it. Each view is anchored in a school of phi-
losophical thought, and people considering this is-
sue can choose from a variety of arguable posi-
tions (see ch. 4).
Prominent within the Western philosophic and
religious tradition is the view that humans have
the right to use animals for the benefit of human-
kind. This view is predicated on the assumption
that human beings have special intrinsic value and
thus may use natural animate and inanimate ob-
jects, including animals, for purposes that will en-
hance the quality of human life. Yet this tradition
suggests that because animals are intelligent and
sentient beings, they should be treated in a hu-
mane manner. Current policies and trends within
the scientific community have reinforced this con-
viction by advocating that pain and suffering be
minimized when animals are used in research, test-
ing, or education.
Advocates of what generally is called animal wel-
fare frequently question the objectives of animal
use, as well as the means. They point out that ani-
mals can experience pain, distress, and pleasure.
Drawing on the utilitarian doctrine of providing
the greatest good for the greatest number, some
animal welfare advocates weigh animal interests
against human interests. In this view, it might be
permissible to use animals in research to find a
cure for a fatal human disease, but it would be
unjust to subject animals to pain to develop a prod-
uct with purely cosmetic value.
ALTERNATIVES
In research, scientists often explore un-
charted territory in search of unpredictable
events, a process that inherently involves un-
certainty, missteps, and serendipity. Some bio
logical research requires-and in the foresee
Some animal rights advocates carry this concern
a step further and do not balance human and ani-
mal rights. They generally invoke the principle of
inalienable individual rights. They believe that ani-
mal use is unjustified unless it has the potential
to benefit the particular animal being used. Ani-
mal rights advocates refer to the denial of animal
rights as a form of “speciesism,” a moral breach
analogous to racism or sexism. Animals, by this
reasoning, have a right not to be exploited by
people.
People throughout the spectrum find common
ground in the principle of humane treatment,
but they fail to agree on how this principle should
be applied. Society does not apply the principle
of humane treatment equally to all animals. A cat
may evoke more sympathy than a frog, for exam-
ple, because the cat is a companion species and
possesses apparently greater neurological sophis-
tication than a frog, endowing it with both favored
status and a familiarity that suggests to humans
that they can interpret its behavior. Even within
a species, all individuals are not treated consist-
ently. Pet rabbits in the home and pest rabbits in
the garden, like human friends and strangers, are
treated differently.
The improvements in public health and
safety made possible through the use of ani-
mals in research and testing are well known.
But these questions remain” Do these advances
justify animal use? How much of the improve=
ments were actually dependent on the use of
animals? Debate on these and other questions is
bound to continue, but most parties agree that con-
sideration of replacing, reducing, and refining the
use of animals is desirable.
IN RESEARCH
able future will continue to require-the use
of live animals if the study of the complex in-
teractions of the cells, tissues, and organs that
make up an organism is to continue. Knowledge
thus gained is applied to improving the health and
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well-being of humans and of animals themselves,
and it may lead to the development of methods
that would obviate the use of some animals.
Some nonanimal methods are becoming available
in biomedical and behavioral research (see ch. 6).
As more develop, animal use in research will likely
become less common. It is important to note, how-
ever) that even if animals cannot be replaced
in certain experiments, researchers can at-
tempt to reduce the number used and also to
minimize pain and distress.
Most alternatives to current animal use in re-
search fall into one of four categories:
l
l
l
l
Continued, But Modified, Use of Animals.
This includes alleviation of pain and distress,
substitution of cold-blooded for warm-blooded
vertebrates, coordination among investiga-
tors, and use of experimental designs that pro-
vide reliable information with fewer animals
than were used previously.
Living Systems. These include micro-organ-
isms, invertebrates, and the in vitro culture
of organs, tissues, and cells.
Nonliving Systems. These include epidemio-
logic databases and chemical and physical sys-
tems that mimic biological functions.
Computer Programs. These simulate biologi-
cal functions and interactions.
The many fields of research—ranging from
anatomy to zoology—use animals differently,
and each thus has different prospects for de-
veloping and implementing alternatives. To de-
termine the prevalence of animal and nonanimal
methods in varied disciplines of research, OTA sur-
veyed 6)000 articles published between 1980 and
1983 in 12 biomedical research journals and 3 be-
havioral research journals (see ch. 5). Research dis-
ciplines were distinguished by their characteris-
tic patterns of animal use, as measured by the
percentages of published reports showing animal
use, no animal use, and use of humans. Animal
methods predominated in most of the journals sur-
veyed, including the three behavioral research
journals. The exceptions in the overall survey were
cell biology, which used primarily nonanimal meth-
ods, and cardiology, which used primarily human
subjects.
Using alternative methods in biomedical re-
search holds several advantages from scientific,
economic, and humane perspectives, including:
l
l
l
l
l
l
l
l
l
reduction in the number of animals used;
reduction in animal pain, distress, and exper-
imental insult;
reduction in investigator-induced, artifactual
physiological phenomena;
savings in time, with the benefit of obtaining
results more quickly;
the ability to perform replicative protocols on
a routine basis;
reduction in the cost of research;
greater flexibility to alter conditions and vari -
ables of the experimental protocol;
reduction of error stemming from interindi-
vidual variability; and
the intrinsic potential of in vitro techniques
to study cellular and molecular mechanisms.
Many of these alternative methods are accom-
panied by inherent disadvantages, including:
l
l
l
l
l
l
l
l
l
reduced ability to study organismal growth
processes;
reduced ability to study cells, tissues, and or-
gan systems acting in concert;
reduced ability to study integrated biochem-
ical and metabolic pathways;
reduced ability to study behavior;
reduced ability to study the recovery of
damaged tissue;
reduced ability to stud-y interaction between
the organism and its environment;
reduced ability to study idiosyncratic or
species-specific responses;
reduced ability to distinguish between male-
and female-specific phenomena; and
a handicap to probing the unknown and phe-
nomena not yet identified.
Behavior encompasses all the movements and
sensations by which living things interact with both
the living and nonliving components of their envi-
ronment. Since one of the chief goals of behavioral
research is an understanding of human behavior,
there are obvious advantages to the use of human
research subjects. There are also advantages to
using animals, including the following:
l Laboratory research on animals offers a
greater opportunity to control variables such
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l
l
l
as genetic background, prior experience, and
environmental conditions, all of which affect
behavior and can obscure the influence of the
factor under study.
The short lifespans of certain animals allow
scientists to study behavior as it develops with
age and across generations.
Some animal behavior is less complex than hu-
man behavior, facilitating an understanding
of basic elements and principles of behavior.
The behavior of certain animals holds particu-
lar interest for humans. These animals include
companion species, farm animals, and agri-
cultural pests.
Although behavior is a biological phenomenon,
behavioral research differs substantially from bio-
medical research in that researchers have fewer
opportunities to study mechanisms isolated from
living organisms. There is little prospect, for ex-
ample, of using in vitro cultures to look at aggres-
sion, habitat and food selection, exploration pat-
terns, or body maintenance activities—all topics
studied by behavioral scientists. Yet in each of these
disciplines, reduction or refinements of animal use
may be possible. It is the continued, but modi-
fied, use of animals that holds the most prom-
ise as an alternative in the field of behavioral
research.
ALTERNATIVES IN TESTING
Several million animals are used each year
in testing substances for toxicity and establish-
ing conditions for safe use. The resulting data—
together with information about use and ex-
posure, human epidemiologic data, and other
information—are used in assessing and man-
aging health risks.
As a reduction in the number of animals is a prin-
cipal alternative, proper statistical design and anal-
ysis in testing protocols play an important role (see
ch. 7). The total number of animals needed for sta-
tistically significant conclusions depends on the
incidence of toxic effects without administration
of the test substance, the degree of variation from
animal to animal for the biological effect that is
of interest, and the need to determine a quantita-
tive relationship between the size of the dose and
the magnitude of the response. Statistical analy-
sis plays a similarly important role in research.
One of the oldest and, perhaps for that reason,
least sophisticated tests is the LD50 (“lethal dose”
for “50” percent of the test animals). In this short-
term, or acute, test, a group of animals, usually
rats or mice, are exposed to a single substance,
and the measured end point is death (although
other observations may be made). The LD50 is the
dose at which half the test animals can be expected
to die. A range of doses is administered to some
30 to 100 animals and the LD50 is calculated from
the results. Tests providing the same informa-
tion have recently been developed using as few
as 10 animals, i.e., a 3- to 10-fold reduction,
The LD50 is used to screen substances for their
relative toxicity and mode of toxic action. Scien-
tists and animal welfare advocates have criticized
it in recent years, in part because it cannot be ex-
trapolated reliably to humans, and in part because
the imposition of a highly toxic or lethal dose seems
particularly inhumane.
Another often-criticized acute toxicity assay is
the Draize eye irritancy test. This involves plac-
ing a test substance into one eye of four to six rab-
bits and evaluating its irritating effects. Results are
used to develop precautionary information for sit-
uations in which exposure of the human eye to
the substance is possible. Substances with certain
properties-e.g., a caustic pH-could be assumed
to be eye irritants and not tested. Draize proce-
dures may also be modified to reduce pain, and
in vitro methods to test for irritancy are under
development. A promising new bioassay for tis-
sue irritancy makes use of the chorioallantoic mem-
brane of the chick embryo (see fig. 1-1).
Other common tests include those for long-term
chronic effects, carcinogenicity, reproductive and
developmental toxicity, skin irritancy, and neuro -
toxicity. In addition to such descriptive toxicology
(i.e., tests that focus on the response of the organ-
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Figure l-l.— Chronological Sequence
Embryo Chorioallantoic Membrane
of Chick
Assay
Day O
/
Day 3
Y I
Ii
Day O: Fertile eggs are incubated at 3 7oC. Day 3: The shell is
penetrated in two places: A window is cut at the top, and 1.5 to 2
milliliters of albumin is removed with a needle and discarded. The
chorioallantoic membrane forms on the floor of the air space, on top
of the embryo. The window is taped. Day 14: A test sample is placed
on the embryonic membrane and contained within a plastic ring. Day
17: The chorioallantoic membrane is evaluated for its response to the
test substance, and the embryo is discarded.
SOURCE J. Leighton, J, Nassauer, and R, Tchao, “The Chick Embryo in Toxicol-
ogy: An Alternative to the Rabbit Eye,” Food Chem. Toxicol. 23:293-298.
Copyright 1985, Pergamon Press, Ltd.
ism as a whole), testing may also be done to deter-
mine the mechanisms by which a substance is
metabolized or excreted, and the chemical re-
actions by which toxic effects are produced. Such
studies of mechanistic toxicology aid in the selec-
tion and design of descriptive tests.
The Federal Government plays a major role
in this area, both through laws that directly or
Chick Embryo Chorioallantoic Membrane Assay
Photo credit: Joseph Leighton, Medical College of Pennsylvania
Typical reaction seen when certain concentrations of
household products are placed on the 14-day-old chorio-
allantoic membrane and examined 3 days later on 17-day -
old membranes. The thin white plastic ring has an
internal diameter of 10 millimeters (0.4 inch). The area
of injury occupies the entire plastic ring. Damaged blood
vessels appear within the ring as an elaborate branching
structure of pale, white, dead vessels of various sizes.
The severity of the reaction is gauged by measuring
the diameter of the injury, in this instance
spanning the entire ring
indirectly require testing and through guide-
lines that influence testing procedures. The
greatest amount of testing is done under laws
administered by the Food and Drug Administra-
tion (FDA) requiring that products be safe and ef-
fective and that labeling claims be substantiated.
The Environmental Protection Agency (EPA) re-
quires testing to support pesticide registrations
and in certain other cases. For substances other
than pesticides, EPA relies largely on published
literature and EPA-sponsored testing. Other agen-
cies that use animal testing data include USDA,
the Consumer Product Safety Commission, the Oc-
cupational Safety and Health Administration, the
Department of Transportation, the Federal Trade
Commission, and the Centers for Disease Control.
Although most laws do not explicitly require
animal testing, requirements of safety im-
plicitly require that the best available means
for determining safety be used. Thus, alterna-
tives are not likely to be used widely until they
can be shown to be at least as valid and relia-
ble as the tests being replaced. Meeting these
criteria is probably not overly difficult with some
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alternatives that involve reduction or refinement,
but it maybe harder to replace whole-animal test-
ing totally with in vitro methods.
Reductions in the number of animals used can
be brought about by using no more animals than
necessary to accomplish the purpose of the test,
by combining tests in such a way that fewer ani-
mals are needed, and by retrieving information
that allows any unintentional duplication of earlier
work to be avoided (see chs. 8 and 10). Refinements
include increased use of anesthetics and analgesics
to ameliorate pain and tranquilizers to relieve dis-
tress. Replacements may involve human cell cul-
tures obtained from cadavers or in surgery, animal
cell cultures, invertebrates, or micro-organisms.
For example, the use of an invertebrate in place
of a vertebrate, as in the case of substituting horse-
shoe crabs for rabbits in testing drugs for their
production of fever as a side effect, is increasingly
accepted as a replacement.
The most promising in vitro methods are based
on an understanding of whole-organ or organism
responses that can be related to events at the cel-
lular or subcellular level. Cells manifest a variety
of reactions to toxins, including death, changes
in permeability or metabolic activity, and damage
to genetic material.
ALTERNATIVES IN EDUCATION
Although far fewer animals are used in edu-
cation than in either research or testing, ani-
mal use in the classroom plays an important
role in shaping societal attitudes toward this
subject. As educational goals vary from level to
level, so does the use of animals and therefore the
potential for alternatives (see ch. 9).
In elementary schools, live animals are gener-
ally present solely for observation and to acquaint
students with the care and handling of different
species. Although the guidelines set by many school
boards and science teachers’ associations limit the
use of living vertebrates to procedures that nei-
ther cause pain or distress nor interfere with the
animals’ health, these guidelines are not observed
in all secondary schools. Science fairs are an addi-
tional avenue for students to pursue original re-
search. The Westinghouse Science Fair prohibits
the invasive use of live vertebrates, whereas the
International Science and Engineering Fair has no
such prohibition.
In the college classroom and teaching laboratory,
alternatives are being developed and implemented
because they sometimes offer learning advantages,
are cheaper than animal methods, and satisfy ani-
mal welfare concerns. As a student advances, ani-
mal use at the postsecondary level becomes in-
creasingly tied to research and skill acquisition.
As graduate education merges with laboratory re-
search and training, animal use becomes largely
Finalist, 1985 Westinghouse Science Talent Search
Photo credit: Gary B. Ellis
Louis C. Paul, age 18, Baldwin Senior High School,
Baldwin, NY, with his research project, “Effect of
Temperature on Facet Number in the Bar-Eyed Mutant
of Drosophila melanogaster. ”
a function of the questions under investigation.
In disciplines such as surgical training in the health
professions, some measure of animal use can be
helpful but is not universally viewed as essential.
Many alternative methods in education are
already accepted practice (see ch. 9). Replace-
ments include computer simulations of physiolog-
ical phenomena and pharmacologic reactions, cell
culture studies, human and animal cadavers, and
audiovisual materials. Clinical observation and in-
struction can also replace the use of animals in
some laboratory exercises in medical and veteri-
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nary schools. Reduction techniques include the use
of classroom demonstrations in place of individ-
ual students’ animal surgery and multiple use of
each animal, although subjecting an animal to mul-
tiple recovery procedures may be viewed as in-
humane and counter to refined use. Refinements
include the use of analgesics, euthanasia prior to
recovery from surgery, observation of intact ani-
mals in the classroom or in their natural habitats,
and the substitution of cold-blooded for warm-
blooded vertebrates in laboratory exercises.
Humane education aspires to instill positive
attitudes toward life and respect for living ani-
mals. Instruction in proper care and handling of
various species may be complemented by exposure
to the principles of animal use in research and test-
ing and to alternative methods. This type of edu-
cation promotes attitudes conducive to the devel-
opment and adoption of alternatives.
COMPUTER SIMULATION AND INFORMATION RESOURCES
Recent advances in computer technology
hold some potential for replacing and reduc-
ing the use of animals in research, testing, and
education (see chs. 6, 8) 9, and 10). Inmost cases,
however, research with animals will still be
needed to provide basic data for writing com-
puter software, as well as to prove the validity
and reliability of computer alternatives.
In research, scientists are developing computer
simulations of cells, tissues, fluids, organs, and or-
gan systems, Use of such methods enables less use
of some animals. Limitations on the utility of com-
puter simulations are due to a lack of knowledge
of all the parameters involved in the feedback
mechanisms that constitute a living system, which
means the information on which the computer
must depend is incomplete.
In testing, computers allow toxicologists to de-
velop mathematical models and algorithms that
can predict the biological effects of new substances
based on their chemical structure. If a new chem-
ical has a structure similar to a known poison in
certain key aspects, then the new substance also
may be a poison. Such screening can thus preempt
some animal use.
ment and the effects of extraneous variables, help-
ing students concentrate on a lesson’s main point.
Aside from their direct use in research, testing,
and education, computers also could reduce ani-
mal use by facilitating the flow of information
about the results of research and testing. Scien-
tists routinely attempt to replicate results of ex-
periments to ensure their accuracy and validity
and the generality of the phenomenon. Uninten-
tional duplication, however, can waste money and
animal lives. To avoid such situations, the scien-
tific community has established various modes of
communication. Research and testing results are
published in journals, summarized by abstracting
services, discussed at conferences, and obtained
through computer databases.
One way any existing unintentional duplication
might be ended, and thus animal use reduced, is
to establish or refine existing computer-based regis-
tries of research or testing data. The National Can-
cer Institute and the National Library of Medicine
(NLM) developed a limited registry in the late 1970s,
but it failed: The Laboratory Animal Data Bank
(LADB) had few users, as it did not serve user needs.
Any new registry should contain descriptions
In education, computer programs simulate class- of the methods of data collection and the labora -
room experiments traditionally performed with tory results for both experimental and control
animals. The most advanced systems are video- groups of animals. Inclusion of negative results
disks that combine visual, auditory, and interac - (which are seldom reported in journals) could 40
tive properties, much as a real classroom experi- reduce animal use, Entries should undergo peer
ment would. Computer simulations can eliminate review before inclusion in the registry; that is,
both the detailed work of conducting an experi- studies should be scrutinized to judge the validity
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and reliability of the data. A registry along these
lines would probably be 3 to 15 times as complex
and costly as the unsuccessful LADB.
As alternative methods are developed and im-
plemented, a computerized registry of informa-
tion about these novel techniques might serve to
speed their adoption. In 1985, the NLM incorpo-
rated “animal testing alternatives” as a subject head-
ing in its catalogs and databases, which help users
throughout the world find biomedical books, arti-
cles, and audiovisual materials. In amending the
Animal Welfare Act in 1985, Congress directed the
National Agricultural Library to establish a serv-
ice providing information on improved methods
of animal experimentation, including methods that
could reduce or replace animal use and minimize
pain and distress to animals.
ECONOMIC CONSIDERATIONS
The total dollar cost of the acquisition and main-
tenance of laboratory animals is directly related
to the length of time animals stay in the labora-
tory. With no accurate source of data on various
species’ length of stay, it is impossible to calculate
the actual total dollar cost of animal use. Reduc-
ing the number of animals used can lower acqui-
sition and maintenance costs. Yet, the overall sav-
ings will not be proportionate to the smaller
number of animals used, as the overhead costs of
breeding and laboratory animal facilities must still
be met.
Animal use carries with it both great expense
and major economic and health benefits (see
chs. 5, 7, and 11). Nonetheless, it is difficult to ex-
press many of the costs and benefits monetarily.
What price does society put on the pain and dis-
tress of an animal used in research, for example,
or on the life of a person saved by a new medical
treatment that was made possible by the use of
animals?
In research, there is no way of knowing when
a particular result would have been obtained if
an experiment had not been done. Thus, it is im-
possible to predict many of the costs related to
the use of alternatives in research. Attempts to
do so are likely to result in economic predictions
with little basis in fact.
The primary reason a company conducts ani-
mal tests is to meet its responsibilities to make safe
products under safe conditions. For pharmaceu-
ticals, the need extends to the assurance of product
effectiveness. In testing, animal methods gener-
ally are more labor-intensive and time consuming
than nonanimal methods, due to the need, for ex -
ample, to observe animals for toxic effects over
lifetimes or generations. Testing can cause delays
in marketing new products, including drugs and
pesticides, and thus defer a company’s revenue.
Rapid, inexpensive toxicity tests could yield ma-
jor benefits to public health. There are more than
50,000 chemicals on the market, and 500 to 1)000
new ones are added each year. Not all must be
tested, but toxicologists must expand their knowl-
edge of toxic properties of commercial chemicals
if human health is to be protected to the extent
the public desires. Rapid and economical testing
would facilitate the expansion of that knowledge.
Government regulatory practices can be read
as promoting animal testing although the laws
and practices appear flexible enough to accept
alternatives when such tests become scientifi-
cally acceptable. To date, regulatory practices
have not, in fact, provided a basis for companies
to expect that acceptance of alternative methods
will be an expedient process. In addition to re-
sponding to regulatory requirements, companies
conduct animal tests to protect themselves from
product liability suits. Here, the necessary tests
can exceed government requirements.
Because of the great expense and long time re-
quired for animal research and testing, priority
in research results has considerable value to in-
vestigators and testing results bear considerable
proprietary value for industry. Some data are made
public by statute, and various arrangements can
be made for sharing testing costs. Yet many data
are held in confidence, for example, by the com-
pany that generated them.
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FUNDING FOR THE DEVELOPMENT OF ALTERNATIVES
The Federal Government does not explicitly
fund the development of alternatives to animal
use per se. Because research on and development
of alternatives is founded on a broad base of disci-
plines, it is difficult to ascertain the dimensions
of the effective level of support. No category of
research funds, for example, distributed by the
National Institutes of Health (NIH) or the National
Science Foundation is earmarked for the develop-
ment of alternatives. Yet despite this lack of iden-
tifiable, targeted funding, Federal dollars do sup-
port areas of testing and research that generate
alternatives.
In biomedical and behavioral research, it is not
clear whether targeted funding efforts would pro-
duce alternatives faster than they are already being
devised. The research areas most likely to result
in useful alternatives include computer simu-
lation of living systems; cell, tissue, and organ
culture technology; animal care and health;
and mechanisms of pain and pain perception.
Funding to improve animal facilities can result
in healthier, less stressed animals and can free
research from confounding variables bred by
a less well defined or inferior environment.
Some Federal agencies, notably the National Toxi-
cology Program and FDA, conduct in-house re-
search on alternatives to animal testing, as do some
corporations. Industry has also committed funds
to university researchers seeking alternatives. Rev-
lon has given $1.25 million to the Rockefeller
University to support research on alternatives to
the Draize eye irritancy test. The Cosmetic, Toi-
letry, and Fragrance Association and Bristol Myers
Company have given $2.1 million to the Center for
Alternatives to Animal Testing at The Johns Hop-
kins University, which funds research into test-
ing alternatives, especially in vitro methods.
Alternatives to animal use in education gener-
ally build on techniques developed in research and
funded by research monies. Some Federal support
for research in science education addresses the
development of alternatives, particularly in the
area of computer simulation. In 1985, the enact-
ment of Public Law 99-129 authorized the Secre-
tary of the Department of Health and Human Serv-
ices to make grants to veterinary schools for the
development of curriculum for training in the care
of animals used in research, the treatment of ani-
mals while being used in research, and the devel-
opment of alternatives to the use of animals in re-
search.
Colleges and universities may offer courses re-
lated to humane principles or principles of experi-
mentation. In addition, animal welfare groups are
active sponsors in the areas of humane education
and attitudes about animals.
A number of humane societies and animal welfare
groups fund research on alternatives in research,
testing, or education. Several private foundations,
notably the Geraldine R. Dodge Foundation, des-
ignate support for research in animal welfare as
among their funding missions.
REGULATION OF ANIMAL USE
Several Federal and State laws, regulations, Care and Use of Laboratory Animals by Awardee
guidelines, and institutional and professional so- Institutions (revised in 1985; see app. C).
cieties’ policies affect the use of animals in research
and testing (see chs. 13, 14, and 15; app. B). Chief
among these are the Animal Welfare Act, the Health Federal Regulation
Research Extension Act of 1985 (Public Law 99-
158), rules on good laboratory practices established Prompted by publicity about pet dogs used in
by FDA and EPA, the NIH Guide for the Care and research, Congress passed the Animal Welfare Act
Use of Laboratory Animals (revised in 1985), and to halt the use of stolen pets in experimentation.
the Public Health Service (PHS) Policy on Humane Enacted in 1966 and amended in 1970, 1976, and
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1985, the statute also contains provisions for the
care and treatment of certain animals used in ex-
periments. The act defines “animal” as:
. . . any live or dead dog, cat, monkey (nonhuman
primate animal), guinea pig, hamster, rabbit, or
such other warm-blooded animal, as the Secre-
tary [of the Department of Agriculture] may de-
termine is being used, or is intended for use, for
research, testing, experimentation or exhibition
purposes . . .
USDA, empowered to identify other mammals
and birds to be regulated, has done so only for
marine mammals. In fact, in 1977, USDA promul-
gated a regulation excluding birds, rats, mice, and
horses and other farm animals from coverage by
the Animal Welfare Act. The use of rats and mice,
the most common laboratory animals, is therefore
not regulated.
The act does not cover facilities that use none
of the regulated species. Facilities that use regu-
lated species but that receive no Federal funds and
maintain their own breeding colonies also fall out -
side the act’s coverage.
The Animal Welfare Act regulates housing,
feeding, and other aspects of animal care but bars
USDA from regulating the design or performance
of actual research or testing. A facility need only
report annually that the provisions of the act are
being followed and that professionally acceptable
standards are being followed during actual experi-
mentation. Facilities must also describe procedures
likely to produce animal pain or distress and pro-
vide assurances that alternatives to those proce-
dures were considered.
The Food Security Act of 1985 (Public Law 99-
198) amended the Animal Welfare Act (amend-
ments effective December 1986) to strengthen
standards for laboratory animal care, increase en-
forcement of the Animal Welfare Act, provide for
the dissemination of information to reduce unin-
tended duplication of animal experiments, and
mandate training for personnel who handle ani-
mals. For the first time, the Department of Health
and Human Services is brought into the enforce-
ment of the Animal Welfare Act, as the Secretary
of Agriculture is directed to “consult with the Sec-
retary of Health and Human Services prior to the
issuance of regulations” under the act.
Each research facility covered by the Animal
Welfare Act—including Federal facilities—is re-
quired to appoint an institutional animal commit-
tee that includes at least one doctor of veterinary
medicine and one member not affiliated with the
facility. The committee shall assess animal care,
treatment, and practices in experimental research
and shall inspect all animal study areas at least twice
a year.
Many groups concerned about animal welfare
want the act and its enforcement strengthened,
They criticize USDA’s exclusion of rats and mice,
the level of funding for enforcement, and the choice
of USDA’s Animal and Plant Health Inspection Serv-
ice as the enforcement agency. Inspectors, whose
primary concern is preventing interstate transport
of disease-carrying livestock and plants, spend
about 6 percent of their time enforcing the re-
search provisions of the Animal Welfare Act. Ad-
ditional criticism is leveled at the act’s failure to
offer guidance in research practices during experi-
mentation. A 1982 report by the Humane Society
of the United States indicates that USDA regula-
tions and guidelines failed to provide “information
sufficient to demonstrate that researchers have used
pain-relieving drugs ‘appropriately’ and in accord-
ance with ‘professionally acceptable standards ’.”
The Health Research Extension Act of 1985
mandates the establishment of animal care com-
mittees at all entities that conduct biomedical and
behavioral research with PHS funds. [t requires
all applicants for NIH funding to submit assurances
that they are in compliance with the law’s provi-
sions for the operation of animal care committees
and that all personnel involved with animals have
available to them training in the humane practice
of animal maintenance and experimentation. The
NIH Director is empowered to suspend or revoke
funding if violations of the act are found and not
corrected. In essence, the act puts the force of
Federal law behind certain elements of the PHS
Policy.
The act also directs the NIH Director to estab-
lish a plan for research into methods of biomedi-
cal research and experimentation that do not re-
quire the use of animals, that reduce the number
of animals used, or that produce less pain and dis-
tress in experimental animals than methods cur-
rently in use.
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FDA and EPA both established rules on good lab-
oratory practices to ensure the quality of toxicity
data submitted by industry in compliance with the
agencies’ regulations. Because proper animal care
is essential to good animal tests, these rules in-
directly benefit animals.
The NIH Guide for the Care and Use of Labora-
tory Animals prescribes detailed standards for ani-
mal care, maintenance, and housing. It applies to
all research supported by NIH and is in fact used
by most animal facilities throughout the public and
private sector.
The Department of Defense (DOD) has been crit-
icized for its use of animals in weapons research
and in training for treatment of wounds, In 1973,
Congress prohibited DOD from using dogs for re-
search and development of chemical or biological
weapons. In 1983, publicity caused an uproar
about the use of dogs, pigs, and goats to train mili-
tary surgeons in the treatment of gunshot wounds.
The furor led to congressional action that pro-
hibited DOD from using dogs and cats in such train-
ing during fiscal years 1984 and 1985.
State Regulation
Most State anticruelty statutes forbid both ac-
tive cruelty and neglect (see ch. 14). Many of these
laws incorporate vague terms, and alleged offend-
ers offer a variety of defenses. Enforcement may
be delegated to humane societies, whose members
are not well trained to build criminal cases skill-
fully and are underfunded for the task.
Twenty States and the District of Columbia reg-
ulate the use of animals in research to some ex-
tent. As in the case of the Federal Animal Welfare
Act, most State laws address such matters as
procurement rather than the actual conduct of
experiments.
All 50 States and the District of Columbia allow
some form of pound animal use for research and
training. In some States, laws permitting or requir-
ing research and teaching facilities to purchase
stray dogs and cats from pounds and shelters have
been the targets of repeal efforts. To date, 9 States
prohibit in-State procurement (although not im-
portation from out-of-State) of pound animals for
research and training. Of these, Massachusetts will
in October 1986 prohibit the use of any animal
obtained from a pound.
Institutional and Self-Regulation
Opponents of increased government regulation
of research assert that investigators and their in-
stitutions are best suited to determine what con-
stitutes appropriate care and use of animals. To
regulate animal use at this level, the scientific com-
munity relies on a variety of policies and adminis-
trative structures (see ch. 15).
Taken together, the requirements for institu-
tional animal committees contained in the Ani-
mal Welfare Act (as amended), the Health Re-
search Extension Act of 1985, and the PHS
policy bring the overwhelming majority of
experimental-animal users in the United States
under the oversight of a structured, local re-
view committee.
Institutions that receive funds from PHS for re-
search on warm-blooded laboratory animals must
have committees that oversee the housing and rou-
tine care of animals. NIH reports that about a quar-
ter of these animal care and use committees cur-
rently review research proposals to determine
whether experimental procedures satisfy concerns
about animal welfare. Committees with such re-
sponsibility are not unique to research with ani-
mals: For 15 years, similar groups have been weigh-
ing ethical issues raised by the use of human
research subjects, and these committees have
served as models in the development of animal care
and use committees.
Committees usually have included the institu-
tion’s attending veterinarian, a representative of
the institution’s administration, and several users
of research animals. Some committees also have
nonscientist members, or lay members not affil-
iated with the institution. Nonscientist and lay seats
have been filled by clergy, ethicists, lawyers, hu-
mane society officials, and animal rights advocates.
Animal care and use committees at PHS-sup-
ported facilities are today required to consist
of not less than five members, and must include
at least:
l one Doctor of Veterinary Medicine with
training or experience in laboratory ani-
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mal science or medicine, who has respon-
sibility for activities involving animals at
the institution;
l one practicing scientist experienced in re-
search using animals;
l one member whose primary concerns are
in a nonscientific area; and
l one individual who is not affiliated with
the institution in any way.
The minimum committee structure required by
the PHS policy is thus more rigorous than that man-
dated by Federal law. The Animal Welfare Act and
the Health Research Extension Act do not require,
for example, that the committee veterinarian be
trained in laboratory-animal medicine. The acts
require a minimum committee of three individ-
uals, whereas the PHS policy requires five.
Institutional regulation generally entails compli-
ance with some type of minimum standards for
an animal facility, usually those of the NIH Guide
for the Care and Use of Laboratory Animals. Com-
pliance can be checked in-house or through ac-
creditation by the American Association for Ac-
creditation of Laboratory Animal Care (AAALAC),
a voluntary private organization. As of April 1985,
a total of 483 institutions had received AAALAC
accreditation, which requires site visits that include
interviews, inspection of facilities, and review of
policies and records. Accredited institutions in-
clude hospitals, universities, facilities of the Vet-
erans’ Administration (VA), and pharmaceutical
manufacturers (see app. D).
A number of scientific and professional socie-
ties, universities, and corporations have promul-
gated statements of policy concerning their mem-
bers’ or employees’ standards of conduct in animal
use. These policies generally require:
l
l
l
l
humane care and use of animals,
minimization of the number of animals used,
alleviation of pain and suffering, and
supervision of animal use by qualified personnel.
Twelve of fifteen such policies reviewed by OTA
encourage or require consideration of the use of
alternatives. But only 3 of the 15 include enforce-
ment provisions or mention sanctions against vio-
lators.
Regulation Within Federal Agencies
Six Federal departments and four independent
agencies use laboratory animals intramurally and
account for approximately one-tenth of the animal
use in the United States. Beginning in December
1986, Federal facilities in those departments and
agencies using animals will be required by the 1985
amendments to the Animal Welfare Act to install
institutional animal committees. Each committee
shall report to the head of the Federal agency con-
ducting the experimentation.
Most Federal agencies that use animals in re-
search or testing have formal policies and admin-
istrative structures to ensure that the animals re-
ceive humane treatment. At the request of the
Executive Office of Science and Technology Pol-
icy, the Interagency Research Animal Committee
developed a 450-word policy statement, Principles
for the Utilization and Care of Vertebrate Animals
Used in Testing, Research, and Education, to be
followed by all Federal agencies supporting ani-
mal use (see ch. 13).
No one Federal agency policy on animal care
and use has all the characteristics needed toad-
dress all issues adequately. Combining certain
aspects from each would produce an effective
uniform Federal policy. Almost all policies today
require adherence to the NIH Guide and the Ani-
mal Welfare Act. Most agencies also require an
attending veterinarian and an animal care and use
committee at each facility. The committees gen-
erally review research protocols to ensure that
animals are not used in excessive numbers, that
adequate provisions are made for animal care and
pain relief, and that alternatives are used when-
ever possible. Most committees and attending
veterinarians have little enforcement power, and
those who have such power rarely use it.
Some agencies’ policies have features that would
be considered advantageous by animal welfare ad-
vocates. NIH and the National Aeronautics and
Space Administration have laypeople on their ani-
mal care and use committees. The VA requires all
its animal facilities to acquire AAALAC accredita-
tion. The Department of Defense has a separate
policy and committee for nonhuman primates. The
Air Force has solicited evaluation of its policies by
a panel of independent experts and plans to im-
plement the group’s recommendations.
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International Regulation
OTA surveyed laws controlling use of experi-
mental animals in 10 foreign nations, including
countries of Western Europe (see table 1-2) and
Australia and Canada. Comparative analysis of reg-
ulation of animal use abroad can yield lessons from
foreign regulatory experiences, models for regu-
lation, and models for funding of alternatives.
A review of foreign laws, especially those revised
or instituted in the last decade, indicates three
trends of note in government control of animal
research (see ch. 16):
l Attention is shifting away from intentionally
or negligently “cruel” treatment and toward
the avoidance of pain and suffering. This
change in perspective raises the difficulty of
defining prohibited conduct, and disagree-
ment arises over the definition of animal pain
and suffering. Newer statutes rely on author-
ized reviewers who check experimental plans
in advance and apply their own sensibilities
to satisfy themselves—and thereby the pub-
lic interest–that pain and suffering are not
being inflicted without justification.
l There is increasing emphasis on finding alter-
natives. The old method of justifying animal
research by reference to its potential for pro-
viding new knowledge is being enhanced by
the greater burden of demonstrating that no
less painful method is available to achieve the
same result. Increasingly, animals are being
viewed as having an interest in not being hurt.
Countries with comprehensive reporting sys-
terns (e.g., the United Kingdom) have found
that fewer animals are now being used in ex-
periments. The data are insufficient to deter-
mine the reasons for these reductions or what
the effect may be on the production of new
information.
These trends indicate a growing interest in
Western Europe in replacing, reducing, or re-
fining the use of animals through legislation.
It is not clear whether the tighter control
found in some West European countries can be
applied in the United States. Most West Euro-
pean nations are more homogeneous than is this
country of federated States. In geographical dis-
persal and size, the research enterprises in those
countries are small—there are fewer than 300 in-
vestigators using animals in Denmark, for exam-
ple. The British system functions well, despite its
complexity, because it has been refined over the
course of a century. New scientists are weaned
on it, and the inspector is a familiar sight in the
laboratory. The British system’s enforcement is
based more on advice and negotiation than on con-
frontation.
P O L I C Y  I S S U E S  A N D  O P T I O N S  F O R  C O N G R E S S I O N A L  A C T I O N
Seven policy issues related to alternatives to ani-
mal use in research, testing, and education were
identified during the course of this assessment.
The first concerns the implementation of alterna-
tives and examines options that might encourage
the research, testing, and education communities
to adopt currently available methods of replacing,
reducing, and refining their use of animals. The
second issue explores options for promoting re-
search and development leading to more and bet-
ter alternatives. Both recognize that scientifically
valid alternative methods can make positive con-
tributions to research, testing, and education and
might therefore be promoted.
The five additional policy issues examined are:
disseminating information about animal experi-
mentation, restricting animal use, counting ani-
mal use, establishing a Federal animal use policy,
and changing the implementation of or amending
the Animal Welfare Act. Although these policy is-
sues do not explicitly address either the implemen-
tation or development of alternative methods, they
are inextricably linked to the replacement, reduc-
tion, and refinement of animal use.
Associated with each policy issue are several op-
tions for congressional action, ranging in each case
from taking no specific steps to making major
Table 1=2.—National Laws for the Protection of Animals in Selected European Countries
Federal Republic
Provisions Denmark of Germany Netherlands Norway Sweden Switzerland United Kingdom
Species protected . . . Vertebrates All animals Vertebrates, native Vertebrates Vertebrates Vertebrates
Distinctions among species . . . Should use lowest Better to use
rank; dogs, cats, invertebrates or cold-
monkeys purpose-bred blooded vertebrates
Alternatives must be used
if available . . . . . . . . .Yes
Anesthetics, analgesics, or
approval required for
painful experiments . . . . . . Except for minor or
transient pain
Educational uses. . . . Higher education,
technique
Ban on animal use for more
than one painful experiment .All dogs, cats,
monkeys; most
experiments
License/permit for dealers,
facilities, and investigators ., .All facilities, head
investigators
Review of experiments . . . . . . . Most experiments need
approval by national
Board
Administration. . . . . . Centralized,
government/
nongovernment board
iicensee is
responsible
Animal welfare representation ...3 nominees to
national Board
Reporting . . . . . . . .Annual report
Yes
if pain, suffering, or
injury likely
High school and above
No multiple surgeries
on vertebrates
Dealers, facilities,
investigators
Not needed; proposed
that facility’s animal
welfare officer review
States enforce and
administer (proposed
that facilities have
animal welfare
officer)
Being considered
in-house
recordkeeping
species
Vertebrates better
protected
Vertebrates
If injury or pain likely
University and
vocational
Rarely reused because
of pain requirements
Dealers (dogs and cats),
facilities
Head of institute
reviews
Central enforcement
and reporting;
administration by
institute
Not required, but
facility reports are
public
Annual report
Vertebrates,
crustaceans
Monkeys, dogs, cats
better protected
Yes
if pain is possible
(unless Board
approves)
Professional training
Only one experiment
allowed per animal
Investigators or facilities
licensed
investigator or facility
(licensee) review
Central coordination,
some functions
delegated to licensees
Not required
Annual report
Should use lowest Should use lowest rank
rank; all purpose-bred
Alternatives promoted
Surgery on mammals
unless committee
approves
Allowed, but restricted
Rarely reused because
of pain requirements
Breeders, facilities
Notification/application;
tiered system
Central coordination
with oversight by
facility head and
committee
On all committees;
being reconsidered
Government
recordkeeping
Yes
Slight pain or anxiety;
if too painful, must
forgo
Not allowed
Only reused if pain
was slight
Breeders, facilities
2 State committees
review
Central coordination,
administered by
States
Members of national
commission
in-house
recordkeeping
. -
SOURCE: Office of Technology Assessment
Primates, dogs, cats,
equidae preferred; no
stray dogs
Alternatives encouraged
Statute does not specify,
but certificate may
require
Some demonstration; not
for practicing
if anesthetized or
because of pain
requirements
Facilities registered,
investigators licensed
Home Office and
Advisory Committee
Centralized, shared by
Head Office, Advisory
Committee, Royal
Society
Advisory Committee
Annual reports
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changes. The order in which the options are pre-
sented should not imply their priority. Further-
more, the options are not, for the most part, mutu-
ally exclusive: Adopting one does not necessarily
disqualify others in the same category or within
any other category. A careful combination of op-
tions might produce the most desirable effects.
In some cases, an option may suggest alterations
in more than one aspect of alternatives to using
animals, It is important to keep in mind that
changes in one area have repercussions in others.
Some of the options involve direct legislative ac-
tion. Others are oriented to the actions of the ex-
ecutive branch but involve congressional oversight
or encouragement. Congress can promote alterna-
tives in at least three ways, It can provide incen-
tives through tax policies, grants, or educational
assistance. It can mandate the adoption or devel-
opment of alternatives by means of appropriations
or legislation. And it can provide encouragement
via oversight or resolutions. Table 1-3 summarizes
the seven policy issues and associated options de-
rived from this assessment.
ISSUE: Should steps be taken to encourage the
use of available alternatives in research,
testing, or education?
Alternatives to animals become accepted prac-
tice in the research, testing, and educational com-
munities as methods are developed through re-
search, validated by independent measurements,
gradually accepted by the scientific community,
and implemented as they come to be relied on or
required. Several alternatives to the use of animals
are in the validation or implementation phase to-
day; for the most part, these methods are based
on reductions and refinements. Approaches that
replace the use of animals have generally not been
completely validated and accepted. Instead, these
represent possibilities for the longer term. (An ex-
ception may be educational simulations of living
systems where an adequate range of physiologi-
cal variables is known. ) The processes of valida-
tion and gradual implementation are certain to con-
tinue, and they could be accelerated.
Analysis of alternatives in research (see ch. 6),
testing (see ch. 8), and education (see ch. 9) dem-
onstrates differing availability both among and
within these three areas. In research, for exam-
ple, animal methods can be complemented by com-
puter models, and experiments may be designed
to provide the desired information with fewer ani-
mals. Dissemination of information within the re-
search community may reduce any instances of
unintentional duplication, thereby lowering the
number of animals used. In testing, the LD50 pro-
tocol has in many cases been modified to use fewer
animals. And eye irritancy can be assumed—with-
out testing—for substances exhibiting strong skin
irritation or having a strongly acid or alkaline pH.
In educational settings, exercises not involving ani-
mals may be substituted to teach the scientific
method or to introduce biological concepts. In
other instances, animals are destroyed humanely
following a single surgery in a teaching session,
rather than experiencing multiple recovery pro-
cedures. Four options address the implementation
of alternatives such as these.
Option I: Take no action.
As alternatives are developed and validated, they
are likely to continue being implemented at an un-
even pace, influenced by factors largely external
to Congress. Science and technologies will continue
to evolve, and as nonanimal methods emerge from
research and validation, they may or may not be
accepted and implemented by the scientific com-
munity.
This course does not necessarily pass judgment
on the value of adopting alternatives per se. Nor
does it mean that alternatives will not be imple-
mented. It would merely indicate that Congress
has decided against encouraging or forcing the im-
plementation of alternatives beyond its direction
in 1985 to NIH to establish a plan to develop and
assess alternatives in biomedical research (Public
Law 99-158). This option might illustrate the be-
lief that external political, ethical, economic, and
scientific factors are sufficient to govern the im-
plementation of alternatives.
Further congressional action toward implemen-
tation might be judged unnecessary because vari-
ous other sources are already acting to implement
alternatives. For example, EPA has defined circum-
stances where the LD50 test can be replaced by
a limit test (see ch. 8), and FDA has stated that it
does not require data derived from the LD50 test;
industry is watching to gauge the practical effects
. .
Table 1-3.-Policy Issues Related to Alternatives to Animal Use and Options for Congressional Action
Policy issue
Using existing Developing new Disseminating Restricting Counting animals Establishing a Federal Changing Animal
alternatives alternatives information animal use used animal-use policy Welfare Act
Options for congressional action
Take no action Take no action
Charge a Federal entity charge a Federal
with coordinating the entity with
implementation of coordinating the
alternatives development of
Encourage alternative alternatives
methods in Federal Fund development of
testing requirements alternatives
Ban procedures for which
alternatives are
available
aAnimal and plant Health Inspection ServiCe.
SOURCE: Office of Technology Assessment.
Take no action
Mandate easy access
to federally funded
testing and research
data
Promote greater use
of testing data
submitted to
Federal agencies
Require literature
searches
Create new data-
bases
Translate foreign
literature into
English
Take no action
Restrict use of certain
kinds of animals
Restrict use of certain
protocols
Restrict acquisition of
animals from certain
sources
License animal users
for certain protocols
and/or kinds of
animals
Prohibit animal use
Take no action
Eliminate APHISa
census
Correct inadequacies
in present APHISa
reporting system
Expand APHISa
census to include
rats and mice
Establish independent
census
Take no action
Establish intramural
Federal policy of
minimum standards
Take no action
Eliminate funding for
enforcement
Increase funding for
enforcement
Amend to expand
coverage to include
experimentation
Amend to realign
enforcement authority
Amend to preempt
State and local laws
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of these statements. Also, members of the soap
and detergent industry have implemented modifi-
cations of the LD50 test. Noteworthy, too, is the
important role of institutional animal care and use
committees in all phases of animal experimenta-
tion. In education, medical schools are conduct-
ing some laboratory exercises with computer simu-
lations or video demonstrations in lieu of live
animals. Medical students in some instances by-
pass experiments and training involving animals,
proceeding from cadavers to people. Activities such
as these are likely to continue without new con-
gressional action.
Additional congressional steps may be deemed
inappropriate because implementation of alterna-
tives may be judged unimportant. Some people do
not object to animal use, for example, in toxico-
logical testing. They believe the status quo brings
the comforts and health benefits of new products
and technology and protects them from hazards.
Option 2: Require a new or existing Federal en-
tity to coordinate the validation and im-
plementation of alternatives.
This action is based on the assumption that vali-
dation and implementation of alternatives would
occur more rapidly with enhanced Federal coordi-
nation. Along this line, an information service at
the National Agricultural Library on improved
methods of animal experimentation was mandated
by Congress in 1985 (Public Law 99-198). A clear-
inghouse for resources required to implement
alternatives would further hasten their adoption.
This entity might, for example, be a central source
for computer software or cell culture material.
Existing Federal entities that might be assigned
such responsibilities include some component of
the National Institutes of Health (e.g., the Division
of Research Resources), the National Toxicology
Program, or the National Center for Toxicological
Research. Coordinating activities could include
symposia, workshops, newsletters, scholarships,
grants, and the issuance of model protocols or
guidelines. The coordinating body could monitor
both public and private initiatives. In 1985, Con-
gress took a step toward coordination of the use
of alternatives in biomedical research conducted
by or through NIH. It directed NIH to disseminate
information about alternatives found to be valid
and reliable to those involved in animal experimen-
tation (Public Law 99-158).
Educational programs play a central role in this
type of effort. Training scientists in replacement
methods and raising awareness about reductions
and refinements is likely to increase the implemen-
tation of alternatives. This type of education is
closely allied with the teaching of principles of hu-
mane care and use (see ch. 9).
Animal care and use committees at individual
institutions might function as a relay between Fed-
eral coordination efforts and individual investiga-
tors (see ch. 15). The institutional animal care and
use committee might be required to suggest alter-
native methods as part of its review of animal care
and use. Linked in this way to a Federal implemen-
tation effort, these committees would both feed
into and draw on the resources of the Federal
entity.
A different type of coordination, particularly in
research, would be the attachment of provisions
to Federal grants regarding the implementation
of alternatives. Research grant applications using
alternative methods could be awarded higher pri-
ority scores in the grant evaluation process or be
otherwise favored. This strategy would require
sufficient flexibility to ensure that valuable, state-
of-the-art scientific proposals that may not involve
alternatives are not handicapped. Funding mech-
anisms could also be used to encourage coordina-
tion between laboratories. The responsibility for
overseeing the implementation of alternatives via
funding mechanisms could be borne by each source
of Federal funding (see ch. 12).
Option 3: Encourage regulatory agencies to re-
view existing testing guidelines and re-
quirements and to substitute alterna-
tives whenever scientifically feasible.
Through oversight or legislation, Congress could
encourage or require Federal agencies to evalu-
ate existing alternatives in testing, to participate
in their validation, to adopt them where appro-
priate, and to report to Congress on their prog-
ress in implementing alternatives, as the NIH has
been asked to do (Public Law 99-158). Such agency
review would have to be a periodic or continuing
effort, given rapid advances in the state of the art.
Some review of testing guidelines now occurs in
keeping requirements up to date, although the pur-
pose of that review is to improve the science rather
than to protect animals per se. Formal agency re-
view of international testing guidelines, such as
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those of the Organization for Economic Coopera-
tion and Development, could also be encouraged
(see ch. 7 and app. E). The costs of agency review
should be moderate, entailing input from agency
experts, comment from outside experts, and pub-
lication. If Federal laboratories were involved in
the validation of alternative testing methods, ad-
ditional costs would be incurred. Such a policy
could encourage industry to develop alternatives
because the barriers to acceptance would be
reduced.
Option 4: Ban procedures for which alternatives
are available, or give a Federal agency
authority to ban procedures as valid
alternatives become available.
This option recognizes that prohibitions can be
used to force technological change. Prohibiting
procedures for which scientifically acceptable
alternatives are already available would acceler-
ate the implementation of such alternatives. Ex-
isting reductions and refinements in animal use
include the greater use of analgesics in research,
the use of fewer animals in the LD50 and Draize
eye irritancy tests, and reliance on videotaped dem-
onstrations and computer simulations in edu-
cation.
A ban could not only force implementation of
existing alternatives, but, over time, help focus the
development of new techniques (as discussed in
the next section) and allow considerable flexibil-
ity in achieving the desired end. A disadvantage
of banning a specified procedure is that the replace-
ment, or the process of developing one, may be
even more politically unacceptable (e.g., the in vitro
culture of human fetal nerve cells). A prohibition
also takes no account of the question of judging
the scientific acceptability of an alternative.
In pursuing this option or the preceding one,
it is important to appreciate that the swiftest adop-
tion of alternatives may come about if regulatory
agencies avoid mandating specific testing require-
ments. Requiring specified tests might actually
serve as a strong inhibitor to the implementation
(and development) of alternative methods. Greater
flexibility is achieved when testing requirements
are defined in a manner that allows judgment and
encourages use of alternate methods, Viewed from
this perspective, the adoption of alternatives might
be best stimulated by regulatory requirement for
evaluation of a potential toxic response, such as
mutagenicity, rather than requirement of a speci-
fied test for mutagenicity.
ISSUE: Should the more rapid development of
new alternatives in research, testing or
education be stimulated?
Alternatives are currently being developed in
many phases of animal use. It is worth noting that
development of many of these techniques, espe-
cially their validation, cannot occur without ani-
mals being used (unless humans are used instead).
In addition, many replacement systems will never
be fully divorced from animal research and test-
ing, and therefore they will serve to reduce but
not eliminate animal use.
Certain research and testing methods now be-
ing developed, such as in vitro culture of animal
components, bear great promise as alternatives.
Similarly, the growing capabilities of computer
modeling, for example biological simulation (see
ch. 6) and pharmacology (see ch. 8), may reduce
the number of animals needed. Development of
an enhanced ability to detect and relieve pain can
help refine animal use.
Research that spawns alternatives usually takes
place across traditional disciplinary lines—princi -
pally within the life sciences–but also in applied
mathematics, statistics, engineering, physics, and
chemistry. The principal support for such research
comes from Federal funds, predominantly NIH and
the National Science Foundation. In general, there
is little incentive for private investment in meth-
odologies at a stage so remote from commerciali-
zation and, in the case of testing, so governed by
regulation. Some private concerns, however, spe-
cifically fund research into alternative testing
methods (see ch. 12).
Clearly, research and development require
money. Determining the optimum level of fund-
ing, however, and the best way to distribute funds
remains elusive, Nonetheless, the promotion of
such research is likely to increase the number of
alternatives available for implementation; in turn,
increased implementation is likely to spur research
in this area.
Option 1: Take no action.
If Congress takes no specific steps beyond its
recent charge to NIH to establish a plan for the
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development of alternatives in biomedical re-
search, the development of alternatives will con-
tinue to be a function of ethical, political, economic,
and scientific factors.
That alternatives are being developed in the ab-
sence of direct legislation is best illustrated by re-
search centers at Rockefeller University and The
Johns Hopkins University funded by corporate and
private donations (see ch. 12). In addition, corpo-
rations are undertaking work in-house or sponsor-
ing it in universities, often in response to scien-
tific, economic, animal welfare, and public relations
considerations.
An uncertain pace of development marks the
chief disadvantage of this option. Although alter-
natives may emerge, changing research priorities
in both the public and private sectors will affect
the rate of development. From another perspec-
tive, this is an advantage: It permits researchers
to respond to changing needs and priorities with
minimal Federal interference.
Option 2: Require a new or existing Federal en-
tity to coordinate the development of
alternatives.
Implementation of this option would have great
symbolic value within the scientific and animal wel-
fare communities and could lead to more rapid
development of alternatives. A central clearing-
house for the development of alternatives could
compile and maintain records of all federally
funded research and development (R&D) on alter-
natives. Information on R&Din the private sector
would be a valuable component of the coordina-
tion effort, though it may prove difficult to obtain.
Coordination could involve identifying research
areas likely to lead to new alternatives and review-
ing Federal support for those areas across agency
lines. The latter responsibility might preclude hous-
ing this entity within an existing Federal agency
involved in funding R&D on alternatives to avoid
either a real or apparent conflict of interest.
As in the implementation of alternatives (see pre-
ceding issue), education plays a central role in the
development of such approaches. Coordination of
efforts aimed at informing investigators and stu-
dents about animal research (see ch. 9) could be
among the responsibilities of this Federal entity.
Option 3: Provide intramural and extramural Fed-
eral funding for the development of
alternatives.
An effective mechanism for encouraging R&D
on alternatives is funding. Small pilot programs
might assess whether or not targeted development
is effective.
Development of alternatives in testing within the
Federal Government is a natural offshoot of and
closely allied with toxicological research. The agen-
cies most likely to produce alternatives in response
to new Federal funding are the National Cancer
Institute and NIH. Because testing is so closely tied
to regulation, funding could also be directed to
FDA, EPA, the Consumer Product Safety Commis-
sion, and the National Institute for Occupational
Safety and Health. Regulatory agencies could be
required to develop alternatives to specified tests
or to spend funds generally toward their devel-
opment.
To stimulate extramural R&D, granting agencies
reviewing applications could be required to assign
priority to those that contain research with prom-
ise for the development of new alternatives. Post-
doctoral training programs could be established,
along the lines of NIH’s National Research Service
Awards, to ensure a steady supply of young re-
searchers schooled in traditional disciplines, rang-
ing from molecular biology to animal behavior,
with applications in the development of alter-
natives.
Financial incentives to private groups develop-
ing alternatives could take the form of tax incen-
tives—perhaps tax credits in addition to those al-
ready in place for R&D. Such groups could also
be eligible for a new program (analogous to the
Small Business Innovation Research program) that
would target the development of alternatives (see
ch. 12).
ISSUE: Should improvements be made in infor-
mation resources to reduce any unin-
tentionally duplicative use of animals
in research and testing?
Science is able to advance rapidly because infor-
mation about what has been done is disseminated
(see ch. 10). If attempts to find prior work are in-
adequate or prior work is not sufficiently accessi -
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ble, unintentional duplication may occur. Such
unnecessary repetition of experiments must be
distinguished from replication of experiments to
demonstrate the reproducibility of a method or
to confirm the validity of results.
The amount of unintentional, largely duplica-
tive research and testing that occurs today is un-
known. Investigations into the amount and cir-
cumstances of unintentional duplication would be
valuable in determining whether it results in sub-
stantial waste of animals or funds. Moreover,
consultations with potential users of any new in-
formation resources would be essential in imple-
menting certain options addressing this issue.
Although the storage and retrieval of data are
costly, there are clear benefits to making infor-
mation that reduces unintentional duplication
readily available. Among these benefits are sav-
ings in the expense and time associated with ani-
mal research and testing. Other benefits are sav-
ings in animal lives and the additional work that
might be done if resources are not wasted (see ch.
11).
Option 1: Take no action.
By making the National Agricultural Library the
focus of a service to provide information on im-
proved methods of animal experimentation (Pub-
lic Law 99-198), Congress in 1985 indicated its
intention to facilitate the dissemination of infor-
mation about alternatives and to prevent unin-
tended duplication of animal experimentation.
Even if no further improvements in information
resources are made specifically for the sake of
avoiding unintentionally duplicative animal use,
general improvements in information resources
will proceed as a matter of course. Many resources
already exist. The National Library of Medicine,
the National Toxicology Program, and other Fed-
eral entities maintain large databases that contain
information or citations to published sources. Ma-
jor commercial databases exist as well. National
libraries and information centers provide the full
text of articles and reports. The National Techni-
cal Information Service (NTIS) catalogs, stores, and
distributes on request many unpublished Federal
reports. Improvements in these resources can be
expected, either to fill needs for which the bene-
fits justify the costs or to achieve other informa-
tion policy goals, such as openness in government
or advancement of science.
Option 2: Require that results of all federally
funded research and testing be conven-
iently accessible.
By means of oversight authority or legislation,
all Federal entities could be required to provide
convenient access to the results of all federally
funded animal research and testing. Implementa-
tion could be largely through mechanisms already
available—publishing in the scientific literature;
circulating published reports or depositing them
with NTIS, NLM, the National Agricultural Library,
or other entity; or entering the results in a pub-
licly available database. New databases might also
be established. Requirements that results be made
conveniently accessible could apply to Federal em-
ployees, contractors (through contract terms), and
grantees (as a condition of awards). Contractors
and grantees, however, may not be enthusiastic
about assuming the burden of publicizing their
results and responding to requests for information.
This option recognizes that much research and
some testing using animals is federally funded, that
dissemination of research and testing results could
be more comprehensive, and that better dissemi-
nation might reduce any unintentional duplication.
Because publication and information dissemina-
tion are normally much less costly than obtaining
original data, the benefits of enhanced communi-
cation extend beyond saving animal lives.
It is important to note that most federally funded
work, indeed the vast majority of significant work,
is already accessible, although access comes with
different levels of convenience. And the results
of federally funded work (except some grants) are
available under the Freedom of Information Act
(FOIA). Requiring that all results be conveniently
accessible may burden databases and libraries with
inconclusive results or other information that will
not be used.
Option 3: Promote greater use of animal testing
data submitted by industry to Federal
agencies, except where confidentiality
protections apply.
Industry must submit data to regulatory agen-
cies before it can market certain products or some-
times in response to reporting requirements. Stat-
utory and regulatory provisions already exist that
make some of this information publicly available,
thus theoretically avoiding unintentional duplica-
tion. In addition, information that is voluntarily
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submitted and not claimed as confidential is avail-
able under FOIA.
Using oversight authority or legislation, greater
use of nonconfidential information could be pro-
moted, for example, by requiring that it be put
into databases, compiled in reports, or summarized
in newsletters. Industry could bear the cost of in-
formation dissemination, and any data submission
to the Federal Government would have to be ac-
companied by evidence of intent to publish non-
confidential testing data. Industry may be unen-
thusiastic about such a procedure, because in some
cases nonconfidential data provide direct clues to
confidential data. Nevertheless, greater availabil-
ity of nonconfidential data could aid in avoiding
unintentionally duplicative testing.
The extent to which researchers who need such
data already know how to obtain them is not
known. The needs of those engaged in animal test-
ing must be carefully gauged prior to considera-
tion of this option. A further consideration is the
willingness of those who generate the data to en-
courage others to benefit from their investment.
Option 4: Require comprehensive literature searches
to ensure that federally funded research or
testing involving animals is not duplicative.
A literature review is normally conducted by an
investigator in the course of preparing a grant ap-
plication, contract proposal, or data submission.
In addition, the reviewers of such proposals are
expected to be familiar with work that has already
been done. Implementation of this option would
require proof of a literature search through, for
example, a companion document in any proposal
to conduct federally funded research or testing.
The funding entity would presumably have to
judge the appropriateness of the literature search.
Both the investigator’s act of searching the litera-
ture and the funding agency’s certification of the
search may reduce any unintentional duplication.
To make a mandatory literature search palatable
to investigators, free access to some or all of the
necessary information resources may have to be
provided.
An alternative strategy is to require a literature
search by the funding agency, or other entity, prior
to the release of any funds. The disadvantages of
requiring a comprehensive literature search be-
fore work could be funded include the delay that
an additional step would cause, the cost of the
search itself to the Federal Government, and pos-
sibly part of the cost of developing new informa-
tion resources.
Option S: Create new databases designed to re-
duce unintentional duplication of ani-
mal use in research and testing.
New computerized databases might play an
important role in reducing any unintentionally
duplicative animal use. There are at least three
types that could contribute to this end:
l
l
l
Unpublished Results, Including Negative
Results. Such a database would disseminate
results that are otherwise distributed narrow-
ly or not at all. The major problem with un-
published information is that its quality is dif-
ficult to evaluate because it is rarely subjected
to peer review. Another problem is that the
most useful unpublished data are owned by
industry and would not be disclosed because
of their proprietary value (although provision
could be made for voluntary submissions). A
category of special interest, particularly from
the standpoint of duplicative testing, is nega-
tive results (e.g., showing the absence of toxic
effects). Few journals are willing to publish
negative testing results. Dissemination of neg-
ative results could spare any unintentional
duplication, direct investigators away from
fruitless paths, or suggest improvements in
methodologies.
Data From Untreated, or Control, Animals.
Data pertaining to the health or behavior of
animals not given a test substance could be
used in choosing the best species for experi-
mentation (e.g., a species most likely to yield
unambiguous results). This information might
obviate the need to use more than one species
or might allow smaller control groups in some
experiments (see ch. 7). Compiling the data-
base could be both difficult and costly because
the necessary data are often not published (see
ch. 10).
Experimental Protocols and Results. This
database could be as narrow as abbreviated
listings of methods and results, perhaps ar-
ranged by species, or as comprehensive as the
on-line full text of all published scientific liter-
ature. (The full text of a scientific report in-
cludes not only protocol and results, but also
discussion and interpretation of the results,
tables, figures, and bibliography. At present,
38-750 0 - 86 - 2
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the full text (minus figures and images) of a
few dozen scientific journals is available on-
line.) The greatest obstacle to the successful
creation of a database of this size is catering
to the diverse needs of animal users. In its
fullest incarnation, this would cost hundreds
of millions of dollars to start and maintain.
Most important, the extent to which any of these
databases would be used is unknown. Within the
Federal Government, the NLM has the greatest ex-
pertise in establishing and operating large data-
bases, and implementation of any form of this op-
tion is likely to build on the experience and existing
resources of that library.
Option 6: Facilitate the use of foreign data by pro-
viding translations of foreign journals.
An often-overlooked source of published data
is foreign-language literature, although most im-
portant scientific work is routinely published in
or translated into English. The advantages of pro-
viding translations of additional work are thought
by many experts to be quite limited and economi-
cally unjustifiable. English translation costs for the
four principal languages of science (French, Ger-
man, Russian, and Japanese) range from $40 to
$88 per thousand words. An estimated $4 billion
to $5 billion would be required, for example, to
translate the current foreign-language holdings of
the NLM into English, with an ongoing yearly trans-
lation cost of $150 million (see ch. 10). Copyright
protections might involve costly inconvenience as
well. The impact of this option is uncertain, as Eng-
lish abstracts are today available for most foreign
journals, and translations can be obtained on an
ad hoc basis by those interested in a particular
report.
ISSUE: Should animal use in research, testing,
or education be restricted?
The use of animals for research, testing, and
educational purposes is not closely restricted in
the United States. Only four types of constraints
can be identified. The Animal Welfare Act requires
humane handling, care, and treatment of nonhu-
man primates, dogs, cats, rabbits, guinea pigs, and
hamsters. However, any regulation of these ani-
mals within an actual experimental protocol is spe-
cifically excepted by the Animal Welfare Act (see
ch. 13). Second, at the State and local levels, cru-
elty to animals is generally proscribed, although
such statutes are generally not applied to animal
use during experimentation (see ch. 14). Third, self-
regulation takes place at individual institutions and
facilities through the implementation of Federal
policies. These call for assessment of animal care,
treatment, and practices in experimentation by
institutional animal care and use committees.
Fourth, the Department of Defense was prohibited
in fiscal years 1984 and 1985 from expending any
funds for training surgical personnel by treating
in dogs and cats wounds that had been produced
by weapons (see app. B).
The few existing restrictions on animal use illus-
trate two phenomena. First, they show that pri-
mates and pets have a privileged position in pub-
lic policy. The Animal Welfare Act names only six
kinds of animals, omitting the rats and mice that
together constitute approximately 75 percent of
the animals used in research, testing, and educa-
tion. It requires exercise for dogs and a physical
environment adequate to promote the psychologi-
cal well-being of primates. In the case of the DOD
appropriation, dogs and cats were named, while
goats and pigs (also used in surgical wound train-
ing) were not.
Second, the restrictions demarcate the long-
standing frontier of legislative province over ani-
mal use—the laboratory door. The actual conduct
of experiments stands largely outside of any spe-
cific mandatory provisions of law. (In contrast, Brit-
ish investigators are licensed to carry out speci-
fied procedures using specified animals and face
inspection visits to the laboratory bench by gov-
ernment officials; see ch. 16.) Solely in the case
of the prohibition of DOD expenditures is one use
of two particular species addressed.
Considering the issue of restriction of animal use
may require the resolution of four difficult
questions:
l Are there some kinds of animals on which
experimentation is inherently inappropriate?
l Are some methods or procedures beyond
the realm of societal acceptability?
l Should some sources of animals be deemed
off limits for animal use in research, testing,
or education?
l Should licensed investigators alone be per-
mitted to engage in animal experimentation?
The resolution of these questions turns on sci-
ence, law, politics, and, to a large degree, ethics.
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Six options for congressional action have been iden-
tified.
Option 1: Take no action.
In the absence of new restrictions, animal use
in research, testing, and education will continue
to be governed loosely at the Federal level. Like
the American system of education, control of ani-
mal use can be largely a local issue, and institu-
tional animal care and use committees stand as
the arbiters of community standards. One draw-
back of a minimal Federal role is the possible de-
velopment of conflicting or confusing State and
local policies.
Maintenance of the status quo would reaffirm
that Congress concurs that no methods or proce-
dures are beyond the realm of societal acceptabil-
ity (except the training of military personnel in sur-
gical techniques on wounded dogs and cats in fiscal
years 1984 and 1985). Maintenance of the status
quo would leave unaffected the acquisition of ani-
mals for research, testing, and education: Sources
of animals today include breeders, dealers, pounds,
and in-house breeding. Some States will continue
to bar the acquisition of pound animals for research
(see ch. 14). Finally, in the absence of a licensing
scheme, investigators and their areas of inquiry
will remain wholly a function of available resources
and individual interests.
Option 2: Restrict the use of certain kinds of
animals.
Some people feel it is wrong to use particular
animals in research, testing, or education. This be-
lief may stem from respect for apparent intelli-
gence, and animals most closely related to humans,
such as nonhuman primates, may be considered
off limits for investigation or manipulation. Simi-
larly, attachment to companion animals such as
dogs and cats or to pet species such as hamsters
may lead to a desire for their legislated immunity
from experimentation.
A restriction of this nature is likely to have sev-
eral consequences. The restricted species would
be protected while investigators faced, at a mini-
mum, an inconvenience until new methods are
developed. Development of new model systems
would likely necessitate the generation of new fun-
damental data about the characteristics of the
model system, while the existing base of data—
which could be large—about the restricted animal
is set aside because it is no longer useful. In some
cases, new methods would lead to a substitution
of a less favored species for the restricted one. Per-
haps the most important consequence would be
that where the restricted species (e.g., monkey or
dog) is the most scientifically appropriate model
for research or testing, a prohibition on the use
of that species may affect the ability to extrapo-
late results to humans.
Given that few, if any, kinds of animals are ex-
clusively used in testing, research, and education,
a restriction of this nature would be difficult to
impose. How, for example, might a restriction dis-
tinguish between primates under behavioral ob-
servation in a field colony and those observed by
tourists at a safari-style game preserve? Restric-
tion of the use of particular kinds of animals may
be inconsistent with the popular treatment and
use of those same animals (e.g., circus, zoological
park, sport, hunt, or farm) throughout the United
States. Combining this option with the next one—to
restrict the use of a species in a certain protocol—
would yield a more limited, more practicable form
of restriction than a blanket prohibition on use
of a species.
Option 3: Restrict the use of particular protocols.
Some people feel that it is inhumane to manipu-
late animals in certain ways, irrespective of the
motivation for the procedure. Such concerns usu-
ally focus on procedures that cause the animal pain
or are painful for humans to watch. The Draize
eye irritancy test is such a procedure, as are in-
flictions of blunt head trauma in neurology re-
search and of bullet wounds in surgical training.
In research, blanket prohibitions either of a par-
ticular animal’s use (the preceding option) or of
a specified procedure entail a risk of being overly
inclusive. They could have unintended or un-
foreseen consequences, especially in the face of
incomplete knowledge about how animals are used
and in what protocols and what the results might
portend. One risk of such a restriction would be
the elimination of the use of animal models that
may be the best available or the sole method of
studying conditions present in humans but that
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do not lend themselves to systematic study in hu-
mans (see ch. 5).
In testing, procedures like the Draize test and
the LD50 are used in part because investigators be-
lieve that Federal regulatory agencies, such as FDA
and EPA, require the results of these tests in data
submissions (see ch. 7). Exercise of oversight au-
thority could induce Federal regulatory agencies
to make explicit their disinterest in data derived
from objectionable tests and to demonstrate their
ready acceptance of data obtained through alter-
nate means. Such oversight action, coupled with
active research into alternative methods, would
probably end most use of the targeted procedures.
It is likely that review of protocols by commit-
tee, particularly a committee with expertise in bio-
ethics, laboratory animal science, and anesthesia,
would effectively restrict procedures to those that
are generally accepted as humane. In both research
and testing, banning animal use for a specific pur-
pose would reflect the judgment that knowledge
gained via that procedure could never justify the
cost in animal suffering or lives.
Option 4: Restrict the acquisition of animals from
particular sources.
For several decades, States and municipalities
have wrestled with the issue of the release of dogs
and cats from pounds to research and educational
institutions (see ch. 14). Some people feel that the
release of pound animals for experimentation is
wrong, because the animals are former pets or
are too unhealthy to be proper subjects for study.
In some jurisdictions, research and educational
institutions are barred from acquiring pound ani-
mals, while other jurisdictions require that pound
animals be released to researchers after a certain
number of days in captivity.
As pound animals are usually sold at low cost
(see ch. 11), banning their sale would lead to higher
procurement costs as the pound animals were re-
placed with animals that are purposely bred for
experimentation. (Some animals are already pur-
pose-bred because certain pound animals are not
suitable candidates for experimentation.) The pur-
poseful breeding of such animals for experimen-
tation in parallel with routine euthanasia of pound
animals would probably work out to a net increase
in dogs and cats being killed.
Option 5: License animal users (e.g., for specified
uses or for particular kinds of animals).
Animal users could be granted licenses specify-
ing the procedures they are authorized to perform
or the animals with which they may work. Such
a system is in place in the United Kingdom under
the auspices of the Home Office (see ch. 16). Given
that at least five to six times as many animals are
used in the United States annually (17 million to
22 million) as in the United Kingdom (3 million to
4 million), achieving and maintaining licensure here
would be a considerably larger and more costly
enterprise than now exists in any country.
Implementation of this option would require a
Federal licensing body with inspection and enforce-
ment capability. If the British system is the model,
licenses would be legally enforceable personal doc-
uments. A license to perform a particular experi-
ment or a series of experiments or to work with
a particular species would be nontransferable.
Confidentiality would be guaranteed in order to
protect, for example, an investigator’s claim to pri-
ority in research results. Comprehensive annual
reporting by licensees and auditing by an over-
sight body—both integral parts of the British
system—would be necessary. It is noteworthy that
in the United Kingdom this system allows every
animal experiment to be logged (see ch. 16).
The British system works. It relies heavily on
a tradition of cooperation between experimenter
and Home Office inspector. The feasibility of such
a system in the United States is difficult to predict
because the dimensions of animal use are so poorly
characterized. Hence, the number of licensees and
the resources required for monitoring are un-
known. perhaps most important, the extent to
which the parties involved would cooperate is un-
certain.
Option 6: Prohibit the use of animals in research,
testing, and education.
No other country and no jurisdiction in the
United States has completely banned animal use
in research, testing, or education. In Switzerland,
a binding referendum of this nature was presented
to the public for a vote in December 1985, but it
was defeated (see ch. 16).
Action to ban animal use fully is the most ex-
treme of the six options related to the issue of re-
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striction. It would undeniably provide great impe-
tus towards implementing alternatives. Indeed, the
alternatives of reduction and refinement of ani-
mal use would be immediately and completely
achieved. However, the development of many re-
placements to animal use depends itself on ani-
mals. A ban would, for example, eliminate the use
of organ cultures, nonhuman tissue cultures, and
cell cultures, except for those self-perpetuating
ones already in existence. Replacements would
have to be drawn from among human and veteri-
nary patients, micro-organisms, plants, chemical
and physical systems, and simulations of living sys-
tems. The development of new computer simula-
tions would faker, with new data from animal sys-
tems being unavailable. The ability to verify new
simulations or proposed replacements would also
come to a halt.
Implementation of this option would effectively
arrest most basic biomedical and behavioral re-
search and toxicological testing in the United States.
Education would be affected, too, although per-
haps not as severely as research and testing. In
the advanced life sciences and in medical and
veterinary training, students might be handi-
capped, although not to as great a degree as once
thought. Some medical schools today, for exam-
ple, use no animals in physiology curricula (see
ch. 9).
The economic and public health consequences
of a ban on animal use are so unpredictable and
speculative that this course of action must be con-
sidered dangerous. Caution would demand, for
example, that any new products or processes have
substantial advantages over available ones to merit
the risk of using them without animal testing.
ISSUE: Should more accurate data be obtained
on the kinds and numbers of animals
used in research, testing, and education?
Accurate data on the kinds and numbers of ani-
mals used in research, testing, and education in
the United States do not exist (see chs. 3 and 9).
The best numbers now available on the use of cer-
tain species (nonhuman primates, dogs, cats, rab-
bits, guinea pigs, and hamsters) are produced by
the Animal and Plant Health Inspection Service of
the USDA. The APHIS Animal Welfare Enforce-
ment Report submitted to Congress each year is
best viewed as a rough estimate of animal use. It
records approximately 10 percent of all animals
used annually; omitted are rats, mice, birds, fish,
reptiles, and amphibians.
Estimates of animals used yearly in the United
States range to 100 million and more. Although
the development and implementation of alterna-
tives do not require an accurate count, public pol-
icy formation would be helped by better data. Reg-
ulating animal use, for example, or funding the
development or validation of alternatives to a par-
ticular procedure, may depend on how many ani-
mals are used and what fraction of the total this
represents. Trends in animal use have similar ap-
plications. In the United Kingdom, the exact ani-
mal use records kept since 1876 have influenced
policymakers (see ch. 16).
Some animal welfare advocates suggest that the
moral and ethical issues surrounding animal use
are independent of the precise number of animals
used. Others question whether the value of the
data obtained is worth the cost of obtaining ac-
curate numbers. A rough estimate based on mini-
mal data may be all that is necessary to put the
relevant issues into context. Selecting among the
following options will depend, therefore, on judg-
ment of how important it is to know the number
and kinds of animals used, who uses them, and
what trends exist.
Option 1: Take no action.
The primary advantage of this option is that no
additional funding would be required, since noth-
ing within the system would change. Continued
funding of current APHIS activities would keep
yielding rough estimates of the use of six kinds
of animals that account for about 10 percent of
total animal use.
The major disadvantage of maintaining the sta-
tus quo is that an inaccurate and ambiguous report-
ing system would be perpetuated, yielding mar-
ginally useful analysis of animal use in the United
States, The APHIS counting system is ineffective
because of problems with ambiguous reporting
forms and a failure to audit the forms that are
returned.
Funding for the APHIS survey has been derived
from the approximately $5 million allocated an-
nually in recent years to APHIS to enforce the Ani-
mal Welfare Act. Depending on the uses to which
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data on animal use are put, maintaining the status
quo may be adequate, an unnecessary expense,
or not nearly enough.
Option 2: Eliminate the APHIS reporting system.
If the value of the information obtained by the
APHIS system is not justified by the money allo-
cated for its collection, the APHIS reporting sys-
tem could be terminated. In adopting this option,
Congress would signal a willingness to rely on esti-
mates produced by nongovernment organizations
and individuals without the benefit of reports or
inspections.
Option 3: Correct inadequacies in the present
APHIS system of reporting use of ani-
mals mandated by the Animal Welfare
Act.
To gain a more accurate picture of the use of
nonhuman primates, dogs, cats, rabbits, guinea
pigs, and hamsters in the United States, oversight
authority could be used to require that APHIS alter
its present practices in one or more of the follow-
ing ways:
l
l
l
l
l
correct its reporting form to eliminate am-
biguities;
change the reporting deadline or publication
schedule for the annual Animal Welfare En-
forcement Report, so that fewer institutional
reports are excluded;
audit or spot-check the “Annual Report of Re-
search Facility” forms and facilities;
strictly enforce the regulation requiring that
all institutions within the United States using
mandated species register with APHIS and
complete the “Annual Report of Research Fa-
cility” forms as required by law; or
allocate more of APHIS’ resources for enforce-
ment of the Animal Welfare Act to reporting.
These changes would require little additional
government funding or expenditure by regulated
entities, although it could affect how they allocate
their resources. Adoption of this option would
bring APHIS closer to delivering the information
it is obliged to deliver under the Animal Welfare
Act.
Option 4: Alter the APHIS system to count addi-
tional kinds of animals (e.g., rats and
mice).
Rats and mice account for approximately 75 per-
cent of the animals used in research, testing, and
education in the United States. They go uncounted
because a USDA regulation under the Animal Wel-
fare Act excludes them from its definition of ani-
mals. There is, however, some voluntary report-
ing of the use of these species on the APHIS “Annual
Report of Research Facility” forms.
Data on rats and mice (or other currently un-
regulated animals) could be obtained in either of
two ways. Congressional oversight of the Secre-
tary of Agriculture could lead to a requirement
that the use of rats and mice be reported. This
would require additional funding for APHIS, be-
cause the number of facilities under the act’s reg-
ulations would increase. On the other hand, the
counting mechanism is already in place, and only
minor changes would be needed.
Expanding the APHIS animal counting require-
ment to include rats and mice would raise costs
for some members of the research and testing corn-
munities. Accurate counting of these species, in-
cluding categorization of experiments for pain and
pain relief, is a labor-intensive activity and hence
costly. Such costs will be of exceptional concern
to institutions using large numbers of rats and
mice, and these users can be expected to question
whether accounting needs for policy evaluation
require the extra expense.
A broadening of the APHIS census to include rats
and mice would still leave some uncounted. The
Animal Welfare Act’s definition of research facil-
ity covers any institution that uses primates, dogs,
cats, rabbits, guinea pigs, hamsters, or other warm-
blooded animals, as the Secretary of Agriculture
may determine are used in experimentation, and
that either purchases or transports animals in com-
merce or receives Federal funds for experiments.
Thus, a facility that breeds all its animals in-
house—most likely rats or mice—falls outside the
scope of the Animal Welfare Act and accompany-
ing USDA regulations. The number of facilities
breeding and using rats and/or mice exclusively
is unknown. Some toxicological testing laboratories
are likely to fall into this group.
Option 5: Establish an independent census of ani-
mal use, either on a one-time or peri-
odic basis.
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Fundamental changes could be made in the ways
animals are counted. An animal census could be
periodic-e.g., occurring every 2, 5, or 10 years.
An organization other than APHIS, such as the pri-
vate Institute for Laboratory Animal Resources
(ILAR) of the National Research Council, could do
the counting. In 1986, ILAR will undertake another
in its series of surveys of laboratory-animal facil-
ities and resources in the United States. (The last
survey was conducted in 1978.) ILAR will survey
the use of two classes of vertebrates—mammals
and birds-at approximately 3,000 facilities.
Another approach to gathering information on
the kinds and numbers of animals used would be
to conduct a comprehensive, one-time study of re-
search, testing, and education. Such a study could
survey all species acquired or bred for research,
testing, and education; count the number of ani-
mals actually used in experimentation; record the
length of stay in animals in the facility; and catego-
rize the purposes of the experimental-animal use.
Such a comprehensive survey would not merit
repetition every year—the purposes of animal use
in research, for instance, do not change that
quickly.
A different way to count animals used would
be to obtain figures from breeders on the num-
ber of animals bred for experimentation. This
would not take into account the percentage of ani-
mals bred that are never used in experimentation,
or animals bred within a laboratory, but it would
yield a valuable index of animal use. Yet another
source of information would be to count the num-
ber of facilities or individuals using animals for
specified activities.
It is noteworthy that the revised PHS Policy on
Humane Care and Use of Laboratory Animals by
Awardee Institutions (effective Dec. 31, 1985) re-
quires listing the average daily inventory, by spe-
cies (with none excepted), of each animal facility,
as part of each institution’s annual report to the
NIH Office for Protection from Research Risks.
Thus, PHS-supported facilities are now required
to report more complete census data to NIH than
facilities covered by the Animal Welfare Act re-
port to APHIS. Consequently, a portion of animal
use in research (e.g., NIH-supported animal re-
search) and testing (e.g., FDA-supported animal
testing) is about to become more closely censused.
The choice among census types under this op-
tion will depend on the ways in which the infor-
mation is to be used, the resources available for
obtaining it, and the utility of the new census re-
quired by PHS.
ISSUE: Should Federal departments and agen-
cies be subject to minimum standards
for animal use?
The Federal Government has six cabinet depart-
ments and four independent agencies involved in
intramural animal research or testing (see ch. 13
and app. B). These departments and agencies ac-
count for at least 1.6 million animals for intramural
research (see ch. 3). Federal agencies have gener-
ally followed the existing PHS policy and as of De-
cember 1986 will be required to operate institu-
tional animal committees (Public Law 99-198).
Many departments and agencies also follow the
NIH Guide for the Care and Use of Laboratory Ani-
mals. Yet there is no stated, detailed policy of min-
imum standards for animal use within the Fed-
eral Government. Therefore, this issue has just two
options: either maintaining the present system or
establishing a minimum policy for intramural ani-
mal use. Financial considerations are not a major
factor because funds will be needed either to con-
tinue the present system of variable policies or to
implement and enforce a minimum, government-
wide policy.
Option 1: Take no action.
The advantages of the present system are its flex-
ibility and minimal bureaucratic structure, The
policies mentioned previously, along with the In-
teragency Research Animal Committee’s Principles
for the Utilization and Care of Vertebrate Animals
Used in Testing, Research, and Training, allow each
agency or department to have policies and mech-
anisms unique to its situation. The disadvantages
are the potential for conflicting policies and the
lack of a neutral enforcement authority.
Option 2: Establish minimum standards for all in-
tramural animal use in Federal depart-
ments and agencies.
This option would require that a policy be de-
veloped and perhaps that an organizational entity
be established to oversee its implementation and
enforcement. This could be accomplished by an
interagency committee or by a designated agency.
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Setting minimum standards would still give each
agency and department the flexibility to tailor spe-
cific policies to unique situations, yet it would estab-
lish a Federal model for standards of animal care
in experimentation and ensure humane proce-
dures in Federal facilities.
A Federal intramural policy might incorporate
policies and procedures that address facility ac-
creditation and institutional review of research
proposals. A composite, minimum Federal policy
could reflect the most progressive parts of vari-
ous current agency standards.
It is noteworthy that this type of action has been
taken to protect human research subjects. A Model
Federal Policy for the Protection of Human Re-
search Subjects involved in research conducted,
supported, or regulated by Federal departments
or agencies is now in draft form. The policy will
be implemented through routine policy and pro-
cedural channels of the departments and agencies.
The advantage of minimum standards is that all
concerned parties know the policy and can im-
mediately and permanently put in place the appro-
priate organizational structure and facilities to
guarantee adherence.
ISSUE: Should the Animal Welfare Act of 1966
be further amended, or its enforcement
enhanced?
One criticism of the Animal Welfare Act is the
lack of coverage of practices other than anesthe-
sia and analgesia during actual experimentation.
Although the most recent amendments to the act,
in 1985, direct institutional animal committees to
assess practices in experimentation and require
that professionally acceptable standards are fol-
lowed during experimentation, the act at the same
time forbids any regulation related to the design
or performance of experiments. Additional com-
plaints concern the adequacy of resources for its
enforcement, the enforcement structure, the
choice of APHIS as the primary enforcement
agency, and the cumbersome recordkeeping.
In considering whether the act should be strength-
ened, some related issues must be kept in mind.
First, a change in authority may require funding
for implementation and enforcement. Second, any
change must take into account the present re-
sources of those affected and their ability to achieve
compliance without compromising other objec-
tives. Thus, an important consideration is whether
or not regulated institutions have sufficient institu-
tional and independent veterinary resources to ef-
fect meaningful compliance with a strengthened
law and still meet their testing or research objec-
tives. Finally, strengthening the Animal Welfare
Act in the face of differences within the scientific
and animal welfare communities will carry con-
siderable symbolic value.
Option 1: Take no action.
By maintaining the status quo, Congress would
give a strong signal to all concerned parties that
it is satisfied with the present regulatory structure
for animal use in the United States and that no
change is deemed necessary. More specifically,
selection of this option would imply that current
enforcement efforts are sufficient and that it is
not necessary to regulate rats and mice used in
experimentation.
Option 2: Eliminate funding for enforcement of
the Animal Welfare Act.
Elimination of funding for enforcement of the
Animal Welfare Act by APHIS would save the Fed-
eral Government approximately $5 million annu-
ally. Without these funds, there would be no in-
spections of facilities (including exhibitors, dealers,
and research institutions) using nonhuman pri-
mates, dogs, cats, rabbits, guinea pigs, or hamsters
and no annual census of these six kinds of animals.
Action taken by APHIS against violators would
cease. Therefore, the objective of the Animal Wel-
fare Act—to safeguard the humane care and treat-
ment of certain animals—would no longer be met.
Option 3: Increase funding for enforcement of the
Animal Welfare Act.
Increased funding for the enforcement of the
Animal Welfare Act would bolster enforcement
of the present law. Additional funds could be used
to:
l
l
l
increase the training of inspectors;
increase the number of enforcement agents
in the field, so as to raise the number of in-
spections;
oversee consistent interpretation of existing
regulation by inspection and enforcement
agents in the field; and/or
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l replace voluntary assurances and simple cer-
tifications of compliance with more rigorous
procedures.
Additional funding could help stimulate the present
passive regulatory situation to become a more ac-
tive, aggressive regulatory environment. Such a
transition would rest on APHIS’ level of enthusiasm
for enforcing the Animal Welfare Act.
Option 4: Expand the jurisdiction of enforcing
agencies to include standards of care,
treatment, and use during the actual
conduct of experimentation.
The Animal Welfare Act exempts the treatment
of animals while they are actually involved in ex-
perimentation, except for a requirement for ap-
propriate anesthesia or analgesia and the use of
professionally acceptable standards in the care,
treatment, and use of animals. The original law
exempted actual experimentation because Con-
gress did not want to interfere with the conduct
of the scientific process (see ch. 13). Animal care
and treatment are essentially regulated only be-
fore and after a scientific procedure. Implemen-
tation of this option would broach the design and
execution of experimental protocols and would
require statutory change. Such action would in-
crease the responsibility of APHIS and its enforce-
ment would require additional funding. A deter-
rent to implementation of this option is APHIS’ lack
of expertise in reviewing experimental protocols.
Option 5: Realign existing and any new responsi-
bilities for enforcement among Federal
departments and agencies.
APHIS spends little of its resources, either mone-
tary or personnel, enforcing the Animal Welfare
Act (see ch. 13). It was selected by Congress in 1966
to enforce the act because it had some expertise
in animal issues but did not have the conflict of
interest that an entity such as NIH or DHHS might
have.
Enforcement power could be changed by trans-
ferring enforcement authority for violations of the
Animal Welfare Act from USDA (APHIS) to DHHS.
This would set up a potential conflict of interest:
A single department would both sponsor animal
experimentation and have oversight authority. In
addition, many of the regulations in the Animal
Welfare Act affect areas in which DHHS has no
expertise (e.g., animal use by exhibitors).
In amending the Animal Welfare Act in 1985,
Congress mandated that the Secretary of Agricul-
ture consult with the Secretary of Health and Hu-
man Services prior to issuing regulations under
authority of the act. The implementation of this
provision may lead to DHHS having increased in-
fluence on the enforcement of the act,
Option 6: Amend the Animal Welfare Act to pre-
empt State and local laws concerning
animal use in areas not already covered
by the Animal Welfare Act.
Although the Edward Taub case in Maryland (see
ch. 14) did not decide the preemption question,
it did bring up the issue of whether the Animal
Welfare Act could preempt a State statute. Con-
gress may wish to examine its authority to preempt
State anticruelty statutes and may then wish to
specify for the judiciary whether it intended its
law to supersede any State or local laws on this
issue. In doing so, Congress could remove uncer-
tainty in the law by making clear whether it in-
tends the Animal Welfare Act to be a comprehen-
sive, exclusive system of control over the use of
animals in experimental facilities and activities in
interstate and foreign commerce. Without such
clarification, the possibility exists for local crimi-
nal prosecution, seizure of animals, injunctions to
close facilities, and cessation of animal investi-
gations.
Current State and local efforts to assure humane
treatment have been criticized for several reasons.
Compliance schemes are overly complex, training
and resources are inadequate, and existing laws
are not specific enough in their standards for care,
treatment, and use. If Federal preemption is not
exercised, then State and local laws will be con-
sidered concurrent and complementary to exist-
ing Federal laws.
It is important to note that Federal preemption
means that the administrative system for moni-
toring, including on-site inspection, should be made
adequate to ensure continued compliance with na-
tional standards for humane treatment. Otherwise,
State-level organizations with a sincere and rea-
sonable concern about the care of animals will be
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justified in demanding local enforcement and sur- question of whether the Federal Government has
veillance of research, testing, and education in- the authority to assert itself into areas tradition-
volving animals. ally regulated by the States (e.g., pound animal use)
Finally, it should be recognized that if Federal may well land in the courts.
preemption is deemed necessary, the constitutional
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Donahue: What doesn’t feel pain? When do you stop feeling pain? Does a frog feel pain?
McArdle: Yes.
Donahue: Frogs feel pain? . . . now what about laboratory high school? You remember, you
had to dissect the frog? . . . Should we eliminate that? How about fishing? . . .
how about baiting a hook with a worm? IS that fair? In other words, where do
we stop?
McArdle: You bring up fishing and I think that's a good point. I used to wonder whether or
not the nonvertebrate animals would feel pain. A few years ago they found en-
dorphins, which are substances that handle chronic pain, in earth worms. So,
earth wvrms may in fact be subject to chronic pain when you’re putting them on
that hook.
Phil Donahue with John E. McArdle, Humane Society of the United States
Donahue (transcript #02065)
February 1985
Although the highest standard of protection must be applied to all animals, we acknowl-
edge that it is right to pay special attention to the companions of man [non-human primates,
cats, dogs, and equidae] for whom there is the greatest public concern.
Scientific Procedures on Living Animals, Command 9521
British Home Office
May 1985
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Chapter 2
Introduction
This report assesses the state of the art and the
potential for alternatives to using animals in three
contexts: biomedical and behavioral research, test-
ing of products for toxicity, and education. Dis-
tinguishing among these three areas is important
because both the patterns of animal use and the
potential for alternatives vary among them. Re-
search develops new knowledge and new technol-
ogies; although prediction of results is one goal,
unpredictable results may prove even more sig-
nificant. Testing relies on standardized procedures
that have been demonstrated to predict certain
health effects in humans or animals. It entails the
measurement of biological phenomena, such as
the presence or absence of cancer or of skin irri-
tation, or the concentration of certain substances
in tissue or in bodily fluids. Education involves
teaching students in the life sciences, health profes-
sionals and preprofessionals, and research scien-
tists, as well as the cultivation of humane attitudes
toward animals at all levels. Alternatives in each
of these three areas consist of procedures that re-
place animals with nonanimal methods, that re-
duce the number of animals used, or that refine
existing protocols to make them more humane.
In addition to evaluating alternatives in three
areas, the assessment also examines ethical con-
cerns regarding the use of animals, economic con-
siderations of their use and the alternatives, funding
for the development of alternatives, and current
regulation of animal use, Most important, this re-
port delineates seven major public policy issues
(and associated options for congressional action)
in relation to alternatives (see ch. 1).
With a focus on the prospects for alternatives
to animal use in research, testing, and education,
this assessment necessarily excludes certain re-
lated topics and treats others only in brief. The
role of animals in food and fiber production falls
outside the scope of this study, as does the role
of animals in the commercial production of anti-
bodies and other biological materials. In addition,
OTA has not evaluated the use of animals for compan-
ionship, sport, or entertainment. Although laboratory
animals are an integral part of this assessment, OTA
did not examine contemporary standards of their
care (e.g., cage size, sanitation, ventilation, feeding,
and watering). Lastly, the use of human subjects is
not considered in this assessment.
WHAT IS AN ANIMAL?
In any biological definition of the word “animal,” Political and scientific discussions often incor-
all vertebrate and invertebrate organisms are in- porate other subdivisions for the term “animal.”
eluded and plants and unicellular organisms are Although not strictly part of the definition in this
excluded. For the purposes of this report, how- report, the terms “lower” and ‘(higher” are used
ever, an “animal” is defined as any member in many discussions of alternatives that refine ex -
of the five classes of vertebrates (nonhuman isting animal procedures or that replace certain
mammals, birds, reptiles, amphibians, and animal species with other ones. In these contexts,
fish). These five classes of vertebrates can be fur- the substitution of “lower” animals for ‘(higher”
ther divided into two major groups, cold-blooded animals usually refers to using cold-blooded ver-
vertebrates (reptiles, amphibians, and fish) and tebrates instead of warm-blooded vertebrates. In
warm-blooded vertebrates (mammals and birds). addition, within the class of mammals, “lower” is
Invertebrates, therefore, are not discussed as generally used to designate, for example, rodents,
animals. while “higher” refers to primates, companion ani-
37
38 l Alternatives to Animal Use in Research, Testing, and Education
mal species (e.g., dogs, cats, or rabbits), and do- and education. It indicates the laboratory species
mestic farm animals (e.g., horses, cattle, or pigs). falling within this assessment’s definition of an ani-
—
Table 2-1 is a classification of the principal liv-
mal and the species that can be classified as “alter-
natives.”
ing organisms that are used in research, testing,
Table 2.1.—Some Types of Living Organisms Used in Research, Testing, and Education
Alternatives:
1. Prokaryotes (any living organism without a nuclear
membrane)
A. Bacteria
1. Escherichia coli
2. Salmonella
3. Streptococcus
4. Bacillus
B. Fungi—e.g., yeast
Il. Eukaryotes (any living organism with a nuclear
membrane)
A. Plants
B. Invertebrates
1. Protozoa
a. Paramecium
b. Amoeba
2. Porifera—e.g., sponges
3. Coelenterates—e. g., Hydra and Jellyfish
4. Flatworms—e.g., Planaria
5. Segmented worms
a. Earthworms
b. Leeches
c. Annelids
6. Nematodes—e.g., Caenorhabdiitis elegans
7. Molluscs
a. Gastropods—e.g., snails and Aplysia
b. Pelecypods—e.g., mussels
c. Cephalopods—e.g., squids and octopuses
8. Arthropods
a. Lirnulus (horseshoe crabs)
b. Arachnids
(1) Spiders
(2) Ticks
(3) Mites
(4) Scorpions
c. Crustaceans
(1) Daphnia
(2) Brine shrimp
(3) Crayfish
d. Insects
(1) Crickets
(2) Cockroaches
(3) Drosophila (fruit flies)
(4) Lice
(5) Beetles
(6) Moths
(7) Butterflies
9. Echinoderms
a. Sea urchins
b. Sand dollars
c. Sea cucumbers
Animals:
C. Vertebrates
1. Cold-blooded vertebrates
a. Fish
(1) Jawless fish–e.g., lampreys
SOURCE: Off Ice of Technology Assessment.
(2) Cartilaginous fish–e.g., sharks
(3) Bony fish
b. Amphibians
(1) Frogs—e.g., Rana
(2) Toads–e.g., Xenopus
(3) Salamanders
c. Reptiles
(1) Turtles
(2) Crocodiles
(3) Alligators
(4) Snakes
(5) Lizards
2. Warm-blooded vertebrates
a. Birds
(1) Quail
(2) Chickens
(3) Pigeons
(4) Doves
(5) Ducks
b. Mammals
(1) Bats
(2) Rodents
(a) Mice
(b) Rats
(c) Gerbils
(d) Guinea pigs
(e) Hamsters
(f) Squirrels
(3) Marine mammals
(a) Dolphins
(b) Whales
(c) Seals
(d) Sea lions
(4) Rabbits
(5) Armadillos
(6) Carnivores
(a) Dogs
(b) Cats
(c) Ferrets
(7) Ungulates
(a) Cattle
(b) Sheep
(c) Horses
(d) Pigs
(e) Miniature pigs
(f) Goats
(g) Donkeys
(h) Burros
(8) Primates
(a) Baboons
(b) Capuchins
(c) Chimpanzees
(d) Macaques, Cynomolgous
(e) Macaques, Pig-tailed
(f) Macaques, Rhesus
(g) Marmosets
(h) Squirrel monkeys
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WHAT IS AN ALTERNATIVE?
Defining the word “alternative” is in a sense al-
ways doomed to failure: Regardless of how accom-
modating or strict the definition, many will fault
it. The term evolved in the political arena, coined
by animal welfare activists and for the most part
nonscientists, and yet it has direct implications for
scientists using laboratory animals. Its meaning
varies greatly, depending on who uses it and the
context in which it is used.
The definition of “alternatives” employed by OTA
obviously affects this entire assessment: It defines
the scope of the study. Too narrow a definition
would dispose of the need for this report, while
too broad a definition would render it unmanage-
able. Defining alternatives as the nonuse of ani-
mals, as some would have it, would restrict the
bounds of the study to the consideration of inver-
tebrate organisms, chemicals, plants, and comput-
ers. On the other hand, stretching the definition
to include humans, for example, would create a
whole new series of issues that would be virtually
impossible to address within one assessment. With
these concerns in mind, OTA chose to define
“alternatives” as encompassing any subjects,
protocols, or technologies that ‘(replace the
use of laboratory animals altogether, reduce
the number of animals required, or refine
existing procedures or techniques so as to
minimize the level of stress endured by the
animal” (4; adapted from 5).
Some examples of alternatives under this defi-
nition include computer simulations to demon-
strate principles of physiology to medical students,
the use of the approximate lethal dose methodol-
ogy in acute toxicity studies, and the increased use
of anesthetics with pain research subjects. The “re-
duction” part of the definition indicates that the
increased use of cultured cells, tissues, and organs
instead of whole animals is also an alternative. A
very broad interpretation of alternatives might also
include the substitution of cold-blooded for warm-
blooded vertebrates.
BIOLOGICAL MODELS
When animals-or alternatives—are used in re-
search, testing, and education, it is because they
possess a simpler or more accessible structure or
mechanism in comparison with the object of pri-
mary interest (which is often the human) or are
themselves the object of primary interest, or be-
cause certain procedures cannot be carried out
on humans. Viewed from this perspective, both
animals and alternatives stand as models. In the
broadest sense, a biological model is a surrogate,
or substitute, for any processor organism of ulti-
mate interest to the investigator. It is a represen-
tation of or analog to some living structure, orga-
nism, or process.
In addition to analogy, biology has another ana-
lytical tool at its disposal—homology, which is cor-
respondence in structure and function derived
from a common evolutionary origin (i.e., a com-
mon gene sequence). The most closely related spe-
cies are generally presumed to offer the best homo-
logs. Relationships between species are not always
known in detail, however, and unresolved ques-
tions about evolutionary events and pathways are
numerous. Care must therefore be used in evalu-
ating the degree of homology and the extent to
which it relates to analogy (3).
Some biological mechanisms, such as the cod-
ing of genetic information and the pathways of
metabolism, arose early in evolution. These mech-
anisms have been highly conserved and are widely
shared by organisms, including humans, at the cel-
lular and molecular levels. Thus, good models for
these fundamental molecular mechanisms in hu-
mans can be found in a wide array of organisms,
some of which, such as bacteria, have structures
and functions far less complex than those of mam-
mals (3).
Several characteristics are important in choos-
ing a model for research, testing, or educational
purposes. The most important is the model’s dis-
crimination-the extent to which it reproduces the
particular property in which the investigator is
interested. With greater discrimination, the pre-
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dictability between the model and the property
under study increases.
After the discrimination or predictability of a
model, certain other criteria stand out as being
necessary for a good biological model (1)2). A model
should:
l
l
l
l
l
l
l
l
l
l
l
l
accurately reproduce the disease or lesion un-
der study;
be available to multiple investigators;
be exportable from one laboratory to another;
be large enough to yield multiple samples;
fit into available facilities of most laboratories;
be capable of being handled by most investi-
gators;
survive long enough to be usable;
exhibit the phenomenon under study with
relative frequency;
be of defined genetic homogeneity or heter-
ogeneity;
possess unique anatomical, physiological, or
behavioral attributes;
be accompanied by readily available back-
ground data; and
be amenable to investigation with available,
sophisticated techniques.
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Depending on the type and needs of the investiga-
tion, certain of these criteria might be more im-
portant than others. Overall, a model with more
of these characteristics will have higher discrimi-
nation and stronger predictive ability,
In research, testing, and education, a small num-
ber of species have achieved prominence as experi-
mental tools because they have been extensively
studied from a number of perspectives and thus
provide well-understood paradigms that have been
described in detail in terms of genetics, biochem-
istry, physiology, and other aspects. These organ-
isms include the laboratory rat, laboratory mouse,
fruit fly, and bacterium Escherichia coli. Yet taxo-
nomic breadth is also required in research and
testing, since it is often impossible to predict what
species will lend themselves particularly well to
the study of specific problems. In biological mod-
eling, concentration on selected species and taxo -
nomic diversity are not mutually exclusive; both
play a role in the establishment of a maximally use-
ful matrix of biological knowledge (3).
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Patterns of Animal Use
Twenty million rats, rabbits, cats, dogs, mice, and monkeys are killed each year in the
name of science. And the number has quadrupled in recent years . . . 150 living creatures
are sacrificed every minute.
Paul Harvey
Radio broadcast of April 30, 1985
Each minute around the clock, 150 creatures are sacrificed ., . a total of 70 million a
year. Included are 25,000 primates . . . and nearly 500,000 dogs and cats.
parade, January 13, 1985
Each year in the United States, almost 100 million animals are used in scientific research.
Nearly a million are dogs and cats.
Ed Bradley
CBS News, 60 MINUTES
October 14, 1984
OTA ignores the fact that more than one-half of all research goes unreported because
unfunded. Secondly, funded researchers consistently understate the number of animals
used for several reasons I won ‘t enumerate. My personal guess is that 120-150 million
animals is the right ballpark figure.
Sidney Gendin
Eastern Michigan University
The Research News 36(3-4):17, 198.5
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Chapter 3
Patterns of Animal Use
Humans “use” animals in several different ways.
In addition to animal use in research, testing, and
education, animals are involved in food and fiber
production, the production of biological products,
sports, and entertainment. Animals can also be kept
as pets for the purpose of companionship. It has
been roughly estimated that 2 billion to 4 billion
animals are used in food and fiber production
every year and that Americans have approximately
75 million dogs and cats as household pets. The
uses not considered in this assessment therefore
account for many times more animals than the esti-
mated 17 million to 22 million animals used annu-
ally in research, testing, and education.
There are no easily obtainable data in the United
States allowing an accurate estimate of animal use
for research, testing, and education that satisfies
all interested parties; estimates range over a full
order of magnitude, from approximately 10 mil-
lion to 100 million animals. These estimates have
all been prepared by different people or institu-
tions with different data sources under different
standards (e.g., different time periods or defini-
tions). Comparison of the various estimates is dif-
ficult and, in many cases, impossible.
The issue of numbers is important to any dis-
cussion of animal use in research, testing, and edu-
cation. Most basically, a number is needed from
which to consider arguments to decrease or elim-
inate animal use. In addition, comparing absolute
numbers in different years would provide some
idea of whether laboratory-animal use is increas -
ing or decreasing in the United States; these num-
bers are powerful and important to many people.
A high overall total, or high numbers of certain
species (such as nonhuman primates or companion
species), supports the claims of interest groups hop-
ing to restrict or ban such experimentation. On
the other hand, a low number indicates the issue
is not as important as some claim. In addition, a
decreasing trend in animal use supports the posi-
tion that the present system will lower animal use
on its own.
For this assessment, some idea was needed of
the scope of animal use in terms of both the num-
bers of particular species used and the different
major users. In addition, an analysis of different
data sources helps put the various estimates of ani-
mal use into some comparative perspective. It pro-
vides the context in which to discuss alternatives
and how much effect they might have. Although
it is true that the development of alternatives and
alternative methods does not require a perfectly
accurate estimate of usage, the planning of public
policy certainly should be based on firm data.
By looking critically at the different data sources
and coming up with possible estimates of labora-
tory-animal use in the United States, this assess-
ment attempts to base discussions on a realistic,
factually backed range of figures. Without such
an analysis, any discussion or decisions on policy
issues and possible solutions lack an important per-
spective.
THE FEDERAL GOVERNMENT’S USE OF ANIMALS
To document the scope and extent of animal use about animal use in each department or agency.
for research by Federal departments and agen- Together, the information illustrates:
cies, information was obtained from the Animal
and Plant Health Inspection Service (APHIS) an- l
nual reports for Federal research facilities for 1983,
the Animal Welfare Enforcement Reports for fis- l
cal years 1978 through 1983 (both obtained from
the U.S. Department of Agriculture (USDA)), and l
personal communications or written material
the extent of animal use in different de-
partments,
the amount and type of animals being used
in the Federal Government,
the experimental conditions under which
most animal experiments are carried out,
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the general purpose for which animal re-
search and testing is carried out in different
departments and agencies, and
how much research and testing for the Fed-
eral Government is conducted intramurally
(i.e., within Federal facilities).
Federal Departments and Agencies
Using Animals in Research
Six departments and four independent Federal
agencies conduct intramural research or testing
involving animals. Uses of animals range from
combat-casualty-care investigations in the Depart-
ment of the Army, to acute toxicity studies by the
Consumer Product Safety Commission of poten-
tially hazardous substances, to National Aero-
nautics and Space Administration research on pro-
tecting the health of American astronauts. (For
additional information on the use of animals within
the Federal Government, see chs. 7 and 13 and
app. B.)
Department of Agriculture
USDA performs biomedical research using ani-
mals under the authority of the Animal Welfare
Act in order to improve animal breeds, food, and
fibers. Most of the research is conducted in-
tramurally by the Agricultural Research Service,
although some extramural research (i.e., research
supported by USDA, but conducted in non-USDA
facilities) is contracted out by the Cooperative State
Research Service. Some of this USDA animal re-
search involves farm animals, however, which are
largely excluded from Government regulatory pol-
icies and are exempt from the Animal Welfare Act
and APHIS regulations (44).
Department of Commerce
The Department of Commerce conducts a small
amount of intramural research with animals and
lets some extramural contracts that involve ani-
mal studies. There are no specific Commerce guide-
lines or policies governing the humane treatment
and appropriate veterinary care for laboratory ani-
mals (33).
Department of Defense
The divisions within the Department of Defense
(DOD) that conduct experimental research on ani-
mals are the Air Force, the Army, the Navy, the
Uniformed Services University of the Health
Sciences, the Defense Nuclear Agency, and the
Armed Forces Institute of Pathology; the first three
of these account for most of the research. To-
gether, all the divisions have approximately 40 re-
search facilities that conduct animal experimen-
tation.
The Aerospace Medical Division (AMD) of the
Air Force accounts for about 95 percent of that
service’s use of animals. Of this, 84 percent is due
to intramural research (9). AMD research and de-
velopment projects fall within the following areas:
humans in space,
chemical defense and threat countermeasures,
safety and environment,
logistics and technical training,
air combat training,
human components of weapons systems, and
personnel and force management.
The safety and environment program uses the
most animals, while those on human components
of weapons systems and chemical defense also have
some animal use (50).
The Army does medical research to protect the
soldier by the authority in the mission of the US.
Army Medical Research and Development Com-
mand. Medical research and development (R&D)
are carried out in five areas: infectious diseases
(tropical disease and biological warfare defense),
combat casualty care, combat systems, dental re-
search (facial injuries), and chemical defense.
About one-third of the research is done in-house
and two-thirds is contracted out (38).
The Navy in fiscal year 1985 allocated $58 mil-
lion for the life sciences or biomedical research.
Of this, $37 million (64 percent) is for extramural
research while the remainder is for intramural
use. The two main branches of the service doing
research involving animals are the Naval Medical
Research and Development Command and the Of-
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fice of Naval Research (ONR). The Naval Medical
Research and Development Command does re-
search in:
l submarine and diving medicine,
l electromagnetic radiation,
l aviation medicine/human performance,
l fleet health care systems,
. infectious diseases, and
l oral and dental health.
ONR conducts research using animals in four ma-
jor areas: molecular biology, neurophysiology/
physiology, cellular biosystems, and psychologi-
cal sciences (45).
Department of Energy
The Department of Energy has no intramural
research facilities and so contracts out all its re-
search (47). The primary research objective within
its Office of Health and Environmental Research
is to study the health and environmental effects
of energy technologies and programs. To do this,
in the past, the Department contractor used dogs.
Recently, though, there has been a gradual shift
from whole animals to cellular and molecular re-
search and a much greater emphasis on rodents
as opposed to companion species or primates (12).
Department of Health and
Human Services
Intramural animal research or testing is carried
out by four components of the Department of
Health and Human Services’ Public Health Serv-
ice: the National Institutes of Health (NIH), the Food
and Drug Administration (FDA), the National In-
stitute on Drug Abuse (NIDA) (a part of the Alco-
hol, Drug Abuse, and Mental Health Administra-
tion), and the National Institute for Occupational
Safety and Health (NIOSH) (a part of the Centers
for Disease Control).
NIH is the largest research institution in the Fed-
eral Government and uses more animals than any
other department or agency. The mission of NIH
is to uncover new knowledge that will lead to bet-
ter health (51). It does this by both intramural and
extramural research. Approximately 88 percent
of the NIH budget is spent on extramural programs
while 10 percent goes to intramural research and
2 percent is used for NIH administration. Some
44 percent of the research awards go to research
involving animals (28).
Research in the FDA is mission-oriented, with
the principal objective being to provide data to sup-
port regulatory decisions. Research is conducted
to determine the safety of human and animal foods;
detect contaminants in human and animal foods;
determine the safety and efficacy of human and
animal drugs, biological products, and medical de-
vices; reduce unnecessary exposure to artificial
radiation; and increase fundamental understand-
ing of the toxicological effects of chemicals. Ninety
percent of the dollar budget for FDA research is
allocated to intramural research studies while the
other 10 percent goes to extramural research (5).
Department of the Interior
The Department of the Interior does more than
95 percent of its research in-house (31). Most ani-
mal research is performed by the U.S. Fish and
Wildlife Service to support its mission “to provide
the Federal leadership to conserve, protect, and
enhance fish and wildlife and their habitats for
the continuing benefit of people. ” This involves
maintenance of relevant research and education
programs in cooperation with other State and pri-
vate organizations to enhance fish and wildlife re-
source management (53).
Department of Transportation
The Department of Transportation conducts ani-
mal research under the authority of the Hazard-
ous Transportation Act of 1974 to determine the
level at which substances become Class B poisons
(see ch. 7). Most of the research involving animals
is conducted extramurally (42). The Department
also performs animal research under the author-
ity of the National Traffic and Motor Vehicle Safety
Act of 1966 (10).
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Consumer Product Safety Commission
The Consumer Product Safety Commission (CPSC)
both relies on data provided by manufacturers and
conducts its own testing to determine the toxic
potential of consumer products. Animals are used
by CPSC’s Directorate for Health Sciences in de-
terminations of substances’ acute oral toxicity,
their potential for skin and eye irritation, and their
combustion toxicity (16).
Environmental Protection Agency
The Environmental Protection Agency (EPA) per-
forms research involving animals under the stat-
utory and regulatory authority of the Toxic Sub-
stances Control Act and the Federal Insecticide,
Fungicide, and Rodenticide Act. The general pur-
pose of this research fits into one of three catego-
ries: methods development to assess potential haz-
ards to the environment, dose-response data for
risk assessment, or low dose to high-dose data for
risk assessment. EPA has two major research fa-
cilities, one in Cincinnati, OH, and the other in Re-
search Triangle  Park, NC. In addition to the intra-
mural research done in these facilities, EPA does
contract extramural research. The amount done
outside the agency varies from year to year and
depends on the program, but it usually does not
exceed 40 percent of total research (48).
National Aeronautics and
Space Administration
The National Aeronautics and Space Adminis-
tration (NASA) has three facilities that maintain
or conduct research with animals, although ap-
proximately 65 percent of NASA’s Life Sciences
research is conducted extramurally. About 12 per-
cent of the life sciences budget was used to fund
animal research in fiscal year 1984 (37).
The general purpose of NASA’s research is to
acquire knowledge that can be used to protect and
ensure the health of American astronauts, both
during their missions in space and after their re-
turn to Earth.
National Science Foundation
The National Science Foundation awards grants
for scientific research involving animals but per-
forms no intramural research.
Veterans’ Administration
The Veterans’ Administration (VA) has 174 fa-
cilities, 91 of which have the ability and authori-
zation to do animal research. The VA’s mandate
to do research that may involve animals comes
from part of the agency’s defined mission to un-
derstand health maladies better, with a special em-
phasis on those that affect veterans. The VA uses
animals in its research and development divisions
and its education programs, which are located in
many of its local facilities. All research funded by
the VA is done intramurally, and some of the re-
search done by the VA is funded by other agen-
cies, such as NIH (29).
Research and development within the VA has
three elements: the Medical Research Program,
Rehabilitative R&D, and Health Services R&D. The
Medical Research Program includes research basic
to disease and deformities, while Rehabilitative
R&D includes studies on artificial appliances or
substances for use in restoring structure or func-
tion of parts of the human body. Finally, Health
Services R&D includes research toward improve-
ment, replacement, or discontinuance of health
care delivery systems (32). Thus, the VA’s man-
date for research and development is extremely
broad and holds the potential to use animals in
many programs.
Patterns of Federal Animal Use
APHIS is the agency within the U.S. Department
of Agriculture responsible for administering and
enforcing the Animal Welfare Act of 1966 (Public
Law 89-544) and its amendments (see ch. 13). The
act defines research facility as any individual, in-
stitution, organization, or postsecondary school
that uses or intends to use live animals in research,
tests, or experiments  and that purchases or trans-
ports live animals in commerce or that receives
Federal funds for research, tests, or experiments.
It defines “animal”to include “any live or dead dog,
cat, monkey (nonhuman primate mammal), guinea
pig, hamster, rabbit, or such other warm-blooded
animal, as the Secretary [of the Department of Agri-
culture] may determine is being used, or is intended
for use, for research, testing, experimentation, or
exhibition purposes, or as a pet .“ The act excludes
horses not used for research purposes and other
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farm animals intended for use as food or fiber.
Under this definition, dead frogs used in biology
classes or animals killed prior to usage are not in-
cluded. Rats, mice, and birds were specifically ex-
cluded from the act coverage by regulations pro-
mulgated in 1977 by the Secretary of  Agriculture
(9 C.F.R. 1.l(n); 42 FR 31022); reporting the use
of these animals is voluntary.
The regulations that APHIS enforces require that
each research facility fill out an Annual Report of
Research Facility (see fig. 3-1) by December 1 on
the preceding Federal fiscal year (October 1- Sep-
tember 30). Elementary and secondary schools are
exempt, as are facilities using only exempt species
(rats, mice, or birds). In addition, any facility that
does its own in-house breeding and does not re-
ceive Federal funds does not have to file a report.
Although Federal research facilities are not re-
quired to register with APHIS, many of them do
fill out the annual reporting forms. Each year,
APHIS reports to Congress on the data collected
from these forms in its Animal Welfare Enforce-
ment Report.
Since 1982, two lines on the Annual Report of
Research Facility have listed rats and mice under
column A, ‘(Animals Covered by the Act” (which
is therefore no longer an accurate heading). Al-
though not legally required, many respondents
who used mandated species filled in the number
of rats and mice anyway, either not realizing that
reporting on these species is voluntary or elect-
ing to report their use, Thus, for many institutions
a usage figure for rats and mice is given. In other
cases, though, facilities reporting on mandated spe-
cies omitted data on rats and mice.
Table 3-1 details the total reported animal use
by research facilities within the Federal Govern-
ment broken down by departments, major divi-
sions, and agencies for fiscal year 1983. The An-
nual Report of Research Facility requires not only
that total animals used be reported, but that the
animals used be categorized as being used in re-
search, experiments, or tests: 1) involving no pain
or distress; 2) where appropriate anesthetic, anal-
gesic, or tranquilizer drugs were administered to
avoid pain or distress; or 3) involving pain or dis-
tress without administration of appropriate anes-
thetic, analgesic, or tranquilizer drugs (see fig. 3-1).
Several qualifications are necessary on the num-
bers reported in table 3-1, which are based on the
annual reports obtained from APHIS:
l
l
l
l
The 131 research reports include only intra-
mural Federal research done at Federal fa-
cilities.
The 131 facilities are not all the Federal facil-
ities that might have used animals in 1983; at
least 25 facilities did not file a report for that
year.
The numbers obtained were tabulated from
each report. The reports were checked and
corrected for improper coding of information
and inaccurate addition. In many cases, these
changes reflected substantial differences in
the number of animals used for specific insti-
tutions.
The numbers for mice and rats are included
from any institution that reported them volun-
tarily. Several facilities, however, specifically
mentioned that they were not required to sub-
mit these data and did not do so.
In addition to these general limitations on over-
all numbers, some specific qualifications for indi-
vidual departments and agencies are also war-
ranted:
l For FDA, table 3-1 does not include its primary
research facility, the National Center for Tox-
icological Research (NCTR), since no report
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was filed for 1983. This probably excludes a
substantial number of animals since the fis-
cal year 1984 annual report for NCTR reported
the use of 8 dogs, 334 rabbits, 29 primates,
14)621 rats, and 11,744 mice.
l The VA has 81 facilities accredited by the
American Association for Accreditation of
Laboratory Animal Care (AAALAC) yet only
63 reports were filed for 1983. Therefore,
there is a strong possibility that the numbers
for the VA are underreported.
Bearing in mind all the limitations and qualifica-
tions of the data used to generate table 3-1, OTA
estimates that a minimum of 1.6 million ani-
mals are used annually by the Federal Gov-
ernment in intramural research. The Depart-
ment of Defense, the Department of Health
and Human Services, and the Veterans) Ad-
ministration together account for 96 percent
of reported Federal animal use. DHHS alone
reported 49 percent of the total.
Among the six kind of animals whose inclusion
in annual reporting forms is mandated by the Ani-
mal Welfare Act, guinea pigs are used most often—
twice as frequently as hamsters or rabbits (the sec-
ond and third most used species). Overall, about
the same number of dogs and primates are used,
while far fewer cats are involved in Government
experiments. Finally, table 3-1 suggests that cer-
tain agencies do research on specific species. For
example, the VA uses a disproportionately large
number of dogs and the Department of the Interior
is the major user of wild animals.
Reports of Federal facilities indicate that most
animal use falls into the experimental situation
categorized as involving no pain or distress. Sixty-
three percent of the animals used were in this cat-
egory while 32 percent were given drugs to avoid
pain or distress and only 5 percent experienced
pain or distress without receiving anesthetics, anal-
gesics, or tranquilizers. The largest user of drugs
in experiments was the VA (62 percent of the ani-
mals in this category), whereas the largest user
of animals experiencing pain or distress was the
Department of Defense (84 percent of the animals
in this category). The latter figure maybe inflated,
however, by the fact that DOD has reported mice
and rats voluntarily under these categories in many
cases and has listed in this column all animals dy-
ing in infectious and neoplastic disease studies,
which many Federal agencies may not do (43).
Table 3-2 shows the trends in animal use for Fed-
eral agencies as a group from 1978 to 1983, accord-
ing to the Aninal Welfare Enforcement Reports
submitted by APHIS to Congress (49). As with the
numbers from the 1983 Annual Reports of Re-
search Facilities, these data do not tell the whole
story. Most important, these data do not include
rats and mice, which together make up a majority
of the animals used. Second, only reports that have
been received by December 31 each year (the re-
ports are due December 1) are included (26). It
has been estimated that between 10 percent and
20 percent of the total reporting institutions fail
to report by December 31 and are therefore not
included in the Animal Welfare Enforcement Re-
ports (17). (Thus, the 1983 data are lower in table
3-2 than in 3-1, which included all available an-
nual reports.)
The data are difficult to interpret due to the dif-
ferent numbers of research facilities included each
year. Therefore, no conclusions can be drawn
about whether the trend in animal use is increas-
ing or decreasing. This is also the case for trends
in the use of individual species. The 1983 data do
indicate, however, that no more than 8 percent
of animals used in Federal programs reported here
have experienced pain or distress in an experiment
since 1978. The percentage of animals experienc-
ing no pain or distress has remained between 50
and 60 percent, while drugs have been used to
alleviate pain or distress for 30 to 40 percent of
the animals.
ANIMAL USE IN THE UNITED STATES
OTA surveyed the available data concerning the corrected for methodological deficiencies, and
numbers of laboratory animals used for research, evaluated for their statistical reliability. As a final
testing, and education. These were summarized, step, estimates were made of current levels of an-
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Table 3-1.—Research=Animai Use in the Federai Government, by Major Department and Division for
Fiscai Year 1983
Department of
Department of Defense Health and
Animals used USDA Commerce Misc. Air Force Army Navy Total Human ServicesFDA NIDA
Facilities reporting . . . . . . . . 11 1 3 6 20 10 39 1 1
Dogs . . . . . . . . . . . . . . . . . . . . 25 0 994 635 827 344 2,800 113 51
‘/0 row. . . . . . . . . . . . . . . . . . . <1 0 11 7 9 4 31 1 <1
Cats . . . . . . . . . . . . . . . . . . . . 39 0 491 61 214 36 802 0 84
‘/0 row. . . . . . . . . . . . . . . . . . . 1 0 18 2 8 1 29 0 3
Guinea pigs . . . . . . . . . . . . . . 6,105 0 1,601 586 26,695 609 29,491 0 98
0/0 row. . . . . . . . . . . . . . . . . . . 9 0 2 1 41 1 46 0 <1
Hamsters. , . . . . . . . . . . . . . . 7,487 0 627 1,352 4,822 417 7,218 0
‘/0 row. . . . . . . . . . . . . . . . . . . 21 0 2 4 14 1 21 : o
Rabbits . . . . . . . . . . . . . . . . . 1,047 0 1,863 703 3,731 264 8,581 0 0
‘/0 row. . . . . . . . . . . . . . . . . . . 4 0 6 2 13 1 23 0 0
Primates ., . . . . . . . . . . . . . . 0 418 527 676 219 1,840 0 0
‘/0 row. . . . . . . . . . . . . . . . . . . : o 6 7 9 3 25 0 0
Rats . . . . . . . . . . . . . . . . . . . . 7,862 0 25,259 10,570 55,057 4,243 95,128 0 312
‘/0 row. , . . . . . . . . . . . . . . . . . 2 0 6 2 13 1 22 0 <1
Mice . . . . . . . . . . . . . . . . . . . . 30,625 0 72,085 6,140 143,503 42,094 263,822 0 600
‘/0 row. . . . . . . . . . . . . . . . . . . 3 0 7 1 14 4 26 0 <1
Wild animals . . . . . . . . . . . . . 24 43 1,377 34 2,762 479 4,652 0
‘/0 row. . . . . . . . . . . . . . . . . . . < 1 < 1 10 <1 19 3 32 : o
Total . . . . . . . . . . . . . . . . . . . . 53,214 43 104,715 20,806 238,287 48,705 412,315 113 1145
‘/0 row. . . . . . . . . . . . . . . . . . . 3 <1 6 1 15 3 25 <1 <1
KEY: USDA-United States Department of Agriculture; FDA-Food and Drug Admlnistration; NIDA-National  Institute on Drug Abuse; NIH-National  Institutes of Health;
CDC-Centers  for Disease Control; NIOSH-National  Institute for Occupational Safety and Health; DOT-Department of Transportation; EPA-Environmental Protec-
tion Agency; NASA-National Aeronautics and Space Administration; VA-Veterans’ Administration; CPSC-f.kmsumer  Product Safety Commission.
Percentages may not add up to 100 due to rounding.
SOURCE: Office of Technology Assessment, from 1963 APHIS  Annual Reports of Research Facilities (Form 18-23); CPSC data from K.C. Gupta, Deputy Director, Divi-
sion of Health Sciences Laboratory, Directorate for Health Sciences, U.S. Consumer Product Safety Commission, Washington, DC, personal communica-
tion, Sept. 24, 19S5.
nual animal use in the United States. The purpose
of this exercise was to examine numbers on ani-
mal use and compare the reliability of estimates
from different data sources.
The figures published in this assessment
on the number of animals used are not abso-
lute. They are only as accurate as the data
from which they were obtained. All publicly
available information on past and current animal
use was collected from a variety of sources, often
through personal contacts. Data from the two most
reliable sources, the Institute of Laboratory Ani-
mal Resources (ILAR) of the National Research
Council and the USDA’s Animal and Plant Health
Inspection Service, were corrected to take into ac-
count the actual years of reporting and the omis-
sion of certain data that were not received before
a deadline.
Laboratory-animal use was then estimated and
projected using statistical techniques where appro-
priate. For this purpose, the corrected ILAR and
APHIS data were used, as well as more indirect
means based on National Institutes of Health fund-
ing, National Cancer Institute (NCI) usage, and NIH
total usage as a function of NIH intramural use.
Although the number of animals bred should lead
to good estimates of animals used in the labora-
tory, the larger laboratory-animal breeders would
not confirm or deny sales figures that had appeared
in the news media and literature. Therefore, esti-
mates based on such reports are of uncertain relia-
bility.
Limitations of Animal-Use Study
Two types of limits on this study exist: intrinsic
and extrinsic. The major intrinsic limitations were
funding constraints and a limited time span dur-
ing which the study could be performed. This pro-
hibited the collection of raw data and required that
OTA rely on existing data sources. The extrinsic
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Table 3-1 .—Research.Animal Use in the Federal Government, by Major Department and Division for
Fiscal Year 1983 (Continued)
Department of Health and Human Services
Animals used NIH CDC/NIOSH Total Interior DOT EPA NASA VA CPSC Total
Facilities reporting . . . 3
Dogs . . . . . . . . . . . . . . . 756
0/0 row. . . . . . . . . . . . . . 8
Cats . . . . . . . . . . . . . . . 503
0/0 row. . . . . . . . . . . . . . 18
Guinea pigs ... , . . . . . 23,973
0/0 row. . . . . . . . . . . . . . 37
Hamsters. . . . . . . . . . . 14,003
0/0 row. . . . . . . . . . . . . . 40
Rabbits . . . . . . . . . . . . 8,783
0/0 row. . . . . . . . . . . . . . 30
Primates . . . . . . . . . . . 4,452
0/0 row. . . . . . . . . . . . . . 61
Rats . . . . . . . . . . . . . . . 196,458
0/0 row. . . . . . . . . . . . . . 45
Mice . . . . . . . . . . . . . . . 533,094
0/0 row. . . . . . . . . . . . . . 52
Wild animals . . . . . . . . 2,787
0/0 row. . . . . . . . . . . . . . 19
Total . . . . . . . . . . . . . . . 784,809
% row. . . . . . . . . . . . . . 48
2
0
0
0
0
0
0
10
0
30
<1
287
4
3,750
<1
1,120
<1
0
0
5,197
<1
7
920
10
587
21
24,071
37
14,013
40
8,813
30
4,739
65
200,520
46
534,814
52
2,787
19
791 ,264
49
2
0
0
0
0
0
0
0
0
0
0
0
0
900
<1
923
<1
4,228
29
6,051
<1
1
30
<1
0
0
0
0
0
0
0
0
0
0
150
0
4,552
<1
0
0
4,732
<1
4
2
<1
0
0
978
2
1,723
5
842
3
33
<1
0
0
0
0
0
0
3,578
<1
2
14
<1
40
1
58
<1
0
0
74
<1
184
3
3,936
1
622
<1
232
2
5,160
<1
63
5,187
58
1,304
47
3,747
6
4,732
14
11,508
39
461
6
122,872 ‘
28
188,560
18
2,393
17
340,764
21
1
0
0
0
0
0
0
0
0
600
2
0
0
2,080
<1
0
0
0
0
2,680
<1
131
8,978
100
2,772
100
84,450
100
35,173
100
29,445
100
7,257
100
433,449
100
1,023,918
100
14,358
100
1,619,801
100
KEY: USDA-United States Department of Agriculture; FDA-Food and Drug Administration; NIDA-National Institute on Drug Abuse; NIH-National Institutes of Health;
CDC-Centers for Disease Control; NIOSH-National Institute for Occupational Safety and Health; DOT-Department of Transportation; EPA-Environmental Protec-
tion Agency; NASA-National Aeronautics and Space Administration; VA-Veterans’ Administration; CPSC-Consumer Product Safety Commission.
Percentages may not add up to 100 due to rounding.
SOURCE: Office of Technology Assessment, from 1983 APHIS Annual Reports of Research Facilities (Form 18-23); CPSC data from K.C. Gupta, Deputy Director, Divi-
sion of Health Sciences Laboratory, Directorate for Health Sciences, U.S. Consumer Product Safety Commission, Washington, DC, personal communica-
tion, Sept. 24, 1985.
Table 3=2.—Total Numbers of Animals Used in Federal Government Facilities as
Reported to Congress in APHIS Animal Welfare Enforcement Reports, 1978-83
Fiscal year
1978 1979 1980 1981 1982 1983
Federal facilities
included in reports. . . . 188 150 118 131 131
Dogs . . . . . . . . . . . . . . . . . 20,128 15,605 13,153 13,930 6,369
Cats. . . . . . . . . . . . . . . . . . 5,354 4,709 3,388 3,183 1,940
Primates . . . . . . . . . . . . . . 7,286 5,031 3,459 3,081 6,907
Guinea pigs . . . . . . . . . . . 65,009 40,425 25,402 33,495 45,972
Hamsters . . . . . . . . . . . . . 45,291 25,213 17,830 32,367 35,220
Rabbits , . . . . . . . . . . . . . . 43,867 32,205 21,631 21,962 16,209
Wild animals . . . . . . . . . . 5,537 4,137 3,209 2,007 7,618
Total animalsa . . . . . . . 192,472 127,325 88,052 110,025 120,235
aT~tala fjo not lnCIU& rats or mice, two species that together account for the majority of animals used.
6 , 6 ;
1,825
1,837
36,033
18,992
16,355
8,037
89,747
SOURCE: Office Technology Assessment, from APHIS Animal Welfare Enforcement Reports, 1978-1983.
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limitations include various information deficien-
cies, such as:
l
l
l
l
l
inadequacies of information on most of the
survey and data collection methodologies,
difficulties with definitions,
problems with categorizing
areas of use,
reporting requirements of
sources, and
animals under
different data
an inability to verify completeness of data
sources.
For example, there is often a discrepancy in the
definition of the term “use.” In some cases, the term
reflects the number of animals acquired; in other
cases, it corresponds only to those used in labora-
tory experiments. This distinction is frequently
obscured in the data sources, and only after care-
ful reading of the documents (and, sometimes, per-
sonal inquiry) was the definition used in each case
clarified. This leads to large differences in num-
bers, since not all animals acquired are used in
experiments. It also makes any comparative anal-
ysis between surveys very unsound.
In addition to this problem of the difference be-
tween production and use, the extrinsic problem
of the number of animals not used in a procedure
because they do not fit the proper criteria comes
into any extrapolation of animal use from labora-
tory-animal market share data, A substantial pro-
portion of the animals bred for research die or
must be discarded because they do not meet pro-
tocol specifications (age, sex, weight, general
health). The number has been estimated as be-
tween a few percent of those acquired to almost
50 percent. In general, the unused proportion of
a species is inversely related to the cost of the ani-
mals. In other words, the more expensive the ani-
mal, the less likely it will be unused, once bred
or purchased. Thus, nonhuman primates are much
less likely to go unused than are mice or rats; in
some cases 50 percent of a rodent species may go
unused. Using only one sex of a rodent species in
a given experiment, for example, would account
for 50 percent of the animals going unused. This
information must be borne in mind when compar-
ing “production” with “use” and when estimating
animal use.
Overall, these limitations reflect on the accuracy
of the data and any projections based on them.
The limitations are such that the only reasonably
credible source for current use and projections
is APHIS, particularly its institutional data sheets
(the Annual Report of Research Facility discussed
earlier). Only the detailed APHIS institutional data
sheets for fiscal years 1982 and 1983 were used
in this assessment, though those for earlier years
were also available (although they would not have
had any data on mice or rats, which were not even
listed on the form until 1982). Consequently, the
APHIS data are less reliable for the years before
1982 inasmuch as these are based on reports to
Congress that did not contain late-reporting insti-
tutions. (The Animal Welfare Enforcement Reports
to Congress underestimate use of the mandated
species by 10 to 20 percent due to the cutoff date
and do not treat data from Federal institutions con-
sistently (17).) For some species, such as fish and
birds, only rough estimates of use could be ob-
tained, due to the diffuse nature of use and the
fact that they are not included in the APHIS data.
Critical Evaluation of
Animal-Use Estimates
In evaluating the reliability of various data
sources, the following parameters were con-
sidered:
l
l
l
l
ability to trace the methodology used in pro-
ducing the numbers, including the survey
technique;
ability to extrapolate to nonreporting institu-
tions, which implies that there is a clear state-
ment as to which institutions did or did not
report data;
method of data collection, whether some for-
mal manner or through a few interviews, re-
sulting in broad estimates; and
ability to determine the fraction of animals
.
reported as being actually used in lab experi-
mentation, as contrasted to, for example, ani-
mal husbandry.
These parameters were chosen because meet-
ing these criteria permits extrapolation of the
limited data to the entire population of institutions.
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In general, if the numbers cannot be justified
through some rational process (such as the above),
too much significance should not be attached to
them.
These four criteria were used to assign a confi-
dence rating to each data source. The confidence
categories are: ‘(excellent)” “good,” “fair,” ‘(poor, ”
and “indeterminate .“ (These ratings refer only to
the published numbers, not to their usefulness as
a predictive tool.) Such a confidence rating is nec-
essarily subjective; the categories are comparative
and should not be viewed as absolute.
Upon reviewing all the data sources avail-
able for predicting the laboratory-animal use
in the United States, it is clear that no source
accurately portrays the number of animals
being used. Each has methodological prob-
lems that prevented it from accurately count-
ing all users of animals. What follows is an anal-
ysis of the available data sources and how they
rank in comparison with the other surveys in terms
of confidence and reliability.
USDA Animal and Plant Health
Inspection Service (APHIS)
The 1982 and 1983 data were analyzed on a case-
by-case basis. Copies of the original report forms
were obtained from USDA; they were sorted by
institution type, checked, coded, and entered into
a computer database. Comparing the 1982 and
1983 APHIS data (see table 3-5, in the ‘(Summary
and Analysis of Estimates” section) with the USDA
Animal Welfare Enforcement Report for 1980 (the
APHIS 1980 data in table 3-5) reveals a large dis-
crepancy. The USDA reports invariably contain
lower numbers for all species, as the data sheets
received after the December 31 cutoff date are
not included in reports in either the current or
the next fiscal year. It is estimated that between
10 and 20 percent of the reports are not used to
compile the report to Congress in a given year (17).
This limitation does not apply to the results con-
tained in the present compilation for 1982 and
1983, since all data for a given year were used no
matter when received. The assumption is made
that copies of virtually all of the data sheets re-
ceived by USDA in the 1982 and 1983 are used
in this study. No verification was made of which
institutions did not report.
The number of institutions reporting to APHIS
has hovered around 1,000 since 1972. The num-
bers for 1982 and 1983 (shown in table 3-6, in the
“Summary and Analysis of Estimates” section) were
tabulated from the actual summary data sheets
provided to APHIS by the institutions and include
all possible reports. Even these figures—1, 127 for
1982 and 1,146 for 1983—are probably low, as not
all institutions submit reports. (The total number
of institutions registered by APHIS was 1,113 in
1982 and 1,166 in 1983; this excludes Federal agen-
cies, which are not required to register.) Some of
the institutions may not report because they have
not used any animals that year, or because they
have only used exempt species.
For the six required species listed on the form
(dogs, cats, guinea pigs, hamsters, rabbits, and pri-
mates), the numbers reported provide a very close
approximation of the animals actually used. Thus
these data were assigned a confidence rating of
‘(excellent .“ (For a summary of all the data sources
discussed in this section and their confidence rat-
ings, see table 3-3.) For exempt species (primarily
rats and mice), it is possible to estimate the num-
ber of unreported rats and mice by extrapolating
from the numbers reported (see the section on ‘(Es-
timate Using Corrected APHIS Data”). Some com-
mentators (1)3)2 7) claim, however, that a certain
number of exempt animals go unreported—and
would be missed in an extrapolation-because they
are purchased directly by the user and not re-
ported to the central facility. This contention could
not be confirmed. Therefore, the voluntarily re-
ported data on rats and mice on the 1982 and 1983
APHIS annual reports received a confidence rat-
ing of “good. ”
ILAR Surveys
The Institute for Laboratory Animal Resources,
a component of the National Research Council,
periodically surveys users of laboratory animals
(18,19,20,21,22,23), although it is generally more
concerned with facilities and personnel than with
quantity of animals used. The ILAR data repre-
sent the number of animals “acquired by own
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Table 3-3.-ReIiabiiity of Various Data Sources
Years Confidence
Source covered rating Strength(s) Limitation(s)
USDA/APHIS:
Mandated species 1982-83 Excellent Required by law. Data available
by institution, thus extrapolation
to nonreporters is possible
Mandated species 1972-81 Fair Required by law. Data by 10 to 20 percent of institutions
institution available, but not not included in reports to Con-
used gress. Totals not consistent
(some years include Federal
agencies, others do not)
Data by institution available. Not required by law
Rats and mice were on the
form so anyone who reported
probably provided an accurate
number. Many did not realize
that these were voluntary since
they were listed on form. Extra-
polation possible
Exempt species 1982-83 Good
ILAR Surveys of 1965-71 Poor Of some use in establishing
Laboratory Animal Use trends for that period
1968 Survey 1967 Fair Statistically sound survey.
Possibility of extrapolating to
other institutions
1980 Survey 1978 Fair Thorough and statistically
solid. Extrapolation to non-
reporting institutions possible
Old data. Cannot extrapolate
to missing data
Limited to 683 Federal-grant-
eligible institutions
Primary attention given to
nonprofit Federal-grant-eligible
institutions. Not required by
law to be filled out
W.B. Saunders & Co. 1965 Indeterminate Company defunct, survey
methodology unclear; no
evaluation possible
Foster D. Snell 1975 Indeterminate Data appear to be based on in-
terviews with two breeders
Methodology unclear. Person-
nel no longer available
SOURCE: Office of Technology Assessment.
breeding and from commercial sources,” not nec-
essarily the number actually used in experimen-
tation.
The ILAR and APHIS surveys are so different
in their organization and methodology that it is
not meaningful to compare the two sources, even
in years for which data from both are available.
It is also difficult to point out significant changes
within this data source because the ILAR method-
ology varied over time and could not be verified
adequately, so changes in numbers are difficult
to substantiate.
ILAR Surveys of Laboratory Animal Use (20) con-
sist of tables summarizing the results of question-
naires on the number of animals used for research.
As ILAR personnel cannot discern who was sur-
veyed and who responded, extrapolation for miss-
ing data is impossible. The surveys could, how-
ever, be of some use in assessing trends between
1965 and 1971. A “poor” confidence rating was
given.
The 1968 Survey of Laboratory Animal Facilities
and Resources (21) appears to have been a very
thorough and statistically sound survey including
all known users of laboratory animals. The results
shown, however, are only for the 683 organiza-
tions eligible for Federal grants that responded be-
cause of the interest of the survey sponsor (NIH).
It is possible, however, to normalize for missing
data based on the reported biomedical research
expenditures for these 683 organizations of $920
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Table 3-3.–Reliabiiity of Various Data Sources (Continued)
Years Confidence
Source covered rating Strength(s) Limitation(s)
Alex Brown & Sons 1981 Poor At the time, it was thought to Data based on a few inter-
represent best estimate for lab views, and mostly broad
animals in U.S. market estimates
Andrew N. Rowan 1985 Poor Data distinguishes between Broad analysis with many
production, acquisition, and assumptions. Based mainly on
actual use one breeding facility
Amphibians:
Emmons 1989 indeterminate Giobal estimates
Culley 1981 Indeterminate Many assumptions
Nace 1974-81 Fair Fair detail for basis of Difficult to know actual
estimates numbers due to large number
of users
Various, on fish 1983 Fair Data consistent Global estimates only
usage
Various, on bird 1983 Poor Good detail by institutions Uncertainty about nonreporting
usage institutions, and fraction of
fowl used by lab experimentation
Data on animal trends:
Wadsworth Center, NY 1980-83 Poor Good detail of different Difficult to predict any trends
species used
Johns Hopkins, MD 1975-85 Poor Limited data that are
impossible to analyze
SOURCE: Office of Technology Assessment.
million in fiscal year 1967. (The results for all re-
spondents, while not mentioned in the report, were
compiled and reported for comparison purposes
in the ILAR 1980 survey,) The confidence rating
was “fair. ”
The ILAR National Survey of Laboratory Ani-
mal Facilities and Resources (22) also appears to
be a thorough and statistically solid report, al-
though the data (for fiscal year 1978) are now 8
years old. Since it also was funded by NIH, pri-
mary attention was given to nonprofit biomedical
research institutions eligible for Federal grants.
In addition, data were received from Federal orga-
nizations, commercial research labs, and the phar-
maceutical industry. Seventy-two percent of the
2,637 questionnaires were returned; 47 percent
of those were acceptable, thus providing 1,252 re-
spondents (including 992 nonprofit Federal-grant-
eligibles, 137 commercial  laboratories, 25 compo-
nents of the DOD, 21 units of NIH, and 77 compo-
nents of other Federal agencies). Although the
individual identities of the respondents are un-
known, the biomedical research expenditures of
the nonprofit organizations are known. Since their
data are reported separately from all respondents,
an extrapolation to the unknown cases can be at-
tempted based on the known national (meaning
“all use in the United States”) biomedical research
expenditures. This source was assigned a confi-
dence rating of ‘(fair.”
W.B. Saunders & Company
W.B. Saunders&Company (41) surveyed the lab-
oratory animal market in 1965 and projected fig-
ures for 1970. The survey and its estimates are
widely quoted as one of the first estimates of ani-
mal use. The survey methodology is unclear and
the company no longer exists, so these data fall
under the “indeterminate” category.
Foster D. Snell, Inc., for
Manufacturing Chemists Association
A study performed by Foster D. Snell, Inc., for
the Manufacturing Chemists Association (25) esti-
mated that 35 million mice and 40 miIlion rats were
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produced domestically in the United States in 1975,
and that 20)000 monkeys were imported from
India. The report’s authors could not be located
and the methodology is unclear, thus making it
impossible to validate. It appears that the data are
based on interviews with personnel at two ani-
mal breeding facilities (Charles River Breeding
Labs, Inc., and White Eagle Farms) and perhaps
a few other people in industry, academia, and gov-
ernment. As it is difficult to give any credibility
to such data, the source was assigned a confidence
rating of “indeterminate. ”
Alex Brown & Sons
An Alex Brown&Sons (2) report on Charles River
Breeding Labs, Inc., stated that the company pro-
duces 22 million animals annually worldwide, spe-
cializing in mice, rats, guinea pigs, hamsters, and
primates. It did not give any breakdown by spe-
cies, nor do any other analyses of Charles River.
The number was primarily a guess based on a few
interviews and so its value must be questioned.
The confidence rating of this source was “poor.”
Andrew N. Rowan
In a 1984 book, Of Mice, Models, & Men:A Criti-
cal Evaluation of Animal Research, Andrew N.
Rowan estimated that approximately 71 million
laboratory animals are used each year, including
45 million mice and 15 million rats (39), These
figures were obtained by looking at all the availa-
ble data sources for animal use in the United States,
especially information on Charles River breeding
production. In 1985, Rowan revised these estimates
to distinguish between production, acquisition, and
actual use. The new estimates on animals used sug-
gest that between 25 and 35 million animals are
used per year (40). As these are based on a very
broad analysis with many assumptions, they have
been given a confidence rating of “poor.”
Surveys and Estimates on Amphibians,
Fish, and Birds
There is little good survey information on labora-
tory use of amphibians, fish, or birds. Use of these
animals is not required to be reported on the USDA/
APHIS annual reports. Therefore, the only sources
of estimates are personal communications with
experts in these fields.
The most recent assessments of amphibian use
were the ILAR surveys of 1965-71, which indicated
the use of 3.37 million amphibians in 1971. As men-
tioned earlier, however, it is not known how to
normalize for institutions that did not report, so
the usefulness of these data are questionable and
the confidence rating is “indeterminate.”
Several individuals who use or produce amphib-
ians were surveyed, yielding a wide range of esti-
mates. A former general manager of a major sup-
plier of amphibians estimated that approximately
9 million frogs were shipped by suppliers in 1969
for educational and teaching purposes (13). This
is a global estimate and so its confidence rating
was considered “indeterminate. ” An amphibian
researcher at Louisiana State University did a sur-
vey of the use of bullfrogs that estimated that
150,000 bullfrogs and 200,000 tadpoles” could have
been used in 1981 (a decrease since 1971, he found).
He then assumed that bullfrogs represent roughly
10 percent of amphibian use and estimated that
about 1 million frogs and 2 million tadpoles were
used in the United States for teaching and research
in 1981 (8). The assumptions in this method are
very general and so the value of this estimate is
questionable; an “indeterminate” rating was as-
signed. Finally, George Nace (34,35) estimated that
about 9 million frogs were shipped by suppliers
in 1971, but that this dropped to roughly 4.5 mil-
lion in 1981 and stabilized at that level in 1984,
with 90 percent of the usage educational and 10
percent research. There is fairly good detail for
the basis of the estimates, but it is difficult to con-
firm the totals due to the large number of users.
This source was given a confidence rating of “fair.”
Reliable data on fish used in laboratories were
particularly difficult to obtain. Estimates were
received from commercial and institutional (includ-
ing Government) users in the field. For fish over
half an inch long, the yearly use appears to range
between 500,000 and 1 million. For smaller fish,
the best estimate is that 2 million to 3 million are
used yearly. Most are used for toxicological studies.
Although the numbers are fairly consistent from
source to source, they are only global estimates
and so were given a confidence rating of “fair. ”
These numbers apply only to laboratory use. They
do not include fish that are used in the wild in
propagation, contamination, feeding, and other
ecological studies.
Ch. 3—Patterns of Animal Use l 5 7
For birds, many of those completing the APHIS
data sheets voluntarily reported bird use under
the “wild animal” category. According to these data,
at least 33,910 birds were used in fiscal year 1982
and 29,781 in fiscal year 1983. Of these, the Univer-
sity of Maryland used 17)915 birds in 1982, and
12,305 in 1983 (46). Since this one institution used
such a large fraction of the reported total, inquiries
about other large possible users indicated that
many of the poultry research institutions (mostly
land-grant universities in the East and South) did
not report birds on their APHIS forms, The largest
of these, in terms of poultry research, is North
Carolina State University, from whom it was learned
that approximately 41,000 birds were used for
poultry science and 1,100 in veterinary schools
(7). Checking the APHIS data sheets for other land-
grant institutions showed that most had reported
bird usage. In addition, discussions with research-
ers at several institutions established that only 80
to 85 percent of the poultry science usage is in
laboratories with the remainder mostly in feed-
ing, management, and breeding studies. Therefore,
although there is good detail for many institutions
on bird use, there is uncertainty in the APHIS data
about nonreporting institutions and about the pro-
portion of fowl used in actual experimentation.
Several individuals have estimated bird use in
the United States. James Will of the Animal Re-
source Center at the University of Wisconsin in
Madison, WI, estimated that 25,000 to 100,000
avian individuals are used for laboratory experi-
mentation (54). Andrew N. Rowan of Tufts Univer-
sity School of Veterinary Medicine in Boston, MA,
estimated that at least 500,000 birds are used in
biomedical research (0o). Both of these figures are
based on very weak data and so are assigned a
confidence rating of “poor. ” Thus, using these esti-
mates and the APHIS bird data, an annual use of
between 100,000and 500,000 birds is as accurate
an estimate as can be made.
Data on Trends in Animal Use
Several limited data sources exist that suggest
trends in animal use in the past several years. At
Wadsworth Center for Laboratories and Research,
New York State Department of Health (Albany, NY),
the use of mandated species decreased 40 percent
from 2,925 in 1980 to 1,754 in 1983. The use of
rats and mice also decreased substantially (22 per-
cent), from 72,796 in 1980 to 56,681 in 1983, at
a time when total research dollars available con-
tinued to increase (11. At The John Hopkins School
of Hygiene and Public Health in Baltimore, MD,
the daily census of animals decreased from over
8,000 in 1975 to approximately 2,000 in 1985 while
animal care personnel dropped from 10 to 4 and
research expenditures more than doubled (14).
These data sources are limited in scope, use differ-
ent counting mechanisms, and can be considered
anecdotal in nature. They were assigned a confi-
dence rating of “poor. ”
Calculating Rat and Mouse Usage
Using these same data sources, estimates for an-
nual laboratory use of rats and mice in the United
States were calculated. The criteria and scales de-
scribed earlier were also applied to assign confi-
dence ratings to the estimates. To gauge annual
laboratory-animal use, minimum average costs of
$4 per rat and $2 per mouse (6,15,24,30,36,55)
were assumed to represent conservative prices for
a typical research subject. This permitted extrap-
olations based on price to represent an expected
maximum of animals that could be purchased.
Three different methods were used to estimate
the use of rats and mice in the United States. The
first involved using indirect means for the calcu-
lations, while a second method used 1978 ILAR
data. The third, and most reliable, method relied
on corrected USDA/APHIS data and involved cal-
culations using regression equations.
Indirect Estimates
Possible methods for estimating rat and mouse
usage under this category involve extrapolations
from data based on NIH funding, NCI usage, NIH
total use as a function of intramural use, and ani-
mal breeder information. For example, an estimate
based on NIH funding involves the following steps
and assumptions:
l NIH funds 37 percent of all national biomedi-
cal research expenditures (52).
l In 1983, NIH awarded $582,571)000 in direct
costs to 5,011 extramural projects utilizing rats
and other species (4). If it is assumed that all
38-75o 0 - 86 - 3
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expenditures went to projects that used only
rats, an upper limit can be extrapolated for
rats purchasable using NIH funds.
Twelve percent of direct costs of NIH-
sponsored research funds go toward the pur-
chase of supplies, glassware, chemicals, re-
search animals, and items listed as expenda-
ble (55).
If it is assumed that half of the supply funds
went toward the purchase of animals, then
$34,954,260 would be available for the pur-
chase of rats.
At $4 a rat, 8.7 million rats could be purchased.
In 1983, NIH awarded $531,519)000 in direct
costs to 4,080 projects using mice. At an aver-
age cost of $2 per mouse, 16 million mice could
be purchased with NIH funds.
Assuming that NIH supports 37 percent of ani-
mal use in the country, then the potential num-
ber of these two species purchasable in the
United States is estimated at 23.6 million rats
and 43.1 million mice. This indirect method
(whether it uses NIH data or NCI data or ani.
mal breeder information) involves many as-
sumptions, limited data sources, and cannot
be considered very reliable. It was assigned
a “poor” confidence rating.
Estimate Using Corrected ILAR Data, 1978
The results of the 1978 National Survey (22) per-
mit approximation of animal use for all users with
techniques that fill in the missing data of non-
respondents based on a method such as the fol-
lowing:
l
l
l
The NIH-grant-eligible nonprofit biomedical
research organizations responding to the sur-
vey reported biomedical research expendi-
tures of $2,2 billion for 1978.
Total national biomedical research expendi-
tures are estimated at $6.27 billion for 1978
(52).
If it is assumed that animal use (in numbers)
is proportional to the dollar amount spent on
research utilizing them and that the usage rate
of animals by all institutions is proportional
to that of nonprofit institutions, national usage
equals (nonprofit ILAR 1980) X 6.27/2.2. This
yields an estimate of 16 million mice and 5.6
million rats used in 1978. Such methods do in-
volve some assumptions not easily justifiable
and so the confidence rating is somewhat
lower than for the ILAR data on which they
are based. In addition, they are based on in-
formation already 8 years old.
Estimate Using Corrected APHIS Data
About two-thirds of the institutions completing
APHIS annual reports for 1982 and 1983 volun-
teered information on the number of rats and mice
used. Regression equations based on those insti-
tutions reporting the specific species on the An-
nual Report of Research Facility forms were used
to estimate the numbers of rats and mice for those
institutions not reporting these species (17). The
estimates obtained using these regression equa-
tions and then simply applying the mean value for
reporting institutions to the nonreporters are
shown in table 3-4 (which summarizes all the esti-
mates discussed). These regression equations yield
estimates of 8.5 million mice and between 3.4 mil-
lion and 3.7 million rats used annually in 1982 and
1983; applying the mean value for reporting insti-
tutions to those that did not report yields higher
estimates. Given the fairly detailed database to
which the regression equations were applied, these
estimates received a confidence rating of “good. ”
The estimates generated from these corrected
APHIS data are likely the most accurate that can
be obtained with data currently available.
Summary and Analysis
of Estimates
Table 3-5 summarizes the various estimates on
animal use discussed in this chapter. Several fac-
tors reduce the usefulness of these data, however:
APHIS’s definition of animal (which excludes rats,
mice, and birds) and the exemption from regula-
tion of research facilities that do in-house breed-
ing and receive no Federal funds. These limitations
may cause the numbers generated from the APHIS
data to be underestimations of the total animal use
in the United States for research, testing, and edu-
cation. For example, the Directory of Toxicology
Testing Laboratories published by the Chemical
Specialties Manufacturers Association, Inc., lists
110 facilities in the United States. In checking these
against the list of APHIS registered research facil-
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Table 3-4—Estimates of Rat and Mouse Usage in Laboratories, 1978, 1982, 1983
Mice Rats
(millions) (millions)
Confidence
Basis of estimation 1978 1982 1983 1978 1982 1983 rating
Indirect means—NIH funding . . . . — — 43.1 — — 23.6 Poor
Corrected ILAR data:
Nonprofit funding share. . . . . . 16.0 — — 5.6 — — Fair
Corrected APHIS data:
Regression . . . . . . . . . . . . . . . . . — 8.5 8.5 — 3.4 3.7 Good
Average . . . . . . . . . . . . . . . . . . . . — 10.2 11.2 — 4.1 4.6 Good
SOURCE: Off Ice of Technology Assessment.
ities, 40 percent were not registered and so would
not file a report. Any animals used in those facil-
ities would not be reported in the APHIS data. The
1978 ILAR National Survey of Laboratory Animal
Facilities and Resources stated that 35 percent of
mice and 19 percent of rats acquired for research
were bred in-house by the researchers (22), so
these too might not appear on the the APHIS data
sheets. Thus, all these limitations mean the APHIS
data may be underestimations of total animal use,
but it is impossible to estimate if the difference
is significant. Ideally, the results based on APHIS
data could be compared with estimates based on
animal breeder numbers. However, since informa-
tion on distribution of costs per animal is proprie-
tary, such an analysis is impossible. Therefore, al-
though the data contained in the APHIS reports
are the most reliable, they do not include all possi-
ble users of laboratory animals.
Inspection of some 150 institutional Annual Re-
port of Research Facility forms raises several other
doubts as to the accuracy of the data collected by
APHIS. In general, the form seems to lack any in-
struction to the individual institutions on how it
should be filled out. As a result, there is no con-
sistency in the ways in which forms are completed.
The reliability of the data on the forms today is
in question. Figures 3-2, 3-3, and 3-4, which exem-
plify the reporting problems, are actual forms re-
turned to APHIS for 1983, although the institution
names have been deleted. For example:
l Some forms have an error that can lead to
miscalculations of the number of animals used:
Column F asks for the addition of columns
B +C +D +E. The actual number desired
is C +D +E. Thus, some reports have dou-
l
l
l
bled the number of animals used (since
B =C +D +E) (see fig. 3-2). These types of mis-
calculations, along with normal mathemati-
cal errors, were corrected in the OTA esti-
mate of animal use in the Federal Government.
Thus, the numbers for Federal agencies in
these two sections are different for the same
APHIS institutional reports. (For Federal agen-
cies, this difference is fairly small.)
In many cases, respondents did not seem to
understand how to classify the animals used
in the different experimental categories. If
the APHIS form is read literally, any animal
given drugs to avoid pain or distress is also
an animal that experiences no pain or dis-
tress and could be counted in both catego-
ries (See fig. 3-3).
The answers to the category “wild animals”
differed greatly. Some forms listed legitimate
wild animals, such as seals, while others in-
cluded as wild such animals as gerbils, cattle,
sheep, and pigs (see fig. 3-4). In fact, the “wild
animals” line was often filled in with farm ani-
mals, which are exempt from being reported.
The forms are now improperly labeled in
that rats and mice are included under col-
umn A, “Animals Covered by the Act, ” yet
they are specifically exempted by USDA
regulation from coverage by the Animal
Welfare Act. Many institutions that filled out
APHIS forms may have been unaware that re-
porting rats and mice was voluntary.
These examples serve to characterize the present
system as lacking clarity and uniformity in def-
inition and accurate reporting, Redesign and en-
hanced explanation of the APHIS form would lead
to collection of more accurate data on animal use.
Table 3-5.—Various Estimates of the Number of Animals Used in the United States
W. B. Saunders W. B. Saunders ILAR ILAR ILAR APHIS APHIS APHIS Health Designs
(estimate) (projection) (estimate)
Group Species 1965 1970 1967 1970 1978 1 9 8 0a 1982 b 1983 b 1983
1,371 1,523 1,252Number of reporting institutions . . . . . . .
Rodents Total
Mice
Rats
Hamsters
Guinea pigs
Other rodents
Rabbits Total
Carnivores Total
Cats
Dogs
Other carnivores
Ungulates Total
Nonhuman primates Total
Birds Total
Amphibians Total
Frogs and toads
Other Total
ALL ANIMALS TOTAL
975 1,127 1,146— —
13,175,716
8,500,000
3,700,000
454,479
521,237—
509,052
237,771
55,346
182,425—
—
59,336
Ioo,oooc
500,000C—
4,000,000 c’f
18,561,875
58,440,000
36,840,000
15,660,000
3,300,000
2,520,000
120,000
94,480,000
59,560,000
25,320,000
5,340,000
4,070,000
190,000
30,363,000
22,772,300
6,131,000
785,900
613,300
60,500
504,500
370,400
99,300
262,000
9,100
106,200
57,700
2,070,500
—
—
—
33,472,300
37,247,377 18,646,171
25,687,067 13,413,813
9,870,628 4,358,766
870,056 368,934
737,899 426,665
81,727 79,993
494,591 439,986
247,310 242,961
56,646 54,908
182,728 183,063
7,936 4,990
95,636 144,595
54,437 30,323
667,263 450,352
2,039,490 —
2,022,755 —
601,663d —
41.667.767 19,956,386
828,216 10,530,685— 6,889,744
— 2,725,814
405,826 417,267
422,390 497,860— —
12,156,377
7,913,167
3,269,494
454,479
521,237
—
1,560,000 2,520,000 471,297 547,312 509,052
257,265 254,628
68,482 59,961
188,783 194,867
— —
237,771
55,346
182,425—
—
—
—
—
—
— — — —
58,024 54,565 59,336— —
— — —
—
—
—
— —
— —
—
—
4 9 , 1 0 2e ——
60,000,000 97,000,000 1,661,904 11,387,390 12,964,536. .
aDatq obtained from A“/ma/ we/fare Enforcement Ffepoti to Congress for 19S0. They do not include any numbers for rats and mice
bData ~ompild by H=lth @signs, lnc, (RWhester, Ny) with all available Annual Reports of Re~arch Facilities The data for rats and mice are from volunta~ reporting of the use of these SpeCieS.
cEStimateS Stated are highest value Of a rough ran9e.
‘Marine mammals, fish, and reptiles.
‘Wild animals.
‘Fish.
SOURCE: Office of Technology Assessment.
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Figure 3-2.—Example A of APHIS “Annual Report of Research Facility”
U N  ITEo ST A T ES OEPA RT M  E N T o r A G  RICU L T u  R E I 1. OAT E O F R E P O R TA N  I M A S -  A  N O  P L A N T  H E  A L T H  I N S P E C T I O N  S E  R V  I C E 1 . “ ” w !  - . . ” ” ”v E T E R I N A R Y  S E R V I C E S ?larch 7, 1984 -. - - -—.
Th IS report Is rectutrect by law ( 7 USC 2 143). Fa!l
r
I report accoralng to the regulations cdn
result In an oraer to cease dna ales, st and to be sub 3 penalt Ies as provlaea for tn Section 2150. \
[ ‘ a ’ ” ”  ‘ n - - -  E D
i
UMtl NU. 0579-0036
I
2. HE AOQU A RTERS R ESEA RC M FACILITY f ,A’r2m@ .& A ddres.c, as WgSS.
I
tared wt(h L’SLl . \ ,  i n c l u d e  Z IP C o d ? )
ANNUAL REPORT OF RESEARCH FACILITY
(’Required For Ldc/I Rcportl)tf Fucllif}, 11’/terc .4 ntmu/s ,ire ffeid
.4 d .-111 A trelldl~ig [ ‘ercn~]urla!; Has Respmlstbility)
INSTRUCTICsNS
Repssrtmg FacIIItv - complete Itcms 1 ckough 24 and submit to vour
Headquarters FacIII:>’ Attach additional sheets If ncccssary.
S .  R E G I S T R A T I O N  N O.
4 R E P O R T I N G  F Acl L I T  V f \“ome a n d  A d d r e s s ,  i n c l u d e  Z IP C o d e /
I
Headquarters Facdity - complete ]tcms 25 though 27 and submit on or before
December 1 of’ each year for the precedin~ Fedcr~! fiscal }“ear (October 1, to
Septcmbcr 30’ to rhc Veterinarian In Ch.irgu fur the Sutc where t hc research
facd~t~ hcadqu~rtcrs IS rcgtstcrcd.
R E P O R T  o  F A N tM A LS uSEO IN ACTUAL RESE A RCfi ,  TESTING, O R E X P E R I M E N T A T I O N  - S S C t l O n  2.28 O f  A n i m a l  w e l f a r e  R 0 9 U l a t t 0 n S  r S @ U l r e S  a P P r @
Dr Ia te use of anesthetics, analgesics, ana tranau,1 Izlng arugs aur{ng re;eafch, test lng, or exDerlmentat Oon. Exsrertments !nvolvtng pain or atstress w!thout use of
tnese aruqs must De feoortea and a br !ef statement explatnnnq the researcn.
A. la. / c. ) D. }E. I F,
An&mals COvereC!
B Y A c t
Number of animals used
Number of animals usea
in research, exper!mants,
New Num Ber of an!rnals usea
!a :ase.c:ci-l, :;:perfm, erots,
o. tests where agtwotsriate
or tests !nvolvtng pain or
An!mals !n research. exDerlmer, ts, distress without aamtn(s.
T O T A L  N O .
Aadeo th, $ or tests /rrvolv!rsg no pa~n
i anesthctlc, l nalgestc, or
tra!lon of apDr09rlate
Of An#mals
tranau!ltzer drugs were
Year or rrlstress. anesthetic, analgeslc, or
( C o k .  B + C + D + k’)
aamlnfsterea  to a v o f d
pain or alstress.
tranq ”ulozer drugs,
fA ttach brwf exp/anatlon} I
5. Dogs
~ 610 I
I I
o I 610 I o 1220
- —
7. Guinea Pigs 1 0 0 r!
~. iidmstcrs
o 0 1 (-)
I
9. Kabblts ?4 24 0 0 48
I
10. Pr imates
o 0 0 I f-l I n
I
11. Rats 4500 0 4500 0 9000
12. Mice 2000 1200 800 0 4000
Wii’&RKi?tT3i3 (specz~y)
~ 3 . G ~ ~ b i l ~ 50 0 0
.- 0 50
i<. sheep 8 1 7 16
~ 5 ’ C a t t l e 10 0 10 0 20
CERTIF ICATION BY ATTENDING VETERINARIAN FOR REPORTING FACIL ITY OR INSTITUTIONAL COMMITTEE
I (we) hareby certify that the ;YIM wsa amount of l sa19esIc. anestfsetlc, l nd tranaulllzln9 drum used on an~mals durm9 l ctual research, te3tln9 or •xoer~mem
tatlOn tnCJ;aln9 POSt -ODOratlva l nd O,OSt-OrOCddUral CW8 was deefnea l fsss?ooriate to relieve Daln Jnd dlstreas for tfso subject l nimal.
1 6 .  S I G  W A T U R E  O F  A fis?NDING U ETJ?Rl N4Rt AN s 7. ~STLE I  a .  O A T C  S t G U E O
. 3 / s / P ~ /
A T E  S l G f 4 = D
22.  w GN ATU R h q  C O M MI T T E E  M E M B E R 23.  f C 4 T L E  “
C E R T I F I C A T I O N  B Y  H E A D Q UA R T E R S  R E S E A R C H  P A c I L I T Y  OF F I CI A L
I CertlfY that the l bove 15 true, COrreCt, and COm Olete l nd that Professlorrally l cceptable stana?rds governtng the care, tr~tment, l nd uee of l mmals Includlng
l rsgroertatc use of anesthetic, dfIa19eSW ana tranQu Nlzln9 arugs, durlnq actual raeezrch, testing. or axperlmwstat!on including post-operative and post-procedural
~re are bsdnq followea by the above research fac!llt tes Or Sites ( 7 U.S. c. Section 2 143).
2 S  S I G N A T U R E  O  F  R E S P O N S I B L E  O  F F I C l  A L 2 6 .  T I T L E 2 7 ,  D A T E  S I G N S I D
b
VS FORM 18-23 PreL,Ious edtl!on obsolete
{AUG 81)
SOURCE: Animal and Plant Health Inspection Service, U.S. Department of Agriculture.
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Figure 3=3.-Example B of APHIS “Annual Report of Research Facility”
Thk reoort Is retaulrotl DY law ( 7 USC 2143). Failure to rWJrt acC0rd~n9 to tne ro91Jl~t10ns Can
-esult in l n order to ceJse l nd desist and to b. subject to penaltles as cwovidetl f In SectIon 2150.
UN 17=0 ST ATSSS OSS?ARTMCNT O F AG RICU LTU RC 1. D A T E  O  F  R E P O R T
A N I M A L  A N O  l L A N T  H E A L T H  I N S P E C T I O N  S S S R V  I C C 10/17/8s I
FOR  M  APPROVED
V C T E R I N A R V  S E R V I C E S
OMB NO. 0579-0036 I
ANNUAL REPORT OF RESEARCH FACILITY
(Required For Each Reporting Facifity Where Animals Are Held
Artd An Attertdirtg Veterinarian MU Responsibility)
INSTRUCTIONS
Reporting Facility . complete items 1 through 24 and submit to your
Headquarters Facility. Attach additional sheets if necessary.
Headquarters Facility . complete items 25 through 27 and submit on or before
December 1 of each year for the preceding Federal fucal year (October 1, to
September 30) to the Veterinarian in Charge for the State where the research
facility headquarters is rcuistered.
R E P O R T  O F  A N I M A L S  U S C O  I N  A C T U A L  R S S S E A R C H ,  T C S T  I NC. OR E X P
prlate use of anesthetics, ana19eslcs, l nd tranqutlizlng drugs during research, tOSl
these drWS must be rePOrted l nd a brief statement explaining thsj rsaearch.
4
Z . H E  A O Q U  A RTE R S  R E S E A R C H  FACI  L I T V  ( N a m e  &  A d d r e 6 &  w  r e i ? u -
tered with USDA, melude Zip Code)
. -- ,
3. REGISTRATION N O
4. R E P O R T I N G  F A C I LITY (Name and A d d r w a ,  i n c l u d e  Z a p  C o d e )
II MC NT AT ION - Sect Ion 2.28 of Animal Welfare Regulations retruires aocwm
), or experimentation. Experiments involvlng pain or dlstreas without uee of
A . 8 . c . t D . E. F.
Number  of animals U i e d Numbw of l nimals used
In research, l xperlmonts, In research, experlmcnts,
New Number of l nimals used
Animals Covered or tests where l ppropriate or tests involving pain orAnimals in research, l xperiments, distress without arYminls- TOTAL NO.
B Y A c t Added this or tests involvlng no pain
anestlwtic, analgesic, or tratlon of l ppropriate Of An!mals
Year
transrullizer drugs were
or distress. anesthetic, analgesic, or
(cola. + C + D + E)
l dmlnktered to l void
Pain or distress.
tran~ullizer drugs.
(Attach brwf explanation)
5. Dogs I 14 I 14
6. Cats 6 6 12
7. Guinea Pigs 18 18
8. Hamsters
I 36
I
9. Rabbits 130 130 260
10. Primates
il.. Rats 20 20 40
12. Mice 250 250 500
Wild Anisnda (specify)13.
-14.
i5.-
CERTIF ICATION BY ATTENDING VETERINARIAN FOR REPORTING FACIL ITY OR INSTITUTIONAL COMMITTEE
I (W.) hwcby csrtlfy that the typo l nd l mount of •nalgssl~ l toathot.i~ l fid trMIqulllZlra9 drugs used on l tlmms during l ctual rsaserch, t4Stln9 or l Xparhrrem
tition Including peat-operathre and post-procedural c4re was desmed l ssprowlate to r.lleV4 PSln l nd dlatmaa fOr the subject l fSl_l.
16. SS* A TU W C  O r ~ N O I N G  V C T K R I N A R I A N s 7.  TITLE 8  S .  DA7C  S IGNCD
19. s i ~ U R E  ~
/o/4/1~3
M C M B C R 2 0 .  T I T L E 2t .  DATE S#eNCO .
I I
22. SIG NATURC Of COMMITTCX M B . E R 23. TITLE 24. OATC SIGNCD
I I
CERTIF ICATIC$N BY HEADQUARTERS RESEARCH FACIL ITY OFFICIAL
I certify that the l bove Is true, COrrSCt, l nd complete and that profosslonally l cceptable standards 9overning the ~re, trsatmont, l nd use of wslmals Irrcludlng
aPPrOPrlatO use of l nOSttS6tlC, l na194Sk, and tranquilizing strugs, durlrw l ctual reasarch, testing, or sxparlmontatlon Inclsrdlng peat.opwatlw l nd post-procedural
u r e ~ rch facllltles or sltea (7 U.S. C. Sactlon 2143).
28. SI+NATUR* OF 27. DATE SIGNED
1- 1 1
VS FORM 18-23 Rsviorw l ditfon obookte
(AUG 81)
SOURCE: Animal and Plant Health Inspactlon Service, U.S. Department of Agriculture.
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Figure 3=4.—Example C of APHIS C’Annual Report of Research Facility”
&I&C& &w,r6  DI .w(7  USC21431.  F . , lUreto , . ,o r ta .co~d , .g  tot .e reg . , . t iomcan
result in l n order to cease ana desl$t ana to be sublect tO Penaltles as Drovlded fOr In section 2150.
T ATCS DEPARTMENT O F AG R ICV  LTU RE
DEG&wT&fh
1. OAT E O F RcPO RT
O l LA NT H E A LTH INSPECTION SE RV ICf?
I
FORM APPROVED
V E T E R I N A R Y  s E R V I C E S 30 NOV 83 OMB NO. 0579-0036
2. HE AOQU ART E R S R ESE A RCU FACI LIT Y 1,\aMC A AOareSS, a W17U-
w . m l & . B
tered with t)SD,l, Include X IP Code)
ANNUAL REPORT OF RESEARCH FACILITY
(Required For 12ZCII Reporflrrg Facility It’here Animak Are Held
Artd An .~ttendtng l’ctermurwt Ha-s Responsibility)
[
INSTRUCTIONS
I 3. R E G I S T R A T I O N  N O .
Roportmg Faclltty - complete Items 1 through 24 and subm]t to your
1
4 R E P O R T I N G  F AC! L I T +  ( A  a m c  a n d  A d d ? e s $ ,  ! n c ) u d e  Z w  C O d e )
Headquarters Facihty. Atuch addmonal  sheets If necessary.
Headquarters Facilny . complete Items 25 through 27 and submit on or before
December 1 of each year for the preceding Federal fual yczr (Octobe: 1, to
September 30) to the Vcceruuran m Charge for the State where the research
facilltv headquarters K reg~stered.
REPORT o F A NtM A LS USEO I N ACTU A L RESEARCH, TESTING, O R E X PE RI M IS NTAT ION - Sect ton 2.28 Of Animal We! fare Reguiat ,On S rCOU lreS aPOrG
prlate use of Jnesthetlcs, analgesics, and tranou[l Izlng drugs CIurlng research, teStln9, or 8x Perlmentatmn. Exper{ment$ tnvolvtng patn or dtstress wlrnout use of
these Orugs KIU51 be fCPOrterJ and a or !el statement exolaonlng the rS!sear Ch.
A . ifs. I c . I o. Ic. 1 F.
Number of l n!mals used Numtser of l nimals used
In reuarcn, l xpeflments, on fesearcn, exoer$ments,
N e w Number of animals used
An8mals Covered
or tests where aopromiate
or tests lnvolvtng Pain or
An!mals 1 In research, exver oments, d,strem without aamlnts.
T O T A L  N O .
B Y A c t I AcS~g?rthlS
anestnetlc. analgeslc, or Of An8mals
or rests Involvong no patn tfanaulllzer drugs were
tratlon of l oprorwmte
or Olstress. anestnetlc. analgesic, or
(Cols. X l C l D + L“)
l dm!nlsterest to l vo!d
pain or cststress.
t rancaual tzer  dru9s.
(A ttoch bwrf l xaslanation)
5. Dogs I 44 I 12 189 0 I 201
I 16. C&:s o { o 1 0 I o 0
7. Guinea Pigs I 383 I 137 186 0 323
8. Hamsters
~ 207 0 207 [ o I 207
9. Rabbits I 638 ~ 40 598 0 638
1
10. Primates I o I 12 i 119 0 I 131
11. Rats 4357 1940 1444 I o 3384
12. Mice 1373 363 739 0 1102
Wild Animals (spec:fy)
13. TURTLES 293 0 293 0 293
14. DOMESTIC PIGS 609 0 609 0 609
15
. GERBILS 100 0 100 0 100
CERTIF ICATION By  ATTENDING VETERINARIAN FOR REPORTING FACIL ITY OR INSTITUTIONAL COMMITTEE
I (We) hereby certlfY that th. tYPe l nd l mount of l nalgeslc, anesthetic, ~nd trantsulllzlng drugs used on l nimals dtsrln9 actual research, tssattng or l xpertmen.
tation #nclurSlng POSt-OP*rative l nd. oost-orocodural-r~ wasKteemeO l ptxom!atc to relleve oaln l nd distress for the subject l nimal.
ts. sIC3NATu RE OF ATT fsNOING V =TEfelN4~~ — f 7. TITLE $8. OATE SIGNEO
30 NOV 83
t e. SIGNATURE OF C O SAM IT T C SS MS@fBER 2 0 .  T I T L E 2 1 .  O A T E  S I G N E D
30 NOV 83
2 2 .  S I G N A T U R E  O  F  C O M M I T T E E &
- .
E M B E R 2 3 .  T I T L E 2 4  O A T E  S I G N E D
1 I
CERTIF ICATION BY HEADQUARTERS RESEARCH FACIL ITY OFFICIAL
correct, and complete and tfsat rxofesslonally l cceptable stanaards governing the care, treatment, and usc of animals Inclualng
l pwopriate use of anesthet analgeslc, and trancrutlazlng Orugs. Ourting l ctual rosearcn, testtng, or ex$aertmentataon Including post-osserat!vo arm post- Proc@aural
above researcn facll It les or sites ( 7 U.S. C. section 214 3).
25.  S IGN ATU RE O & 2 6 .  T I T L E 2 7 .  O A T E  S I G N E D
I 30 NOV 83b ,
VS FORM 18-23 Previous edat:on obsolete
[AUG 81)
SOURCE: Animal and Plant Health Inspection Service, U.S. Department of Agriculture.
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Even with these limitations and qualifications,
the numbers generated by the APHIS data pro-
vide a range that can be used in discussions of ani-
mal use. The totals include: 1.8 million mandated
species, 100,000 to 500,000 birds, 100)000 to
500,000 amphibians, 2.5 million to 4.0 million fish,
and 12.2 million to 15.25 million mice and rats.
Therefore, it appears that between 17 million
and 22 million animals are used in united
States laboratories annually.
The largest group is represented by mice and
rats. For reporting institutions, mice represent 60.8
percent of all animals used, and rats 25.1 percent.
In addition, for the mandated species, certain in-
stitutions use specific species disproportionately
to their percentage of overall total use (see table
3-6). Fifty percent or more of all cats and dogs are
used by universities and medical schools. Guinea
pigs are used mostly by the pharmaceutical indus-
try, whereas hamsters are used more often in bio-
medical research, and to a lesser extent in univer-
sities, medical schools, and the pharmaceutical
firms. Sixty-two percent of rabbits are used in
universities, medical schools, and the pharmaceu-
tical industry, as are 75.6 percent of the primates.
For rats and mice, the trends indicated in table
3-6 are clouded by the fact that there was more
reporting of rat and mouse usage in 1983 than in
Table 3-6.–USDA/APHlS Data, Changes 1982-83
(reporting Institutions only)
Institution type
Univers i t ies  Hospi ta ls Bio- Toxicology Pharmaceu- State & Food, feed
& medical nonuni- medical testing Chemical tical, device local & miscel. Federal
schools versity research labs companies  &  d iagnosis  government Ianeous agencies Total
..— –
rear
Rats:
1982
1983
0/0 change
Mice:
1982
1983
0/0 change
Dogs:
1982
1983
%O change
Cats:
1982
1983
0/0 change
Guinea
pigs:
1982
1983
0/0 change
Hamsters:
1982
1983
0/0 change
Rabbits:
1982
1983
‘/0 change
Primates:
1982
1983
0/0 change
lnstitutions
reporting:
1982
1983
0/0 change
1,079,208
1,234,864
14
1,678,300
1,951,466
16
98,983
90,001
- 9
34,555
32,535
–5
82,198
64,554
–21
151,365
115,483
–23
173,716
158,058
- 9
23,353
22,201
- 4
410
402
- 2
86,472
108,430
23
203,768
222,080
8
13,622
12,605
- 7
2,716
2,265
–16
6,104
7,195
17
5,501
5,472
– 0.5
15,171
15,042
-0.8
557
1,059
90
129
140
8
343,915
408,938
18
1,579,664
1,512,424
–4
22,291
21,483
–3
7,697
6,788
-12
25,225
30,696
21
65,146
169,272
159
63,863
64,626
1
13,543
13,272
–2
167
159
–4
97,237
144,162
48
431,464
495,087
14
3,457
5,003
44
137
172
25
35,145
28,753
-18
12,954
11,922
–7
60,785
55,785
- 8
2,577
5,809
125
: :
8
176,874
114,215
-35
161,659
158,752
–1
2,194
1,591
–27
115
44
–61
18,182
14,722
– 19
3,180
612
–80
20,970
22,034
5
144
25
–82
27
31
14
558,630
778,425
39
1,669,629
2,021,157
21
37,604
38,311
1
9,073
8,624
–4
272,405
297,849
9
131,227
112,618
– 14
177,289
159,276
- 1 0
7,709
9,376
21
145
155
6
11,299
30,378
168
200,150
477,250
138
322
436
35
87
72
-17
9,044
10,090
11
8,401
3,193
–61
2,102
1,948
–7
329
243
–26
19
18
- 5
12,700
14,355
13
6,247
3,632
–41
3,698
3,400
- 8
2,040
2,092
2
1,504
930
–38
23
22
–4
1,862
2,504
34
66
82
24
26
32
23
359,479
439,729
22
958,863
1,071,339
11
12,696
9,595
–24
3,541
2,774
–21
48,053
66,448
38
39,490
35,885
- 9
31,554
29,779
–5
6,287
7,269
15
125
123
–2
2,725,814
3,269,494
19
6,889,744
7,913,167
14
194,867
182,425
–6
59.961
55,346
- 7
497,860
521,237
4
417,267
454,479
9
547,312
509,052
–6
54,565
59,338
8
1,127
1,146
2
SOURCE: Office of Technology Assessment.
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1982. So, although it appears from table 3-6 that
the usage increased, this was in fact not so (as can
be seen from table 3-4). Data for all institutions
from the regression equations show no change in
mice and a small increase in the use of rats. How-
ever, since the same pattern of increase by institu-
tional group reporting can be seen from table 3-6,
there has likely been no increase or decrease in
use of these two species between 1982 and 1983.
In table 3-6, the number of reporting institutions
includes those that reported any number for any
species, whether these included rats or mice or
not. Few significant changes occurred as a func-
tion of institution type for the 2 years surveyed.
No trend in animal use can be identified be-
tween 1982 and 1983, and the available data
provide no justification for predicting either
increases or decreases in future years. It
would have been possible to examine the 1981
APHIS data sheets and determine whether, on the
basis of 3 years’ data, a trend for the mandated
species existed, but the 1981 data sheets would
not indicate trends for rats and mice. The other
methods of estimating laboratory-animal use do
not match the reliability of the APHIS data, and
thus do not lend much credence to the numbers
reported in the past.
Future Animal Censuses
The major limitation with this estimate of an-
nual laboratory-animal usage was the need to de-
pend on available data sources, with all the limita-
tions just described. Although the APHIS data
sheets were of considerable value, they still do not
substitute for an appropriately designed stratified
random sampling of all possible users. Only then
would all possible institutions be represented. The
APHIS scheme depends on institutions to request
certification. Some may be operating and not re-
porting to APHIS. Still, with considerable further
effort, a post-hoc stratification could be done based
on the APHIS data.
Estimates could be improved by two major ap-
proaches. The first, and least expensive, would in-
volve the use of all annual APHIS reporting forms—
following an imperative redesign of the form—as
well as thoroughly determining which registered
institutions in each year did and did not report.
Then appropriate statistical estimation techniques
could be used on an institution-type and year-
specific basis to correct for missing data. The sec-
ond, and more ambitious, approach would be to
conduct a stratified random sample study of all
possible users. The stratification would be by type
of institution, size of institution, and species of ani-
mals. From such a sample, appropriate statistical
techniques could be used to project to the entire
population of user institutions.
In 1985, the National Research Council’s Insti-
tute of Laboratory Animal Resources announced
plans for another in its series of surveys of experi-
mental animal usage. The 1986 census will include
mammals and birds, but omit fish, amphibians, and
reptiles.
SUMMARY AND CONCLUSIONS
A rough analysis of the number of laboratory the individual annual reports furnished by each
animals used is important to provide some non- registered facility for 1982 and 1983 were evalu-
text in which to discuss alternatives to using ani- ated. Generally, it was found that great dispari-
mals, evaluate progress toward the goal of using ties existed among the different sources. No sin-
fewer animals, and judge the effect that alterna- gle data source presents an accurate count of the
tives might have. OTA therefore evaluated exist- number of laboratory animals used in the United
ing data on the number of laboratory animals used States since not one includes all potential users.
each year in the United States. In addition, it is impossible to compare data among
The data sources considered included various sources due to the inadequacy of information on
reports and surveys published by the National Re- survey and data collection methodologies, defini-tions, areas of use, reporting requirements, andsearch Council’s Institute of Laboratory Animal
Resources, various market surveys, and the an- the inability to justify completeness of the data.
nual reports submitted to USDA’s Animal and Plant In a comparative analysis of data sources, it was
Health Inspection Service. For the latter source, found that the most useful data were the APHIS
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data sheets completed by every institution that uses
laboratory species regulated under the Animal
Welfare Act, APHIS requires that registered insti-
tutions report all use of dogs, cats, guinea pigs,
hamsters, rabbits, and nonhuman primates. Even
with this requirement, though, it seems that APHIS
does not receive animal-use information from all
possible users. The data from these forms were
found to be more accurate than the Animal Wel-
fare Enforcement Report, a summary submitted
annually by APHIS to Congress. This report usu-
ally neglects 10 to 20 percent of the annual reports
(those submitted late,  usually after December 31)
and so underestimates the actual number of dogs,
cats, guinea pigs, hamsters, rabbits, and nonhu-
man primates used.
For fiscal years 1982 and 1983, the numbers of
these kinds of animals used, according to the APHIS
data sheets, are shown in table 3-7. For other lab-
oratory species—mice, rats, birds, amphibians, and
fish–the ability to obtain accurate estimates of the
number used is impaired by a lack of reliable data
sources. The best estimates are that 100,000 to
500,000 birds, 100,000 to 500,000 amphibians, 2.5
million to 4.0 million fish, and 12,2 million to 15.25
million rats and mice were used. (Animal use in
medical and veterinary education is estimated to
beat least 53,000 animals per year and is discussed
in ch. 9.) Total animal use in the United States,
therefore, is estimated as between 17 million and
22 million a year.
The great discrepancies in data sources meant
no trends could be observed overtime and among
different types of institution. Even within the
APHIS data for six kinds of animals, no clear trends
Table 3-7.–Animai Use Reported to the U.S.
Department of Agriculture, 1982 and 1983
Number used Number used
Animal in 1982 in 1983
Dogs . . . . . . . . . . . . . . . . . . 194,667 182,425
Cats . . . . . . . . . . . . . . . . . . 59,961 55,346
Hamsters . . . . . . . . . . . . . . 417,267 454,479
Rabbits. . . . . . . . . . . . . . . . 547,312 509,052
Guinea pigs . . . . . . . . . . . . 497,860 521,237
Nonhuman primates. . . . . 54,565 59,336
Total . . . . . . . . . . . . . . . . 1,771,832 1,781,875
aTOtalS  d. not lncl~e  ratg  or mice, two species that together represent the
majority of animals used.
SOURCE: Office of Technology Assessment.
were found. Indeed, the most important finding
was that no accurate source exists on the num-
bers of animals used annually in the United States.
A stratified random sample of all possible user in-
stitutions done with a correct statistical analysis
would probably be the best way to estimate labora-
tory-animal use in the United States.
In the Federal Government, six departments and
four agencies use animals for intramural research
and testing. These investigative efforts range from
uncovering new knowledge that will lead to bet-
ter health (within the National Institutes of Health),
to evaluating hazardous substances in consumer
products (within the Consumer Product Safety
Commission’s Directorate for Health Sciences), to
protecting the health of American astronauts
(within the National Aeronautic and Space Admin-
istration’s Life Sciences Division).
OTA used the APHIS Annual Report of Research
Facility forms to track animal use within the Fed-
eral Government itself by department (and by di-
vision within departments) and by species. In this
way, it was possible to identify what portion of
the estimated 17 million to 22 million animals used
yearly were used within Federal facilities. In 1983,
the Federal Government used at least 1.6 million
animals, largely rats and mice. Ninety-six percent
of the 1.6 million animals were used by DOD,
DHHS, and the VA. Of the total, about 9 percent
were dogs, cats, hamsters, rabbits, guinea pigs,
and nonhuman primates.
The APHIS forms require that all experiments
be categorized as: 1) involving no pain or distress;
2) involving appropriate anesthetic, analgesic, or
tranquilizer drugs to avoid pain or distress; or 3)
involving pain or distress without administration
of appropriate anesthetic, analgesic, or tranquilizer
drugs. Sixty-three percent of the animals used
within Federal departments and agencies were in
the experimental situation categorized as involv-
ing no pain or distress while 32 percent were given
drugs and only 5 percent experienced pain or
distress.
The APHIS reporting system lacks clear defini-
tions and uniform reporting, If accurate data are
to be obtained, the forms must be revised and bet-
ter explanations of how to complete them must
be provided.
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either human or non-human animals for purposes that are not in their own
is both ethically unjustifiable and, in the long run, counter-productive.
Alex Pacheco
People for the Ethical Treatment of Animals
appropriately
March 15, 198.5
concerned for theFortunately there are many who, while deeply and
compassionate treatment of animals, recognize that human welfare is and should be our
primary concern.
One cannot intelligently assess vivisection
areas of human life: for food, furs, leather,
Frederick A. King
Yerkes Regional Primate Research Center
Psychology Today, September 1984
in isolation f-rem animal exploitation in other
in so-called sports, in movies, in the wild.
Vivisection, properly seen, is simply one variation on the cultural theme of animal
sacrifice.
Michael A. Giannelli
The Fund for Animals, Inc.
March 10, 1985
The use of any particular animal-say, a sheep—in medical research is more important
than its use as lamb chops.
The
The Research
Carl Cohen
University of Michigan
News 35(1()- 1 2):9, 1984
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Chapter 4
Ethical Considerations
The range of opinion on the rights and wrongs
of using animals to satisfy human needs is as broad
as the political spectrum itself. At one extreme,
animals are thought to be entitled to at least a por-
tion of the respect, individual freedom, and dig-
nity that are considered to be basic human rights.
Some say that animals should be recognized as be-
longing to a community that includes humans. At
the other extreme, humans are thought to have
broad and absolute authority over the lives and
interests of animals. From this perspective, expe-
diency alone, not morality, dictates what we may
do with animals.
To illustrate the distance between these extremes,
a recent legal brief for animal rights can be con-
trasted with a televised interview with three scien-
tists who perform animal experimentation. Ac-
cording to the brief (43):
If being alive is the basis for being a moral ob-
ject, and if all other interests and needs are predi-
cated upon life, then the most basic, morally rele-
vant aspect of a creature is its life. We may
correlatively suggest that any animal, therefore,
has a right to life.
The scientists, in a televised exchange with Harvard
philosopher Robert Nozick, were asked whether
the fact that an experiment will kill hundreds of
animals is ever regarded by scientists as a reason
for not performing it. One answered: “Not that
I know of .“ When Nozick asked whether the ani-
mals count at all, one scientist replied, “Why should
they?” while another added that he did not think
that experimenting on animals raised a moral is-
sue at all (45).
People at both extremes would probably agree
that, given a choice between experiments equiva-
lent in cost and scientific value, one that does not
require the destruction of animals would be prefer-
able to one that does. This consensus, however,
would probably evaporate if animal experimen-
tation produced greater scientific validity or the
technique that used animals had significant cost
advantages.
In morals, as in politics, most people tend to shun
extremes. However, a middle view is at once the
most defensible and the most difficult to defend,
Pitted against extreme or esoteric positions, the
numbers on its side create a presumption in its
favor. Yet a presumption given only by the weight
of opinion will not amount to a moral justification.
A belief is not shown to be true simply by count-
ing the votes of those who accept it. Some basis
for an opinion, independent of it being accepted,
must be found.
Adoption of a middle view is hazardous in two
respects. First, it runs the risk of inconsistency.
Propositions located at polar extremes will usu-
ally contradict one another, and a position that
seeks to incorporate both may find itself embrac-
ing a contradiction. In the case of toxicity testing,
for example, it may not seem possible to respect
the interests of experimental animals and yet use
them as tools for enhancing human health and
safety.
The second risk is that consistency will be se-
cured at a price too high, by way of a theoretically
unattractive ad hoc device. In principle, two con-
tradictory propositions can be reconciled simply
by making one an exception to the other. It could,
for example, be stipulated that the general rule
against harming animals does not hold when they
are used to test for toxicity. But it is one thing to
say this and another to give a reason for it. Com-
plex rules, introduced for no reason other than
to remove a particular inconsistency, muddy a
point of view without shedding any light on the
hard moral cases it must address. More important,
they are arbitrary.
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Interest in the moral status of animals is by no
means modern. The ancient religions had much
to say about the place that animals were to occupy
in the cosmic scheme of things. Oriental creeds
were, as a rule, reluctant to draw a sharp distinc-
tion between humans and other species. All ani-
mal lives were judged worthy of protection and
some were thought to be sacred. The doctrine of
transmigration left still more room for caution—
any animal body might house a soul entitled to spe-
cial care. The various forms of the doctrine of trans -
migration share the thesis that a single, continu-
ous, immaterial individual may pass from one body
to another, which maybe of the same or a differ-
ent species. If the latter, its conduct in the earlier
incarnation may determine the kind of body it in-
habits next. For such reasons, the prescribed die-
tary regimen in the Orient was frequently vegetar-
ian. Modern influences have relaxed, but not
wholly removed, the grip of these beliefs.
In the West, a different tradition took root, one
that seems to have assigned value to animals only
as they serve human purposes. Judeo-Christian
doctrine appears to have condoned an indiffer-
ent, if not openly exploitative, attitude toward non-
human animals (38,45). (For an opposing view, see
refs. 6 and 49.) The Genesis account suggests that
humans are the last and most perfected of God’s
creatures. Humans alone, of all living things, bear
the likeness of God, and receive the divine com-
mission to exercise “dominion over the fish of the
sea, and over the birds of the air, and over the
cattle, and over all the earth, and over every creep-
ing thing that creeps upon the earth” (Genesis 1:26-
28; all Biblical references and quotations are to
the Revised Standard Version). After the flood, God
rewarded Noah and his sons with this blessing:
“Every moving thing that lives shall be food for
you; and as  I gave you the green plants, I give you
everything” (Genesis 9:3). A brief Talmudic story
indicates that Judaic practice was to the same ef-
fect: “A calf was being taken to the slaughterer,
when it broke away, hid his head under the Rabbi’s
skirts, and lowed in terror. ‘Go,’ said he, ‘for this
wast thou created’ “ (12).
These passages do not warrant the inference that
humans are permitted to treat animals in any way
they please. Even when suffering is inflicted as
a means to some human end, humans are subject
to the condition of using the animal. Wanton cru-
elty would not be allowed. Nor is it clear just what
human dominion includes, until the terms of a
model ruler-subject relation are spelled out. Hu-
mans must presumably rule well, and the good
ruler does not take authorized but unjustified ac-
tions. Much depends, too, on whether human sov-
ereignty over nature is to be thought absolute or
limited by a divine will that may have set some
value on animals in addition to their utility for
humans.
In a number of passages, the scriptures seem
to place a rein on the use of animals. Genesis con-
firms that God had already judged the world as
good–that is, possessed of some value–before hu-
mans were created (Genesis 1:3,10,13,18,21). And
on several occasions in the later books of the Old
Testament, humans are expressly directed to show
kindness to the animals under their control. Thus,
“you shall not muzzle an ox when it treads out
the grain” (Deuteronomy 25:4). And, “a righteous
man has regard for the life of his beast, but the
mercy of the wicked is cruel” (Proverbs 12:10).
The most persuasive evidence for restraint may
lie in the role-model of the good shepherd, often
cited in both testaments. At one point, by report
of the prophet Ezekiel, God becomes annoyed
(Ezekiel 34:2,4):
Ho, shepherds of Israel who have been feeding
yourselves! Should not shepherds feed the sheep?
. . . The weak you have not strengthened, the sick
you have not healed, the crippled you have not
bound up, the strayed you have not brought back,
the lost you have not sought, and with force and
harshness you have ruled them.
God’s own rule is often compared with the con-
cern that shepherds should have for their flocks
(Ezekiel 34:11-13; John 10:11; Luke 15:4-7). De.
signed to show that God stands to humans as they
stand to animals—a kind provider even if there
are no duties to provide for them—that simile
would fail if the shepherds could wholly disregard
the welfare of their animals.
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Aside from this figurative guide, the New Testa-
ment is spare in its references to handling animals.
Saint Paul’s discussion of the proscription against
muzzling the ox suggests a human benefit: “Is it
for oxen that God is concerned? Does he not speak
entirely for our sake? It was written for our sake,
because the plowman should plow in hope and
the thresher thresh in hope of a share in the crop”
(I Corinthians 9:9-10). Thus, the thresher was to
let the ox feed from the corn being worked, not
so much for the good of the ox, but because a well-
fed animal would yield a larger return.
This passage suggests a shift in sentiment from
the old to the New Testament. For Christians, the
paramount practical concern is the condition and
future of the immortal soul possessed by human
beings. Animals are not believed to have immor-
tal souls, nor be repositories for human souls. In
the Christian world view, then, animals are left
without the one thing that has special value in
itself—a soul. An animal’s welfare is a good thing
only as it is good for the human being.
The letter containing Paul’s reading of the Old
Testament rule was written only a generation af-
ter Christ’s death, when Christianity was still anew
faith. The distinction between humans and other
animals hardened as the creed acquired the trap-
pings of theory, but in such a way as to raise new
questions about its real source. The legacy of Greek
philosophy exercised such a pervasive influence
over Christian theology in its formative years that
the distinction could be traced to Athens as easily
as to Jerusalem.
It might be said that in theology all roads lead
back to Augustine or Aquinas. On the subject of
animals, the Augustinian position finds expression
in his critique of a competing doctrine, which, on
the premise that animals also had souls, would not
allow killing them. Augustine cited the conduct
of Christ as a lesson to the contrary (7):
Christ himself shows that to refrain from the
killing of animals and the destroying of plants is
the height of superstition, for judging that there
are no common rights between us and the beasts
and trees, he sent the devils into a herd of swine
and with a curse withered the tree on which he
found no fruit.
If Christ could use animals for his own purposes,
then so apparently could we. Augustine’s view,
however, was tempered in two respects. First, he
denied that animals were mere instruments of hu-
mans. As creatures made by God, they also pos-
sessed a good of their own (7)8). Second, animals’
utility was the use to which human intelligence
might put them, not the convenience or incon-
venience that they might present. Augustine did
not hold that humans were to treat animals accord-
ing to their own pleasure or displeasure (8).
Aquinas ’view of animals was more sophisticated
and less sympathetic. Every natural being that
underwent development had an end or perfected
state that God had created it to achieve. God made
humans, however, as free and rational agents, with
control over their actions. People’s lives took their
objectives from their designs. Being neither free
nor rational, an animal was merely a means to an
end existing outside it (in the form of some pur-
pose that a rational individual might have for it).
Thus, the nonhuman animal was ordered, by na-
ture and providence, to the use of humans (l).
From Aquinas’ perspective, the Old Testament
concern for animals had been appropriately char-
acterized by Saint Paul. People should avoid mis-
treating animals not because this would be best
for the animals, but because cruelty could be harm-
ful to humans. Strictly understood, disinterested
charity towards animals was impossible, since there
was no common fellowship between humans and
them (2).
In its essentials, this view prevails within the
Catholic Church today. Its implications for research
in the life sciences have not gone unnoticed. Writ-
ing at the turn of this century, Father Joseph Rick-
aby, the English Catholic moral theorist, denied
that the suffering of animals was an obstacle to
biological inquiry (42):
Brutes are as things in our regard: so far as they
are useful to us, they exist for us, not for them-
selves; and we do right in using them unsparingly
for our need and convenience, though not for our
wantonness. If then any special case of pain to
a brute creature be a fact of considerable value
for observation in biological science or the medi-
cal art, no reasoned considerations of morality
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can stand in the way of man making the experi-
ment, yet so that even in the quest of science he
be mindful of mercy.
Protestantism retains the thesis that humans en-
joy a rightful hegemony over other animals, but
suggests a shift towards a “stewardship” interpre-
tation of that role. John Calvin, the 16th-century
Reformation theologian, maintained that when
God placed animals “in subjection unto us, He did
it with the condition that we should treat them
gently” (13). They were brute beasts, to be sure,
but for Calvin as for Augustine they were also crea-
tures of God. Calvin went a step further, however,
in making this fact about animals a limitation on
humans’ use of them. Here humans would seem
to be less the sovereigns of nature than deputies
appointed to manage God’s earthly estate. Every
creature would still be subject to God’s ownership
and control. A person was still worth more than
any number of sparrows, yet ‘(no one of them will
fall to the ground without your Father’s will” (Mat-
thew 10:29). Thus, Karl Barth, a leading modern
Protestant theologian, urged that people possess
the right to use and sometimes to kill animals, but
only because God has so authorized it in order that
humans might live (9).
There have been a few distinguished Judeo-Chris-
tian defenders of a position much closer to the
oriental view. Saint Francis and Albert Schweitzer
both pressed for a principle of reverence toward
every living thing. But their ideal has been received
as just that: a norm perhaps for saints, and some-
thing all should desire, but not binding on imper-
fect individuals in less-than-ideal circumstances.
In the absence of mainstream philosophical sup-
port, the intellectual authority of the reverence-
for-all-life rule is thought to be outweighed by the
personal prestige of its practitioners (21).
Until 1600, the philosophical mainstream was
Aristotelian. Using a much broader conception of
the soul than the current one, Aristotle distin-
guished living from nonliving beings by the pres-
ence or absence of some form of a soul, or life-
giving power. Its function might be nutrition,
sensation, desire, locomotion, or thought. The first
of these, but not the rest, was found in plants. All
animals had sensation and desire as well, and most
also had locomotion. Humans alone had the power
of thought (4). This advantage made humans nat-
urally suited to rule over other living beings and
made animals natural slaves. Aristotle reached this
conclusion by generalizing from phenomena al-
ready at work within humans: Those with greater
rationality exhibited an internal mastery of rea-
son over desire and an external mastery over those
who, because they lacked the mental equipment
to tend to more than their bodily needs, required
direction from others (5). This resulted in leader-
ship by those most competent to rule.
Natural fitness implied that nature worked toward
certain ends that together formed a master plan.
The significance of the 17th-century scientific rev-
olution lay not so much in its overthrow of church
authority in the empirical realm as in its discov-
ery of a method and a subject matter (i.e., mechan-
ics treated as a branch of physics) that dispensed
with the hypothesis that nature had purposes. Na-
ture became simply the sum of matter in motion,
mathematically describable without reference to
goals that phenomena might serve.
The philosophical foundations for the new world
view were supplied by Rene Descartes, who rec-
ognized only two kinds of existence, material and
mental. Bodies were extended in space and time
and divisible into parts, with properties of size,
shape, and weight. Minds contained beliefs, emo-
tions, and intentions, but no physical properties.
The human was a composite being-the only one—
with both a body and a mind (18).
Animals did not fit comfortably into the Carte-
sian scheme. They obviously had bodies, but did
they not also have sensations and desires? Des-
cartes answered that in a sense they did, but that
their behavior could be duplicated by a machine,
while human behavior could not. In their use of
language and thought, humans revealed a capac-
ity to respond to stimuli in a variety of ways,
whereas animals would respond in only one, “ac-
cording to the arrangements of their organs” (19).
For all their differences, the Aristotelian and
Cartesian theories joined hands in making the activ-
ities that required reasoning the distinctive mark
of humanity. Both defined the human being as a
rational animal. That thesis was not questioned
until the following century, when British empiri-
cists criticized it as inflated claims for the power
of reason. The Scottish skeptic David Hume con-
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curred with Descartes that the human mind was
capable of creatively entertaining a variety of pos-
sible conclusions from a given body of experience.
But this, Hume argued (29), was nothing more than
a habit of inference formed from repeated obser -
vations, something that dogs could do as well (30):
'Tis necessary in the first place, that there be
some impression immediately present to their
memory or senses, in order to be the foundation
of their judgment. From the tone of voice the dog
infers his master’s anger, and foresees his own
punishment. From a certain sensation affecting
his smell, he judges his game not to be far distant
from him.
Secondly, the inference he draws from the pres-
ent impression is built on experience, and on his
observation of the conjunction of objects in past
instances. As you vary the experience, he varies
his reasoning. Make a beating follow upon one
sign or motion for some time, and afterwards
upon another; and he will successively draw
different conclusions according to this most re-
cent experience.
The issue dividing Descartes and Hume survives,
still unsettled, in current controversies over artifi-
cial intelligence and animal cognition. Recent decades
have witnessed an explosion of empirical inves-
tigations into the behavior of nonhuman animals
(26,35,50). Among these, various efforts to teach
higher primates how to use a nonverbal language
have captured the public’s imagination. Inferences
drawn from such studies, however, encounter two
obstacles. First, to argue that chimps consciously
use gestures in the same way that human deaf-
mutes do is to assume a certain theory about the
relation between bodily behavior and mental oper-
ations. No consensus on mind-body relations exists
today. The same difficulty, it is worth noting, af-
fects various efforts to use similarities in brain
structure and function as evidence for similari-
ties in thought.
Even if such matters could be resolved, a greater
conceptual hurdle would remain: what is the con-
nection between language and thought? Language
requires combining terms into well-formed sen-
tences using rules of grammar and meaning. Lin-
guistic mastery includes the capacity to create
novel sentences in situations not precisely like
those already encountered and the resources to
express thoughts indifferent modalities (as descrip-
tions, questions, commands, and so on) (48). It also
seems to require recognition that something said
is true, false, or uncertain (17,24).
Although no one knows whether other primates
will ever approach human beings in linguistic per-
formance, it would be a mistake to focus on that
issue. Evidence is mounting that animals can rec-
ognize visual patterns, remember where their food
is located, learn how to perform nonmechanical
tasks, and foresee where a moving prey will even-
tually be positioned, even if they cannot master
a language (26,50). In this sense, animals exhibit
intelligence as defined by ability to adapt to envi-
ronmental conditions. From a Darwinian (evolu-
tionary) perspective, humans do not hold a privi-
leged status over animals. Humans are not more
highly evolved than other animals; all have evolved
to fill their respective niches.
Neither linguistic nor nonlinguistic findings hold
all the answers. The moral issue is not simply
whether animals have some and lack other abili-
ties that human beings possess, but whether the
differences between them make for differences
in how humans and animals should be treated.
Sometimes the differences matter, common sense
might say, and sometimes they do not.
T H E  E T H I C A L  Q U E S T I O N S
HOW, if at all, should animals be used in research,
testing, and education? Before this can be answered,
a preliminary question must be asked (14,15,44,47):
What moral standing does an animal have? Is it
the kind of being to which humans could possibly
have moral duties and obligations? Taking one side
or another on the question need not include any
particular moral judgment. Whatever its resolu-
tion, the separable moral issue remains: what con-
straints, if any, regulate humans’ use of animals?
These constraints might be weaker if animals lack
moral standing, but not necessarily absent al-
together.
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Moral Standing
Modern moral theory operates under a “law con-
ception” of ethics (3). It judges particular human
actions as right (lawful) or wrong (unlawful) as they
comply with or violate some universal principle
of conduct. In this, it departs from the classical
theory of the virtues, which makes individual char-
acter the unit of evaluation and does not attempt
to reduce ethics to a system of rules. Under the
law conception, moral standing also goes to per-
sons, but it is not conferred by an individual, insti-
tution, or community. From this point of view, an
individual counts as a person because of some in-
herent characteristic. This is the chief reason why
it is within the moral domain to speak of the natu-
ral duties and the natural rights of a person. A le-
gal system can, of course, recognize natural duties
and rights.
For obvious reasons, no one has ever argued that
animals can have moral duties (40). That would
require that they freely choose to act among alter-
natives they judge to be right or wrong—a skill
as demanding as full-blown linguistic competence
would be. Nevertheless, it is possible to take the
view that animals have moral standing but do not
have rights.
There are two broad theoretical approaches to
the subject of rights. The first, sometimes called
the  will theory, would discourage efforts to attrib-
ute rights to animals. In its classical form, as given
by Emmanuel Kant, it would define a right as a
capacity to obligate others to a duty. Possession
of a right carries with it an authorization to use
coercion to enforce the correlative duty (3 I). This,
in turn, implies that the right-holder’s capacity is
a power of discretion, either to enforce or waive
the right. A right is therefore something that a
right-holder may choose to exercise or not. The
choice itself will be an act of will.
H.L.A. Hart, a leading contemporary defender
of the will theory, treats a right as a choice that
gives the right-holder authority to control the ac-
tions of someone else. The possessor of a moral
right has a moral justification for limiting the free-
dom of another, not because the action the right-
holder is entitled to require has some moral qual-
ity, but simply because in the circumstances a
certain distribution of human freedom will be
maintained if the right-holder has the choice to
determine how that other shall act (28).
The will theory helps to avoid confusion between
claims of right, and other, separable requirements
to promote or secure some valued state of affairs
(e.g., to assist someone in need). Since animals could
not be said to have waived or exercised the rights
they had, all references to animal rights could sim-
ply be translated into talk of human duties.
Those who would assign rights to animals have
embraced the alternative interest theory of what
it means to have a right. A right, in their view, is
a claim to the performance of a duty by someone
else, but the right -holder need not be in a position
or possess the competence to make this claim by
an act of will. It is enough that the right-holder
has interests that can be represented (by others)
in a normative forum (20). These interests will in-
clude things that are intrinsically good and things
in which the right-holder “takes an interest, ” self-
ish or not (40). To have a right, then, will be sim-
ply to have interests that can be affected by some-
one else.
The interest theory surfaces in Peter Singer’s
Animal Liberation, among the first contemporary
theoretical statements of the case for animals. In
that work, Singer uses the term “right” to describe
any claim that individuals may make to have their
interests equally considered with those of others.
It implies, therefore, nothing more than a capac-
ity for suffering, which both humans and animals
possess (45).
The modest measure of animal awareness that
such a test demands has been one source of its
appeal. It has not, however, been free of contro-
versy. Some have objected that animals cannot
have interests because interests require beliefs and
animals cannot have beliefs in the strict sense (24,
36). This criticism suggests that pain-avoidance is
not an “interest” because it is not a “belief ,“ a dis-
tinction that seems more semantical than useful.
Nevertheless, a more serious charge remains. As
stated, the interest theory shows only that having
interests is a necessary condition for having rights,
not that it is sufficient. Singer himself has since
abandoned the attempt to show sufficiency and,
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accordingly, recanted his earlier references to the
language of rights (46):
I could easily have dispensed with it altogether.
I think that the only right I ever attribute to ani-
mals is the “right” to equal consideration of inter-
ests, and anything that is expressed by talking of
such a right could equally be expressed by the
assertion that animals’ interests ought to be given
equal consideration with the interests of humans.
Singer effectively acknowledges Hart’s charge that
the notion of a right has lost its distinctive func-
tion in this context because it no longer refers to
the discretionary control that one individual has
over the conduct of another.
There is one very general consideration that ap-
pears to weigh against the will theory, if not en-
tirely in favor of the interest theory. It underlies
a form of argument so ubiquitous in the animal-
rights literature that it deserves a name. The con-
sistency argument is exemplified in the following
passage from an essay on vegetarianism by Tom
Regan. Rejecting rationality, freedom of choice,
and self-consciousness as conditions for having a
right to life, Regan adds (41):
It is reasonably clear that not all human beings
satisfy them. The severely mentally feeble, for
example, fail to satisfy them. Accordingly, if we
want to insist that they have a right to life, then
we cannot also maintain that they have it because
they satisfy one or another of these conditions.
Thus, if we want to insist that they have an equal
right to life, despite their failure to satisfy these
conditions, we cannot consistently maintain that
animals, because they fail to satisfy these condi-
tions, therefore lack this right.
Another possible ground is that of sentience,
by which I understand the capacity to experience
pleasure and pain. But this view, too, must en-
counter a familiar difficulty—namely, that it could
not justify restricting the right only to human
beings.
In short, given that some human beings (infants,
mental defective, and senile adults) lack such ca-
pacity as well, Regan points to the inconsistency
of holding both that this capacity is a condition
of having a right and that all humans and only hu-
mans have moral rights. Any less burdensome test,
however, will presumably admit animals as possi-
ble right-holders (33)45). (For an opposing perspec-
tive, see refs. 22 and 24.)
This reasoning appears to overlook a significant
difference between an incompetent human being
and an animal. In most cases, human beings have
the capacity for rationality, freedom of choice, and
self-consciousness, whereas in all cases animals
do not. If most humans have these characteristics,
it might be appropriate (or at least convenient) to
treat humans as a homogeneous group, even though
some members lack these characteristics. If all
animals lack certain characteristics, it maybe sim-
ilarly appropriate to treat them as a group, re-
gardless of whether some humans also lack these
characteristics.
Furthermore, if rights do not imply present pos-
session of the qualifying condition (as suggested
by the way that people treat those who are men-
tally incapacitated only for a time), then babies who
have yet to mature and people who have become
incapacitated after a period of competence will
still have rights. The animal, as far as can be ascer-
tained, has never met and will never meet this qual-
ification. The rare human being whose deficiency
is complete over a lifespan is nevertheless differ-
ently situated from the animal. The condition is
a disability—the loss of some skill the person would
normally be expected to have. The animal’s con-
dition is not disabling, even though it lacks the same
skill. The very fact that the human has been de-
prived of an ability implies that the person has been
harmed; a human’s failure to acquire an ability
means that person is in need of help. The condi-
tion of the animal does not call for either infer-
ence. This difference, to be sure, makes no men-
tion of rights. Yet it creates a special duty to meet
the human need that would not extend to animals.
Because the animal without a will has not lost what
it was biologically programmed to possess, it “needs”
a will only as a human might ‘(need” to fly. In nei-
ther case does the condition give rise to a moral
demand for assistance.
Ironically, the consistency argument contains
a basic inconsistency. On the one hand, the argu-
ment asserts that humans are not superior to ani-
mals; animals should therefore be treated like hu-
mans. On the other hand, the very nature of the
moral argument is promotion of morally superior
behavior: Humans should refuse to exploit other
species, even though the other species exploit each
other.
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The consistency argument nevertheless succeeds
to the extent that it shows that the genera] reason
for moral concern in the cases discussed cannot
be limited to humans. Other things being equal,
the fact that a condition is harmful or threatens
harm to an individual—human or animal-creates
amoral reason to intervene. That reason need not
take the form of a duty owed to the victim, with
a correlative right that this would entail. It need
not always be a duty of any sort. The highest ap-
proval is often reserved for the good deed that,
like the good samaritan’s, goes beyond what duty
strictly requires.
There is a spectrum of possible positions, be-
ginning atone end with a strict prohibition against
the cruel infliction of suffering, moving to a still
powerful requirement to lend help when the indi-
vidual alone is in a position to provide it for someone
in great need, and then to the milder requirements
of charity and generosity when the individual can
provide them without great personal sacrifice
(even if others can do the same), and finally, at
the other extreme, to the highly praised but not
binding act of genuine self-sacrifice that distin-
guishes the moral saint. The moral vernacular cov-
ers this spectrum with a single term. The act in
question is called the ‘(humane” thing to do, and
sometimes failure to perform it is labeled in-
humane.
The term itself refers to the actor, not the recip-
ient. Humane treatment, following the Oxford Eng-
lish Dictionary, is “characterized by such behavior
or disposition toward others as befits a man.” This
meaning, which dates back to the 18th century,
applies to conduct marked by empathy with and
consideration for the needs and distresses of
others, which can include both human beings and
animals.
This does not mean that animals will generally
command the same degree of affection and atten-
tion as humans. The attitude of empathy, which
is the psychological spring for humane treatment,
consists in ‘(feeling like” the object of sympathy,
and the basis for this response must be a certain
understanding of what it is like to be in the other’s
position. Other human beings are much more ac-
cessible in this respect, not only because they are
structurally and functionally like each other, but
because they can communicate their feelings in
ways that animals can scarcely approach. In such
areas as the capacity for experiencing pain, how-
ever, the differences across species are by no
means so great as to make empathetic identifica-
tion impossible. Here the mark of the humane in-
dividual will be the extent to which sympathy
jumps the barrier between species (11).
There are differences among animals, too, in the
capacities they have, the things they do, and the
relations they have with humans, all of which af-
fect the moral weight that humane considerations
will have. A gorilla will gather more sympathy than
a trout, not so much because it is more intelligent
as because it exhibits a range of needs and emo-
tional responses to those needs that is missing al-
together in the trout, in which evidence of pain
can barely be detected. Predatory animals and wild
rodents rarely elicit affection because their char-
acteristic activities do not mark them as helpless
and in need. Even within one species, the regard
an animal may receive will rise with the social ties
and responsibilities that human beings have de-
veloped with it. As a possible recipient of humane
treatment, the garden-pest rabbit will stand to the
pet rabbit much as the stranger does to an ac-
quaintance.
Each of the morally significant differences
among animal recipients of humane treatment
builds on an analogy to the human case. Thus,
whatever the merits of the consistency argument
on the score of rights, it applies here because the
humane treatment principle crosses the species
border. Mary Midgeley has put the point eloquently
in another context (33):
[Animals] can be in terrible need, and they can
be brought into that need by human action. When
they are, it is not obvious why the absence of close
kinship, acquaintance or the admiration which
is due to human rationality should entirely can-
cel the claim. Nor do we behave as if they obvi-
ously did so. Someone who sees an injured dog
lying writhing in the road after being hit by a car
may well think, not just that he will do something
about it, but that he ought to. If he has hit it him-
self, the grounds for this will seem stronger. It
is not obvious that his reasons for thinking like
this are of a different kind from those that would
arise if (like the Samaritan) he saw an injured hu -
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man being. And he too may feel about equally jus-
tified in both cases in being late for his uncle’s
party.
Humane treatment is the most commonly cited
standard in Federal legislation concerning animals.
Its wide range of application due to its lack of pre-
cision, however, leads to a temptation to dismiss
it as a pious but essentially vacuous sentiment. A
theory of moral constraints is needed to determine
whether this or some other standard is sufficiently
precise to serve as a guide for legislation regulat-
ing the use of animals.
Moral Constraints
A rule that allows an individual to do whatever
that person wished would not be a moral rule.
Morality by its very nature operates as a check
on the tendency to go wherever desire leads. The
constraints it imposes can be applied prospectively,
contemporaneously, or retrospectively. Prospec-
tive analysis looks ahead to the possible conse-
quences, while retrospective analysis may restrict
the results it is permissible to promote (37). Be-
fore the action is taken, it can be said that the ac-
tion that morally ought to be performed is the one
with the best consequences. An individual succeeds
in this objective to the extent that an action pro-
duces as much benefit and as little harm as possi-
ble. During the course of the action, conditions
concerning the intention of the individual and the
consent of the recipient may have to be met be-
fore a moral license to pursue the best conse-
quences is granted. The fact that a lie will produce
more benefit than the truth will not necessarily
make it the right thing to do.
Moral theories divide according to the weight
they give to one or the other kind of constraint.
In its purest form, the prospective approach holds
that an action or policy is right if it has better con-
sequences, for everyone affected by it, than any
available alternative. The language here is care-
fully drawn. “Better” does not mean “morally bet-
ter.” A good consequence is simply an outcome
that someone finds desirable. If an action gives
pleasure to someone, the enjoyment is a good thing;
if it causes pain, the person’s suffering would be
a bad thing. It is not necessary to ask whether the
pleasure or pain is morally fitting.
Intuition will ideally play no part in determin-
ing an outcome. One consequence will count as
better than another if, after assigning positive nu-
merical values to its good elements and negative
values to its bad ones, the sum of positive values
exceeds that of negative values (10).
Better for whom? The utilitarian principle, still
the most influential formulation of the forward-
looking approach, holds that actions and policies
are to be evaluated by their effects, for good or
ill, on everyone, not just the individual alone or
some select group of individuals. Between an in-
dividual’s own good and the good of others, “utili-
tarianism requires him to be as strictly impartial
as a disinterested and benevolent spectator” (10,34).
The interests of each affected individual are to
count equally. Any two experiences that are alike
except that they occur indifferent individuals are
to be given the same value. Among utilitarians, en-
joyment is a good and suffering an evil, and so every
animal with the capacity for such experiences will
also count as one individual. Sentience suffices for
possessing this value, even if it does not confer
rights. “The question, ” as  Bentham once put it, “is
not, Can they reason? nor Can they talk?, but Can
they suffer?’’.
Because it extends the scope of moral concern
to animals without committing itself to a vulner-
able theory of animal rights, utilitarianism has be-
come the theory of choice among those who would
press for more constraints on humans’ treatment
of animals. Singer derives the credo that all ani-
mals are equal from the utilitarian conception of
equality (45). If the principle of utility requires that
suffering be minimized, and if some kinds of suffer-
ing are found in animals as well as humans, then
to count human suffering while ignoring animal
suffering would violate the canon of equality. It
would make a simple difference of location-in one
species rather than another—the basis for a dis-
tinction in value. Like racism, such "speciesism ”
enshrines an arbitrary preference for interests
simply because of their location in some set of in-
dividuals (45). (For arguments that speciesism is
not immoral, see refs. 16,23,51,52.)
As a general moral principle, utilitarianism is sub-
ject to several objections, the most serious being
that its standard of equality is much too weak to
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satisfy the demands of justice (25,37,39). Since it
only requires that individuals with interests be
given the same consideration, but in its summa-
tion of interests allows the claims of any one indi-
vidual to be overridden by the sheer weight of
numbers on the other side, it seems to sanction
a tyranny of the majority that permits violations
of individual rights. This may not, however, under-
mine the utilitarian case for animals if animals have
doubtful standing as right-holders.
Some commentators have suggested that there
may be an acceptable double standard in morals,
consisting of a nonutilitarian principle for agents
with standing as persons and a utilitarian rule for
handling individuals with interests but not rights
(21,37). The use of different rules for different
kinds of individuals is already well established.
Rules that would be objectionably paternalistic if
applied to adults are admissible if restricted to chil-
dren. The dangers are that inconsistent standards
might hold for the same individual or that differ-
ences between the two classes of individuals might
be arbitrary.
The suggestion that the adult-child and human-
animal distinctions are comparably rational and
justifiable (21) is superficial for two reasons. First,
it does not seem to be arbitrary to distinguish be-
tween the adult and the child, because human soci-
ety understands that children may be intellectually
and experientially unable to make wise choices.
Thus, society can choose for children that which
society believes is in their best interests. The prob-
lem with the human-animal distinction is that an
animal may in fact be able to make and communi-
cate a decision that expresses the animal’s self-
interest: It wants no part of any scientific proce-
dure that results in pain or distress. Even if the
animal could not make or communicate a decision,
it may be arbitrary to distinguish between such
animals and humans who are similar in their in-
ability to make such decisions (the profoundly men-
tally handicapped), allowing society to use the
former but not the latter as research subjects.
The second difference between the adult-child
and human-animal distinctions relates to the pur-
pose for distinguishing between two groups. The
first distinction is permissible because it allows so-
ciety to protect the interests of the child, while
the purpose of the human-animal distinction is to
allow society to ignore, or at least diminish, the
interests of the animal.
The device of a double standard is often used
to explain the sharp differences in the constraints
governing the treatment of animals and humans
as experimental subjects. For animals the stand-
ard is humane treatment, which forbids unneces-
sary suffering but otherwise allows experiments
that harm and even kill the animal. That same rule,
proposed for human subjects, is generally consid-
ered unethical. There are many experiments in
which perfectly reliable results can only be ob-
tained by doing to a human what is now done to
an animal. Nevertheless, without the subject’s in-
formed consent—indeed, sometimes even with it—
such experiments are absolutely impermissible,
no matter how beneficial the consequence might
be. They would violate the rights of the human
subject.
The proscription against unnecessary suffering
is best understood as a corollary of the principle
of utility. Since suffering is a bad consequence,
there is an initial utilitarian onus against behavior
that would produce it. Such treatment calls for
justification. To meet this burden, a bare appeal
to some offsetting good consequence will not be
sufficient. The principle of utility, as formulated,
is comparative. It requires that an action or policy
have better consequences than any available alter-
native. Among the alternatives will be uses that
do not involve animal suffering. If one of them has
consequences at least as good as or better than
the one proposed, the suffering will be unneces-
sary. Other things being equal, then, it should prove
harder to establish necessity than the contrary,
since the former must rule out all the alternatives
while the latter need find only one.
Necessity is a relation between a means (an ac-
tion or policy) and an end (its objective). Restricted
necessity takes the end as given—that is, not sub-
ject to evaluation—and asks only whether the
course of action suggested is an indispensable
means to that end, For example, in an LD50 test
for toxicity that uses 40 rats as subjects (see chs.
7 and 8), if no alternative procedure using fewer
or no rats could get the same results with the same
reliability, that test would be necessary in the re -
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stricted sense. In unrestricted necessity, the end
is open to assessment on utilitarian grounds:
l
l
How likely is the objective to be met, in compari-
son with other possible goals? If the LD50 test
yields unreliable results, its necessity in the
unrestricted sense would be open to challenge.
Assuming that the objective  will be met, how
beneficial will it be? Suppose, for instance, that
an LD50 test were to be run on a new cosmetic
not significantly different from those already
on the market. The test may be considered
unnecessary because the objective is unnec-
essary.
Unrestricted necessity is more difficult to prove,
because it always includes restricted necessity and
more. Thus, a stringent standard of necessity, one
that lets fewer procedures through, would require
that a procedure be necessary in the unrestricted
sense. In addition, since necessity is more difficult
to establish than the possibility of substitution, the
burden of proving both the existence of necessity
and the absence of alternatives could be placed
on those who would use the procedure. A more
lenient test could invert these priorities by pre-
suming that the procedure is necessary and that
alternatives are lacking unless shown otherwise.
This approach would not expect the user to show
beforehand that no other alternative was avail-
able; it is generally followed when a research pro-
posal is reviewed by a scientist’s peers or an insti-
tutional animal care and use committee (27).
Nonutilitarian positions on the use of animals
have one feature in common: Although virtually
none ignores consequences, they unite in deny-
ing that a course of action can be justified wholly
by appeal to the value of its consequences (39).
This leaves room for substantial variation, with
the differences traceable to the considerations they
would add in order to complete amoral assessment.
Ironically, both extremes in the animal treatment
debate are nonutilitarian. The hard line support-
ing unlimited exploitation of animals builds from
the premise that animals lack moral standing. With-
out rights, they cannot be recipients of a duty owed
to them. On some theories of value, moreover, en-
joyment does not count as a good thing in itself,
nor is suffering per se an evil. Kant, for example,
thought that the only unconditional good was a
will whose choices are undetermined by desire
for enjoyment or fear of punishment (31). Not hav-
ing a will, animals could not have this value.
Morally, they were indistinguishable from inani-
mate tools—mere means to be used for the pur-
poses of beings who do have a will. Like Aquinas,
however, Kant did acknowledge an indirect duty
of kindness, given that “tender feelings toward
dumb animals develop humane feelings toward
mankind” (32).
The indirect duty theory stumbles in the attempt
to explain why there should be any empirical con-
nection at all between people’s feelings for animals
and their feelings for other humans. Some simi-
larity must be seen in the objects of the two senti-
ments if one is to influence the other; yet the the-
ory says that there is no such likeness in reality.
Thus either a person’s motive is proof by itself that
humans have a direct moral interest in animals,
in which case the theory is mistaken; or the the-
ory is correct and the individual has misunder-
stood it, in which case the person will be free, once
educated in the theory, to abuse animals without
fear that this will tempt abuse of human beings.
Kant cannot have it both ways: He cannot require
individuals to act on a belief that his own theory
alleges to be false (33).
The Kantian position could be turned on its head
if animals had moral standing after all. In The Case
for Anhnal Rights, Regan gives the most cogent
defense to date for that view. He concedes that
animals are not moral agents: Since they are un-
able to choose freely among impartially determined
moral alternatives, they cannot have any moral
duties. At least some animals, however, have be-
liefs, desires, memory, a sense of the future, prefer-
ences, an identity overtime, and an individual wel-
fare of their own (41). In these respects, they are
indistinguishable from human infants and men-
tal defective, who also fail to qualify as moral
agents. Nevertheless, these animals possess an in-
herent value, independent of the value that their
experiences may have, that gives them standing
as “moral patients” — that is, as individuals on the
receiving end of the right and wrong actions of
moral agents. They have this value equally, and
equally with moral agents (40). Inherent value in
turn gives them a claim, or right, to certain
treatment.
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Regan’s major thesis is that, as moral patients,
animals enjoy a presumptive right not to be harmed.
He considers this principle a radical alternative
to utilitarianism. But once the reference to rights
is filtered out, the utilitarian might find Regan’s
theory quite congenial. Both Regan and utilitarians
would hold that harm to animals is a bad conse-
quence and so it would be wrong, in the absence
of an overriding consideration, to harm them. The
conflict between the two theories, therefore, lies
in the kind of justification that each theory would
permit to overturn this presumption.
Regan offers two guiding principles (40). By the
first, when the choice is between harm to a few
and harm to many and when each affected indi-
vidual would be harmed in a comparable way, then
the rights of the few ought to be overridden. As
Regan acknowledges, the utilitarian commitment
to minimize suffering would have the same result.
By the second principle, when the choice is be-
tween harm to a few and harm to many, if a mem-
ber of the affected few would be worse off than
any member of the affected many, the rights of
the many ought to be overridden. This “worse-
off” rule parts company with utilitarianism in set-
ting aggregate consequences aside and protecting
minority interests.
In view of this possibility, it is surprising to find
that Regan calls for a blanket prohibition against
the use of animals in research and toxicity test-
ing. That conclusion would follow only if his two
rules for defeating the right not to be harmed could
never be successfully invoked in these areas. Re-
gan is apparently drawn to this result by a con-
straint he attaches to the rules: They hold only
for harms suffered by innocent victims. Animals
are always innocent, in the sense that Regan gives
to that term (41). But human patients will be, too,
and at least sometimes human agents will also be.
Regan would have to show that these occasions
can never arise in research, testing, or education,
or that, if they do, the human agent/patient never
faces the greater harm. His analysis does not show
this.
This difficulty aside, Regan’s theory can be read
as holding, first, that the necessity standard can-
not be applied until the innocence of all parties
has been established and, second, that when it does
apply, the worse-off rule should replace the util-
ity principle in cases where they diverge.
It is unclear whether the worse-off rule is prefer-
able to the utilitarian principle for the purposes
of animal use. But the notion of innocence, with
its judicial implications, appears to have no place
in the issue of experimental-subject rights for three
reasons. First, the notion that animals are always
innocent because they cannot be otherwise is prob-
lematic. Innocence makes sense only when guilt
does, because innocence means that one has done
no wrong though doing wrong was an option. If
animals are not rational decisionmakers, if they
cannot choose between right and wrong, then the
concept of innocence has little meaning. Second,
most human subjects are probably innocent in the
sense that Regan uses the term, so that the con-
cept does little to advance the theory that ex-
perimenting on humans is preferable to experi-
menting on animals. Finally, even a guilty person
may have certain rights. While a person guilty of
a crime against society maybe imprisoned or other-
wise punished, society holds that the guilty have
a right to avoid cruel and inhumane punishments.
Bioethics similarly rejects the involuntary use of
guilty prisoners in medical experiments.
SUMMARY AND CONCLUSIONS
The present debate over animal use in research,
testing, and education is marked by a cacophony
of voices. A critical survey of the religious and philo-
sophical backgrounds to the debate yields some
hope that, if the competing voices were muted by
reflection, they would begin to coalesce as varia-
tions around a single theme. That theme would
be the standard of humane treatment, extended
to animals as well as to humans.
Much has been made of the historical contrast
between Western and Oriental religious views on
animals. The biblical and theological texts in the
Judeo-Christian tradition do not give us a princi-
ple of unconditional respect for animals. Humans
alone are accorded inherent value as being cre-
ated in the image of God, and this gives them a
license to use animals for their own purposes. Not,
however, to abuse them. Cruelty and callous in-
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difference to the needs of animals find no scrip-
tural support, and virtually all religious thinkers
condemn them. If God is a good shepherd, treat-
ing humans kindly without being bound to, hu-
mans can be as much to the animals in their care.
The Christian position thus amounts to a synthe-
sis of two elements in tension. On the one hand,
animals are inferior in worth to humans, as the
body of a person is inferior to the soul. On the
other hand, they are not so inferior that their own
welfare cannot stand in the way of unbridled use
of them.
Modern religious and philosophical patterns of
thought are branches of the same ancestral trunk.
It should not be surprising, then, that the philo-
sophical tradition exhibits the same tension on the
subject of animals. Humans have standing as per-
sons—that is, as individuals who can assume duties
and enjoy rights. To join them, animals must at
least be capable of possessing rights. But they can-
not assume duties and do not have the power of
discretion that gives rights a distinctive role in
morals. Consistency suggests rights should be
ascribed to animals once rights are given to infants
and mentally handicapped humans who also lack
discretion. Yet it would be inconsistent to assert
that humans are not superior to animals while sug-
gesting that humans should refuse to exploit other
species, even though other species exploit each
other.
Even if animals are not moral persons, however,
it does not follow that they are mere things, morally
indistinguishable from machines. They are suffi-
ciently like humans in one morally relevant re-
spect—their capacity for suffering in basic forms—
to generate a moral claim on humans. It would
be inconsistent to hold that, other things being
equal, human suffering ought to be relieved, but
animal suffering ought not.
Because it extends the scope of moral concern
to animals without committing itself to a vulner-
able theory of animal rights, utilitarianism has be-
come the theory of choice among those who would
press for more constraints on humans’ treatment
of animals. If the principle of utility requires that
suffering be minimized, and if some kinds of suffer-
ing are found in animals as well as humans, then
to count human suffering while ignoring animal
suffering would violate the canon of equality. It
would make a simple difference of location-in one
species rather than another—the basis for a dis-
tinction in value. Like racism, such “speciesism”
enshrines an arbitrary preference for interests
simply because of their location in some set of in-
dividuals.
The rule that suffering ought to be relieved, in
humans or animals, is the principle of humane
treatment. It covers a large and heterogeneous
range of situations; the most germane, for the de-
bate over animal use, are those in which someone
inflicts suffering on someone else. The humane
treatment principle establishes a presumption
against doing this, but that presumption can be
overcome—always in the case of animals, and
sometimes even in the case of a human—by show-
ing that the harm done is necessary. Necessity here
is not bare utility, but necessity overall. The harm
must not only be a means to a good end, it must
be the only means. A broader definition of neces-
sity might also require that the harm be a means
to an end whose value is considered in light of the
degree of harm necessary to achieve that end. In
addition, necessity always implies a comparison
with available alternatives.
Animal use in research, testing, and education
creates a conflict of interests between the liberty
that humans have to use animals for human ends
(knowledge, health, safety) and the need that ani-
mals have to be free of suffering. There is no rea-
son why either one of these broad interests should
always prevail over the other. The fulcrum on
which they are balanced is the necessity standard
itself. That is, when the suffering inflicted on ani-
mals is not necessary to satisfy a desirable human
objective, the animal interest will prevail. And
when the suffering is unavoidable, the human in-
terest will be controlling. Animals are morally en-
titled to be treated humanely; whether they are
entitled to more than that is unclear.
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—chapter 5
The Use of Animals
in Research
I know that half of what I teach as fact, ” said a wise medical pedagogue, “will be proved
false in 10 years. The hard part is that I don’t know which half. ” His statistics may not be
exact, but the notion is right enough. No one knows which half, and it is impossible to
know except in retrospect.
That is what research is—the reason for the prefix. The half that is wrong is at least as
important as the half that is right, because the new questions come in ferreting out the
errors-and new answers too.
Kenneth L. Brigham
Vanderbilt University School of Medicine
N. Engl. J. Med, 312:794, 1985
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Chapter 5
The Use of Animals in Research
Research, as the word denotes, is an ongoing
search—a search for new information and for
novel ways to apply existing information. Re-
search assumes a multitude of directions in a wide
variety of disciplines. It is not surprising, then,
that the use of animals in research—and the po-
tential for alternatives to using them—mirrors the
multifaceted nature of research itself.
Viewed broadly, almost any research investi-
gation involving members of the animal kingdom,
including humans, and sometimes even members
of the plant kingdom, can be categorized as bio-
medical research. In this sense, biomedical re-
search covers a long list of disciplines: anatomy,
anesthesiology, behavioral biology, biochemistry,
biomedical engineering, biophysics, cardiology,
cell biology, dentistry, developmental biology, en-
docrinology, entomology, epidemiology, genetics,
gerontology, histology, immunology, metabolism,
microbiology, molecular biology, neurology, nu-
trition, oncology, parasitology, pathology, phar-
macology, physiology, psychology, radiology, re-
productive biology, surgery, teratology, toxicol-
ogy, veterinary science, virology, and zoology.
When considering animal use—and alternatives
to animal use—in research, it is useful to isolate
behavioral research from the broader category
of biomedical research. Behavioral research is a
part of biomedical research, yet is distinguished
from the larger topic by the nature of the exper-
iments, the identity of the researchers, and the
kinds of alternatives available (see ch. 6).
This chapter defines and describes animal use
in biomedical and behavioral research. Also in-
cluded are the results of a brief survey done by
OTA of the use of animal and nonanimal meth-
ods in published research reports in selected dis-
ciplines of biomedical and behavioral research.
T H E  R O L E  O F  A N I M A L S  I N  B I O M E D I C A L  R E S E A R C H
To discuss alternatives to using animals in bio-
medical research, it is important to review the
context in which animals are presently included.
A comprehensive review of this subject (see ref.
41) is beyond the scope of the present assessment.
However, animals’ broad role in contemporary
biomedical research can be at least partly delin-
eated by considering:
l the manifold contributions to biomedical re-
search of a single group of animals—non-
human primates;
l the role of experimental animals in the de-
velopment of a single medical procedure,
namely coronary artery bypass surgery; and
l the reasons multiple species are used in bio-
medical research.
These perspectives illustrate two fundamental
principles of animal use in biomedical research.
First, a single species or group of animals often
serves a multitude of purposes in widely varying
research enterprises. Second, a single advance in
applied research often represents results gener-
ated from many species.
Nonhuman Primates in
Biomedical Research
Primates—humans, monkeys, and apes—share
a common genetic basis and anatomical, physio-
logical, biochemical, and behavioral traits that
provide unique research opportunities. As a con-
sequence, humans and other primates are sus-
ceptible to many of the same diseases and have
many of the same disease-fighting capabilities. Re-
viewing the use of nonhuman primates is also
appropriate because they are relatively expensive”
research animals (e.g., a rhesus monkey costs
from $600 to $2,000) and the object of much pub-
lic interest. Two recent reports describe the role
of primates in biomedical research (29,45). Those
89
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reports are summarized in table 5-1; highlights mans had been made by the early 1900s, but the
of the studies follow. cause of the disease was still unknown. A break-
through occurred in 1908, when scientists exper-
Polio
imentally transmitted the poliovirus to monkeys
for the first time. Studies in rhesus and cynomolgus
The development of the polio vaccine exempli- monkeys and in chimpanzees followed isolation
fies the key role of primates in the research lab- of the virus, but a vaccine remained elusive. Af -
oratory. Many thorough studies of polio in hu- ter nearly a half-century, researchers were able
Table 5-1.—Some Uses of Nonhuman Primates in Research on
Human Health and Disease
Human health concern Primate experimental model
Acquired immune deficiency syndrome
(AIDS) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Chimpanzee, African green monkey
Atherosclerosis . . . . . . . . . . . . . . . . . . . . . . . . . . Cynomolgus monkey
Balding . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Stumptail monkey
Cancer from solid tumors . . . . . . . . . . . . . . . . . Chimpanzee
Cholesterol gallstones . . . . . . . . . . . . . . . . . . . .Squirrel monkey
Circadian rhythms . . . . . . . . . . . . . . . . . . . . . . . .Squirrel monkey
Cornea transplant . . . . . . . . . . . . . . . . . . . . . . . . Rhesus monkey, African green monkey,
Stumptail monkey, Patas monkey,
Cynomolgus monkey
Dental implants . . . . . . . . . . . . . . . . . . . . . . . . . . Pig-tailed monkey
Diabetes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Celebes black macaque
Dietary fats and heart disease . . . . . . . . . . . . .Cynomolgus monkey
Embryo transfer . . . . . . . . . . . . . . . . . . . . . . . . . . Rhesus monkey, Cynomolgus monkey
Eye damage from ultraviolet radiation . . . . . . . Rhesus monkey
Eye disorders in children . . . . . . . . . . . . . . . . . . Rhesus monkey
Fetal alcohol syndrome . . . . . . . . . . . . . . . . . . . Pig-tailed monkey
Fetal surgery . . . . . . . . . . . . . . . . . . . . . . . . . . . . Rhesus monkey
Genital herpes . . . . . . . . . . . . . . . . . . . . . . . . . . .African green monkey
Gilbert’s syndrome . . . . . . . . . . . . . . . . . . . . . . . Bolivian squirrel monkey
Glaucoma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Rhesus monkey
Hearing impairment. . . . . . . . . . . . . . . . . . . . . . . Rhesus monkey
Hepatitis B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Rhesus monkey, Chimpanzee, African green
monkey
Herpes-virus-induced cancer . . . . . . . . . . . . . . . Owl monkey, Marmoset
High blood pressure . . . . . . . . . . . . . . . . . . . . . . Cynomolgus monkey
Hyaline membrane disease in newborns. . . . . Rhesus monkey, Pig-tailed monkey
In vitro fertilization . . . . . . . . . . . . . . . . . . . . . . . Rhesus monkey, Chimpanzee, Baboon,
Cynomolgus monkey
Infertility . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Rhesus monkey
Inflammatory bowel disease . . . . . . . . . . . . . . .Marmoset
Laser surgery on damaged nerves . . . . . . . . . . Baboon
Leprosy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Sooty mangabey
Liver disorders . . . . . . . . . . . . . . . . . . . . . . . . . . . Rhesus monkey
Malaria. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Chimpanzee, Owl monkey, Rhesus monkey
Male and female behavior patterns . . . . . . . . .Rhesus monkey
Male birth control . . . . . . . . . . . . . . . . . . . . . . . . Rhesus monkey, Cynomolgus monkey
Menopausal problems. ., . . . . . . . . . . . . . . . . . . Rhesus monkey, Stumptail monkey
Mother-infant behavior . . . . . . . . . . . . . . . . . . . . Rhesus monkey
Motion sickness . . . . . . . . . . . . . . . . . . . . . . . . . Squirrel monkey
Nonhormonal fertility regulation . . . . . . . . . . . . Bonnet monkey, Chimpanzee
Obesity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Baboon
Parkinson’s disease , ... , . . . . . . . . . . . . . . . . . Rhesus monkey
Polio. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Rhesus monkey, Cynomolgus monkey,
Chimpanzee
Premature labor . . . . . . . . . . . . . . . . . . . . . . . . . . Rhesus monkey, Baboon
Rh factor disease . . . . . . . . . . . . . . . . . . . . . . . . Rhesus monkey
Slow viruses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Owl monkey, Squirrel monkey, Stumptail
monkey
Systemic lupus erythematosus . . . . . . . . . . . . . Cynomolgus monkey
SOURCES: Adapted from “Toward Better Health: The Role of Primates in Medical Reaearch,”  Primate News 21(1):1-24,  1984;
and F. A. King and C. J. Yarbrough,  “Medical and Behavioral Benefits From Primate Research,” Physlo/ogkt  28:75-87,
1985,
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to grow the poliovirus in human tissue culture
(15), and an effective vaccine became available to
the public in 1955. When the vaccine was devel-
oped, monkey kidney tissue was essential for pro-
duction of pure virus in great quantities, and live
monkeys were essential for safety and effective-
ness testing. Today, noninfectious polio vaccine
can be produced in continuously propagating cells
without the need for monkeys, although monkeys
are required to test for safety. The impact of the
polio vaccine has been dramatic: In 1952, at the
height of one epidemic, 58,000 cases of polio
occurred in the United States; in 1984, just 4 cases
were reported (39).
Hepatitis B
Hepatitis B is the most dangerous form of hepa-
titis, a debilitating liver disease characterized by
fever, weakness, loss of appetite, headache, and
muscle pain. There are nearly 1 million hepatitis
B virus carriers in the United States today, and
the infection is estimated to cost $1 million per
day in this country. Worldwide, there are some
200 million carriers, primarily in Asia and Africa.
Up to 1 percent of those infected with hepatitis
B die of the disease, and 5 to 10 percent become
chronic carriers of the virus who can remain in-
fectious indefinitely (21). Since there is no known
treatment for hepatitis B infection, prevention is
essential.
Research with rhesus monkeys and chimpan-
zees led to the development just a few years ago
of a vaccine, derived from human plasma, against
hepatitis B infection. In 1981, the Food and Drug
Administration (FDA) licensed this vaccine for hu-
man use. In 1984, recombinant DNA technology
was used to prepare a hepatitis B vaccine from
yeast cells (the first vaccine for human use so
produced). Prior to its trial in 37 human volun-
teers, this yeast recombinant hepatitis B vaccine
was administered to African green monkeys in
order to gauge its effectiveness (52). These new
vaccines are expected to have a worldwide im-
pact on the disease, and they may also reduce the
incidence of hepatocellular carcinoma, a form of
liver cancer associated with chronic hepatitis B
infection (40).
Herpes
Estimates of the number of persons afflicted
with recurrent genital herpes virus infections
range from 5 million to 20 million worldwide (61).
A new antiviral drug, acyclovir, was recently li-
censed for use against human genital herpes in-
fections and appears to yield antiviral and clini-
cal benefits when taken orally (48). Acyclovir was
extensively tested in African green monkeys. The
opportunity to run such tests arose because of
a natural outbreak of a virus closely related to
that causing both chickenpox and shingles (i.e.,
herpes zoster) in humans. The infected monkey
colony at the Delta Regional Primate Research
Center in Louisiana enabled scientists to study the
herpes disease process and test antiviral drugs.
In 1984, researchers reported an in vitro model
system for studying the herpes simplex virus,
using human fetal nerve cells as the host. This
in vitro model is expected to enable analysis of
the state of the herpes virus as it establishes and
remains latent in human nerve cells (62).
High Blood Pressure
High blood pressure, when untreated, increases
the risk of stroke, heart disease, and kidney fail-
ure. In most cases, the cause or causes of high
blood pressure remain unknown, and the condi-
tion is a public health problem of immense pro-
portions. Data from the early 1980s indicate that
fully one-third of Americans use medication to
control blood pressure. From 1971 to 1981, visits
to physicians for diagnosis and therapy of high
blood pressure increased by 55 percent, while
visits for all other causes decreased by approxi-
mately 5 percent (32).
Monkeys are used to examine mechanisms of
high blood pressure because the natural hormone
molecules controlling blood pressure (e.g., the kid-
ney hormone renin) are identical in humans and
other primates. In contrast, the renin molecules
of humans and nonprimate species are dissimi-
lar. In addition to using monkeys to study the ef -
fects of diet and drugs on high blood pressure,
researchers are examining the genetic transmis-
sion of high blood pressure. One breeding colony
of cynomolgus monkeys exhibiting high blood
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pressure has been monitored for 5 years; this per-
mits the study of high blood pressure in parents,
offspring, and future generations to analyze the
tendency to inherit the condition.
Parkinson's Disease
Parkinson’s disease is a neurological disorder
of older adults characterized by palsy and rigid
muscles. Progress in understanding the cause and
development of the disease and in refining meth-
ods of long-term drug therapy has been ham-
pered by lack of an adequate animal model. At-
tempts to induce the disease in rats, guinea pigs,
and cats either have failed to produce all the
symptoms or have yielded symptoms that do not
last long and so cannot be effectively researched.
In 1983, the first animal model of Parkinson’s
disease was developed. Scientists at the National
Institute of Mental Health (NIMH) induced a form
of parkinsonism in eight rhesus monkeys by giv-
ing them a drug, l-methyl-4-phenyl-1,2,3)6-tetra-
hydropyridine (MPTP), that selectively destroys
specific cells in the substantial nigra, a region of
the brain destroyed in humans by Parkinson’s dis-
ease. The monkeys exhibited all the major clini-
cal features of Parkinson’s disease in humans.
They also responded dramatically to L-dopa, the
standard medication for people with this disease
(8). NIMH researchers have speculated that the
availability of this new animal model may lead to
understanding the reason Parkinson’s disease oc-
curs in older adults, the course of the disease, and
drug therapy and its side effects (30).
In 1984, squirrel monkeys were used to shed
further light on the mechanism of MPTP-induced
parkinsonism. Pargyline, a drug currently pre-
scribed for high blood pressure in humans (Eu-
tonyl, Abbott Laboratories, North Chicago, IL),
was used to prevent the neurotoxic effects of
MPTP (31). These results in squirrel monkeys sug-
gested that MPTP itself may not be the actual neu-
rotoxic agent. Instead, attention is now focused
on an MPTP metabolize and on the mechanism
of MPTP metabolism in the brain (33).
Baldness
Like many men, stumptail monkeys become
bald as they age. This trait has made the stump-
tail monkey the animal of choice in baldness
research. Although it is not life-threatening, bald-
ness is a matter of concern for many people:  Hair-
combing patterns suggest that many men desire
to have hair where there is none, and advertise-
ments for hair restoration abound in the popular
media. The public spends large sums on hair-
restoration nostrums, and in 1985 the FDA pro-
posed banning the sale of all nonprescription drug
products sold to prevent or reverse baldness, hav-
ing concluded there is no scientific evidence that
such lotions and creams are effective (50 FR 2191).
A drug originally developed to manage high
blood pressure, minoxidil, has the unexpected
side effect of causing thick hair growth from fol-
licles that normally produce only fine, downy
hair. To test the potential of minoxidil for hair
growth, researchers applied it externally to the
bald front scalp of stumptail monkeys. The results
with monkeys showed promise, and clinical trials
are now in progress with bald men across the
United States. Monkey studies are continuing to
assess the effects and safety of minoxidil as a
means of counteracting hair loss.
Menopausal Hot Flashes
Of the 30 million postmenopausal women in the
United States, as many as 75 percent have ex-
perienced or will experience hot flashes brought
on by increased blood flow to the skin. Hot flashes
produce a feeling of warmth for several minutes,
and they are often followed by sweating. These
physical symptoms may be accompanied by ner-
vousness, irritability, and depression. At present,
physicians can treat the symptoms of menopause,
but the causes of the symptoms remain unknown.
Research into the mechanisms of menopause and
the development of therapy for menopausal
problems has been hampered by the difficulty of
studying this condition in animals. This difficulty
stems from three facts: only primates, and no
other nonhuman species, have menstrual cycles;
monkeys do not exhibit symptoms of menopause
until at least age 25; and monkeys brought into
the laboratory from the wild are rarely of meno-
pausal age.
Throughout the last decade, researchers have
studied the menstrual cycle and its cessation in
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Left: Bent, flexed posture and absence of movement
exhibited by a rhesus monkey treated with the drug
MPTP to induce Parkinson’s disease. Other symptoms
in both monkeys and humans include tremor, eyelid
closure, difficulty swallowing (drooling), and difficulty
with vocalization and speech.
Right: Reversal of abnormal posture and return of nor-
mal movement following treatment with L-dopa. The
right photograph was taken 2 hours after the left one.
Photo credit: f?. Stanley Bums, National Institute of Mental Hea/th
First animal model of Parkinson’s disease, developed in 1983
a limited number of rhesus monkeys reaching 25 and of hormones in the control of this problem.
to 30 years of age (11). In 1984, hot flashes were Once the underlying mechanisms that produce
described in another primate, the stumptail mon- hot flashes are better understood, more effective
key (25). The aim of developing an animal model treatments may be developed for women who
for hot flashes is to determine the role of the brain suffer from menopausal problems.
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Experimental Animals’ Contribution
to Coronary Artery Bypass
Graft Surgery
A second way to describe the role of animals
in biomedical research is to review the ways in
which a single advance in applied biomedical re-
search came about. As an illustration of this proc-
ess, the development of the coronary artery by-
pass graft operation, recently recounted (9,46),
is summarized here.
Coronary or arteriosclerotic heart disease, often
caused by a narrowing or blocking of the arteries
supplying blood to the heart, is the number one
cause of death in the United States. In 1982, it
was responsible for approximately 500,000 deaths
(59). Coronary artery bypass graft surgery was
introduced in the early 1970s. In this procedure,
which has become the primary surgical approach
to treatment of coronary artery disease, a grafted
vessel is attached to the coronary artery to cir-
cumvent the constricted portion. The graft im-
proves the blood and oxygen supply to the heart
muscle. The growth of the procedure has been
quite rapid: Approximately 70,000 operations
were performed in 1977; 160,000 in 1981 (7); and
191)000 in 1983 (38).
Coronary artery bypass graft surgery is now
the most commonly performed major operation
in the United States (7). It is accepted as far more
effective than medication in relieving the severe
chest pain, or angina pectoris, associated with
coronary heart disease (47). The long-term ben-
efit of this procedure, in terms of mortality, varies
among patient groups (60).
The experimental steps leading to the success-
ful coronary artery bypass graft operation are
depicted in figure 5-1, in which the cardiac sur-
geon stands at the summit of Mt. Coronary Ar-
tery Bypass. In the early stages of research—that
is, in the foothills of the mountain—there was a
great deal of variability in the kinds of animals
required. Studies in frogs, reptiles, horses, cats,
dogs, sheep, and deer contributed to scientists’
understanding of the fundamental principles of
circulation, blood pressure, and temperature reg-
ulation. As problems became more specialized,
the choices of animal species became more re-
stricted. Dogs, chimpanzees, and, ultimately, hu-
mans contributed to the later stages of research
leading to the coronary artery bypass. Virtually
every step up Mt. Coronary Artery Bypass re-
quired initial stages of study on living animal
models of various species.
Today, in retrospect, the experimental steps
leading to this surgical procedure appear as a sim-
ple and logical progression. In this sense, figure
5-1 is deceptive. It is important to note that the
first step was not predictive of the second step,
the second not predictive of the third, and so on.
The advance from each step involved uncertainty,
missteps, and serendipity. All are inherent in the
process of basic biomedical research. Moreover,
only a poor understanding exists of the path lead-
ing from basic to applied biomedical research. Al-
though Mt. Coronary Artery Bypass stands as a
bona fide illustration of the integration of data
drawn from several species, it was formed with-
out a blueprint.
Use of Multiple Species in
Biomedical Research
The contributions of animals are an important
part of the history of human health, disease, and
medicine. It is noteworthy that animals have not
only contributed to human welfare, but deterred
from it as well. The benefits and detriments de-
rived from animals involve numerous species.
The number of animal diseases labeled zoo-
noses-diseases transmissible from animals to
humans–now stands at about 200. These exact
a heavy toll of human morbidity and mortality
on a worldwide scale. Research to combat zoo-
noses logically focuses on the species that are the
principal sources of the diseases. And the more
species that are infected by a particular agent,
the greater are the biological resources available
for research to overcome it. Numerous animal
vectors of an infectious agent provide increased
opportunities for the study of variation among
species in the incubation of, transmission of, and
susceptibility to the infectious agent. Most of the
threats to humans from animals—including ra-
bies, tuberculosis, brucellosis, toxoplasmosis, an-
thrax, and dengue fever—infect a sufficient va-
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Figure 5-1.—Steps in Biomedical Research That Preceded Successful Coronary Artery Bypass Graft Surgery
dog, human
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Direct autograft - dog, human
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SOURCE: Redrawn from W, C Randall, ‘iCrises in Physiological Research,” Physiologist 26:351  -356, 1963, after J. H. Comroe,  Jr., and R. D. Dnpps,  “Ben Franklln and
Open Heart Surgery,” Circ  Res. 35:661-669,  1974
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riety of species that effective research on their
control has been possible (19). Perhaps ironically,
the same diverse mix of species that transmits dis-
ease to humans forms the substrate for research
to ameliorate human disease.
Infection of multiple animal species has led to
virtual control in industrial countries of the
plagues just mentioned. Yet a paucity of animal
vectors or models hampers control of certain
other human infectious diseases. Leprosy, herpes,
and gonorrhea (which are not  zoonoses) have yet
to be brought under control, owing partly to the
lack of effective animal models. Recent discoveries
of leprosy and herpes infections in primates, the
culture of the leprosy bacillus in armadillos, and
adaptation of the gonorrhea organisms to some
species of laboratory animals offer promise that
effective animal models will soon become avail-
able for research (19). Yet research on other con-
ditions of still-unknown etiology, such as Alz-
heimer’s disease, remains impeded by the inability
to identify an appropriate animal model.
Additional impetus for employing a variety of
species in the course of research comes from a
consideration of the immune response, which rec-
ognizes material that is foreign to the body. The
immune system thus serves as an animal’s defense
against infections due to viruses, fungi, or bacte-
ria. When foreign proteins, or antigens, are in-
troduced into an animal, the immune system re-
sponds by manufacturing a protein of its own,
an antibody, to counter the invader. This is the
principle on which the development of vaccines
is based: An antigen is injected, and it stimulates
production of an antibody that combats the for-
eign antigen.
The strength of an immune response varies
from species to species, and even within a spe-
cies, according to the genetic constitution of the
animal used. Researchers often cannot gain a full
understanding of how to develop useful vaccines
unless they test several species to examine sub-
tle differences in immune responses. In this way,
species differences in response to foreign antigens
are found and can be exploited in the production
of effective vaccines for humans and animals. It
is this use of the immune system that has con-
trolled most of the major infectious viral diseases,
including smallpox, which was controlled through
the use of the cowpox, or vaccinia, virus.
No one animal species is the complete research
model for the human. In general, nonhuman pri-
mate species have the greatest anatomical, physio-
logical, and metabolic similarities to humans. Yet,
as table 5-2 indicates, much important biological
information can be provided by using dissimilar
organisms. (This table oversimplifies the use of
various animals in studying human health and dis-
ease because it does not rate the closeness of the
similarity of the conditions between humans and
animals (19).)
It is important to establish any new biological
principle or a new phase of understanding a dis-
ease condition in as many species as possible in
order to improve safely the extrapolation from
one animal to another and to humans (19). Re-
search results derived from multiple systems in
varied species, such as those listed in table 5-2,
complement each other to approximate human
anatomy, physiology, and metabolism.
Some biomedical research, collectively known
as veterinary research, seeks to understand the
life processes of animals and applies this knowl-
edge to serve animals themselves, as well as hu-
mans. Veterinary research addresses the normal
structure and function of animals and the causes,
diagnosis, prevention, and treatment of disease
in experimental animals and clinical (i.e., patient)
animals. Research on food- and fiber-producing
domestic animals supports the utilization of plant
and animal resources for human sustenance.
Veterinary research plays a prominent role in
controlling diseases of importance in food-produc-
ing animals and, hence, of importance to humans.
Veterinary research supports, and is closely al-
lied with, veterinary medicine. Practitioners of
veterinary medicine maintain and improve the
health and well-being of animals. The profession
concentrates on the health of animals important
for food and fiber and on companion animals.
other species receiving veterinary attention in-
clude laboratory animals, fish and aquatic ani-
mals, and zoo and wild animals, Thus, the ma-
jority of veterinary medicine addresses 30 to 40
different species of economic, ecologic, and envi-
ronmental importance. These include:
l domestic animals (e.g., cats, cattle, chickens,
dogs, donkeys, goats, horses, sheep, and
turkeys);
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Table 5-2.—Some Anatomical, Physiological, and Metabolic Similarities and
Differences Between Humans and Various Laboratoy Animals
Conditions, systems, or structures
Animal Similarities to humans Differences from humans
Cat . . . . . . . . . . . . . . . . . Splenic vasculature
Sphenoid sinus in skull
Liver
Middle ear and ear drum
Epidermis
Cattle. . . . . . . . . . . . . . . Ascending colon
Electrolyte excretion
Chicken . . . . . . . . . . . . . Palate
Chinchilla . . . . . . . . . . . Inner ear structures
Dog . . . . . . . . . . . . . . . . Pituitary gland vasculature
Renal arteries
Splenic vasculature
Sphenoid sinus in skull
Superficial kidney vasculature
Liver
Epidermis
Adrenal gland innervation
Goat. . . . . . . . . . . . . . . . Embryonic blood circulation
Guinea pig . . . . . . . . . .Spleen
Immune system
Horse. . . . . . . . . . . . . . . Pulmonary vasculature
Bile duct
Pancreatic duct
Lung
Mouse . . . . . . . . . . . . . . Senile hepatic changes
Pig . . . . . . . . . . . . . . . . . Maturation of red blood cells
Cardiovascular tree
Teeth
Adrenal gland
Skin
Penile urethra
Retinal vessels
Spleen
Reaction to foreign protein
Laryngeal structures
Sweat glands
Mediastinum (interior chest tissue)
Development of embryonic gonads
Sleep
Heat regulation
Digestion
Plasma gamma globulins in
newborn
Sleep
Heat regulation
Vomiting
Sweat glands
Retinal vessels
Lymphoid tissue in liver
Pituitary gland
Respiratory system
Oviduct
Reproductive system
Acetate metabolism
Intestinal circulation
Anal sacs
Sweat glands
Pancreatic ducts
Heat regulation
Sleep
Laryngeal nerves
Mediastinum
Stomach and digestion
Heat regulation
Sweat glands
Vomiting
Sleep
Plasma gamma globulins in
newborn
Sweat glands
Carotid body
Spleen
Cecum and colon
Gall bladder
Plasma gamma globulins in
newborn
Spleen
Spleen
Liver
Plasma gamma globulins in
newborn
Sweat glands
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Table 5-2.—Some Anatomical, Physiological, and Metabolic Similarities and
Differences Between Humans and Various Laboratory Animals (Continued)
Conditions, systems, or structures
Animal Similarities to humans Differences from humans
Nonhuman primates . . Brain vasculature lnguinal canal
Rabbit . . . . . . . . . . . . .
Rat . . . . . . . . . . . . . . . .
Sheep . . . . . . . . . . . . .
Intestinal circulation
Placenta
Pancreatic duct
Adrenal gland
Innervation
Nucleic acid metabolism
Teeth and mandible
Brain
Larynx
Kidney
Reproductive performance
Menstrual cycle
Spermatozoa
.Splenic vasculature Liver
Spleen Sweat glands
Immunity Lung elasticity
Innervation
Middle ear and ear drum
. Spleen Cardiac circulation
Senile splenic changes Abdominal circulation
Senile pancreatic changes No gall bladder
. Splenic vasculature Stomach and digestion
Sweat glands Heat regulation
Breeding
Vomiting
Sleep
Plasma gamma globulins in
newborn
SOURCES: Adapted from B.M.  Mitruka, H.M. Rawnsley,  and D.V. Vadehra, Animals for Researclr, Mode/s for the  Study  of Human
Disease (New York: John Wiley & Sons, 1976); and W.1. Gay and J.D.  Wlllett,  “The Spectrum of Biological Systems
and the Selection of Models, ” in National Symposium on Imperatives in Research Animal Use: Scientific Needs
and Anima/  Welfare, NIH Pub. No. 652746 (Bethesda, MD: National Institutes of Health, 1965).
laboratory animals (e.g., mice, rats, guinea
pigs, rabbits, hamsters, and ferrets);
nonhuman primates (e.g., baboons, new-
world monkeys, and old-world monkeys);
exotic birds (e.g., parakeets, parrots, cock-
atiels, and cockatoos);
birds of prey (e.g., falcons, hawks, and
eagles);
freshwater and marine fish;
marine mammals (e.g., porpoises and whales);
large terrestrial mammals (e.g., deer, ante-
lope, elk, lion, tigers, elephants, and llamas);
and
assorted reptiles and amphibians.
Choice of Species
The variety of animal species used in research
spans the animal kingdom, and some species are
used more often than others (see ch. 3). Various
reasons exist for
search:
l
l
l
l
Some species
using particular species in re-
are more available than others.
For example, certain primate species are in
chronic short supply. Conversely, in the case
of rats and mice, large numbers of commer-
cial breeding businesses can supply particu-
lar strains, ages, and sex on the purchaser’s
demand.
Existing databases and literature have been
built on a particular species. Additional work,
in order to contribute to the field in a direct
way, needs to be based on the same species.
For most research purposes, nonendangered,
commercially available animals are preferred
over endangered ones.
Some species exhibit the physiology or be-
havior of interest in a more vivid and robust
form than do other species. For example, the
desert-adapted kangaroo rat is the species of
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choice for studies of the kidney’s role in
water conservation,
Certain aspects of physiology or behavior are
exhibited by only a limited number of spe-
cies. For example, studies of echolocation are
best done with bats, which emit sounds in
radar-type fashion.
The costs of acquisition vary widely among
species. For example, a mouse costs approx-
imately $2, a hamster approximately $5, and
a guinea pig approximately $19. (The actual
cost for a particular species varies with the
sex, strain, weight, age, quantity ordered,
method of shipping, and distance shipped.)
Maintenance costs vary widely among spe-
cies. Depending on the laboratory lifetime of
the animal, maintenance expenses can quick-
ly exceed acquisition costs. For example,
T H E  R O L E  O F  A N I M A L S  I N
Like all of biomedical research, behavioral re-
search relies on animals to identify models for and
aid in the understanding of human phenomena.
Behavioral research has the further goal of un-
derstanding the behavior of animal species of eco-
nomic or intrinsic interest to people.
Behavior encompasses all the movements and
sensations by which organisms interact with both
the living and nonliving components of their envi-
ronment (2). The environment includes not only
objects and events external to the organism, but
internal events as well (e.g., visceral cues, moti-
vations, and emotions). Behavior is not an object
or a thing. It is a process that continues in most
organisms until they die. Even sleep is a form of
behavior. Unlike coloration or size, behavior is
a dynamic property that functions primarily to
enable an organism to adapt to changing environ-
mental conditions.
What is Behavioral Research?
Classes of Behavioral Research
There are several classes of behavioral re-
search, each with a distinct focus:
l Abnormal Behavior. In the broadest sense,
abnormal behavior is any that deviates from
l
maintaining a mouse in a research laboratory
costs approximately 5 cents per day, a ham-
ster approximately 11 cents per day, and a
guinea pig approximately 40 cents per day.
(The actual per diem cost varies among differ-
ent animal facilities, depending, for example,
on accounting practices and local labor costs.)
Results obtained from different  species varv
in their ability to be generalized, both among
animals and between animals and humans.
Generalizations are more readily made among
species that are more closely related than
among species that are less closely related.
Attempts to identify alternatives to using animals
in research are likely to be influenced by these
considerations.
BEHAVIORAL RESEARCH
l
l
l
l
l
normal patterns. Instances among animals in-
clude seemingly suicidal, self-induced beach-
ings by whales, phobic and neurotic prob-
lems in pets, and various laboratory-induced
animal models of human psychopathology
(e.g., depression, drug addiction, or obesity).
Aggression Aggression can be defined as an
organism’s threatening to inflict, attempting
to inflict, or actually doing physical harm to
another organism.
Animal Movements Animal movements rep-
resent major changes in location over time
and space, such as patterns of migration,
herding, homing, navigation, orientation, and
dispersal.
Body Maintenance. Behaviors that function
to provide body maintenance and homeo-
stasis include hunger, thirst, respiration, ther-
moregulation, excretion, grooming, preening,
and parasite removal.
Cognition Although this label has been used
indiscriminately to encompass practically all
aspects of learned behavior (36), the term is
more strictly applied to instances of appar-
entmentalistic activity in animals (e.g., con-
sciousness, thinking, imagery, self-awareness,
intention, or attribution).
Communication. Communication consists
of an exchange of information between two
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l
l
l
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or more organisms that results in a change
in behavior. Instances of this range from
those that are stereotyped and instinctive,
such as the dance “language” of honey bees,
to those that might appear to have a symbolic
basis, as in the case of the recent attempts
to teach chimpanzees various forms of sign
language. Depending on species, communi-
cation can involve visual, auditory, olfactory,
or tactile cues.
Exploration and Activity. In addition to in-
stances of curiosity and exploratory behavior,
patterns of activity included in this discipline
are circadian rhythms, sleep, hibernation,
roost-time restlessness, and different patterns
of locomotion (e.g., swimming, swinging, or
flying).
Habitat and Food Selection. Habitat and
food selection refer to the areas where ani-
mals live under natural conditions (e.g., fresh-
water streams, forests, or deserts) and the
ways they exploit resources. Areas of inquiry
by behavioral researchers include competi-
tion between species and optimal foraging
strategies.
Learning Memory, and Problem Solving.
These behaviors are represented by the ac-
quisition and retention of new information
that allows organisms to anticipate recurring
environmental events, as well as changes in
behavior that maximize or minimize certain
outcomes. Included in this discipline is the
cultural transmission of information from
one generation to the next and imitation.
Motivation and Emotion The study of moti-
vation looks at mechanisms and manipulations
that activate and sustain behavior. Emotion
typically includes reactions that accompany
different motivational states and is often asso-
ciated, for example, with fear, anxiety, appre-
hension, pleasure, and rage.
Predator-prey Relations As a consequence
of selective pressure associated with preda-
tion, many prey species have developed an
extensive and elaborate array of predator
defenses couched in terms of sensory and/or
behavioral adaptations, such as burrowing or
voluntary immobility. Likewise, predators
use a variety of behavioral strategies in prey
identification and capture.
l
l
l
l
Reproduction and Parental Care. Patterns
of courtship, mate selection, copulatory be-
havior, nest building, nurturing, and care of
offspring all fall within this discipline.
Sensation and Perception. Sensation and
perception refers to the ways in which orga-
nisms detect and interpret their environ-
ment. Topics included in this discipline in-
clude studies of sensory mechanisms, the
development of search images, and highly
specialized sensory mechanisms, such as
echolocation.
Social Behavior. Social behavior is defined
by a situation in which the behavior of one
organism serves as a stimulus for the be-
havior of another, and vice versa. Instances
of social behavior range from simple forms
of aggregation to complex exchanges among
individuals (e.g., dominance, cooperation, and
reciprocal altruism).
Spacing Mechanisms Spacing mechanisms
are intimately tied to social behavior, and
range from such topics as individual distance
to the maintenance of territories.
Behavioral v. Biomedical Research
Distinctions between behavioral and biomedi-
cal research, although they are commonly made
(and are followed in this assessment), frequently
break down. Behavior, in the final analysis, is a
biological phenomenon, Behavior presupposes a
living organism, and the way that organism be-
haves is influenced in complex ways by its genetic
makeup, hormonal status, physiology, and neuro-
chemistry. Intervening between the input of envi-
ronmental events and the output of behavioral
events are complex neuroanatomical networks in-
volving receptors, electrochemical reactions,
nerve impulses, and effecter organs. Behavior
does not occur in a vacuum. The biology of the
organism provides the foundation that makes be-
havioral events possible.
It is increasingly apparent that many aspects
of behavioral research must be viewed in conjunc-
tion with biomedical research. Strong compo-
nents of both behavioral and biomedical research
are evident, for example, in the study of obesity,
hypertension, drug addiction, headaches, aggres-
sion, alcoholism, sexual dysfunction, brain  dam-
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age, epilepsy, schizophrenia, depression, learn-
ing disorders, smoking, anorexia nervosa, stomach
ulcers, mental retardation, and a variety of other
psychological disorders.
Why Are Animals Used in
Behavioral Research?
Control
The use of animals under laboratory conditions
enables the manipulation and control of a vari-
ety of factors that in different settings would con-
fuse, contaminate, and confound any attempt to
interpret a behavioral outcome. Animal models
also allow the control of genetic background,
prior experience, temperature, humidity, diet,
and previous social encounters. When these vari-
ables are uncontrolled, observed behavioral re-
sponses can be virtually impossible to interpret.
objectivity
Two prerequisites to any research are objec-
tivity and impartiality. When humans study hu-
mans, as can be the case in behavioral research,
unique problems may arise. Not only can it be dif-
ficult for the investigator to remain objective in
interpreting behavioral phenomena, but a vari-
ety of other complications can arise from the so-
cial relationship among those conducting the re-
search and those participating as subjects (50).
The use of nonhuman species partially amelio-
rates this problem.
Developmental Effects
Among many species behavior changes as a
function of age. The problem this poses for hu-
man research is one of time. Human development
continues for many decades. To chart behavioral
changes within the same persons would take
many years, involving exhaustive followup studies
and the ever-present danger of losing research
subjects, for example, because of death or relo-
cation. The alternative to such longitudinal work
is to conduct cross-sectional studies, where simul-
taneous samples are drawn from different age
groups. A problem in this case is that sociologi-
cal and cultural changes over time (e.g., 50 years
ago, an eighth-grade education was the norm)
confound apparent differences between people
of different ages. Because a range of lifespans is
available among laboratory species, the use of ani-
mal models can minimize or circumvent al-
together some problems associated with the study
of behavior over time.
Genetic Effects
There is growing evidence of a variety of ge-
netic effects on behavior (23). With animal models,
selective breeding studies can establish, pinpoint,
and quantify genetic effects on behavior. The op-
portunity for human research in this area, apart
from studies of identical twins, is limited.
Methodology
The fact that animals cannot talk seems at first
to constitute a serious disadvantage to conduct-
ing behavioral research with animals. Yet, the
stark limits of trans-species communication help
to keep human investigators unbiased in their
work. The use of animal models forces the be-
havioral scientist to develop objective, operational
definitions and research techniques that may later
be applied to humans.
Lower Complexity
Behavior, notably human behavior, can be ex-
tremely complex. The use of animals that appear
to be structurally and functionally less complex
presents a way to identify some of the basic ele-
ments and principles of behavior that might other-
wise remain inextricably embedded in a mosaic
of other factors.
Species-Specific Behaviors
Certain behavioral phenomena fall outside the
realm of human sensory or motor abilities. For
example, flight, echolocation, infrared detection,
and homing require the use of nonhuman spe-
cies as subjects for research purposes.
Heuristic Value
Research on the behavior of animals has been
an important source of hypotheses about human
behavior and an impetus to research on humans
(35). Much of what is now known about the  prin-
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ciples of learning, for example, was initially de-
rived from research on animals. Likewise, a vari-
ety of therapeutic techniques (e.g., desensitization)
were derived from work with animals, Human
studies were done to verify what was learned
from animal research and to gauge the limits of
extrapolation from animals to humans.
Practical Application to Animal Species
In addition to providing models of a variety of
biomedical and psychological problems in hu-
mans, research on animal behavior is in many in-
stances focused on benefits to the animals them-
selves. For example, an understanding of behavior
has proved crucial for designing optimal captive
environments for the protection and breeding of
endangered species (55). Increased attention has
also been paid to the behavior of farm animals.
The study of mother-infant attachments, social
behavior in groups, stress resulting from over-
crowding and confinement, and habitat prefer-
ences has led to important insights into farm-
animal welfare and husbandry (13,27,54).
It is also noteworthy in this context that knowl-
edge gained about behavioral problems in humans
through animal research is now being applied to
animals. Effective treatments have been devel-
oped for aggressive problems in cats (5) and fears
and phobias in dogs (24)58).
A knowledge of animal behavior has helped
identify and solve ecologic problems. The discov-
ery and subsequent synthesis of insect sex attrac-
tants, or pheromones, has important implications
for the control of agricultural pests. Rather than
having to use toxic pesticides applied over vast
areas, there is already some application and much
future potential in baiting traps with specific
pheromones, which precludes environmental
contamination.
One unique application of laboratory findings
to the solution of ecologic problems involved stud-
ies of taste-aversion conditioning in rats (18). Re-
searchers paired unpleasant, chemical- or radia-
tion-induced illness with different flavors. After
just one or two trials, rats developed highly dura-
ble aversions to the flavors paired with unpleasant
stimuli. outside the laboratory, by pairing lithi-
um-chloride-induced illness with the flesh of vari-
ous prey species, it is now possible to control coy-
ote attacks on sheep and turkeys  (14). Indeed, one
or two trials is sufficient to eliminate attacks on
specific domestic farm animals but leave the coy-
ote free to feed on alternative prey (22).
This procedure has recently been extended to
reducing crop damage by crows and even appears
to have promise for dealing with cancer patients
undergoing radiation therapy (l). (A frequent
complication of radiation therapy has been un-
pleasant gastrointestinal illness that the patient
generalizes to all food; the patient may be una-
ble to eat. Using the principles of conditioned taste
aversion developed in rats, it is now possible to
circumvent the problem by restricting patients
to one particular kind of food during radiation
treatment, so that the aversion that develops is
specific to that food alone.)
Individual Animals in the
Service of Humans
Behavioral research occasionally centers on a
trait of a particular species that maybe especially
well suited to assist humans. For example, using
animals to help handicapped persons has required
a knowledge of animal behavior. Seeing eye guide
dogs, usually German shepherds or golden re-
trievers, assist the blind (20), and trained capu-
chin monkeys perform as aides for quadriplegics
(63). Pet dogs and cats have been shown to have
therapeutic value for psychiatric patients (10), the
handicapped (12), and the elderly (49), and they
may even hold promise for alleviating depression
resulting from loss of a child (57).
Methods of Behavioral Research
The methods of behavioral research are as var-
ied as the disciplines, but most fall into one of
three general categories: field studies and natural-
istic observation; developmental studies; and lab-
oratory studies.
Field studies represent an attempt to examine
the behavior in question as it occurs under natu-
ral circumstances, Such studies do not typically
involve attempts to manipulate or control the con-
ditions of observation. watching animals in nat-
ural conditions has frequently been suggested as
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an alternative to using them in laboratory re-
search (6,44). The following benefits and limita-
tions of naturalistic observation have been rec-
ognized:
l
l
l
l
Naturalistic observation is frequently a start-
ing point. Observation of animals in the field
provides a base of descriptive information
and serves as a source of hypotheses to be
subsequently tested under laboratory con-
ditions,
Naturalistic observation can be used to com-
pare behavior observed in the field with that
occurring in the laboratory to assess the ex-
tent to which an artificial environment may
alter behavior, and whether the results can
be generalized.
Field studies can increase the efficiency with
which animals are used by providing impor-
tant information on natural species variables
and biological constraints on behavior.
The principal drawback to naturalistic obser-
vation is the absence of control. Under nat-
ural conditions, events frequently change in
both important and spurious ways, often
making it impossible to establish cause-and-
effect relations (37).
Behavioral research often requires study of one
animal or a group through time, as development
proceeds. Among many species the emergence of
different patterns of behavior is a reflection of
both maturational and experiential factors. De-
velopmental variables have been identified as be-
ing important in the expression of such diverse
behaviors as aggression, communication, activity,
learning, and social behavior.
Laboratory studies undertake to manipulate
and control the condition of observation so as to
specify more precisely the variables and condi-
tions that influence the behavior in question. Most
laboratory studies of behavior can be subdivided
into those that attempt to identify the environ-
mental determinants of behavior and those con-
cerned with the organic basis for behavior.
Within the latter category are a number of ap-
proaches involving attempts to identify the neu -
roanatomical, neurochemical, endocrinological,
and genetic underpinnings for behavior.
Use of Multiple Species in
Behavioral Research
Many behavioral phenomena appear common
to different species. Patterns of migration, for ex-
ample, are common to such diverse groups as in-
sects, fish, birds, and even some species of mam-
mals. Much the same appears true for learning,
motivation, and bodily maintenance. Yet, gen-
eralizations about categories of behavior (e.g.,
parental care or hoarding) in unrelated species
may be misleading, because the species evolved
independently (34). Moreover, comparing the per-
formance of different species on a simple task
may have no bearing on larger issues such as in-
telligence (26). What used to be seen as general
principles and “laws” of learning, for example,
now turn out to be specific to certain species un-
der certain situations (3,4,53).
There are some behaviors that are of limited
scope across species but of profound importance
in terms of their bearing on the question of hu-
man behavior. For example, the capacity to rec-
ognize one’s own reflection in a mirror has only
been found in humans, chimpanzees, and orangu-
tans, and much the same may apply to instances
of intentional deception, gratitude, grudging, sym-
pathy, empathy, attribution, reconciliation, and
sorrow (17).
P A I N  A N D  D I S T R E S S  I N  R E S E A R C H  A N I M A L S
There are two general kinds of animal ex- tion of pain and the monitoring of the responses
perimentation in which pain may occur. First, to pain are usually integral parts of the experi-
there are studies that investigate the nature of mental procedure. The goal is the prevention,
pain itself and the anatomical, behavioral, chem- treatment, and amelioration of human and ani-
ical, pharmacological, and physiological mecha- mal pain. The second, and much larger, class of
nisms responsible for it. In such studies, the inflic- animal experimentation in which pain may occur
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consists of those studies in which pain is but a
byproduct of the procedures used (28).
When indices of pain are observed or antici-
pated in living research animals as byproducts of
an experimental protocol, the investigator is both
informally and formally obliged to supply pain re-
lief. (For a further discussion of the investigator’s
responsibilities in this area, see chs. 4, 13, 14, 15,
and 16.)
Pain relief for a laboratory animal is usually ac-
complished by one of three means. An analge-
sic is an agent that relieves pain without caus-
ing loss of consciousness. The most frequent use
of analgesic drugs in laboratory animals is likely
to be in the postoperative period. An anesthetic
is an agent that causes loss of the sensation of
pain, usually without loss of consciousness. An
anesthetic may be classified as topical, local, or
general, according to the breadth of its effect.
Topical anesthetics find only limited use in ani-
mal research, usually as components of ointments
applied to minor injuries, whereas local anes-
thetics are used for many minor surgical proce-
dures. The use of local anesthetics requires post-
surgical care, because anesthetized surfaces are
particularly liable to accidental and self-inflicted
damage (43). General anesthetic, either injected
or inhaled, is widely used in research. A tran-
quilizer is an agent that quiets, calms, and re-
duces anxiety and tension with some alteration
of the level of consciousness and without effect-
ing analgesia. Tranquilizers are particularly use-
ful in reducing distress and resistance to con-
finement.
The perception of pain is largely subjective. It
is best described as an awareness of discomfort
resulting from injury, disease, or emotional dis-
tress and evidenced by biological or behavioral
changes. A frequent companion to pain is dis-
tress—the undesirable stress resulting from pain,
anxiety, or fear (51). Distress can also occur in
the absence of pain. An animal struggling in a re-
straint device may be free from any pain, but it
may be in distress.
Despite the difficulty associated with objectively
defining pain, it can usually be recognized. The
most obvious sign is an animal’s behavior (16)42,
56),
l
l
l
l
l
l
l
Signs of pain include the following:
Impaired activity. Animals may be rela-
tively inactive or may remain completely im-
mobile within their pen or cage. If they do
move, it is often with an abnormal gait, such
as limping or not using a leg.
Change in personality. Pain may result in
guarding behavior (attempting to protect or
move away). Animals may also be uncharac-
teristically aggressive.
Restlessness. Animals may move about
continually or may rise up and lie down
repeatedly.
Decreased intake. Food and water con-
sumption are usually severely retarded, often
to the extent that moderate or severe de-
hydration can occur.
Abnormal vocalization. Dogs may whine or
whimper, rats and hamsters may squeak at
a high pitch, and primates may scream or
grunt.
Abnormal posture. Dogs, cats, and rodents
may tense the muscles of the back and ab-
domen to effect a “tucked-up” appearance.
Self-mutilation. Dogs and rodents may
gnaw at the site of a lesion on their own flesh
or, for example, remove their own tumor.
In identifying pain, all these criteria must be
considered in conjunction with the nature of the
experimental procedure and the previous normal
behavioral characteristics of the animal. Also, it
should be noted that no one criterion is a wholly
reliable indicator of pain.
An experimental procedure probably involves
pain if it includes, for example, induction of any
pathological state, administration of toxic sub-
stances, long-term physical restraint, aversive
training, or major operative procedures such as
surgery and induction of physical trauma. Vari-
ous procedures employed in the research labora-
tory can be compared, ranking each for the esti-
mated degree of pain for the animal subject (see
table 5-3). Educated estimates of pain perception
in animals can be made by understanding animal
behavior; by drawing analogies based on compar-
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Table 5-3.—Classification of Research Experiments and Procedures
According to the Degree of Pain or Distress for the Animal
Level of
pain/distress Examples of types of experiments Examples of procedures
Absent or
n e g l i g i b l e  .
l
l
Low l
l
l
Moderate l
l
High
Noninvasive behavioral testing
Studies of migration or homing
Dietary preference studies
Determination of pain threshold
Manipulation of blood chemistry
Experiments carried out on anesthetized
animals that do not wake up again
Behavioral study of flight or avoidance
reactions
Operations carried out under anesthesia or
analgesia, with the animal waking up or
experiencing the cessation of the action of
the painkiller (postoperative pain)
Chronic stress studies
Drug withdrawal studies
Studies of certain infectious agents
Experiments on mechanisms of pain in
conscious animals
Experiments on mechanisms of healing
Studies of radiation toxicity
l
l
l
l
l
b
l
l
l
l
l
l
b
l
l
l
l
l
l
l
l
l
l
l
l
l
Banding for identification or tracking
Field observation
Fecal examination
Conditioned learning with food reward
Flinch or jump response
Injections
Tube feeding
Tattooing
Administration of anesthetic
Surgery under deep anesthesia and subsequent
sacrifice
—Removal of organs for histological or biochemical
investigation
—Culture of surviving organs
Blood sampling
Stimulation of unanesthetized animal
Biopsies
Implantation of chronic catheters
Castration
Mild electric shock
Implantation of electrodes
Central nervous system lesions
Exposure of internal organs
Food or water restriction for more than 24 hours
Prolonged physical restraint
Chronic sleep deprivation
Intense electric shock
Production of pain clearly beyond threshold tolerance
Induction of burns or wounds
Surgery on conscious animal
SOURCE: Office of Technology Assessment.
ative anatomy, physiology, and pathology; and by enced by laboratory animals—ranging from ab-
basing inferences on subjective responses to pain sent or negligible to high-can provide a basis for
experiences by humans. Careful attempts to esti- efforts to minimize the pain or distress caused
mate and categorize the degree of pain experi- by research procedures.
ANIMAL AND NONANIMAL PROTOCOLS IN BIOMEDICAL AND
BEHAVIORAL RESEARCH REPORTS
One way to measure the balance of animal and mal and nonanimal protocols in contemporary re-
nonanimal methods in research is to survey the search.
end-product of experimentation—the published
literature. OTA examined approximately 6,000 re- Fifteen leading scientific journals were selected
search reports published from 1980 through 1983 to represent disciplines within biomedical and be-
in an effort to document the prevalence of ani- havioral research, These journals were chosen be-
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cause of their primary emphasis on research done
in the United States by American scientists and
because of the respect accorded them by scien-
tists in each discipline. The editors of all 15 sub-
ject manuscripts to independent peer review
prior to publication.
For each year from 1980 through 1983, OTA
examined the first 100 research papers published
in each journal; in a few cases, fewer than 100
papers were published in a given year. Short com-
munications and review articles were not in-
cluded. In each report, OTA checked whether ani-
mals were used. Thus, the materials and methods
employed in each article were categorized as ei-
ther use of animals, no use of animals, or use of
humans. ‘(Animal” is defined as described earlier
(see ch. 2), any nonhuman vertebrate. “Use” of
animals is defined conservatively as any use of
an animal in an experiment. Table 5-4 lists some
examples of the ways specific protocols were
categorized by OTA.
Survey Findings
The results of this survey indicate that the re-
search journals—and perhaps the disciplines they
represent—fall into two categories:
Table 5-4.—Classification of Pubiished Research
Protocois in OTA Survey of 15 Journais
Examples of protocols classified as use of animals:
Whole animals used as experimental subjects
Animals used to obtain cell, tissue, or organ of interest
Animals used in the establishment of new cell, tissue, or
organ cultures
Extraction of protein or other biological molecule from
animals
Production of antibodies by whole animals or animal
components
Use of egg, sperm, or embryo from animal source
Use of animal epidemiologic data
Examples of protocols classified as no use of animals:
Use of invertebrate organisms
Use of computer systems
Use of previously established cell lines
Acquisition of biological molecules from a commercial
manufacturer
Use of physical or chemical systems
Examples of protocols classified as use of humans:
Use of living human subjects
Use of cadavers
Use of human placenta
Use of human blood cells or components
Use of human epidemiologic data
SOURCE: Office of Technology Assessment.
l journals representing disciplines that have al-
ready largely incorporated nonanimal meth-
ods into the research process; and
. journals representing disciplines that either
have not incorporated, or may not have avail-
able, nonanimal methods.
For most of the 15 journals (see table 5-5), pub-
lished protocols fall predominantly into just one
of the three categories of methods; in many cases,
over 80 percent of the protocols are in one cate-
gory. Only Cell, representing cell biology, had a
majority of articles using nonanimal methods. The
American Journal of Cardiology contained a ma-
jority of articles using humans or human mate-
rials as research subjects. All the remaining jour-
nals except Developmental Biology and the Jour-
nal of Biological Chemistry included a majority
of articles using animals. Developmental Biology
and the Journal of Biological Chemistry contained
approximately equal percentages of articles em-
ploying animal and nonanimal methods.
The 12 biomedical research journals included
in this survey cover a diverse array of disciplines
under this one rubric. The differing patterns of
animal, nonanimal, and human use make gener-
alizations misleading at best and perhaps impos-
sible. In the same way that biomedical research
itself is not monolithic, the patterns of animal use
among disciplines of biomedical research are not
uniform. Perhaps not surprisingly, veterinary re-
search, insofar as it is represented by two jour-
nals, relies primarily on animals, a minimal per-
centage of nonanimal methods, and no protocols
with humans.
The three behavioral research journals included
in this survey registered a predominance of ani-
mal methods—more than 90 percent of the pro-
tocols in each case. The research reported in these
journals involved minimal use of humans or
nonanimal methods. Other behavioral research
journals, for example those reporting on clinical
psychology, largely publish reports of research
with human subjects.
Survey Limitations
This attempt to gauge the implementation of
nonanimal methods in selected areas of biomedi-
cal and behavioral research had certain limita-
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Table 5-5.–Percentage of Papers (Average, 1980-83)
Using Animal, Nonanimal, and Human Subjects in
15 Biomedical and Behavioral Research Journals
Surveyed by OTA
Percentage of papers using:
Journal Animals Nonanimals Humans
to distinguish between different vertebrate spe-
cies. Any alternative protocol, therefore, that
tended to reduce or refine an existing animal pro-
cedure was still categorized as “use of animals. ”
An example of the problem of overestimation
of animal use by a survey such as this exists in
immunology. Today, antibodies, needed in most
immunology research, can be obtained by inject-
ing rabbits with foreign proteins, or antigens, and
extracting the antibodies that the rabbit produced
or by using mouse spleens and the monoclinal
antibody technique to produce antibodies to an
antigen. Each process requires animals. Once the
monoclinal cells are in culture, however, there
is a virtually unlimited supply of the needed anti-
body, and there is essentially no further need for
animals. Thus the monoclinal technique can de-
crease animal use, as was the case in many of the
most recent articles surveyed in the Journal of
Immunology. These articles, though, were still
coded under the “use of animals” category be-
cause the primary methods and materials in-
volved animals. But the total number of animals
in a given experiment decreased, for they were
used in just one aspect of the experiment instead
of two. The monoclinal antibody technique is be-
ing used as an alternative to the repeated use of
rabbits, yet its impact is underestimated in a sur-
vey such as this. The OTA scoring of protocols
published in the Journal of Immunology did not
reflect certain reductions that are currently be-
ing implemented.
Along with underestimating the implementation
of nonanimal methods, the boundaries within
which the OTA survey was carried out also
tended to overestimate the use of animals as ex-
perimental subjects. This was due principally to
two factors included in the scoring procedure
under animal use-epidemiologic studies and the
study of biological molecules obtained from
animals.
Epidemiologic data are the primary sources in
some articles in the American Journal of Cardi-
ology, the Journal of the National Cancer Insti-
tute, and in many veterinary studies. These pro-
tocols were included under “use of animals,” yet
they did not manipulate animals in any way as
experimental subjects.
Biomadical research:
American Journal of
Veterinary Research . . . .
Journal of Animal
Science . . . . . . . . . . . . . . .
Endocrinology . . . . . . . . . . .
American Journal of
Physiology . . . . . . . . . . . .
Anatomical Record . . . . . . .
Proceedings of the Society
of Experimental Biology
and Medicine . . . . . . . . . .
Journal of Immunology . . .
Journal of the National
Cancer Institute . . . . . . . .
Developmental Biology . . .
Journal of Biological
Chemistry . . . . . . . . . . . . .
Cell . . . . . . . . . . . . . . . . . . . .
American Journal of
Cardiology. . . . . . . . . . . . .
Behavioral research:
Behavioral and Neural
Biology . . . . . . . . . . . . . . .
Journal of Comparative
and Physiological
Psychology . . . . . . . . . . . .
Phvsioloav and Behavior . .
96 4a o
4b
8
96
91
0
1
90
88
6
3
4
9
10
10
7
19
83
71
60
54
9
46
31
0
9
2
39
31
52
67
12 0 88
96 4 0
96
93
3
1
1
6
aprimarily  virus research.
bprimarily  computer  rn~d~lin~  or grain  fermentation applicable to ruminant
nutrition.
SOURCE: Office of Technology Assessment.
tions. The conservative scoring procedure tended
to underestimate the use of alternatives to ani-
mals as defined in this assessment (see ch. 2). For
instance, if an experimental protocol used both
animal and nonanimal methods, it was catego-
rized under use of animals. If a study involved
both nonanimal methods and humans, it was
counted as use of humans. Further, if a study in-
volved both animal methods and humans, it was
counted as use of animals. The approach used to
categorize protocols took into consideration only
the replacement, not the reduction or refinement,
of animal methods. Whether a protocol involved
1 or 100 animals, it still fell under the category
of “use of animals, ” and all reports bore equal
weight in determining percentage of protocols
using humans or animal or nonanimal methods.
In addition, there was no attempt to quantify the
pain or stress of an animal in an experiment or
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Obtaining many biological molecules that are
studied experimentally requires that they be ex-
tracted from animals who produce them. Subse-
quent experiments on these molecules themselves
(reported, for example, in the Journal of Biologi-
cal Chemistry) do not involve animals at all. In
such cases, animals may be used in preparation
for an experiment but are not actually involved
in the experiment being performed. Therefore,
protocols that involved animals as donors of bio-
logical molecules (e.g., bodily fluids) for an exper-
iment prior to its initiation were also included
under use of animals, and this tended to overesti-
mate the use of animals as research subjects.
It is important to distinguish between the num-
ber of published articles involving animal meth-
ods and the actual number of animals used in re-
search. The OTA survey provides no information
on the latter. Some protocols may involve only
a few animals, while others may employ tens or
hundreds. Moreover, depending on the species
and type of research, some subjects might be used
in multiple experiments. In primate research, for
example, it is not uncommon for animals to be
used in a succession of either related or unrelated
studies over a period of years; this would not be
the case for rodents.
SUMMARY AND CONCLUSIONS
Biomedical and behavioral research center on
the understanding of human health and disease
and rely on animals to achieve this goal. They use
animal subjects to understand not only human
phenomena, but animal phenomena as well. The
broad spectrum of enterprises involved in these
fields of research includes disciplines ranging
from anatomy to zoology. Although the varied dis-
ciplines that make up biomedical and behavioral
research have distinct foci, they often overlap.
Animals are used throughout these disciplines
to address an array of questions. Nonhuman pri-
mates, for example, have contributed to an under-
standing of polio, hepatitis B, high blood pressure,
Parkinson’s disease, baldness, menopausal hot
flashes, and other human conditions. Beyond the
nonhuman primates, diverse species are used in
biomedical research because of their anatomical,
physiological, and metabolic similarities to or
differences from humans. Principles and tech-
niques developed in varied animal species (e.g.,
dog, horse, and sheep) may combine to support
a single application to humans, as in the case of
coronary artery bypass graft surgery. In be-
havioral research, different animal species may
also be used to learn about characteristics unique
to the species under study, usually one of eco-
nomic importance or intrinsic interest to humans.
Animals may suffer pain or distress in the
course of research on the mechanism of pain, or,
more generally, as a byproduct of experimental
procedures. In such cases, the investigator is
obliged to supply pain relief to the animal or to
justify withholding pain-relieving drugs as nec-
essary to the experiment. Institutional animal care
and use committees play an important role in
overseeing this process (see ch. 15). Pain relief is
usually effected by the administration of analge-
sic, anesthetic, or tranquilizing agents. Indices of
pain can usually be recognized in experimental
animals, and experimental procedures can be
ranked according to estimates of the degree of
pain produced. Such a ranking provides a basis
for efforts to minimize the pain caused by re-
search procedures.
An OTA survey of published research reports
in 15 scientific journals documented the preva-
lence of animal v. nonanimal protocols in contem-
porary research. Each research journal, and per-
haps the discipline it represents, can be identified
by a characteristic balance of protocols using ani-
mals, nonanimals, and humans. The data permit
research journals to be classified as representing
disciplines that either rely on nonanimal meth-
ods or that do not incorporate such methods (or
do not have them available). In the same way that
research itself is not monolithic, patterns of ani-
mal use and the use of nonanimal methods among
research disciplines are not uniform.
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Chapter 6
Alternatives to Animal Use
in Research
Unless we get a handle 011 what is happening in the mammalian brain, there’s no way of
knowing whether any of these [invertebrate] models is right or not.
Richard F. Thompson
Stanford University
Science 85 6(4):33, 1985
Investigators often ask statisticians how many observations they should make (fortunately,
usually before the study begins). To be answerable, this question needs fuller formulation.
There is a resemblance to the question, How much money should I take when I go on
vacation? Fuller information is needed there too. How long a vacation? Where? With whom?
Three questions need to be answered before the sample size is determined. How variable
are the data that will be collected? How precise an answer is needed? How much
confidence should there be in the answer obtained? These questions can be well worth
probing even if the question of sample size will foreseeably be answered by the size of the
budget or the time available for the study. Sometimes a planned study is dropped because
sample-size analysis shows that it has almost no chance of providing a useful answer under
the constraints of time or budget that apply.
Lincoln E. Moses
Stanford University
N. Engl. J. Med. 312:890-897, 1985
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Chapter 6
Alternatives to Animal Use in Research
Alternatives to animal use in biomedical and be-
havioral research fall into four broad categories:
l
l
l
l
continued, but modified, animal use, in-
cluding a reduction in the number of animals
used, improved experimental design and sta-
tistical analyses of results, substitution of cold-
blooded for warm-blooded vertebrates, substi-
tution of laboratory mammals for domestic
or companion mammals, and reduction of pain
or experimental insult;
use of living systems, including in vitro cul-
tures (of cells, tissues, and organs; see table
6-l), embryos, invertebrates, micro-organ-
isms, and plants;
use of nonliving systems, such as chemical
or physical systems; and
computer simulation.
In this chapter, various disciplines within bio-
medical and behavioral research are surveyed in
order to focus attention on the most promising
areas for development of alternatives to animal
methods. Areas not amenable to the implementa-
tion of such alternatives are also identified.
As noted in chapter 5, distinctions within and
among the varied disciplines of biomedical and be-
havioral research are artificial in one sense: Bound-
aries among disciplines are often blurred, and
broad areas of overlap exist. Yet the examination
of discrete areas of research highlights the great
variability among disciplines in the potential for
using alternatives to animals.
Using alternative methods in research holds sev-
eral advantages from scientific, economic, and hu-
mane perspectives, including:
l
l
l
l
l
l
l
l
reduction in the number of animals used;
reduction in animal pain, suffering, and ex-
perimental insult;
reduction in investigator-induced, artifactual
physiological phenomena;
savings in time, with the benefit of obtaining
results more quickly;
the ability to perform replicative protocols on
a routine basis;
reduction in the cost of research;
a greater flexibility to alter conditions and vari-
ables of the experimental protocol;
reduction of error stemming from inter-
individual variability; and
the intrinsic potential of in vitro techniques
to study cellular and molecular mechanisms.
At the same time, these methods are fraught with
inherent disadvantages, including:
l
l
l
reduced ability to study organismal growth
processes;
reduced ability to study cells, tissues, and or-
gan systems acting in concert;
reduced ability to study integrated biochem -
ical and metabolic pathways;
Table 6-1 .—Research Methods Involving Living Components
Isolated perfused Isolated tissue or Isolated single Subcellular
organs using: tissue sample using: cell using: constituents using:
liver striated muscle fat cells nuclei
muscle iris liver cells mitochondria
heart trachea neurons microsomes
lung bronchi glial cells Iysosomes
adrenal gland lung striated muscle cells synaptosomes
pituitary gland uterus smooth muscle cells cell membranes
intestine intestine red blood cells muscle actin/myosin
testis seminal vesicle leukocytes
skin vas deferens platelets
spleen bladder mast cells
kidney spleen
salivary gland
fat pads
liver slice
SOURCE” Adapted from W. Paton, Man and Mouse: Anima/s  in Medical Research (New York: Oxford University Press, 19S.4),
1 1 3
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reduced ability to study behavior;
reduced ability to study the recovery of
damaged tissue;
reduced ability to study interaction between
the organism and its environment;
reduced ability to study idiosyncratic or
species-specific responses;
reduced ability to distinguish between male-
and female-specific phenomena; and
. a handicap to probing the unknown and phe-
nomena not yet identified.
This general listing of advantages and disadvan-
tages provides a framework for examining the use
of alternatives in specific disciplines of biomedi-
cal and behavioral research. Many of these pros
and cons are cited in this chapter’s detailed descrip-
tion of alternatives.
CONTINUED, BUT MODIFIED, USE OF ANIMALS
IN BIOMEDICAL RESEARCH
Animal use in biomedical research can be modi-
fied in a number of ways, including strengthen-
ing experimental design to use fewer animals, re-
ducing the degree of experimental insult, and
substituting one organism for another. In the
case of substitution, cold-blooded vertebrates may
supplant warm-blooded ones.
Reduction in the Number
of Animals Used
Up to half the animals used in research protocols
may be untreated, or control, animals. The impor-
tance of using parallel, internally controlled de-
signs for experimentation may be one of the first
lessons learned by science students whose results
are rejected for not providing comparable data
from treatment groups of animals matched for size,
age, sex, and dosage. Studies with investigator-
initiated, internal controls support substantially
stronger inferences than those without them.
Common and Historical Controls
Fewer animals may be used in an experiment
by sharing a control group with other investiga-
tors or by not using a concurrent control group.
In both cases, all the physical and genetic charac-
teristics of the treatment group(s) must be matched
to those of the control group, and the conditions
under which the data are collected must be as pre-
cisely duplicated as possible. There are difficul-
ties unique to each method. Investigators may en-
counter constraints on their particular study when
sharing controls. For example, sharing may be im-
possible if one group needs to extend its studies
beyond the time agreed for termination and au-
topsy of the shared animals, or if the actions of
one group adversely affect the other, as might hap-
pen by the inadvertent spreading of a parasite or
pathogen. In the case of historical controls, the
difficulty rests in exactly duplicating earlier con-
ditions. Use of such controls must be carefully doc-
umented and justified (82).
Animal Sharing
Another way to use fewer animals is to share
individual experimental animals or their tissues
between research groups. Although this method
may encounter the same types of difficulties de-
scribed for the sharing of controls, it appears to
be gaining in popularity among compatible groups,
At the University of Virginia, investigators in en-
docrinology (Department of Internal Medicine) and
in the molecular genetics of heme synthesis (De-
partment of Biology) use the pituitaries and livers
of the same rats even though the two departments
are on opposite sides of the campus (54).
Research animals may also be shared among dif-
ferent sites. This is especially practicable in the
case of long-lived primates. As long as sequential
protocols are not deemed inhumane or scientifi-
cally conflicting, primates may be shipped from
one research site to another. The Primate Research
Institute (PRI) of New Mexico State University, for
example, will loan chimpanzees and rhesus and
cynomolgus monkeys to qualified U.S. scientists.
PRI currently has 240 chimpanzees on campus,
with another 150 animals on loan.
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Using animals maximally in a confined area is
a mandatory part of experimental design in the
research program of the National Aeronautics and
Space Administration (NASA). Protocols typically
call for investigators to combine projects and make
efficient use of one small group of animals (125).
Improved Experimental or
Statistical Design
“Every time a particle of statistical method “is
properly used, fewer animals are employed than
would otherwise have been necessary,” wrote Rus-
sell and Burch some 27 years ago (174). Since then,
progress has been made both in the number of
statistical tools available and in the training of in-
vestigators in the use of these tools. Yet training
still lags behind the availability of tools. Insuffi-
cient information for critical evaluation and inap-
propriate statistical analyses appear frequently in
the literature, particularly with investigators using
the t-test in cases for which analysis of variance
is the appropriate measure (82).
An analysis of variance simultaneously tests two
or more parameters of treatment groups for indi-
cation of significant difference. When the test sta-
tistic falls in the rejection region, the researcher
can be reasonably sure that a real difference ex-
ists between treatments. The t-test estimates the
difference between the mean values of one param-
eter of two treatments. It is a powerful measure
of significance when the number of comparisons
is small, but it is subject to an increasingly large
potential for error as the number of parameters
grows. Using multiple t-tests increases the risk of
finding a significant difference between treatments
where there is none. Such observations are not
esoteric, since poor summarization and statistical
usage may reflect poor experimental design, call-
ing into question the results of an investigation
and leading to otherwise unnecessary repetition.
At least one group, the Harvard Study Group on
Statistics in the Biomedical Sciences, is pursuing
ways to improve statistical practice and report-
ing (64).
Serial sacrifice, crossover, and group sequen-
tial testing are three experimental designs that can
reduce animal use in laboratory research (82). In
serial sacrifice, animals with induced effects are
randomly selected for sacrifice and examination
for the occurrence and progress of effects over
time. Such studies, as in radiation oncology (22),
have the dual advantage of cutting short the time
some animals must spend in an affected state and
providing information about changes within the
animal other than those observed when it is al-
lowed to die without further interference. The pri-
mary disadvantage is that survival information is
compromised; therefore, the resulting data can-
not be compared with other studies in which sur-
vival serves as an end point.
A crossover design maybe appropriate for stud-
ies in which short-term effects are expected. Each
animal serves as its own control by first receiving
either a drug or a placebo, and then receiving the
reverse. Such a design can be highly useful in lab-
oratory and clinical testing, but crossovers must
be used judiciously. Should there be any unex-
pected long-term effects, the entire test is invali-
dated and would need to be repeated as two sepa-
rate tests.
In the group sequential design, treatment groups
are compared with each other in stages. For ex-
ample, if two groups are given the same dosage
of two different drugs, experimentation at higher
dosages is undertaken only if there is no statisti-
cally significant difference between the responses
of the two groups. The sooner a difference be-
tween groups is observed, the fewer the number
of trials run. Both crossover and group sequential
designs have potential applications in anesthesiol-
ogy, endocrinology, nutrition, pharmacology, ra-
diology, teratology, and toxicology.
A commonly mentioned method of reducing the
number of animals used is smaller treatment
groups. Yet within the biomedical research com-
munity a frequently heard complaint is that too
few animals to yield useful estimates are likely to
be included in each treatment group, particularly
in fields such as radiology (95). Problems of this
nature generally grow out of the extreme economic
pressures being applied to investigators to con-
trol animal costs. Well-established techniques such
as saturation analyses, particularly radioimmuno-
assays, have radically reduced the number of ani-
mals used for any one procedure, but they may
have resulted in little or no reduction in overall
116 l Alternatives to Animal Use in Research, Testing, and Education
use, since they have made previously difficult anal-
yses more accessible to many more investigators.
Substituting one Species
for Another
In some instances, laboratory mammals (e.g., ro-
dents) or nonmammalian vertebrates can be used
in place of companion mammals (e.g., dogs), domes-
tic species (e.g., sheep), or primates (e.g., monkeys).
As more information on the physiology, biochem-
istry, and endocrinology of laboratory mammals
and nonmammalian species accumulates and is
demonstrated to be like or unlike that of humans,
greater use can be made of laboratory species,
which in turn can generate more information and
reduce future needs for research. Comparative
neuroscience is perhaps the most rapidly expand-
ing field and is related to physiology, biochemis-
try, pharmacology, developmental biology, and
zoology (33). Some brain components have been
found to be remarkably similar between vertebrate
species (69).
Economics plays a large part in the selection of
how many and what kind of animals will be used
in some research (see ch. 11). An investigator fol-
lowing upon previous work will generally begin
with the species already in use, changing only if
money becomes scarcer or if a better model is
clearly demonstrated. Investigators starting anew
are likely to seek the advice of a facility veterinar-
ian or of colleagues as to which species best fits
their needs and to begin with the smallest accept-
able animal. Still other researchers deliberately
begin work with a novel animal model in order
to create a new research niche.
One of the principal reasons for the increased
use of rodents in all areas of biomedical research
has been the availability of genetically homogene-
ous or pathogen-free strains. For some studies,
however, a further degree of genetic definition
is needed. These studies require that the research
animal carry some specific genetic traits that are
suited to the objectives of the research, Because
of their high reproductive potential, rodents are
ideal for this type of “custom designing” and ex-
tensive use is being made of these animals in a va-
riety of disciplines (109). Oncology and immunol-
ogy are two of the more familiar areas of use (92).
Pharmacological research using an ethanol-prefer-
ring strain of rats has prepared the way for explo-
ration of the genetics of alcoholism (212). Further,
the male Lewis rat, an animal that rapidly acquires
testicular lesions and antibodies to sperm after
vasectomy, is a candidate for study of the rever-
sal of vasectomy. This research could answer ques-
tions of human concern in anatomy, physiology,
immunology, endocrinology, and reconstructive
surgery (100).
Chickens and their embryos play an important
role in developmental biology, endocrinology,
histology, and zoology. Other current uses are in
molecular biology, in which embryonic chicken
brain tissue is being cultured to study the neural-
cell adhesion molecule (193), and biochemistry, in
which the embryonic chicken liver is being used
to study the acquisition of hormone responsive-
ness during embryogenesis (62). In cardiology, tur-
keys with inherited Turkey Round Heart disease
serve as models of cardiomyopathy (107), and tur-
key erythrocytes are fused with amphibian eryth-
rocytes to study receptors that mediate physio-
logical functions in heart, smooth muscle, and
other tissues (199).
Frogs have long been used in anatomy, biochem-
istry, developmental biology, physiology, and zool-
ogy. They continue to be widely used in those dis-
ciplines and, additionally, are currently being used
by NASA in radiology studies (125). In dental re-
search, frogs are used to assess digital transplants
to augment tooth and jaw regeneration (101). The
newt Triturus-able to regenerate its limbs, eye
lens, tail, and spinal cord—is used in developmen-
tal biology to explore mechanisms of organ regen-
eration (90). Turtles are used in physiology to study,
for example, retinal mechanisms subserving color
vision. The cone cells of the turtle retina are espe-
cially conducive to such research (161).
Fish are used in research to a lesser degree than
other vertebrates, considering that there are over
30,000 species and their care is relatively uncom-
plicated. It has been suggested that fish would make
excellent subjects for nutritional research, since
many are known to show specific vitamin deficien-
cy symptoms (210). Physiologists have used gold-
fish to study the implications of myelin-sheath
resistances in demyelinating diseases (73). Rain-
bow trout embryos are being used in oncology re-
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search (93). Further, there has been recent inter-
est in a specialized feature of some piscine species:
the electric organ. This tissue is exceptionally rich
in a single class of cholinergic synapses. Biochem-
ists, geneticists, and molecular biologists working
with this material have determined that the struc-
ture of the acetylcholine receptor protein is re-
markably like a human’s (39).
Reduction of Pain or
Experimental Insult
Until recently, the probability of a research ani-
mal receiving the correct amount or type of anes-
thetic depended largely on the inclination of indi-
vidual investigators. They could accept information
about anesthesia available from previous research
or attempt to improve on it. In some cases where
little information was available, guesswork was
required. Now, the enhanced presence of facility
veterinarians and animal care and use committees
with oversight authority (see ch. 15) has resulted
in experimental animals being recognized as veteri-
nary patients entitled to protection from as much
pain and distress as possible, while maintaining
the integrity of research.
Analgesics, anesthetics, and tranquilizers are the
principle tools for the reduction of experimental
pain and distress (see ch. 5). Terminal anesthesia
and death has become the method of choice follow-
ing major organ surgery on animals, even though
it might be argued that observation of the healing
process logically constitutes a part of surgical re-
search (224). Where postsurgical study is consid-
ered necessary, as in cardiology, intensive post-
operative control of pain can be used in lieu of
maintaining the animal under general anesthesia
until death (24).
Advances in Instrumentation
New types of instruments are critical to a reduc-
tion in experimental insult, as they can lead directly
to the more refined or reduced use of live animals
or living material. In the past decade, practically
every piece of instrumentation in biomedical lab-
oratories has been adapted to handle “micro” sam-
ples or has been replaced by new microtechnol-
ogy. Some examples of microinstrumentation
include:
l In reproductive physiology, a 1.0 microliter
sample of rat epididymal fluid collected by
micropuncture can be used to examine sperm
motility, determine total protein, and deter-
mine androgen-binding protein activity (207).
l In biochemistry and molecular genetics, elec-
trophy biological techniques are being used to
explore the possibility of recording the open-
ing and closing of single membrane channels,
tiny pores controlling cellular function (105).
l To study leukemias, blood diseases, and in-
born errors in metabolism, a method for meas-
uring the enzyme kinetics within a single white
blood cell has been developed (134).
l A device is available that will dispense a 1.0
microliter sample as 1)000 aliquots (1 nanoliter
each) for use in biochemical enzyme research
or for clinical samples such as cerebrospinal
fluid from infants (97),
The use of small samples for analysis by mass
spectrometry (146) and by gas or liquid chroma-
tography (86,208) exemplifies minimally invasive
technology. Each year, an entire issue of Science
magazine is devoted to trends in analytical instru-
mentation (2,3). Continued developments in ana-
lytical instrumentation, including noninvasive
imaging techniques such as magnetic resonance
imaging (MRI), will likely reduce the experimental
insults faces by research animals.
In vivo measurements using fiber optics now pro-
vide miniaturized spectrophotometric analysis
from within the ducts and blood vessels, deter-
mine blood velocity, measure temperature changes,
monitor intracranial and intracardiac pressure,
measure fluorescent marker molecules in tumors,
measure pH, and even determine glucose concen-
tration (166). Fiber optics offer great promise: They
can be inserted into vessels and ducts via small
catheters with little discomfort and into the ab-
dominal cavity using local anesthetics (a laparos-
copy), and they can be used repeatedly within the
same animal to obtain measurements without per-
manent damage. Chronic intravascular catheters
are used in a similar way to obtain repeated blood
samples for hormone measurement from freely
moving, undisturbed animals (see fig. 6-1) (189).
Other minimally invasive techniques in animal
research include immunoscintigraphy, amniocen-
tesis, and use of the laser. In immunoscintigraphy,
-. —
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Figure 6=1.–Apparatus for Remote Blood-Sampling
via Chronic, Intravascular Catheter
From Unrestrained Ferret
-
SOURCE: C.L.  SIsk, Michigan State University.
the production of target-specific monoclinal anti-
bodies has improved the ability of external radio-
imaging techniques to locate tumors and to iden-
tify certain noncancerous diseases; radiolabeled
antibodies attach to the target tissue and are then
visualized (59). Amniocentesis is used for the early
detection of genetic diseases, teratological events,
and fetal distress, particularly in domestic species
(67). A new application of the laser in oncology
involves its ability to initiate a lethal photochemi-
cal reaction in cancerous tissue during photoradi -
ation therapy (41).
Some apparently new noninvasive techniques
are actually adapted, miniaturized, or computer-
ized versions of older methods. One such exam-
ple is a small, inflatable tail cuff used to measure
blood pressure in a rat’s tail during hypertension
studies (225). In another example, urine is used
in some specialized methods: In physiological re-
search, electrical impedance measures canine uri-
nary output (1).
Tandem mass spectrometry is being used for
breath analysis to screen for diabetes, cirrhosis,
renal disease, and ovulation. Many diseases remain
to be examined, but there is potential for use of
this technique in toxicology, nutrition, metabolic
diseases, endocrinology, anesthesia, physiology,
and pathology (133).
A technique developed for the determination of
the quality of agricultural crops (162) and the per-
cent of fat in beef (135) uses amplified, digitized,
computer-corrected diffuse reflectance spectro-
photometry in the near-infrared region. It involves
simply placing an appropriate sensor on the sur-
face of the skin and it can be adapted for oncologi-
cal, physiological, and nutritional research (102).
Other increasingly popular noninvasive tech-
niques include ultrasonography -which is used
in cardiology to locate vessels (145), to determine
blood-flow velocity (176), and to detect early ath-
erosclerosis (108)-and magnetic resonance imag-
ing, used to examine the energetic of skeletal mus-
cle in gerontological research (201), to diagnose
metabolic disorders (32), and to provide details of
molecular structure and dynamics in liquids and
solids (130).
USE OF LIVING SYSTEMS IN BIOMEDICAL RESEARCH
In Vitro Research
In vitro biomedical research entails the mainte-
nance of organs, tissues (or fragments of organs
and tissues), and cells outside of the body. Depend-
ing on the conditions of harvesting and preparing
the living material for in vitro maintenance, the
cells may be grown as a population of independ-
ent cells (cell culture) or with the normal tissue
or organ architecture preserved. In the former,
the cells may be encouraged to proliferate, result-
ing innumerous descendant cell populations suit-
able for studies on growth, nutrition, cell division,
and gene expression and regulation.
Table 6-2, which summarizes the characteris-
tics of in vitro systems, makes it clear that as orga-
nization is disrupted or lost, the in vitro system
has less and less of the kind of intercellular and
intracellular interactions that characterize organs,
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Table 6-2.-Properties of In Vitro Culture Systems
Expression Genetic alteration
Preparation and Level of tissue similar to by mutation Environmental
consequences organization Reproducibility in vivo and/or selection control
Intact system (no consequence). . . . + + + + + + + + + + + + + +
Organ culture (remove influences of
whole organism). . . . . . . . . . . . . . . . + + + + + + + + + to + + + + + +
Tissue culture (remove influences of
whole organisms). . . . . . . . . . . . . . . + + + + + + + to + + + + + + +
Primary cell cultures (disrupt
intercellular relationships) . . . . . . . 0 ++ + to + + + + + + + +
Cell lines (intercellular relationships
are reduced; cell proliferation is
enhanced, at times with little
control) . . . . . . . . . . . . . . . . . . . . . . . 0 ++++ + to + + + + to + + + + + + + +
KEY: + + + + = High degree; + + + = Moderate degree; + + = Modest degree; + = Some degree; O = None.
SOURCE: Adaoted from R.M.  Nardone and L.A.  Ouellette, “Scoge of ‘Alternatives’: Overview of the State of the Art, ” contract re~orl cweoared  for the Office of Technoloav
-.
Ass&sment,  US,  Congress, July 1984.
tissues, ’and cells in the body. Nevertheless, im-
proved accessibility of added chemicals and the
opportunity to achieve genetic homogeneity by
cloning and genetic manipulation by selection and
fusion are important trade-offs. Indeed, at times
cell-to-cell interaction may interfere with an ex-
perimental objective (156).
The explosive growth of in vitro research dur-
ing the 1960s and 1970s is illustrated by the fact
that the index of Tissue Culture had 84 pages of
entries in 1965, 207 pages in 1970, 566 pages in
1975, and 636 pages in 1980, when the publica-
tion was discontinued because computerized in-
formation retrieval was warranted. There is vir-
tually no field of biomedical research that has not
been affected by in vitro technology. In vitro mod-
els for the study of cell senescence, atherosclero-
sis, development, growth, and immune reactions
are illustrative of the diversity of applications in
biomedical research (156).
The specific conditions that best support the
maintenance, growth, or differentiation of each
type of culture must be determined before any
useful information can be garnered. Some of the
general requirements of culture systems are com-
binations of the proper gas atmosphere, humid-
ity, temperature, pH, and nutrients. other culture
systems may also have specific light, motion, pres-
sure, and physical or chemical support require-
ments, Under the proper conditions, many can be
subculture for months or frozen in liquid nitro-
gen for years without loss of their unique, differen-
tiated properties.
The ability to maintain many continuous cell lines
has opened the floodgates of experimentation and
made the new technologies accessible to all the
disciplines of biomedical research. Other advan-
tages include ease of transport from one labora-
tory or country to another, the ability to culture
both normal and abnormal tissue for comparison
and research, the use of human cells to eliminate
species variation, and the ability to expose cultures
directly to exogenous molecules at specific concen-
trations for precise time periods. Disadvantages
include the changes in structure or function ob-
served in some cultures, and the fact that isolated
systems give isolated results that may bear little
relation to results obtained from the integrated
systems of whole animals.
Organ Culture
At some point in the history of research, inves-
tigators have attempted with varying success to
isolate and maintain every major and minor mam-
malian organ, for a variety of purposes. In recent
years, improved techniques, such as the availabil-
ity of artificial blood media, have increased the
probability of successful organ culture. Blood, or
artificial blood media, can be pumped through the
organ to sustain it (“perfusion”) (see fig. 6-2). Cur-
rent applications of organ perfusion include the
study of protein synthesis in lactating guinea pig
mammary tissue (136) and the use of human pla-
centas in toxicology studies, with additional po-
tential for use in oncology and gerontology re-
search (99).
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Figure 6=2—Schematic of Experimental
Organ Perfusion
PRESSURE- . ,A - OXYGENATOR
SOURCE: C. Chubb, The University of Texas Health Science Center at Dallas.
Organ Perfusion: Mouse Testis With
Pipette Introduced Into Artery
Photo credit: C. Chubb, The University of Texas Health Science Center at Dalias
whole organs are not generally amenable to long-
term in vitro culture or growth. The size and com-
plexity of whole organs make it impossible for them
to receive sufficient nourishment for normal func-
tion without external support. Nevertheless, whole
organs are fundamental to many types of anatomy,
histology, and pathology because of their suitabil-
ity for the examination of relationships between
cells and tissues, and they can be sustained in cul-
ture for hours or days.
Cryostat sections (thin slices of frozen tissue cut
with a microtome) through organs are maintained
in vitro for oncology studies into organ-specific
adhesion of metastatic tumor cells. This method
closely reflects the in vivo event and therefore
could eventually reduce the use of whole animals
in a very active research area (159).
Whole mammalian embryos, in addition to their
obligatory use in the investigation of basic devel-
opmental biology, have been cultured in vitro for
other purposes. Protocols have included exami-
nations of the effects of hormones and teratogens
(42).
Tissue Culture
Many normal and pathological tissues from hu-
mans and a variety of animal species can be suc-
cessfully maintained and studied in culture. Indeed,
the progress that has been achieved since 1907,
when R.G. Harrison first maintained frog neural
tissue outside of the body for weeks, has changed
the field of tissue culture from an art into a science.
Keeping cultures of anything other than bacteria
or viruses alive for more than a few hours was
problematic until the 1950s) when investigators
began to gain a better understanding of the re-
quirements of cells and the addition of antibiotics
to culture systems. The viability of cultures was
extended substantially by controlling bacterial con-
tamination.
In tissue culture, isolated pieces of a living organ-
ism are maintained with their various cell types
arranged as they were in the original organism
and with their differentiated functions intact. Such
cultures are both “better” and “worse” than cul-
tures of a single cell type. They are better in that
the effects of manipulation can be observed in a
more natural environment and different cell types
can interact as they would in vivo. They are worse
in that they are much more difficult to maintain.
Although tissue-culture experiments require the
sacrifice of an animal, they can be viewed as alter-
natives to animal use since numerous sections of
adjoining tissue can be removed and compared.
In this way, two or more treatments are adminis-
tered to tissues, rather than to a number of indi-
vidual animals.
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Tissue culture is being successfully employed
in many disciplines of biomedical research. In neu-
rology, the use of embryonic rat mesencephalon
tissues to examine the destruction of dopamine
neurons has replaced the use of primates (154).
Prior to this development, the monkey had served
as the best model for the study of degenerative
effects observed in humans. Adult rats, cats, and
guinea pigs have been shown to be resistant to
the destruction of dopamine neurons. Metabolic
studies of an experimental antiarthritis agent have
made use of the inside of hamster and rat intesti-
nal walls (202). Physiological experiments exam-
ined the dynamics of secretion with mouse
epididymis (70).
Cell Culture
Although cell culture is not a new technique,
developments and applications during the past dec-
ade have come so rapidly as to create whole new
research institutions and industries. Cell culture
today touches every discipline of biomedical re-
search, as well as clinical practice. The following
illustrates the pervasiveness of this approach in
biomedical research:
l
l
l
l
l
l
l
Eggs and sperm from many species have been
used by endocrinologists, physiologists, and
biochemists to study the mechanisms involved
in fertilization and early development (58,157).
A hamster ovary cell line and its mutants are
being used to explore the biochemistry of a
membrane-associated protein essential to all
animal cell function (175).
In oncology, human interferon derived from
bacterial recombinant DNA induces a trans-
formation of human white blood cells similar
to that observed during infection, cancer, and
rheumatoid arthritis. This change in white
blood cells provides clues to the pathology of
cancer (216).
Steroid metabolism is being studied using cul-
tured rat epididymal cells (29).
A monkey kidney cell line was employed to
demonstrate the metabolic effects of several
general anesthetics (26).
Geneticists are developing an in vitro method
of studying heme gene expression (54).
Surgical research into the use of cultured hu-
man epitheliums for permanent coverage of
large burn wounds has moved from the lab-
oratory into clinical trials (76).
In immunology, studies on antibody synthesis
and response have been bolstered by the Nobel-
prize-winning elucidation of monoclinal antibod-
ies. In its initial steps, this technique consumes large
numbers of animals, as the varying immune re-
sponses of many mice are probed. Then, cloned
cells from the spleen of one mouse can be exploited
to produce valuable, highly specific antibodies. An-
tibodies so produced can obviate the need for many
rabbits, sheep, and even humans in the large-scale
production of antibodies. Perhaps of even greater
importance for research is the high quality of the
antibody produced by monoclinal cells. A compre-
hensive listing of current research being conducted
with monoclinal antibodies from cloned cells is
beyond the scope of this assessment. Some of the
diagnostic potentials of monoclinal antibodies be-
ing ‘ “ “ “ “ “ ‘
l
l
l
l
l
l
explored in biomedical research are:
the characterization of malignant and benign
tumors;
the identification of autoimmune antibodies
in rheumatoid arthritis, systemic lupus erythe-
matosus, myasthenia gravis, and other auto-
immune diseases;
the identification and quantification of serum
proteins, hormones, and their cell-surface
receptors;
the monitoring of therapeutic drugs and iden-
tification of novel therapeutic drugs;
the rapid diagnosis of bacterial, viral, fungal,
and parasitic diseases;
the monitoring and identification of lymphoid
and hematopoietic cells in disease states; and
pregnancy testing.
Biologists have developed techniques for the con-
trolled disruption of cells that can leave many or-
ganelles intact or allow the harvesting of selected
intracellular membranes. These fractions have
proved to be invaluable in the search for informa-
tion at the molecular level. For example, micro-
somal membrane fractions from rat and human
liver have been used in comparative anesthesia
research (27). In endocrinology, human placental
and ovarian microsomes were used to demonstrate
inhibition of steroid hormone synthesis by plant
chemicals (112). In dentistry, proteins purified
from unerupted fetal buds were shown to be in-
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hibitory toward seeded enamel growth in culture
(56). In virology, infected cell nuclei isolated from
a hamster cell line were used to study influenza
virion RNA replication (16). In metabolic studies,
the inhibition of chick-embryo-derived collagen
fibril formation by glucose suggests a direct rela-
tionship between excess glucose and poor wound
healing observed in people with diabetes mellitus
(126). One of the most unique uses of subcellular
fractions involves the bringing together of mixed
species systems in biochemical studies of protein
transport across intercellular membranes. For ex-
ample, researchers studying intracellular protein
translocation used dog pancreatic microsomes, bo-
vine pituitary and rabbit reticulocyte messenger
RNA, bacterial nuclease, and a wheat germ cell-
free system to elucidate the structure of the sig-
nal recognition particle (213).
Human Tissues and Cells
Cultured human fetal lung cells have been found
to be excellent hosts to support the developmental
cycle of a protozoan parasite that causes severe,
persistent, life-threatening diarrhea in immuno-
deficient patients. There has been no effective ther-
apy for this illness, so the in vitro system offers
an opportunity to study the parasite’s behavior,
development, and metabolism and provides a po-
tential method for screening therapeutic agents
(50).
Virologist and oncologists have been very quick
to take advantage of new human in vitro culture
systems. For example, an embryonal carcinoma
cell line from the stem cells of a teratocarcinoma
is being used to study cytomegalovirus replication
(83). Lysis of herpes simplex virus (HSV) type 2 is
being investigated using human monocytes (117),
and HSV latency is studied by using isolated neu-
rons obtained from human fetuses (220).
The use of postmortem material from humans
has significance in many areas of biomedical re-
search, but particularly in neurology. Investigators
studying the unconventional slow-virus diseases
use brain tissue from humans with Creutzfeldt-
Jakob disease and from animals with scrapie (144).
Postmortem material from schizophrenics has pro-
vided evidence for two distinct categories of that
disease (181), and temporal lobe structures from
Alzheimer patients have revealed specific patho-
logical cellular patterns in the brain hippocampal
formation (104).
Examples of the use of human tissue for investi-
gations aimed at human treatment can today be
drawn from every discipline of biomedical re-
search. Advances in in-vitro culture methods are
likely to increase this use further. Postmortem tis-
sue use is likely to continue.
Invertebrates
Invertebrates represent over 90 percent of non-
plant species on the earth. Although their body
structure is much less similar to humans than is
vertebrate body structure, invertebrate anatomy,
physiology, and biochemistry offer avenues for
new approaches that have been only partially
explored.
Caenorhabditis elegans, a 1 millimeter roundworm,
is of intense interest to developmental biologists.
As they have traced this nematode’s complete cell
lineage, it offers an unprecedented opportunity
for the study of individual living cells (38).
Other terrestrial invertebrates are used in many
disciplines of biomedical research. For example,
flies, bees, earthworms, and leeches are involved
in various aspects of anatomy, physiology, and bio-
chemistry (5,33). Ants and bees are used in vision
research (4). Fruit flies are well known for their
participation in genetic studies. Age-related meta-
bolic changes in other insects are being investi-
gated for possible use in aging research (184).
Marine invertebrates represent an important,
largely untapped research resource. one commen-
tator (190) has suggested that the lack of opportu-
nity by medical scientists to learn marine biology
and the failure of marine biologists to learn pathol-
ogy have combined to leave marine species over-
looked. A notable exception to the underuse of
marine invertebrates is neurobiology. The coelen-
terates, including hydra, corals, anemones, and
jellyfish, have helped scientists understand primi-
tive nervous system biochemistry. Lobsters and
squid have contributed to knowledge of brain anat-
omy and physiology, and the grazing snail and cray-
fish have broadened understanding of cell biol-
ogy (33).
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Four advantages of using invertebrates in bio-
medical research are:
l
l
l
l
different phylogenetic levels of structural and
functional specialization can be exploited (e.g.,
different types of circulatory systems, novel
chemical compounds);
invertebrates reproduce rapidly and produce
numerous offspring; experiments can be exe-
cuted in days and weeks instead of months
and years;
storage, upkeep, and maintenance are inex-
pensive; and
invertebrates are not prone to spreading dis -
ease throughout a colony;
The overwhelming disadvantage is the consid-
erable phylogenetic distance between inverte-
brates and humans.
Micro-organisms
From its origins within the medical disciplines
of bacteriology, pathology, and virology, the study
and use of microorganisms has branched out to
influence practically every area of biomedical re-
search, as these examples indicate:
l
l
l
l
l
l
Salmonella typhimurium—bacteria used in
mechanistic studies in genetics (124) as well
as the Ames mutagenicity/carcinogenicity test
(see ch. 8);
Escherichia coli—bacteria used by develop-
mental biologists to derive theories of gene
control (90) and by molecular biologists in re-
combinant DNA research (75);
Streptococcus mutans—bacteria used in den-
tal research on the metabolic activity of plaque
(91);
Bacillus subtilis (bacteria) spores, Artemina sa -
lina (brine shrimp) eggs, and Sordaria fimil-
cula (fungi) ascospores-all incorporated into
NASA’s biostack (monolayer of biological test
organisms sandwiched between thin foils of
different types of nuclear track detectors) ra-
diology experiments inside Spacelab I (31);
Tetrahymena pyriformis—a ciliate protozoan
being used to study the effects of anesthetics
on metabolism (44); and
a host of microscopic protozoans, metazoans,
and rotifers used to investigate the physiol-
ogy and biochemistry of photoreception and
vision (4).
The advantages of using micro-organisms in bio-
medical research are fourfold: They reproduce
rapidly at body temperature; rapid division (every
20 to 30 minutes) makes them useful for short-
term studies; multigenerational studies can be per-
formed in a short period of time; and they are in-
expensive in terms of storage, upkeep, and main-
tenance. The major disadvantage stems from the
fact that these are unicellular organisms: As a con-
sequence, the interaction of cells cannot be stud-
ied (156).
Plants
One advantage of using organisms from the plant
kingdom is that they lack anything resembling a
nervous system. Presumably, plants do not feel
pain; they appear to be good potential alternatives
to animals. Plants, like micro-organisms, are rela-
tively easy and inexpensive to propagate (156).
Although there is some interest in the potential
use of plant cells in toxicology and oncology re-
search (191), the use of whole cells from plants
is obstructed by their very rigid cell-wall struc-
ture compared with the relatively fluid animal cell
membrane. This prevents their use in many dis-
ciplines where intimate cell surface contact or
transmembrane communication is essential.
Once removed from the cell, comparable organ-
elles from plants and animals (including micro-
organisms) are essentially indistinguishable in both
appearance and function. For example, in studies
having potentially broad applications in endocri-
nology and immunology, yeasts have been found
to contain active steroid hormone systems (118).
Yeast is used in cell biology in studies of the im-
port of proteins into mitochondria, organelles that
are essentially the same whatever their source
(129). An extensive literature in cell biology, genet-
ics, molecular biology, and virology supports the
use of subcellular fractions from plants and ani-
mals, separately or together, for research into basic
molecular mechanisms (213).
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USE OF NONLIVING SYSTEMS
Chemical and Physical Systems
Long before the advent of modern technology,
researchers were constructing chemical models
of certain phenomena that occur in living systems.
There is a long and rich history in biochemistry,
for example, of the application of nonliving sys-
tems to experimentation (128,147).
Enzyme biochemistry continues to be a principal
area of application of nonliving methodology in
biomedical research. Enzyme mechanisms maybe
studied in a totally chemical system. Magnetic res-
onance imaging is used to obtain from enzymes
in solution detailed structural data and informa-
tion about the mechanism of enzyme action. By
combining MRI with cryoenzymology-the use
of enzyme solutions held at subzero temperatures—
enzymatic reactions can be slowed enough to study
intermediate products that would ordinarily ex-
ist for too short a time to be detected. Investiga-
tions that had been restricted to in vivo manipula-
tions can now be expanded into a far wider range
in vitro (131).
In dental research, a chemical system mimics
the mechanics of the formation of dental caries.
A two-chambered diffusion cell pairs an excess
amount of specific protein crystals with a chemi-
cal solution of artificial “plaque-saliva .“ Dissolution
of the crystals can be studied under varying chem-
ical conditions relevant to a better understanding
of the caries process (40).
In the field of membrane biophysics, the advent
of synthetic membranes has proved a boon to re-
search and stands as one of the premier examples
of nonliving alternatives to animal use. Liposomes
are synthetic vesicles made of protein and fatty
molecules. Their structure can be dictated by the
investigator, who can combine proteins and lipids
of different types and in different ratios to yield
COMPUTER SIMULATION
Modern approaches to biomedical research de-
scribe the functions of living systems at all organiza-
tional levels by the language of science—mathe-
matics. Knowledge is acquired by investigating
IN BIOMEDICAL RESEARCH
an artificial membrane. As with true biological
membranes, the barriers formed by liposomes are
selectively permeable. These artificial membranes
are particularly useful in basic studies of the trans-
port of molecules across membranes and of mem-
brane damage (12).
Except for the use of mannequins to simulate
accident victims in the transportation industry and
in trauma centers, the principal use of physical
and mechanical systems today is in education (see
ch. 9) rather than in biomedical research. How-
ever, it is not inconceivable that future combina-
tions of mechanical and electronic technology
could provide biomedical researchers with artifi-
cial research subjects capable of independent, un-
anticipated responses.
Epidemiology:
Using Existing Databases
The use of existing databases to gain new infor-
mation and insights in biomedical research may
be a major underused resource, if the paucity of
published results is any criteria. One study that
relied on such information concentrated on the
relationship between 17 nutrients and the poten-
tial for development of hypertension cardiovas-
cular disease in more than 10,000 people from the
database of the National Center for Health Statis-
tics’ Health and Nutrition Examination Survey
(HANES I) (137). The results proved to be highly
controversial, with some of the criticism aimed
at the use of the database (119).
Too little information is currently available to
evaluate fully the potential dimensions of the salu-
tary use of epidemiologic databases in basic bio-
medical research. The possibility exists that their
enhanced use may constitute an important non-
animal method.
relationships among cells, tissues, fluids, organs,
and organ systems. By the processes of trial and
error and of hypothesis and testing, relationships
begin to be understood and can be described by
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mathematical expressions. These can range from
simple, linear functions to various types of curved
functions to multidimensional surface functions
and may involve kinetic data expressed by differen-
tial equations. Variables in these equations include
physical terms, such as time, temperature, weight,
energy, force, volume, and motion. Complex math-
ematical relationships may be developed to express
these cause-and-effect relationships more clearly.
In some instances, a relatively simple relationship
may be shown to exist, but this is unusual, since
living systems are highly interactive and multi-
dimensional in nature (48).
A relationship that can be reasonably expressed
in a mathematical equation maybe considered to
be a candidate biological model. The limits within
which the expression will hold determine the util-
ity and validity of the model. If it is possible to
change one or more parameters in the equation,
and thereby obtain the same response or responses
as found in live animal research, the model may
be used to “simulate”a biological preparation. Simu-
lation implies that an investigator can manipulate
the parameters at will and observe the resultant
effects on the model. Used in this way, computer
simulation is a useful tool for research and espe-
cially for suggesting new mechanisms or hypoth-
eses for further study (48).
At the subcellular level, information is usually
gained by electron microscopic examination or by
analytical methods for the sequencing of amino
acids and nucleic acids. Such information tends
to be of a descriptive or topological nature rather
than numerical. Recent strides in genetic engineer-
ing based on increased knowledge of DNA, RNA,
and protein amino acid sequencing have required
computers to store and match nucleic acid and
amino acid sequences numbering in the millions
(163). These capabilities are not equivalent to simu-
lation, but they share with simulation a reliance
on computers for storage and processing.
At the level of one or a few cells, models are be-
ing sought for computer simulation of sliding fila-
ment systems—believed to be the basic movement
of muscle fibers, cilia, and flagella (28). Modeling
of the function of individual cone cells in the eye
is under study at the National Institutes of Health
(NIH) (167).
Most efforts toward computer simulation of bio-
logical systems are directed at higher levels of orga-
nization, such as organs and organ systems. This
bias is a consequence of the need to understand
numerous feedback systems within living systems.
Feedback systems are the basis for an organism’s
ability to maintain a homeostatic, or steady, state,
Feedback mechanisms involve several organs as
well as communication via the bloodstream and
nervous system. For a simulation to succeed, the
system must be considered as a whole. In model-
ing the cardiovascular system, for example, a simu-
lation must take into account the heart, brain,
lungs, and kidneys.
In the 1980s, computer modeling of organ sys-
tems is progressing on many fronts. The brief sam-
pling of simulations listed in table 6-3 illustrates
the variety of organ systems under study.
One development in this field deserving particu-
lar attention was the establishment by NIH’s Divi-
sion of Research Resources in 1984 of the National
Biomedical Simulation Resource, a computer fa-
cility at Duke University that may be used onsite
or over a telephone data network. Any project in
which the results are free to be published in open
scientific journals and where no profit is involved
can apply to use the facility. Training sessions in-
troduce biological scientists to the concepts of mod-
eling, and special aid is provided in the develop-
ment of simulation software (120). Projects under
Table 6-3.-Some Examples of Computer Simulation
of Phenomena in Biomedical Research
Kidney function:
• Transport of electrolytes, nonelectrolytes, and water
into and out of the kidney (142)
Cardiac function:
l Enzyme metabolism in cardiac muscle (214)
l Cardiac pressure-flow-volume relationships (1 52)
l Malfunctions of instrumented cardiovascular control
systems (9)
Lung function:
l Respiratory mechanics (150)
Sensory physiology:
l Peripheral auditory system, and single auditory nerve
fiber transmission of vibrations (180)
Neurophysiology:
l Impulse propagation along myelinated axons (73)
Developmental biology:
l Shape changes i n embryonic celIs that develop into
mature organs (98)
SOURCE: Office of Technology Assessment,
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way in 1985 involved research in cardiology, phys- Limitations on the utility of computer simula-
iology, endocrinology, toxicology, and neurology. tions stem from the lack of knowledge of all possi-
Specific simulations included: ble parameters that may play a role, however slight,
l
l
l
l
l
l
l
l
l
regulation of sodium, potassium, and calcium
in heart muscle;
electrolyte diffusion in heart muscle;
propagation of activity in heart muscle;
heart volume potentials;
mathematical modeling of blood coagulation;
regional dose responses in the human and ani-
mal lung;
ciliary motility;
cochlear function in the inner ear; and
a molecular model of ion transport in nerves
in the melange of feedback-mechanisms that cons-
titute living systems. Basic biomedical research
at all levels, some of it involving live animals, will
continue to provide the new knowledge required
to improve existing simulations and develop models
where no satisfactory one exists. The development
of increasingly powerful computer programs de-
pends on the use of animals in biomedical research.
and muscles.
CONTINUED, BUT MODIFIED, USE OF ANIMALS
IN BEHAVIORAL RESEARCH
As in biomedical research, the continued, but
modified, use of animals in behavioral research
encompasses reducing the number of animals used
through changes in experimental design and sta-
tistical analyses, substituting cold- for warm-
blooded vertebrates, and lessening the degree of
pain or experimental insult in general, and in pain
research in particular. Compared with biomedi-
cal research, behavioral research offers markedly
fewer opportunities to substitute cold-for warm-
blooded vertebrates and to use in vitro cultures,
and it holds little chance of using nonliving systems.
Reduction in the Number of
Animals Used
Improved Experimental Design and
Statistical Analyses
Individual animals vary in their behavior both
between subjects and, in the case of one subject,
over time. The goal of a behavioral experiment
is to identify patterns that remain when these two
sources of variability have been eliminated or taken
into account. An investigator attempts to conclude
that observed effects are due to the conditions be-
ing manipulated in the experiment and not to ex-
traneous factors. This decision usually rests on the
outcome of statistical tests. Ensuring the validity
of such tests or improving their design can mean
that fewer experiments are needed. Enhanced sta-
tistical rigor, however, may lead to increases or
decreases in the number of animals required in
a particular protocol.
Statistical Power. —A statistical test’s sensitiv-
ity in detecting experimental effects is termed its
“power.” The most widely recognized method of
increasing power and, hence, the sensitivity of an
experiment is to use a large sample of subjects.
Typically, the more variable the results, the more
power is needed to detect an effect and, therefore,
the greater the need for large samples. Although
the magnitude of variability cannot be determined
prior to an experiment, the amount of variability
likely to be encountered can be estimated by con-
ducting small, pilot studies or by examining previ-
ous research in the same or related areas. Given
an estimate of variability, statistical tables can be
used to determine the sample size needed to at-
tain certain levels of power (221).
In certain instances, the methods of increasing
power may reduce, not increase, the number of
animals needed:
l Choosing a lower level of statistical signifi-
cance (i.e., the likelihood that the results were
due to chance) increases power and reduces
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l
l
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the number of subjects needed. However, this
also increases the chances of concluding that
the experimental procedure produced an ef-
fect when in fact the effect was due to chance
alone. By convention, researchers generally
accept the probability of a chance effect of
5 percent or less as a statistically significant
result.
Greater precision in the conduct of an exper-
iment may reduce variability and increase
power. For example, highly precise behavioral
measurements coupled with the elimination
or control of extraneous variables would re-
duce the need for large numbers of subjects
(198).
The use of different statistical analyses can
increase the sensitivity and power of a proto-
col (e.g., analysis of the data by parametric
rather than nonparametric statistical tests)
(198).
Alterations in experimental designs can in-
crease power. Factorial designs (where two
or more treatments are manipulated concur-
rently), for example, are more powerful and
can be used instead of testing the effects of
different treatments in separate experiments.
Not only does the use of factorial designs in-
crease power, it requires fewer untreated,
control subjects than multiple concurrent
studies do. It is important to note, however,
that in areas that have not been heavily re-
searched there are inherent dangers to the
use of factorial designs. For example, there
may be no observed effect of treatments given
in combination, as one treatment cancels the
effect of another. Without sufficient back-
ground information on the effects of the treat-
ments administered individually, this finding
would be erroneously interpreted.
Power is increased as the magnitude of the
treatment effect is increased. ‘Treatment ef-
fects can be maximized by choosing widely
spaced levels of the treatment variables or by
including conditions that are thought to max-
imize the appearance of the phenomenon
under study (113).
Within-Subjects Design.–Many experiments
on animal behavior are conducted using a between-
subjects design, That is, different groups of ani-
mals are given different treatments, and the per-
formances of the different groups are compared.
However, individuals also vary in their behavior.
Depending on the degree of variability, large num-
bers of subjects maybe needed in each group to
obtain statistically significant results. Under cer-
tain conditions, however, a within-subjects (or
repeated measures) design can be used that re-
quires only one group of animals instead of many.
Under these conditions all members of the group
serve in all treatment conditions. The advantage
of this technique is that it minimizes variability
by taking into account individual differences. The
major drawback, however, is the possibility of con-
taminating the data and nullifying the results:
Treatments already received by a subject may in-
fluence, and thereby confound, performance un-
der subsequent treatments. Carry-over effects can
be partially offset by counter-balancing, wherein
the experimenter ensures an equal occurrence of
each experimental treatment at each stage of the
experiment; this balances any effect of prior test-
ing equally overall treatment conditions (1 13). Al-
though within-subjects designs are effective in re-
ducing both variability and the number of subjects
needed, the inherent danger of carry-over effects
in many instances may invalidate the use of such
designs.
Random Block Design. -Randomized block de-
sign consists of assigning subjects to groups based
on evidence of their being similar to one another
in one or more characteristics known to be related
to the behavior under investigation. Two or more
such blocks are formed and then each block is as-
signed randomly to the treatment conditions. This
design reduces variability by restricting the de-
gree of individual differences within blocks, and
thereby increases power (113). Although random-
ized block designs are effective in lowering the
number of animals needed in an experiment, they
are not applicable to all areas of behavioral re-
search. The technique requires substantial prior
knowledge of the behavior being investigated and
is therefore limited to intensively researched areas.
Analysis of Covariance.—An analysis of covari-
ance uses the same information as randomized
block designs except that an estimate of variabil-
ity is not needed beforehand. The covariance pro-
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cedure is applied to data after they are collected
to adjust for chance differences among groups.
The analysis increases power, and fewer animals
may be needed to obtain statistically significant
results (113).
Single-Subject Design.—In some instances in-
ferences can be made about populations from very
small samples. This is common in psychophysical
experiments in which there is a substantial prior
body of evidence indicating that the behaviors un-
der investigation do not vary appreciably within
the population at large (e.g., visual sensitivity to
light). Although such experiments can be con-
ducted using just one subject, two or three are
typically used to guard against the possibility of
misleading results from an atypical subject (198).
In other than psychophysical experiments, the
general procedure in single-subject research con-
sists of choosing a baseline (which involves meas-
uring the frequency of occurrence of the behavior
of interest), changing one treatment variable at
a time, temporarily withdrawing the experimental
treatment to assess its causal effects, and repeat-
edly measuring the baseline behavior before and
after each treatment. (More sophisticated experi-
mental designs available for single-subject research
are reviewed in ref. 96.) Single-subject designs are
increasingly used in animal operant conditioning
and human clinical research (187). Statistical anal-
yses of these are reported infrequently due to the
lack of many statistical techniques for handling
such data, although using time-series analyses to
test for changes over time is one acceptable method
available (111),
A limitation to studying a single subject is the
uncertainty of the generality of the findings, a prob-
lem commonly dealt with by replicating the experi-
ment with different subjects (96). Thus the reduc-
tion in animals used may be illusory.
Inbred Strains.-One way of reducing variabil-
ity (and hence increasing power) is to use highly
homogeneous populations of subjects. Inbred
strains of animals, produced as a result of 20 or
more generations of brother-sister matings, rep-
resent one approach, though it is usually much
more expensive than using randomly bred animals.
Inmost inbred strains all subjects are highly iden-
tical genetically and genetically stable; they change
only as a result of the slow accumulation of muta-
tions. In contrast, outbred stocks of animals are
genetically variable. They contain an unknown and
uncontrollable degree of genetic variation that may
obscure or mask experimental treatment effects.
Inbred strains not only increase statistical power,
they also reduce variability between experiments
conducted indifferent laboratories or in the same
laboratory at different times (68).
It can be argued that experiments should rely
on animals drawn from heterogeneous,  outbred
populations in order to get a broad genetic basis
for results that can be extrapolated, for example,
to heterogeneous human populations. Yet the
differences between different inbred strains are
usually greater than the differences between in-
dividuals of an outbred stock. Greater generality,
then, may be obtained by conducting experiments
with two or more inbred strains (68).
Sharing Animal&—A team approach to re-
search questions across biomedical and behavioral
research disciplines could reduce the number of
animals needed for behavioral research (173). For
example, researchers studying a behavioral phe-
nomenon by noninvasive means could, at the ex-
periment’s conclusion, give their animals to biolo-
gists investigating the anatomy or physiology of
that species. Likewise, scientists from different dis-
ciplines could collaborate on research proposals:
A psychologist maybe interested in studying preda-
tor-prey relations, while a biologist wants to study
endocrinological changes in response to stress; ef -
fective collaboration could yield two different data
sets from the same animals.
Substitution of Cold-Blooded for
Warm-Blooded Vertebrates
The modified use of animals in biomedical re-
search includes the replacement of mammals and
birds with fish, amphibians, and reptiles. In be-
havioral research, however, the often vast differ-
ences between species are likely to make such sub-
stitutions difficult. At the moment, researchers
know more about why warm-blooded vertebrates
cannot be replaced with cold-blooded ones, as this
description of seven behavioral research dis-
ciplines illustrates.
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Aggression
Aggressive interactions between members of the
same species have been studied in a variety of fish
and reptile species under both laboratory and field
conditions. Considerable work has been done on
intermale rivalry among sticklebacks (183) and cich-
lid fish (11). Aggressive interactions among cold-
blooded vertebrates are frequently stereotyped
and species-specific. Among sticklebacks fish, for
example, full-fledged attacks can be elicited by a
model that is the same color but a different shape
(30). In contrast, aggression in primates can em-
body a variety of highly sophisticated introspec-
tive social strategies such as deception, grudging,
delayed retaliation, and reconciliation (77). Thus
extrapolation among all vertebrates of the results
of research into aggression is difficult.
Animal Movements
Migration and homing abilities have been inten-
sively studied in several species of fish, particu-
larly eels and Pacific salmon. Among American and
European eels, for example, the eggs hatch in the
Sargasso Sea, near Bermuda. The juvenile fish
make a year-long migration toward the coasts of
North America and Europe. On reaching sexual
maturity in 7 to 15 years, the adult eels migrate
back to the Sargasso Sea to breed (217), a move-
ment primarily dependent on the use of chemical
cues in the water (60). In contrast, birds use solar,
stellar, and magnetic cues to navigate, and whales
use the topography of the ocean floor and coast-
line to remain on course for migratory purposes.
Such dramatic differences in the way different spe-
cies respond to and perceive the environment limit
the use of cold-blooded vertebrates in modeling
animal movements of warm-blooded ones.
Communication
Visual cues, such as changes in coloration, pos-
ture, or body appearance, have been shown to
be important determinants of social interaction
among fish (3o), which, unlike most mammals, gen-
erally have color vision. Fish also exhibit dramatic
changes in appearance, such as flaring of the gill
apertures, which are relatively rare among mam-
mals. Auditory communication is marked by spe-
cies differences, too. Communication among am-
phibians and reptiles, primarily to attract a mate,
consists of simple one- or two-note utterances.
Vocalization in birds and mammals consists of a
wide range and variety of sounds. Moreover, un-
like cold-blooded species, many birds have to learn
species-specific songs. Many rodents communicate
by ultrasonic vocalizations (123) that have no ap-
parent counterpart among cold-blooded species.
Learning, Memory, and
Problem Solving
Learning has been studied in a variety of diverse
species (179, 183), and many differences are mani-
fested. Comparing learning in goldfish and turtles
with that in rats yields both similar and distinguish-
ing features. For example, rats show a decrement
in performance when an accustomed reward is
changed, while goldfish and turtles do not (23).
The existence of so-called biological boundaries
of learning (182), apparently shaped by unique eco-
logical pressures, precludes most substitutions of
one species for another in learning paradigms.
Predator-Prey Relations
Prey-catching behavior and predator avoidance
have been studied in fish, frogs, and turtles (60,
103,203). The similarity across species in behaviors
used by prey to avoid being caught suggests that
when a general question about reactions to pre-
dation (rather than the behavior of a given spe-
cies) is of interest, cold-blooded vertebrates can
substitute for warm-blooded ones (103). But there
is growing evidence of neurochemical differences
underlying predator avoidance behaviors even
among birds and mammals (78).
Predators exhibit marked differences across spe-
cies. Frogs, for example, sit passively and wait for
an insect to come within striking distance, while
some carnivores have developed sophisticated
hunting strategies that often embody elements of
cooperation and may even culminate in sharing
foods (30).
Reproduction and Parental Care
With some notable exceptions (e.g., the African
Mouthbreeder fish), parental care of offspring is
absent inmost cold-blooded vertebrates, since the
eggs are typically abandoned shortly after fertili -
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zation. In contrast, all birds are subject to some
type of parental care, and mammalian parent-off-
spring relations become even more complicated.
Species differences in external versus internal fer-
tilization, seasonal breeding, courtship, pair-
bonding, and nest-building preclude substitutions
of one species for another in this research.
Sensation and Perception
The sensory and perceptual differences among
species are vast. For example, many snakes’ pri-
mary mode of prey identification is chemical cues
transferred from the tongue to a structure at the
roof of the mouth, called Jacobsen’s organ. Inges-
tively naive baby snakes appear to have an innate
preference for prey extracts that represent species-
typical foods across a variety of different snakes.
Each species shows unique attack profiles that ap-
pear to be independent of maternal diet and not
subject to modification by experience (e.g., baby
snakes of a minnow eating species that are force-
fed liver still show attack responses to minnow
extracts but not to liver) (34,35).
In contrast, baby rats seem predisposed to eat
the same diet as their mother, and the flavor of
the maternal milk serves as a medium for the trans-
mission of cues that rat pups use to make their
initial food choices. Manipulating maternal diet
during lactation has produced corresponding
changes in subsequent pup food preferences.
Moreover, rat pups poisoned in association with
a mother’s milk later avoid the types of food she
had been eating (74).
Reduction of Pain or
Experimental Insult
As noted earlier, a general anesthetic is prefer-
able to a local one for surgical manipulations be-
cause it suppresses both pain and fear (114). Pain-
relieving drugs should be administered to animals
after surgery whenever this would not interfere
with the behavior under study, and animals should
be carefully monitored so that any complications
that develop may be treated (197).
Transection of the spine or brain stem is recom-
mended for surgical experiments when possible,
because it renders the animal incapable of feeling
pain (114). This technique has limited applicabil-
ity in behavioral research, however, as postsurgi -
cal behavioral assessment requires a relatively
intact animal. Similarly, the nonrecovery experi-
ments on completely anesthetized animals that
were described earlier, in the biomedical research
section, are rarely used in behavioral research,
since most behaviors of interest do not occur when
the animal is unconscious and behavioral testing
is typically conducted postsurgically. Multiple sur-
geries on the same animal are to be avoided when-
ever possible, because painful consequences may
be cumulative (197).
The analysis of pain in behavioral research is
complicated by recent theoretical and empirical
developments suggesting that fear and pain acti-
vate quite different kinds of behavior (25). Rather
than being on a continuum, as might seem to be
the case intuitively, data suggest that fear and pain
are associated with fundamentally different mo-
tivational systems. Fear activates species-specific
defensive behaviors, such as freezing, flight, or
fighting, that serve to minimize encounters with
pain-producing stimuli (e.g., predators). Pain, on
the other hand, appears conducive to the kinds
of behaviors that provide for healing and recuper-
ation (e .g., rest, grooming, licking the affected area,
and sleep). A growing body of evidence shows that
fear takes priority over pain, and that fear can ac-
tually inhibit pain under some circumstances (pos-
sibly through the release of endogenous opiates).
For example, soldiers who are wounded in battle
frequently continue fighting and feel no pain from
their injuries until after they are removed from
the front lines (211). Likewise, a deer wounded
by hunters may flee the scene with defensive be-
havior indistinguishable from that of uninjured
animals, But once the deer is out of danger, pain-
related recuperative behaviors predominate (25).
Brain Manipulation
In studies of the physiological bases of behavior,
the recording of brain-wave patterns maybe sub-
stituted for electrical stimulation whenever pos-
sible, and brain areas may be stimulated instead
of lesioning or ablating sections of the brain (121).
These techniques, however, are not completely
interchangeable. Recording neuronal firing as an
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animal behaves allows correlational inferences to
be made, but not causal ones. If the experimental
goal is to determine a particular brain area that
is responsible for a certain behavior, that area must
be manipulated directly. Electrical stimulation of
brain areas is useful in establishing causal rela-
tionships, and the most definitive and reliable re-
sults are obtained when stimulation is used in con-
junction with lesioning or ablation (20).
Drug Administration
In research on the behavioral effects of experi-
mental or currently available drugs, animals are
injected either intraperitoneally (within the body
cavity), intravenously, intramuscularly, or intra-
cranially (within the skull, via an implanted can-
nula). Depending on whether the drug must be
given repeatedly, the injection procedure can be
stressful and may cause discomfort. Within the
last decade alternative administration methods
have been developed that may replace the need for
multiple injections in some chronic drug treatment
studies. Capsules of porous rubber (Silastic@,
produced by Dow-Corning) implanted beneath the
skin release a drug slowly into the animal’s body,
and stress produced by repeated injections is
avoided. The method produces minimal discom-
fort and is well tolerated by animals (63). Small,
implantable minipumps are also available to de-
liver drugs for days or weeks.
The use of aerosols has also been suggested (174);
although this would seem to hold promise for al-
leviating the stress of injections, it has drawbacks.
For example, animals may differ greatly in their
inhalation rates, and dispersal of the drug into the
air prevents adequate control of drug dosage.
Food Deprivation
It is important to distinguish between the differ-
ent methods of depriving animals of food and the
reasons for using any method. In most cases, ani-
mals are deprived of food to motivate them to per-
form various tasks or behaviors for food reward.
The nature of the subject’s performance of such
tasks—and not the food deprivation—is the object
of study.
Food deprivation is typically applied one of two
ways: Animals are deprived of food for a stand-
ard period of time (e.g., 24 hours) prior to testing
or they are maintained at some percentage of their
normal body weight (e.g., 80 percent) (43). Each
procedure has advantages and disadvantages. Food
deprivation for specified intervals of time is easy
to implement, but it fails to take into account spe-
cies differences in metabolic rates, For example,
24 hours of food deprivation for a mammal is less
severe than it would be for a bird, while for a snake
it would be inconsequential. Maintaining animals
at a percentage of normal body weight avoids this
problem, but it requires daily handling and the
delay of the trial for long periods of time to stabi-
lize body weights.
When food deprivation is applied according to
a standard time period in behavioral protocols, the
most common interval is 24 hours (43). It is note-
worthy that the feeding of domestic pets once a
day parallels this laboratory protocol. When main-
taining animals at some percentage of their normal
body weight, behavioral protocols usually involve
up to 20 percent weight loss (43). Experimental
animals’ reduced food intake is associated in some
instances with enhanced longevity (172).
Several suggestions have been made to reduce,
ameliorate, or eliminate food deprivation in be-
havioral research:
l
l
l
l
Water deprivation, sometimes used concur-
rently with food deprivation, should be used
to motivate behavior only if thirst or drink-
ing is the object of study. Water deprivation
affects an animal’s physical condition more
severely than food deprivation does, because
death by dehydration occurs much more rap-
idly than death by starvation (121).
The normal eating pattern of a species should
be taken into account when deciding on the
duration of food deprivation. For example,
sparrows eat only during the light hours of
the day; hamsters feed largely at night.
In some cases, food deprivation might be
avoided by using a highly preferred food as
a reward (121).
Food deprivation may also be avoided by tak-
ing the experiment into the animal’s living
quarters, so that it is required to perform for
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food as and when it wants to eat. In this way,
any deprivation would be self-imposed as
under natural conditions (121,151). This tech-
nique has been used successfully in work on
sensory-motor functioning in monkeys (168).
Pain Research and the Use of
Electric Shock
The experience of pain is a highly adaptive ca-
pacity. It prevents organisms from engaging in be-
haviors that would otherwise prove maladaptive.
For example, humans who are congenitally insen-
sitive to pain become terribly scarred and muti-
lated, often develop a sense of being invincible,
and have short life expectancies (141)143,196). Per-
haps because pain plays such an essential role in
regulating the behavior of organisms, pain thresh-
olds are surprisingly consistent across a great
diversity of species (115). The discovery of en-
dogenous opiates in earthworms (5) and recent
findings with spiders (61) suggest that inverte-
brates may also feel pain.
Pain can be induced through mechanical, ther-
mal, electrical, or chemical stimuli (127). Of the
various stimuli used for research purposes, elec-
tric shock at the levels normally used in experimen-
tation is the only one that does not damage tissue.
Most studies of pain in animals use what are called
flinch-and-jump thresholds—an index of the min-
imal amount of electric shock or heat needed to
produce a reaction. Electric shock is used as a
stimulus for research into the mechanism of pain
for
l
l
l
several reasons:
Electric shock is easily quantifiable. The pa-
rameters of shock can be manipulated and
specified with a high degree of precision over
a wide range.
Electric shock can be administered so as to
have a discrete or gradual onset and offset.
Electric shock of the type most often used (i.e.,
a brief current of 0.001 amperes, the equiva-
lent of a tingling sensation in the finger) does
not yield physical damage, bleeding, or tissue
destruction.
However, electric shock is a highly atypical stimu-
lus (79). No contemporary terrestrial species ap-
pears to have evolved under conditions of elec-
tric shock. The question of whether data obtained
this way are widely generalizable in mechanisms
of pain remains unanswered.
A survey of the 608 articles appearing from 1979
through 1983 in the American Psychological Asso-
ciation journals that typically publish animal re-
search (e.g., Journal of Comparative and Physio-
logical Psychology and its successors Behavioral
Neuroscience and Journal of Comparative Psychol-
ogy) identified 10 percent of the studies as using
electric shock. Four percent of the studies admin-
istered inescapable shocks stronger than 0.001 am-
peres. Most of the experiments with electric shock
involved rodents; those with monkeys, dogs, and
cats accounted for 0.5 percent of the total 608 arti-
cles (43).
Recommendations that have been made to re-
duce pain or discomfort in animal experiments in-
volving aversive stimulation include:
l
l
l
l
l
l
The lowest possible level of electric shock
should be used that will at the same time main-
tain the behavior under study (52). However,
this may reduce the statistical power and re-
quire a large sample size.
Animals should be given predictable rather
than unpredictable shock and an opportunity
to control its termination (52). Rats, for ex-
ample, will choose to receive more shocks at
greater intensity in order to receive a warn-
ing cue prior to each shock delivery (10).
If aversive stimulation must be used, alterna-
tives to electric shock such as loud noise or
bright lights should be considered (121).
In developing models of chronic pain, the
model should closely simulate a particular
chronic pain syndrome in humans (e.g., arthri-
tis or cancer). Otherwise, there is no justifi-
cation for the procedure (114).
Animals should have an opportunity to con-
trol the intensity of the stimulus in chronic
pain studies. While the objection to this might
be that, given this option, the animal would
“turn off” the pain stimulus, this might be cir-
cumvented by giving a preferred food reward
for keeping the stimulus “on” at a given level,
as in experiments with electric shock titration
techniques (114).
A reward, such as a preferred food, should
be used for the correct responses instead of
a punisher, such as electric shock, for incor-
rect response (121).
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USE OF LIVING SYSTEMS
In behavioral research, using living components
derived from whole animals or living nonanimal
systems as alternatives to animals could conceiva-
bly involve embryos; cell, tissue, and organ cul-
tures; invertebrates; and plants. The greatest po-
tential in this area, however, appears to rest with
the use of invertebrates.
Several factors limit the use of embryos (used
here to refer to the conceptus, embryo, and fetus
prior to birth) as an alternative or complement to
young or adult animals:
l
l
l
l
l
Some studies involving embryos may be con-
ducted when the subject is very close to birth
or hatching. The advanced developmental sta-
tus of the organism at this point raises the same
kinds of ethical considerations that would ap-
ply to the use of postnatal animals (see ch. 4).
In behavioral studies involving mammalian
embryos, the mother is necessarily involved
in most experimental manipulations performed
on the embryo. As a consequence, embryo-
logical manipulations on mammals cannot log-
ically avoid the use of adult mammals.
Behavioral studies using embryos may involve
testing for effects later in adult life (e.g., be-
havioral teratological studies). In these in-
stances, embryos are not being used as alter-
natives, since the procedures also require
postnatal assessment.
Only a limited number of behaviors can be
studied in embryos, partly because of practi-
cal problems associated with access to the
embryo.
Embryos live in a dramatically different envi-
ronment than fully developed adult animals.
This difference constrains the generalizabil -
ity of behavioral data obtained from them.
Cell, tissue, and organ cultures do not figure
prominently in the equation of alternatives to ani-
mal use in behavioral research. In isolation and
in culture, cells, tissues, and organs exhibit few
activities that fall among the disciplines of be-
havioral research.
A rare example of the use of cell culture in be-
havioral research comes from studies of the bio-
chemical basis of depression and manic mood
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changes. Skin fibroblast cells obtained from hu-
mans and maintained in culture for several months
were assessed for their ability to bind a variety
of pharmacologic agents. The cultured cells of pa-
tients and relatives of patients with manic-depres-
sive illness exhibited markedly different biochem-
ical properties than the cultured cells of persons
without a history of manic depression (155).  One
commentator characterized this as ‘(a step forward,
applying to psychiatry the techniques of tissue sam-
pling and cell culture that have been of great value
in characterizing molecular abnormalities in nu-
merous medical diseases” (192). Continued devel-
opment of this line of research could reduce the
use of animals in such investigations.
Invertebrates
Few behavioral studies use invertebrates as sub-
jects (139). As a consequence, relatively little is
known about invertebrate behavior. In behavioral
research, invertebrates offer a fertile testing
ground for any theory that claims to be broadly
based across the phyla of the animal kingdom (138).
Certain groups of invertebrates are promising sub-
jects for behavioral research.
The brains of octopuses and squid approach
those of vertebrates in relative size and complex-
ity (178). Visual discrimination learning has been
studied extensively in the octopus. Octopuses can
discriminate between pairs of geometric shapes
that differ with respect to vertical, horizontal, and
oblique orientations. The octopus and squid show
learning performance on a par with mammals on
such tasks as detour problems, reversal learning,
delayed response, and delayed reinforcement
(178,218).
Among all the invertebrates, the only species
with a neuroanatomy and learning ability compa-
rable to vertebrates are the octopus and squid.
Practical problems in obtaining, transporting, and
housing these marine species have always pre-
cluded their widespread use as alternatives in be-
havioral research (178), However, recent advances
in the laboratory culture of octopuses make them
promising research candidates, although provid-
ing live food (e.g., shrimp) on a consistent basis
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remains a major logistical obstacle. The develop-
ment of a dead or artificial food ration is currently
a high priority in octopus culture (88). The same
highly developed nervous system that makes the
octopus and squid desirable replacements for ver-
tebrates may cause some ethical objections to use
of these invertebrates. In addition, their adapta-
tion to a completely aquatic existence would also
make tenuous any extrapolations to the behavior
of terrestrial mammals.
Starfish and sea urchins exhibit habituation—
the waning of a response to stimuli, as a result of
repeated elicitation of that response—and they can
learn escape behaviors in response to a cue paired
with aversive stimulation (46).
Earthworms exhibit habituation (45), can learn
to associate light with a food reward (66), and can
learn to travel a maze to receive darkness and mois-
ture as reinforcing stimuli (85). Flatworms are also
of considerable interest, since they represent a
bilateral body form, as do mammals. Flatworms
exhibit a concentration of nervous tissue and sen-
sory organs in the anterior, or head, portion of
their bodies, and they have refined internal or-
gan systems (47). Flatworms exhibit habituation,
can be conditioned to avoid alight after it has been
paired with shock, and can learn to approach an
area for food reward. There are also claims that
such learned events are remembered after these
worms undergo regeneration, and that learning
can be transferred from one animal to another
by cannibalism (reviewed in ref. 47).
Insects are valuable behavioral models in com-
munication, navigation, learning and memory, and
behavioral genetics.
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Communication. Honeybees recruit others
to a new food source through a dance per-
formed at the hive that conveys distance and
directional information (209). Many species
of insects (e.g., moths and ants) communicate
chemically by pheromones, which serve sex
attractant, repellant, and/or trail-marking
functions (reviewed in ref. 30). Other species,
such as the cricket, communicate by songs
produced by rubbing body parts together (19).
Navigation. Honeybees have demonstrated
extraordinary abilities to locate and return to
a food source “mapped out” for them by other
bees. They can also return to an artificial feed-
ing source designed for experimental pur-
poses to test their navigation abilities (37,
209)215).
Learning and Memory. Habituation has been
demonstrated in a variety of insect species (46).
Honeybees also appear capable of more ad-
vanced forms of learning, such as learning to
associate a specific color with a food reward,
and they can remember this association after
a 2-week interval (219). Cockroaches can learn
to leave their preferred dark retreats and stay
in the light to avoid being shocked; ants have
been trained to travel a maze to receive food
rewards (85).
Behavioral Genetics. Because of the relative
ease with which their chromosomes and in-
dividual genes can be identified, fruit flies have
been used extensively to elucidate the genetic
basis for a variety of behaviors (132).
Habituation has been demonstrated in a variety
of spiders (45), and spiders are capable of learn-
ing and remembering the location of prey in their
webs (85). They can also be trained to associate
food dipped in quinine or sugar with different
tones (46).
Even though protozoa possess both plant- and
animal-like characteristics and lack nervous tis-
sue, some forms of learning have been demon-
strated in these  single  celled organisms. Habitua-
tion has been demonstrated in paramecia (45).
Although the results generated much controversy
(reviewed in ref. 45), one investigator claimed to
have trained paramecia to enter a specific area
of their water container in order to receive food
reinforcement (81). It has also been reported that
paramecia show spontaneous alternation in a T-maze,
a phenomenon also observed in rodents (139).
A recent study of learning ability in paramecia
has demonstrated classical conditioning of an es-
cape movement (94). This study also found that
paramecia develop memory for the training event,
since significantly fewer trials were needed 24
hours later to relearn the response. Data such as
these challenge the widely held assumption that
learning is a property of synaptic interactions be-
tween nerve cells—absent in protozoa—and not
of individual cells themselves.
Plants
From a behavioral perspective, plants differ from
animals in two principal ways. First, plants lack
the means of achieving rapid intra- and inter-
organismal communication and coordination due
to the absence of a nervous system. However,
plants do regulate intra-organismal activities occur-
ring at different sites through the use of hormones.
Plants and animals thus share the basic principles
of endocrine function. Second, plants differ from
animals in that they are stationary. They must wait
for energy to come to them, while most animals
move about to obtain different sources of energy.
Despite these differences, plants do show rudi-
mentary forms of behavior (188). Plants can grow
and move in response to light, and some plants
have achieved the capacity for relatively rapid
movement to exploit certain animals as prey (e.g.,
the venus fly trap). The mimosa plant, which can
fold its leaves when touched, has been a subject
of particular interest. Certain of its cells appear
to generate primitive action potentials-electrical
activity that may be analogous to neuronal func-
tioning in animals (186). There have also been
reports that the folding response of the mimosa
plant shows habituation (6) and even some of the
rudiments of classical conditioning (8). Although
some claim evidence of feelings, emotions, and
even thinking in plants based on polygraph record-
ings (206), others contend these are artifactual (80).
A number of plants defend themselves from
predators via thorns, stickers, or toxic chemicals
that produce sickness, irritation, or even death if
touched or consumed. It has been demonstrated
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that some plants, under attack by insects and These impressive features of the botanical world
micro-organisms, develop highly sophisticated notwithstanding, it is unlikely that plants will make
defenses involving the emission of antibiotic-like an important contribution to behavioral research.
substances and chemicals that inhibit insect diges- The lack of a central nervous system, and in par-
tive enzymes. Indeed, some plants can apparently ticular a brain, renders the plant an inappropri-
communicate chemically with as-yet-unaffected ate model for use among the disciplines of be-
neighboring plants to induce leaf-chemistry havioral research.
changes in advance of infestation (reviewed in
ref. 164).
USE OF NONLIVING SYSTEMS IN BEHAVIORAL RESEARCH
Inanimate chemical or physical systems are un-
likely to prove useful in behavioral research, for
reasons intrinsic to the nature of behavior. A dy-
namic, emergent process, behavior functions to
allow organisms to adapt to moment-to-moment
changes in the environment. In a sense, all behavior
ultimately functions to aid and abet survival and
reproduction (50. Adaptation, survival, and repro-
duction are not properties of nonliving systems.
And behavior involves information processing and
a continuous series of choices among an array of
alternatives (140). Although chemical or physical
systems may change in response to certain envi-
ronmental stimuli, the nature of such changes does
not involve decisionmaking or information-proc-
essing.
Behavior is a byproduct of interactions between
sensory, neural, hormonal, genetic, and experien-
tial factors. As such, it is influenced by the situa-
tion at hand, the developmental history of the
organism, and prior experience with similar and
related situations. It appears inappropriate to im-
bue inanimate chemical or physical systems with
the capacity for experience. Devoid of such a ca-
pacity for experience, nonliving systems are un-
likely alternatives to using animals in behavioral
research.
Examples of the application of chemical or phys-
ical systems to behavioral research are sparse. One
involves the use of chemical reagents to mimic the
properties of rhythmic behavioral phenomena in
animals. Certain chemical reagents exhibit changes
in state that oscillate periodically in a fashion sim-
ilar to some biologically based rhythms. However,
the chemical reactions themselves remain poorly
understood (222).
COMPUTER SIMULATION IN BEHAVIORAL RESEARCH
A computer simulation is an operating model that
depicts not only the state of a behavioral system
at a particular point in time but also changes that
occur in that system over time. Because dynamic
processes are of quintessential importance in be-
havioral research, computer simulation stands as
a potentially useful tool for the behavioral scientist.
In order to simulate a living system, a computer
programmer must have information about that
system. The more information at hand, the better
the simulation (53). In the strictest sense, a com-
pletely accurate simulation presupposes that every-
thing that there is to know about the system in
question is known. To construct a computer simu-
lation that would fully replace the use of a live
organism in behavioral research would require
knowing everything about the behavior in ques-
tion, which in turn would preclude the need for
a computer simulation for research purposes.
Yet, if computer simulation cannot fully replace
living organisms, it can and does contribute to be-
havioral research. Although the fundamental be-
havioral qualities of adaptation, survival, and re-
production do not pertain to computer programs,
computer soft ware does, for example, embody in-
formation processing and decisionmaking. Exam-
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pies of recent attempts toward computer simula-
tion in behavioral research are listed in table 6-4.
Computer simulations are used in behavioral re-
search in a number of ways. Statistical simulations,
in particular, are increasingly frequent. For ex-
ample, one computer program simulates random-
choice behavior in mazes (194), and two programs
simulate random movements of animals under
various conditions (17,49). The output generated
by these kinds of simulations is compared with
animal-generated data to see if factors other than
pure chance are influencing the animals’ behavior.
Statistical simulations are also used to test hy-
potheses that may not be subject to empirical con-
firmation. One investigator used a computer simu-
lation to test the proposition that “if enough
monkeys were allowed to pound away at type-
writers for enough time, all the great works of
literature would result” (21). The larger objective
Table 6-4.—Some Examples of Computer Simulation
of Behavioral Phenomena
Spacing mechanisms and animal movements:
l Space use and movement patterns (17,49)
l Movements of juvenile Atlantic herring (110)
l Animal spacing (153)
l Mosquito flight patterns (165)
l Foraging of the honey eater bird (169)
l Random choice in radial arm mazes (194)
Learning, memory, and problem solving:
Ž Classical conditioning (15,18)
l Learning in neural systems (177)
l Habituation (195)
l Behavior in a psychoecological space (84)
l Mechanisms for reducing inhibition (223)
Sensation and perception:
l Visual pattern analysis (13)
l Landmark learning by bees (37)
l Chemical recruitment in ants (106)
Communication:
l Bird song (55,185)
l Animal vocalizations (57)
Sensation and perception:
• Neuron models (122)
l Neural basis for pain and touch (148)
Body maintenance:
l Food intake (14)
Ž Control of drinking behavior (204)
Reproduction and parental care:
l Sexual behavior of the male rat (72,205)
Ž Infanticide in Iangurs (89)
l Evolution of reproductive synchrony (116)
l Mating behavior of Spodoptera littoralis (200)
SOURCE: Office of Technology Assessment.
in this study was to determine if the extreme cases
of human genius could be accounted for through
chance processes.
The simulation was based on an initial assump-
tion that monkeys typing at random— or a com-
puter simulation using random numbers–would
generate huge volumes of nonsense. Statistical
properties of the English language (e.g., the rela-
tive frequencies of individual characters or se-
quences of characters) were added to the simula-
tion. As higher-order properties of English (i.e.,
the relative frequencies of three- and four-letter
sequences) were incorporated into the algorithm,
the rate of generation of intelligible words, phrases,
and sentences increased. These results led to a hy-
pothesis that genius could be simulated by a proc-
ess of random choice with a weighting procedure,
subject to a prior preparatory process in which
an individual absorbs the necessary operational
patterns that characterize the discipline. In studies
such as this, it is not merely the output generated
by the computer model that is of interest, but the
simulation process as well.
Computer simulations have considerable heuris-
tic value (65): They may yield insight about the sys-
tem or phenomenon being modeled (71) and, as
a consequence, stimulate additional research. The
value of computer simulation as a heuristic device
has been summarized as follows (158):
Simulation gives a means of exploring the plausi-
bility of models in which theoretical sophistica-
tion exceeds the state of the art in empirical test-
ing. Simulations provide tools for empirically
analyzing theories in order to better understand
their implications and predictions. Simulations
are a means of exploring interactions between
components of complex models. They pose a prac-
tical challenge to operationalize theoretical con-
structs, which can lead to incidental discoveries
about related processes. Finally, they engender
a concern with issues of process control that con-
tributes to the development of general principles
with broad applications.
Computer simulation holds promise for under-
standing complex cognitive processes. For exam-
ple, the computer is often considered analogous,
at least in some ways, to the human brain (7)—
both process large amounts of information, and
their respective outcomes are a consequence of
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multiple, relatively simple operations. On the other
hand, there are major differences:
l
l
l
l
computers have larger and many fewer com-
ponents than the brain;
computer operations occur with much greater
speed than neural operations;
computers operate through sequential proc-
essing; and
computers attend to all input, while the brain
is selectively attentive.
Such differences do not, however, preclude the
use of computers as functional models (170). More-
over, one advantage of computers is that they de-
mand rigorous and exact description. And an in-
vestigator need not invoke a variety of hypothetical
or mentalistic variables (e g., hope, fear, desire,
and intention) to describe their functioning (170.
It is important to note that any predictions gen-
erated by a computer simulation must be tested
and verified using the system the computer was
designed to replace (149). In this sense, the use
of animals in behavioral research is likely to con-
tinue in lockstep with the development of com-
puter simulation software.
One commentator summarized the use of com-
puters as an alternative to animals in behavioral
research in this way (114):
At the present time and for the foreseeable fu-
ture it seems clear that the computer will not be
a feasible substitute for experiments on animals.
The fundamental reason is that a computer can-
not acquire data other than those that are gener-
ated by carefully designed experimental studies
in animals. What the computer does provide is
a superb technique for processing vast amounts
of data with great speed and accuracy and for
presenting them in almost any manner the inves-
tigator desires. To suggest that enough data are
already available from previous work, so that
from them programs can be generated and sub-
jected to a variety of permutations that would lead
to new insights, overlooks an important fact. In
any animal experiment there are numerous vari-
ables over which we have little control, and there
are virtually always as many more about which
we as yet know nothing but which may have very
significant influences on the phenomenon under
investigation. In real life, which after all is what
matters in biologic research, these variables may
be crucial and may give important clues to en-
tirely unsuspected phenomena that are some-
times far more important than the original sub-
ject of the study. In a word, computers do not
generate new concepts or acquire new data. They
process data and permit the investigator to view
it in more manageable or novel ways, and this
may facilitate new hypotheses or insights.
In summary, computer simulation can serve to
facilitate behavioral research. The need for cer-
tain protocols may be precluded, or protocols may
be refocused by computer simulation before they
commence. Modeling techniques using computer
simulation lead to the refinement of experimental
protocols to be conducted on animals (36). Yet as
the preceding quote implies, in facilitating be-
havioral research computer simulation may actu-
ally increase, rather than decrease, the use of ani-
mals because data can be analyzed more quickly
and in much greater detail, leading to proportion-
ately more hypotheses to investigate (87,160).
SUMMARY AND CONCLUSIONS
Animal use in research can be modified in a num-
ber of ways, including strengthening experimental
design to minimize the number of animals used,
reducing the degree of experimental insult, and
substituting one species for another. The outright
replacement of animals with nonanimal methods
in research is not at hand, and, because of the na-
ture of biomedical and behavioral research, in
many instances it is not likely to become feasible.
Advances in instrumentation are critical to the
more refined or reduced use of live animals or liv-
ing material. In the past decade, practically every
piece of instrumentation in biomedical laboratories
has been adapted to handle ‘(micro” samples or
has been replaced by new microtechnology. The
use of small samples for analysis by mass spec-
trometry and by gas or liquid chromatography
leads to less invasive technology. Fiber optics, for
Ch. 6—Alternatives to Animal Use in Research l 139
example, can be used to perform analyses inside
ducts and blood vessels with little discomfort and
no permanent damage to the animal. Continued
developments in analytical instrumentation, in-
cluding noninvasive imaging techniques such as
magnetic resonance imaging, will likely ameliorate
the degree of experimental insult faced by research
animals.
In vitro technology has affected virtually every
field of biomedical research. This technology en-
tails the maintenance of organs, tissues, and cells
outside of the body and may affect research ani-
mal use in two important ways. First, when or-
gans, tissues, or cells are removed from animals
and cultured, experiments may be conducted with
fewer animals than would be necessary in whole-
animal experiments and, of course, without pain.
Cells from one animal, for example, may be divided
among a dozen experimental cultures and a dozen
control cultures, replacing 24 animals that might
be used in a comparable whole-animal experiment.
Second, when cells proliferate in culture, com-
mercially available cell lines can completely elimi-
nate animal use in some experiments. Such cell
cultures are derived directly from preexisting cell
cultures—not animals, Researchers have used, for
example, a monkey kidney cell line to study the
metabolic effects of general anesthetics.
In vitro experiments are not equivalent to whole-
animal experiments. In in-vitro systems, as orga-
nization is disrupted or lost, the in vitro system
has less and less of the kind of interactions that
characterize cells in the body. This can be an advan-
tage and a disadvantage. Interactions may cause
extraneous phenomena that obscure the process
under study. Conversely, the absence of interac-
tions may produce results that are at variance with
what actually occurs in the live animal. Conclu-
sions drawn from in vitro studies must eventually
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Distress caused by the Draize eye test is sometimes so acute that rabbits do scream out in
pain.
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Chapter 7
The Use of Animals in Testing
Testing for the safety or efficacy of a substance
or product accounts for a major use of animals
as defined in this assessment, most of which are
rats and mice (see ch. 3). Of these, probably the
largest portion are used in developing drugs. A
significant portion are also used to test other sub-
stances—pesticides, industrial chemicals, and con-
sumer products—to assess possible toxicity and
to establish conditions under which they can be
used safely.
Research and testing have been differentiated
for purposes of this assessment, but the bound-
ary between them is not sharp. From the stand-
point of developing alternatives, a key difference
is that a particular test maybe performed for hun-
dreds, perhaps thousands of substances and use
hundreds or thousands of animals, whereas a given
research method will be used on far fewer. As a
corollary there are far more research procedures
than testing procedures from which to choose, Fur-
thermore, individual researchers are much more
likely to develop their own methods than are those
conducting testing. These differences make the
task of developing alternatives more manageable
for testing than for research.
Testing for efficacy has some attributes of re-
search and some of toxicity testing. A particular
protocol may be used on a small number of sub-
stances and is likely to be tailored either to the
application or to the family of substances being
tested. Experimenters testing for efficacy need to
have a better understanding of the mechanisms
by which a particular effect occurs than those test-
ing for toxicity, primarily because efficacy test-
ing is closely related to the physiological mecha-
nisms that the new drug may affect, whereas toxic
effects may be quite independent. Finally, an im-
portant distinction of efficacy testing is that the
animals used would ordinarily be diseased.
Other kinds of tests include those for safety
other than for toxicity, as in testing of diagnostic
techniques or quality control tests in the manu-
facture of medical devices. These have endpoints
even more specific than those for toxicity, and are
thus good candidates for the development of alter-
natives (see ch. 8).
Toxicity testing is the focus of this and the fol-
lowing chapter for three reasons. First, this is an
area of animal use in testing in which the govern-
ment has great influence on nongovernmental ac-
tivities. Second, these tests are used in a more rou-
tine fashion than are tests for efficacy or general
safety and therefore have a greater tendency to
lag in the application of state-of-the-art technol-
ogy. Third, toxicity tests include methods that have
attracted the largest political attack.
All substances can be toxic at some exposure
level, even water. Conversely, even substances
known to be highly toxic maybe harmless at low
doses or under certain circumstances. Determin-
ing the hazard to humans requires information
about the potential hazard and the expected level
of exposure, resulting in an estimate of the prob-
ability that a substance will produce harm under
certain conditions (8). This assessment of risk is
a scientific endeavor, whereas the management
of risk is a sociopolitical one (31,36).
Although toxicity data on humans are invaluable
in conducting risk assessments, they are usually
unavailable. Some information comes from epi-
demiologic studies or episodes of accidental hu-
man exposure. Most often, however, testing on
animals is used. An appropriate weight is given
to the following factors on a case-by-case basis,
considering the seriousness of the hazard and the
kind of assumptions needed to estimate risks to
humans:
l
l
l
l
l
•
the relationship between dose and response;
the effects at the molecular, cellular, organ,
organ system, and whole-organism levels;
conflicting results between studies and pos-
sible explanations for the conflicts;
the effects of structurally similar substances
on humans or animals;
any known metabolic differences between hu-
mans and the test species that could affect the
toxic response; and
statistical uncertainties and difficulties in ex-
trapolating to a low dose (55).
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TESTING
Toxicology as a science began in the 16th cen-
tury and has advanced with the growth of the
chemical, pesticide, drug, and cosmetic industries.
The concept of protecting the public from harm-
ful effects of chemicals dates back to laws of an-
cient civilizations that made it illegal to adulterate
the food supply (25). The importance of toxicol-
ogy to public health has received considerable at-
tention in the United States since the 1930s. Pub-
lic awareness of the value of toxicological testing
has also been furthered by disasters such as Mina-
mata disease (methyl mercury poisoning in Japan),
the thalidomide tragedy, and, more recently, the
development of cancer in those exposed to diethyl-
stilbestrol (DES) in utero.
Designing a Test
There are two approaches to toxicology-mech-
anistic and descriptive—and these affect the de-
sign of experiments and the choice of biological
end points to be measured. Mechanistic toxicol-
ogy focuses on the chemical processes by which
a toxic effect occurs and relies heavily on the tech-
niques of physiology, biochemistry, and analyti-
cal chemistry to monitor these processes. A sim-
ple example of this approach would be a series
of experiments showing that a certain substance
is metabolized in the liver, that one of the by-
products of metabolism happens to be a potent
liver carcinogen, and that liver cancer typically
follows administration of that substance. Mech-
anistic tests are custom designed and are closely
related to research. They can contribute greatly
to the design and interpretation of descriptive tests,
Mechanistic toxicology plays a major role in the
development of methodologies that could replace
whole-animal testing.
Descriptive toxicology deals with phenomena
above the molecular level and may rely heavily
on the techniques of pathology, statistics, physi-
ology, and pharmacology, e.g., the evaluation of
changes in the appearance of an organ or its con-
stituent cells, the presence of tumors, or signs of
irritation. This approach does not necessarily re-
quire an understanding of the mechanisms by
which toxic effects occur, although if mechanis-
tic information were available, it would be used.
METHODS
In terms of the test substance and species in the
preceding hypothetical case, descriptive toxicol-
ogy would show that a certain substance causes
liver cancer in a particular species within a cer-
tain time. It might also show the approximate rela-
tionship between the substance dose and the inci-
dence of the liver cancer. Regulatory schemes
requiring testing most often rely on descriptive
toxicology.
Mechanistic toxicology provides an approach to
extrapolation from one species to another based
on known similarities and differences in physiol-
ogy. The closer the test animal is biologically to
humans or the greater the number of species in
which the effect is detected, the more likely it will
occur in humans as well. The reliability of extrap-
olations from descriptive experiments is greatly
enhanced when mechanistic information is also
used. Similarly, the use of mechanistic informa-
tion in the design of descriptive tests contributes
greatly to the reasonableness of any later extrapola-
tion to humans if human toxicity data are lacking.
Most state-of-the-art toxicological tests require
whole animals. Although in vitro alternatives are
being developed (see ch. 8), different end points
would be measured. For example, whole animals
will probably continue to be needed to look for
effects in previously unknown target organs, to
evaluate effects that represent an interaction of
multiple organ systems, to monitor metabolism and
pharmacokinetics, or to evaluate healing or dimin-
ished responsiveness to the toxic substance. Thus,
whole-animal use is unlikely to stop entirely in the
foreseeable future.
Choice of Species and Strain
In 1$104) the Food and Drug Administration (FDA)
was still using human employees to test food pre-
servatives (e.g., boric acid, salicylic acid, their de-
rivatives, and formaldehyde) for toxicity (25). Use
of animals remained limited until a few decades
ago, when breeding technology provided large
numbers of animals with carefully controlled
genetic characteristics, thus allowing toxic effects
to be more easily detected than had previously
been the case. Animal use has grown with increas-
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ing demands by the public for safe and effective
products.
The most appropriate animals are ideally those
that, for the substance being tested, predict the
human response most accurately. There is no other
animal wholly identical to humans in terms of toxic
effects. The choice of animal is influenced by
known similarity to humans for the organ system
or mechanism of interest, as well as convenience
of breeding or purchasing, familiarity with the spe-
cies, existing data, lifespan, ease of handling under
experimental conditions, cost of obtaining and
maintaining, litter size, and gestation period. Ro-
dents have been used extensively, as have rabbits,
primates, and dogs.
Rodents have been used in almost all carcino-
genicity testing despite the fact that such tests are
the most difficult to extrapolate to humans. Mice
and rats have been used because their lifespan is
short, they are small and easily handled, and they
have a number of metabolic pathways and patho-
logical responses similar to those of humans. Some
specially developed strains are sufficiently suscep-
tible to cancer that test groups can be small. These
factors contribute greatly to the economic feasi-
bility of conducting carcinogenicity testing with
rodents. Extensive experience in using them, and
in using particular strains, is often an important
reason for continuing their use (55). A large amount
of data are already available on spontaneous tumors
at specific organ sites (l).
Although rodents are routinely used for many
kinds of tests, other animals maybe used for spe-
cific reasons. For example, the rabbit is used for
eye irritation tests because it has large, easily
manipulated eyes and because its eyes have many
characteristics found in human eyes (19). Hens
have been shown to be a good model for delayed
neurotoxic effects of organophosphorous com-
pounds (12).
Dose Levels and Route and
Duration of Exposure
The way in which exposure to a substance oc-
curs can affect the kind and severity of toxic ef-
fects. For example, if a chemical does not present
a hazard when applied to skin because it is not
absorbed, it may nonetheless be very toxic if taken
orally. When the route of exposure does not affect
the portion of the dose taken up or its distribution
in the body, testing might be done in the manner
most easily controlled. For other than the most
preliminary tests to characterize toxicity, most
would administer the substance by the same route
as would occur in the course of accidental exposure
or use by humans. Sometimes the palatability, volu-
bility, stability, or volatility of a substance will de-
termine which routes are feasible.
Certain tests, such as the acute toxicity for a sin-
gle exposure, are used as inexpensive screening
tools for estimating the relative hazard presented
by a substance. As discussed later in this chapter,
the acute toxicity test known as the LD50 is used
in classification schemes for the transportation or
disposal of chemicals. Acute toxicity testing might
also be used to determine the risks of one-time
exposure, as might occur in an accident. Ordinar-
ily, the duration of exposure in an animal study
is greater (at least in proportion to the lifespan)
than the exposure period for which data will be
used in extrapolating the risks to humans.
The dose levels administered depend on a vari-
ety of factors. On the one hand, it is not possible
to detect long-term effects if the dose is so large
that many animals die before the end of the test.
On the other hand, administered doses represent-
ative of human exposure levels may not produce
detectable effects with what may be considered
a reasonable number of test animals. Generally,
three dose levels are used; they are chosen so as
to span the range of responses from a “no-observed-
effect level” to fully observable toxic effects,
For carcinogenicity and other long-term testing,
the highest dose should be one that will produce
measurable toxicity without significantly altering
lifespan. Other levels may depend on whether the
carcinogenicity is being looked for in combination
with chronic toxicity (55). The lowest dose could
be one for which there are no observed effects
or it might be related to the level of estimated hu-
man exposure (38).
Another approach is to choose doses that will
yield levels in the blood similar to those expected
for humans. Although this is perhaps a more real-
istic test, effects may be more difficult to detect.
In addition, the criterion of similarity may require
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more than one administration per day because
metabolic rates and excretion rates tend to be
faster in small animals than in humans (24).
Statistical Considerations
To obtain valid results, an experiment must be
designed so that what is measured provides useful
and sufficiently accurate information. Statistical
methods allow a scientist to estimate the minimum
number of test animals from which conclusions
can be drawn to estimate the reliability of any con-
clusions. Statistical analysis can help reduce the
number of animals needed for a particular test
procedure.
To allow for the unexpected (including death,
illness, or error), the number of animals used al-
ways exceeds the minimum number needed to de-
tect expected effects reliably. Determining that
minimum number of animals is more difficult for
longer tests, both because the passage of time
makes the probability of something going wrong
during the experiment increase, and because cer-
tain problems are more likely to occur as the ani-
mals age.
Another factor affecting the number of animals
needed is the variability in the sensitivity of indi-
vidual animals to the substance involved. Thus,
as few as 6 animals might be used for an eye irrita-
tion test or 10 per dose level for an acute toxicity
test. In carcinogenicity or teratogenicity testing,
many of the animals maybe unaffected by the test
substance, and 100 animals may be needed for each
dose level.
Most species experience some cancer and other
diseases during their life. Any measurement of in-
cidence as it relates to the dose given must be taken
against this background incidence, which is gauged
in an (untreated) control group. Control groups
may also be important if a test substance is being
carried in a particular vehicle needed to administer
the test substance, such as in solution with another
chemical, that is not itself being tested (vehicle con-
trol group). The sensitivity of the test animals to
a substance known to be toxic may also be meas-
ured for comparison (a positive control group). Be-
cause there are so many variables that can influ-
ence a test, toxicologists consider it vital that the
control and test groups be drawn from the same
pool of animals and be tested concurrently.
Any experiment suffers from experimental er-
ror, of which there are three sources: the natural
variation due to differences among test animals,
the variation in experimental conditions, and error
arising in measurement. Determining the amount
of error is crucial to drawing reliable conclusions
from experimental results, but it is also important
to keep the error as low as possible by controlling
conditions carefully. Differences among test ani-
mals are controlled by using genetically similar
and sufficiently large groups for each condition.
Even minor environmental factors can influence
toxic response (15,23). Sources of measurement
error depend on the measurement technique and
the equipment.
Use of Standardized Test Methods
and Guidelines
Testing methodologies are standardized to con-
trol experimental variables, thus allowing results
to be easily compared. Methodologies may be-
come standardized through round-robin testing
in many labs, through publication and imitation,
and through development by recognized organi-
zations or agencies. Methodologies or guidelines
are published by the Food and Drug Administra-
tion, the Environmental Protection Agency (EPA),
the Organization for Economic Cooperation and
Development (OECD), the National Cancer Insti-
tute, the American Society for Testing and Mate-
rials, the American National Standards Institute,
the British Standards Institute, the International
Agency for Research on Cancer, and others (see
app. A for information on FDA, EPA, and OECD
guidelines).
The most important reason to strive for com-
patibility among guidelines is to avoid the need to
repeat identical tests to satisfy particular require-
ments of various governments and agencies. Com-
patibility can also avoid nontariff trade barriers,
Any government that would like to change its test-
ing requirements to further the cause of animal
welfare needs to consider the effects of its pol-
icies on testing in other countries.
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Pharmacokinetics
Pharmacokinetic studies provide information
about the mechanisms of absorption, about a sub-
stance’s distribution among the various body com-
partments, and about metabolism and elimination.
They facilitate the interpretation of results from
other tests and their extrapolation to humans be-
cause the distribution and elimination of a foreign
substance will often explain its toxicity or lack
thereof.
Absorption of a substance into the body can oc-
cur by a variety of routes. If exposure is by inhala-
tion, absorption can occur in the lungs, in the path-
ways leading to the lungs, and sometimes in the
gastrointestinal tract. If exposure is by mouth, ab-
sorption would occur as the substance passes
through the gastrointestinal tract. What is not ab-
sorbed is excreted in the feces, With dermal ex-
posure, the substance must be absorbed through
the skin. If exposure is via injection into a body
cavity, the substance cannot be removed without
the involvement of other parts of the body.
Once a substance is absorbed, it maybe excreted
unchanged. Excretion could be through the skin,
in the urine, feces, semen, or breast milk, or, if
it is volatile, in exhaled air. It might also be stored
in tissues, organs, or body fluids, perhaps for the
life of the organism. A substance might also be
chemically modified until it can be excreted or until
the body is unable to metabolize it any further.
This metabolism normally takes place in the liver,
the site where detoxification of substances takes
place. A test substance or its metabolic products
can react with the chemicals that make up the
body, perhaps resulting in toxic effects.
Pharmacokinetic studies are usually conducted
through the sampling of body fluids, both those
that are excreted (urine, saliva) and those that are
not (blood, cerebrospinal fluid). Tissue samples are
often taken, although normally not until the end
of a study (4).
Acute Toxicity Tests
Acute toxicity testing is used to detect the toxic
effects of single or multiple exposures occurring
within 24 hours. These are frequently the first tests
performed in determining the toxic characteris-
tics of a substance and may serve as a basis for
classification or labeling or for concerns about acci-
dental exposure. The results are used to establish
toxicity relative to other substances, to determine
specific toxic effects, and to provide information
on the mode of toxic action and the relationship
between dose and adverse effects. Results may also
help in designing long-term tests.
One of the most common acute toxicity tests is
the LD50 (from Lethal Dose for 50 percent), devel-
oped in 1927 for comparing batches of dangerous
drugs (52). The LD50 is calculated to be the dose,
within statistically established confidence inter-
vals, at which half the test animals can be expected
to die upon exposure to a test substance. A sub-
stance is administered once by the oral, dermal,
or parenteral (injection into a vein or the body
cavity) route or it is inhaled. The animals, usually
rodents, are observed for 14 days and then sacri-
ficed so that their organs and tissues can be evalu-
ated for gross changes. Other measurements and
observations can be added to increase the amount
of information this test provides.
A related procedure is the limit test. A high dose
is given, often 5 g/kg body weight (54); if no ani-
mals die, the test ends. This is based on the as-
sumption that if an organism is not killed by an
extremely large dose, it does not matter what dose
it takes to actually cause death. Other tests using
fewer animals have been devised and are receiv-
ing growing acceptance (see ch. 8).
Acute toxicity testing has its limitations, particu-
larly because the end point is death. Death can
come about in many ways and the mechanism is
not conveyed in the numerical value of an LD50.
In addition, the results may vary greatly both
among and within species, with the animals’ sex,
age, and diet, and with other test conditions. Acute
toxicity testing, although not necessarily the clas-
sic LD50 procedures, will continue to be of inter-
est because there are many substances for which
the toxic effects of acute exposure are quite differ-
ent from those produced by chronic exposure (8).
It may also continue to be used in selecting doses
for long-term studies. Nonetheless, circumstances
may be identified in which acute toxicity testing
is not needed because other tests more relevant
to the use should be performed. The Toxicity Com-
mittee of the Fund for the Replacement of Ani-
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reals in Medical Experiments recommended that
study of the consequences of not acquiring knowl-
edge of acute toxicity of products be undertaken
and that in the case of products such as drugs,
LD~Otests should be replaced by acute toxicity tests
that emphasize the nature of the effects observed
(18).
Skin and Eye Irritation/Corrosion Tests
Irritation is the production of reversible tissue
damage such as swelling, while corrosion is the
production of irreversible tissue damage. Skin and
eye irritation tests normally involve acute expo-
sure. Repeated exposure can be used to test for
allergic reactions, which involve the organism’s
immune system, and cumulative effects. Skin irri-
tation studies are used to initially characterize a
substance’s toxicity and to develop precautionary
information for situations in which human skin
or eye exposure is possible.
Although it is not yet possible to reliably predict
the degree of irritation or corrosion a substance
will cause, a considerable body of knowledge ex-
ists. The factors that determine damaging effects
to eyes or skin are:
l intimacy and duration of contact,
l physical properties that determine the amount
of penetration, and
l the reactivity of the substance with tissues (10).
Intimacy is affected by both the ability of the sub-
stance to spread over the surface (such as soaps
or detergents) and its concentration. Penetration
of the skin or other membranes is greatest in sub-
stances with small molecular size and with abili-
ties to mix with both water and oil. A substance
that can react with proteins and enzymes in tis-
sues is especially damaging if it can penetrate to
the delicate structures of the eye (50).
Skin irritation tests are usually conducted on rab-
bits, guinea pigs, rats, and mice, although other
mammals may also be used. The test substance
is applied to a small area of skin from which the
fur has been clipped or shaved and maybe held
in place with a dressing. Using untreated skin of
the same animal for comparison, the degree of red-
ness or blistering is scored at intervals (e.g., 38,54).
There are many similarities between the skin
cells of humans and other mammals, but there are
important differences as well. For example, there
are structural differences that affect permeabil-
ity (32). Animal models have been shown to be par-
ticularly poor in the evaluation of mild irritants
(27). The extrapolation of animal models is further
complicated by large differences in the race, age,
and skin condition of humans (21,26,58).
The method most commonly used to evaluate
eye irritation is the Draize test, which has remained
largely unaltered since it was introduced more than
40 years ago (9). A single dose of a substance is
applied to one eye of at least three adult rabbits.
The other eye remains untreated. The degree of
irritation or corrosion to the cornea, iris, and con-
junctival is scored by comparison with standard
pictures over a period of 3 days. The rabbits may
be observed for 3 weeks to determine whether
the effects are reversible.
A substance shown to be highly corrosive to skin
will be highly irritating to the eye and thus might
not be tested. Similarly, a substance with a pH of
2 or less (strongly acid) or 11.5 or more (strongly
alkaline) is assumed to be highly irritating or cor-
rosive to skin or eye and need not be tested (38,54).
The cornea tolerates substances with a pH rang-
ing from 3 to 11 variably, with the severity of a
reaction depending in large part on a substance’s
ability to affect protein structure or function
(17,35).
Repeated-Dose Toxicity Tests
Humans are often exposed repeatedly to a sub-
stance and this does not necessarily cause the same
effects as an acute, one-time exposure. Chronic
toxicity effects differ from acute toxicity ones when
the test substance or its metabolizes accumulate
in the organism to a toxic level or when it causes
irreversible toxic effects that accumulate with each
administration (8). Rats are most frequently used,
and testing in a second, nonrodent species, usu-
ally a dog, is also common.
Repeated or prolonged exposure to the test sub-
stance is used in chronic, subchronic, and short-
term toxicity tests. The term chronic generally
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refers to tests with exposure for at least 1 year
or most of the lifetime of the test species. Sub-
chronic usually refers to tests of intermediate dura-
tion-3 to 6 months. Short-term repeated dose tox-
icity tests last from 2 to 4 weeks.
Some have suggested that there is little to be
gained by exposures of more than 6 months dura-
tion for chronic toxicity testing (18)34). One com-
mentator has argued that studies of 3 to 6 months
are easier to interpret because the complicating
effects of aging are avoided (44)45). Another finds
longer tests necessary for detecting effects that
occur only late in life or for which cumulative tox-
icity is an important consequence (42).
Throughout repeated-dose testing, animals
would be observed for general appearance, res-
piratory problems, central and peripheral nerv-
ous system function, coordination, and behavioral
changes. During and following the course of ex-
posure, observations are made of hematology
(hematocrit, white cell count, platelet count, clot-
ting factors), ophthalmology, electrolyte balance,
carbohydrate metabolism, liver and kidney func-
tion (as determined from concentrations of cer-
tain substances in the blood), body weight, and
the appearance of lesions. After the animals have
been sacrificed, observations are made of body
surfaces, orifices, cavities, and organs. Microscopic
examinations are made of selected tissues and or-
gans, of gross lesions, and of organs that changed
in size. one technique used in repeated dose tox-
icity testing to determine whether the toxic effects
are reversible is to give a satellite group the high-
est dose of the test substance and then give the
animals time to recover before sacrificing them.
Carcinogenicity
Cancer is a major human health concern, strik-
ing one out of four and killing one out of five Ameri-
cans (53). Consequently, carcinogenicity is an im-
portant animal test. Detecting human carcinogens
presents special problems because a latency period
of 20 years or more can occur. Animal testing, par-
ticularly in rodents, is useful because the latency
period for tumor formation is much shorter (1 to
2 years for rodents), thus allowing potential hu-
man carcinogens to be detected during testing and
before use, at which point they could become ma-
jor public health problems. It is also much easier
to control the animal environment than the hu-
man environment, and therefore to investigate
causal relationships.
Although many human carcinogens were dis-
covered without animal testing, several have been
identified by first using such tests, e.g., DES, vinyl
chloride, and bis(chloro-methyl) ether (55). Ani-
mal use has its limitations; many substances cause
cancer only in certain species. The known human
carcinogens benzene and arsenic have never
proved to be animal carcinogens. Hundreds of sub-
stances have been identified as carcinogens in tests
with one or more animal species but not in hu-
mans, in part because of insufficient human epi-
demiologic data and in part because some of them
undoubtedly do not cause cancer in humans (41).
Nonetheless, the use of animals in testing for car-
cinogenicity is widely endorsed (55).
Carcinogenicity testing is more costly and re-
quires far more animals than other tests. Chronic
toxicity testing may use about 160 rats and 32 dogs,
whereas carcinogenicity testing would use about
400 rats and 400 mice. (In order to economize, car-
cinogenicity testing and chronic toxicity testing
are often combined. ) Cancer is easy to detect if
tumors are visible, but it can only be detected in
its early stages by microscopic examination of mul-
tiple samples of 30 or more tissues and organs that
may appear normal. Typically, 500,000 data points
must be analyzed (41).
These large numbers of animals and multiple
data points are needed for statistical reasons. Can-
cer has a high background incidence and large var-
iations from animal to animal, making it difficult
to establish that cancer was caused by the test sub-
stance. The higher the incidence of spontaneous
cancers, the more difficult it is to establish a link
between cancer and the test substance. For ex-
ample, if the background rate of cancer is 10 per-
cent and the common criterion for statistical sig-
nificance of 0.05 is used, the number of animals
required to detect carcinogenicity in 90 percent
of the tests is as shown in table 7-1. As can be seen,
if a test substance causes cancer in 80 percent of
the animals, 48 animals are needed to demonstrate
carcinogenicity. If the incidence is only 15 percent,
over 3,000 animals are needed. It has been sug-
gested that the background incidence could be re-
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Table 7.1 .—Number of Animals Needed to Detect
Carcinogenicity in 90 Percent of All Tests
for a Statistical Significance of 0.05
Number of animals
Rate of incidence caused by (3 dose levels
test substance (percent) plus control group)
80. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 48
60. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 84
40. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 184
20. . . . . . . . . . . . . . . . . . , . . . . . . . . . . 1,020
15. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3,304
SOURCE: Adapted from l.F.H. Purchase, “Carcinogenicity/’A  nh-naLs  artdA/ter.
natives in Toxicity  Testktg, M. Balls, R.J.  Ridden, and A.N.  Worden (eds,)
(New York: Academic Press, 1983).
duced, and the sensitivity of the method thereby
improved, if animals were not kept under condi-
tions that aggravate cancer (excessively nutritious
diet, little exercise, and isolation) (42).
Developmental and Reproductive
Toxicity
The effects of chemicals on human reproduc-
tion are difficult to assess because of the complex-
ity of the reproductive process and the many kinds
of insults that can be inflicted before reproduc-
tive maturity as well as during fetal development
(8). Reproductive functions that can be harmed
by foreign substances include the storage and
maturation of the germ cells, fertility (including
factors that affect sperm maturation and implan-
tation of the fertilized egg), and the development
of the fetus. Possible toxic effects to the fetus in-
clude birth defects (teratogenicity), low birth
weight, abnormal gestation time, and prenatal or
postnatal death (7).
There are a variety of experimental protocols
by which these effects can be determined in ani-
mals. Some involve more than one generation;
others involve evaluation of a fetus before birth.
Exposure to a substance can start before the fe-
male ovulates or as late as some specific stage of
fetal development. Exposure can be chronic or
acute. The great variety of procedures available
can lead to a certain amount of overlapping test-
ing (2).
Rats and rabbits are the most commonly used
species. Mice and hamsters and other mammals
are used as well. Three dose levels are normally
used, the highest of which causes minimal toxicity
in the adult female. Groups of about 20 pregnant
females are typically used. In the OECD Testing
Guidelines, if no teratogenic effects are observed
at a dose of 1,000 mg/kg body weight, other dose
levels are not necessary (38).
Neurotoxicity
Neurotoxicity (damage to the nervous system)
is observed in acute and chronic testing, but the
range of neurotoxic effects is so great and the signs
so varied that special tests for damage to the nerv-
ous system are sometimes warranted, Neurotoxic
effects that tend to be associated with acute expo-
sure are functional, sometimes reversible changes
in the nervous system that might not involve struc-
tural damage or degeneration. Most chronic neuro-
toxic effects do involve structural changes or de-
generation and are not readily reversible (6). The
type of neurotoxic effect tends to depend on the
size of the dose and the duration of exposure (46).
There are many types of nerve cells, each per-
forming special functions. Damage can occur to
the functioning of the cell itself, to its connections
to other nerve cells or to muscle cells, or to the
supporting cells. Neurotoxicity can be manifested
in the following ways: motor disorders such as
weakness, lack of coordination, paralysis, tremor,
convulsions, or slurred speech; sensory disorders
such as numbness, pain, or auditory, olfactory,
or visual deficits; disturbances of autonomic func-
tion such as sweating, incontinence, vomiting, im-
potence, or tear formation; increased state of
excitability such as hyperactivity, irritability, or
euphoria; impairment of short-or long-term mem-
ory, disorientation, or confusion; sleep disorders;
psychiatric disturbances; impaired temperature
regulation; or alterations in appetite, or weight gain
or loss (6).
More than any other kind of toxicity test, neuro -
toxicity does not lend itself to standard procedures
or in vitro tests because the range of effects is so
broad. There are considerable differences among
species, and little standardization of tests across
species has occurred. Neurotoxicity tests would
typically follow acute or chronic toxicity ones in
which neurotoxic effects had been observed or
were suspected (6).
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Mutagenicity
A mutation is a permanent change in a gene that
is passed along to any descendants of the cell. Thus,
mutations in germ cells will be passed along to off-
spring. If recessive, the mutation will not be ob-
served in the offspring but will become part of
the gene pool from which future generations will
draw. If the mutations dominant, it may be lethal
to the developing fetus or it might affect the off-
spring in a variety of ways, including impairing
its fertility. If the damage is to a somatic cell, the
mutation could lead to cancer or, in a developing
fetus, birth defects.
There are several nonanimal and in vitro tests
based on mammalian or human cells that would
be considered alternative mutagenicity tests (see
ch. 8). There are several whole-animal tests as well.
One is the dominant lethal assay, in which a male
is exposed to the test substance and then mated
with an untreated female. Part way through the
pregnancy, the female is killed and the number
and condition of the fetuses observed. Another
is the heritable translocation assay, in which the
male progeny of treated males are mated with un-
treated females and the effect on fetuses deter-
mined. The mutations transmissible to the next
generation are of special interest because of their
implications for the human gene pool (5).
The in vivo sister chromatid exchange and mouse
micronucleus tests rely on microscopic examina-
tion of the chromosomes themselves after the test
substance has been administered to the whole ani-
mal. In vitro versions of these techniques also exist
(see ch. 8). Changes can be observed using a micro-
scope. Host-mediated assays are a hybrid of non-
animal and whole-animal techniques in which the
test substance and a micro-organism are adminis-
tered to an animal and the effects on the micro-
organism determined (5).
Current Trends
Many factors are likely to influence testing prac-
tices in the near future. Public pressure to use alter-
natives to whole animals, increasing costs of using
animals, and improvements in toxicological meth-
ods are likely to reduce the use of some tests, such
as the LD50 and the Draize eye irritation tests. This
pressure is also likely to result in changes in some
existing tests in order to reduce animal suffering.
These developments could bring about a review
of current legal requirements for testing, perhaps
reducing the amount of testing per chemical and
the number of animals per test. Such a review,
as well as advances in the state of the art, might
better tailor testing to the substance being exam-
ined and to the circumstances of human exposure.
On the other hand, the number of substances be-
ing tested could increase with greater regulatory
or product liability requirements, with greater
funding available for testing, or with less expen-
sive tests available.
Interpretation and extrapolation of test results
to humans can be expected to improve as the mech-
anisms of toxic responses are better understood.
Increasing use of pharmacokinetics and mechanis-
tic studies is likely to result in improved designs
and better selection of tests.
THE ROLE OF GOVERNMENT IN TESTING
The Federal Government and each of the States
are involved in testing in a variety of ways. Per-
haps the most important are various explicit and
implicit requirements for testing under existing
statutes. Another area is the funding of research
and development leading to new methods (see ch.
12). Yet another is the funding of toxicological test-
ing, conducted primarily by the National Toxicol-
ogy Program (NTP), supported largely by the Na-
tional Institute of Environmental Health Sciences.
This program, chartered in 1978, is a cooperative
effort among agencies within the Department of
Health and Human Services (see chs. 11 and 12).
Four principal Federal agencies have a signifi-
cant role in animal testing for regulatory purposes:
FDA, EPA, the Consumer Product Safety Commis-
sion (CPSC), and the Occupational Safety and Health
Administration (OSHA). Other agencies whose reg-
ulatory activities affect animal use include the
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Centers for Disease Control (CDC), the Department
of Transportation (DOT), the Federal Trade Com-
mission (FTC), and the US. Department of Agri-
culture (USDA). Animal testing is also funded by
the Department of Defense.
Testing is covered by several types of statutes
and regulations. Most common are laws that re-
quire a product to be safe and effective. Given the
state of currently accepted technology and prac-
tice, such a statute implicitly (although not explic-
itly) calls for animal testing. Such tests are rou-
tinely expected as an indication of meeting the
standard of product safety and effectiveness. A
second stimulus for animal testing involves pre-
market approval. Under this authority, testing with
animals is explicitly required by regulations of the
agency involved. Or, animal testing may be explic-
itly required by statute, as in the case of the Fed-
eral Hazardous Substances Act administered by
CPSC. As a practical matter, it makes little differ-
ence whether the tests involving animals occur
under implicit or explicit statutory or regulatory
authority: The procedures used are quite similar.
The specific tests performed and the methodol-
ogies used may be dictated by informal or formal
requirements of the agency. These may take the
form of promulgated regulations, published guide-
lines, unpublished guidelines, or customary prac-
tices. Some guidelines and the use of specific tests
are accepted internationally (see app. A.)
With these general principles in mind, this dis-
cussion summarizes current Federal regulatory
requirements relating to testing with animals (see
also app. B). This review is not intended to evalu-
ate the justification of such testing, only to describe
its scope and magnitude. It is meant to provide
sufficient background to permit an evaluation of
the reasons testing is conducted and of the regu-
latory needs that any alternatives to such testing
must satisfy.
Food and Drug Administration
FDA is responsible for administering several stat-
utes that regulate animal and human food, animal
and human drugs, medical devices, cosmetics,
color additives, and radiological products. This
regulation takes place primarily under the 1938
Federal Food, Drug, and Cosmetic Act as amended
(21 U.S.C. 301 et seq.) and the Public Health Serv-
ice Act of 1944 (42 U.S.C. 200 et seq.).
FDA evaluates each product on a case-by-case
basis. The exact testing regime is determined by
considering the type of product, the method of
exposure, the amount and duration of intended
use, and the potential hazards associated with the
specific product. In support of its regulatory re-
sponsibilities and to assure quality testing, FDA
has issued standards for good laboratory practice
(see ch. 13) and has developed guidelines and test-
ing protocols. Although some special guidelines
or testing protocols are established for specific
products, most tests are the same as or similar to
the toxicological tests used by other agencies. Ap-
pendix A lists the types of tests used.
The National Center for Toxicological Research
(NCTR) in Jefferson, AR, and the National Toxicol-
ogy Program are the research and testing arms
of FDA. Although NCTR and NTP have no direct
regulatory responsibilities, they provide informa-
tion needed to evaluate the safety of chemicals.
Research that involves the use of animals or alter-
native methods includes studies of effects of low-
dose, long-term exposure to chemicals; develop-
ment of new methodology to investigate toxic ef-
fects; study of biological mechanisms of toxicity;
and investigation of methods for estimating human
health risks using experimental laboratory data.
The misbranding or adulteration of virtually any
product regulated by FDA is prohibited. In addi-
tion, testing is required both to substantiate label-
ing claims and to demonstrate safety. These re-
quirements should be assumed to apply to the
substances and products discussed in this section
unless otherwise stated.
Food for Humans
Under the law, a food additive is defined as a
food substance that is not “generally recognized
as safe” (as defined in the Federal Food, Drug, and
Cosmetic Act) and that has not previously been
approved as safe by FDA or USDA between 1938
and 1958. No such additive may be used until it
has been subjected to extensive toxicity testing,
a food additive petition has been submitted to FDA,
and FDA has approved the additive as safe and
promulgated a food additive regulation govern-
ing its use.
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The safety of an additive is established by evalu-
ating data from combinations of tests. The amount
of testing that must be performed is determined
by the amount of information already available
and the degree of toxicological concern. Guidelines
have been developed (Toxicological Principles for
the Safety Assessment of Direct Food Additives
and Color Additives Used in Food (56), known as
the Red Book) that contain detailed procedures ade-
quate to meet minimum requirements. However,
manufacturers are permitted to modify the test-
ing as they deem necessary as long as the data are
equal to or better than what would be derived by
using the guidelines.
Food safety has been important to FDA since the
early 1900s. However, the use of animals to test
food additives was not begun until the passage of
the 1954 Pesticide Chemical Amendments and the
1958 Food Additive Amendments. The most fa-
mous amendment, sponsored by Delaney, required
that any additive that induces cancer in animals
or in humans be banned.
Drugs for Humans
FDA regulates all human drugs, including bio-
logical ones. The 1938 amendments of the Federal
Food, Drug, and Cosmetic Act require drug man-
ufacturers to submit evidence to FDA that a new
drug is safe prior to commercialization. Safety
evaluations are primarily based on preclinical ani-
mal testing and subsequent clinical testing in hu-
mans. In 1962, amendments to the act required
that the effectiveness of a new drug also be dem-
onstrated, and this is accomplished through clini-
cal testing.
The requirements to use animals to test new hu-
man drugs depend on the proposed scope of clini-
cal investigation and on the drug’s anticipated use,
Determining the best procedures for testing is com-
plex because of the variation that exists in the use
and activity of drugs. Testing must be tailored to
each drug and specific requirements are deter-
mined by considering the route of administration,
the target population, the length of treatment, and
the relationship of the drug to others already in
use. In addition to the formal procedures required
under the Good Laboratory Practices regulations
(see ch. 13), guidelines are available to aid manu-
facturers in designing test protocols. Manufac-
turers commonly discuss their programs with FDA
before and during testing, as well as afterward.
Guidelines are available for tests required for
drugs intended for oral, parenteral, dermal, inhala-
tion, ophthalmic, vaginal, and rectal uses, and those
used in combination. Duration of proposed human
administration is a major factor for determining
the particular animal test species, the number of
animals, and the duration of the test.
Biological products—any virus, therapeutic se-
rum, toxin, antitoxin, vaccine, blood, blood com-
ponent or derivative, or allergenic product used
to prevent, treat, or cure human diseases or in-
juries—are regulated under the Public Health Serv-
ice Act and the Federal Food, Drug, and Cosmetic
Act. As with drugs, before a new vaccine or aller-
genic can be marketed, the manufacturer must
provide test data to show that the product is safe
and effective. FDA Center for Drugs and Biologics
licenses the product and the manufacturing facil-
ity. For some products, tests are performed on each
batch to assure that standards of potency and
safety are met prior to release. For most of these,
requirements are specified in the Code of Federal
Regulations.
Food and Drugs for Animals
Food for pets, food-producing animals, and any
other animal is subject to the same basic regula-
tory requirements as food for humans, with the
addition of testing in the target species.
The Federal regulation of animal drugs, medi-
cated feeds, and feed additives began under the
1938 act. The 1968 Animal Drug Amendments con-
solidated animal food and drug laws, keeping the
1962 standard for safety and effectiveness. The
basic intent of these statutes and their resultant
regulations is to avoid using substances that may
leave harmful residues in animal products intended
for human consumption, and to avoid harm to
food-producing and other animals.
FDA regulates all animal drugs except those
derived from living matter (biologic), which are
regulated by USDA. Animal drugs may not be mis-
branded or adulterated. Testing is done to sub-
stantiate labeling claims and to prove safety. A “new
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animal drug” is defined as one not “generally rec-
ognized as safe” and effective. It must be tested
to demonstrate both safety and effectiveness be-
fore marketing is permitted.
Medical Devices
Extensive regulatory provisions relating to the
safety and effectiveness of medical devices for hu-
mans were enacted in 1976 (21 U.S.C. 321). For
devices available before then, FDA may at anytime
require that proof of safety and effectiveness be
submitted. For post -1976 medical devices that are
substantially equivalent to those for humans be-
fore 1976, the same rule applies. But for those not
substantially equivalent, testing must be under-
taken to prove both safety and effectiveness, a pre-
market approval application must be submitted
to FDA, and FDA must approve the device as safe
and effective before it maybe marketed. Because
of the diversity of medical devices, the testing re-
quired is tailored specifically to the product in-
volved and there are relatively few guidelines.
As the materials involved and methods of appli-
cation are often unique, determining the safety
of medical devices from the standpoint of toxicity
presents special problems. Consequently, recom-
mendations for specific tests are based on an evalu-
ation of the following factors:
l
l
l
l
l
the population for which the device is in-
tended, with special reference to the target
group’s age and sex, and the benefit to be
derived;
the intended use of the device and its poten-
tial to contact the body or, for leachable or
absorbable materials, to be distributed in the
body;
the location of the device in the immediate
vicinity of various organs that might be ad-
versely affected by its presence;
the size of the device and the amount of
leachate potentially available to the body; and
chemical or toxicological information suggest-
ing the potential for adverse toxic effects, such
as when a leachable substance belongs to a
chemical family that contains compounds with
known potential for these effects.
Requirements for testing ophthalmic devices and
products, color additives used in devices, and fe-
male contraceptive devices are more standardized.
For color additives used in devices, the same types
of tests are recommended as for color additives
used in foods. For female contraceptive devices,
the requirements are the same as those used for
contraceptive drugs.
Medical devices for animals may not be mis-
branded or adulterated either. Testing can involve
animals and is undertaken to substantiate label-
ing claims and safety. The law does not require
premarket approval of such devices, however.
Cosmetics
Although the law prohibits misbranding or adul-
teration of cosmetics, FDA has no statutory au-
thority to require testing of cosmetics for safety
(other than their color additives) before they are
marketed. However, animal testing is commonly
undertaken to substantiate labeling claims and, by
regulation, FDA has stated that any cosmetic with
an ingredient that has not been substantiated for
safety or that itself has not been substantiated for
safety in its final product form must bear a promi-
nent label declaration that the safety of the prod-
uct has not been determined.
Color Additives
The law requires that any color additive used
in food or drugs for animals or humans, in medi-
cal devices for humans, or in a cosmetic must be
proved safe; must be the subject of a color addi-
tive petition filed with FDA; and must be deter-
mined by FDA to be safe before it is used (2 1 U.S.C.
321 et seq.). Color additives in use at the time of
the enactment of this provision in 1960 have been
placed on a provisional list and are subject to the
same requirements for testing and approval as
post-1960 color additives.
Radiological Products
The law authorizes FDA to regulate the emis-
sion of radiation from electronic products through
the establishment of performance standards and
a program of research and other activities to min-
imize human exposure. Testing on electronic prod-
uct radiation is undertaken both in relation to pro-
posed and promulgated performance standards
and to determine other aspects of potential haz-
ard for humans from such emissions.
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Environmental Protection Agency
In fulfilling its statutory responsibilities, EPA
uses toxicity data derived from animal testing in
a variety of ways. EPA has the authority to require
such data be submitted under laws it administers,
but data are obtained through other means as well.
They are submitted voluntarily by those who con-
duct or sponsor testing and are obtained from the
open literature, from other government agencies,
through contracts and grants, and from EPA lab-
oratories.
This section describes the regulatory programs
for which animal testing data are needed and the
authorities under which existing data or testing
can be required. (EPA’s testing guidelines are de-
scribed in app. A.)
Pesticides
The Federal Insecticide, Fungicide, and Rodenti-
cide Act (FIFRA) (Public Law 92-516, 7 U.S.C. 136
et seq.) is designed to protect human health and
the environment from adverse effects of pesticides
while allowing the benefits of their use. This is
done by granting or denying registrations; approv-
ing labeling; setting maximum residue levels on
or in raw agricultural commodities; and establish-
ing procedures for safe application, storage, and
disposal. In registering the approximately 50,000
formulations of “pesticide products,” EPA uses
comprehensive registration standards that include
animal testing data, as well as physical properties,
analytical methods, and descriptions of manufac-
turing and use conditions.
EPA also relies on animal toxicity data when it
issues emergency exemptions, experimental-use
permits, and temporary tolerances for experi-
mental purposes in response to unexpected and
temporary food or health emergencies. Emergency
exemptions may be granted to State or Federal
agencies for uses not included in the registration.
Experimental-use permits allow large-scale test-
ing of new pesticides or new uses of a registered
pesticide.
The Agency’s Data Requirements for pesticide
Registration specify the kinds of material that must
be submitted to EPA to support registration of each
pesticide under Section 3 of FIFRA. EPA uses the
information to determine the identity and com-
position of pesticides and to evaluate their poten-
tial adverse effects and environmental fate. Tests
are either ‘(required” or “conditionally required”
depending on such factors as the results of pre-
liminary tests, whether the pesticide use is for a
food crop, whether the use is experimental, where
and how the pesticide is to be applied, and the fate
of the pesticide residue. Certain tests are required
for new products, and guidelines for conducting
these tests have also been developed (40 CFR 158,
49 FR 42856). Many are conditionally required
through “tiered testing,” whereby the results of
the first tier of tests determine the need for addi-
tional ones. Three tiers have been described.
There is some flexibility in the application of
these testing requirements, but EPA is to be con-
sulted if test protocols other than those described
are to be used. Additional flexibility in the testing
requirements is available through EPA’s proce-
dures for waivers and for minor uses (40 CFR 158).
Virtually all data are submitted in the context
of obtaining, maintaining, or renewing a registra-
tion. Another requirement is that the registrant
must submit any health or safety information that
would be of interest to EPA regarding a registered
pesticide. This includes the submission of ongoing
or completed studies for pesticides subject to regis-
tration standards, cancellation, or review; incidents
involving adverse effects to human or nontarget
organisms resulting from exposure; or incidents
regarding lack of efficacy that could indirectly pose
a hazard to human life.
Industrial Chemicals
The Toxic Substances Control Act (TSCA) (15
U.S.C. 2601) authorizes EPA to regulate chemical
substances that present an “unreasonable risk” of
injury to health or the environment and to require
the reporting or development of data necessary
for EPA to assess risks posed by a given substance.
Toxicological testing data derived from animals
form the basis for risk assessment and subsequent
regulatory actions taken by EPA in implementing
TSCA.
If a chemical substance presents an unreason-
able risk, EPA can regulate its manufacturing, proc-
essing, distribution in commerce, use, or disposal.
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Such regulatory actions would be based on toxic-
ity data and exposure data, as well as on data re-
garding the beneficial uses of the substance. Reg-
ulation can be in the form of prohibiting or limiting
certain actions, requiring warnings or instructions
for use, or requiring the submission or retention
of certain records.
If EPA has reason to believe that a substance
presents an unreasonable risk but the agency lacks
sufficient information to make such a finding, it
can require reporting of existing toxicity or ex-
posure data. EPA can also require that a substance
be tested in animals for specific toxic effects.
Under TSCA, EPA has authority to require test-
ing of industrial chemicals if testing is needed to
perform a risk assessment. To aid in identifying
relevant chemical substances, TSCA authorized
an interagency testing committee to make sugges-
tions. EPA must consider these suggestions and
either initiate rulemaking or publish reasons for
not doing so.
TSCA requires that 90 days before the manu-
facture or import of a “new” chemical (a chemical
not on the TSCA Inventory of Chemical Substances)
can begin, a Premanufacture Notification must be
submitted to EPA. The submitters must provide
all information in their possession or control re-
lated to health or environmental effects or to ex-
posure. EPA can also require hazard or exposure
information for substances already in commerce.
Air
The Clean Air Act (42 U.S.C. 7401 et seq.) requires
the Federal and State Governments to take cer-
tain actions to improve or maintain the quality of
ambient air. Animal testing data support various
activities under the act. EPA designates certain sub-
stances as “criteria pollutants” and establishes na-
tional standards for ambient air based on toxicity
and other concerns. Under Section 112, EPA also
designates certain very toxic pollutants as “haz-
ardous” and establishes standards for their emis-
sion or other control.
For registrations of any fuel or fuel additive, the
EPA Administrator may require the manufacturer
to conduct tests to determine whether there are
potential short- or long-term health effects. Tests
may be for acute effects, chronic effects, immuno-
toxicity, carcinogenicity, teratogenicity, or muta-
genicity.
Radiation
EPA’s authority over radiation was delegated in
the President’s Reorganization Plan of 1970 (35 FR
15623), under which EPA makes recommendations
to other Federal agencies (the Nuclear Regulatory
Commission, the Department of Energy, and OSHA)
regarding acceptable levels of emissions for the
byproducts of producing fuel-grade uranium and
from other low-level wastes. Most of the data used
to develop regulatory standards were gathered
from humans inadvertently exposed to radiation,
but data from animals are used for genetic and
other effects, dose-response relationships, and me-
tabolism.
Water
The Clean Water Act (33 U.S.C. 466) requires
Federal and State efforts to restore and maintain
the integrity of U.S. waters. Data needed to fulfill
these requirements are obtained primarily from
testing fish and other aquatic organisms.
The 1977 amendments to the act listed toxic sub-
stances that are commonly referred to as the 126
priority pollutants, primarily because of their toxic
effects on humans and animals. These are con-
trolled through nationally uniform limitations on
the effluents containing them. Water Quality Cri-
teria have also been promulgated for permissible
ambient concentrations of these substances and
are used to establish State water quality standards.
Other toxic chemicals will also be regulated under
the Clean Water Act.
The Clean Water Act calls for National Water
Quality Criteria to be derived. The complete data
set is developed by conducting a series of acute
and long-term bioassays using organisms from at
least eight different families. Acute tests are re-
quired on a salmonid, another family belonging
to the class Osteichthyes (bony fish), and another
representative of the phylum Chordata. The long-
term tests required are chronic tests with one spe-
cies of fish and a bioconcentration test with one
aquatic species,
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In 1982, EPA published a Water Quality Stand-
ards Handbook that provides guidance for develop-
ing site-specific water quality criteria that reflect
local environmental conditions based on toxicity
testing in fish.
The Safe Drinking Water Act (42 U.S.C. 300) is
designed to protect public drinking water supplies
through minimum national standards that are im-
plemented by the States. Under this act, EPA also
regulates the underground injection of fluids and
other imminent or substantial hazards to drink-
ing water. In addition, health advisories are pre-
pared on specific problems.
Primary drinking water regulations are devel-
oped for certain contaminants that may have ad-
verse effects on human health, Maximum contami-
nant levels are established or health advisories
published using mammalian testing data.
EPA’s authority over groundwater is based on
a number of the laws that the agency administers.
The management of groundwater is a joint Fed-
eral and State responsibility, but EPA provides tech-
nical assistance to State agencies and prepares
advisories dealing with common problems that en-
danger groundwater. To some extent, these sup-
port activities rely on toxicity data.
Because groundwater is the source of drinking
water for about half the U.S. population, the iden-
tification and characterization of groundwater
problems is an important part of the drinking water
program. Over 700 synthetic organic chemicals
have been identified in various drinking water sup-
plies. Some epidemiologic evidence is available, and
more is being collected to help characterize the
toxicity of these contaminants, but animal testing
data are mainly used.
Solid Waste
The Resource Conservation and Recovery Act
(RCRA) (Public Law 94-580, 48 U.S.C. 6901) pro-
tects public health and the environment by con-
trolling the disposal of solid waste and by regulat-
ing the management and handling of hazardous
waste materials. EPA is authorized to develop reg-
ulations governing the generation, transportation,
treatment, storage, and disposal of hazardous
wastes. These regulations, in addition to State laws
on waste, are enforced by the States.
Animal testing is used to identify hazardous
wastes. Toxicity is one of the criteria. RCRA regu-
lations list chemicals that have been determined
to be hazardous and processes that are presumed
to generate hazardous waste. Analytical proce-
dures for determining the contents of waste are
also described, as are criteria for determining
whether the contents are toxic or otherwise haz-
ardous. When information does not exist for cer-
tain wastes, EPA must develop it. RCRA does not
require those who generate hazardous waste to
test the toxicity of the waste.
Because RCRA deals with solid waste, the pre-
dominant health problems arise from the leach-
ing of waste from disposal sites. EPA is in the
process of selecting and validating tests for char-
acterizing waste. These will look for acute and
chronic effects on aquatic animals, primarily fat-
head minnows. Partial or full life-cycle bioassays
and fish bioaccumulation tests will also be required.
The potential hazards to humans are character-
ized with several mutagenicity tests.
Data from tests with humans and animals are
used under RCRA to develop “acceptable daily in-
take” levels that are regulated under the act. Be-
cause of the nature of exposure to these wastes,
data from short-term and dermal tests are not used.
Superfund
The Comprehensive Environmental Response,
Compensation, and Liability Act (CERCLA) (42
U.S.C. 9601), known as Superfund, authorizes the
Federal Government to clean up or otherwise re-
spond to the release of hazardous substances or
other pollutants that may endanger public wel-
fare. The most significant activity under CERCLA,
from the standpoint of animal testing, is the desig-
nation of hazardous substances. Substances des-
ignated as hazardous under certain sections of
other laws (TSCA, the Clean Air Act, the Clean
Water Act, and RCRA) are also considered haz-
ardous under CERCLA, and the EPA Administra-
tor is to designate specific amounts of hazardous
substances to be “reportable quantities, ” based in
part on toxicity data.
One activity under CERCLA that diminishes the
need for animal testing (because it assembles data
on humans) is the compilation of a Toxic Substances
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and Disease Registry under the Department of
Health and Human Services. This registry will track
persons exposed to hazardous substances, along
with the medical testing and evaluation that fol-
lows the exposure.
Consumer Product Safety
Commission
The CPSC administers the Consumer Product
Safety Act (I5 U.S.C. 401 et seq.), the Federal Haz-
ardous Substances Act (15 U.S.C. 1261 et seq.), the
Poison Prevention packaging Act (15 U.S.C. 1471
et seq.), and the Flammable Fabrics Act (15 U.S.C.
1191 et seq.).
The Consumer product Safety Act empowers
CPSC to prevent unreasonable risks of injury from
consumer products. Included are both the risk of
acute and chronic toxicity and the risk of physical
injury. Under this statute, industry regularly con-
ducts animal toxicity testing to determine the safety
of consumer products.
The Federal Hazardous Substances Act provides
for the regulation of hazardous substances used
in or around the household. These are defined as
any substance or mixture that is toxic, corrosive,
flammable, or combustible, that is an irritant or
a strong sensitizer, or that generates pressure
through decomposition, heat, or other means, if
such substance may cause substantial personal in-
jury or illness during customary or reasonably
foreseeable handling or use. Unlike its usual meth-
od of letting a regulatory agency or the manufac-
turer determine what kind of testing is needed to
determine safety, in this act Congress defines a
“highly toxic” substance in terms of the results of
the LD50 test and requires certain labeling when
the LD50 is less than 50 mg/kg body weight, 2 mg/l
of air inhaled for an hour or less, or 200 mg/lcg
of dermal exposure for 24 hours or less. Although
the act does not literally require that these tests
be done, a manufacturer cannot know whether
they are in compliance with the act unless they
perform the tests. CPSC has issued regulations re-
garding testing requirements needed to determine
whether a substance is a skin or an eye irritant
(16 CFR 1500).
The Flammable Fabrics Act authorized regula-
tion of wearing apparel and fabrics that are flam-
mable. Industry regularly conducts animal test-
ing to determine the toxicity of substances applied
to fabric in order to reduce or eliminate flamma-
bility.
Department of Labor
The Occupational Safety and Health Act of 1970
(29 U.S.C. 651 et seq.) requires the National Insti-
tute for Occupational Safety and Health (NIOSH)
to conduct health hazard evaluations of the work-
place (see section on Centers for Disease Control).
A goal of the act is that no employee suffer
diminished health as a result of conditions in the
workplace. To this end, employers have a duty to
communicate safety information about substances
present in the workplace through labels, material
safety data sheets, and training. Most safety test-
ing is done with animals.
Under the Federal Mine Safety and Health Act
of 1977 (30 U.S.C. 801 et seq.), employers must
determine whether substances found or used in
mines are potentially toxic at the concentrations
at which they occur.
Department of Transportation
The Hazardous Materials Transportation Act (49
U.S.C. 1801 et seq.) requires that any materials
shipped in interstate commerce be properly la-
beled and contained in a manner reflecting the
degree of hazard present. DOT requires that acute
toxicity studies be carried out on substances not
already classified or for which toxic effects to hu-
mans or test animals are not already known. A
substance would be treated as a class B poison (and
thus as presenting a health hazard during trans-
portation) if its administration to 10 or more rats
at a single dose of a specified amount (orally, der-
mally, or by inhalation) killed at least half the ani-
mals within 48 hours. Analogous authority exists
for the U.S. Coast Guard under the Dangerous
Cargo Act (46 U.S.C. 179) and the Ports and Water-
ways Safety Act (33 U.S.C. 1221 et seq.).
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Department of Agriculture
USDA administers the Virus-Serum-Toxin Act
of 1913 (21 U.S,C. 151 et seq.), under which it
licenses animal biologics. The regulatory require-
ments are similar to those administered by FDA
for other animal drugs. Animal testing is under-
taken to substantiate labeling claims for animal
drugs and to prove their safety. The testing re-
quired by USDA for proof of safety and effective-
ness of these animal biological drugs is extensive.
Under a series of statutes, USDA exercises close
inspection authority over the processing of meat,
poultry, and eggs for human consumption. These
statutes prohibit any misbranding or adulteration,
Testing is required to substantiate labeling claims.
Although most safety issues are handled by FDA,
testing may also on occasion be required by USDA
to demonstrate safety under particular conditions.
USDA administers a number of statutes designed
to control and eradicate disease in plants and ani-
mals. This authority extends from research through
to control of interstate and foreign transportation.
Substantial testing is undertaken by USDA in pur-
suing these statutory mandates.
Centers for Disease Control
The Public Health Service Act (42 U.S.C. 201 et
seq.) authorizes CDC to take appropriate action
to prevent the spread of communicable disease.
Pursuant to this authority, CDC regulates any agent
that could cause such illnesses. CDC uses animal
data to determine the agents that should be reg-
ulated.
Under the authority of the Occupational Safety
and Health Act of 1970, the National Institute for
Occupational Safety and Health, a component of
CDC, develops and periodically revises recommen-
dations for limits of exposure to potentially haz-
ardous substances or conditions in the workplace.
When morbidity cannot be explained on the basis
of current toxicological knowledge, NIOSH must
design toxicological investigations to discover the
cause. Such occupational hazard assessments are
based on data on humans and animals collected
by NIOSH.
Federal Trade Commission
The Federal Trade Commission Act (15 U.S.C.
41 et seq.) prohibits any advertisement that is mis-
leading in a material respect. FTC has adopted the
position that an advertiser must have adequate sub-
stantiation for any claims relating to safety or ef-
fectiveness. Thus, manufacturers and distributors
regularly test their products, using data on humans
and animals to substantiate their claims.
STATE USES OF ANIMAL TESTING DATA
States engage in a variety of regulatory activi- Pesticide Registrations
ties that rely directly or indirectly on animal test-
ing data. One of the most important longstanding All States are required to register pesticides un -
uses is the registration of pesticides. Air, water, der Section 24 of FIFRA. Most States have 5,000
and waste have also been the subject of State leg- to 10)000 pesticides registered and grant 5 to 10
islation in recent years. State laws often use ani- emergency exemptions per year. As part of the
mal testing data for the identification and classifi- registration process, States receive animal testing
cation of substances for control. Several States have data for evaluation. Much of the time, the infor-
also enacted right -to-know laws that may give peo- mation is required only in summary form, unless
ple greater access to testing data, although such the State specifically requests the raw data. The
legislation does not necessarily affect the amount data are usually obtained directly from the regis-
of testing done. trant to avoid possible delays or confidentiality
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problems. Although States generally rely on EPA’s
assessment of data for registration purposes, they
regularly review it for emergency exemptions and
special local needs (22).
California and Florida have the largest pesticide
programs. These States also have the authority to
require additional testing (e.g., field testing locally).
In addition, California also recently passed a law
giving its Director of Food and Agriculture the au-
thority to require data for which EPA has granted
a waiver or exemption (e.g., experimental-use per-
mits). California law also requires that data gaps
for 200 pesticides be filled and that the first re-
port of an injury to a worker exposed to a pesti-
cide be reported to the Health Department (Cali-
fornia Food and Agriculture Code, Div. 7, ch. 2).
Identification and Classification of
Toxic Substances
Identification and classification of substances is
an important function in most environmental laws.
Such activities take place under each Federal envi-
ronmental statute. Coordination among offices in
EPA or with other agencies is common. State agen-
cies also coordinate these activities with their Fed-
eral counterparts.
Sometimes, Federal law or regulations are sim-
ply adopted by a State and remodified. For exam-
ple, certain provisions of the New York and Florida
regulations governing hazardous wastes incor-
porate, by reference, EPA regulations appearing
at 40 CFR 261 and its Appendices (New York Com-
pilation of Rules and Regulations, Title 6, ch. 366).
These regulations list hazardous waste and their
constituents, provide analytical procedures to de-
termine the composition of a waste so that it can
be classified, and provide for variances from these
regulations that may be granted by EPA’s Admin-
istrator. Much more common are statutes that in-
corporate Federal laws and regulations and that
add other requirements or combine Federal re-
quirements in new ways.
The Wisconsin Pollution Discharge Elimination
Law (Wisconsin Statutes Annotated, ch. 147)
adopts EPA effluent limitations, effluent standards,
and prohibitions. In addition to substances already
regulated by EPA, Wisconsin effluent limitations
apply to all toxic pollutants “referred to in table
1 of committee print number 95-30 of the Commit-
tee on Public Works and Transportation of the U.S.
House of Representatives.” Additional pollutants
are to be identified under Section 147.07 of the
Wisconsin law.
The Colorado Hazardous Waste Management
Regulations (Code of Colorado Regulations, Title
5, ch. 1007) adopt EPA toxicity provisions of 40
CFR 261 but include “any other substance which
has been found to be fatal to humans at low doses,
or in the absence of human data, has an oral LD50
in the rat of 50 mg/kg or less, an inhalation LC50
(lethal concentration) in the rat of 2 mg/l or less,
or a dermal LD50 in the rabbit of 200 mg/kg or less .“
The Texas Water Quality Acts (Texas Water
Code, Title 2, chs. 5, 26, 30, 313) use several Fed-
eral laws to classify a substance as hazardous:
CERCLA; the Water Pollution Control Act; the Solid
Waste Disposal Act; the Clean Air Act; and TSCA.
If it is hazardous under any one of these laws, it
is hazardous for purposes of Texas law.
Under Oregon Hazardous Waste Management
Regulations (Oregon Administrative Rules, ch. 340,
div. 62, 63), a substance is considered toxic if it
is a pesticide or pesticide manufacturing residue
and has one of the following properties:
l oral toxicity in a 14-day test with an LD50 less
than 500 mg/kg,
. inhalation toxicity over 1 hour with an LC50
less than 2 mg/l gas or 200 mg/m3 dust or mist,
l dermal toxicity over 14 days with an LD50 less
than 200 mg/kg, or
l aquatic toxicity over 96 hours at an LC5o less
than 250 mg/l.
It would also be considered toxic if it contains a car-
cinogen identified by OSHA at 29 CFR 1910.93(C).
Washington Dangerous Waste Regulations (Wash-
ington Administrative Code, Title 173, ch. 303) re-
quire the polluter to use EPA toxicity information,
EPA’s Spill Table, NIOSH’s Registry of Toxic Effects
of Chemicals (see ch. 10), and any other reason-
ably available sources to determine if a pollutant
is toxic. Carcinogens are identified by an Interna-
tional Agency for Research on Cancer finding that
a substance is a positive or suspected human or
animal carcinogen. Additional criteria are provided
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in the Toxic Category Table, which contains five
categories of hazards based on an LC50 test for fish,
an oral LD50 for rats, an inhalation LC50 for rats,
and a dermal LD50 for rabbits.
Some State laws do not explicitly provide for har-
monization with Federal requirements regarding
the identification and classification of toxic sub-
stances. Under the California Air Pollution Laws
(California Air Pollution Control Laws, 1979 Edi-
tion), the California Air Resources Board and the
State Department of Health Service are to prepare
recommendations for substances to be regulated
and to consider all relevant data. State officials may
PRODUCT LIABILITY
Toxicological testing and research play an im-
portant role in the law of product liability. Manu-
facturers are responsible for knowing what dan-
gers their products may present and must pay for
any damages these products cause. Animals are
used to discover possible dangers, and courts may
award damages to a party whose injuries could
have been prevented with additional testing or re-
search (see ch. 11).
This discussion of product liability law focuses
primarily on drugs because animal use plays such
an important role in determining safety. Drugs are
also an interesting case study because they are re-
viewed for safety and effectiveness by the Food
and Drug Administration before they are mar-
keted, and yet satisfying FDA’s testing require-
ments does not necessarily fulfill the manufac-
turer’s duty to test.
The Manufacturer’s Duty to Produce
a Safe Product
In general, a manufacturer has a duty to pro-
duce a safe product with appropriate warnings
and instructions. This is based on an individual’s
responsibility to exercise care to avoid unreason-
able risks of harm to others. The duty extends to
all persons who might foreseeably be injured by
the product manufactured. Under the Uniform
Commercial Code—a law governing commercial
transactions involving goods, which varies only
request information on any substance under evalu-
ation, although they do not have the authority to
require testing. However, any person who wishes
the board to review one of its determinations must
specify additional evidence that is to be consid-
ered. Similarly, the California Hazardous Waste
Control Act (California Health and Safety Code,
Div. 20, chs. 6.5, 1039; California Administrative
Code, Title 22, div. 4, ch. 30) directs the California
Department of Health Services to prepare lists of
hazardous waste and extremely hazardous waste
and to develop regulations for their management.
CONSIDERATIONS
slightly from State to State—failure to produce a
safe product results in liability for the manufac-
turer for the damages thereby caused.
Generally, an injured plaintiff must prove that
the drug in question was unreasonably danger-
ous, that the defect existed at the time the drug
left the manufacturer’s control, that the consumer
was injured or suffered damages from the use of
the drug, and that the defect in the drug was the
proximate cause of the injury (13,37).
product liability law inmost jurisdictions follows
the “strict liability” standard—that is, no matter
how careful a manufacturer is, it is liable for inju-
ries caused by its products. Some jurisdictions only
hold the manufacturer to a high standard of care,
and many that do have strict liability standards
also have exceptions.
One exception is for drugs that are necessary
but that cannot be made safe. Some have a high
risk of harmful side effects but treat conditions
that are even more harmful if left untreated, such
as rabies (57). (Conversely, when the advantages
a product offers are small, such as where vaccines
were combined instead of using multiple injections,
the manufacturer is more likely to be held liable
(51).) Another exception is for products for which
no developed skill or foresight could have avoided
the harm (14). Even though a toxic effect might
not have been tested for using existing methods
with animals, a manufacturer must not ignore in-
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juries its product may cause after marketing (13).
Similarly, if a new test becomes available, the man-
ufacturer may be required to use it (14,29,47).
Methods of Testing Required
A manufacturer must normally use the safest
and most effective testing method available. Thus,
when monkeys provided the only reliable means
for testing polio vaccine, they had to be used to
test individual batches of drugs, despite the diffi-
culty and expense of obtaining them (20). Although
no cases could be found pertaining to drugs, this
standard might not apply when testing is imprac-
tical in relation to the risk of harm (30,48).
Testing must reflect conditions of actual use as
closely as possible. Thus, where the drug DES was
to be used on pregnant women, the manufacturer
should have tested pregnant animals and was held
SUMMARY AND
The most widespread kind of testing with ani-
mals is conducted for the elucidation of toxicity
from drugs, chemicals, and so forth. Toxicology
has advanced with the growth of the synthetic
chemical industries and the use of chemicals in
consumer products. Toxicological testing is used
in the assessment of hazards and the management
of health risks to humans. The use of animals for
such testing did not become common until a few
decades ago; it now accounts for several million
animals per year.
Many toxicological tests are standardized to aid
in the comparison of results and because they have
been shown to be acceptable tools for measuring
certain phenomena. Most of the standard tests are
descriptive in that they indicate an end result but
do not necessarily elucidate the processes leading
to it. Knowledge of the mechanisms by which a
toxic effect occurs allows much greater reliabil-
ity in extrapolation to humans.
The design of a test involves many trade-offs.
The choice of species is affected by its physiologi-
cal similarity to humans, its cost and availability,
and the amount of data for other substances avail-
liable for cancer in offspring (3). Several smokers
have tried to recover from cigarette manufactur-
ers. They have been denied recovery to date be-
cause when they started smoking, the risk of can-
cer had not been demonstrated (28,40)43).
A judge or jury would normally decide whether
testing was adequate, but if there was a failure
to comply with regulatory requirements, this would
normally prove insufficient testing (16)33,39). How-
ever, compliance with such requirements would
not prove that testing was adequate (14).
In addition to examining what tests were done,
the judge or jury might look at the adequacy of
the test protocols themselves. For example, the in-
jured plaintiff might argue that the number of test
animals was not large enough to determine if a
risk was presented (11) or that the conditions un-
der which the drug was tested did not represent
actual use conditions (49,51).
CONCLUSIONS
able for comparison. The route of exposure, dura-
tion of exposure, and size of doses are affected
by the possible nature and extent of exposure in
humans, by the dose needed to produce a meas-
urable toxic effect, and by convenience. Expected
variability in the toxic response governs the num-
bers of animals used.
Commonly used tests include the following:
l
l
l
l
l
acute toxicity—a single dose at high enough
concentrations to produce toxic effects or
death, often used to screen substances for rela-
tive toxicity;
eye and skin irritation—usually a single ex-
posure, generally used to develop warnings
for handling and predict accidental exposure
toxicity;
repeated-dose chronic toxicity—repeated
exposure for periods ranging from 2 weeks
to more than a year, used to determine the
possible effects of long-term human exposure;
carcinogenicity—repeated exposure for
most of lifespan, used to detect possible hu-
man carcinogens;
developmental and reproductive toxicity–
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a variety of exposures to determine the pOS -
sible production of infertility, miscarriages,
and birth defects;
. Ž neurotoxicity--a variety of doses and routes
to determine toxic effects to nerves, with toxic
end points such as behavioral changes, lack
of coordination, or learning disabilities; and
. mutagenicity—a variety of methods for de-
termining if genetic material of germ or so-
matic cells has been changed.
To aid in the design of tests and in the extrapola-
tion of results to humans, studies are sometimes
done to determine the mechanisms by which tox-
icity occurs or to characterize the processes by
which the test substance enters, is handled, and
leaves the body.
The Federal Government has considerable im-
pact on testing practices through a variety of laws
and regulations. Sometimes testing is required for
premarket approval; more often, it is implied by
requirements for safe and effective products. In
only a handful of instances, such as the Federal
Hazardous Substances Act administered by the
Consumer Product Safety Commission and the
Hazardous Materials Transportation Act admin-
istered by the Department of Transportation, do
Federal statutes explicitly require animal testing.
The four agencies with the largest roles are the
Food and Drug Administration, the Environmental
Protection Agency, the Consumer Product Safety
Commission, and the occupational Safety and
Health Administration. FDA uses animal testing
data in the approval of food additives, drugs, bio-
logics, medical devices, and color additives for hu-
mans and animals. EPA and State Governments
use such test results in the registration of pesti-
cides and the regulation of industrial chemicals,
as well as in the protection of water and air and
in the regulation of waste disposal. CPSC relies on
animal data in identifying and regulating risks to
consumers, while OSHA indirectly uses them in
requiring employers to maintain a safe workplace.
Testing also plays an important role in the liabil-
ity of a manufacturer for unsafe products. In most
States, a manufacturer is responsible for any in-
juries arising from use of its products, regardless
of how much testing was done. Exceptions may
be made where suitable tests do not exist or the
product is known to present risks but those risks
are preferable to the harm that would occur with-
out the product, as in the case of rabies vaccine.
Despite the problems of extrapolating to humans
and other shortcomings of animal testing tech-
niques, the use of animals in testing is an integral
part of the Nation’s attempt to protect human
health. Ideally, as the practice of toxicology ad-
vances, there will be less emphasis on numerical
values in certain tests and more consideration of
the mechanisms by which toxic effects occur.
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Queen: I will try the forces
Of these compounds on such creatures as
We count not worth the hanging, but none human . . .
Cornelius: Your Highness
Shall from this practice but make hard your heart.
Shakespeare, Cymbeline
Act I, Scene VI
The experimental means to be used for safety evaluations is left open to suggestion. As
unorthodox as this might sound, leaving such means open for consideration is the best
solution. Safety evaluations should not be based on standard, specified series of tests. They
are best approached by first raising all pertinent safety questions and then searching for
the experimental means to provide the best answers. Under such circumstances, even the
standard LD test might on occasion be the best experimental means to resolve outstanding
satfety questions.
Constantine Zervos
Food and Drug Administration
Safety Evacuation and Regulation of Chemicals 2,
D. Homburger (cd.) (Base]: Karger, 1985)
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Chapter 8
Alternatives to Animal Use in Testing
Alternatives to using animals in testing serve the
same purposes that using whole animals does—
protecting and improving human health and com-
fort. The technologies on which alternatives are
based result primarily from biomedical and bio-
chemical research. Several of them are reviewed
in this chapter, though they are discussed in
greater detail in chapter 6. Some alternatives that
might eventually replace the tests covered in chap-
ter 7 are also described here.
Notable progress in the move to alternatives has
been achieved in certain areas (78). For example,
biochemical tests to diagnose pregnancy have re-
placed those using rabbits, and the Limulus ame-
bocyte lysate test, which relies on the coagulation
of a small amount of blood from a horseshoe crab,
has replaced rabbits in testing for the presence
of bacterial endotoxins that would cause fever
(25,117). Many companies have modified the widely
used LD5O test to use fewer animals (22) and have
otherwise refined the methods used to test for tox-
icity (100). Mammalian cell culture assays are used
extensively in industrial laboratories for safety test-
ing of medical devices (52,53) and pharmaceutical
CONTINUED, BUT MODIFIED,
It has been suggested that many more animals
are used for testing than are needed (90) and that
changes in experimental design or improved meth-
ods of data analysis could substantially reduce the
number of animals used. Each experiment has
unique requirements (see ch. 7), and the ways in
which the number of animals might be reduced
will vary accordingly.
Many of the methods discussed in chapter 6 for
the modified use of animals in research are also
applicable to testing, such as gathering more data
from each animal or improving the analysis of re-
sults by using random block design or covariance
analysis. In random block design, animals with a
particular characteristic, such as litter mates or
animals of a certain size, are randomly assigned
to different groups to balance whatever effect
substances (1,84) and as immune response assays
(97,98).
The development of alternatives to animals in
testing has accelerated in recent years with the
establishment of programs having development
and implementation of alternatives as their goal
(see ch. 12). However, the barriers to adoption of
these tests are more than the technical barrier of
developing and validating anew technology. Test-
ing is an integral part of many regulatory schemes
and product liability law, and validation ultimately
rests on acceptance by the scientific, regulatory,
and legal communities.
Public concern over animal
to be increasing in tandem
for product and drug safety
use in testing appears
with public concern
. Ironically, the pub-
lic’s-increasing concern for safety could lead to
more testing. Yet it also provides an incentive to
develop new techniques, particularly those that
promise to be cheaper and faster than current
whole-animal methods. A further irony is that de-
veloping alternatives, as well as validating them,
sometimes requires animal use.
USE OF ANIMALS IN TESTING
these variables might have. If the groups being dis-
tributed are sufficiently large, the results can also
be analyzed to determine the effect of the mask-
ing variable (47). Covariance can be used to ana-
lyze results when some of the experimental varia-
bles are uncontrolled but known, thus estimating
their effect on the results.
As in research, the number of animals needed
as controls can be reduced by using the same group
as a control for several simultaneous experiments.
A laboratory’s ability to do this will be limited by
its size and the amount of lead time available to
allow testing to be coordinated. Another difficulty
is that environmental conditions must be exactly
the same and the tests must start and finish at ex-
actly the same times. The reduction in animal use
that simultaneous experiments brings about is
175
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modest because the control group should be larger
if it is being used in several simultaneous experi-
ments (34),
The use of historical data for control groups is
constrained by the difficulty of exactly duplicat-
ing the conditions of a study. However, the size
of the groups and other controlled variables can
be better planned if historical data are used to dis-
cover the background incidence of specific tumors
or other diseases before testing begins. This use
of historic controls has been recognized by the
National Cancer Institute, the world Health Orga-
nization, the Canadian Government, and the now-
defunct Interagency Regulatory Liaison Group
(104). The Federation of American Societies for
Experimental Biology has developed a data book
containing such information based on the Labora-
tory Animal Data Bank (see ch. 10) (2).
Avoiding Duplicative Testing
Animal use in testing can and has been reduced
by industry and others through improved commu-
nication and cooperation in the planning and exe-
cution of testing, thereby avoiding unintentional
duplication. Trade groups such as the Chemical
Manufacturers Association, the Pharmaceutical
Manufacturers Association, and the Soap and De-
tergent Association play important roles in this co-
ordination.
The sharing of data after testing has occurred
is often done for pesticides (see chs. 10 and 11).
And in 1978, the Food and Drug Administration
implemented a policy of permitting approval of
new drug applications solely on the basis of pub-
lished scientific papers (113). The possibility of an
unintentional repetition of an experiment is also
avoided through the work of organizations such
as the Chemical Industry Institute of Toxicology
(CIIT) (Research Triangle Park, NC). Using contri-
butions from member companies, CIIT conducts
toxicological tests and distributes the results
widely.
Governments contribute greatly to information
sharing, which allows duplicative testing to be
avoided, by providing both access to test results
and information about their own planned and on-
going tests. The International Agency for Research
on Cancer makes it easy for duplicative carcinoge-
nicity testing to be avoided by informing testing
facilities and governments about planned and on-
going testing, Federal and international databases
and publications also contain information about
planned tests and those under way (see ch. 10).
Reducing Pain and Distress
As with research, testing can be modified to re-
duce animal pain or distress in two ways: by pro-
viding relief with drugs or by changing the proce-
dures so that less pain or distress is produced (see
ch. 6). A third alternative might be to use a less
sensitive species, but there is no method by which
relative distress among species can be discerned.
Relief from pain and distress is accomplished through
analgesics, anesthetics, tranquilizers, or sedatives
and modification of the test itself.
Few pain-relieving drugs have been developed
and marketed for animals. Little information is
available on recommended doses (122) or on the
likely effect on test results. Thus, before pain re-
lief could be incorporated into a test, it would be
necessary to determine the needed dose and the
effect on the toxic response, thus using additional
animals as well as subjecting them to pain.
Several small changes that do not interfere with
the experimental design can be made by an inves-
tigator. Small needles can be substituted for large.
Animals can be comforted by petting. Social ani-
mals can be caged in groups, although there are
often reasons that multiple housing cannot be used.
Smaller doses can be used and tests can be ended
at the earliest feasible time. Sometimes, smaller
doses will actually result in increased sensitivity
of the test (38). Making such changes sometimes
depends on the attitude and expertise of individ-
ual researchers rather than the contents of test-
ing guidelines, which may not be sufficiently
detailed.
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USE OF LIVING SYSTEMS IN TESTING
As detailed in chapter 6, two kinds of living sys-
tems can reduce whole-animal use—in vitro sys-
tems based on animal or human components (cell,
tissue, and organ cultures) and systems based on
organisms not considered animals for purposes
of this report (micro-organisms and invertebrates).
(Some people consider both of these in vitro
system s.)
In Vitro Systems
Cells, tissues, and organs can be kept alive out-
side a living organism and used for testing. Al-
though animals are still required as a source for
these in vitro systems, the animal would experi-
ence distress for a much shorter time, and per-
haps less distress overall, than occurs with whole-
animal testing because it would be killed before
any experimental manipulations were carried out.
Occasionally, different cells, tissues, or organs from
the same animals can be used for different inves-
tigations. In addition, many fewer animals would
be required for a given test, in part because varia-
bility in the toxic response is smaller than it is with
whole-animal tests and in part because one ani-
mal can be used for multiple data points, further
reducing variability. The fact that human tissues
sometimes can be used confers an additional ad-
vantage because the need for extrapolation from
animal data is obviated.
These isolated components also have disadvan-
tages. They are usually unable to produce the com-
plete physiologic responses of a whole organism.
The components often become undifferentiated
and lose their ability to perform their special func-
tions when isolated from the organism, particu-
larly when the sample is broken up into its con-
stituent cells, and even more so when the cells
replicate. Another disadvantage is that the effect
of the route of exposure, a variable that can have
profound effects on test results, is often impossi-
ble to determine.
There are many measures of damage to differen-
tiated or undifferentiated cells—the rate of repro-
duction, the rate of synthesis of certain substances,
Microscopic View of Cell Culture From Rabbit Corneal Epitheliums
Photo credit: Kwan Y. Chan, University of Washington
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changes in membrane permeability, and damage
to some part of the cell structure. Those functions
having to do with viability and growth are most
frequently measured because they require an in-
tegration of many physiologic events within the
cell, are sensitive, and lend themselves to automa-
tion (73).
Quantifiable tests are preferred over subjective
ones, and a wide variety of quantitative approaches
are available to measure irritation, including the
release of prostaglandins (35); the production of
enzymes (46), proteins (57), antigens, antibodies,
or hormones (73); and the migration of certain
white blood cells (macrophages) to the area of ir-
ritation (12,101). Irritation can also be measured
by the extent to which cells exfoliate from the sur-
face of the tissue. The extent of damage can be
determined by counting cells and by examining
the nuclei (1O2). Another indicator of irritation,
the integrity of cell membranes, can be monitored
through the uptake of nutrients through the cell
wall. Where the nutrient uptake is active (that is,
when the cell is required to expend energy for
transport), uptake can also be used to indicate
changes in metabolism (86,102).
Liver cells have been the subject of considerable
research, in part because they play such an im-
portant role in an organism’s removal of toxic sub-
stances and in part because they retain most of
their special functions when cultured. The re-
sponse of liver ceils to toxic substances may be
measured in many ways: the use of sugar as an
indication of metabolic activity; the production of
proteins or other substances that have been cor-
related with toxicity; uptake of amino acids as an
indication of protein synthesis; changes in appear-
ance that parallel those observed in livers of whole
animals (106); and morphological changes and re-
ductions in viability (75). Other promising tech-
niques in this rapidly expanding field include cul-
turing:
l
l
l
l
beating heart cells to detect the effect of cer-
tain vapors on irregularities in heartbeat (68);
rabbit kidney tubules to detect substances that
can cause acute renal failure, and rat vaginal
tissue to test vaginal irritancy of contracep-
tives (27);
various kinds of cells to test for biocompati-
bility of implants (15,52,53); and
nerve cells to test for the synthesis of neuro-
Dispensing Apparatus for Deiivery of Cuiture Medium to Ceiis Within a Piastic Cuiture Piate
Photo credit: The Johns Hopkins University
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transmitter chemicals, the formation of syn-
apses, and the conduction of impulses (7).
Although tissue and organ cultures may approx-
imate more closely the physiology of the human
or whole-animal model, they are more difficult to
manipulate than cell cultures (see ch. 6). Sophisti-
cated equipment must be used to monitor and con-
trol the environment and to perfuse the sample
with nutrients. Where the sample is more than
a few cell layers thick, uniform delivery of the test
substance, nutrients, and oxygen is difficult, as is
the removal of waste products. Cell differentia-
tion can usually be maintained in tissue and or-
gan cultures, albeit with some difficulty (50).
Human placentas have proved quite useful in
testing the ability of a drug to cross the placenta
from mother to fetus. There are certain logistical
problems with this method, however. The placenta
must be transferred to the perfusion apparatus
within 5 minutes after it is eliminated from the
uterus, and it is only useful for about 3 hours af-
terward (77).
Nonanimal Organisms
There are a variety of nonanimal organisms that
can replace some animals in testing, ranging from
plants to single-celled organisms to invertebrates.
All of these can respond to certain noxious stimuli,
and some may experience pain. However, many
commentators believe that they do not experience
pain or suffering in the same way that animals do,
particularly in those cases where there is no brain
or neural tissue (90). The use of such organisms,
which has never been controlled under any Fed-
eral or State law, is regarded as a replacement for
animals in this report.
Micro-organisms
In recent years, increased emphasis has been
placed on the use of bacteria and fungi to meas-
ure certain genotoxic effects. A major advantage
of these organisms is that they can be cultivated
much more easily and quickly than most animal
or human cells. Their genetic makeup is simple
compared with that of animals and humans and
the fact that a great deal is known about it facili-
tates their use, particularly in toxicological re-
search leading to new methods (74). A change in
genetic material is relatively easy to detect and
characterize. Fungal systems have been shown to
be especially useful in mutagenicity testing and
seem to be more sensitive than bacteria (126), per-
haps at the expense of falsely indicating a hazard.
Other species that have proved useful include slime
molds, algae, and protozoa (74).
Protozoa, although rather primitive overall, fre-
quently have specialized functions that mimic those
of humans. For example, the cilia of protozoa re-
spond to smoke or phenols as do the cilia in the
human bronchial tube (5). Various protozoans have
been used in toxicity testing of cigarette smoke.
protozoans are currently being evaluated for use
in screening tests for carcinogenesis, mutagene-
sis, and reproductive toxicity (93).
Invertebrates
Invertebrates have made major contributions in
biomedical research because certain aspects of
their physiology are sufficiently similar to that of
mammals  (74). Although models for toxicity test-
ing require greater similarity to animals or more
thorough characterization of differences than
models for research, invertebrates offer exciting
possibilities.
Of the invertebrates, insects offer the greatest
selection of models, there being over 2 million spe-
cies from which to choose (74). Among them, the
fruit fly, Drosophila rnelanogaster, is the best un-
derstood. procedures have been developed for de-
tecting mutagenicity (18), as well as teratogenic-
ity (11) and reproductive toxicity (93).
The sea urchin has long been a favored test
organism for basic reproductive research (74). Con-
sequently, the mechanisms and procedures of
testing this invertebrate can easily be developed
and performed. The sea urchin model for fertili-
zation and development can be used in screening
for reproductive toxicity, teratogenicity, and muta-
genicity. Nematodes, annelids, and mollusks are
also used for alternative mutagenesis testing re-
gimes and, additionally, mollusks are used in the
area of reproductive toxicology. Sponges, mollusks,
crustaceans, and echinoderms are being used in
metabolism studies, as understanding metabolize
formation in nonmammalian species can lend in-
sight to interspecies variation (93).
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USE OF NONLIVING SYSTEMS IN TESTING
Animal use can sometimes be avoided altogether
with nonliving biochemical or physiochemical sys-
tems, although most such systems currently re-
quire animal derived components. Computer simu-
lation can also be used when there are sufficient
data available for substances related to the one
of interest and when the mechanisms of toxicity
are at least partially understood.
Chemical Systems
Whole animals have been replaced with analyti-
cal chemistry for tests involving detection of a sub-
stance or measurement of potency or concentra-
tion, such as for vaccines, anticancer drugs, and
vitamins (10). However, toxicity testing in nonliv-
ing systems is quite limited at this time.
Recently developed methods of detection or
measurement are based on the selective binding
that occurs between a particular substance and
the antibodies to it. In an assay for botulism toxin
(which traditionally required up to 200 mice), an-
tibodies obtained from rabbits are modified so that
the binding of the toxin can be detected easily. The
rabbits are initially injected with a small, harm-
less dose of the botulism toxin. Small amounts of
blood are then removed from the rabbits at regu-
lar intervals. In 4 weeks, a rabbit can produce
enough antibody, with little discomfort, to perform
tests that would otherwise require thousands of
mice (32).
Chemical systems that test for toxicity are based
on determining whether a substance undergoes
a specific reaction. For example, it is well known
that carbon monoxide binds to hemoglobin in the
blood, thus greatly reducing the blood’s ability to
carry oxygen. The extent to which a substance
would displace oxygen in hemoglobin can be a
measure of its ability to produce asphyxiation. Sub-
stances can also be tested in isolation for their ef-
fects on enzymes crucial to certain bodily functions.
An important limit of chemical systems is that
they do not indicate the extent to which an organ-
ism can recover from or prevent these reactions.
For example, a substance that binds strongly to
hemoglobin may not be a problem because it is
not absorbed. A substance will not have a signifi-
cant effect on an enzyme of interest if it is excreted
before it has an effect.
Physiochemical systems have some ability to
determine whether a substance will be absorbed
and what will happen to it. The tendency of a sub-
stance to accumulate in a biological system can
be roughly estimated by the relative proportions
that dissolve in equal volumes of water and the
organic solvent octanol (34,55). Artificial skin made
with filter paper and fats is being tried as a means
of mimicking absorption of cosmetics and drugs
(45). Reactivity and other toxicity-related proper-
ties can be deduced from chemical structure alone
(109).
Mathematical and Computer Models
Advances in computer technology during the
past 20 years have contributed to the development
of sophisticated mathematical models of quantita-
tive structure activity relationships (QSAR). These
models are used to predict biological responses
on the basis of physical and chemical properties,
structure, and available toxicological data. The limi-
tations of such models are due in part to a lack
of understanding of the mechanisms by which
toxic effects occur.
In applying QSAR, the biological effects of chem-
icals are expressed in quantitative terms. These
effects can be correlated with physiochemical
properties, composition, and/or structure. Fre-
quently used properties include an affinity for fats
versus water (octanol/water partition coefficient),
the presence of certain reactive groups, the size
and shape of molecules, and the way reactive frag-
ments are linked together.
The simplest extrapolation is for a series of
closely related chemicals. The several character-
istics they have in common need not be incorpo-
rated into the model as variables. This type of
analysis has been performed for several hundred
families of chemicals and has established that rela-
tionships within a series are fairly predictable (64).
Another approach, more broadly applicable, is
to examine the contributions of various portions
of a molecule. In more elaborate computer pro-
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grams, it is possible to identify likely reactions and
cascading physiological events in various species,
techniques first developed for pharmacology (54).
A similar approach is the use of multitiered clas-
sification schemes that use large databases to draw
semiempirical conclusions (36).
Epidemiologic Data on Humans
Perhaps the most useful alternative to animal
testing is epidemiologic studies on humans. Such
studies were used to detect carcinogenicity in hu-
mans as early as the 18th century (49,85,87). The
most well known study detected scrotal cancer
in chimney sweeps (85). A more recent example
in which epidemiologic evidence was used to de-
tect a human carcinogen was the finding that vi-
nyl chloride causes a rare liver cancer in humans
(26). A major disadvantage of epidemiologic studies
is that considerable human exposure can take place
before a toxic effect is detectable, particularly in
the case of diseases that take many years to de-
velop. Another disadvantage is that they can be
quite expensive to conduct. Privacy must also be
considered (112), preventing many data that would
be useful from being collected or analyzed.
Epidemiologic studies may be divided into three
general types: experimental, descriptive, and ob-
servational. Experimental epidemiology is the hu-
man equivalent of animal testing—providing or
withholding a substance to determine its toxic or
beneficial effects. Such studies are greatly limited
by ethical and legal considerations, as well as the
difficulties involved in securing the cooperation
of a large number of people.
Descriptive epidemiology analyzes data on the
distribution and extent of health problems or other
conditions in various populations, trying to find
correlations among characteristics such as diet,
air quality, and occupation. Such comparisons are
frequently done between countries or smaller geo-
graphic regions, as is the case for cancer statistics
collected and analyzed by the National Cancer In-
stitute (9).
observational epidemiology uses data derived
from individuals or small groups. Data would be
evaluated statistically to determine the strength
of the association between the variable of interest
and the disease. In cohort studies, a well-charac-
terized and homogeneous group is studied over
time. In case-control studies, a control group is
selected retrospectively based on variables thought
to be relevant to the effect, Both methods rely on
an accurate prediction of the variables that are
important and are subject to various selection
biases (62)112).
THE LD50 TEST
The LD5O testis one of the most widely used tox-
icity tests, and the development of alternatives to
it is regarded by many as a high priority. As de-
scribed in chapter 7, this acute toxicity test meas-
ures the amount of a substance needed to kill half
the population of the test species. The LD5O is
used as a rough indicator of the acute toxicity of
a chemical,
The LD5O is useful for testing biological thera-
peutics, although there remain few such sub-
stances for which the LD5O is the only available
means of standardization (13)90). Other applica-
tions, perhaps not so well justified (90), are deter-
mining doses for other toxicological tests and set -
ting regulatory priorities.
There has been political pressure to abolish the
LD5O and it has been criticized by many toxicolo-
gists on scientific grounds. It has poor reproduci-
bility and the results are difficult to extrapolate
to humans because there are so many mechanisms
by which death could occur (70,90,125).
Despite the many criticisms of the LD5O, most
toxicologists agree that acute toxicity information
has valid uses, and that measurements of lethality
also are important. Nevertheless, the precision with
which the LD5O is measured is often unjustified
for several reasons. First, most applications of the
information do not require precision. Second, even
if the information were precise for a given spe-
cies, the LD5O varies so much from species to spe-
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cies that extrapolation to humans is only rough.
Third, the LD50 of a given substance varies signifi-
cantly from laboratory to laboratory, and even in
the same laboratory.
Various regulatory classification schemes make
distinctions between levels of toxicity (“highly toxic”
versus “toxic, ” versus “moderately toxic, ” versus
“nontoxic”). The LD50 for two neighboring levels
typically differs by a factor of 4 to 10. Yet, the
reproducibility of test results does not justify even
these distinctions. A recent study, though not nec-
essarily typical, indicates the magnitude of the
problem. A series of LD5O tests were performed
in 60 European laboratories for five substances
on one species. The LD5O for one substance ranged
from 46 mg/kg body weight to 522 mg/kg, possi-
bly ranging over three toxicity levels in some clas-
sification schemes. Although the variations were
not this large for the four other chemicals tested,
the smallest variation was 350 to 1,280 mg/kg. Each
test was done with 50 or more animals so that the
results would be precise (61).
Using Fewer Animals
The standard LD5O requires at least three groups
of 10 animals or more each. An alternative proce-
dure for determining the Approximate Lethal Dose
(ALD) was developed as early as the 1940s (29),
in which individual animals are administered doses
that increase by 50 percent over the previous dose.
Depending on the initial dose level, the total num-
ber of animals needed is usually 4 to 10. Because
the test substance might not be cleared between
doses or because there maybe cumulative effects,
the ALD can be lower than the LD50, perhaps by
70 percent, though more typically by less than 20
percent (29).
Many other acute toxicity tests that require fewer
animals than the LD50 have been developed (14,
17,33,61,69,71,94,105,107). Most require that the
doses increase sequentially, thereby allowing the
experiment to stop when a certain limit is reached.
Thus, fewer animals die in the conduct of a test,
but its duration could increase from 2 weeks to
a month or more. Although many investigators
are moving to less precise LD5O tests, no generally
accepted alternative seems to have emerged.
The Limit Test and
Other Refinements
If a substance is not lethal at high doses, its pre-
cise LD5O is not very important. In the limit test
(80), a small number of animals is given a single
oral dose, e.g., 5 g/kg body weight. If no animals
die and no major ill effects occur, no further test-
ing is needed. However, this limit is so high that
this approach may have little practical value in re-
ducing animal use (24).
Rather than determining the dose that is lethal,
studies can also be done to detect toxic effects at
doses that are not lethal. As with the LD5O, increas-
ing doses can be administered to a small number
of animals, perhaps stopping when some limit is
reached. This approach can be further refined so
that animals that are in distress could be sacrificed
without affecting the outcome of the test (14).
In Vitro and Nonanimal Methods
Cell toxicity—changes in cell function or death
of cells-can sometimes be used to detect acute
toxicity. However, cell toxicity cannot be expected
to function as a replacement for the LD5O because
lethality can occur by so many mechanisms that
are supercellular. Cell toxicity is particularly use-
ful in comparing members of chemical families,
such as alcohols and alkaloids (79).
At present, mathematical modeling has limita-
tions, although it may have some utility in range-
finding and in screening substances for testing
(109). Modeling of acute toxicity fails to meet one
of the criteria suggested by a working party on
quantitative structure activity relationships, namely
that the mechanism by which the response occurs
should involve a common rate determining step
(88). Nonetheless, in a large study involving thou-
sands of substances, a computer program was de-
veloped that predicted LD5O values within a fac-
tor of 2.5 for 50 percent of the substances and
within a factor of 6 for 80 percent. Considering
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the reproducibility of the test itself, this might be
satisfactory for some purposes, and it certainly
warrants further investigation. Furthermore, many
of the larger deviations in this study, upon fur-
ther examination, were found to involve report-
ing errors. This program relied on a multi-tiered
classification scheme based on chemical structure
(36).
SKIN AND EYE IRRITATION
The widely used Draize eye irritation test and,
to a somewhat lesser extent, the skin irritation test
have been criticized because of the amount of pain
inflicted and because they are unsatisfactory mod-
els for human irritation (91,95). First, the rabbit
eye has structural differences, such as a thinner
cornea and differing tearing apparatus (103), and
animal skin is much less sensitive and discriminat-
ing than human skin (56,63). Second, both of these
tests are sensitive to too many variables, making
reproducibility poor (83,118).
As with most tests, the number of animals used
can sometimes be reduced. Several refinements
have also been proposed. For example, screening
tests based on pH or skin irritancy might also serve
as alternatives to eye irritancy tests in limited cir-
cumstances, although preliminary studies indicate
that this approach is frequently misleading (119).
Other refinements involve local anesthetics (51,65,
110), applying smaller (43) or more dilute (120)
doses, and testing whole eyes in vitro (20). The lat-
ter method has particular appeal when cow eyes
are used because they are so readily available from
slaughterhouses. In the case of smaller doses, a
recent comparison with over 500 accidental human
exposures showed that doses smaller than those
now in use yielded results more predictive of the
human response while causing less severe irrita-
tion (38).
Skin and eye irritation are similar in many re-
spects. Thus, even though little work has been done
to develop alternatives to skin irritation tests, the
many approaches just summarized for eye irrita-
tion may eventually be applied to skin testing as
well (91).
In Vitro Tests
Several in vitro alternatives have been examined,
and it appears to some commentators that no sin-
gle alternative will be adequate, but that a battery
of in vitro tests might be a useful replacement (67).
Several types of cell cultures have been used in
developing an in vitro test for eye irritation. The
cells used are rabbit and human corneal cells (72),
mouse and hamster fibroblasts, human hepatoma
cells, and mouse macrophages (96).
A variety of effects have been used as surrogates
for eye irritation, such as the rate of uptake of uri-
dine as an indication of cell functioning and re-
covery, visible changes in cell structure, decreases
in the concentration of cell protein (96), and re-
lease of plasminogen activator from the injured
cells (21). Some techniques appear promising, par-
ticularly in their ability to rank substances based
on irritancy, Rapid progress is being made in the
development of techniques, but none can be con-
sidered validated at this time (91).
To date, little work has been done on in vitro
replacements for skin irritancy testing. However,
the growth of skin in tissue culture is of interest
for treating burn victims, and it is expected that
culture techniques currently being developed for
that purpose can be used in testing methods. In
addition, it has also been suggested that suitable
specimens can be obtained from cadavers and
surgery and from judicious use of human volun-
teers (63).
Chick Embryo
One test system receiving considerable attention
is the fertilized chicken egg. A part of the eggshell
is removed and the test substance applied to the
chorioallantoic membrane surrounding the devel-
oping embryo (see fig. 8-l). This test has the po-
tential for assessing both eye and skin irritancy.
The chorioallantoic membrane of the chick em-
bryo is a complete tissue, including arteries, capil-
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Figure 8-1.—Chronological Sequence of Chick laries, and veins, and is technically easy to study.
Embryo Chorioallantoic Membrane Assay An embryonic membrane tested after 14 days of
incubation responds to injury with a complete in-
flammatory reaction, a process similar to that in-
Day O duced in the conjunctival tissue of the rabbit eye.
The embryonic membrane can show a variety of
signs of irritation and has capabilities for recov-
ery (59,60).
/ Assessment of toxicity is made and the embryo
l
l
l
Day 14
size,
contours and surface,
color,
retraction of surrounding chorioallantoic
membrane,
spokewheel pattern of vessels,
l overall grade of severity, and
l necrosis (confirmed microscopically).
Although this is, strictly speaking, an in vivo test,
the chorioallantoic membrane does not have nerve
cells, and thus it is unlikely that the organism ex-
periences any discomfort. In addition, fertile eggs
are inexpensive and do not require elaborate ani-
mal room facilities.
Day O. Fertile eggs are incubated at 37” C. Day 3. The shell is
penetrated in two places: A window is cut at the top, and 1.5 to 2
milliliters of albumin is removed with a needle and discarded. The
chorioallantoic membrane forms on the floor of the air space, on
top of the embryo. The window is taped. Day 14. A test sample is
placed on the embryonic membrane and contained within a plastic
ring. Day 17. The chorioallantoic membrane is evaluated for its
response to the test substance, and the embryo is discarded.
SOURCE: J. Leighton, J. Nassauer,  and R. Tchao, “The Chick Embryo in Toxicol-
ogy: An Alternative to the Rabbit Eye,” Food Cherry. Tox/co/.  23:293-298.
Copyright 19S5, Pergamon Press, Ltd.
REPEATED-DOSE TOXICITY TESTS
Repeated-dose toxicity testing involves the re- peated-dose testing, the long-term effects of
peated application of a substance to a biological repeated, sublethal exposure to a substance are
assay system and subsequent measurement of of interest, rather than acute, lethal effects. Cell
many different effects of the substance. In re- cultures may be useful adjuncts for suspected tar-
Ch. 8—Alternative to Animal Use in Testing l 185
Chick Embryo Chorioallantoic Membrane Assay
Photo credit: Joseph Leighton, Medical College of Pennsylvania
Typical react ion seen 3 days after certain concentrations
of household products have been placed on the 14-day-
old chorioallantoic membrane. The thin white plastic ring
has an internal diameter of 10 millimeters. The area of
injury within the ring is well defined with a distinct edge.
All of the cells in the injured area are degenerating or
dead. The severity of this positive lesion is quantified by
measuring its diameter.
get organs or tissues, but they are not a replace-
ment for whole-animal testing. The most promising
alternatives in the near future involve modifica-
tions of animal use (for example, by combining
tests), and the use of screening tests and computer
simulation for improved experimental design. The
screening tests with the greatest promise are for
hepatotoxicity and neurotoxicity.
Hepatotoxicity
Several in vitro alternatives for hepatotoxicity
have been developed, including perfused liver
(108), liver cell suspensions (39), and liver cell cul-
tures (39)44). Liver perfusions can only be main-
tained for a few hours, and with some difficulty.
Cell cultures can retain the special functions of
liver cells with specially prepared culture media
(76,81). However, the cells are viable for only a
limited period of time and do not replicate in a
reproducible manner. Although these techniques
have been used to study mechanisms of liver tox-
icity, only limited attention has been given to their
use in screening or as alternatives (91).
Neurotoxicity
The development of alternatives for neurotox-
icity is more difficult than for hepatotoxicity. The
nervous system is the most complex organ in the
body, both in terms of structure and its function.
Because many neurotoxins affect only one kind
of cell, a battery of in vitro tests would probably
be required to replace whole-animal testing–if
anything could. Substances can also affect vari-
ous areas differently, partly because of distribu-
tion factors, For example, very few substances are
able to enter the brain because of the ‘(blood-brain
barrier.” Thus, pharmacokinetic studies will con-
tinue to be very important.
Some in vitro tests (41) and tests using inverte-
brates (8) seem useful, at least for screening. As
yet, however, the primary use of in vitro tech-
niques has been the elucidation of mechanisms
of known toxic effects (31). Many toxic effects to
neural tissue have been correlated with concen-
trations of specific chemicals in or around the cells,
thus offering the means for developing in vitro
tests (31).
MUTAGENICITY
Mutation, the change in the DNA sequence of is passed from the mutated cell to its descendants.
genes, is a mechanism by which toxic effects may Mutation can lead to cell death or the gain or loss
be initiated. If the DNA replicates, the mutation of certain functions. When it occurs in germ cells,
38-750 0 - 86 - 7
186 l Alternatives to Animal Use in Research, Testing, and Education
the gene pool is affected, even if the mutation is
not expressed in the progeny. The mutations that
occur in somatic cells that are of greatest concern
are those that lead to cancer (18).
Recent advances in the techniques of cell biology
have led to an increase in the types and sophisti-
cation of mutagenicity tests available. Mutations
can be detected by analyzing DNA or its fragments
or by observing changes in the size, shape, or num-
ber of the chromosomes (which contain DNA), as
well as by observing changes in a whole organism
(34). Mutation can also be detected by measuring
the amount of DNA repair.
Micro-organism Tests
The most commonly used test for mutagenicity
is the Ames test for “reverse mutation” in Salno-
nella typhimurium (3). Mutagenicity is detected
by exposing an already mutated strain to poten-
tial mutagens. If the mutation is reversed, the bac-
teria regain their ability to produce the amino acid
histidine and will proliferate in a histidine-deficient
culture medium.
The Ames test, as well as most other mutagenic-
ity tests involving micro-organisms, does not avoid
animal use entirely, To determine whether the meta-
bolic products of a substance might be mutagenic
even if the substance itself is not, liver prepara-
tions from rats or other rodents are used to pro-
duce at least some of the likely metabolic products.
Microorganism systems may fail to detector may
overpredict mutagenic changes that could occur
in whole animals or humans. For example, the sys-
tem provided for metabolism may not be capable
of reproducing conditions in vivo, or in the case
of screening for carcinogenicity, mutation may not
be the initiating event. on the other hand, such
systems may indicate mutagenicity when the DNA
repair system of mammals would reverse the mu-
tation.
.
Other bacterial tests have been developed using
S. typhimurium, Escherichia coli, and Bacillus sub-
tilis. These systems do not seem to offer any par-
ticular advantage over the Ames test, although
thorough evaluation is hampered by lack of a com-
parable database of results (28). Tests have also
been developed for molds (30)) fungi (16), and
yeasts (18,82).
In Vitro Tests
In vitro mutagenicity tests maybe done with cul-
tured mammalian cells that are exposed to toxic
substances, although many mammalian in vitro
tests also have an in vivo variant. Such tests typi-
cally measure acquired resistance or lost resistance
to the effects of the toxic substance. Most com-
monly used are a mouse lymphoma ceil line or ham-
ster ovary cells, but almost any well-characterized
cell can be used. ovary cells are often used be-
cause, as germ cells, they have half the number
of chromosomes to be evaluated (18).
A test known as the specific locus test can be
done with Chinese hamster ovary cells. They are
exposed to a test substance and their response to
the normally lethal 8-azaguanine or 6-thioguanine
in cell culture determined. The cell’s ability to sur-
vive, requiring the ability to metabolize the 8-
azaguanine or 6-thioguanine, is an indication of
the occurrence of mutation as a result of exposure
to the test substance. This test can also be done
with mouse lymphoma cells exposed to 5-bromo-
deoxyuridine or trifluorothymidine (23).
The sister chromatid exchange test relies on the
fact that certain substances will cause DNA break-
age and reunion. This damage can be observed
by staining the original chromosomes so that any
segments exchanged during replication can be ob-
served. Commonly used cells include human lym-
phocyte cells and rodent and human fibroblasts
(37). Both the specific locus test and the sister chro-
matid exchange can also be performed as in vivo
procedures (see ch. 7).
Although the cells are usually derived from ani-
mals, there is a considerable net savings in animal
lives when in vitro mutagenicity tests are per-
formed. For example, the rat mast cell assay can
be used to screen severe irritants, and one rat can
supply enough tissue to replace the use of 48 ani-
mals in in-vivo procedures (103).
Tests Using Insects
The most widely used insect for genetic studies
is the fruit fly, Drosophila melanogaster (114, 115).
The fruit fly has well-characterized genetics and
is similar to mammals in many key reactions, A
variety of end points can be detected. The most
common, and probably most sensitive, test is the
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sex-linked recessive lethal assay (18). Treated males ured include the loss, gain, or breakage of chro-
are mated with untreated females, and the progeny mosomes detected by examining germ cells. With
are mated to each other. The number and charac- the availability of mutant strains, the measurement
teristics of the male progeny are evaluated to de- of reverse mutations can be a valuable tool. Eye
termine if lethal mutations (that is, mutations that color is a popular method of following genetic ef-
prevent viability) have occurred. fects in the fruit fly (18).
Other tests involving fruit flies also exist or are
likely to be developed. End points that can be meas -
CARCINOGENICITY
Many assays meant to replace carcinogenicity
testing are designed to detect the initiation of can-
cer rather than the formation of tumors. First, de-
tecting initiation is faster and easier than detect-
ing cancer. Second, although not all initiation leads
to cancer, certain kinds are considered reliable
surrogates for the disease.
A major problem with evaluating the predictive-
ness of alternatives to whole animals for carcinoge-
nicity testing is that very few human carcinogens
have been positively identified. Most substances
treated as human carcinogens, although docu-
mented to be known animal carcinogens, must be
viewed as probable or suspected human carcino-
gens. The development of alternatives is somewhat
hampered by a lack of epidemiologic data on hu-
mans.
Various molecular and physiochemical prop-
erties of substances have been correlated to car-
cinogenicity. Some structure-activity models de-
veloped for families of chemicals have predicted
the carcinogenic properties for 75 to 97 percent
of them. The chemicals modeled include polycyclic
aromatic hydrocarbons (123), nitrosamines (89,99,
121), and aromatic amines (124).
The Ames Test
Because mutation is often the first step in car-
cinogenesis, the Ames test has been suggested as
a possible screen or replacement for carcinoge-
nicity testing. It has been evaluated for this pur-
pose, both alone and as one in a battery of tests.
Alone, it is less predictive than whole-animal tests.
In a battery, it has been shown to be about as pre-
dictive as animal testing for certain families of
chemicals and substantially less predictive for
others for the substances tested. Table 8-1 shows
the predictiveness of mouse and rat bioassays and
the Ames test for some known human carcinogens.
The Ames test has been performed thousands
of times in over 2,000 laboratories throughout the
world and has provided results on over 1,000
chemical substances since it was developed less
than two decades ago. Portions of this large body
of analytical data have been reviewed in over a
dozen evaluation studies with the intent of deter-
mining the test ability to predict carcinogenicity
(6,19,66). These evaluations show that the percent-
age of human carcinogens that are also mutagens
(mutagenic carcinogens) ranges from 50 to 93 per-
cent and is most likely about 80 percent (48). About
20 percent of the human carcinogens were not
mutagens (nonmutagenic carcinogens) in the Ames
test, and it is believed that cancer associated with
these carcinogens is initiated by a mechanism other
than mutation.
A critical analysis of several studies (19) identi-
fied several sources of variation. These include
methods of chemical selection, sample coding, use
of a high proportion of chemicals known to work
well or poorly with Ames testing, and differences
in metabolic activation during the test procedure.
The conclusion was that a reasonably careful ap-
plication of the Ames technique to a nonbiased
group of chemicals would be expected to yield a
predictive accuracy of approximately 80 percent
for mouse and rat carcinogens.
The Ames test tends to be positive for a large
proportion (about 40 percent) of substances that
have not been identified as carcinogens in rodent
bioassays. It should be noted, however, that these
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Table 8.1.—The Response of Known Human Carcinogens to
Rodent Carcinogenicity and Bacterial Mutagenicity Assays
Rat Mouse Ames
Chemical bioassay bioassay test
4-Aminobiphenyl . . . . . . . . . . . . . . . . . . . . . . . . .
Arsenic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Asbestos . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Benzene. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Benzidine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Bis(chloromethyl)ether . . . . . . . . . . . . . . . . . . . .
Chromium; some chromium compounds . . . . .
Cyclophosphamide . . . . . . . . . . . . . . . . . . . . . . .
Diethylstilbestrol . . . . . . . . . . . . . . . . . . . . . . . . .
Melphalan . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Mustard gas . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2-Naphthylamine . . . . . . . . . . . . . . . . . . . . . . . . .
Soot, tars . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Vinyl chloride.. . . . . . . . . . . . . . . . . . . . . . . . . . .
+
—
+
—
+
+
+
+
+
+
n.d.
—
—
+
+
—
+
+
+
+
—
+
+
+
+
+
+
+
+
—
—
+
+
+
+
—
+
+
+
+
+
KEY:+ = Positive results (carcinogenic to rodents or mutagenic to bacteria)
– = Negative results (not carcinogenic ornot  mutagenic)
n.d.  = No data.
SOURCES: From H. Bartsch, L. Tomatis,  and C. Malaveille,  ’’Mutagenicity and Carcinogenicityof  Environmental Chemicals:’
Regu/  Tox/co/.  Pharmacoi.  2:94-105, 1982;D.  Brusick, devaluation of Chronic Rodent Bioaasays andAmes Assay
Tests as Accurate Modeis for Predicting Human Carcinogens,” Application of Bioiogicai Markets to Carcinogen
Testing, H. Milman and S. Sell (ads.) (New York: Plenum Press, 1963); B.D. Goldstein, C.A.  Snyder, S. Laskin et
al., “Myelogenous  Leukemia in Rodents Inhaling Benzene,” TcJx/coi.  f.ett. 13:169-173,  1962; and J.V.  Soderman (cd.),
Handbook of identified Carcinogens and Noncarcinogens,  Vols. / and Ii (Boca Raton, FL: CRC Press, 1982),
substances have not been shown to be noncarcino-
genic, and many authorities maintain that the in-
formation is insufficient to make any statement
about the proportion of noncarcinogens that are
also nonmutagens in the Ames test (4,116).
Use of the Ames Test in
a Battery of Tests
The predictive value of the Ames test, or other
mutagenicity tests, can be improved by combin-
ing it with additional short-term assays to form
a test battery. Although no US. regulatory agency
has yet recommended a specific combination, most
authorities recommend that an appropriate bat-
tery should include information from a minimum
of three types of tests:
l
l
l
gene mutation (Ames test, mouse Iymphoma
test);
chromosomal mutation (in vivo Chinese ham-
ster ovary cell cytogenetics); and
DNA damage (sister chromatid exchange,
—
unscheduled DNA repair).
At least one test should include a mammalian in
vitro cell, tissue, or organ culture assay (4).
In a recent study, 18 Ames tests averaged 66 per-
cent “accuracy” (number of chemicals correctly
identified/number of chemicals tested). Compara-
tive results from six batteries of short-term tests
that included the Ames test increased the accuracy
to 82 to 90 percent (58,111).
CURRENT TRENDS
As long as toxicological data continue to be re- thermore, there are several impediments to devel-
quired by regulators and by the courts to protect opment and implementation:
human health, animal testing will continue for the
foreseeable future. Even major progress in the de- . A large number of scientists have been trained
velopment and implementation of alternatives will to solve health problems and to invent new
not necessarily eliminate whole-animal tests. Fur- products using animal models.
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l
l
l
Regulatory schemes, product liability law, and
patent law also incorporate notions of animal
models.
A large body of animal testing information al-
ready exists that is useful in interpreting new
testing data.
There are substantial costs and delays associ-
ated with the development and adoption of
alternatives. One study indicated that it takes
about 20 years for an in vitro test to be devel-
oped, validated, adopted, and implemented
(92).
At the same time, there are several factors
facilitating the development and implementation
of alternatives:
l
l
l
l
Rapid progress is being made in techniques
for culturing mammalian cells and organs, in
instruments for detecting and quantifying
cellular and molecular changes, and in the
understanding of the cellular and molecular
processes underlying toxicity. Improved un-
derstanding is leading to the ability to predict
long-term effects and carcinogenicity from
short-term biochemical and morphological
changes.
As such advances are made, the research lab-
oratories that have developed the expertise
are often willing to apply it to the develop-
ment of new testing methods, and can do so
efficiently (42).
Organizations such as The Johns Hopkins Cen-
ter for Alternatives to Animal Testing and the
Rockefeller University laboratory have been
set up to facilitate and coordinate research
on alternatives (see ch. 12).
Many organizations have been established to
pressure those who conduct animal testing
or use data based on it to adopt alternatives
or conduct research that will lead to alter-
natives.
Strategies to speed the development and adop-
tion of alternatives will depend on the needs and
resources of the organization involved. The fol-
lowing recommendations encompass a variety of
perspectives. They were promulgated by the Tox-
icity Committee of the Fund for the Replacement
of Animals in Medical Experiments, which met
from 1979 through 1982 (40). Some involve re-
assessment of testing needs and priorities; others
involve technical strategies thought to be likely to
lead to better methods, both in testing and in evalu-
ating results:
l
l
l
l
l
l
l
l
l
l
l
l
l
Provide a mechanism for reviewing the need
for a given test.
Investigate the consequences of not requir-
ing or possessing testing data other than what
already exists. Particular attention should be
given to widely used tests such as the LD5O
and skin and eye irritation tests with a view
toward eliminating unnecessary requirements.
Encourage flexible use of testing guidelines
and frequent reappraisal of them in light of
new knowledge.
Strive for broader-based international har-
monization and mutual recognition of data
from other countries so that duplicative test-
ing can be avoided.
Encourage detailed publication of all testing
results, particularly for costly or painful tests
or those requiring many animals.
Investigate the possibility of time limits on the
confidentiality of test results.
Make greater use of studies on absorption,
distribution, biotransformation, and excretion
in humans, as well as in test animals, to select
the most relevant exposure conditions, to aid
in extrapolation of results, and to improve the
reliability of test results.
Perform preliminary studies before undertak-
ing long-term studies so that results can be
as useful as possible.
Make greater use of the structural and con-
formational computer models used in devel-
oping drugs for the prediction of toxicity.
Standardize screening tests based on in vitro
and nonanimal tests, both to promote efficient
use of testing resources and to evaluate the
predictiveness of these tests.
Try to predict toxic reactions before testing,
both as a means for improving prediction tech-
niques and to avoid testing highly irritating
substances, particularly in the eye, if possible.
Conduct research on the mechanisms by which
toxic effects occur to facilitate the develop-
ment of new testing methods.
Develop more accurate, reproducible instru-
mentation for measuring toxic effects, avoid-
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l
l
l
l
l
l
l
l
l
ing subjective measurements and reducing
measurement errors.
Make greater use of depositories in standard-
izing cell lines or strains of micro-organisms
used for testing.
Study the relationship between physiochemi-
cal properties and pharmacokinetic proper-
ties, as well as between physiochemical and
toxicologic properties.
Develop techniques for detecting nonmuta-
genic carcinogens.
Develop systematic methods for objectively
evaluating new techniques.
Conduct postmarketing surveillance for ad-
verse effects, noting any discrepancies with
test results from animals.
Substitute very specific tests for the LD5O and
other general toxicity tests, particularly for
substances having specialized uses, such as
drugs.
Use skin irritation testing as a rough screen-
ing tool for eye irritation.
Attempt to describe specific effects in eye ir-
ritation studies, rather than reporting only
the magnitude of the response.
Investigate specific effects such as neurotox-
icity to the extent possible when conducting
general toxicity tests.
l
l
l
l
l
l
l
l
Search for cell lines that retain their special
functions upon replication and develop tech-
niques for culturing them.
Evaluate the statistical precision needed in
various circumstances with a view toward
using the smallest number of animals likely
to be adequate.
Use statistics to maximize the utility of results.
Techniques such as blocking, covariance anal-
ysis, and factorial design should be used rou-
tinely.
Improve standards of care and diet to reduce
background effects.
Take care that those conducting tests are qual-
ified to do so, including having been trained
in humane handling of animals.
Combine tests wherever possible and keep
them as short as possible, compatible with the
nature of the test,
Place greater emphasis on “no observed effect
levels” than on lethal doses when they have
greater predictive value.
Use more than one species only to answer spe-
cific questions, and not for general safety as-
sessments.
SUMMARY AND CONCLUSIONS
There has been a small but significant shift away
from whole-animal testing to in vitro and non-
animal techniques in recent years, partly as a re-
sult of advances in biological techniques and partly
in response to political and economic pressures.
Many new methods are being developed for com-
monly used tests. Most of these are not yet vali-
dated, but they already have potential uses for
screening substances for the animal testing they
may eventually replace.
There are several kinds of alternatives. The first
entails the continued, but modified, use of ani-
mals-changes in experimental design or data anal-
ysis so that fewer animals are needed or changes
in protocols to reduce pain or distress. Living tis-
sues, organs, and cells derived from humans or
animals can sometimes be used instead of whole
animals. These systems require a larger investment
of time and money to develop than do modifica-
tions of whole-animal techniques, but their advan-
tages may also be greater. They are usually faster
and often cheaper than the corresponding whole-
animal test, and they have scientific advantages
as well. However, they almost always are less
predictive than whole-animal tests and often fail
to provide reliable dose-response data, informa-
tion that is critical in estimating potential toxicity
to humans.
Data, both anecdotal and epidemiologic, on toxic
effects in inadvertently exposed humans are some-
times useful. However, these data are often con-
founded by lifestyle and exposure to other toxic
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factors. Another drawback is that human exposure
can be great if there are long delays between ex-
posure and observable effects.
The LD5O, probably the most common and most
criticized toxicity test, is well suited to the limited
use for which it was first developed. The biggest
obstacle to limiting or eliminating use of the LD5O
is institutional: Many regulatory schemes rely on
it for classifying substances. The most promising
alternatives in the short term are testing sequences
that require fewer animals. Cell culture techniques
and computer modeling show some promise, but
they have limited value at this time.
Another common and widely criticized test is
the Draize eye irritation test. Several promising
in vitro alternatives have been developed with cell
cultures. Another technique uses the outer (chorio-
allantoic) membrane of a 14-day-old chicken em-
bryo. This technique, although it uses a whole ani-
mal embryo, is thought to involve no pain because
the membrane has no nerves. These alternatives
may also apply to skin irritation.
Alternatives to carcinogenicity testing and re-
peated dose toxicity testing are of special interest,
in part because the potential savings in testing costs
and time are quite large, and in part because these
tests require large numbers of animals. The most
promising replacements are batteries of tests in-
volving cell cultures and living, nonanimal organ-
isms. Mutagenicity testing uses many in vitro or
nonanimal protocols. Mutagenicity is of particu-
lar interest because mutation can be the first event
in other kinds of toxicity, including carcinogenic-
ity, and because it can permanently affect the hu-
man gene pool. The most well known nonanimal
mutagenicity assay is the Ames test. When it is com-
bined with other tests, the Ames shows promise
as an alternative to carcinogenicity testing, but it
is not yet validated for this use.
In general, the development of alternatives is
being facilitated by the rapid development of bio-
logical techniques, which are being applied to the
search for- alternatives in many different labora-
tories. Major contributions to the coordination of
these developments in the United States are being
made by Rockefeller University and The Johns
Hopkins Center for Alternatives to Animal Testing.
The implementation of alternatives is hindered
by various forms of institutional inertia, such as
regulatory schemes (see ch. 7), product liability
law (see ch. 7), and general resistance to change.
Important impediments are the large body of ex-
isting information —derived from animals—that is
relied on for the interpretation of new data and
the lack of sufficient information to support the
use of alternatives.
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Chapter 9
Animal Use in Education
and the Alternatives
Any experienced teacher of physiology knows that the ‘Tiling” of a beating heart in the
opened chest of a dog does more to reinforce the lessons about cardiac physiology than any
words he can speak. This is not an argument for unlimited use of animals, but it is a recog-
nition that biology is ultimately about living organisms and that learning about living organ-
isms require some experience with them.
Joel A. Michael
Rush-Presbyterian-St. Luke’s Medical Center
March 4, 1985
Generations of surgeons and veterinary surgeons have been trained without practicing on
live animals and the Government intends future generations to do so as well.
Microsurgery will be the only surgical skill which we at present contemplate permitting
to be practised on living animals.
Scientific Procedures on Living Animals, Command 9521
British Home Office
May 1985
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Chapter 9
Animal Use in Education
and the Alternatives
Measured by the number of animals involved,
the use of animals is far less significant in educa-
tion than in research and testing. Yet few students
emerge from the educational system without some
contact with animals in the classroom—an inter-
action that may range from the observing and
handling of small mammals in grade school to sur-
gical training in medical school. In terms of foster-
ing attitudes, education exerts a vital influence over
the use of animals and the development and im-
plementation of alternatives.
This chapter examines the patterns of animal
use and the prospects for alternatives in primary,
secondary, and college education and in the 127
accredited medical schools and the 27 accredited
veterinary schools in the United States. Replace-
ments, reductions, and refinements of animal use
can today be found at all levels of education. More-
over, principles of humane treatment of animals
are increasingly an integral part of curricula
throughout the life sciences.
PATTERNS OF ANIMAL USE IN EDUCATION
Out of every 1,000 students entering the fifth
grade, 285 will enter college and about 40 will ob-
tain science degrees (2 I). Some of those 40 con-
tinue their education to become doctoral scien-
tists and health professionals. As students journey
from elementary school through high school and
then perhaps onto college, universities, and other
postgraduate programs, their educational expo-
sure to animals takes many forms. The elements
of the scientific method and scientific principles
pervade every curriculum. In at least 21 States,
some type of instruction in the value of animals
and humane considerations is required. Acquaint-
ance with animals instills a respect for and appreci-
ation of life and conveys as well the fundamental
principles of biology.
Three distinct educational goals dictate ways in
which animals are used in the classroom:
Development of positive attitudes toward ani-
mals. In the best instances, such development
incorporates ethical and moral considerations
into students’ course of study.
Introduction of the concept of “biological mod-
els,” by which students learn to single out par-
ticular animal species as representative of bio-
logical phenomena. Such models vary in the
degree to which they provide general infor-
mation about a broader spectrum of life.
l Exercise of skills vital to intellectual, motor,
or career development. Familiarity with liv-
ing tissue, for example, enhances a student’s
surgical dexterity.
Alternatives to using animals in education there-
fore must satisfy these goals. In addition, the educa-
tional use of animals and alternatives can foster
positive attitudes toward alternatives in research,
testing, and education, which may in turn perpetu-
ate the search for such options as these students
themselves become scientists. The sum total of the
educational use of animals and alternatives can
be to reinforce as the guiding principle of the
scientific method the judicious selection of the
most appropriate system to generate the desired
knowledge.
Primary and Secondary Education
Animals in the Classroom
Most students become initially acquainted with
animals and their role in the biological sciences
during primary and secondary education. In pri-
mary schools, animals are generally not subject
to experimentation or invasive procedures of any
sort. They are usually present in the classroom
to teach students about care and to observe the
social interactions of people and other animals.
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Such interactions provide the vehicle for devel-
oping humane attitudes toward animals. In jun-
ior high and high school, students begin a more
aggressive pursuit of science, which is reflected
in the patterns of animal use. Dissections and in-
vestigational laboratory exercises are introduced
into the curriculum. For most students, high school
provides their last formal science education, in the
form of biology class.
A recent study identified three stages in the de-
velopment of students’ attitudes about animals (6).
The period from 2nd to 5th grade (ages 6 to 10)
was characterized by an increase in emotional con-
cern about and affection for animals. The years
between 5th and 8th grades (10 to 13 years of age)
were marked by increased factual understanding
and knowledge of animals. From 8th to 1lth grade
(ages 13 to 16), students exhibited broadening
ethical concern about and ecological appreciation
of animals.
Each phase of primary and secondary education
appears to offer varying opportunities for educa-
tion about animals. The 8th through 11th grades
seem to be the most appropriate times for exer-
cising meaningful influence on the development
of attitudes toward animals (6).
Several national organizations and local school
systems have issued specific policy statements on
the use of animals; these suggest the practices both
permitted and prohibited in the classroom at the
secondary level (see table 9-1). All the policy docu-
ments generated by national groups share one dis-
tinct limitation: They have neither the power nor
the mechanisms to enforce their provisions. They
are merely guides and statements, not rules.
Science Fairs
Active involvement in the day-to-day aspects of
science and the scientific method is not a usual
component of primary and secondary science edu-
cation, science fairs provide an opportunity for
some students to enhance their understanding of
science by pursuing independent investigations
and competing with their peers in various local,
Table 9-1 .—Sample Policies Governing Animal Use in Primary and Secondary Schools
Year last
Group revised Description of policy
Connecticut State 1988 Policy urges that no vertebrate animal should be subjected to any procedure that inter-
Board of Education feres with its normal health or causes it pain or distress. No experiment should be car-
ried out without the personal direction of an individual trained and experienced in ap-
proved techniques for such animals.
Alexandria (VA) City 1989 No vertebrate animal used for secondary school teaching maybe subjected to any ex-
Public Schools periment or procedure that interferes with its normal health or causes it pain or dis-
tress. Dissections are not banned; however, they are to be done only with commercially
prepared specimens.
Canadian Council on 1975 Guiding principles apply to animal use in the classroom, not to science fairs. No exper-
Animal Care imental procedures are permitted on vertebrates that subject them to pain or discom-
fort or that interfere with the organism’s health.
National Association of 1980 Guidelines for the use of live vertebrates at the pre-university level apply to classrooms
Biology Teachers as well as school-related activities. No experimental procedures should be attempted
that would subject the animals to pain or distinct discomfort. No experimental studies
should be done outside the school. No live vertebrates are permitted in science fair
exhibits. Exemptions to these guidelines maybe granted under limited conditions that
include direct supervision by a qualified research scientist in the field, an appropriate
facility designed for such projects, and the utmost regard for the humane care and treat-
ment of the animals involved in the project.
.
National Science 1981 Code of practice applies to the use of vertebrates in schools or school-related activi-
Teachers Association ties. Experimental procedures conducted should include only those that do not involve
pain or discomfort to the animal. Extracurricular protocols should be reviewed in ad-
vance of the start of the work by a qualified adult supervisor, and should preferably be
conducted in a suitable area in the school. This code has been endorsed by the Na-
tional Academy of Sciences and the American Veterinary Medical Association.
SOURCES: Connecticut State Board of Education, State Board  Po//cy  on Animals  In the  School, Feb. 7, 1968. Alexandria City Public Schools, Policy File 3107, Jan.
6, 1%9.  Canadian Council on Animal Care (Ottawa), Guiding Principles Governing the Use of Animals in the Classroom at the Pre-Un/versity  Levels, May
1975. “National Association of Biology Teachers Guidelines for the Use of Live Animals at the Pre-Unlverslty Level,” Amedcan  Biology Teacher 41:426, 1980.
National Science Teachers Association, Code of Practice on Animals In Schoo/s,  Washington, DC, 1981.
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State, and national competitions. The fairs stimu-
late an interest in science, and they reward active
involvement. Many scientists have taken the first
steps in their career paths by this route. The com-
petitive nature of the fairs encourages budding
scientists to stretch their skills to often sophisti-
cated levels of investigation.
The National Science Teachers Association’s
Code of Practice on Animals in Schools (see table
9-1) applies to science fairs as well as animal use
in the classroom and prohibits experimental pro-
cedures that would involve pain or discomfort to
the animal (10). This code governs both projects
conducted by students at schools that adhere to
the policy, and science fairs that have adopted the
standards. Several of the most prominent fairs have
adopted other rules in addition.
The International Science and Engineering Fair
(ISEF) is held annually with several hundred en-
trants in grades 9 through 12, drawn from many
thousands of participants in local fairs. ISEF rules
require that a Scientific Review Committee con-
sider all research involving vertebrate animals
prior to competition. Criteria include a completed
research plan, evidence of a literature search,
documentation of the type and amount of super-
vision, use of accepted techniques, demonstrated
skill in such techniques, and compliance with any
required certifications.
ISEF explicitly disallows procedures that would
develop new surgical techniques or would refine
existing ones, as well as research where the ani-
mal is not humanely killed (4). Surgical procedures
may not be done at home. Sacrifices of animals
and experiments involving anesthetics, drugs, ther-
mal procedures, physical stress, pathogens, ioniz-
ing radiation, carcinogens, or surgical procedures
must be done under the direct supervision of an
experienced and qualified scientist or designated
adult supervisor. Nutritional deficiency studies and
studies of toxic effects may only proceed to the
point where the symptoms appear. Steps must then
be taken to correct the deficiency, or the animals
are to be humanely killed. LD5O experiments (see
chs. 7 and 8) are not permitted.
The Westinghouse Science Talent Search, an an-
nual competition involving more than 15,000 par-
Finalist, 1985 Westinghouse Science Talent Search
Photo credit: Gary B. Ellis
Louis C. Paul, age 18, Baldwin Senior High School,
Baldwin, NY, with his research project, “Effect of
Temperature on Facet Number in the Bar-Eyed Mutant
of Drosophila melanogaster. ”
ticipants, has since 1970 forbidden experimenta-
tion with live vertebrates with the exception of
projects involving behavioral observations of ani-
mals in their natural habitat or of human subjects
(17). In 1985, none of the 39 Westinghouse finalists
carried out experiments on nonhuman vertebrate
animals. One entrant studied gene expression in
cultured mammalian cells. Living organisms used
in the winning projects included leeches, butter-
flies, fruit flies, water fleas, and bacteria.
In Canada, all animal experimentation for science
fairs is subject to Regulations for Animal Ex-
perimentation in Science Fairs, the 1975 policy
statement of the Youth Science Foundation of Ot-
tawa, Ontario. Key provisions include:
l Vertebrate animals are not to be used except
for observation of normal living patterns of:
1) wild animals in the free-living state or in
zoos, aquaria, or gardens; or 2) pets, fish, or
domestic animals.
l No living vertebrate animal shall be displayed
in exhibits in science fairs.
Other rules include:
l
l
Chick embryos may be used for observational
studies only.
If eggs are to be hatched, then humane con-
siderations must be met in the disposal of the
chicks.
—202 l Alternatives to Animal Use in Research, Testing, and Education
l
l
l
If humane requirements cannot be met, em-
bryos must be destroyed by the 19th day of
incubation.
No eggs capable of hatching maybe exhibited
at science fairs.
All experiments shall be carried out under the
supervision of a competent science teacher.
Enforcement mechanisms for these restrictions
specify that students sign a declaration of compli-
ance, and that this compliance be certified by the
science teacher supervising the project.
Animal Use at the
Postsecondary Level
Animals are used in undergraduate education
for both the acquisition of knowledge and the ac-
quisition of particular skills. Procedures involv-
ing animals can, of course, serve both purposes.
Graduate science education (and, in some instances,
advanced undergraduate education) involves an
additional component—the student’s first genu-
ine research experience. The distinction between
teaching and research virtually disappears in grad-
uate school because the student simultaneously
learns the methods and actually conducts research.
The guidelines that dictate practices of animal use
in graduate education are those that govern ani-
mal use in research (see ch. 15). Effects of earlier
exposure to humane concerns may manifest them-
selves in graduate education through the student’s
choice of avenues of research and selection of
model systems for investigation.
BLOOM COUNTY
Because attitudes about animals will almost cer-
tainly affect the ways in which students may use
(or not use) animals in education and, later, profes-
sionally, it is noteworthy that U.S. colleges and
universities offer about two dozen full-length
courses on ethics and animals, according to a 1983
survey (see table 9-2). These courses cover the bio-
ethical issues surrounding humans’ responsibili-
ties regarding laboratory, agricultural, and wild-
life animals. The Scientists Center for Animal
Welfare maintains information on college courses
on ethics and animals and advocates the inclusion
of such courses as a standard component of the
education of all students entering careers in the
biological sciences (18). At virtually all veterinary
schools, lecture material on ethical considerations
of working with animals is included in required
courses as part of the veterinary curriculum.
Determining the number of animals used strictly
for undergraduate and graduate education is dif-
ficult because laboratory education is often mixed
with laboratory research. This is especially true
for graduate education. The last survey of animal
use that included questions regarding animals used
for teaching purposes was done for fiscal year 1978
by the National Academy of Sciences/National Re-
search Council’s Institute of Laboratory Animal
Resources (ILAR) under contract to the National
Institutes of Health (23). Respondents that used
animals for educational purposes included 69 med-
ical schools, 10 veterinary schools, 42 additional
health professional schools (e.g., dental, public
health), 65 hospitals, and 149 colleges and univer-
by Berke Breathed
I
I
Reprinted with permission. © 1985 Washington Post Writers Group.
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Table 9-2.—Courses on Ethics and Animals Offered at U.S. Colleges and Universities, 1983.84
Institution Course name (department and course number)
Appalachian State University . . . . . . . . . . . . .
California State University. . . . . . . . . . . . . . . .
Central Michigan State University . . . . . . . . .
Colorado State University . . . . . . . . . . . . . . . .
Eastern Michigan State University . . . . . . . . .
Elmira College . . . . . . . . . . . . . . . . . . . . . . . . . .
Indiana University-Purdue University . . . . . . .
Michigan State University . . . . . . . . . . . . . . . .
Moorhead State University . . . . . . . . . . . . . . .
North Carolina State University . . . . . . . . . . .
Purdue University . . . . . . . . . . . . . . . . . . . . . . .
Stanford University . . . . . . . . . . . . . . . . . . . . . .
State University of New York at Stony
Brook . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
University of Connecticut . . . . . . . . . . . . . . . .
University of Maryland . . . . . . . . . . . . . . . . . . .
University of Minnesota. . . . . . . . . . . . . . . . . .
\/irginia polytechnic Institute . . . . . . . . . . . . .
Wagner College. . . . . . . . . . . . . . . . . . . . . . . . .
Washington State University. . . . . . . . . . . . . .
People, Plants, and Animals (Philosophy 3560)
Animal Rights (Philosophy 1941; General Studies 4279)
Religion and Social Issues (Religion 335)
Attributes of Living Systems (Biology 102; Honors)
Moral and Conceptual Issues in Veterinary Medicine (Veterinary Medicine 712)
Introduction to Philosophy (Philosophy 100)
Mankind? We and Other Animals (Humanities 0530)
Ethics and Animals (Philosophy 493)
Ethics and Animals (Philosophy 494)
Perspective in Veterinary Medicine (Veterinary Medicine 517)
Animal Rights (Philosophy 215)
Philosophical Issues in Environmental Ethics (Philosophy 332)
Ethics and Animals (Philosophy 280)
Animal Rights: Issues and Politics (Stanford Workshop on Political and Social
Issues Program 161)
Human/Pet Bonds (Psychology 391)
Problems in Environmental Law: Issues in Animal Rights and Protection (Law 852)
Philosophy and Environmental Ethics (Philosophy 0255)
Perspectives: Animal-Human Relationships and Community Health (Public
Health 5-303)
Special Study, Ethics, and the Treatment of Animals (Philosophy 2980)
Bioethics (Biology 230)
Reverence for Life (Veterinary Anatomy, Physiology, and Pharmacology 499)
SOURCE Scientists Center for Animal Welfare (Bethesda, MD), “College Course on Ethics and Animals, ” Newsletter 5(2):3-6, 1963.
sities. Some of the health professional schools were
included in other categories (e.g., universities with
affiliated professional schools) and thus accounted
for a smaller number of such schools identified
separately than expected.
For this assessment, animal use in medical edu-
cation and veterinary education was examined in
detail for the school year 1983-84. Comparisons
with the 1978 ILAR survey are inappropriate be-
cause of different survey methodology.
Medical Education
Animals are used in many capacities in medical
education. In the basic sciences, they are often used
to illustrate the structure and function of the sys-
tems under study and the complex physiologic
interactions within a single organism. They func-
tion as intermediaries during a medical student’s
transition from trainee to practicing physician, let-
ting students cultivate their skills on other living
creatures before they actually apply those same
techniques to human patients. Techniques such
as venipuncture, insertion of catheters, and other
procedure-oriented exercises are those cited by
medical educators as needing practice before pa-
tients are worked with. The need to practice inva-
sive surgical procedures prior to human surgery
is probably the most compelling use of animals by
medical students.
It is generally held that doctors must learn the
techniques of their profession. And most commen-
tators acknowledge the need for students in the
health professions to subject animals to some prac-
tice surgery, albeit closely regulated (17). The is-
sue of animal use in medical education thus seems
more a question of degree and manner of use
rather than one of whether or not animals should
be used at all.
Yet, practicing techniques on animals is not
universally condoned. In the United Kingdom, live
animals cannot be used by students practicing or-
dinary surgery solely to improve manual dexterity
and technique. (This does not necessarily mean
that medical and veterinary students do not im-
prove their techniques by using live animals, but
such activities must have some other purpose.) Phy-
sicians are trained by a process similar to appren-
ticeship, learning by observation, demonstration,
and example. They assist an accomplished surgeon
and expand their active role only as their abilities
increase.
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In 1985, the British Government relaxed its stric-
ture in order to allow animal use in microsurgical
training (22):
Generations of surgeons and veterinary sur-
geons have been trained without practicing on
live animals and the Government intends future
generations to do so as well. But the new devel-
opment of microsurgery—which is surgery per-
formed with miniature instruments under a mi-
croscope, for example, to repair blood vessels or
nerves—presents special problems. The delicate
techniques involved cannot be practised satisfac-
torily on dead subjects. Surgeons at present have
to go abroad or practise on decerebrate animals
which for this purpose is technically complicated
and sometimes more wasteful of animals than
using terminally anaesthetised ones. Microsur-
gery will be the only surgical skill which we at
present contemplate permitting to be practised
on living animals. The consent of the Secretary
of State will be required in every case, and he
will only give it to qualified surgeons working
on approved microsurgical courses on rodents
which are anaesthetised throughout the proce-
dure and killed before the animal can recover con-
sciousness,
In general, adequate training through staged ex-
ercises is regarded as a prerequisite for success-
ful microsurgery (11).
To ascertain patterns of animal use in medical
education during the school year 1983-84, the Asso-
ciation of American Medical Colleges (AAMC) sur-
veyed 16 of the 127 accredited medical schools
in the United States. The 16 schools surveyed were
selected in an effort to achieve balance in three
characteristics: ownership (10 public and 6 pri-
vate); geographical region (4 each in the North-
east, Midwest, South, and West); and research ex-
penditures (5 high, 5 medium, and 6 low) (2).
The AAMC distributed questionnaires to each
department in the sample schools and followed
up with telephone calls. Because differing curric-
ula made analysis by department problematic,
queries were oriented to each of the disciplines
known to be present in undergraduate and grad-
uate medical education. Anatomy, for example, is
taught by the surgery department in some schools,
but animal use in these exercises was still recorded
in the discipline of anatomy (2).
Anatomy, biochemistry, microbiology, pathol-
ogy, pharmacology, and physiology are part of the
curriculum leading to the M.D. degree everywhere,
and data for these disciplines were obtained from
all 16 schools. The data for all other disciplines
except family medicine and advanced trauma life
support were obtained from at least 15 of the 16
schools surveyed. Family medicine is offered at
only 10 of the 16 institutions (all responded). Ad-
vanced trauma life support, a course for house
staff rather than medical students, is offered at
only 7 of the 16 institutions (all responded) (2).
The use of animals was common in only a few
disciplines (see table 9-3), although all 16 institu-
tions used animaIs in some discipline. Animal use
in medical education was most common in physi-
ology (10 of 16 schools), surgery (10 of 16), and
pharmacology (8 of 16). In other disciplines, no
more than 7 of the 16 medical schools used ani-
mals for educational purposes. Advanced trauma
life support involved animal use at all 7 schools
where it was offered (2).
Table 9=3.—instructional Use of Animals in 16 Selected
U.S. Medical Schools, by Discipline, 1983-84
Number of
schools with Use Do not use No
Discipline discipline animals animals response
Advanced trauma life
support . . . . . . . . . . . 7 7 0 0
Anatomy ., . . . . . ., . . . 16 2 14 0
Anesthesiology . . . . . . . 16 2 14 0
Biochemistry . . . . . . . . . 16 3 13 0
Dermatology . . . . . . . . . 16 0 15 1
Family medicine . . . . . . 10 0 10 0
Internal medicine . . . . 16 1 14 1
Microbiology ... , . . . . . 16 4 12 0
Neurology . . . . . . . . . . . 16 0 16 0
Neurosurgery . . . . . . . . 16 5 11 0
Obstetrics and
gynecology . . . . . . . . 16 1 14 1
Ophthalmology ., ., . . . 16 3 13 0
Otolaryngology . . . . . . . 16 2 14 0
Pathology . . . . . . ., . . . 16 0 16 0
Pediatrics . . . . . . . . . . . 16 3 12 1
Pharmacology . . . . . . . . 16 8 8 0
Physiology. . . . . . . . . . . 16 10 6 0
Psychiatry . . . . . . . . . . . 16 1 15 0
Radiology . . . . . . . . . . . 16 0 16 0
Surgery. . . . . . . . . . . . . 16 10 6 0
Surgery, orthopedic . . . 16 4 12 0
Urology . . . . . . . . . . . . . 16 1 15 0
SOURCE: Association of American Medical Colleges, UseofAnima/s  in Undergraduate and Gradu-
ate Medkd Education  (Washington, OC: 1985).
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Table 9-4 shows the numbers of animals used
by the 16 medical schools. The principal species
used by those surveyed were rats, dogs, and mice.
Most animals (84 percent) were sacrificed either
before or at the end of the demonstration or lab-
oratory, but over half the cats and all the sheep
were allowed to recover. Anesthesiology, psychia-
try, and biochemistry were the disciplines most
likely to subject animals to multiple recovery pro-
cedures. According to this survey, only slightly
more than 10 percent of the animals used in sur-
gery are allowed to recover at all (2).
The majority of animals used in the 16 schools
surveyed were used in the teaching of surgery (51
percent) and physiology (16 percent). No other sin-
gle discipline accounts for even 10 percent of all
animals used. Most of the dogs (64 percent) were
used in the teaching of surgery and physiology.
The total of 7,274 animals can be placed in con-
text by noting the number of students taking part
in the laboratory exercises and demonstrations—
approximately 7,900 medical students and 6,700
residents, for a total of approximately 14,600 stu-
dents at both levels. Calculating roughly from this,
approximately one animal is sacrificed each year
to support the training of two students (2).
The purposes for which animals are used vary,
even within a discipline. Several general surgery
and surgical specialty departments offer their resi-
dents a course in microsurgery. Residents learn
microvascular suture techniques that they will
later apply in human surgery designed to restore
circulation. Nearly all small-animal use (i.e., rats,
hamsters, and rabbits) is for such microsurgery
training. Some general surgery departments of-
fer their residents training in major surgery (e.g.,
splenectomy) using dogs, cats, or pigs, with the
goal of recovery of animals. ophthalmology de-
partments use rabbits to teach new residents the
fundamentals of microsurgery of the eye (2).
Table 9-4.—Animals Used in Laboratory Exercises and Demonstrations in Medical Education in
16 Selected U.S. Medical Schools, 1983-84
Kind of animal
Guinea
Discipline Primate Dog Cat Pig Rabbit Rat Mouse pig Hamster Other Total
Advanced trauma life
support . . . . . . . . . .
Anatomy. . . . . . . . . . .
Anesthesiology . . . . .
Biochemistry . . . . . . .
Dermatology . . . . . . .
Family medicine . . . .
Internal medicine . . .
Microbiology . . . . . . .
Neurology . . . . . . . . .
Neurosurgery. . . . . . .
Obstetrics and
gynecology. . . . . . .
Ophthalmology . . . . .
Otolaryngology . . . . .
Pathology. . . . . . . . . .
Pediatrics. . . . . . . . . .
Pharmacology . . . . . .
Physiology . . . . . . . . .
Psychiatry . . . . . . . . .
Radiology. . . . . . . . . .
Surgery. . . . . . . . . . . .
Surgery, orthopedic .
Urology. . . . . . . . . . . .
Miscellaneous/basic
sciences . . . . . . . . .
Other. . . . . . . . . . . . . .
—
—
—
—
—
—
—
—
—
—
—
4
—
—
—
—
—
—
—
10
—
—
—
—
39
—
6
7
—
—
115
—
—
12
52
—
5
—
—
44
490
—
—
612
—
20
365
4
13
—
1
—
—
—
—
—
—
—
—
20
1
—
14
50
—
—
—
151
—
—
16
13
10
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
54
—
—
—
—
—
—
—
—
—
—
—
2
—
6
—
122
—
—
4
—
2
—
—
113
113
—
16
—
—
75
—
—
—
—
—
—
—
100
—
—
5
—
—
264
294
—
—
1,689
279
—
72
—
—
—
—
40
—
—
—
12
—
—
—
—
9
—
—
300
—
—
—
930
20
—
‘ 6
—
—
—
—
—
—
—
9
—
—
—
—
—
—
—
—
—
—
—
27
—
—
—
—
—
—
—
—
—
—
—
3
—
—
—
—
—
—
—
G
—
—
130
—
20
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
327
4
—
—
1
—
72
—
62
75
7
47
0
0
115
26
0
118
52
146
20
0
18
658
1,193
4
0
3,716
413
40
541
23
Total . . . . . . . . . . . . 14 1,771 279 64 378 2.778 1.317 36 233 404 7,274>—
alncludes frogs, sheep, and Pi9e0ns.
SOURCE: Association of American Medical Colleges, Use of Animals in Undergraduate and Graduate Medical Education (Washington, DC: 1985).
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Dogs and pigs are used to teach techniques for
incubation (establishing an emergency airway) and
the installation of intravenous/intra-arterial cath-
eters, In the AAMC survey, one anesthesia depart-
ment used dogs to teach insertion of Swan-Ganz
catheters into the right chamber of the heart, a
common procedure in cardiac intensive care units.
Two otolaryngology departments used dogs to
teach the musculature and innervation of the tra-
chea and oropharynx to ear, nose, and throat resi-
dents. One obstetrics and gynecology department
used dogs as models to teach exposure and isola-
tion of the Fallopian tubes from the nearby ure-
ters, and three pediatrics departments use young
cats as models for instruction in incubation of pre-
mature newborn babies. All of the techniques
taught in these graduate medical programs must
be learned to achieve competence in the desired
specialty. In those programs that do not use ani-
mals, the techniques are mastered through experi-
ence with human patients during surgery (2).
The AAMC survey found no relation between
a medical school’s level of research expenditures
(high, medium, or low) and its use of animals in
education. The medium expenditure schools used
the most animals in education, perhaps because
in the more research-intensive schools there is a
greater opportunity for students to observe ani-
mal surgery in the course of participation in faculty
research and less need to include such experience
in the curriculum. Most of the schools surveyed
expressed regret that they were not able to use
Instruction in Incubation of Premature Newborn Babies,
Using a Young Cat as a Model
Redrawn by: Office of Technology Assessment.
animals to a greater extent in student instruction,
often citing cost as a factor limiting instruction with
live animals (2).
National estimates of the numbers of animals
used in medical education (see table 9-5) were cal-
culated based on the assumptions that the 16
schools surveyed are typical of the 127 accredited
schools in the United States. The mean number
of animals of each species used in the sample
schools was accepted as the best estimate of the
mean for all schools, and an extrapolation was
made to 127 schools (2).
Rats and dogs are the principal species used in
medical education, accounting for about 70 per-
cent of the estimated 36,700 animals used annu-
ally. These figures are very rough—the potential
error inherent in the estimates ranges from 22 and
25 percent for rats and dogs to 100 percent for
pigs and hamsters. The great uncertainty stems
from variability among the 16 institutions in the
sample. One school used 10 primates, for example,
while another used 4, and 14 schools used none
at all. Use of dogs and cats was more general; less
uncertainty is associated with the national esti-
mates of those species’ use (2).
It is unlikely that any of the 127 medical schools
in the United States train physicians without using
any live animals. This is neither surprising nor
alarming, particularly in light of the fact that the
ultimate recipients of medical attention-humans—
are not available for many of the types of educa-
Table 9-5.—Estimated Animal Use in Medical
Education in the United States, 1983.84
Kind of animal Number useda
Rat . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Dog . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Mouse . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Rabbit . . . . . . . . . . . . . . . . . . . . ... , . . . . . . . .
Cat . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Hamster . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Pig . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Primate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Guinea pig , . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other b . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
14,000
12,000
3,000
1,700
800
200
130
70
4,000
Total. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36,700
aEst/mate /s b-On  an extrapolation of a survey of 16 Seiected  mSdiC@  schools
evenly distributed by geographic region (Northeast, Midwest, South, or West),
ownership (public or private), and research expenditures (low, medium, or high).
bfncludes frogs, sheep, and Pi9eons.
SOURCE: Association of American Medical Colleges, Use of Anima/s  in Under-
graduate and Graduate Medical Education (Washington, DC: 1965).
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tional exercises that medical students routinely
must perform. It should be noted, however, that
it is possible for a student to complete medical
school without using animals.
Veterinary Education
Being admitted to the profession of veterinary
medicine, I solemnly swear to use my scientific
knowledge and skills for the benefit of society
through the protection of animal health, the re-
lief of animal suffering, the conservation of live-
stock resources, the promotion of public health,
and the advancement of medical knowledge.
I will practice my profession conscientiously,
with dignity, and in keeping with the principles
of veterinary medical ethics.
I accept as a lifelong obligation the continual
improvements of my professional knowledge and
competence,
The Veterinarian’s Oath
American Veterinary Medical Association
Twenty-seven accredited veterinary schools in
the United States educate and train veterinary
scientists and veterinarians in the basic biomedi-
cal sciences and comparative animal health. An
OTA survey of the 27 schools indicated that every
veterinary school uses animals in its curriculum.
As in medical education, the question of the use
of animals in veterinary education is a matter of
degree and practice.
Veterinary students—unlike medical students—
train on models identical to their prospective pa-
tients. Animals are used in laboratory exercises
and demonstrations, and students have the addi-
tional opportunity to interact with clinical cases
owned by their schools as well as those brought
in by clients. Privately owned pets, domestic live-
stock, and zoo animals all serve as resources for
the clinical education of veterinary students,
Most animal use occurs in the third year of the
curriculum, when surgical training takes place,
using principally dogs and sheep. In earlier basic
science courses, anatomy involves dissection of
cadavers with live animals present in the lab for
comparison, and physiology exercises involve the
observation of live animals. The fourth year of
veterinary studies is largely clinical apprenticeship.
With cooperation from the Association of Amer-
ican Veterinary Medical Colleges, OTA conducted
a census of animal use in veterinary education in
the 27 accredited veterinary schools in the United
States for the school year 1983-84. The survey
counted only those animals that began an exer-
cise alive and either died or were subjected to
euthanasia during the course of the laboratory ses-
sion or demonstration. Cadavers or animals sub-
jected to euthanasia prior to educational use were
not counted, and clinical patients were not counted.
Of 16,655 animals used in 1983-84, half (8,020)
were dogs. Mice, rats, and birds accounted for the
bulk of the remaining animals (see table 9-6). No
primates were killed during or after educational
exercises in veterinary schools.
Laboratory-Animal Training
Technicians with specialized training in public
health and animal care are needed at all levels by
public health organizations, research institutions,
pharmaceutical manufacturers, and universities.
During the 1970s, several 2-year training programs
were developed in response to an increasing need
for personnel formally qualified to assist in pri-
Table 9.6.—Animals Used in Veterinary Education
in the United States, 1983-84
Kind of animal Number useda
Dog . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8,020
Mouse . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,180
Rat . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,083
Bird . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,323
Reptile. ., . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 433
Sheep . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 423
Cat . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 414
Horse. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 378
Rabbit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 195
Goat. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 194
Pig . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 140
Guinea pig . . . . . . . . . . . . . . . . . . . . . . . . . . . . 112
cow . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 111
Hamster . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 71
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 578
Total. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16,655
aThis census of all 27 U.S. veterinary schools does not include privately owned
or pet animals used for clinical demonstrations, animals purchased as cadavers,
or those subjected to euthanasia prior to the laboratory exercise. It krcfudes
only those animals that began the course alive and then either died or were
subjected to euthanasia during the course of the laboratory session.
bincludes fish, frogs, and exotic SPecies.
SOURCE: Office of Technology Assessment,
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vate veterinary practices, biological laboratories,
animal research, food inspection, and other areas
requiring expertise in both science and animal care
and use.
Graduates of these programs are generally re-
ferred to as animal technicians. The terminology
may vary slightly among different schools or with
individual State laws and regulations. Many em-
ployees of animal care and research and testing
facilities have received training on the job, in sec-
ondary schools, or at less than the 2-year college
level. These individuals are commonly referred
to as animal attendants, animal caretakers, or ani-
mal health assistants. Two other types of animal-
support personnel are laboratory-animal techni-
cians (whose training has been oriented primarily
toward laboratory animals) and animal technolo-
gists (who have had training in a 4-year bacca-
laureate degree program).
Most accredited animal technician
cover 2 academic years of college-level
programs
study and
lead to an Associate in Applied Science degree or
its equivalent. The core curriculum usually in-
cludes animal husbandry, animal care and man-
agement, animal diseases and nursing, anesthetic
monitoring and nursing, ethics and jurisprudence,
veterinary anatomy and physiology, medical ter-
minology, animal nutrition and feeding, necropsy
techniques, radiography, veterinary urinalysis,
veterinary parasitology, and animal microbiology
and sanitation (l).
Many States require animal technicians to be reg-
istered or certified. The Laboratory Animal Tech-
nician Certification Board sponsored by the Amer-
ican Association of Laboratory Animal Science
provides examinations and registry for technicians
who are eligible and employed in laboratory-animal
facilities.
In addition to increasing interest in laboratory-
animal technician degree programs, a number of
graduating veterinary students have begun to seek
additional training and certification in laboratory-
animal medicine. To date, about 700 full-time veter-
inarians are certified in this field nationwide (see
ch. 15). As more’ laboratory-animal technicians are
trained and as the number of veterinarians spe-
cializing in laboratory-animal medicine increases,
the resulting base of skills and knowledge will likely
improve animal care in the laboratory.
THE ALTERNATIVES
Finding alternatives to the use of animals in edu-
cation is a complex challenge. Alternatives must
satisfy the demands of science education, teach-
ing both the scientific method and the fundamen-
tal skills and techniques necessary to carry out
scientific investigation. Yet science education does
more—as it trains aspiring students, it establishes
a framework of values and molds attitudes that
will long influence their work. Therefore, exposure
to alternatives, particularly the concepts under-
lying animal use and alternative methods, strongly
influences the paths investigators choose to fol-
low in the future. Viewed from this perspective,
the acceptance (or rejection) of a specific alterna-
tive method in education assumes an importance
that is, in fact, secondary to the impact it may have
on the development of a student’s overall attitude
toward animal use in research, testing, or edu-
cation.
Implementing alternative technologies and meth-
ods in education does not necessarily mean banish-
ing animals from the classroom or laboratory. As
in research (see ch. 6) and testing (see ch. 8), cer-
tain techniques are available that allow for the con-
tinued, but modified, use of animals, the use of
living systems, the use of nonliving systems, and
the use of computers. In education, computer simu-
lation stands as a particularly promising alter-
native.
Continued, But Modified,
Use of Animals in Education
Demonstrations
In contrast to animal experimentation in re-
search and testing, animal use in the educational
laboratory is unlikely to result in novel findings.
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In education, a traditional laboratory exercise with
a well-known outcome is usually repeated by a new
student or group of students. The process of self-
discovery and training is generally of greater im-
portance than the specific data being collected.
Under these circumstances, live demonstrations
can often provide experiences that combine the
best of direct student participation in animal lab-
oratories with a reduction in animal use. Such ex-
ercises, when carried out by practiced professional
instructors, avoid clumsy errors that students may
make at the expense of laboratory animals. They
also provide a convenient intermediate in the con-
stant tension between active student participation
in the laboratory and the limitations imposed by
large class sizes.
In a variation on the laboratory demonstration,
students may work together in groups on a single
animal, again using fewer animals than if each stu-
dent worked alone on a single animal. Exercises
based on animal cells, tissues, or organs may be
coordinated such that the minimum number of
animals required can be sacrificed. Or animals may
be subjected to multiple procedures, although if
these involve sequential survival surgeries the
advantage of reducing the number of animals used
stands in conflict with the undesirability of
repeated insults imposed on a surviving animal.
Noninvasive Procedures
observation can give rise to an appreciation of
the diversity of the animal kingdom in general and
important principles of physiology and behavior
in particular. A sense of responsibility and an
understanding of the life processes of animals are
also conveyed when animals are maintained for
observation in the laboratory. Areas for study in
which animals can be used in a noninvasive man-
ner include:
Ž simple Mendelian genetics (e.g., the inheri-
tance of coat color in successive generations
of small rodents);
l reproductive behavior (e.g., behavioral recep-
tivity of a female during estrus);
. normal physiological processes of maturity,
aging, and death (e.g., the relationship be-
tween aging and body weight);
l disease processes (e.g., the incidence of spon-
taneous tumor growth in a population);
Ž biological rhythms (e.g., nocturnal and diur-
nal feeding and drinking patterns); and
l social interactions (e.g., territoriality and dom-
inance relationships among males).
Reduction in Pain
Reduction in pain and distress may be accom-
plished with the use of anesthetics, analgesics, and
tranquilizers. In education, this is of primary im-
portance in surgical training, when animals are
anesthetized, operated on, and then subjected to
euthanasia. Principles of pain and pain relief—
common to research, testing, and education—are
discussed in chapters 5, 6, and 8.
Substitution of Species
The substitution of nonmammalian for mam-
malian species, of cold-blooded vertebrates for
warm-blooded ones, or of nonpet species for com-
panion animals is occasionally possible in educa-
tion. Swine have replaced dogs in one surgical
teaching and research laboratory (20). The pigs
were especially successful replacements in a basic
operative surgery course offered as an elective t o
medical students. The principal advantages cited
were closely shared anatomic and physiologic char-
acteristics with humans, better health than dogs,
and economic factors.
Use of Other Living Systems
in Education
Invertebrates
The use of invertebrates as an alternative is al-
ready widespread in primary and secondary schools.
Most laboratory manuals include common exer-
cises that teach biological principles and introduce
students to the scientific method of inquiry using
organisms such as hydra, planaria (flatworms), an-
nelids (earthworms), mollusks, and a variety of ar-
thropods (e.g., insects and crustaceans). The use
of invertebrates at the college and graduate levels
may also increase as more is known about them.
These deceptively simple systems are valuable re-
sources for the laboratory investigation of sophis-
ticated biological principles.
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In Vitro Methods
Like the use of invertebrates, in vitro manipula-
tion and maintenance of animal components such
as cells, tissues, or organs (see chs. 6 and 8) can
illustrate many biological principles. The incorpo-
ration of in vitro techniques into students’ educa-
tion and training also bears potential for shaping
their later attitudes about the utility of in vitro
methods. The stimulus provided by in vitro lab-
oratory exercises can therefore ultimately alter
the general course of research and testing.
One noteworthy endeavor in training research-
ers in in-vitro methods is the program of the Cen-
ter for Advanced Training in Cell and Molecular
Biology at Catholic University of America in Wash-
ington, DC. With funding from the American Fund
for Alternatives to Animal Research, the American
Anti-Vivisection Society, and the Albert Schweit-
zer Fellowship, the Center offers courses to stu-
dents interested in the biomedical sciences and
to professional researchers. In 1985, its third year
of existence, the Center offered:
l Basic Cell and Tissue Culture,
l In Vitro Toxicology: Principles and Methods,
l Tissue Culture Technology in Neuroscience
Research, and
l An Introduction to Tissue Culture and In Vitro
Toxicology.
The first three courses were attended by techni-
cians and Ph.D. and M.D. researchers. The last
course was specifically designed for high school
seniors and college freshmen (9). Activities of this
nature are useful in that they enable professionals
and, particularly, beginning students to become
acquainted with and proficient in in-vitro meth-
odologies and to comprehend the possibilities as
well as the limitations of alternative methods.
The debate about whether or not the training
of medical and veterinary students requires ani-
mals has spawned development of an alternative
technique in microsurgery training. The most
prominent use of microsurgery is for reconnect-
ing arteries and veins, for example in restoring
circulation to severed fingers. To reproduce vas-
cular circulation for microsurgical training, a Brit-
ish plastic surgeon connected human placentas to
a pump and an artificial blood supply, thereby
simulating a heartbeat and typical blood pressures.
Because the placenta contains blood vessels of
widely ranging diameters, a single placenta can
provide material for a substantial amount of prac-
tice (14).
At present, the human placenta cannot fully sub-
stitute for living animals. One of the problems is
that the placenta contains an anti-blood-clotting
agent or mechanism that is not understood and
cannot be controlled. Clotting therefore does not
occur in placental vessels. since learning how to
avoid clotting during repair is a critical aspect of
training, and since students training on placental
tissue cannot detect their errors that cause clot-
ting, the existing system is not fully adequate in
microsurgical training (14).
Use of Nonliving Systems
in Education
Audiovisual presentations bring the abstract
prose of lecture and text one step closer to the
biological reality of living organisms. Films and
videotapes can demonstrate principles and proto-
cols performed with live animals, while sparing
additional animals. They may also present experi-
ments and situations that cannot be performed
live in the average classroom setting. As replace-
ments for animals, however, they lack the living
dimension; most cannot behave interactively. Re-
cently developed computerized videodisks offer
an opportunity for student interaction with an au-
diovisual program.
When audiovisual aids are used in concert with
animals, they may enhance the value of live ani-
mals used in the laboratory. Students may learn
a technique from a taped demonstration, for ex-
ample, and then build on that experience as they
perform the actual laboratory exercise in vivo.
Medical education substitutes audiovisual tech-
niques for animals in several cases. This has less
to do with educational philosophy than with fac-
tors external to the particular laboratory exercise,
Those factors include the costs of animals and the
facilities required to perform quality experiments,
large medical school classes, lack of faculty time,
and competition within a tightly packed curriculum.
Animal cadavers (e.g., frogs, sharks, cats, and
fetal pigs) are currently used at all levels of educa-
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Use of the Human Placenta for Training in
Microvascular Surgery
Human placenta perfused under dissecting microscope.
Phcto credits: Pau/l LG Townsend, Consultant Plastic Surgeon,
Frenchay Hospita/, Brlstol
Sutures and valves implanted in vessels of human placenta.
tion as models for dissection. Commercially pre-
pared specimens are often used in junior high and
high school education; medical and veterinary
schools are more likely to prepare their own speci-
mens. In some situations, cadavers may provide
adequate replacements where living animals were
once used.
Computer Simulation in Education
Computer simulation offers a variety of alter-
natives for studying animal and human biology
at all levels of education, and the field is evolving
quickly as experience grows and computer tech-
nology advances. Although at this time popular
expectations for computer simulation still out-
distance actual performance, the options that simu-
lations present to educators can be expected to
increase. Educational computer simulations fall
into two categories: computer models of biologi-
cal events and interactive simulations of biologi-
cal experiments.
Computer simulations of biological events-pri-
marily mathematical models of physiological and
cellular phenomena—present in quantitative form
phenomena that might be difficult or impossible
to study in animals or humans. By altering param-
eters within the programs and noting results, stu-
dents learn principles of biology from an ersatz
animal system, the computer program. For exam-
ple, a dog’s circulatory functions are converted
to a series of mathematical equations, which are
programmed into a computer. As students change
individual values or groups of values, the program
resolves the various equations and reports values
that mimic the effects of altering those parame-
ters of the circulatory system in a living dog. Fig-
ure 9-1 depicts a portion of such a simulation.
An array of computer models of physiological
processes are used in undergraduate and gradu-
ate laboratory exercises. The range of physiological
simulations includes simulations of blood chemis-
try, cardiovascular physiology, the digestive sys-
tem, the musculoskeletal system, respiratory phys-
iology, and renal physiology. Computer simulations
currently used in physiology laboratory exercises
include:
l HUMAN: a comprehensive physiological mod-
el (3),
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Overview of a computer simulation of the complete
cardiovascular system, showing student-controlled variables
such as heart rate (HR%), total active blood volume (BV%),
and total peripheral resistance (TPR%).
SOURCE: N.S. Peterson and K.B. Campbell, “Teaching Cardiovascular Integrations
With Computer Laboratories,” Physlo/oglst 26(3):159-169, 1965.
l
l
l
l
l
l
l
l
pH regulation and carbon dioxide (24),
pulsatile hemodynamics in the aorta (5),
determinants of cardiac output (16),
effects of medically important drugs on the
circulatory system (25),
simulation of the digestion of a meal (25),
responses of organisms to exposure to high
and low temperatures (25),
influence of hormones on muscle cells (25),
and
renal excretory response to volume and os-
molarity changes  (12).
Computer simulation of a particularly sophisticated
laboratory exercise—for example, one that is too
difficult for beginning veterinary students to per-
form-can enable students to carry out laboratory
exercises they otherwise would not have had (13).
Table 9-7 summarizes the advantages, disadvan-
tages, and barriers to substituting computer mod-
els of biological systems for animals in education.
Some characteristics apply to one type of computer
application more than another. Viewed as a whole,
the descriptors of computer simulations listed in
table  9-7 illustrate the potential as well as the limi-
Table 9-7.—Advantages, Disadvantages, and
Barriers to Using Computer Simulations in Education
Advantages:
Quality of teaching material:
l
l
l
l
l
Simplification. Some biological events that are too
complicated or not accessible to human study by vivisec-
tion or dissection are better approached through com-
puter simulation.
Quantitative ski//s. Physical mechanisms and mathemat-
ical variables that underlie biological events are em-
phasized.
Emphasis. Student attention is shifted from techniques
to concepts, supporting lecture and textbook material.
Reliability. Strong consistency from experiment to ex-
periment.
Response time. Simulations yield immediate results.
Cost and efficiency:
l Long-range cost reduction. Following initial purchase
of computer hardware, computer laboratory costs are
often lower than relatively high animal laboratory costs.
l Speed and coordination. Increased teaching efficiency
through expeditious testing, drills, and tutorials.
. Laboratory availability. Increased access for students to
laboratories.
Disadvantages:
l
l
l
l
l
Bio/ogica/ complexity. Computers cannot be programmed
to simulate many integrative interactions between inter-
nal organs.
Missed experiences. In the view of some teachers, stu-
dents should have experience with living tissue.
Bioogical variability. Computers do not accurately por-
tray the large degree of uncertainty that arises from bi-
ological variability, whereas comparisons of animals do
present this concept.
Publication of results. Developers of computer simula-
tions sometimes find publication of their work in the
usual scientific journals difficult since some simulations
require ponderous documentation; in cases where pub-
lications are intrinsic to tenure and other faculty deci-
sions, computer modelers may be discriminated against,
Student attitudes. In some cases, dubious student out-
look on computer replacement of animals undermines
teaching of concepts. In other cases, simulations may
unintentionally train students (e.g., medical students) to
ignore the behavior and appearance of patients and to
place unwarranted importance on data from instruments.
Barriers:
l
l
l
l
Incompatibility. Hardware components and software sys-
tems often are not interchangeable; this is especially
true of graphic simulations.
Computer /imitations. Some complex digital computer
programs are not fully realistic because they must ap-
proximate biological processes that are continuous and
simultaneous by using a series of discrete steps. The
only way to make such a computer approximation more
realistic is to reduce the time the computer takes be-
tween steps. This may require more sophisticated
hardware.
Tradition. Widespread lack of training in mathematics
modeling leads many talented people to write textbooks
rather than computer models.
Proprietary considerations. Many of those who are de-
veloping programs or catalogs of programs for commer-
cial purposes will only disseminate useful information
about computer simulations if they are paid, restricting
applications.
SOURCE: Office of Technology Assessment
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tations of this alternative in a variety of teaching
situations. Several of the disadvantages listed in
table 9-7 underscore the small likelihood that com-
puters can completely replace animals in the class-
room. Those who are developing computer simu-
lations are among the most vocal in maintaining
that this technique is not the optimal method in
every teaching situation; in some cases, they say,
animals serve the lesson better (8,13,15,26).
In addition to providing models of biological ex-
periments, computer programs serve in the class-
room and laboratory as reusable training devices
to teach specific skills, just as airline pilots train
in flight simulators. These simulations are based
on graphic presentation of the experiments and
involve interaction between the program and trainee.
An interactive videodisk program, for example,
enables students to simulate dissections using pho-
tographic images stored on the disks, rather than
animals. Production of such a videodisk can cost
from $60,000 to $200,000 for a 30-minute program
and involves thousands of still photographs, com-
puter overlay, and touch screen interaction. The
sales price of such a videodisk can range from
$1,000 to $5,000.
The most sophisticated types of videodisk pro-
grams have not achieved widespread use, largely
because of economic factors. Apart from steep ini-
tial production costs, the hardware supporting
videodisk use is expensive.
Computer-linked mannequins and robots cur-
rently provide the most sophisticated simulations.
Resusci-Dog, developed at the New York State Col-
lege of Veterinary Medicine at Cornell University
in Ithaca, NY, is a canine cardiopulmonary resus-
citation training mannequin, the equivalent of the
human dummies used in training paramedical tech-
nicians. Constructed of plastic, Resusci-Dog can
simulate a femoral artery pulse, and pressure can
be applied to its rib cage for cardiac massage or
cardiopulmonary resuscitation. The first micro-
processor-laden canine simulator cost $7,000; the
second $700. Resusci-Dog has replaced about 100
dogs per year in veterinary classes at the New York
school (19).
Despite the widespread enthusiasm for the po-
tential of computer models and interactive simu-
lations in the life sciences, three general problems
Scenes From Interactive Videodisk Laboratory Exercise
—Canine Hemorrhagic Shock
Photo credits: Charles E. Branch and Gregg Greanoff, Auburn University
These photographs were taken from the monitor screen
of a video program on blood flow and hemorrhagic shock
in use at the Auburn University School of Veterinary
Medicine. The interactive video simulated experiment
depicts actual experiments conducted by experts.
Several treatments are videotaped and students then
simulate performing the experiment, testing different
treatments and dealing with the results as if they were
actually performing the study. Top: Anesthetized dog
in experimental setup. Bottom: Response of
dog’s pupil to light.
confront computer-based education in the mid-
1980s (7,8):
l The rapid advance of computer technology
has resulted in many–frequently incompat-
ible—machines in competition for the same
market. This has limited the transportability
of existing computer-based education mate-
rials. Users of different systems cannot eas-
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Canine Cardiopulmonary Resuscitation Simuiator
(Resusci-Dog) in Use
Photo credit: Charles R. Short, New York State College of Veterinary Meidiine,
Cornell University
ily share or exchange materials. As a result,
there is a serious problem of duplication of
effort, with individuals and institutions devel-
l
l
oping similar teaching programs. Although
ideas are clearly portable, actual computer
programs may not be, and the avenues for
effective dissemination of programs remain
limited.
The resources available to support research
and development in computer-based educa-
tion are too limited. Few institutions have com-
mitted funds for such activity, and much cur-
rent work is supported by departmental or
individual resources. Many new computer-
based education materials are developed by
individuals on their own time out of personal
interest. There is virtually no external fund-
ing available to support advances in this field.
In the long run, the most serious problem may
well be the lack of professional academic re-
wards for faculty members working in this
area. Promotion, tenure, and salary increments
are awarded predominantly for productivity
in the research laboratory, not for efforts to
develop innovative teaching techniques and
materials, with essentially no external grant
support for computer-based education activ-
ities and with few refereed high-quality jour-
nals in which to publish, two of the measures
by which rewards are apportioned are not
available to developers of novel educational
soft ware. This is a particular problem for jun-
ior faculty members, who often must devote
their major efforts to climbing the academic
ladder. Computer-based education seemingly
fails to meet the perception of an academi-
cally valid and creditable enterprise.
SUMMARY AND CONCLUSIONS
In elementary school, student exposure to ani- Taken together, the approximately 53,000 ani-
mals in the classroom generally takes the form of reals used in accredited medical and veterinary
exercises in humane awareness. Later, involve- schools for education and training make up less
ment in science becomes more active and the role than one-half of 1 percent of the estimated 17 mil-
of the animal as a tool of science is explored. As lion to 22 million animals used annually in the
students advance to and through college, animal United States for research, testing, and education.
use often becomes more invasive during instruc- (No data are available on the number of animals
tion in laboratory techniques. At the highest levels, used in primary, secondary, and college educa-
especially in professional and research training, tion.) Yet the development of students’ attitudes
students are expected to attain levels of skill that toward animals during the classroom years over-
may be difficult to reach without the use of animals. shadows in importance the actual quantity of ani-
—Ch. 9—Animal Use in Education and the Alternatives . 215
mal subjects used in education. Each phase of pri-
mary and secondary education appears to offer
an opportunity for shaping students’ attitudes
toward animals. Grades 8 through 11 seem to be
the most appropriate times for influencing the de-
velopment of attitudes toward animals.
Alternatives applicable to different levels of
schooling vary with the educational goals of each
level. whereas classroom demonstrations or non-
invasive observation could be appropriate in pri-
mary and secondary education to teach the scien-
tific method and aspects of biology, a nonliving
system is inadequate to teach surgical technique
and manual dexterity to medical and veterinary
students. Computer models of biological phenom-
ena and interactive simulations of biological ex-
periments are especially promising alternatives to
animal use, even in sophisticated laboratory phys-
iology exercises. Interactive videodisk programs—
although expensive and not currently widely avail-
able-offer particularly realistic training simu-
lations.
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Chapter 10
Information Resources and
Computer Systems
One of the biggest harriers to using available information is that most people do not know
how to use existing resources or what systems are available for use.
John S. Wassom
Oak Ridge National Laboratory
March 1985
The best computer programs evolve into large creations. It is rare !v possible to imagine a
very large computer activity at the outset and build it as such.
Charles S. Tidball
The George Washington University Medical Center
March 4, 1985
CONTENTS
P+!@
Sources of Research and Testing Data . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. .219
Primary Literature . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ., . . . . . . . . . . . . .219
Secondary Literature . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ..., . . . ~ ..219
Unpublished Information . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ...........219
Information Centers. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ..220
The Availability of Information . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .......221
Journal Publication Policies. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ...221
Federal Laws Affecting Unpublished Data . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ~ ...221
Barriers to Using Available Information. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ..222
Data Quality and Comparability. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ...222
International Barriers to Sharing Information . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ..223
Retrieving Research and Testing Data . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ......223
Abstracting and Citation Services ~ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ...........223
Retrieving Unpublished Information . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ...224
Computer Systems . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ...........228
Advantages of Computers . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .228
Toxicology Data Bank . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ............229
Registry of Toxic Effects of Chemical Substances . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ,229
On-Line Literature . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .231
Laboratory Animal Data Bank . . . . . . . . . . . . . . . . . . . . . . . . . . . ~ . . . . . . . . . . . . . . . . . . . . ..233
Building Phase, 1975-80 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ...................233
Public Accessibility, 1980-81 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ... ... ..235
Reasons for the Failure of LADB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .............235
Lessons Learned From LADB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ...236
Expanding the LADB Concept: A Computerized Registry of
Research and Testing Data . . . . . . . . .  . . . . . . . . . . . . . . . . . . . . ~ . .................237
Summary and Conclusions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .............238
Chapter 10 References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ~ . . . . .239
List of Tables
Table No. Page
1()-1 Growth and Publication Frequency of Literature Related to Genetic
Toxicology, Carcinogenicity, Mutagenicity’, and Teratogenicity . . . . . . . . .220
10-2. Examples of Databases Available for Searches of Literature
Involving Animal Research and Testing . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .230
10-3. Examples of On-line Databases of the National Library of Medicine. . . . . ..231
List of Figures
Figure No. P a g e
10-1. A Scientific Abstract and Corresponding Index Entry in BIOSIS . ................225
IO-2. Sample Bibliographic Entries in Biological Abstracs/RRM . . . . . . . . . . . . . . . . . . . . ..226
10-3. Promotional Material From Commercial Supplier of Full Texts
of’ Scientific Publications . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .227
10-4. A Typical Substance Entry in the Registry of Toxic Effects of
Chemical Substances (RTECS) . . . . . . . . . . . . . . . . . . . . . ~ . . . . . . . . . . . . . . . . . . . . .. ..232
10-5. A Representative Page of the Eight-Page Data Input Form for the
Laboratory Animal Data Bank . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ..234
Chapter 10
Information Resources and
Computer Systems
Earlier chapters have described the quantity and creases information exchange reduces the need
variety of data generated by using animals in re- of other investigators to perform the same exper-
search, testing, and education. To assess fully the iments. The pivotal role computers can play in that
alternatives to animal use in these areas, there- process has recently become an important topic
fore, it is important to consider how the data are for consideration and is examined in this chapter.
shared once they are generated. Anything that in-
SOURCES OF RESEARCH AND TESTING DATA
Primary Literature
One of the most important ways to make data
publicly available is through the “primary litera-
ture” in which they are published for the first time
and in greatest detail. A significant form of this
is the scientific journal, the most up-to-date and
ubiquitous of the published sources available. Jour-
nal articles that are reviewed by knowledgeable
peers before they are accepted for publication are
considered especially reliable. Most normally con-
tain a description of the methodology of the ex-
periment, the results obtained, the conclusions
drawn by the author or authors, and references
to and discussions of related published and un-
published information.
Other primary sources are published reports
(e.g., of Government-sponsored research), proceed-
ings of technical meetings, or similar collections
of articles. As a rule, reports and proceedings are
not as widely available as journal articles. They
may or may not have been peer-reviewed,
Secondary Literature
Secondary sources contain information drawn
solely from other published material. The most
common forms are books, reviews, and reports.
(A book that contains original material would not
be considered a secondary source.) Handbooks are
a useful secondary source for numerical data and
for citations to the primary literature in which they
were first published. Because secondary sources
draw from primary sources, the information they
report can be somewhat dated, as there is a time-
lag ranging from months to years between the pub-
lication of a primary source and that of any sec-
ondary sources that rely on it.
Many reviews and reports are prepared to meet
the specific needs of various organizations. Gov-
ernment agencies, such as the Food and Drug
Administration and the Environmental Protection
Agency (EPA), prepare reports to support regula-
tory activities. Research institutions, such as the
National Institutes of Health and the Chemical
Industry Institute of Toxicology (CIIT), prepare
reports to announce the results of a particular
study. Other organizations, such as the Chemical
Manufacturers Association and the World Health
Organization, prepare reports to further their
programs.
Unpublished Information
Unpublished information about recent, planned,
and ongoing research and testing can be of even
greater interest than older, published information.
The timelag between submission or acceptance
of data for publication and their actual publica-
tion is often a handicap to those waiting to learn
of experimental results. Time lost while waiting
to obtain another investigator’s published research
results can cost a laboratory its claim to priority
in obtaining research results. In testing, proprie-
tary interests create pressure to obtain informa-
tion as quickly as possible,
One of the oldest sources of unpublished infor-
mation is networking-that is, the use of personal
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contacts. Networking is affected by the economic
factors discussed in chapter 11, such as the pro-
prietary value of testing data and the incentives
to make it public. Membership in scientific and
professional societies and attendance at profes-
sional meetings facilitates this form of informa-
tion exchange. Recent test results are often pre-
sented at meetings of professional societies, and
valuable information about work in progress is
exchanged by participants.
Unpublished data may not be written in report
form, which makes it difficult to share the infor-
mation. Although the data are stored in some kind
of organized fashion, the way one person organizes
information may not be useful to someone else.
Thus, even if it is possible to determine that un-
published useful research or testing data do exist,
it is often difficult to share them.
In addition to unpublished material, a separate
category of information that is fairly inaccessible
includes many Government reports, research insti-
tute reports, and obscure journals. This informa-
tion falls into a grey area—’’published” in a literal
sense, but not in a practical one.
Information Centers
Because of the large volume of published and
unpublished information that is generated, spe-
cial services called “information centers” have been
set up to collect, organize, and disseminate it. An
information center, to be comprehensive, must
have a fairly narrow scope. These centers are a
good vehicle for sharing unpublished information,
although they do not have the resources to seek
it out.
The most well known information center with
holdings of research and testing data is the Inter-
national Agency for Research on Cancer, in Lyons,
France. The United Nations maintains several col-
lections of published and unpublished data on
chemicals potentially of international interest, e.g.,
through the International Program on Chemical
Safety and the International Registry for Poten-
tially Toxic Chemicals in Geneva, Switzerland.
These agencies have a much broader scope than
a typical information center, although they carry
out many of the same functions. The Oak Ridge
National Laboratory in Oak Ridge, TN, has indi-
vidual information centers for environmental car-
cinogens,  teratogens, and mutagens. Statistics on
the volume and rate of growth of publications in
the areas for which Oak Ridge has holdings are
given in table 10-1.
Table 10.1 .—Growth and Publication Frequency of Literature Reiated to
Genetic Toxicology, Carcinogenicity, and Teratogenicity
Papers Publication sources
published Increase in papers providing
Subject per yeara published per yearb information
Genetic toxicology. . . . . . . . . . . . . 4,000-5,000 200-300 3,400
In vivo animal carcinogenicity
studies . . . . . . . . . . . . . . . . . . . . . 1,500-2,000 50-100 1,000
In vitro cell transformation
studies . . . . . . . . . . . . . . . . . . . . . 400-500 25-50 500
Teratogenicity. . . . . . . . . . . . . . . . . 2,000-2,800 100-150 3,500
aFi9ureS  Would & substantially greater if augmented with unpublished or Inaccessible published materiai.
bNumbers shown are projected increases based  on trends cataloged from the literature fOr  the period 1979-M.
clncludes  journais, books, symposium proceedings, 90VWr7mt3nt  reports, and abstracts.
SOURCE:J.S. Wassom, Director, Environmental Mutagen, Carcinogen, and Teratogen Information Program, Oak Ridge Nation-
al Laboratory, Oak Ridge, TN, personal communication, November 1985.
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THE AVAILABILITY
One of the most important incentives to pub-
lish, both for people and for organizations, is to
establish a professional reputation. Although “pub-
lish or perish” is an enduring part of academic tra-
dition, in nonacademic research and testing sec-
tors there is often little incentive to publish. As
a rule, industry is more concerned with the pro-
tection of proprietary information and the con-
servation of financial resources than with pub-
lishing.
Federal organizations are likewise more inter-
ested in carrying out missions required by law than
in the publication of research and testing data (un-
less that is their mission). As a result, many agen-
cies’ reports are never sent to the National Tech-
nical Information Service (NTIS) for distribution
and cataloging, or too little time is spent indexing
them in a fashion that facilitates easy retrieval of
the information.
Journal publication Policies
Because of the importance of journals as a source
of testing data, their publication policies are cru-
cial to the effective exchange of information. Some
journal policies (e.g., the limitations on the length
of an article and the amount of detail it contains)
are related to high printing and distribution costs.
others, such as an unwillingness to publish results
that have already been disclosed publicly, are a
result of the stiff competition that exists among
journals.
One of the most frustrating publication policies
from the standpoint of avoiding duplicative re-
search and testing is that most journals (and there-
fore secondary sources) rarely publish negative
results. It is natural that people would be more
interested in knowing, for example, which chem-
icals have been found to be hazardous than which
chemicals have not. As a consequence, a certain
number of experimental protocols are repeated
because the negative results of earlier experiments
were not published. This policy is not likely to
change without dramatic alterations in the stance
of journal publishers, the policies of professional
societies, and, indeed, the tradition of scholarly
publication in academia. One notable exception
OF INFORMATION
to this is the journal Mutation Research, which in
1977 made it a policy to also publish negative
results.
Federal Laws Affecting
Unpublished Data
one method available to the Federal Government
for collecting testing data is to require them, ei-
ther through registration requirements such as
those under the Federal Insecticide, Fungicide, and
Rodenticide Act (Public Law 92-516, as amended
by Public Laws 94-140 and 95-396), or through
reporting rules such as those promulgated under
the Toxic Substances Control Act (TSCA) (Public
Law 94-469). Section 8(d) of TSCA requires manu-
facturers and processors to submit citations or cop-
ies of health and safety studies they have spon-
sored, or about which they are aware, for specified
chemicals. As of June 1984, EPA had received over
6,000 such submissions, about half of which were
health-effects studies. For the specified chemicals,
when regulatory notices were published in the Fed-
eral Register, about one-quarter of the citations
were to data received under Section 8(d) (10).
Some unpublished data are given to Government
agencies voluntarily, either through personal con-
tacts or in response to publicity that the govern-
ment is working on a particular problem. Much
of the data concern adverse effects, but some con-
cern negative results as well.
Unlike most countries, the United States has a
policy of making information held by the Gov-
ernment as available as possible, consistent with
protecting its proprietary value. Key laws in
implementing this policy are the Administrative
Procedures Act (Public Law 79-404, as amended
by Public Law 89-554), which encompasses the
Freedom of Information Act (Public Law 90-23,
as amended by Public Laws 93-502, 94-409, and
95-454). This act makes all information held by the
executive branch of the Federal Government avail-
able to anyone who asks for it, unless the infor-
mation is specifically exempted or is protected
under another law. The person requesting the in-
formation is frequently required to pay search and
duplication costs, but the burden is on the Govern-
ment to show why information should be withheld.
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Under these laws, the public also has access to
collections of published and unpublished nonpro-
prietary data gathered to support administrative
actions such as rulemaking. This ‘(public docket”
contains all reports, literature, memos, letters, and
other information considered in taking the action.
Once information has been obtained by the Fed-
eral Government, it may be shared within and
among Government agencies. Often such sharing
is very informal, and with informality comes un-
predictability and oversights. Various committees
have been set up to facilitate intragovernmental
networking, such as the Interagency Regulatory
Liaison Group of the late 1970s, the Interagency
Risk Management Council, and the Interagency
Toxic Substances Data Committee. These efforts
increase the amount of information available to
solve particular problems. They also reduce du-
plicative information requests made of industry.
In 1980, an interagency Toxic Substances Strat-
egy Committee examined the sharing of informa-
tion, focusing principally on the data held by Fed-
eral agencies (20). The Committee noted there were
then more than 200 independent data systems,
mostly incompatible. Barriers to sharing informa-
tion included diverse methods of identifying chem-
icals and differing reliability and review of the data-
bases. The Committee noted that coordination of
Federal agencies’ chemical data systems could re-
duce duplication of information gathering, mini-
mize delay, and, to some extent, decrease uncer-
tainties in decisionmaking. The benefits of such
coordination would likely extend beyond the Fed-
eral Government to State and local governments,
industry, labor, public interest groups, academic
institutions, international organizations, and for-
eign governments.
BARRIERS TO USING AVAILABLE INFORMATION
Data Quality and Comparability
Before data are to be used, the user must be con-
fident of their quality. This judgment is based on
a variety of facts and inferences. People will fre-
quently take into account the professional repu-
tation of the investigator or the investigator’s in-
dustrial, academic, or professional affiliation or
organization. If the person has no reputation, good
or bad, many scientists will not rely on that inves-
tigator’s data. This phenomenon is most acute with
investigations carried out in foreign countries and
published overseas (14). Further, many scientists
will not (and perhaps should not) trust results that
have not been peer-reviewed. Lastly, some orga-
nizations tend not to trust any data that they have
not generated.
It is important to assess the quality of data. Thus,
even though numerical databases are convenient
because they contain data in summary form, often
there is no way to determine from the informa-
tion contained there how reliable the data are (un-
less they were peer-reviewed before being put into
the system). This problem has been addressed by
the National Bureau of Standards (NBS), the Chem-
ical Manufacturers’ Association, and others, A
workshop held in 1982 (16) recommended that
computerized databases (discussed at length later
in this chapter) include the following “data qual-
ity indicators” that would allow the user to deter-
mine reliability for specific needs:
l the method(s) used to obtain the data,
l the extent to which the data have been eval-
uated,
l the source of the data, and
l some indication of the accuracy of the data.
An important part of evaluating data is compar-
ing them with data obtained using similar meth-
ods—that is, validating the data. In deciding, for
example, to rely on a particular test protocol, it
is necessary to be confident not only that the test
is a useful model of the effect of interest, but also
that the results can be trusted, even though they
are unexpected. For many investigators, valida-
tion involves repeating at least a portion of an ex-
perimental protocol in their own laboratories.
They might also compare the results with those
generated by other procedures with which they
are more familiar.
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International Barriers to
Sharing Information
Animal research and testing is conducted in
many countries (as described in ch. 16). The im-
portance of communicating scientific information
among nations has been recognized in the United
Nations, in the Organization for Economic Coop-
eration and Development (OECD), and in regional
and bilateral forums. Although much has been
done to facilitate this, many barriers must still be
overcome.
International communications cost more and
take longer than domestic communications. More-
over, there are fewer international personal ac-
quaintances on whom to rely for information than
there are on a national level. Communication prob-
lems are exacerbated by institutional differences.
It is difficult for industry-to-industry communi-
cations to occur, for example, when one industry
is privately owned and another is government-
owned, because governments typically deal
through diplomatic channels.
Political animosities hinder information ex-
change. Defense-related information is affected
the most, but all information sharing must suffer
in such a climate. Even political differences cause
problems in sharing information. It is difficult for
agencies within the U.S. Government to obtain in-
formation from governments that have close work-
ing relationships with their industries, such as Ja-
pan, particularly when any information received
would be subject to Freedom of Information Act
requests in the United States.
Language differences are a large problem, both
in the use of written materials and in personal com-
munications. Translation and interpreting are ex-
pensive, particularly in the United States, where
the number of people who speak more than one
language has been decreasing. English translation
costs for the four principal languages of science
(French, German, Russian, and Japanese) range
from $40 to $88 Per thousand words. An estimated
$4 billion to $5 billion would be required to trans-
late the current foreign-language holdings of the
National Library of Medicine (NLM), for example,
with an ongoing yearly translation cost of $150
million (9). Duplicative translations are avoided
through the clearinghouse effort of the John
Crerar Library in Chicago, IL. Translations donated
by a variety of sources on a broad spectrum of
topics are made available to others.
Common protocols can also facilitate the inter-
national exchange of, for example, testing data.
OECD members decided in 1981 that health-effects
data generated according to OECD test guidelines
should be mutuallv acceptable in all member coun-
tries, regardless of where the testing was done (see
app. A) (17). Although this decision has not been
fully implemented, OECD test guidelines are readily
available and are receiving considerable use.
RETRIEVING RESEARCH AND TESTING DATA
The ways data are obtained and the amount
sought are functions of the resources available for
searching, how the data are to be used, the likeli-
hood that the information exists at all, and how
reliable the information is likely to be. Many meth-
ods for finding information are available, and most
of them overlap to some extent.
Abstracting and Citation Services
In research and testing, several hundred thou-
sand scientific articles in thousands of journals are
published each year in the primary literature (6).
Abstracting and indexing services and biblio-
graphic services play a vital role in making these
accessible to those who need them. (An index based
on references cited, or citations, permits the user
to follow the literature into the future to locate
pertinent articles. For example, a user with a 1981
article in hand who is seeking related, more re-
cent publications can consult a citation index to
identify 1985 publications that referenced the 1981
article.) Because animals are used for a variety of
research purposes (see chs. 5 and 6), however, and
because testing is interdisciplinary (see chs. 7 and
8), information may be indexed in the fields of
chemistry, biology, pharmacology, medicine, and
so on.
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Abstracting and indexing services and biblio-
graphic services have existed since the 17th cen-
tury and have grown in number and size as pub-
lished literature has expanded. The first major
services for scientific information were published
by professional societies (e.g., Chemical Abstracts).
Some were sponsored by the Federal Government
(e.g., Air Pollution Abstracts and AGRICOLA) or
by commercial enterprises (e.g., Current Contents
and Environmental Abstracts) (8). Some, such as
the Chemical Information System, originated in
Government and were later converted into com-
mercial enterprises (12).
The largest abstracting and indexing service for
biological and biomedical research is BIOSIS, the
Biosciences Information Service. In 1985, its cov-
erage extended to 440,000 items from over 9 )000
sources worldwide. The file accumulated to date
contains over 6 million items, the largest biologi-
cal file in the English language. Items covered in-
clude abstracts and citations for journal articles
and other serial publications, and citations to
reports, reviews, and scientific meetings (6).
A typical abstract of a journal article and an il-
lustration of how it is indexed by BIOSIS appear
in figure 10-1. Information like this is contained
in the semimonthly publication Biological Ab-
stracts. Another publication, Biological Abstracts/
RRM, contains bibliographic entries for research
reports, reviews, meetings, and books (see fig.lo-
2). BIOSIS also offers several computer-based serv-
ices that provide citations tailored to the custom-
er’s information needs. All of these resources are
regularly used by scientists. As the figures illus-
trate, however, it is often difficult to tell from a
title, or even from an abstract, whether a particu-
lar article would satisfy a reader’s needs.
Once a citation has been obtained, it is easy to
acquire the full text of a research report. Most
libraries have the necessary services available, or
the inquirer can write to the author and ask for
a reprint. In addition, some commercial vendors
offer to supply by mail the full text of virtually
any article (see fig. 10-3).
A recent comparison of databases for literature
on 10 pesticides illustrates the problem of over-
lap (15). Eight databases had to be searched in or-
der to get 90 percent of all data relevant to a par-
ticular regulatory decision. The share of citations
produced by these databases that were not rele-
vant ranged from 11 to 27 percent. Used together,
the four most consistently relevant databases—
TOXLINE, CAB Abstracts, BIOSIS, and Chemical
Abstracts—produced 25 to 91 percent of all rele-
vant citations, with an average of 69 percent.
These statistics illustrate the fragmentation that
may accompany a literature search. Although the
number of databases that need to be searched may
be small for some fields, questions of an interdis-
ciplinary nature require substantial resources for
a complete literature search.
Retrieving Unpublished Information
Citation services are available for some unpub-
lished data and testing in progress. Federal data-
bases and publications include the Bioassay Status
Report and Tox-Tips of the National Toxicology
Program (NTP), the EPA Chemical Activity Status
Report, the Current Research Database of the Na-
tional Institute for Occupational Safety and Health,
NTIS’s Federal Research in Progress, and the Smith-
sonian Science Information Exchange (no longer
active). There are also many small databases used
to keep track of specialized data, such as informa-
tion used in the implementation of a specific law.
Similar citation services to unpublished data or
ongoing testing exist on an international level. The
International Agency for Research on Cancer,
which has substantial U.S. support, coordinates
the sharing of information about current carcino-
genicity testing in laboratories around the world
and publishes an information bulletin, Survey of
Chemicals Being Tested for Carcinogenic Activity.
The International Program on Chemical Safety of
the United Nations Environment Program (UNEP)
is establishing a database for Chemicals Currently
Being Tested for Toxicological Effects. This data-
base is designed for long-term or otherwise expen-
sive studies other than those on carcinogenicity.
Participants in both programs include govern-
ments, industry, academia, and research institutes.
In addition, Infoterra, a service of UNEP, publishes
a directory through which experts in numerous
subject areas can be located. Assistance is also pro-
vided by national representatives. The U.N.’s In-
ternational Registry of Potentially Toxic Chemi-
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Figure IO-l.—A Scientific Abstract and Corresponding Index Entry in BIOSIS
ABSTRACT FORMAT
TOXICOLOGY- Major Headlng
E N V I R O N M E N T A L  A N D  I N D U S T R I A L  ~ Subheadlng
Authors
/ \
Author
Roforsnco Address
N u m b e r  ~ 23330. CARSONS, JOANNE N and JOHN O. GOULDEN (Arch=
Oceanogr. Inst., Phila., Pa. 19103, USA.) The effects of chlorine Article
pollutlon on growth and respiration rates of larval lobsters ~  T i t l e
(Homarus americanus). BIOL RES 11(12): 1433-1438. 1985. The -
length, dry weight and standard respiration rate of Iarval lobsters
(H. americanus) were measured following 20 days Immersion In
coastal waters surrounding a power plant. Significantly lower
increases in dry weight (P<. 05) and significant reductions in stan-
dard respiration rates (P<. 01) were measured in exposed
organisms when compared to control organisms. Water samples
taken from the immersion site contained high concentrations of
free Cl.
BIOSIS’ INDEXING SYSTEM
AUTHOR INDEX (Personal or Corporate Names)
Author Index NAME REF. NO. NAME REF. NO.
CARSONS J N 23330+ ELL A W 26787
(Personal or Corporate Names) CASEY N 29606 FINEMAN C 26884
DAVIES R 24001 GOULDEN J O 23330
BIOSYSTEMATIC INDEX (Taxonomic Categories)
Biosystematic index ARTHROPODA. . . . . . . . . . . . . . HIGHER TAXONOMIC CATEGORY
Crustacea. . . . . . . . . . . . . . . . . .
. Malacostraca. . . . . . . . . . . . . I LOWER TAXONOMIC CATEGORIES
(Broad Taxonomic Categories) Environmental and Industrial Toxicology. . . . . . . . . . . . . . MAJOR CONCEPT
23330 23572 25352 . . . . . . . . . . . . . REFERENCE NUMBERS
GENERIC INDEX (Genus-species Names)
Generic index GENUS-SPECIES MAJOR CONCEPT REF. NO.
(Genus-species Names) HOMARUS-AMERICANUS TOXIC INDUS 23330WILDLIFE AQU 24063
MICROCERUS- BERONI CRUSTAC SYST 19145’s
SUBJECT INDEX (Specific Words)
A l p h a b e t i c  P O S I T I O N
Subject index SUBJECT CONTEXT  KEYWORD REF. NO.
GHT/ THE EFFECTS OF CHLORINE POLLUTION ON GROWTH 23330
(Specif ic Words) TOBACTER/ EFFECT OF SUBSTITUTION ON THE 26575LORINE POLLUTION ON GROWTH AND RESPIRATION RATES 2 3 3 3 0
GERMINATION RADICAL BARRIER TEMPERATURE 27304
SOURCE: The  1985 8/0S/S Information Catalog (Philadelphia, PA’  Biosciences Information Service, 19S5).
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Figure 10=2. -Sampie Bibliographic Entries in Blological Abstracts/RRM
EXAMPLES OF BIBLIOGRAPHIC ENTRIES IN BA/RRM:
CONTENT SUMMARY FORMAT
SOURCE: The 1985  EUOS/S  Information Catalog (Philadelphia, PA: Biosciences Information Service, 1985).
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Figure 10=3. - Promotional Material From Commercial
Supplier of Full Texts of Scientific Publications
Pick an article-any article from
this issue of CC! It can be in your
hands fast when you order it from
ISI*’S document delivery service, The
Genuine Article
The Geniue Article can supply
you with original article tear sheets
or quality photocopies of nearly all
journal articles, editorials, letters, and
other items you see in this issue of
Current Contents’ To order, simply
fill out the coupon below and mail it to
ISI, together with your check or
money order
Price information: Any article
of ten or fewer pages costs $7.50
(when order includes ISI Accession
Number), This amount includes first
class mail delivery to the U. S. A.,
Canada, and Mexico Air mail to all
other Iocations costs $8.50. For every
additional ten pages or fraction of ten
pages, there IS an additional charge of
$2 per article.
For complete information on our
document delivery service, write
ISI Customer Services at the address
shown.
FAST, RELIABLE DOCUMENT DELIVERY
r 1
To receive your order from The Genuine Articie ‘“, fill in oval with ISI accession
number adjacent to journal title in CC.
Name Tme . —.
Organization Dept — . . —
Address ——
City State Province C o u n t y  —
ZIP PostaI Code Telephone
Prices are subject to change Payment must accompany order
The Genuine Article. 3501 Market Street, Philadelphia, PA 19104 U.S.A.
Telephone. (21 5) 386-0100, ext. 1140, Cable SCINFO, Telex: 84-5305
European Office: 132 High Street, Uxbridge, Middlesex uB8 1 DP, UK. 1985 ISI
Telephone: 44-895-70016. Telex: 933693 UKISI CC-S 716
SOURCE: Institute for Scientific Information, Inc., Philadelphia, PA.
228 . Alternatives to Animal Use in Research, Testing, and Education
cals sometimes refers information requests among per month would be referred to some combina-
member countries through its national corre- tion of government agencies, industry, academia,
spondents. and research institutes that might have unpub-
.
lished data relevant to the request, The mecha-A recent U.S.-led project of the OECD, generally nisms for referring&quests on the national levelreferred to as “Switchboard,” has also addressed
the problems of obtaining information from other and the enlistment of various organizations, eitheras requesters or responders, is the responsibilitycountries. Unpublished information may be re-
quested through the Switchboard system for use of Switchboard’s national focal point. This project
in risk assessments or to otherwise protect health
and the environment. A pilot system is to be run
in which two requests per participating country
will begin on a small scale and will be monitored.
If appropriate, it could be expanded (18).
COMPUTER
Computers have two applications as an alterna-
tive to using animals in research, testing, and edu-
cation. First, they can be used to model or simu-
late biological, chemical, and physical systems. In
this way, a computer could be used as a direct
replacement for some number of animals used in
laboratories. This form of computer use is dis-
cussed in chapters 6,8, and 9. Second, computers
are used to disseminate information that has been
generated from prior use of animals in research
and testing, thus avoiding the needless repetition
of a procedure by other scientists. It is this role
of computers as information disseminators that
is discussed in the rest of this chapter.
Advantages of Computers
Biological testing (see ch. 7) can be described as
the repetitive use of a standard biological test situ-
ation, or protocol, employing different chemicals
or different test parameters (e.g., species or bio-
logical end points). Because the protocols in test-
ing are more stereotyped and less varied than those
in research, biological testing is more amenable
than research to the institution of a computerized
data retrieval system. In fact, testing emerged in
the 1970s as the first discipline in which such a
system was developed.
If a comprehensive, computerized registry of bio-
logical research or testing data were established,
certain benefits might accrue. These benefits are
predicated on the inclusion in the computerized
registry of both control and experimental data,
and of both positive and negative results. (Data
SYSTEMS
obtained from testing fall into two broad catego-
ries: those derived from untreated (control) sub-
jects, and those from treated (experimental) sub-
jects. Data obtained from treated subjects may
either show an effect from the treatment (“posi-
tive results”) or no effect (’(negative results’’).) Fur-
thermore, the advantages of such a registry de-
pend on the acceptance by working scientists of
the data contained in it—acceptance that seems
possible only with the imprimatur of peer review
of the data. The anticipated benefits of a computer-
based registry of research or testing data include:
l
l
Decreased Use of Animals in Research or
Testing. In some instances, an investigator
would locate the exact data desired, possibly
from a previously unpublished source, thus
avoiding unintentional duplication of animal
research or testing. Baseline data could per-
mit the selection of a dose, a route of adminis-
tration, or a strain of animal without the need
for new animal experiments to establish these
factors. Efficiencies could also include the use
of fewer doses on smaller numbers of animals.
Conceivably, the number of animals required
for control groups could be reduced, although
many experimental protocols require the use
of concomitant control subjects, rather than
of data from a pool of control subjects, in or-
der to achieve statistical significance.
A Check for Genetic Drift. Certain experi-
mental results can change over a span of many
generations due to subtle, progressive changes
in the underlying genetic constitution of the
strain of animals ((’genetic drift”). The  regis-
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try would provide baseline data within speci-
fied time frames of measurement, and make
it easy to check for the possibility of genetic
drift.
New Perspectives on Old Data. By perform-
ing statistical comparisons across data sets and
identifying relationships not already obvious,
unforeseen relations could be established
without animal experimentation.
The scientific community makes use of a num-
ber of computerized literature retrieval services
to obtain bibliographic citations and abstracts to
the published literature. Most abstracting and in-
dexing services started as publications, but most
are now available on-line as well. Others, such as
AGRICOLA, are only available on-line.
Many handbooks and other numerical databases
are also available on-line. Several numerical data-
bases are sponsored by the Federal Government.
The most comprehensive, the recently terminated
Laboratory Animal Data Bank, is reviewed in de-
tail in the next section. Two current systems, the
Toxicology Data Bank and the Registry of Toxic
Effects of Chemical Substances, are discussed in
some detail here. Table 10-2 lists a number of data-
bases available for searches of the research and
testing literature. Table 10-3 lists some widely used
databases of the NLM.
Toxicology Data Bank
The Toxicology Data Bank (TDB) was made public
by NLM in 1978. It is designed to address some
of the needs of the testing and regulatory com-
munities for toxicity information. TDB is organized
by individual chemicals or substances, now totaling
more than 4,000. Its fixed format includes:
l
l
l
data on the production and use of each
chemical;
a description of the physical properties of each
chemical; and
the results of pharmacological and biochemi-
cal experiments, and information on toxico-
logical testing.
TDB is based on conventional published sources
and does not include unpublished data. Thus, base-
line data on control animals, which might be used
in place of a control group, could not be included
because so little has been published.
The most valuable feature of TDB is the fact that
all the data it contains are peer-reviewed. As a con-
sequence, its data summaries are acceptable to
most users (5). (Another database containing only
peer-reviewed data is the Environmental  Protec -
tion Agency’s Gene-Tox.)
Registry of Toxic Effects
Chemical Substances
o f
The Registry of Toxic Effects of Chemical Sub-
stances (RTECS) has been published annually since
1971 by the National Institute for Occupational
Safety and Health, under Section 20(a)(6) of the
Occupational Safety and Health Act of 1970 (Pub-
lic Law 91-596). RTECS is a compendium, extracted
from the scientific literature, of known toxic and
biological effects of chemical substances. RTECS
does not evaluate the data it cites, leaving that
responsibility to the reader. An example of the in-
formation contained in a typical substance entry
in RTECS is given in figure 10-4.
By congressional mandate, those data that indi-
cate a toxic effect of a chemical are to be included
in RTECS; those that show no toxicity are to be
excluded. Thus, RTECS does not include negative
results. Moreover, a chemical might not be in-
cluded in the registry for a variety of reasons, in-
cluding the following:
l
l
l
The test results could not be cited because
the protocol of the study did not meet the
RTECS selection criteria.
The substance has not yet been tested or the
results have not yet been published.
The substance has been tested and the results
published, but the information has not yet
been entered into the RTECS file.
The exclusion of negative results from RTECS and
its incompleteness for these other reasons may
lead to the repetition of toxicity testing of essen-
tially nontoxic substances.
The production of RTECS costs approximately
$500,000 per year. The current quarterly update
includes a total of 68,000 compounds, and it con-
tinues to grow steadily toward the estimated 100,000
unique substances for which toxicity data may be
available. If  RTECS were expanded to include all
results of whole-animal toxicity testing, including
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Table 10.2.—Examples of Databases Avaiiabie for Searches of Literature Involving Animal Research and Testing
Database Description
First year
covered
AGRICOLA Worldwide journal and monograph literature on agriculture and related subjects; from 1970
the National Agricultural Library
AQUACULTURE
AQUALINE
ASFA (Aquatic Sciences
and Fisheries Abstracts)
BIOSIS Previews
CA Search
Comprehensive
Dissertation Abstracts
Conference Papers Index
CRIS (Current Research
Information System)
Enviroline
Environmental
Bibliography
Excerpta Medica
INSPEC
I PA (International
Pharmaceutical
Abstracts)
IRL Life Sciences
Collection
ISI/BIOMED
ISI/COMPUMATH
ISI/lSTP&B
LISA (Library Science
Abstracts)
Microcomputer Index
NIMH
Oceanic Abstracts
Pollution Abstracts
Population Bibliography
Psychological Abstracts
SCISEARCH
Growth requirements, engineering, and economics of marine, brackish, and freshwater
organisms; from National oceanic and Atmospheric Administration
Abstracts from world literature on water, waste water, and aquatic environments; from
Water Research Centre, Stevenage, U.K.
Life sciences of seas and inland waterways plus legal, political, and social implica-
tions of aquatic life; from UNESCO
International coverage of life science research; from Biological Abstracts
International coverage of chemical sciences; from Chemical Abstract Service
Author, title, and subject guide to nearly all American dissertations since 1861 and
many from foreign countries; abstracts added beginning in July 1981; from Xerox Univer-
sity Microfilms
Records of scientific and technical papers presented at major regional, national, and
international meetings each year; from Data Courier, Inc.
Research in agricultural sciences; from U.S. Department of Agriculture’s State Research
Service
International coverage of biology, chemistry, economics, geology, law, management,
planning, political science, and technology of environmental issues; from Environment
Information Center, Inc.
Atmospheric studies, energy, general human ecology, land resources, nutrition and
health, and water resources; from Environmental Studies Institute
Worldwide citations and abstracts from 3,500 biomedical journals; from Excerpta
Medica
Coverage of literature in computers, electrotechnology, and physics; from the Amer-
ican Institute of Electrical Engineers
Literature on drug development and use of drugs; from the American Society of Hos-
pital Pharmacy
Worldwide coverage of life sciences including conferences; from Information Retrieval,
Ltd.
Index of 1,400 biomedical journals; from the Institute of Scientific Information
Covers literature in computer science, mathematics, statistics, operations research,
and related areas; from the Institute for Scientific Information
Computerized version of Scientific and Technical Proceedings and Books. Covers 3,000
proceedings and 1,500 books annually; from the Institute for Scientific Information
international coverage of library and information science literature; from Learned in-
formation, Ltd.
Subject and abstract guide to 21 microcomputer journals; form Microcomputer infor-
mation Services
Mental health literature from 950 journals, symposia, government reports, and other
sources; from the National Institute of Mental Health
International literature on geology, governmental and legal aspects of marine resources,
marine biology, marine pollution, meteorology, and oceanography; from Data Courier,
Inc.
Literature on the sources and control of environmental pollution; from Data Courier, Inc.
international coverage of population research: abortion, demography, family planning,
fertility studies, and migration; from Carolina Population Center, University of North
Carolina
Worldwide coverage of literature in psychology and related social-behavioral litera-
ture; from the American Psychological Association
International literature of sciences and technology; from the institute for Scientific
Information
1970
1974
1978
1969
1967
1861
1973
1974
1971
1973
1974
1969
1970
1978
1979
1976
1978
1969
1981
1969
1964
1970
1966
1967
1974
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Table 10-2.—Examples of Databases Availablea for Searches of Literature
Involving Animal Research and Testing (Continued)
First year
Database Description covered
SOCIAL SCISEARCH Worldwide coverage of social and behavioral sciences literature; from the Institute 1972
for Scientific Information
TELEGEN Covers literature on biotechnology and genetic engineering in 7,000 sources includ- 1973
ing conference and symposia papers, government studies, periodicals, and the popu-
lar press; from Environment Information Center, Inc.
Zoological Record Covers zoological literature from 6,000 journals; from Biosciences Information Serv- 1978
ice and the Zoological Society of London
aThe~~ d~~aba~~~  are available bY tel~~h~n~ ~On”~Ctl~n  to one or more of the following:  Lockheed Information System DIALOG, SyStem  Development Corp  ‘S ORBIT,
and Bibliographic Retrieval Service, Inc.
SOURCE  Adapted from R,V. Smith, Graduate  Research (Philadelphia, PA: ISI Press, 19S4).
Table 10-3.—Examples of On-Line Databases of the National Library of Medicine
Number of records
Name Description (average length) Type of record
MEDLINE 1966-present. Bibliographic citations and abstracts from 3,300,000 Bibliographic
primary biomedical literature (1,250 char.)
TOXLINE 1965-present. Abstracts from primary toxicological literature 1,400,000 Bibliographic
(1,050 char.)
CHEMLINE Dictionary to chemicals contained in TOXLINE and other MED- 500,000 Chemical compound
LARS data bases (275 char.)
RTECS Brief summaries of toxicity results from primary literature 68,000 Chemical compound
(1,000 char.)
TDB Detailed chemical, pharmacological, and toxicological data and 4,000 Chemical compound
extracts from monographs and handbooks (17,000 char.)
SOURCE: Office of Technology Assessment
negative results, its size would be increased by an
estimated 10 to 15 percent (11). RTECS is avail-
able in hard copy (19), on microfiche, on magnetic
tape, and on-line from both the MEDLINE service
of NLM and the Chemical Information System, a
joint resource of several Federal agencies that is
managed by EPA.
On-Line Literature
The research community makes use of a num-
ber of computerized literature retrieval services
to obtain bibliographic citations and abstracts from
primary literature. Among these, for example, is
NLM’s MEDLINE database, a bibliographic file now
exceeding 3,300)000 entries. In the private sector,
Biosciences Information Services prepares hun-
dreds of thousands of abstracts each year, pro-
viding access to essentially the entire published
biological research literature. However, the re-
search community is not presently served by a
computerized database that includes comprehen-
sive descriptions both of experimental protocols
and of the resulting data.
Movement toward on-line delivery of the full text
of scientific publications has begun in the private
sector. For example, Mead Data Central (Dayton,
OH) offers MEDIS, a medical literature database.
In 1985, the MEDIS service included about 70 pub-
lications, with some stored journal articles going
back to 1980. MEDIS includes the full text of the
Journal of the American Medical Association (since
1982), Archives of Internal Medicine, and some
textbooks and newsletters. In 1984, Bibliographic
Retrieval Services (Latham, NY) joined with pub-
lisher W.B. Saunders Company to offer the full
text of the New England Journa/ of A4edicine and
several other journals on-line. A serious limitation
to any current full-text literature retrieval system
is the inability to retrieve graphs, photographs,
and other images (7).
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Figure 1O-4.—A Typical Substance Entry in the Registry of Toxic Effects of Chemical Substances (RTECS)
Q4 76
MOLFM: C. Re-S-Te
“ TSL (06 S.)
- A M I H B C
AMIHBC
PNASA6
10,61,64
10,61,64
72,513.75
MUREAV4,53,67
TXAPA9 23,288,72
GISAAA 42(1),32,77
TJADAB 19.41A,79
NTIS*” AD-900-000
TOXID9 1,125,81
29ZUA8 -,183,80
JTEHD6 - [SUPPL.2;,69,77
BJCAAI 16,275,62
AIHAAP 23,95.62
MarJV# 26 Apr 76
FCTXAV 17(3),357.79
WQCHM” 2,-.74
IARC 20,151,80
PLMJAP 6(1),160,75
DTLVS* 4,368,80
DTLVS” 4,358.80
FEREAC 39,23540,74
FEREAC 41,57018,76
NTIS**
STATUS. SELECTED BY NTP FOR CARCINOGENESIS BIOASSAY AS OF SEPT 1982
STATUS: NTP SECOND ANNUAL REPORT ON CARCINOGENS, 1981
STATUS: NIOSH MANUAL OF ANALYTICAL METHOOS, VOL 3 S255
STATUS: NIOSH CURRENT INTELLIGENCE BULLETIN 41, 1980
STATUS: REPORTED IN EPA TSCA INVENTORY, 1962
STATUS: EPA TSCA 8(a) PRELIMINARY ASSESSMENT INFORMATION
FINAL RULE
FEREAC 47,26992,82
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Key to Figure 10-4
A. RTECS accession number, a sequence number assigned to each substance in the Registry.
1.
2.
3.
4.
5.
6.
8.:
9.
10.
11.
12.
13.
14.
15.
16.
17.
Substance name.
Date when substance entry was last revised.
American Chemical Society’s Chemical Abstracts Service unique identification number for
the substance.
Molecular weight of the substance,
Molecular or elemental formula of the substance.
Synonyms, common names, trade names, and other
Skin and eye irritation data.
Mutation data.
Reproductive effects data.
Tumor-causing data.
Toxicity data.
chemical names for the substance.
Acronyms for the references from which the data and other citations were abstracted.
Aquatic toxicity rating.
Reviews of the substance.
Standards and regulations for the substance promulgated by a Federal agency.
A Criteria Document supporting a recommended standard has been published by NIOSH.
Status information about the substance from NIOSH, EPA, and the National Toxicology
Program.
SOURCE: US.  Department of Health and Human Services, National Institute for Occupational Safety and Health, Registry of Toxic
Effects of Ctremica/  Substances, R.L,  Tatken and R,J. Lewis, Sr.  (eds.)  (Cincinnati, OH: DHHS (N IOSH) Pub. No. 83-107, 1983).
LABORATORY ANIMAL DATA BANK
The Laboratory Animal Data Bank (LADB) is a
computerized set of records of baseline data of
physiological, histological, and other biological
properties of mammalian species (largely rodents)
used in research and testing. The data contained
in LADB were derived from both research and test-
ing, and are relevant to both areas of animal use.
Although LADB exists today only as an archival
reference, and is no longer publicly available on-
line, it is of great historical interest in a considera-
tion of computer-based information resources.
In 1970-73, as the carcinogenesis bioassay pro-
gram of the National Cancer Institute (NCI) was
developed, NCI’s Division of Cancer Cause and Pre-
vention anticipated needing better access to base-
line data for experimental animals. In 1973-74, NLM
helped formulate the concepts leading to LADB.
The major contributor of funding for LADB was
NCI.
Data for LADB were derived from published and
unpublished reports. Only control, or baseline,
data from groups of animals were included. The
data were collected and entered into LADB via a
standard, eight-page form (reproduced in ref. 2)
that surveyed 306 variables, including:
l
l
l
l
l
l
name and manufacturer of the animals’ feed,
vaccinations given to the animals,
organs or tissues routinely examined at autopsy,
blood variables that were analyzed,
detergent used in washing cages, and
source of the animals.
The first page of that form s reproduced in fig-
ure 10-5.
Building Phase, 1975-so
Battelle Laboratories (Columbus, OH) was awarded
an NLM contract in 1975, after a competitive pro-
curement, and began detailed design activities in
1975-76. Methods for obtaining data were devel-
oped, and the data file was designed to permit inter-
active access, or time-sharing, by users. Sufficient
data were entered to permit initial study by NLM
staff in 1976, and in the following year 13 outside
users were allowed to test the system.
In June 1976, NLM requested the Institute of Lab-
oratory Animal Resources (ILAR) of the National
Academy of Sciences to provide advice on scien-
tific and technical aspects of LADB. A Committee
on Laboratory Animal Data was formed by ILAR
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Figure 1O-5.—A Representative Page of the Eight-Page Data Input Form for the Laboratory Animal Data Bank
Animal Group Environment and
Husbandry Conditions [
FOR INTERNAL LADB USE ONLV
LADB Animal Group Number
+
Related Animal Group Numbers
Carnivores
Now go to qtitlori 3s 1 Now(pJLoquowbon35
Iv
l Includes all animals postquarantine and under onwonmwntal  condtmns  pnOI  to voatmwnt  roglmrn
SOURCE: P.L.  Altman and K.D. Fisher, Review of Standards Related to the  Laboratov  Animal  Data Bank—lnlerirn F7eporf  (Bethesda, MD: Federa-
tion of American Societies for Experimental Biology, 1980),
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to advise NLM. It met in 1977 and 1978 to con-
sider reports from the NLM and Battelle staff and
to respond both to specific requests for guidance
concerning LADB developmental aspects and to
feedback from the 13 outside users. The NLM staff
further requested ILAR to review the basic con-
cept, purpose, scope, validation of data, and utili-
ty of LADB.
In 1978, ILAR prepared such a report and rec-
ommended that peer review of data for inclusion
in LADB be performed, together with peer exami-
nation of the criteria for data acceptability (13).
NLM contracted with the Life Sciences Research
Office (LSRO) of the Federation of American Soci-
eties for Experimental Biology (FASEB) to organize
an ad hoc LADB User Assessment Panel to review
data descriptors and coverage of various disciplines
by LADB.
In 1979, each member of the LSRO ad hoc panel
had a computer terminal with unlimited access
to the LADB database. The resulting hands-on ex-
perience provided the basis for an objective assess-
ment of the data descriptors and the scope of
coverage of LADB. The ad hoc panel’s report, pub-
lished in 1980 (2), made some 20 suggestions for
improving LADB. The recommendations focused
on increasing the data coverage, ensuring the qual-
ity of the data included, and facilitating statistical
comparisons of data within LADB. The panel’s prin-
cipal recommendations were:
l
l
l
l
l
put the individual animal data files on-line with
the grouped animal data files;
standardize diagnostic terms for pathology
data, by using a system such as Systematized
Nomenclature of Medicine;
add new data elements to LADB for growth,
development, reproduction, and teratology;
provide capability for on-line statistical anal-
ysis for determining relationships between
different data sets; and
adopt new acceptance criteria for data sub-
mitted to LADB.
Public Accessibility, 1980-81
LADB first became available on-line to the pub-
lic in April 1980, via the Battelle computer in Co-
lumbus, OH. Some 100 subscribing organizations
logged 96 billable hours over the first 6 months
of public availability. This usage was far lower than
that of other databases operated by NLM, even
in their beginning stages. The paucity of user
hours, coupled with other financial considerations
(see following section) led NLM to stop LADB file-
building in January 1981. Slightly more than 1 mil-
lion animal measurements were contained in LADB
at this point, mainly obtained from 30,000 rats and
mice. A small amount of data came from cats, dogs,
hamsters, minipigs, monkeys, and tree shrews (2).
Approximately 80 to 85 percent of the total was
obtained from investigators holding contracts
awarded by the National Cancer Institute, under
its cancer treatment and bioassay programs. When
the collection of data was halted, 44 organizations
and 15 Federal contractors had contributed data,
and 9 other sources had agreed to do so. The Fed-
eral commitment to LADB from 1975 through 1980
totaled slightly over $3 million.
Battelle continued to make the file available to
the public, but usage did not increase sufficiently
to make the project self-sustaining. In early 1982,
just 2 years after becoming available on-line, LADB
was taken off -line. The file was turned over to the
National Technical Information Service for pub-
lic distribution via licensing. One copy of LADB
has been licensed by NTIS to date, to Pergamon
International Information Corporation. In 1985,
Pergamon, in a joint venture with FASEB, published
hard-copy data books created from LADB records
(l). There are no plans to add data to the existing
file, or to make it publicly available on-line.
Reasons for the Failure of LADB
Financial Considerations
As mentioned, only 96 on-line hours were logged
by about 100 LADB users over the first 6 months
of public availability. This total was far too small
to provide any useful base for self-sufficiency—
one of the initial goals for the system. When the
Federal Government was vigorously seeking ways
to reduce its long-term financial commitments in
late 1980, NCI dropped its major financial support
in December, and other agencies of the Depart-
ment of Health and Human Services declined to
pick up the slack, under pressure from the Office
of Management and Budget to reduce expenses.
The LADB contract with Battelle was terminated
in early 1981 for lack of funding.
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User Friendliness and User’s Needs
The interactive software used in LADB was de-
signed in 1975. As such, it predated many major
software developments that have emphasized “user
friendliness . ’’The users the system was aimed at–
biologists–found it hard to retain procedural
familiarity with infrequent use.
Another problem with the use of the LADB data,
according to the FASEB ad hoc panel (2), was the
inability to perform on-line statistical comparisons
between different data sets. This limitation, which
makes some desirable statistical comparisons dif-
ficult to perform, arose from inadequate design
and would probably not be a problem with today’s
soft ware.
User Community
LADB was publicly available for too short a time
to permit many conclusions to be drawn about
the users. By definition of the content, its users
would be expected to be pharmacologists and toxi-
cologists concerned with toxicity testing, particu-
larly chronic toxicity testing. This community,
numbering about 3)000 to 5,000 scientists, is far
smaller than the community of basic biological
scientists (about 200,000). The pool of prospective
users of LADB, therefore, seems too small to sus-
tain it.
Peer Review of LADB Design and Data
Although the Institute of Laboratory Animal Re-
sources of the National Academy of Sciences evalu-
ated LADB in 1978, it had not been involved in the
original design considerations. Similarly,  FASEB
entered the review process in 1979—too late to
have substantial impact on the design and most
of the file-building process. The March 1980 FASEB
review (2) pointed out several major design prob-
lems, including lack of on-line availability of the
individual animal data files. The LADB records that
are searchable on-line are composites from groups
of animals. Failure to include data on individual
animals prevents users from performing statisti-
cal comparisons between different data sets.
Lessons Learned From LADB
The acceptance of a biology data bank by the
user community and its success in supplying use-
ful research and testing data are actually deter-
mined well in advance of the collection or dissem-
ination of data. The first step in assembling a
computerized data registry should be the clear def-
inition of its potential users and their specific needs.
No adequate study of this nature was performed
prior to the original design of LADB. The results
of a preliminary feasibility study should identify
the various users, their needs, and their desire (or
lack thereof) to use and support the proposed data-
base (3).
A 1981 FASEB report, “Guidelines for Develop-
ment of Biology Data Banks” (4), emphasized three
important steps in planning and developing a data
bank of biological information. First, the stimulus
for establishing a research and testing data bank
may be the realization by a scientist, a government
agency, or a private organization that the required
information is not readily accessible from pub-
lished, unpublished, or on-line resources. Never-
theless, the need for such an information resource
must be determined independently. Most appro-
priately, this is done by an organization unrelated
to the proposing institution. Determination of need
involves answering the following questions:
l
l
l
l
l
How many institutional, organizational, or in-
dividual users would find the database useful?
How many would be willing to subscribe, and
to what extent would cost be a factor in sub-
scribing?
How many institutions, organizations, or in-
dividual scientists could supply data? How
many would?
How are potential users distributed among
disciplines?
How much unpublished and presently inac -
cessible data could be made available to in-
vestigators by developing a data bank?
If the responses to these questions indicate a solid
foundation of perceived need, then the establish-
ment of the data bank is probably justified.
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Second, the collection of descriptive data on those
scientists interested in the proposed database and
on their disciplinary specialties provides a basis
for matching the scope of the database to the
breadth of disciplinary interest. Specifically, the
scope and design of the database depend on the
range of purposes for collecting the research and
testing data, the size of the prospective audience,
and the needs of the users. It is essential to recog-
nize that the needs of any user audience are dy-
namic and subject to change. A feasibility study
should include an analysis of current trends in user
application as a basis for inclusion of sufficient flex-
ibility to permit later modification.
In identifying the potential user community, the
following considerations are key:
l Can a model be developed to estimate with
a high level of accuracy the number of poten-
tial users?
l Can a projection of the number of potential
donors be made from a similar model?
l To what extent will the user community sup-
l
port assessment of operational charges to de-
fray costs?
What will it cost to collect, systematize, store,
and retrieve the data for a computerized, on-
line system?
Third, critical to the acceptance and success of
a registry of research and testing data is peer re-
view by experts, at all levels of database develop-
ment. These levels include:
l
l
l
l
l
system design;
definition of data elements;
establishment of standards for data acceptance;
compilation and building of data files; and
post-hoc evaluation of the system (i.e., feed-
back resulting from experience gained by ac-
tual use of the system).
The peer-review process assures that experi-
enced researchers have judged the design, stand-
ards, and data to be used. The process enhances
quality control, although it imposes the penalty
of high costs and slow input of data.
EXPANDING THE LADB CONCEPT: A COMPUTERIZED REGISTRY
OF RESEARCH AND TESTING DATA
The concept behind the LADB could be expanded
in at least two important dimensions. First, the
scope could be broadened beyond baseline results
to include experimental results from research and
testing. How great an increase in size would this
be? For every measurement obtained from a group
of control animals, measurements are obtained
from an estimated one to nine groups of experi-
mental animals. This makes a registry of control
and experimental data from 2 to 10 times the size
of a registry of baseline data alone.
Second, the coverage could be enlarged beyond
principally rodents to all vertebrate species. How
great an increase would this entail? Several hun-
dred vertebrate species could be involved. The
number of species would increase by a factor of
more than 100. Yet the bulk of the results would
still be derived from rats and mice, since rats and
mice account for 12 million to 15 million of the
17 million to 22 million animals used annually in
the United States (see ch. 3). Increasing the scope
from rats and mice to all vertebrates would there-
fore likely enlarge the size of the data registry by
a factor of 1.5 (17 million to 22 million animals
divided by 12 million to 15 million rats and mice).
The creation and maintenance of a computer-
ized registry of baseline and experimental results
from all species of vertebrate animals would rep-
resent an enterprise 3 to 15 times more complex
than the unsuccessful Laboratory Animal Data
Bank.
The factors that led in the 1970s to the assign-
ment of the LADB project to the NLM remain valid
today should a similar project be undertaken. NLM
has related experience in handling substance-ori-
ented databases (as detailed in table 10-3), such as
the TDB and RTECS. NLM also operates much larger
databases, such as TOXLINE and MEDLINE, that
are bibliographic rather than substance-oriented.
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Other entities that could be considered for oper-
ating a centralized registry of research and test-
ing data include:
l National Toxicology Program. NTP never
had as its mission the development of a data
bank, and it is not presently equipped to do
so. The scope of NTP’s mission would have
to be redefined if it were to undertake this
responsibility.
l National Bureau of standards. Although
NBS specializes in physical, chemical, and engi-
neering databases, it has never been involved
in a biological database operation. NBS does
not appear to be a viable candidate.
l National Agricultural Library (NAL). Unlike
NLM, NAL has not developed any specialized
computerized biological data registry systems.
It does not appear to be a viable candidate for
operating a centralized registry of research
and testing data. The 1985 amendments to the
Animal Welfare Act (see ch. 13) directed NAL–
in cooperation with NLM—to provide infor-
mation that could prevent unintended dupli-
cation of animal experimentation, and infor-
mation on improved methods of animal exper-
imentation.
l Chemical Industry Institute of Toxicology.
Unless the chemical industry chose to increase
funding to CIIT for this express purpose, it
could not support this activity. Also, CIIT lacks
personnel experienced in large-scale database
development and operation,
l Pharmaceutical Manufacturers’ Associa-
SUMMARY AND
The sharing of information on research and test-
ing is vital to scientific progress. There are a vari-
ety of ways in which such information can be
shared.
Published materials, especially articles appear-
ing in scientific journals, are an indispensable
source of information on the results of completed
research and testing, Unfortunately, a substantial
body of information is not published, although
some of it is publicly available.
Publication is a means of establishing a reputa-
tion in the scientific community. This is especially
important to academics. For scientists in indus-
try, however, the efforts required for publication
tion(PMA).  PMA is not independent of direc-
tion by its members (as is CIIT, for example).
Further, PMA is not engaged in large database
efforts, making it an unlikely candidate.
Federation of American Societies for Ex-
perimental Biology. FASEB has published
handbooks of biological data and is currently
embarked on a venture to extract some data
from LADB files. However, because of limited
resources for data-base development and op-
eration, FASEB’s most appropriate role might
be as the coordinator of peer-review groups.
Chemical Abstracts Service of the Amer-
ican Chemical Society, and Biosciences In-
formation Services Each of these services
annually prepares hundreds of thousands of
abstracts that report biological research and
testing results. These files are document-
oriented and indexed systematically. How-
ever, the detail of the abstracts published does
not begin to approximate the depth of infor-
mation found even in LADB. Both services
could conceivably undertake the development
and operation of a computerized data regis-
try, particularly with NLM supervision.
In summary, it appears that virtually no exist-
ing private or public entity, save the NLM, has the
resources and expertise to design, develop, and
maintain a computerized registry of research and
testing data. If NLM were to undertake such a task,
it would probably rely on contractors from the
private and nonprofit sectors.
CONCLUSIONS
compete with other demands on resources, as well
as with the need to keep information with some
proprietary value confidential.
Much data generated by the Government are
published, Yet, when an agency’s mission is regu-
latory,  less attention is given to publication than
to other concerns.
Because of the importance of journals, their pub-
lication policies have a great impact on the kinds
of information available. The most troublesome
policy is the tendency to publish only results that
show an effect, Thus, protocols that yield nega-
tive results may be unintentionally duplicated in
subsequent experiments.
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Federal Government agencies have access to
some of the unpublished information held by in-
dustry, through reporting rules promulgated un-
der the Toxic Substances Control Act, for exam-
ple, and through registration requirements of the
Federal Insecticide, Fungicide, and Rodenticide Act.
This information is used for a variety of regula-
tory activities and is frequently available to the
public under the Freedom of Information Act. It
may also be added to databases.
There are several barriers to using available in-
formation. One is that users who wish to base im-
portant decisions on data need to know how relia-
ble the data are. In assessing reliability, scientists
will consider not only the protocol used but also
the professional reputation of the scientist, the
journal in which the article is published, and where
the research or testing was done. If the format
of the data (e.g., a numerical database) does not
allow the quality to be assessed, the data may have
little value. The imprimatur of peer review is an
additional factor when assessing data quality.
International barriers to sharing information in-
clude language, the delays and expense of com-
munication, the lack of personal acquaintances
who could facilitate net working, and political and
institutional differences.
Hundreds of thousands of research and testing
articles are published each year. Most of these arti-
cles and other resources are available through ab-
stracting and indexing services and through bib-
liographic services. No service, unfortunately, is
so comprehensive that it can be relied on as a sole
source. However, when multiple sources are used,
there can be a great deal of overlap. Another prob-
lem is that the summary information may be in-
adequate to judge whether the complete article
should be obtained. Citation services also exist for
unpublished data and ongoing experiments, some
on an international level.
Computers are quite valuable in obtaining ac-
cess to information. Many of the abstracting and
indexing services and bibliographic services are
available on computer. Recently, the full text of
some scientific journals-except for graphs and
images—has become available on-line. In princi-
ple, a computer-based registry of research and test-
ing data could reduce the use of animals in research
and testing. In practice, the best design of such
a computerized database remains uncertain.
One attempt toward a modest, well-defined data
registry, the Laboratory Animal Data Bank, failed.
Any new effort to establish a comprehensive data-
base that includes descriptions of experimental
protocols, control and experimental results, and
peer review will benefit from the lessons learned
from LADB. The creation and maintenance of a
computerized registry of baseline and experi-
mental results from all species of vertebrate ani-
mals would be 3 to 15 times more complex than
the defunct LADB.
The initial step towards assembling a computer-
ized data registry is the clear definition of both
its potential users and their specific needs. The
acceptance of a new biological data bank by the
user community and the registry’s success in sup-
plying useful research and testing data are closely
linked to how well the databank meets user needs.
Thus, the probable success or failure of a new data
bank can be predicted in advance of the collec-
tion or dissemination of the data,
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Chapter 11
Economic Considerations
It would not be reasonable to make decisions on alternatives to animal use without having
some idea of the consequences to the health and welfare of the public.
Kennerly H. Digges
National Highway Traffic Safety Administration
U.S. Department of Transportation
March 20, 1985
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Chapter 11
Economic Considerations
Economic considerations play an important role
in decisions on the use of animals in research, test-
ing, and, to a lesser extent, education. It is demon-
strable that many valuable techniques, pharma-
ceuticals, pesticides, and other products have
been developed or tested using animals. Yet ani-
mal use is often very expensive and time-consum-
ing. A new pesticide, for example, may require
$5 million worth of testing with animals before
it can be registered. Even higher animal costs may
be incurred in developing a new drug. Large in-
centives thus exist to find alternatives that reduce
the cost and time involved in animal research and
testing while maintaining the ability to improve
human health, assess and manage the risks of
toxic substances, and acquire fundamental new
biomedical knowledge. Considerable investments
are required to develop and validate such alter-
natives before they can be implemented with con-
fidence.
This chapter examines costs and benefits sur-
rounding animal use and the development, vali-
dation, and implementation of alternatives in
research and testing. Data are provided for bio-
medical research as it relates to human health and
disease, but a precise determination of costs and
economic benefits of animal use within biomedi-
cal research is elusive. Several aspects of using
animals in toxicological testing are examined,
including the development of pesticides, the eco-
nomic incentives to develop and validate nonanimal
tests, and the extent of liability a manufacturer
might incur for insufficient product testing.
In education, it is hard to put a price tag on the
use of animals. At the college and graduate levels,
benefits of animal use include the training of bi-
ologists, psychologists, toxicologists, physicians,
and veterinarians. Education involving animals
contributes indirectly to research and testing by
training those who eventually carry out this work.
The benefits of using animals in primary and sec-
ondary education include increasing students fa-
miliarity with animal behavior and care (see ch. 9).
HOW MUCH DOES ANIMAL USE COST?
In either research or testing, the principal cost
associated with animal use is that of human la-
bor. Animals must be fed, watered, and have their
cages cleaned. They require attendant veterinary
care and are housed in facilities needing labor-
intensive sanitation. Such labor costs are the ma-
jor component of both the expense of producing
animals in breeding facilities and the cost of main-
taining them in laboratory facilities prior to and
during research and testing.
The total cost of animal use is the sum of the
cost of acquisition of the animals and that of main-
taining the animals prior to and during their use.
Acquisition expenses vary widely among species.
Mice, for example, cost on average about $2
apiece, hamsters about $5, and guinea pigs about
$19. Dogs range in price from $5 for a pound ani-
mal to several hundred dollars for a purpose-bred
animal. Primates can cost from $400 to more than
$2,000. The actual cost for a particular species
varies with the sex, strain, weight, age, quantity
ordered, method of shipping, and distance shipped.
Maintenance costs also vary. Maintaining a
mouse, for example, costs about 5 cents per day,
a hamster about 11 cents per day, and a guinea
pig about 40 cents per day. The actual cost varies
among different laboratory facilities, depending,
for example, on accounting practices and local la-
bor costs. The total maintenance cost of an animal
is directly related to its length of stay in the lab-
oratory. It is important to note that maintenance
expenses can quickly exceed and even dwarf ac-
quisition costs. A 2-month-old hamster costing $5,
for example, used in research until the age of 10
months costs $26 to maintain.
Figure 11-1 illustrates the relation between the
number of animals used in research and testing
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Figure 11-1 .—Relation Between Number of Animals Used and Cost of Animal Use
Acquisition Maintenance Total
i h
. .
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I
The total cost of animal acquisition and maintenance equals the sum of the acquisition cost and the maintenance cost.
maintenance cost depends-on the animal’s length of stay in the animal facility.)
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Using fewer animals will yield a decrease in the total cost of animal acquisition and maintenance, but the proportionate sav-
ings ‘will be less than the decrease in the number of animals used. Both the price of each animal and the cost of maintenance
per animal can be expected to increase to support the operating costs of breeding facilities and animal facilities.
SOURCE: Office of Technology Assessment.
and the total cost of animal use. Although the
numbers and species of animals used (see ch. 3)
and the price per animal can be estimated, it is
currently impossible to estimate with any ac-
curacy the laboratory lifetime-and hence the to-
tal maintenance costs-of animals used in the
United States. Therefore no actual dollar figure
can be affixed to the cost of animal acquisition
and maintenance in research and testing. Begin-
ning in 1986, the Public Health Service (PHS) will
require reports on the average daily census of all
species housed in PHS-funded facilities (see app.
C). These data may permit an estimate of the to-
tal cost of animal use in a sizable portion of ani-
mal research—namely, that conducted in PHS-
funded facilities.
The relationship shown in figure 11-1 empha-
sizes several aspects of the economics of animal
use. If the number of animals used is reduced,
the total cost of animal acquisition and mainte-
nance will decline. But the proportional decrease
in total cost will not match the proportional de-
crease in the number of animals used. Reducing
animal use by 15 percent, for example, will not
effect a cost savings of 15 percent; the savings
will be somewhat less, for two reasons, First, if
the number of animals used decreases, the cost
of acquiring each animal can be expected to in-
crease somewhat. (A temporary drop in price for
some species that are in immediate oversupply
may occur, but this would last only through the
laboratory-useful lifespan of animals already on
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hand and ready for sale.) With reduced demand, would have to spread the cost of operation over
vendors would have to raise prices to cover their fewer animals. In both breeding and laboratory
overhead. Second, if the number of animals used maintenance of animals, there are economies of
decreases, the expense of maintaining each re- scale such that breeding and maintenance of mar-
maining animal in a laboratory facility can be ex- ginally fewer animals does not yield a correspond-
pected to increase. Laboratory-animal facilities ing decrease in costs.
COSTS AND BENEFITS IN RESEARCH
The many important economic contributions of
research with animals are difficult to character-
ize. First, research does not lend itself to such
analysis. Normally, one experiment will draw
from many others and contribute to future re-
search, making allocation of costs and benefits to
a particular activity virtually impossible. Second,
the outcome of each experiment is uncertain, and
the experiences in one program would not nec-
essarily apply to others. Third, the delay between
research and commercialization is long, reaching
a decade or more, with payoff taking even longer.
Thus, it is not possible to evaluate with any rea-
sonable confidence the costs and benefits of cur-
rent or even recent animal and nonanimal re-
search practices,
Biomedical Research
This section discusses biomedical research in
general, which unavoidably averages many di-
verse research experiences. Biomedical research
is of interest because it is a major user of animals,
because it affects human health, and because it
affects an important sector of the economy—the
health care industry. As with most areas of re-
search, many of the contributions are indirect and
many are not easily quantified in economic terms
(see ch. 5). Most benefits are realized in the health
care industry, which in 1983 accounted for $355.4
billion (10.8 percent) of the gross national prod-
uct (9). Drugs, which require both biomedical re-
search and toxicological testing in their develop-
ment, have annual sales of about $30 billion and
contribute about 20,000 jobs to the economy (29).
The first medical discovery that was largely a
result of research with animals was diphtheria
antitoxin at the end of the 19th century. Its use
reduced the likelihood of death for those contract-
ing diphtheria from 40 to 10 percent (28). Ani-
mals eventually came to be used in all phases of
biomedical research and in the development of
medical products such as drugs and devices and
of services such as surgery and diagnostic tech-
niques.
Research with animals that leads to practical
applications can last from a few days to many
years. It may involve inexpensive equipment or
hundreds of thousands of dollars’ worth of in-
strumentation, may be performed by a laboratory
technician with little supervision or by a team of
highly educated scientists, and may be done with
fruit flies or with primates. The costs will vary
accordingly.
The benefits and rates of return on a given ex-
periment vary widely. The rate of return for a
given research program can only be determined
reliably many years after commercialization. In
the case of products with high research and test-
ing costs and long lead times to commercializa-
tion, which applies to many of the products of bio-
medical research, the lag can be several decades.
A 1972 study on the rates of return for six large
pharmaceutical companies for research they con-
ducted in 1954 through 1961, when animals were
widely used, estimated the pretax private rate of
return to be 25 to 30 percent (2). The social rate
of return—the benefits to the public, was esti-
mated to be at least twice as high (20).
Another approach to gauging costs and bene-
fits involves looking at expenditures from 1900
to 1975 and comparing them with the benefits
of medical advances in preventing sickness and
death in the work force over the same period (4).
All data were adjusted to 1975 conditions. Anal-
ogous comparisons were made for 1930 to 1975.
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Of course, this approach ignores both the costs
of research before 1900 (or 1930) that contrib-
uted benefits after those years and any research
conducted before 1975 for which the benefits had
not fully accrued. The latter is more confound-
ing because much more research was done in the
last decade of the study than any other, so the
benefits could not be fully counted. Undervalue
also occurs because it is impossible to measure
the value of not being ill. Yet, other assumptions
in the study may overvalue the benefits by ne-
glecting changes in nutrition, lifestyle, and work-
ing conditions.
Benefits exceeded costs in this study by factors
ranging from 4 to 16, depending on the assump-
tions made in calculating benefits and whether
the time period is from 1900 to 1975 or 1930 to
1975. Expressing the results in another way, the
savings in health-related costs due to the increase
in knowledge was estimated to be $115 billion to
$407 billion (4,20).
Savings were also calculated for various disease
categories. As can be seen in table 11-1, research
costs in certain areas have exceeded benefits ac-
cruing over the same period (as indicated by a
minus sign). Table 11-2 provides related informa-
tion about levels of funding in selected years,
showing how funding grew during the same
period. The research budget for 1975 corresponded
to almost 9 percent of the costs associated with
neoplasms (data not shown in tables), whereas all
other budget-to-cost ratios were below 1.4 per-
cent (20).
Although economic and financial data such as
these are useful in making policy judgments, most
decisions about using animals are more compli-
cated and take into account political and technical
considerations, as well as economic ones. Mone-
tary costs and benefits must be balanced with fac-
tors such as scientists’ desire to be certain and
society’s desire to have animals treated in a hu-
mane fashion. Economic analysis focuses on only
part of the equation, and cannot be the sole basis
for decisions.
one example of the tension between financial
and other criteria is exemplified by the question
of whether pound animals should be used in lab-
oratory studies. A recent survey indicates that
about three times as many dogs and cats are ob-
tained from pounds and dealers (who often pur-
chase from pounds) as are purpose-bred for lab-
oratory use (18). Scientists have argued that
Table 11=1.—Total Savings Attributable to Biomedical Researcha (in billions)
Disease categorv 1900-75 simulation 1930-75 simulation
- .
Totalb . . . . . . . . . . . . . . . . . . . . , . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $299.37 to $479.83 $145.65 to $167.76
Infective and parasitic diseases . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Neoplasms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Endocrine, nutritional, and metabolic diseases . . . . . . . . . . . . . . .
Diseases of the blood and blood-forming organs . . . . . . . . . . . . .
Mental disorders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Diseases of the nervous system and sense organs. . . . . . . . . . . .
Diseases of the circulatory system . . . . . . . . . . . . . . . . . . . . . . . . .
Diseases of the respiratory system . . . . . . . . . . . . . . . . . . . . . . . . .
Diseases of the digestive system, oral cavity, salivary glands,
and jaws. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Diseases of the genitourinary system . . . . . . . . . . . . . . . . . . . . . . .
Complications of pregnancy, childbirth, and postpartum . . . . . . .
Diseases of the skin and subcutaneous tissue . . . . . . . . . . . . . . .
Diseases of the musculoskeletal system and
connective tissue. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Congenital anomalies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Certain causes of perinatal morbidity and mortality . . . . . . . . . . .
Svmptoms and ill-defined conditions . . . . . . . . . . . . . . . . . . . . . . . .
Accidents, poisonings, and violence . . . . . . . . . . . . . . . . . . . . . . . .
aMinus signs indicate  costs exceeded benefits.
%otals  may not add due to rounding.
118.35
–2.66
0.28
0.76
9.20
14,76
10.68
71.75
12.96
23.58
4.59
0.93
to 174,16
to –3.17
to 0.95
to 1,27
to 21.88
to 24.31
to 18.11
to 116.38
to 21.62
to 37.28
to 7.88
to 1.76
to 14.59
to 10.08
to 3.73
to 19.80
to 9.39
63.15
– 1.17
– 1.57
5.22
3.73
–3.32
–6.42
23.44
23.53
9.27
10.92
2.98
6.19
7.56
2.80
14.46
4.08
– 11.04
– 1.41
4.38
–2.10
26.05
to 69,23
to – 1.40
to –0.99
to 5.45
to 3.72
to –2.70
to –4.91
to 27.56
to 26.53
to 10.96
to 11.62
to 3.04
to – 10.98
to –1.11
to 6.58
to – 1.67
to 26.86
SOURCES: 1900.75 slmulatlon: S.J.  Mushkin, Biomedical Research: Costs  and Benefits  (Cambridge, MA: Ballinger Publishing Co., 1979); 1930.75 simulation: A. Berk
and L.C. Paringer,  Econornlc  Costs of Illness,  1930-1975 (Washington, DC: Public Services Laboratory, Georgetown University, 1977).
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Table 11-2.—Estimated Biomedical Research Outlays, Selected Years, 1900-75 (in millions)
Disease category 1900 1930 1963 1975
Total a . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . - - - - - -  - - - - - - - - .  - - -  - - - -  - - -
Infective and parasitic diseases . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Neoplasms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Endocrine, nutritional, and metabolic diseases . . . . . . . . . . . . . . . . . . . . . . .
Diseases of the blood and blood-forming organs . . . . . . . . . . . . . . . . . . . . .
Mental disorders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Diseases of the nervous system and sense organs. . . . . . . . . . . . . . . . . . . .
Diseases of the circulatory system. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Diseases of the respiratory system . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Diseases of the digestive system, oral cavity, salivary glands, and jaws .
Diseases of the genitourinary system . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Complications of pregnancy, childbirth, and postpartum . . . . . . . . . . . . . . .
Diseases of the skin and subcutaneous tissue . . . . . . . . . . . . . . . . . . . . . . .
Diseases of the musculoskeletal system and connective tissue . . . . . . . .
Congenital anomalies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Certain causes of perinatal morbidity and mortality . . . . . . . . . . . . . . . . . . .
Symptoms and ill-defined conditions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Accidents, poisonings, and violence . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
aTOtalS  may not add due to rounding.
$0.1570
0.0476
0.0195
0.0006
0.0003
0.0005
0.0072
0.0039
0.0305
0.0060
0.0129
0.0009
0.0002
0.0006
—
0.0085
0.0096
0.0068
$l0.0180
1.0329
2.8291
0.2775
0.0701
0.0461
0.2164
0.9136
1.0609
0.7273
0.9338
0.1142
0.0160
0.0240
0,1092
0.4448
0.2725
0.9377
$1,561.0
17.2
847.6
33.2
4.5
4.1
14.2
252.4
96.5
62.3
25.8
1.2
1.9
3.3
18.4
50.0
19.4
109.0
$4,640.0
37.6
2,464.8
109.0
12.5
22.7
41.3
876.0
261.7
175.4
66.8
0.9
4.6
12.1
32.0
68.7
74.2
379.6
SOURCEDatafrom S.J. Mushkin, Biomedica/  F?esearch:CosM  and Benefits (Cambridge, MA’ Ballinger Publishing Cov  1979)
pound animals are much cheaper than purpose-
bred ones and that it would be wasteful to de-
stroy them when they could be used. The differ-
ence in price between a purpose-bred and a
pound dog ranges from $200 to $500 per animal.
Estimates of the impact on research of a ban on
using pound animals range from a tenfold in-
crease in costs to effectively`stopping research
in Los Angeles County (25). Others have argued
that pound animals are poorly suited to most lab-
oratory work because they are often in poor
health and their genetic background is usually un-
certain (25).
It may seem ethically desirable to make use of
animals that would be killed anyway, but an ani-
mal that had been a pet may find laboratory con-
ditions more stressful than a purpose-bred ani-
mal would. Other nonpecuniary considerations
are that people may hesitate to bring their ani-
mals to a pound if they oppose laboratory use of
pound animals and that those using pound ani-
mals will see them as cheap, disposable experi-
mental tools that need not be conserved (22).
Supporting Patent Claims
Data derived from animal research have pro-
prietary value and are often used to support pat-
ent applications for drugs or devices for humans.
Patents give the inventor an exclusive right to
make and sell the patented invention, thus pro-
viding an incentive to invent, which in turn fuels
a growing economy. Thus, animal use can have
important economic consequences in addition to
improvement in health.
To obtain a patent, an inventor must show that
the invention is novel and useful and must dis-
close how to make it and use it. Data from studies
with humans are normally obtained to support
a patent on an invention to be used by humans,
but data on animals can provide evidence of util-
ity as well (12,15). And because they are normally
obtained before research is done on humans, such
data sometimes play a crucial role in determin-
ing the date of an invention, which could deter-
mine who gets the patent in the case of two com-
peting inventors.
Utility can be demonstrated with animal studies,
but only if the data would convince someone of
ordinary skill in the art that the same effect would
be observed in humans (14). The character and
quantity of evidence needed to show utility de-
pend, in part, on whether the results agree with
established beliefs (13). Courts recognize that an
animal may respond differently than a human
would (16), and in demonstrating the utility of an
invention it is not necessary to demonstrate safety
(11)17).
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In vitro experiments are sometimes sufficient
to demonstrate utility for patent purposes. In one
recent case (7), in vitro tests showed that the
chemical to be patented, an imidazole derivative,
inhibited thromboxane synthetase in blood plate-
lets. The activity of thromboxane synthetase was
thought to be related to hypertension, pulmonary
vasoconstriction, and other cardiovascular dis-
eases, and the demonstration of the chemical’s
ability to inhibit it was sufficient to show utility.
Data showing therapeutic use were not required
in showing that an invention had taken place. In
another case, the fact that the inventor had given
a detailed description of how the substance to be
patented would behave was enough to support
a showing of utility, thus fixing the date of inven-
tion (24).
Although the use of alternatives to support pat-
ents is interesting, it does not have much practi-
cal effect on the use of animals in developing med-
ical products because safety and efficacy must be
demonstrated to satisfy regulatory requirements
(see ch. 7). These patent cases might have some
application, however, in demonstrating the suffi-
ciency of alternatives in other areas.
COSTS AND BENEFITS IN TESTING
There are several major economic benefits to
using animals in toxicological testing. Drugs, food
additives, pesticides, and many consumer prod-
ucts are tested for toxicity or other kinds of haz-
ards before they can be marketed and begin to
generate income for the manufacturer. This is
often done to meet regulatory requirements, but
the tests are also done to avoid marketing unsafe
products. In addition, testing is done to confirm
that a product does in fact confer a benefit.
Testing Pesticides for Toxicity
Over a billion pounds of pesticides are used in
the United States annually, corresponding to over
$4 billion in sales. About 130 firms produce the
active ingredients in pesticides. Thirty of these
produce common products in high volume; the
others tend to produce specialty pesticides. Most
of the pesticides are used in the agricultural sec-
tor. About 7 percent are purchased by consumers
for home and garden use, while industrial and
institutional use account for about 20 percent (31).
Because pesticides are designed to be biologi-
cal poisons, they are among the most toxic sub-
stances commercially available. Most of the haz-
ards result from chronic, low-level exposure.
Exposure and the risk of it are widespread. About
2 million commercial farms in the United States
use pesticides, some of which remain in or on the
food and are eventually consumed. About 40,000
commercial applicators use pesticides to treat
structures and facilities. The Environmental Pro-
tection Agency (EPA) estimates that 90 percent
of all households regularly use or have used pes-
ticides in the home, garden, or yard (31). The re-
sults of tests on animals are used by EPA to iden-
tify hazards and to develop acceptable exposure
levels and safe handling and disposal practices (see
ch. 7). Thus, animal testing plays an important
role in the protection of virtually the entire U.S.
population.
Acute poisonings have been estimated to cost
over $15 million annually (1980 dollars), exclud-
ing the value of saving lives or avoiding suffer-
ing. The estimated cost of each death due to pes-
ticide poisoning is $112,000, whereas the average
cost of a nonfatal poisoning is $200 (23,31). The
costs of cancer, the most important chronic ef-
fect, is over $34 billion in 1980 dollars, with each
cancer costing $52,000 (31). One research goal is
to find new pesticides that are less toxic and more
effective than those now in use, a search that en-
tails animal testing.
There are over 48,000 registered pesticide for-
mulations, with an estimated 1,400 to 1,500 ac-
tive ingredients (5). There are between 5 and 20
new registrations for active ingredients issued an-
nually, each requiring a complete toxicological
evaluation based on animal testing and other data.
Another 1,500 to 2,000 new formulations or uses
are also registered annually (5,31). These require
little additional testing, as a rule, and often rely
on data in EPA’s files.
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Testing costs vary with the product and its uses.
Pesticides intended for food crops require much
more testing than those for other uses. Some of
the required testing depends on results obtained
in screening tests. The cost of testing can range
from $2 million to $5 million for a new active in-
gredient. This represents a small fraction of the
total developmental expenses, which may approach
$100 million (31). Testing costs are incurred pri-
marily in the beginning of the developmental
cycle (see fig. 11-2). As the figure illustrates, test-
ing with animals-during testing for toxicity—is
an integral part of the development of a new pes-
ticide.
Testing and Product Liability
Toxicological testing of consumer products
helps keep unsafe products off the market, It also
may sometimes allow liability for injuries to be
avoided. The cost of product liability litigation can
be enormous, and companies are tending to drop
risky products, as the current situation with vac-
cines illustrates.
Most States have “strict liability, ” in that a
manufacturer is liable for whatever injuries its
products cause. In most jurisdictions, there are
exceptions, such as when the technology for de-
termining that a product is unsafe does not ex-
ist. There are also exceptions when the product
is known to be dangerous but also to confer a
great benefit. Such is the case for rabies vaccine.
A few jurisdictions merely require that a manu-
facturer not be negligent (see ch. 7.) Manufac-
turers are unlikely to adopt alternatives to ani-
mal tests until they believe such methods offer
a level of assurance of product safety equal to that
offered by animal testing.
Testing Costs of Animals
and the Alternatives
An estimated 80 percent of the cost of testing,
whether whole-animal or in vitro, is for labor (6).
Testing costs vary widely with the assay used and
somewhat with the facility. The cheapest, such
as for eye or skin irritation, can be done for un-
\ Figure 11 ”2.—Development of a Typical Pesticide for Agriculture
(Note the integral role of animal toxicity testing in pesticide development, shown in boldface.)
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der $1,000. An LD5O test can be performed for
less than $2,000. Subchronic toxicity tests can cost
under $100,000, and those for long-term toxic-
ity or  carcinogenicity for two species can be done
for less than $1 million, and perhaps for under
$500,000 (10,31). As a rule, the cheaper tests re-
quire fewer animals, but more importantly they
take far less time at each of three stages—plan-
ning, execution, and analysis. Another reason for
large variations in testing costs is the species used,
with maintenance costs approximating $0.05 per
day for a mouse, $4 for a dog, and $11 for a chim-
panzee. Most of the cost of maintaining animals
is attributable to labor expenses.
Various short-term in vitro tests for mutagenic-
ity have been developed over the past 15 years
in an effort to replace the more costly and time-
consuming carcinogenicity test (see ch. 8). The
most popular mutagenicity test, and one of the
first to be introduced, is the Salmonella typhimu-
rium/microsome plate mutation assay (the Ames
test), costing $1,000 to $2,000 (10). This assay has
the most extensive database thus far (1). Used
alone, it does not appear to be as predictive of
human carcinogenicity as are animal tests.
If the Ames test, some yet-to-be developed test,
or a battery of tests proves to be more predic-
tive of carcinogenicity than testing with animals,
the savings could be enormous. A battery of tests
that might indicate  carcinogenicity has been sug-
gested by the National Toxicology Program (30)
and has shown some promise in preliminary
evaluations (see ch. 8). Most testing laboratories
could conduct this particular battery of tests for
under $50,000, and costs would probably decline
as the tests become more commonplace (10).
NATIONAL EXPENDITURES FOR RESEARCH AND TESTING
Research and testing in the United States are
financed and conducted in a variety of ways. The
sources of research funding are Government and
industry. Some Government research funds sup-
port Government laboratories, but a larger share
support research in academia. Industry research
is done primarily at in-house industry labora-
tories, with some funds contracted to other lab-
oratories and to academia.
Most testing is conducted by industry. The
chemical industry is the sector most directly af-
fected by regulatory policies concerning toxico-
logical testing. In 1982, this industry (Standard
Industrial Classification Code 28) had shipments
worth over $170 billion and employed 866,000
people, which represented 8.7 percent of all in-
dustry shipments in the United States and 4.5 per-
cent of the employees.
Drugs, soaps and toilet goods, and agricultural
chemicals account for the greatest use of animals
in testing, and constitute almost a third of their
use by the chemical industry. The rest of the chem-
ical industry, in order to satisfy transportation,
disposal, and occupational health requirements,
does simple tests such as the LD5O for substances
for which the potential exposure is high (see ch. 7).
Corporate research and development (R&D) in
the chemical industry is large and concentrated
in the industrial chemicals and drug sectors. Ex-
penditures by the industry totaled $7.6 billion in
1984 (8), a figure that includes in-house toxico-
logical testing, research involving the use of ani-
mals, and many other activities. It has been esti-
mated that the toxicological testing industry
accounts for just under 10 percent of the R&D
expenditures in the chemical industry (27), mak-
ing testing an estimated $700 million expenditure
in 1984. An unknown percentage is spent on re-
search involving animals.
In the past 10 years, industry’s R&D expendi-
tures have grown at about 13 percent per year,
following a slight decline in the early 1970s. R&D
expenditures for drugs, as a percentage of sales,
are twice as high as the industry average, and
have grown at a slightly higher rate (8). Animal
use could be growing at a similar rate, although
survey estimates (see ch. 3) and other factors (see
ch. 8) do not support this notion.
The Federal Government also plays a major role
in animal research and testing, with almost $6 bil-
lion obligated for research in life sciences for
1985. University research in the life sciences,
which is funded largely by Government and some-
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what by industry, will cost an estimated $2.9 bil-
lion (8).
Projections of future expenditures depend on
a number of factors, including the growth of the
chemical industry and of R&D within it; the areas
of R&D (e.g., new substances, new uses for old
substances, new processes for making old sub-
stances); regulatory policies, both domestic and
foreign; the growth of the overall economy; tax
policy; and further developments in nonanimal
tests.
International developments can have economic
repercussions. For example, Swiss voters defeated
in 1985a referendum virtually banning all animal
testing (see ch. 16). A number of companies have
facilities in Switzerland, and such a change could
have shifted testing to another country. whether
U.S. labs could compete for that business depends
on the strength of the dollar.
Toxicological Testing Services
In 1984, the toxicity testing industry in the
United States was estimated to be worth about
$650 million per year (27). Sixty-five percent of
the testing is done by corporations in-house. The
remaining 35 percent (about $225 million annu-
ally) is conducted by commercial laboratories,
universities, and other organizations. Although
there are over 110 U.S. laboratories that sell test-
ing services, most specialize in a small number
of assays and are not ‘(full service. ” Hazelton is
the largest of the full-service labs, with domestic
sales of $36 million in 1983. Except for Hazelton
and several other large commercial labs, the in-
dustry is a dispersed one, with the many small
commercial firms accounting for approximately
two-thirds of the value of domestic sales (10).
The industry expanded its facilities in the 1970s
in response to Federal regulatory changes and the
passage of the Toxic Substances Control Act. Test-
ing did not increase as much as expected, how-
ever, and in the early and mid-1980s the indus-
try was operating at 60 to 70 percent capacity (27).
This has led to fairly level prices over the past
few years and, in some cases, price cutting to
maintain market position. Because of this com-
petition, current prices reflect the actual costs of
testing. Testing laboratories often do not quote
set prices for some testing procedures or for par-
ticular batteries of tests, preferring to negotiate
on a case-by-case basis.
Government Toxicological
Research and Testing
The U.S. Government programs with strong ties
to toxicological testing are EPA, the National Cen-
ter for Toxicological Research in the Food and
Drug Administration, the Centers for Disease Con-
trol, and the National Institutes of Health (see table
11-3). other programs are not identified with sep-
arate budget line items and are dispersed among
various agencies and departments.
Table n-3.-Selected Federal Expenditures Reiated
to Toxicoiogicai Testing and Research, 1984-86
(in thousands)
1984 1985a 1986a
Environmental Protection Agency:
Program expenses . . . . . . . $327,145 $380,341$376,074
Toxic substances . . . . . . 34,484 39,341 38,660
Pesticides. . . . . . . . . . . . . 32,772 37,805 36,948
Research and
development. . . . . . . . . 144,903 195,449 212,061
Toxic substances . . . . . . 12,327 14,450 26,358
Pesticides. . . . . . . . . . . . . 1,738 5,121 6,938
Interdisciplinary. . . . . . . . 18,522 22,423 14,876
Food and Drug Administration:
National Center for
Toxicological Research . 21,132 21,575 22,284
Drug program ., . . . . . . . . . . 138,248 153,112 152,430
Food program . . . . . . . . . . . 115,541 109,538 113,907
Devices and radiologic
products . . . . . . . . . . . . . . 62,568 67,081 68,368
Centers for Disease Control:
Occupational safety and
health research . . . . . . . . 54,740 54,863 57,645
Research on chronic and
environmental disease . . 25,953 28,568 23,726
National Institutes of Health:
National Cancer Institute:
Cause and prevention. . . 276,075 301,655 285,844
Detection and
diagnosis . . . . . . . . . . . 63,182 70,524 66,839
Treatment . . . . . . . . . . . . . 340,041 367,940 351,683
National Institute of Environmental and
Health Sciences:
Characterization of
environmental
hazards . . . . . . . . . . . . . 19,152 21,136 21,601
Applied toxicological
research and testing. . 57,781 57,303 56,737
Intramural research . . . . . . . 48.643 55.051 52.536
aEstimates.
SOURCE: U.S. Executive Office of the President, Office of Management and Budg-
et, Budget of the United States Government, Fiscal Year IQ%  (Washing-
ton, DC: U.S. Government Printing Office, 1985),
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PROTECTING PROPRIETARY INTERESTS
In commercializing a particular product, animal
use may be limited to toxicity testing, but many
products rely on animals in the initial research
phase as well. These research and testing results
have proprietary value that is sometimes protected
by secrecy, other times by obtaining a patent. The
value of data that lead to a particular product may
depend more on the size of the market and its prof-
itability than on the cost of obtaining them, par-
ticularly when it takes a long time to generate the
data.
Cooperative Research and Testing
Two major competing factors influence the
sharing of research and testing costs— the desire
to keep information that has proprietary value
secret and the desire to share the very large ex-
penses that may be involved in generating it.
These business decisions are only slightly influ-
enced by Government policies. Another factor is
antitrust law, however, which is greatly affected
by such policies.
In considering the role of antitrust law, it is im-
portant to recognize that the results of research
and testing enable society to use resources effi-
ciently. Antitrust laws help ensure that these
efficiencies benefit consumers, by preventing
manufacturers, for example, from colluding to
maintain high prices. However, these statutes
have sometimes been applied in a way that im-
pedes technological development (3) by making
it difficult for companies to pool resources for
research so expensive that none would undertake
it alone.
In recent years, antitrust policies have been
changed or clarified so that resources can be
pooled more easily (19). One component of this
is the National Cooperative Research Act of 1984
(public Law 98-462). The Sherman and Clayton
antitrust acts still apply, but damages in private
suits are reduced from three times the value of
the unfair advantage to the actual value. This will
certainly lower the risks involved in collaborat-
ing, and probably the likelihood of being sued as
well.
Testing costs can be most equitably shared if
potential participants can interact before testing
begins rather than after it is completed, because
a party who has already tested may have an un-
fair advantage (or disadvantage) in negotiating
compensation. It is easiest to identify potential
sponsors for a particular chemical when testing
is required by a regulatory agency, because it is
known that testing will take place and who is re-
quired to test. When industry forms testing con-
sortia to share costs, it is most easily done through
existing trade associations, such as the Chemical
Manufacturers Association. Cooperative testing
is also conducted by industry through the Chem-
ical Industry Institute of Toxicology.
Many testing consortia have been put together
to negotiate agreements in anticipation of re-
quired testing under Section 4 of the Toxic Sub-
stances Control Act. Such negotiations were ruled
invalid in a recent case (2 I). Despite this ruling,
testing consortia will continue to have appeal so
long as testing is expensive and the results have
little or no proprietary value other than in ful-
fillment of regulatory requirements.
Toxicity Testing Data
Many companies begin making other financial
commitments to the commercialization of a prod-
uct before testing is completed. Plant design and
small-scale production may coincide with long-
term toxicity testing. The practical costs of ful-
filling lengthy testing requirements may greatly
exceed the costs of testing. Thus, it is advanta-
geous to be able to use any existing data gener-
ated by another laboratory in order to avoid the
delays and uncertainties of testing. Conversely,
this provides an incentive to prevent data from
being made available to competitors.
The protection of pesticide testing data has been
the subject of much litigation and several amend-
ments to the Federal Insecticide, Fungicide, and
Rodenticide Act (FIFRA). The most recent changes
provide that data submitted after September 30,
1978, are protected from uncompensated use for
15 years. There are two kinds of protection. One
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requires that data be shared as long as compen-
sation is offered. The terms of the compensation
are subject to arbitration if the parties cannot
agree. The other protection only applies to new
pesticides (new active ingredients), not to new for-
mulations of old ingredients. It gives exclusive use
of the data to the data owner for 10 years unless
the data owner explicitly agrees to sell the right
to use the data.
The Supreme Court recently decided in Ruck-
elshaus v. Monsanto (26) that these provisions of
FIFRA are constitutional. For data submitted be-
fore 1972 or after 1978, there is no expectation
of a proprietary interest, thus nothing is taken;
for data submitted between those years, the com-
pensation and arbitration provision, in combina-
tion with the Tucker Act, provides adequate com-
pensation. (See also the Environmental Protection
Agency’s regulations at 40 CFR 1984 ed. 152; 40
FR 30884.)
Congress has recognized the important business
interest in keeping information from competitors,
but it also supports the public’s ‘(right to know”
and the Federal Government’s need to know. An
important barrier to the sharing of confidential
business information among agencies is the differ-
ing standards and procedures for handling it. The
ad hoc interagency Toxic Substances Strategy
Committee, coordinated by the Council on Envi-
ronmental Quality, thought it would be necessary
to pass legislation permitting the sharing of con-
fidential data between health and environmental
agencies (32). Such legislation would establish a
need-to-know standard, require uniform security
procedures for the data to be shared, impose uni-
form penalties for disclosure, and provide for
notification of the data submitted by the data
holder at least 10 days prior to transfer.
SUMMARY AND CONCLUSIONS
The total dollar cost of animal acquisition and
maintenance is directly related to the length of
time animals stay in the laboratory. With no ac-
curate source of data on various species’ length
of stay, it is impossible to calculate the total cost
of animal use. Analysis of the factors involved in
the costs of animal acquisition and maintenance
indicates that a reduction in animal use will be
accompanied by a reduction in cost—although the
proportionate savings will be less than the propor-
tionate decrease in the number of animals used.
Many of the issues involved with using animals
in research and testing have economic implica-
tions, although they do not lend themselves well
to rigorous quantitative economic analysis be-
cause many considerations are nonmonetary. A
highly contested concern, for example, is the
propriety of using unclaimed pound animals in
laboratory studies.
An area of animal use that is of major economic
importance is biomedical research, which contrib-
utes to health care through the development of
drugs, medical devices, diagnostic techniques, and
surgical procedures. Health care accounts for
over 10 percent of the Nation’s gross national
product, or $355 billion in 1983. The results of
research with animals might also reach the pub-
lic through patented products. Although data on
humans may also be required, and although
nonanimal or in vitro methods are sometimes
sufficient, many such patent applications use ani-
mals to show that the invention is useful.
Another use of animals with economic impor-
tance is toxicological testing, used to ensure that
new products are sufficiently safe. One type of
product for which such testing is of major con-
sequence to public health is in the development
of pesticides, which affect virtually all Americans
through the production and contamination of
food. The Environmental Protection Agency has
estimated that 90 percent of all households use
some pesticide product.
Whole-animal tests can be far more costly than
in vitro and nonanimal alternatives, largely be-
cause they are labor-intensive. The incentives to
find alternatives to the LD5O and Draize tests are
primarily nonmonetary, however, as these tests
can be performed for $1,000 to $2,000. This is
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in the price range of the cheaper, currently avail-
able in vitro and nonanimal replacements.
Most research and testing in the United States
is financed by Government or industry. The
chemical industry, including the production of
drugs, has annual sales of over $170 billion and
spends over $7 billion on research and develop-
ment. An unknown fraction is spent on research
involving animals and about $700 million is spent
on toxicity testing.
The Federal Government sponsors much bio-
medical research and testing involving animals
(see  ch. 12). An unknown amount leads to the de-
velopment or use of alternatives. The Government
also has many programs related to testing, includ-
ing the evaluation of testing data generated in
other sectors. Agencies with significant budgets
for such activities include the Environmental Pro-
tection Agency, the Food and Drug Administra-
tion, the Centers for Disease Control, and the Na-
tional Institutes of Health.
The Federal Government also has a special role
in the sharing of data derived from animal use,
as the data have proprietary value. First, antitrust
laws and policies affect industry’s ability to share
data and the costs of generating it. Such sharing
is facilitated by the passage of the National Co-
operative Research Act of 1984. It is also facili-
tated under the Federal Insecticide, Fungicide,
and Rodenticide Act and the Toxic Substances
Control Act.
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Chapter 12
Public and Private Funding
Toward the Development
of Alternatives
The most authoritative source for information on alternatives to the use of live animals in
research is the NIH itself.
Eleanor Seiling
United Action for Animals, Inc.
April 18, 1984
Cutting the NIH appropriation and eliminating this Federal agency will be an excellent
place to start trimming waste from the Federal budget.
Helen Jones
International Society for Animal Rights, Inc.
July 1984
I become very suspicious when I see a grant for $5,664 or a grant for $22,000. What can
a researcher accomplish with $22,000?
Sen. Alfonse M. D’Amato (R-NY)
Senate Hearing
October 2, 1984
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Chapter 12
Public and Private Funding Toward
the Development of Alternatives
Attempts to find alternatives to using animals
in research, testing, and education are so diverse
that it is difficult to cite firm figures on funding
levels. An investigation of public and private fund-
ing practices does make it clear, however, that no
single policy covers such research and develop-
ment (R&D). Much of the work that could lead to
the replacement, reduction, or refinement of ani-
mal use is not even considered R&D of alterna-
tives by the body that funds it.
Research is seldom targeted toward alternatives
as ends in themselves. Few projects are initiated
with this specific goal. Consequently, confining the
inquiry to only those cases where development
of an alternative method is the desired result, such
as programs to find in vitro substitutes for the
Draize eye irritancy test, drastically narrows the
category of funding classified as supporting alter-
natives. In addition, it is especially difficult to ex-
amine funding policies related to reductions and
refinements, because these considerations gener-
ally enter into the construction of any protocol.
This chapter covers targeted as well as inciden-
tal cases of research into alternatives—investiga -
tions directed toward the development of alter-
natives as well as those pursued for other reasons
but that lead to or use alternatives. Also consid-
ered are research into laboratory-animal health
and some types of pain research that may increase
knowledge about the mechanisms of pain and im-
prove methods of alleviating distress. Resources
allocated to upgrading animal facilities are closely
related, since inadequate facilities may skew ex-
perimental results, thereby requiring that more
animals be used.
FUNDING TOWARD ALTERNATIVES IN RESEARCH
Developing replacements for the use of animals
in research is far more likely to be incidental than
targeted. Refinements and reductions may be in-
cidental developments as well, but they are more
likely to result from conscious efforts on the part
of the investigator. Areas in which alternatives,
especially replacements, are discovered will often
be those in which animals are not used at all. This
type of development is exemplified by basic re-
search in cell biology that resulted in improved
cell culture capabilities, and work in basic physics
that led to noninvasive imaging techniques. Iden-
tifying funding in this area is particularly difficult:
Few agencies view these projects as alternatives
to animal use or label them as such, even though
the methods may yield techniques and systems that
could replace animals, reduce the numbers used,
or refine the protocols. (Most testing-related re-
search has been deliberately excluded from this
category.)
In an attempt to obtain a rough indication of ex-
penditures on alternatives, OTA examined the
range of models in use, identifying the number
of projects and amount of research money in each
system area. Of course, not every nonanimal meth-
od evolves into an alternative to animal use. Yet
research in specific techniques, such as biostatis-
tics, may have broad or unanticipated applications
across many areas of research and testing.
Public Funding
Two major granting agencies, the National In-
stitutes of Health (NIH) and the National Science
Foundation (NSF), account for most of the basic
biomedical research sponsored by the Federal Gov-
ernment. Neither agency currently funds alterna-
tives as a targeted goal. In few cases is the devel-
opment of a replacement a major objective of the
research that produces one. However, considera-
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tion of models of all types, and the selection of a
research model appropriate to the problem un-
der investigation, occurs with every grant.  Other
scientific and ethical considerations may lead to
reductions and refinements within protocols dur-
ing the grant review process (see ch. 15).
National Institutes of Health
In fiscal year 1985, national expenditures on
health R&D exceeded $12.8 billion (24). Of this to-
tal, industry accounted for the largest portion (39
percent), followed by the National Institutes of
Health (37 percent), other Federal research, and
other funding groups (24). Of health R&D sup-
ported by the Federal Government, NIH has funded
approximately 90 percent in recent years (13).
About 60 percent of the research funded by NIH
can be characterized as basic (25). NIH basic re-
search has accounted in recent years for about
40 percent of all Federal basic research conducted
(18).
Until recently, NIH had no concerted program
under which it pursued the development of alter-
natives in research, as opposed to any such meth-
ods that may occur as byproducts during investi-
gations. However, the new Biological Models and
Materials Resources Section within the Division
of Research Resources may assume this function.
This office was created in February 1985 and
its function was mandated (Public Law 99-158) in
November 1985 to address the need to explore and
support the use of nonanimal models in biomedi-
cal research, Its missions include developing the
use of cell systems, lower organisms, and nonbio-
logical systems (mathematical and computer mod-
els) for biomedical research and actually provid-
ing biological materials that serve as critically
important resources to the biomedical research
community, such as those just mentioned (28).
The office intends to implement some of the rec-
ommendations offered in the recent report of the
National Academy of Sciences’ Committee on Mod-
els for Biomedical Research:
l As favorable systems are identified, the NIH
should strive to make them readily available
l
l
to the research community by providing sup-
port to supply organisms for research, main-
taining stock centers for mutant strains and
for cell lines, facilitating access to computer
programs for biomedical modeling, maintain-
ing databases like those for protein and DNA
sequences, and providing long-term support
for collections of cloned genes and useful vec-
tors or collections of monoclinal antibodies.
NIH should consider supporting proposals
whose objective is the development of model
systems for specific research areas. Indeed,
funds might be targeted for the development
of new model systems that appear to be par-
ticularly promising.
NIH should encourage interest in nonmam-
malian systems through postdoctoral fellow-
ships, symposia, and direct support of model
development (12).
The office today tracks the use of model systems
in research supported by NIH and serves as NIH’s
focal point for the exchange of information with
individuals, organizations, and institutions con-
cerning the use of model systems in biomedical
research. In addition, the Biological Models and
Materials Resources Section serves as the new
home of four previously existing resources:
l
l
l
l
The American Type Culture Collection:
Support for this collection of cultured cells,
$600,000 in fiscal year 1985, was recently
transferred from the NIH Director’s office.
The Massachusetts Institute of Technology
Cell Culture Center This facility produces
animal cells in large quantities tailored to spe-
cific investigator needs; 85 percent of its users
are NIH grantees. Funding is in the process
of being taken over from NSF in fiscal year
1985 (NIH contribution: $165,000) and will be
complete in fiscal year 1986.
Caenorhabditis elegans Genetics Center
This resource serves as a repository for
nematodal mutants and a clearinghouse for
the mapping of the C. elegans genome. It is
supported jointly with the National Institute
of Aging ($15,000 in fiscal year 1985).
National Diabetes Research Interchange:
This information resource is supported jointly
with the National Institute of Arthritis, Dia-
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betes, and Digestive and Kidney Diseases with
funds ($25,000 in fiscal year 1985) provided
through the General Clinical Research Centers
Program (28).
An analysis of research systems within various
projects and subprojects funded by NIH provides
some idea of the patterns of subjects and models
used overall for NIH; it may also indicate national
patterns because NIH supports more than one-
third of the health-related R&Din the United States
(24). Use of both human subjects and mammals
(expressed as the percentage of research projects
using each) was essentially stable from 1977
through 1982 (see fig. 12-1). At the same time there
was a slight increase (approximately 5 percent) in
the percentage of research dollars being spent on
mammalian systems and a corresponding decrease
in the percentage of research dollars spent on re-
search involving human subjects (see fig. 12-2). The
data in these figures do not indicate, of course,
the number of individual animals used; they only
illustrate the relative percentages of projects
funded and dollars spent among several types of
research subjects.
NIH-supported research uses many models.
Three widely used ones are in vitro cells and tis-
sues, invertebrates, and mathematical and com-
puter simulations, all commonly referred to in dis -
Figure 12-1 .-Trends in NIH Research Subjects,
1977=82, as Percentage of Research Projects
1977 1978 1979 1980 1981 1982
Fiscal year
SOURCE: J.D. Willett, “Biological Systems Used as Research Models in NIH Pro-
grams,” Animal Resources Program, Division of Research Resources,
National Institutes of Health, Bethesda, MD, Sept. 24, 1984.
Figure 12-2.—Trends in NIH Research Subjects,
1977.82, as Percentage of Research Dollars
w  h ~  -
1977 1978 1979 1980 1981 1982
Fiscal year
SOURCE: J.D, Willett, “Biological Systems Used as Research Models in NIH Pro-
grams,” Animal Resources Program, Division of Research Resources,
National Institutes of Health, Bethesda, MD, Sept. 24, 1984.
cussions about alternatives. In fiscal year 1981,
12 bureaus, institutes, or divisions (BIDs) of NIH
supported 378 research projects that used human
cells or tissues, for a total commitment of over $32
million (27). The projects included studies of cel-
lular aging, in vitro studies of immune response
and regulation of antibodies, the cellular basis of
disease, and the mechanisms of DNA repair. A fur-
ther 381 projects and subprojects used cells and
tissues from sources other than humans in the
course of their investigations. These accounted for
nearly $34 million, directed toward research into
models for diseases such as herpes, leprosy, and
parasitic diseases; hormonal effects on the con-
trol and function of differentiated cells; differences
between tumors and normal tissues; and other cel-
lular and biochemical mechanisms. Invertebrates
used in fiscal year 1981 included annelids, aplysia,
cephalopods, crustaceans, Drosophila, echino-
derms, gastropod, helminths, horseshoe crabs,
mollusks, nematodes, platyhelminths, and proto-
zoans, accounting for 608 subprojects and over
$46 million.
Mathematical models were used by 8 BIDs, in
23 projects and subprojects for nearly $1.2 mil-
lion, to analyze renal flow and neural networks,
to model biological waves and kinetics, to model
clinical trials, to predict fetal outcomes, and to sup-
port mathematical biology. Computer simulations
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were supported by 10 BIDs to study a range of
research questions including computer analyses
of cellular differentiation and homeostatic control
mechanisms, modeling of bladder cancer and
structure-activity relationships in drugs, simula-
tions of renal function, imaging reconstruction and
display of biological surfaces, and the modeling
of artificial intelligence. These 54 projects ac-
counted for close to $6 million in awards.
Nonanimal models, including invertebrates and
nonmammalian vertebrates in addition to those
described above, account for approximately 26
percent of NIH’s projects and an average of 29 per-
cent of the funds in any given year. Mammalian
systems account for slightly more than 43 percent
of the projects and about 46 percent of the dollars
spent. Many projects use several systems at once.
National Science Foundation
NSF considers project proposals for support in
all fields of science. Among its programs are eight
that have potential to support alternatives-related
research:
l
l
l
l
l
l
l
l
Behavioral and Neural Sciences,
Biotic Systems and Resources,
Information Science and Technology,
Mathematical and Computer Sciences,
Cellular Biosciences,
Molecular Biosciences,
Research Instrumentation and Equipment,
and
Science and Engineering Education (21).
The National Science Foundation normally does
not support clinical research either with humans
or animals, the development of animal models for
specific diseases or conditions, or the development
of drugs or other therapeutic procedures. For the
most part, it supports only what can be classified
as basic research.
The character of research projects and models
used in investigations funded by NSF varies widely.
Table 12-1 indicates the distribution of the ap-
proaches proposed in NSF research grants for fis-
cal year 1983. In the categories that include living
organisms, only those projects involving actual ex-
perimentation manipulations have been included.
Thus the data do not include studies on animals,
plants, or micro-organisms that are observational
or descriptive in nature; these might be ecologic
studies, population dynamics, and studies of field
behavior, for instance. However, field studies that
included the actual capture of animals, involved
invasive or noninvasive placement of electric track-
ing devices, or used physiological sampling were
included.
In addition, NSF supports three additional
awards that relate to the use of animals in research,
although these projects do not directly use ani-
mals, The first is a grant to the Institute of Labora-
tory Animal Resources of the National Academy
of Sciences for its activities in developing and mak-
ing available to the biomedical community scien-
tific and technical information on laboratory-ani-
mal science resources. The other two, related to
research on ethical issues surrounding the use of
animals, originate in the Ethics and Values in
Science and Technology (EVIST) program in NSF’s
Directorate for Biological, Behavioral, and Social
Sciences.
Table 12.1.—Approaches Used in National Science Foundation Research Grants, Fiscal Year 1983
Number of Range of award sizes
Approach used awards (in thousands) Total expenditure
Whole nonhuman primates . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33 $9-$135 $ 1,875,958
Whole nonprimate vertebrates . . . . . . . . . . . . . . . . . . . . . . . . . . . 552 2-289 32,872,503
Culture of animal-derived components (cells, tissues,
organs, or embryos) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 166 6-250 8,368,526
Mathematical modeling as an adjunct to animal use. . . . . . . . 22 9- 100 747,079
Mathematical modeling without animal use . . . . . . . . . . . . . . . 9 25- 176 657,000
Invertebrates ., . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 298 5- 266 18,451,785
Micro-organisms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 428 7- 250 21,440,070
Plants . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 398 9“ 250 20,288,332
Total ... , . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,906 $2-$289 $104,701,251
SOURCE: B.L.  Ummlnger, Deputy Director, Division of Cellular Biosciences, National Science Foundation, Washington, DC, personal communication, 19S4.
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Although many of the projects listed in table 12-1
involve the culture of animal derived components,
invertebrate animals, micro-organisms, plants, or
mathematical modeling, the intent of NSF-funded
investigations usually is not the development of
alternative methods to experimentation with live
animals. Nevertheless, the outcome of some of
these projects may lay the groundwork for the sub-
sequent development of alternative techniques.
The Biological, Behavioral, and Social Sciences
Directorate houses most of the work related to
alternatives. NSF’s total basic research budget is
approximately $1.5 billion in fiscal year 1986, in-
cluding approximately $260 million for this divi-
sion. If past patterns continue, the bulk of these
funds will not be spent on animal research but
on a much broader group of projects,
Small Business Innovation Research
The Small Business Innovation Act (Public Law
97-2 19) requires agencies of the Public Health Serv-
ice and certain other Federal agencies to reserve
a specified portion of their R&D budgets for the
Small Business Innovation Research (SBIR) pro-
gram. The stated goals of this project are to “stim-
ulate technological innovation, use small businesses
to meet federal research and development needs,
increase private sector commercialization of in-
novations derived from federal R&D, and to fos-
ter and encourage participation by minority and
disadvantaged persons in technological innovation”
(26). The NIH set-aside for the SBIR program to-
tals $18.2 million, NSF retains a similar SBIR set-
aside pool equal to 1.25 percent of its budget in
fiscal year 1986.
Small businesses seeking to commercialize alter-
natives can take advantage of these funds for prod-
uct research and development. The grants are
generally in the range of $35,000 to $100,000, de-
pending on how quickly commercialization is like-
ly to follow the research. For fiscal year 1983, NIH’s
SBIR program funded many projects that might
be related to alternatives, such as:
l phase I structure activity relationship estima-
tion of skin and eye irritation,
l an interactive teaching system for medical
students,
l
l
l
l
l
l
l
l
CAT scanning for carcinogenesis bioassay in
rodents,
cell growth chambers for chemotherapeutic
drug screening,
continuous cell culture for monoclinal anti-
bodies,
a new method to detect immune complexes,
synthetic peptides as animal vaccines,
bacterial/laser bioassay to detect environmen-
tal pollutants,
rapid methods to monitor genetic damage in
humans, and
development of mammalian cell culture aneu-
ploidy-assay.
Although not all of these will develop as replace-
ments, reductions, or refinements of animal use,
some may eventually produce commercially via-
ble alternatives.
Private Funding
Private funding in research, especially basic re-
search, is most difficult to evaluate and classify
according to its applicability to alternatives. And
because most basic biomedical and behavioral re-
search is sponsored by the Federal Government,
it is through public sector funding that alterna-
tives in research are most likely to develop.
Private foundations and research institutes sup-
port biomedical research internally as well as ex-
tramurally. Although some of this research may
pertain to alternatives, it is not often the case un-
less the mission of the institution is specifically re-
lated to animal welfare. Disease-oriented founda-
tions conduct research on aspects of a particular
system or affliction and support a variety of re-
search approaches, animal as well as nonanimal.
Though some of these initiatives may indeed qual-
ify as alternatives, examining this research on a
project-by-project basis is beyond the scope of this
assessment.
In 1985, the Nation’s first professorship in hu-
mane ethics and animal welfare was established
at the University of Pennsylvania School of Veteri-
nary Medicine with the an endowment of $1.25
million from Marie A. Moore. One goal of the en-
dowed professorship will be to investigate alter-
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natives to animal experimentation in medical re-
search (15).
Several foundations have animal welfare as their
primary mission or included as a principal goal.
Since 1981, the Geraldine R. Dodge Foundation has
disbursed over $450,000 in grants related to alter-
natives (7). The foundation awards grants in sev-
eral categories, including that of animal welfare.
Research grants include a 2-year contribution of
$115,409 to the Baker Institute for Animal Health
of Cornell University for the development of a cell
hybridization laboratory to enhance diagnostic,
therapeutic, and disease prevention capabilities.
Dodge has also contributed $63,000 to the Center
for Alternatives to Animal Testing (CAAT) at The
Johns Hopkins University to help cover the costs
of publishing the center’s newsletter. Additionally,
the Scientists’ Center for Animal Welfare (Bethesda,
MD) has received over $90,000 to date.
FUNDING TOWARD ALTERNATIVES IN TESTING
Funding of R&D on alternatives in testing is in
many ways the support most easily identified, espe-
cially when the alternative is intended to replace
a test that currently uses animals. This applied R&D
draws on basic research from other areas, incor-
porates it into a testing methodology, and then vali-
dates the new test. Developing an alternative re-
quires that the alternative system be shown to
correlate with the effect that is of interest. Nar-
row efforts such as these contrast markedly with
the broader goals of basic research, and the de-
velopment of alternatives is correspondingly easier.
Public Funding
Public funding of research toward alternatives
in testing stems from the Federal Government’s
role as regulator and guardian of safety. Federal
agencies conduct toxicological and other tests on
many substances and devices in order to estab-
lish effects as well as standards for safety (see ch.
7). The greatest impetus for Federal funding of
replacements for animal tests would be a strong
indication that an alternative could be found that
would be superior to the comparable conventional
assay with animals. This has not yet occurred in
terms of technologies that would totally replace
the use of animals, nor is it likely to in the near
future, although promising areas like in vitro as-
says may someday replace some whole-animal
tests. It is more likely that short-term in vitro tests,
functioning primarily as screens, will reduce the
number of substances run through the complete
battery of tests with animals (see ch. 8).
Toxicological Testing
The National Toxicology Program (NTP) was
chartered in 1978 as a cooperative effort by the
Department of Health and Human Services (DHHS),
involving four principal groups— the National Can-
cer Institute (NCI) and the National Institute of Envi-
ronmental Health Sciences (NIEHS), both of which
are part of NIH; the National Center for Toxico-
logical Research (NCTR) of the Food and Drug Ad-
ministration (FDA); and the National Institute for
Occupational Safety and Health (NIOSH) of the Cen-
ters for Disease Control (CDC). Fiscal year 1985
funding for the NTP totaled $76.7 million, drawn
from contributions by the DHHS member agen-
cies that were negotiated after each agency re-
ceived its congressional appropriation. NIEHS pro-
vides approximately 86 percent of the program’s
resources (8).
The stated goals of the NTP include the expan-
sion of toxicological information obtained on chem-
icals nominated, selected, and tested; the expan-
sion of the number of chemicals to be tested, within
the constraints of funding; the development, vali-
dation, and coordination of tests and protocols to
match regulatory needs; and the communication
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of program plans and results to the public (22,23).
Figure 12-3 illustrates the relative priorities of these
activities and their components with reference to
spending in fiscal year 1985. Testing activities con-
sume by far the largest share of resources. Within
each of the three divisions, efforts are divided into
four major areas: mutagenesis (cellular and genetic
toxicology), carcinogenesis, toxicological charac-
terization, and fertility and reproduction (repro-
ductive and developmental toxicology).
According to the NTP’s “Fiscal Year 1984 Annual
Plan” (22), planning activities are directed toward
reducing the number of chemicals that require
chronic testing through the development, valida-
tion, and application of more efficient and more
sensitive testing systems. It is in this area—estab -
lishing new batteries of tests and subsequently
validating them—that the development of alter-
natives is most likely to occur.
NIEHS directs between $18 million and $20 mil-
lion toward testing and research related to alter-
native test systems, especially short-term indica-
tors of intoxication. Approximately 85 percent of
this money is channeled through NTP in the form
of grants for research and testing, R&D contracts
for testing and development, and in-house re-
search. These funds cover the actual testing in addi-
tion to methods validation and evaluation of alter-
natives. Test systems receiving the bulk of attention
include bacteria, yeast, insects, and cultured cells
from mammalian tissues including humans (10).
Figure 12.3.—Funding Levels of National
Toxicology Program Activities, Fiscal Year 1985
(dollars in millions)
/
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SOURCE: L.G.  Hart, Assistant to the Director, National Toxicology Program,
Research Triangle Park, NC, personal communication, July 1985.
Beyond NCI, NIEHS, NCTR, and NIOSH (the four
constituent agencies of NTP), DHHS support for
research related to toxicology is also found within
the Alcohol, Drug Abuse, and Mental Health Ad-
ministration, CDC, FDA, and NIH. Substantial Fed-
eral support for toxicological research and testing
is also provided by the Environmental Protection
Agency (see ch. 11, table 11-3).
Food and Drug Administration
FDA conducts primarily mission-oriented, ap-
plied research. Its interest in alternatives derives
from FDA requirements for product testing. Al-
though intramural funds are not allocated on a
project-by-project basis, the agency has tried to
estimate expenditures on the basis of person-years
involved in the work (4). Assuming a person-year
is $40,000 (salary, overhead, and benefits), in-
tramural research into alternatives to testing with
animals was estimated at 35 person-years, an ex-
penditure of roughly $1.2 million. Extramural
work consists of one project, valued at $87,000,
to develop an in vitro model as a primary screen
to detect active agents against Dirofilaria immitis
larvae (a heartworm found in the dog, wolf, and
fox) and microfilariae (the prelarval stage of a para-
sitic roundworm). For the most part, these in vitro
models have been developed elsewhere, and these
projects involve the application to FDA-regulated
products. Tables 12-2 and 12-3 list alternative tests
currently under development and in use at the
Food and Drug Administration.
Private Funding
private sector motivation to develop alternatives
in testing ranges from scientific concerns through
economic and political ones. Investors in this sec-
tor account for perhaps the most diverse group
of supporters of this type of research.
Trade and Industrial Groups
The development of alternatives in testing is sup-
ported by trade groups and industry for several
reasons, mostly linked economically to the finan-
cial health of the company or industry. Commer-
cial concerns find alternative methods generally
take less time and labor and are therefore less ex-
pensive to perform than standard animal-based
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Table 12=2.—Alternative Tests Under Development
at the Food and Drug Administration
Tabie 12=3.-Aiternative Tests in Use
at the Food and Drug Administration
. Genetic probes for toxigenic strains of Campylobacter
jejuni
. Genetic probes for invasive Escherichia coli
. In vitro invasiveness test based on siderophore avidity
for iron
l Enzymatic and chemical in vitro evaluation of infant
formula protein quality
l Development of an assay for genetic transposition in
bacteria
l Cultures of rat embryos to detect agents that cause
developmental toxicity and to determine the
mechanism by which effects are produced
l Porcine kidney explant cultures for screening
potentially nephrotoxic agents
. In vitro macromolecular biosynthesis as an index of
potential tissue damage by chemical agents
. In vitro determination of effects of chemical agents of
T- and B-lymphocyte function
l Improved procedures for use of unscheduled DNA
synthesis for genotoxic effects
. In vitro use of renal cortex tissue to determine
biochemical correlates for evaluating toxicity of
natural toxicants
l In vitro assays to assess biological vaccine potency
and safety (diphtheria antitoxin, rabies, polio vaccines)
l I n vitro assays to assess drug potency (gonadotropin,
Iactogenic hormone, corticotropin, oxytocin, insulin)
l In vitro methods to determine percutaneous absorption
of hydrophobic compounds
l In vitro immunoassay methods (RIA, ELISA) for
assessment of immunotoxic effects of drugs and
environmental pollutants
l Liquid and thin-layer chromatographic methods for
ciguatera and paralytic shellfish toxins
. In vitro immunoassay methods (RIA, ELISA) for
assessment of seafood toxins
SOURCE: A.P. Borsetti,  Staff Scientist, Office of Science Coordination, Food and
Drug Administration, U.S. Department of Health and Human Services,
Rockville, MD, personal communication, 1985.
testing protocols. A desire for improved tests and
responsiveness to public concern over animal use
also drive the search for alternatives. As public
relations tools, nonanimal methods have proved
valuable in reassuring the public that these cor-
porations share their concern about animal use
and are exploring other systems, while being care-
ful not to jeopardize public health and safety.
In 1980, Revlon Research Center, Inc., awarded
a 3-year, $750,000 grant to Rockefeller University
to establish the Rockefeller Laboratory for In Vitro
Toxicology Assay. Revlon’s investment was the first
serious, publicly taken step by industry in the
search for alternatives. The Revlon award has been
extended into a fifth year and totals more than
$1.25 million (5). The laboratory employs four
scientific staff, working on projects including alter-
l Genetic probes for heat-labile and heat-stable
enterotoxin of Escherichia coli
l Genetic probes for invasive strains of Yersinia
enterocolitica
l Genetic probes for classical 01 cholera toxin
l Genetic probes for pathogenic organisms (01 and
Non-01 Vibrio cholerae, Vibrio parahemolyticus, Vibrio
vulnificus)
l In vitro tests for percutaneous absorption of cosmetic
ingredients
l In vitro cell transformation assay
l Unscheduled DNA synthesis in primary rat hepatocytes
l Salmonella microsome assay for gene mutations
• Limulus amebocyte Iysate test for pyrogenicity of
drugs and biologics
l Sister-chromatid exchange for assessing mutagenic
potential
l Use of primary myocytes and endothelial cells from
neonatal rat heart ventricles for identification of
potential cardiotoxic agents
Ž High-performance liquid chromatography as a screen
for the vitamin D assay (used for products other than
infant formula)
l Instrumental analysis assay for potency of three
anticancer drugs for batch release (Dactinomycin,
Doxorubicin hydrochloride, and Plicamycin)
. Instrumental analysis assays to determine the potency
of biological vaccines
l Genetic probes for invasive Shigella
l In vitro assays for tumor-producing potential (HL 60
differentiation, V-79 metabolic cooperativity, and
Epstein-Barr virus activation
. Assays for detection of mycotoxins (mass
spectrometry, instrumental methods, brine shrimp
assay)
SOURCE: A.P, Borsettl,  Staff Scientist, Office of Science Coordination, Food and
Drug Administration, U.S. Department of Health and Human Services,
Rockviile, MD, personal communication, 1985.
natives to the Draize eye irritancy test and other
animal cell culture applications. Prior to the estab-
lishment of this facility, there were no laboratories
committed to alternatives research.
The Johns Hopkins Center for Alternatives to
Animal Testing has committed $2.1 million to the
search for alternatives since 1981, funding 30
grants for research (19). The Center has both an
information program (consisting of a regularly
published newsletter, symposia, and a book series)
and a research program (focused on in vitro acute
and chronic toxicity testing and acute irritancy of
the skin and eye). The center’s enabling sponsor,
the Cosmetic, Toiletry, and Fragrance Association
(CTFA), is joined by other corporate donors, in-
cluding the Bristol Myers Company, as well as by
consumer and industrial groups and private indi-
viduals. CAAT solicits projects from scientists by
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Solicitation for Proposals by The Johns Hopkins
Center for Alternatives to Animal Testing
REQUEST FOR PROPOSALS
REQUEST FOR PROPOSALS
The Johns Hopkins Center for Alternatives to Ani-
mal Testing is soliciting proposals. These research
proposals should provide the fundamental knowl-
edge base to develop alternative methods to whole
animals for the safety evaluation of commercial
products.
The center is specifically interested in the use of
human cells and tissues. Funds are available for
studies of skin and eye irritation, inflammation,
acute toxicity, and other organ specific toxicity. At
the present time funds are unavailable for mutage-
nicity and carcinogenicity.
Grants will normally be funded up to a maximum of
$20,000 per year including 15 percent overhead or
actual costs, whichever IS less. All grants will be on
a yearly basis with continuation funding dependent
upon an acceptable continuation of proposal.
Abstract deadline: 30 March 1985.
Application deadline: 30 May 1985.
Application instructions can be obtained by contact-
ing: Joan S. Poling, Secretary to the Director, Room
2306, School of Hygiene and Public Health.
Taken from Science 227:212, 1985. Copyright 1985 by the
American Association for the Advancement of Science.
circulating requests for proposals either for a
broad, nonspecific area or for specific, investigator-
initiated projects. In the first stage of a two-stage
peer review, a group of scientific experts judges
the proposal on the quality of the science proposed
and its relevance to the mission of CAAT. Second,
the advisory board votes on which projects to fund.
The voting membership of the organization is aca-
demic, although nonvoting members do represent
the sponsors, government, and animal welfare
groups. Table 12-4 lists examples of some of the
projects funded by The Johns Hopkins Center.
The Soap and Detergent Association is support-
ing work at the University of Illinois to develop
alternatives to eye irritancy tests with a 3-year
grant of $218,596. The program is designed to de-
velop a mathematical model that would correlate
the responses to a series of in vitro tests with the
test material’s potential to irritate the human eye
(17). The Fund for Replacement of Animals in Med-
ical Experiments (FRAME) reports that it is col-
laborating with both the Rockefeller and Illinois
groups, providing chemicals for use in blind trials
on alternative methods (3).
These various examples of private funding illus-
trate the variety of mechanisms to provide sup-
Table 12-4.—Selected Research Projects Supported
by The Johns Hopkins Center for Alternatives
to Animal Testing
Condition and organ/Project description
Irritation and inflammation:
Vagina: Tests for vaginal products
Eyes: Corneal cultures for tests
Corneal cultures—plasminogen activator as an
indication of irritation
Skin: Human umbilical cord cells
Fibroblast damage by chemicals
Development of artificial skin
Phototoxic chemicals and skin
Architecture of skin in vitro
Biological change/toxic response
Cytotoxicity and acute toxicity:
Liver Response to toxins in solution
Cells: In vitro production of metallothionein
In vitro production of peroxisomes
Effects of culture media on cells
Chemicals’ effects on protein synthesis
Organ specific effects:
Heart, lung, kidney: Mechanistic data—acute and chronic
organ toxicity
Other projects:
Nerves: Neurotoxicity/neuronal cell culture
Teratology: Fruit fly assays
Botulism: Evaluation of contamination of foods
SOURCE: A.M. Goldberg, Director, The Johns Hopkins Center for Alternatives
to Animal Testing, Baltimore, MD, 1985.
port for the development of alternatives. The first,
the Rockefeller Laboratory, is a case in which a
corporation endows a single laboratory facility and
funds the work of scientists within that group. The
research conducted in the lab is closely allied with
the products manufactured by the sponsor and
with the testing required by those products.
The second model, exemplified by The Johns
Hopkins Center, is a central clearinghouse estab-
lished to collect and disseminate funds in a wider
variety of research areas. The source of the funds
is also varied. The grants distributed within this
structure are small (under $20,000) and not strictly
comparable to the support accorded to the Rock-
efeller lab, but The Johns Hopkins Center funds
many more grants.
The third example, the Soap and Detergent Asso-
ciation, shows a single project within a university
funded by an industrial concern. In this case the
association draws funds from its constituent mem-
bers and then acts as their proxy in distributing
them.
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Both the Animal Protection Institute and the In-
stitute for the Study of Animal Problems have sur-
veyed corporations that do animal research and
testing (2,14). Many companies indicated that they
were taking steps to promote alternatives. Sup-
port often took the form of membership in a trade
association (e.g., CTFA) that sponsors research into
alternatives. Others indicated that investigations
were being undertaken within their own research
programs. Responses and levels of commitment
varied greatly among corporations.
Animal Welfare Groups
Groups such as the American Fund for Alterna -
tives to Animal Research (AFAAR), the American
Anti-Vivisection Society, the New England Anti-
Vivisection Society, the Animal Welfare Founda-
tion of Canada, the Lord Dowding Fund in Great
Britain, the Millennium Guild, and the Muriel Low-
rie Memorial Fund have supported research in the
United States aimed at replacing animals in test-
ing protocols. These grants range in size from a
few thousand to several hundred thousand dollars.
AFAAR, for example, has provided some $130,000
in grants between 1977, when it was founded, and
1985 (l). Included among these are a grant of
$25,905 to develop a test system to determine the
nutritive value of protein in foodstuffs, using Tet-
rahymena (ciliate protozoans) in place of wean-
ling mammals. This test enables food producers
to provide correct diet supplements or therapeutic
diets. In addition, a grant of $45,000 was awarded
to develop a replacement for the Draize eye ir-
ritancy test using the chorioallantoic membrane
of the chick embryo. Additional funding for this
project has been supplied by other animal welfare
groups (a total of $148,500 from the Lord Dowd-
ing Fund, the American Anti-Vivisection Society,
the Muriel Lowrie Memorial Fund, and the Ani-
mal Welfare Foundation of Canada) and by the Col-
gate-Palmolive Company. In 1985, AFAAR joined
three other animal welfare groups in awarding
an additional $133,987 to develop procedures for
toxicology testing using monolayer cell cultures
in gradients of oxygen tension and temperature (l).
The Millennium Guild has offered $500,000 to
encourage the development and implementation
of testing methods that will replace or significantly
reduce the use of animals (11). There is a break-
through award of $250)000 for nonanimal replace-
ments for the Draize eye, the Draize skin, or the
LD5O tests for any scientist or team of scientists
who develops a cost-effective test or battery of tests
that can be validated and accepted by a U.S. regu-
latory agency. An equal sum is available to pro-
mote innovation and to reward the rapid reduc-
tion of widely used animal tests, These incentive
awards have been granted in areas such as uses
of liver culture, quantitative structure activity rela-
tionships, cell culture bioassays, and the use of pro-
tozoans as indicators of eye irritancy.
Foundations and Research Institutes
Foundations and research institutes often de-
vote in-house and other private funds to research
into alternate testing methodologies and systems.
Battelle Columbus Laboratories (Columbus, OH),
for example, is pursuing the development of many
alternatives. Its efforts fall into two major divisions,
mammalian and nonmammalian systems. The ba-
sic areas of system development include cell and
organ culture, in vitro teratology, and neurotoxi-
city. A figure of $500,000 has been conservatively
estimated as the investment in this area. The fund-
ing comes primarily from private sources and in-
cludes both internal and external funds. Some of
the projects now under way are cell culture initi-
atives, including microphage work, and teratolo-
gy research using rat embryo and frog embryo
cultures (16),
FUNDING TOWARD ALTERNATIVES IN EDUCATION
Funding of research toward alternatives in edu- education. Alternatives in education also often orig-
cation, especially within the public sector, stems inate as research simulations, and then move back
more from a renewed emphasis on science and into the classroom. Exceptions to this are projects
math education and on computers than from sub- undertaken for the express purpose of develop-
stantial concerns with methods of animal use in ing replacements for animals in the classroom, or
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programs developed in order to cultivate attitudes
conducive to the further development and imple-
mentation of alternatives (see ch. 9). Some of these
other initiatives, such as those funded by groups
interested in issues pertaining to animal use, have
developed from concerns related to humane edu-
cation.
The Health Professions Educational Assistance
Amendments of 1985 (Public Law 99-129) author-
ized the Secretary of the Department of Health
and Human Services to make grants to veterinary
schools for work related to alternatives. These
grants can support the development of curricula
for:
Ž training in the care of animals used in re-
search,
l the treatment of animals while being used in
research, and
l the development of alternatives to the use of
animals in research.
Since 1981 the Geraldine R. Dodge Foundation
has given over $240,000 toward education-related
alternatives programs including:
l $25,000 to the Biological Sciences Curriculum
Study to support the development of materials
at the high school level relating to animal wel-
fare as a legitimate consideration in biology;
l
l
l
more than $50,000 to the National Associa-
tion for the Advancement of Humane Educa-
tion to support the development of People and
Animals, an interdisciplinary humane educa-
tion guide for preschool through sixth-grade
teachers;
$50,000 to the American Society for the Pre-
vention of Cruelty to Animals to broaden and
strengthen its humane education component,
particularly through four 15-minute humane
education television programs for elementary-
school children developed in cooperation with
the New York City Board of Education; and
$30,000 toward the development at Cornell
University of Resusci-Dog, a canine cardio-pul-
monary resuscitation mannequin (see ch. 9);
this is the first of a series of simulators, in-
cluding one that will demonstrate irregulari-
ties in heartbeat rhythm (7).
The American Fund for Alternatives to Animal
Research supports a series of intensive training
sessions on in vitro toxicology for students plan-
ning a biomedical career to promote the develop-
ment of scientists who are well trained in the uses
and limitations of replacement techniques. This
$39,000 grant supports courses that cover the the-
ory and practice of cell and tissue culture, in vitro
mutagenesis, transformation, and cytotoxicity (20).
RELATED TYPES OF FUNDING
Three additional categories of funds maybe con-
sidered in conjunction with efforts to develop alter-
natives. These types of projects are more likely
to contribute to reductions and refinements than
to replacements. Grants to improve animal facili-
ties, research in animal health, and research into
pain can have broad implications for research, test-
ing, and education.
Animal-Facility Improvement Grants
Research support through grants to improve fa-
cilities for housing animals is not specifically de-
signed to promote the development of alternatives,
but it may assume that role nonetheless. The qual-
ity of animal care provided directly affects the
health of experimental animals. Those maintained
within a more controlled environment are less like-
ly to exhibit variations stemming from exposure
within that environment, And if they are kept un-
der conditions better suited to their individual
needs, they are less likely to exhibit symptoms of
stress. These negative effects, all resulting from
the intrusion of external stimuli, may skew the re-
sults of an experiment. Less reliable results may
in turn demand that more animals be used for each
protocol, perhaps a needless addition under bet-
ter conditions.
To address this problem, the Division of Research
Resources within NIH is offering grants for the
development and improvement of animal facilities
so that institutions can comply with the Animal
Welfare Act and with DHHS policies on the care
and treatment of animals. Eligibility is open to any
nonprofit institutions engaged in research sup-
ported by NIH. Two programs currently exist. The
first, an ongoing program, has funded from two to
four proposals each year for the past several years.
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Funds for alterations and renovations are limited
to $100,000, although requests for funds for equip-
ment may push the total above this amount.
The second program draws from a one-time pool
of $5 million. Support for new construction is not
available, and funding for alterations and renova-
tions is limited to $500,000 for each award, Recip-
ient institutions are required to match these funds
dollar for dollar. As in the ongoing program, funds
may be requested for equipment in addition to this
amount. More than 100 applications have been re-
ceived; of these, only 12 requested the maximum
funds for renovations and alterations. Many, how-
ever, exceeded $700,000 in their total request. The
applications averaged in the $300,000 to $400,000
range. Some 12 to 15 projects are likely to be
funded, and grants will probably range from $65,000
to $750,000 (9).
It is important to note that at least two other
sources of funding for improvement of animal fa-
cilities are available to NIH grantees. First, an in-
stitution’s maintenance of facilities is an allowa-
ble indirect cost of research. Second, the National
Cancer Institute is allowed to make awards for fa-
cilities renovation (6).
Groups other than NIH are also devoting re-
sources to improvements in animal facilities. In-
dustry laboratories, contract laboratories, and
universities are mustering both internal and ex-
ternal funds to improve their facilities. For com-
mercial groups, a longer term economic advan-
tage is recognized in these efforts. Contract testing
labs, in particular, have special incentives to main-
tain the highest laboratory standards in order to
attract clients.
Research in Animal Health and Pain
Funding devoted to research in animal health
can function in an analogous fashion to efforts to
improve animal care facilities. It creates the scien-
tific base on which improvements in facilities and
practices may be based, The larger the knowledge
base on animal research grows, the more exact
and focused research using animals can become
and, ultimately, the smaller the number of animals
included in individual protocols.
Parallel with this, research into the mechanisms
of pain and pain perception can contribute knowl-
edge that allows researchers to alleviate pain in
experimental protocols. This can include research
on the detection of pain and distress, for example,
that would allow an investigator to detect these
phenomena with greater sensitivity. Advances in
analgesics and anesthetics may produce less dis-
tortion in some protocols and allow animals a great-
er degree of comfort.
As an example, Humane Information Services,
Inc., awarded $184,000 in research grants during
1984 to support eight agricultural research projects
directed toward the alleviation of animal suffer-
ing. Included were studies on the behavioral ef-
fects of several types of housing for pigs and
chickens, studies of electronic immobilization, and
projects aimed at reducing the stress of weaning
and pre-slaughter handling. Similar efforts could
be undertaken in testing and research to maximize
the information obtained from protocols while
minimizing pain and suffering for the subjects.
SUMMARY AND CONCLUSIONS
Measuring the funding of alternatives is inex- The development of alternatives, especially re-
act at best. Funding of replacements is easiest to placements, is likely to be the result of multidisci-
measure, while the data are poor for reductions plinary efforts, executed over relatively long pe-
and refinements. The easiest type of research to riods of time. The results of research can be
recognize and categorize as related to alternatives transferred across the sciences—as has happened,
is targeted research. Such work is most often asso- for example, with the noninvasive imaging tech-
ciated with technique development—for example, nologies developed by physicists that are now used
the effort to replace whole-animal testing assays in the biomedical sciences.
with in vitro tests, as with the Draize eye irritancy
test.
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Three types of grants can augment the develop-
ment of alternatives. Funding to improve animal
facilities can result in healthier, less stressed ani-
mals and can free research from the confounding
variables bred by a less well defined or inferior
environment. Grants to investigate improvements
in animal health in general can have the same ef-
fect. And research into the mechanisms govern-
ing pain may spare animals some measure of suf-
fering when the techniques are incorporated into
other protocols.
The development of alternatives in research is
funded largely by incidental means through the
support of basic biomedical research by the Na-
tional Institutes of Health and the National Science
Foundation plus a few targeted efforts that are
supported privately. In a climate of finite research
resources, research and development of alterna-
tives to animal use take their place in the competi-
tion among research priorities. A noteworthy ef-
fort by NIH was the creation of the Biological
Models and Materials Resources Section within the
Division of Research Resources. With funding, this
office may serve as a focal point for the exchange
of both nonvertebrate biological materials and in-
formation about the use of model systems in bio-
medical research.
In testing, a solid organizational structure for
R&D of alternatives is in place, best illustrated by
the National Toxicology Program and the Food and
Drug Administration in the public sector and by
the Rockefeller Laboratory for In Vitro Toxicol-
ogy Assay and The Johns Hopkins Center for Alter-
natives to Animal Testing in the private sector. Any
strong indication that an alternative test method
would be superior to a comparable conventional
animal assay is likely to attract funding readily.
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Chapter 13
Federal Regulation of Animal Use
There is a debate as to what is the right of a mouse. Why are we wasting time in
Washington with taking seriously this business?
James D. Watson
Cold Spring Harbor Laboratory
As quoted in Science 228:160, 1985
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Chapter 13
Federal Regulation of Animal Use
This chapter describes Federal law, as enacted
and currently interpreted, that directly governs
and regulates the acquisition and use of laboratory
animals for research and testing. Federal laws and
regulations governing the purchase, sale, handling,
or transportation in commerce of animals for ex-
hibition, domestic, or other purposes unrelated
to research, testing, and education are not exam-
ined. Federal laws and regulations that have been
interpreted to require testing with certain meth-
odologies or protocols are considered in chapter
7, and appendix B describes regulations promul-
gated and guidelines issued by specific Federal
agencies, pursuant to statutory authority, to reg-
ulate laboratory-animal use in required or spon-
sored research and testing.
FEDERAL LAWS AND
Long before passage of the Laboratory Animal
Welfare Act (Public Law 89-544) in 1966, Con-
gress–following a trend against cruelty to animals
that had manifested itself in some States through-
out the 19th century-in 1873 passed the first
Twenty-Eight Hour Law (Act of Mar. 3, 1873). Ac-
tion was taken by the national legislature under
its powers to regulate interstate commerce because
of the toll exacted in animal flesh, literally, by in-
humane conditions of rail transport for meat-pro-
ducing livestock. The law barred confinement of
livestock in rail cars for longer than 28 hours,
Continuing expressions of concern led to repeal
of the original act and the passage in 1906 of the
Twenty-Eight Hour Law still in effect today (45
U.S.C. 71-74). (In the intervening three decades,
22 States passed general anticruelty statutes (13).)
Since enactment of the 1906 act preceded the rise
of interstate motor traffic, its provisions regulat-
ing length of confinement and conditions of treat -
ment during shipment do not apply to trucks (39).
Similar concerns about needless suffering under-
gone by food-producing animals led Congress to
pass the Humane Slaughter Act (public Law 85-
765) in 1958, permitting slaughter only by “hu-
mane” means.
After 1966, concerns about animals led to Fed-
eral protection of:
l Horses l with the passage in 1970 of the Horse
Protection Act (public Law 91-929), against an
unesthetic physical practice on animals to
produce a physical appearance aesthetically
l
l
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appealing to humans (“soring” the ankles to
produce a high-stepping gait);
marine mammals as a class (whales, por-
poises, seals, and polar bears, for the most
part), with the passage in 1972 of the Marine
Mammal Protection Act (Public Law 92-522)
against extinction or depletion from indiscrim-
inate taking, including hunting, harassment,
capture, and killing (permitted takings, includ-
ing for subsistence and research purposes,
must be accomplished humanely, with “the
least degree of pain and suffering practicable
to the animal”); and
endangered and threatened species, with
the passage in 1973 of the Endangered Spe-
cies Act (Public Law 93-205), making it unlaw-
ful to buy, sell, or transport in interstate or
foreign commerce any species found to be en-
dangered and closely regulating commerce in
any species threatened with extinction.
Thus, Congress has acted on several occasions
over the past century to protect animals, both as
individuals and as species (i.e., marine mammals
and endangered species). The degree of commit-
ment to protection of animals through proscrip-
tion, regulation, and enforcement varied, with
Congress exhibiting a tendency toward stricter
controls beginning in the 1970s. Similarly, recent
exercising of the constitutional authority of the
Federal Government over interstate commerce
seems to be based on interests broader than the
welfare or treatment of individual animals -e.g.,
saving a species from extinction.
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Congressional handling of humane treatment for
experimental animals, discussed in this chapter,
is an interesting mixture: It professes to protect
the individual animal (e.g., the experimental sub-
ject), but it establishes classifications that favor
some animals over others. It uses Federal author-
ity over interstate commerce to regulate the pro-
curement and housing of laboratory animals, but
it does not use it to the same degree as for other
animals in other circumstances. Though Congress
has found less-than-humane treatment of labora-
tory animals to be worth exercising authority over
interstate commerce in order to control, it has not
judged the burden on commerce to be serious
enough to preempt the regulatory field. By a cau-
tious exercise of its power, Congress has acknowl-
edged implicitly that there is some intrinsic pub-
lic value in animal experimentation and that the
uniqueness of the process of experimentation re-
quires a deliberate approach, in order to achieve
one policy objective without sacrificing the other.
The Laboratory Animal Welfare Act
The 1966 Act
Finding increasing evidence that dogs and cats
owned as pets were being stolen by unscrupulous
dealers, moved across State lines, and resold to
research institutions to satisfy a demand for ex-
perimental subjects, Congress enacted the Labora-
tory Animal Welfare Act in 1966. The act sought
to head off these abuses by requiring dealers and
research facilities that handle, care for, treat, or
transport certain animals “in commerce” to fol-
low standards to be developed and issued by the
U.S. Department of Agriculture (USDA). The pur-
poses of the act were:
l
l
l
“In
to protect the owners of dogs and cats from
theft of such pets;
to prevent the use or sale of stolen dogs or
cats for purposes of research or experimen-
tation; and
to establish humane standards for the treat-
ment of dogs, cats, and certain other animals
by animal dealers and medical research fa-
cilities.
commerce” meant interstate commerce be-
tween States, the District of Columbia, territories,
and possessions; between points within a State,
the District of Columbia, a territory, or a posses-
sion, but through an outside point; or within the
District of Columbia, a territory, or possession.
Thus, to be covered by the act a dealer or research
facility would have to acquire, for a use covered
by the act, a regulated animal that had moved, or
at some point would move, “in commerce.”
Although “animal” was defined to include non-
human primates, guinea pigs, hamsters, and rab-
bits, recordkeeping requirements were restricted
to dogs and cats. Humane treatment was required
on the premises of animal dealers, in transit, and
at research institutions. The act established a sys-
tem for licensing dealers and registering research
facilities, with monitoring by Federal regulators.
The Secretary of Agriculture was vested with the
power to promulgate and enforce standards for
humane care, treatment, and housing of protected
animals. The act provided for the suspension of
the license of any dealer violating its provisions
and, upon conviction, imprisonment of not more
than 1 year and a fine of not more than $1,000.
The law’s reach extended to transportation of reg-
ulated animals by the supplier, but not by common
carriers. The Secretary was authorized to coop-
erate with State and local officials to prevent theft
of dogs and cats, apprehend pet thieves, and admin-
ister the previsions of the act. In addition, the Sec-
retary was directed to establish rules for inspec-
tions of premises and of the required records of
licensed dealers and registered research facilities,
primarily to expedite the search for stolen pets.
As applied to research, the act’s reach was short.
Research facilities to be regulated were limited by
definition to those that:
. used or intended to use dogs or cats in exper-
iments, and
l either purchased them “in commerce” or re-
ceived any Federal funds for research, tests,
or experiments.
Covered facilities were required to register with
the Secretary rather than be subject to more strin-
gent licensure requirements. Research-animal sup-
pliers were subject to the new law’s requirements
only if they bought, sold, or transported dogs or
cats and if the dogs or cats supplied were used
for research by the client institution. In other
words, research facilities could continue to pro-
cure experimental animals from farms, munici-
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pal pounds and shelters, and ‘(duly authorized
agents of local governments, ” rather than having
to acquire animals only from licensed dealers. Re-
search facilities were defined to include ‘(major
research facilities and exclude the thousands of
hospitals, clinics, and schools which use other ani-
mals for research and tests, ” though research or
experimentation included use of animals as teach-
ing aids in educational institutions associated with
major research facilities.
A specific and unequivocal exemption from
newly devised standards for humane treatment
for actual research activities was included. USDA
jurisdiction over research activities was confined
to care and treatment of research animals in an
institution’s holding facilities. The drafters of the
bill were careful to point out that the exemption
of research procedures was not to be compro-
mised. The conference report stated the legisla-
tion’s intent was (38):
. . . to provide protection for the researcher in
this matter by exempting from regulation all ani-
mals during actual research or experimentation,
as opposed to the pre- and post-research treat-
ment. It is not the intention of the committee to
interfere in any way with research or experi-
mentation . . . [T]he Secretary is not authorized
to prescribe standards for the handling, care, or
treatment of animals during actual research or
experimentation by a research facility. The im-
portant determination of when an animal is in
actual research so as to be exempt from regula-
tions under the bill is left to the research facility,
but such determination must be made in good
faith.
Regarding the power to require regular record-
keeping and to inspect premises to assure compli-
ance, the committee intended:
. . . that these inspectors will be employees of the
U.S. Department of Agriculture. . . [and that] in-
spectors not be permitted to interfere with the
carrying out of actual research or experimenta-
tion as determined by a research facility. . . [and]
that inspection. . . be specifically limited to searches
for lost and stolen pets by officers of the law (not
owners themselves) and that legally constituted
law enforcement authorities means agencies with
general law enforcement authority and not those
agencies whose law enforcement duties are lim-
ited to enforcing local animal regulations. It is not
intended that this section be used by private citi-
zens to harass or interfere in any way with the
carrying out of research or experimentation. Such
officers cannot inspect the animals when the ani-
mals are undergoing actual research or experi-
mentation.
Unlike dealers, research facilities were subject only
to civil penalties (a fine of up to $500 for each of-
fense) for violation of the act.
In the Senate committee’s report on its version
of the bill leading to the act, comments from rele-
vant executive agencies were included. The De-
partments of Commerce and the Treasury and the
Federal Aviation Administration deferred to the
views of USDA and the Department of Health, Edu-
cation, and Welfare (DHEW). The Under Secretary
of DHEW opposed licensure for research facilities
and restrictions on procurement by them of experi-
mental subjects from other than licensed sources.
Noting that the agency charged with enforcing the
new law would be USDA, the letter expressed sup-
port “for sound legislation to alleviate abuses which
now exist in the transportation, purchase, sale,
and handling of animals intended for use in re-
search laboratories .“ The Secretary of Agriculture
responded as follows (38):
This Department conducts programs in re-
search related to animal production and animal
diseases. In addition, it is charged with the admin-
istration of programs for the control and eradi-
cation of infectious, contagious, and communica-
ble diseases of livestock and poultry; for the
prevention of the introduction and dissemination
[in] the United States of such diseases; and for
the prevention of the exportation of diseased live-
stock and poultry. It also administers laws re-
garding the humane slaughter and treatment of
livestock.
. . . There are many State laws covering [illicit
traffic in family pets] and licensing requirements
pertaining to dogs are common. Since the oper-
ating methods of people who steal family pets and
the commercial aspects of the purchase and trans-
fer of dogs and cats in commerce are not areas
as to which this Department has expertise, we
are unable to evaluate the effectiveness of exist-
ing State laws. In respect to animals, the func-
tions of this Department relate basically to live-
stock and poultry, Accordingly, there is a question
as to whether it would not be desirable that a law
such as that in question be administered by a Fed-
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eral agency more directly concerned and having
greater expertise with respect to the subject than
this Department.
USDA estimated that administration of the act
would cost approximately $2 million per year. It
was authorized to assess “reasonable” fees for
licenses issued. Judging that the exact cost was
undeterminable, because it was not known how
many new dealers would be licensed, Congress
included a general authorization for appropria-
tions (38).
1970 Amendments
Continued allegations of poor treatment of ani-
mals by unregulated parties and expressions of
concern for experimental animals besides dogs and
cats prompted Congress to pass the Animal Wel-
fare Act of 1970 (Public Law 91-579) to cover a
broader class of animals, including those exhibited
to the public and sold at auction, and to regulate
anyone engaged in those activities.
The amendments broadened the 1966 act’s cov-
erage beyond dogs, cats, monkeys, guinea pigs,
hamsters, and rabbits to protect all warm-blooded
animals as the Secretary of Agriculture may de-
termine are being used for research, testing, ex-
perimentation, exhibition, or as pets. Excluded spe-
cifically from the new definition were horses not
used for research and other livestock, poultry, and
farm animals used for food or fiber production
(7 U.S.C. 2132@). The 1970 amendments define
the word “animal” as:
. . . any live or dead dog, cat, monkey (nonhuman
primate animal), guinea pig, hamster, rabbit, or
other such warm-blooded animal, as the Secre-
tary may determine is being used, or is intended
for use, for research, testing, experimentation,
or exhibition purposes, or as a pet.
The act does not appear to give the Secretary
the discretion to determine that a warm-blooded
animal used for experimentation is not an “ani-
mal” for purposes of the act. The act gives the Sec-
retary the authority to determine only whether
or not a warm-blooded animal is being used or is
intended for use for experimentation or another
named purpose. If the warm-blooded animal is
judged as being used in that way, it is an “animal”
under the act’s coverage (6).
In 1977, the Secretary promulgated regulations
that specifically excluded rats, mice, birds, and
horses and other farm animals from the defini-
tion of “animal” (9 CFR I. I(n),(o)). The introductory
comments published by the Secretary upon issu-
ing the regulation did not discuss the basis for this
exclusion (42 FR 31022) (6).
The Secretary’s 1977 regulatory exclusion of rats
and mice from coverage by the act appears to be
inconsistent with the language of the 1970 amend-
ments. The exclusion of rats and mice from the
definition of “animal” appears to frustrate the pol-
icy Congress sought to implement in 1970 and con-
sequently to be beyond the Secretary’s statutory
authority (6).
The Secretary’s enforcement powers over the
expanded classes of licensees and registrants were
broadened by adding to the definitions of “com-
merce” and “affecting commerce.” These expanded
concepts made it plain that the act extended to
trade, traffic, commerce, and transportation among
States and, further, that Congress considered any
activity leading to the inhumane care of animals
used for purposes of research, experimentation,
exhibition, or held for sale as pets as constituting a
burden, obstruction, or a substantial effect on the
free flow of commerce. Penalties exacted against
persons convicted of interfering with, assaulting,
or killing Federal inspectors were increased, and
the Secretary’s authority to obtain adequate infor-
mation to sustain administration was augmented
by broadening discovery procedures. A new provi-
sion was added, establishing a legal agency relation-
ship between a covered entity and any person act-
ing for or employed by that entity, essentially to
ensure that the Secretary could hold licensees and
registrants to account for the acts, omissions, and
failures of their agents or employees.
The definition of research facility was amended
to include those using covered live animals, not
just live dogs and cats, but the Secretary was given
the authority to exempt institutions not intending
to use live dogs or cats, unless other animals would
be used in “substantial numbers.” Regulation of
covered research facilities was increased to require
annual reporting and to add civil penalties for any
refusal to obey a valid cease and desist order from
the Secretary.
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The amendments announced a commitment to
the humane ethic that animals should be accorded
the basic creature comforts of adequate housing,
ample food and water, reasonable handling, de-
cent sanitation, sufficient ventilation, shelter from
extremes of weather and temperature, and ade-
quate veterinary care, including the appropriate
use of pain killing drugs. Besides adding handling
to the basic categories of care, treatment, and trans-
portation of covered animals, the standard of “ade-
quate veterinary care” was broadened to include
the appropriate use of anesthetic, analgesic, or
tranquilizing drugs, when the use of such drugs
is considered proper in the opinion of the attend-
ing veterinarian at a research facility.
The prohibition on interference with research
was qualified in 1970 with a proviso that every
covered research facility must show, at least an-
nually, that professionally acceptable standards
of animal care, treatment, and use are being fol-
lowed by each research facility during actual re-
search or experimentation. However, the intent
regarding the continued prohibition on interfer-
ence in experimentation itself was clear (35):
. . . it is the intention of the committee that the
Secretary neither directly nor indirectly in any
manner interfere with or harass research facil-
ities during the conduct of actual research or ex-
perimentation. The important determination of
when an animal is in actual research is left to the
research facility itself.
Similarly, the House Committee on Agriculture’s
report on this bill stated that the inspection sec-
tion applies only to agencies with general law en-
forcement authority and is not intended to "be used
by private citizens or law enforcement officers to
harass research facilities and in no event shall such
officers inspect the animals when the animals are
undergoing actual research or experimentation .“
In summarizing these provisions, the report said
that “the research scientist still holds the key to
the laboratory door. This committee and Congress,
however, expect that the work that’s done behind
that laboratory door will be done with compas-
sion and with care” (35).
The committee report included a letter from the
USDA Under Secretary indicating the Department:
l
l
l
was doing everything possible to carry out its
assigned responsibilities under the act within
the limitations of available resources of a fis-
cal year 1970 appropriation of $337)000;
agreed with the objective of the legislation con-
cerning the need for humane care and handl-
ing of laboratory animals during actual re-
search and experimentation, but believed “that
the Department of Health, Education, and Wel-
fare is the appropriate agency to administer
such an activity. We would expect to work
with that Department to help assure consist-
ency of standards and make other necessary
arrangements to promote the objectives of
both [laws]”; and
suggested that regulating the humane care and
handling of animals by exhibitors should be
the responsibility of State and local agencies,
rather than the Federal Government.
The committee’s report, noting that license fee
collections and appropriations in fiscal year 1971
were expected to total $376,600, projected that
the responsibilities added by the 1970 amendments
would increase related program costs by approxi-
mately $1.2 million annually. The report responded
to research facilities’ concerns that compliance
with higher standards for adequate veterinary care
would require substantial expenditures for new
plants, equipment, and better trained personnel
by urging “that adequate funds from Federal
sources be made available for those research fa-
cilities which depend to a large extent on support
derived from both State and Federal sources for
laboratory facility improvements” (35).
1 9 7 6  A m e n d m e n t s
Amendments to the Animal Welfare Act in 1976
(Public Law 94-279) enlarged its provisions to de-
fine more sharply and to simplify the regulation
of animals treated inhumanely during transpor-
tation affecting interstate commerce and to com-
bat ventures involving animal fighting. In brief,
the amendments having an effect on experimen-
tation:
l added a specific finding that activities or ani-
mals regulated by the act are in interstate and
foreign commerce and do, in fact, burden or
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substantially affect the free flow of commerce,
making regulation necessary to relieve those
burdens;
reordered the statement of policy to reflect
Congress’ desire to:” 1) insure that animals in-
tended for use in research facilities or for exhi-
bition purposes or for use as pets are provided
humane care and treatment; 2) to assure the
humane treatment of animals during trans-
portation in commerce; and 3) to protect the
owners of animals from the theft of their ani-
mals by preventing the sale or use of animals
which have been stolen’’—in that order;
simplified the definition of “commerce” by
eliminating the definition of “affecting com-
merce)” and substituting a definition of “State”
(the conference committee resisted an attempt
to narrow the definition of “commerce” by
adopting a provision from the Senate-passed
bill that would have done so with an amend-
ment that retained the act inclusion of com-
merce between intrastate points but through
a place outside the State);
extended required “dealer” licensure by re-
defining “dealer” to include persons who ne-
gotiate the purchase or sale of protected ani-
mals for profit;
broadened the definition of animal to correct
a then-existing interpretation that hunting,
security, and breeder dogs did not fall within
the act’s protection;
required carriers and intermediate handlers
of animals, not otherwise required to be li-
censed, to register with the Secretary;
extended the agency relationship, recordkeep-
ing, and other existing regulatory require-
ments to carriers and intermediate handlers;
increased the Secretary’s options for enforce-
ment and collections by revising the section
on penalties and appeals and by increasing
the daily civil penalty for violation of cease
and desist orders from $500 to $1,000 for all
classes of regulated parties;
extended to Federal research facilities the ex-
isting requirement to demonstrate at least an-
nually that professionally acceptable stand-
ards governing the care, treatment, and use
of animals are being followed; and
required the Secretary to consult and coop-
erate with other Federal departments, agen-
cies, or instrumentalities concerned with the
welfare of research animals, where transpor-
tation or handling in commerce occurs.
USDA estimated that the enlarged responsibili-
ties for establishment and enforcement of humane
transportation standards and certification prac-
tices and the oversight of compliance by carriers
and intermediate handlers would increase its an-
nual operating costs by $565,000 in fiscal year 1977
and $385,000 per year thereafter. (The decline in
required outlays in future years was attributed
to a reduced need for training and orientation.)
The Congressional Budget Office (CBO) estimated
a total startup cost in fiscal year 1977 of $968,000—
some $570,000 for transport standards and certifi-
cation enforcement and $398)000 for investigation
of animal fighting ventures. That estimate pro-
jected a gradual increase in each segment of new
enforcement outlays for 5 years, with total costs
for these new responsibilities rising to $1,304 )000
by fiscal year 1981. CBO questioned USDA’s esti-
mates of declining costs, pointing out that USDA
had factored in neither anticipated higher salary
costs in the future nor the total anticipated cost
of enforcing the new Federal ban on animal fight-
ing. Neither agency projected any offsetting in-
crease in miscellaneous receipts, since newly cov-
ered carriers and intermediate handlers would not
be required to become licensed. Reflecting uncer-
tainty about the total costs of the new effort to
regulate animal transport, House and Senate con-
ferees agreed to remove the House-passed funding
ceiling of $600,000 per year, though the annual
ceiling for enforcing animal-fighting prohibitions
was fixed at $400,000 (36).
1 9 8 5  A m e n d m e n t s
With the enactment of the Food Security Act of
1985 (Public Law 99-198), Congress amended the
Animal Welfare Act for the third time. The amend-
ments, effective December 1986, strengthen stand-
ards for laboratory-animal care, increase enforce-
ment of the Animal Welfare Act, provide for the
dissemination of information to reduce unintended
duplication of animal experiments, and mandate
training for personnel who handle animals. For
the first time, the Department of Health and Hu-
man Services is brought into the enforcement of
the Animal Welfare Act, as the Secretary of Agri-
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culture is directed to “consult with the Secretary
of Health and Human Services prior to the issu-
ance of regulations” under the act.
The statute requires the Secretary of Agricul-
ture to issue minimum standards for all aspects
of the veterinary care of animals, including stand-
ards for the exercise of dogs and a physical envi-
ronment adequate to promote the psychological
well-being of primates. The Secretary shall require
that no animal be used in more than one major
operative experiment from which it is allowed to
recover, except in cases of scientific necessity or
by determination of the Secretary.
Each research facility covered by the Animal
Welfare Act—including Federal facilities—is re-
quired to appoint an institutional animal commit-
tee that includes at least one doctor of veterinary
medicine and one member not affiliated with the
facility. The latter is intended “to provide repre-
sentation for general community interests in the
proper care and treatment of animals.” Any mem-
ber of the committee revealing confidential infor-
mation is subject to a fine of up to $10,000 and
three years’ imprisonment. The committee must
inspect all animal study areas at least twice a year.
USDA shall inspect each facility at least once a year,
and each facility is required to report at least an-
nually to USDA that the provisions of the act are
being followed. (Committees in Federal facilities
will report not to USDA, but to the head of the
Federal entity.)
This provision for institutional animal com-
mittees, taken in concert with similar provi-
sions in the Health Research Extension Act of
1985 (Public Law 99-158) and the policy of the
Public Health Service (see app. C), brings the
overwhelming majority of experimental-ani-
mal users in the United States under the over-
sight of a structured, local review committee.
USDA is directed to establish an information serv-
ice at the National Agricultural Library (NAL). The
service, in cooperation with the National Library
of Medicine, shall provide information that could
prevent the unintended duplication of animal ex-
perimentation, reduce or replace animal use, min-
imize animal pain or distress, and aid in the train-
ing of personnel involved with animals.
The law requires research facilities to provide
for scientists, animal technicians, and other per-
sonnel involved with animal care and treatment
training on:
l the humane practice of animal maintenance
and experimentation;
l methods that minimize or eliminate the use
of animals or limit animal pain or distress;
l the utilization of the NAL information serv-
ice; and
l the way to report deficiencies in animal care.
Current  Provis ions  Governing  Research
In addition to the provisions of the 1985 amend-
ments, there are 14 key provisional of the Animal
Welfare Act, as amended, that affect research fa-
cilities:
l Definition of “Research Facility. ” The act
defines “research facility” to cover any indi-
vidual, institution, organization, or postsec-
ondary school that uses or intends to use live
animals in research, tests, or experiments and
that purchases or transports live animals in
commerce or receives Federal funds for re-
search, tests, or experiments. Exemptions may
be granted where dogs or cats are not used,
except where the Secretary determines that
substantial numbers of other types of warm-
blooded animals are used and the principal
purpose of the entity covered is biomedical
research or testing [7 U.S.C.A. 2132(e)]. For
these to be a violation under this provision,
it must be established that Federal jurisdic-
tion extends to the particular facility—either
that some connection exists between animals
acquired or used and interstate commerce,
or that Federal funding support is received
for the contemplated research. Research facil-
ities that receive no Federal support for experi-
mental work and that either purchase animals
IPertinent previsions of the act are discussed in the order they
appear in the U.S. Code, with cross-references where appropriate.
A]] parenthetical references in this section are to current provisions
of chapter 54 of Title 7 of the Code, which can be found in Title
7, “Agriculture,” IV.S.  C’ode  Annotated,  $52131-2152 (St. Paul, NIN:
Wrest  Publishing Co.), 1973 Edition (126-139) and 1984 Supplement
(126-139).
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within their own State or maintain intramural
breeding colonies are not “research facilities”
under this definition.
Registration Requirement. Research facil-
ities not otherwise required to be licensed as
a dealer or exhibitor are required to register
with the Secretary [7 U.S.C.A. 2136]. Most U.S.
research facilities covered by the act are thus
required only to register, rather than to pay
license fees and submit to more stringent com-
pliance requirements and criminal penalties.
A “dealer” is someone engaged in interstate
trade of regulated animals for research, teach-
ing, or exhibition, or for companion, hunting,
breeding, or security purposes. ‘(Exhibitors”
include carnivals, circuses, and zoos touch-
ing commerce in some way, excluding “retail
pet stores, organizations sponsoring and all
persons participating in State and county fairs,
livestock shows, rodeos, purebred dog and
cat shows, and any other fairs or exhibitions
intended to advance agricultural arts and
sciences)” as determined by the Secretary [7
U.S.C.A. 2132(h)],
Acquisition of Dogs and Cats. Covered re-
search facilities (including Federal agencies
[7 U.S.C.A. 2138]) may not purchase dogs or
cats from anyone other than a person hold-
ing a valid license, unless the seller is not re-
quired to be licensed by the act, or an oper-
ator of an auction sale [7 U.S.C.A. 2137], who
may also need a license [7 U.S.C.A, 2142], Only
dealers and exhibitors who meet the act’s defi-
nitions for those activities, and auction sell-
ers who sell dogs or cats “affecting commerce)”
must be licensed.
Responsibility for Employees and Agents.
A principal-agent relationship between re-
search facilities and their agents or employ-
ees concerning any “act, omission, or failure”
is created by statute [7 U.S.C.A. 2139]. This
provision creates a legal presumption that a
covered research entity knows about, and is
responsible for, transgressions of the act by
its employees or authorized agents.
Recordkeeping for Animals Research facil-
ities must make and retain records only with
respect to the purchase, sale, transportation,
identification, and previous ownership of live
dogs and cats [7 U.S.C.A. 2140].
l
l
l
l
Animal Marking Requirements. Generally,
the act requires that all animals delivered for
transportation, transported, purchased, or
sold, in commerce by a dealer or exhibitor be
marked or identified as required by the Sec-
retary. Research facilities need only mark or
identify live dogs and cats (7 U.S.C.A. 2141].
Compliance With Auction Sale Rules. Re-
search facilities involved in purchase, handling,
or sale of animals in commerce at auction sales
must comply with humane standards and rec -
ordkeeping requirements established by the
Secretary to regulate those activities [7
U.S.C.A. 2142].
Standards of Care and Treatment. The gen-
eral grant of rulemaking authority to the Sec-
retary for establishing minimum requirements
for handling, housing, feeding, watering, sani-
tation, ventilation, shelter from extremes of
weather and temperature, adequate veteri-
nary care (including appropriate use of anes-
thetic, analgesic, or tranquilizing drugs, when
such use would be proper in the opinion of
the research facility’s attending veterinarian),
and separation of species when necessary may
not be construed as authorizing the Secretary
to promulgate rules, regulations, or orders
with regard to design, outlines, guidelines, or
performance of actual research or experimen-
tation by a research facility as determined by
such research facility. But the Secretary must
require every facility to show annually that
professionally acceptable standards govern-
ing animal care, treatment, and use, “includ-
ing appropriate use of anesthetic, analgesic,
and tranquilizing drugs, during experimen-
tation are being followed by the research fa-
cility during actual research or experimenta-
tion” [7 U.S.C.A. 2143(a)].
‘Animal Certification Requirements. Re-
search facilities may not deliver for handling
or transportation in commerce any dog, cat,
or other designated animal without a certifi-
cate of inspection, executed by a licensed
veterinarian not more than 10 days prior to
delivery, for freedom from infectious diseases
or physical abnormalities that would endan-
ger the animal or other animals or endanger
public health. The statute permits the Secre -
tarv bv regulation to exempt from this require-
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ment animals shipped to research facilities for
purposes of research, testing, or experimenta-
tion requiring animals not eligible for such
certification [7 U.S.C.A. 2143(b)].
Minimum Age for Transport. Research fa-
cilities may receive dogs, cats, and other des-
ignated animals younger than the minimum
age requirement for transportation in com-
merce established by the Secretary pursuant
to the act [7 U.S.C.A. 2143(c)].
Federal Facilities Federal agencies with lab-
oratory-animal facilities are required to com-
ply with regulations for humane treatment in
commerce as they apply to nongovernmental
research facilities [7 U.S.C.A. 2144].
Inspections Research facilities are required
to grant inspectors reasonable access to their
places of business, facilities, animals, and rec-
ords. Inspectors are empowered to confiscate
or destroy in a humane manner any animal
found to be suffering as a result of a failure
to comply with the act, its regulations, or
standards, if such animal is held by a research
facility and is no longer required by such re-
search facility to carry out the research, test,
or experiment for which such animal has been
utilized [7 U.S.C.A. 2146(a)]. Research facilities
engaged in the purchase, handling, or sale of
animals are also required to permit inspections
by legally constituted law enforcement agen-
cies in search of lost animals [7 U.S.C.A. 2147].
Penalties, Hearings, and Appeals. For any
violation of the act, its regulations, or stand-
ards, a research facility maybe assessed a civil
penalty up to $2,500 for each day of noncom-
pliance. Knowing failure to obey a cease and
desist order can result in an additional pen-
alty of $1,500 for each day of noncompliance.
Research facilities are not subject to criminal
penalties for violations [7 U.S.C.A. 2149(b),
(c),(d)].
Annual Report to Congress. Each March,
the Secretary of Agriculture is required tore-
port to Congress the identification of all re-
search facilities that are required or choose
to be licensed, the nature of all investigations
and inspections conducted and reports re-
ceived, and the Secretary’s suggestions for
legislative changes to improve the administra-
tion of the act. The annual enforcement report
cannot be released to non-Federal entities until
it has been made public by a congressional
committee [7 U.S.C.A. 2155].
Regulations
Congress intended that the broad statutory frame-
work it had erected in the Animal Welfare Act be
fleshed out to achieve the law’s general objectives.
USDA received common grants of discretionary
power and ministerial duties, giving the Secretary
both latitude to exercise judgment in enforcing
the law and the obligation to execute a number
of distinct duties.2
Responsibility for administration was delegated
by the Secretary to the Administrator of the Ani-
mal and Plant Health Inspection Service (APHIS).
Ministerial and enforcement duties are the prov-
ince of the APHIS Deputy Administrator for Veteri-
nary Services, and initial collection of records and
supervision and assignment of inspectors are done
by Veterinarians-in-Charge, based in APHIS’s State
offices in each of five geographic regions through-
out the United States. Except for the Northeast re-
gion (served centrally by a Boston office), every
State has an APHIS office, usually in the capital
[7 CFR 371.2(a),(d); 9 CFR l.l(a)-(j)l. Inspectors
known as Veterinary Services Representatives per-
form investigative tasks in consultation with an
attending veterinarian or with a three-member
committee employed by a registered research fa-
cility (one of whom must be a licensed veterinar-
ian), which is responsible for evaluating the type
and amount of anesthetic, analgesic, and tranquil-
izing drugs used on animals during actual research,
testing, or experimentation where appropriate to
relieve all unnecessary pain and distress in the sub-
ject animals [9 CFR l.l(ee)].
“Animal” includes ‘(any live or dead dog, cat,
monkey (nonhuman primate mammal), guinea pig,
hamster, rabbit, or any other warm-blooded ani-
mal, which is domesticated or raised in captivity
or which normally can be found in the wild state,
ZPertinent  provisions are discussed in this section in the order in
which they appear in the published regulations, with cross-references
where appropriate. All parenthetical references are to Title 7, Part
371, and Title 9, Parts 1-4, of the U.S. Cocfe  of Fecfera/ Regulations
(Washington, DC: General Services Administration, 1984).
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and is being used, or is intended for use, for re-
search, testing, experimentation or exhibition pur-
poses, or as a pet” [9 CFR I. I(n)]. By regulation,
this definition excludes birds, rats, mice, and horses
and other farm animals intended “for use as food
or fiber, or livestock or. . . [for] improving animal
nutrition, breeding, management, or production
efficiency, or for improving the quality of food or
fiber” [9 CFR 1.l(n),(o)l. The definition of “dog” is
enlarged to include those used for hunting, secu-
rity, or breeding purposes [9 CFR l.1(1)-(n),(q)]. The
farm-animal exemption and expanded dog defini-
tion reflect changes in the act made in 1970 and
1976. The only warm-blooded animals, other than
those specified in the act, that the Secretary has
chosen to designate are marine mammals.
A research facility not otherwise required to be
licensed must register with APHIS by completing
a standard registration form and filing it with
the office in the State of its principal place of busi-
ness. The registrant receives a copy of the form
and “applicable standards” from APHIS and is re-
quired to acknowledge their receipt and agree to
comply with the standards by signing a form [9
CFR 2.25-2.26].
Each “reporting facility” (each segment of a reg-
istered facility using experimental animals and for
which an attending veterinarian has responsibil-
ity, including departments, agencies, and instru-
mentalities of the United States) must file an an-
nual report, signed by a legally responsible official,
showing that professionally acceptable standards
governing the care, treatment, and use of animals,
including appropriate use of anesthetic, analge-
sic, and tranquilizing drugs, during actual re-
search, testing, or experimentation, were followed
by the facility. The report, due by December 1 and
covering the preceding Federal fiscal year (Oct.
l-Sept. 30)) must include:
l the location of the facility where animals were
used;
. common names and approximate numbers of
animals on which research, experiments, or
tests were conducted involving:
(a) no pain, distress, or use of pain-relieving
drugs;
(b) accompanying pain or distress to the ani-
mals, for which appropriate anesthetic,
l
analgesic, or tranquilizing drugs were used;
and
(c) pain or distress to the animals for which
the use of appropriate anesthetic, analge-
sic, or tranquilizing drugs would adversely
affect the procedures, results, or interpre-
tation of the research, experiments, or tests
and a brief statement explaining the rea-
sons for the same (in all three cases, rou-
tine procedures—injections, tattooing, and
blood sampling–need not be reported);
and
certification by the attending veterinarian or
institutional committee that the type and amount
of anesthetic, analgesic, and tranquilizing
drugs used on animals during research, test-
ing, or experimentation was appropriate to
relive pain and distress for the subject ani-
mals (9 CFR 2.28).
Research facilities must observe certain require-
ments for maintaining identification of dogs and
cats either received from or consigned for deliv-
ery into commerce. Live dogs and cats so consigned
must bear either the original tag or tattoo, or a
tag, tattoo, or collar supplied by the facility, that
identifies each animal by description or number
[9 CFR 2.50e)].
Records on acquired dogs or cats must be kept
and maintained to disclose the name and address
of the person from whom the animal was acquired;
the official tag number or tattoo; a description of
each live dog or cat, including species, sex, date
of birth or approximate age, color and distinctive
markings, and breed or type; and the number as-
signed to the animal by the facility.
Facilities that transport, sell, or otherwise dis-
pose of a live dog or cat must maintain on forms
furnished by APHIS, in addition to the above in-
formation, the name and address of the person
into whose custody the animal is delivered, the
date of delivery, and the method and identifica-
tion of mode of transportation.
Research facilities may not destroy or dispose
of required records without the written consent
of APHIS, and records must be held for longer
where necessary to comply with any other Fed-
eral, State, or local law (9 CFR 2.100). Research
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facilities (like dealers, exhibitors, and auction oper-
ators) must open their records to APHIS requests
for information and inspections related to the act’s
enforcement as well as their facilities, during or-
dinary business hours, and they must be willing
to have the facility’s name published in a periodic
list of registered facilities (9 CFR 2.126-2.127). They
must also open their premises to inspection by po-
lice or legally constituted law enforcement agen-
cies with general law enforcement authority (other
than agents whose sole authority is to enforce lo-
cal animal regulations) for inspections for miss-
ing animals, where the authority provides a de-
scription of the animal and the owner’s name and
address and agrees to abide by institutional pol-
icies concerning spread of disease and animal
escape, but such searches cannot be extended to
animals undergoing actual research or experimen-
tation, as determined by the facility (9 CFR 2. 128).
An APHIS inspector can act to confiscate and
destroy an animal found to be suffering as a re-
sult
the
l
l
l
of a research facility’s failure to comply with
act, its regulations, or its standards only:
if the animal suffering through such failure
is no longer required to carry out the research,
test, or experiment for which it has been
utilized;
if the inspector has made a reasonable effort
to notify the facility and request that the re-
sponsible condition be corrected or appropri-
ate veterinary care be given, and the facility
refuses to comply; or
if the inspector is unable to locate or notify
a representative of the facility, in which case
a local law enforcement officer may be con-
tacted to accompany the inspector to the
premises to either provide veterinary care or
confiscate and destroy the suffering animal.
Costs of care or destruction are to be borne by
the violator facility. If the animal to be destroyed
is an endangered species, the Deputy Administra-
tor is required to consult with the Department of
the Interior and the International Union for the
Conservation of Nature and Natural Resources [9
CFR 2.129].
Research facilities are required to comply with
detailed standards for humane care and treatment,
except that nothing in the rules, regulations, or
standards may affect or interfere with the design,
outlines, guidelines, or performances of actual re-
search or experimentation by a research facility
as determined by such research facility (9 CFR
2.100(a)).
Part 3 of the regulations details specific stand-
ards for humane care and treatment according
to category of defined animal—dogs and cats,
guinea pigs and hamsters, rabbits, nonhuman pri-
mates, marine mammals, and warm-blooded ani-
mals other than the above species-under three
headings:
l
l
l
Facilities and Operating Standards (general,
indoor, and outdoor facilities and primary en-
closures);
Animal Health and Husbandry Standards
(feeding, watering, sanitation, employees, clas-
sification and separation, and veterinary care);
and
Transportation Standards (consignment to
carriers and intermediate handlers, primary
enclosures used for transport, primary con-
veyances [motor vehicle, rail, air, and marine],
food and water requirements, care in tran-
sit, terminal facilities, and handling).
Although specific environmental requirements
differ by category of defined animal, the pattern
of each set of standards is quite similar. The pri-
mary difference with respect to research facilities
pertains to the veterinary care standards for each
animal, which contain the following common pro-
visions: “Programs of disease control and preven-
tion, euthanasia, and adequate veterinary care
must be established and maintained under the su-
pervision and assistance of a doctor of veterinary
medicine. ” Specifically, research facilities must:
l include the appropriate use of anesthetic, anal-
gesic, or tranquilizing drugs in their programs
of veterinary care, when such use would be
proper in the opinion of the attending veter-
inarian. The use of these three classes of drugs
shall be in accordance with the currently ac-
cepted veterinary medical practice, as cited
in appropriate professional journals or refer-
ence guides, which shall produce in the indi-
vidual subject animal a high level of tranquili-
zation, anesthesia, or analgesia consistent with
the protocol or design of the experiment;
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l provide guidelines and consultation to re-
search personnel regarding type and amount
of the three classes of drugs recommended
as being appropriate for each species of ani-
mal, through the animal care committee or
attending veterinarian; and
l assure that the use of the three classes of drugs
effectively minimizes the pain and discomfort
of the animals while under experimentation
[9 CFR 3.10, 3.34, 3.59, 3.84, 3.110, 3.134].
Few petitions for changes in existing regulations
have been made. No person or organization has
used the formal rulemaking process to seek to add
any classes of warm-blooded animals. In 1982, the
Humane Society of the United States filed a peti-
tion for rulemaking and collateral relief that,
among other things, sought definitions of the terms
‘(pain,” “distress,” and “routine procedures” and
a requirement that research facilities explain in
adequate detail why pain-relieving drugs are with-
held from animals used in experiments acknowl-
edged to cause pain and distress (12).
In summary, USDA’s approach has been literal
and cautious with regard to research facilities. This
position can be traced to two influences. First, both
the act itself and its legislative history make clear
Congress’ desire to avoid any entanglement in the
actual conduct of research. Second, both the legis-
lative and executive commitments of funds and
personnel for enforcement have never lived up
to the expectations of those who believe the pri-
mary mission of the existing law to be the preven-
tion or alleviation of experimental-animal suffering.
Enforcement
The responsibilities of APHIS in enforcing the
Animal Welfare Act fall into three main categories:
. making, implementing, and enforcing policies
and rules for national and international pro-
grams to protect the health of US. livestock
and poultry resources, assuring quality and
safety of veterinary biologics, and providing
for the welfare and humane treatment of cer-
tain animals;
l cooperating and providing technical assistance
to State and local governments regarding in-
ternational quarantines and exotic animal dis-
ease programs; and
l providing professional development and train-
ing for APHIS personnel and training for for-
eign visitors in veterinary service programs.
Nineteen public laws outline APHIS’s duties in
the first area, including the Animal Welfare Act,
the Horse Protection Act, and the Twenty-Eight
Hour Law (49 FR 26674). By far, the most time-
and resource-consuming APHIS objective is pro-
tecting domestic plants and livestock from diseases
and pests, Of 841 pages in the code of Federal Reg-
ulations on APHIS duties and programs, only 100
are devoted to animal welfare activities under the
relevant acts (7 CFR 1984 ed. 371.2). Port-of-entry
inspections by APHIS seek to prevent the introduc-
tion of insects, plant diseases, nematodes, and ani-
mal pests and diseases harmful to crops and crop
products. Plant exports are controlled through a
certification system administered by APHIS, and
cooperative programs with States are conducted
to eradicate domestically established plant pests.
The APHIS mission, then, is traditionally bound
to certification, inspection, and cooperative assis-
tance programs that govern agricultural activities,
devoted almost exclusively to protecting plants and
animals used to produce food and fiber.
The APHIS Assistant Deputy Administrator for
Animal Health Programs, under the Deputy Ad-
ministrator for Veterinary Services, is responsi-
ble for directing enforcement activities through
four regional offices, located in Scotia, NY; Tampa,
FL; Englewood, CO; and Fort Worth, TX (50 FR
31341). (Prior to 1985, five regional offices existed
but this was changed in response to a review of
APHIS activities by the General Accounting Office
(GAO).) Licensing, registration, and inspection of
all regulated entities-dealers, exhibitors, research
facilities, carriers, intermediate handlers, and auc-
tion sales—are handled by a field force directed
by Veterinarians-in-Charge in the APHIS offices
in 45 State capitals. Field officials conducting ani-
mal welfare work include veterinary medical offic-
ers, compliance officers, and animal technicians.
Six veterinarians trained in laboratory-animal hus-
bandry procedures coordinate animal welfare ac-
tivities among the four regions (43), APHIS has 286
Veterinary Medical Officers (inspectors), who
spend approximately 6 percent of their time in-
specting research facilities (25).
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Table 13-I summarizes funding and staff sup-
port dedicated to animal welfare activities, com-
pared with the total APHIS budget and equivalent
staff-years, for Federal fiscal years 1980-85. As a
percentage of the total budget for APHIS activi-
ties, animal welfare has consistently constituted
less than 2 percent.
Animal welfare appropriations have remained
virtually constant since fiscal year 1982, despite
gradual reductions in APHIS’s overall budget.
(Some of the decline in regular appropriations can
be traced to increases in fees collected for a vari-
ety of activities, though program-specific reduc-
tions have occurred (4),) The total number of staff-
years spent on APHIS activities (calculated from
work -years available from authorized positions for
which general appropriations are made) declined
steadily from fiscal year 1980 through fiscal year
1985. That decline is reflected proportionately in
animal welfare activities, but the percentage of
staff -years devoted to those activities has remained
constant and, as a percentage of the total staff time,
is slightly higher than that of appropriated funds.
As of March 1985, a total of 1,286 research facil-
ities had registered with APHIS as using covered
animals, as having acquired them in commerce,
or as receiving related Federal funding support.
Sixty-four percent of the principal registered re-
search facilities (RRFs) are located in just 10 popu-
lous States (California, New York, Pennsylvania,
Ohio, Massachusetts, New Jersey, Texas, Illinois,
Michigan, and Florida; see table 13-2); most facil-
ities are close to urban centers. These numbers
are for the principal registrants only, not the total
number of research sites. A university campus sys-
tem, for example, is only required to register once
under the act, though it may have a number of
sites where research or tests are performed. The
location of licensees (dealers and exhibitors), other
registrants (carriers and intermediate handlers),
and violators of the act animal-fighting prohibi-
tion may not, of course, exhibit a similar distribu-
tion. Given APHIS’s traditional and overarching
duties to protect food-and fiber-producing plants
and animals as well as the Animal Welfare Act’s
exemption from coverage of most agricultural re-
search, it seems that not even the major share of
animal welfare enforcement resources could be
targeted toward monitoring the care and treat-
ment of experimental animals.
As the most widely used experimental subjects—
mice and rats—have been excluded by USDA reg-
ulation from the act’s coverage (9 CFR l.l(n),(o)),
current regulations probably do not affect a sub-
stantial percentage of animals used for experi-
mental purposes. This can be tested in a crude way
by comparing the 1984 Directory of Toxicology
Laboratories, compiled by Chemical Times and
Trends (CT&T), with APHIS’s 1984 List of Regis-
tered Research Facilities. Sixty-eight of 112 test-
ing facilities, or 61 percent, listed in the CT&T
directory also appear by name in the APHIS regis-
tration list; 39 percent are not registered. This im-
plies no wrongdoing on the part of unregistered
toxicity testing labs, since they may not fall under
any of the definitional requirements for compli-
ance with the act. The number of unregistered
facilities is conservative, however; for purposes
of comparison, it was assumed that all university-
affiliated testing sites are covered by the parent
institution’s principal registration and that any
nonuniversity lab whose name approximates that
of another registrant is also covered. If rats and
Table 13.1 .- Requests for Appropriations, Actual Appropriations, and Staff-Years,
USDA Animal and Plant Health Inspection Service, Fiscal Years 1980-85
1980 1981 1982 1963 1984 1985
Total appropriation, APHISa (in thousands) . . . . . . . . . . . . . $249,098 $282,385 $281,967 $275,115 $263,238 $267,558
Executive request, Animal Welfare (in thousands) . . . . . . . $ 3,594 $ 4,355 $ 4,402 $ 1,509 $ 1,568 $ 3,655
Total appropriation, Animal Welfarea (in thousands). . . . . . $ 4,128 $ 4,291 $ 4,882 $ 4,886 $ 4,865 $ 4,865
Proportion (percent) of total appropriation . . . . . . . . . . . . 1.7 1.5 1.7 1.8 1.9 1.8
Total staff-years, APHISb . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5,286 5,099 5,069 4,637 4,416 4,440
Staff-years, Animal Welfare Act enforcement . . . . . . . . . . . 150 137 137 120 119 120
Proportion (percent) of total . . . . . . . . . . . . . . . . . . . . . . . . 2.8 2.7 2.7 2.6 2.7 2.7
%11 appropriations are actual (excluding pay SUPPlf3merrtalS).bstaff.years are ~alCUlat~ from available  ~ork.years for authorized  positions (appropriated  funds only).  All  figures are actual,  except for fiscal year 19S5, which iS projected.
SOURCE: Office of Technology Assessment.
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Table 13-2.—Distribution of Research Facilities,
by State, Registered With USDA/APHIS
Under the Animal Welfare Act
Number of
registered
research Percent Rank
State/jurisdiction facilities of total out of 52
Alabama. . . . . . . . . . . . . .
Alaska ... , . . . . . . . . . . .
Arizona. . . . . . . . . . . . . . .
Arkansas . . . . . . . . . . . . .
California. . . . . . . . . . . . .
Colorado . . . . . . . . . . . . .
Connecticut . . . . . . . . . .
Delaware . . . . . . . . . . . . .
District of Columbia . . .
Florida . . . . . . . . . . . . . . .
Georgia . . . . . . . . . . . . . .
Hawaii ... , ... , . . . . . . .
Idaho . . . . . . . . . . . . . . . .
Illinois . . . . . . . . . . . . . . .
Indiana. , . . . . . . . . . . . . .
Iowa . . . . . . . . . . . . . . . . .
Kansas . . . . . . . . . . . . . . .
Kentucky . . . . . . . . . . . . .
Louisiana . . . . . . . . . . . . .
Maine ....,.... . . . . . . .
Maryland . . . . . . . . . . . . .
Massachusetts. . . . . . . .
Michigan . . . . . . . . . . . . .
Minnesota . . . . . . . . . . . .
Mississippi . . . . . . . . . . .
Missouri . . . . . . . . . . . . . .
Montana . . . . . . . . . . . . . .
Nebraska . . . . . . . . . . . . .
Nevada . . . . . . . . . . . . . . .
New Hampshire . . . . . . .
New Jersey ..., . . . . . . .
New Mexico . . . . . . . . . .
New York. . . . . . . . . . . . .
North Carolina . . . . . . . .
North Dakota . . . . . . . . .
Ohio . . . . . . . . . . . . . . . . .
Oklahoma . . . . . . . . . . . .
Oregon . . . . . . . . . . . . . . .
Pennsylvania. . . . . . . . . .
Puerto Rico . . . . . . . . . . .
Rhode Island . . . . . . . . . .
South Carolina . . . . . . . .
South Dakota . . . . . . . . .
Tennessee, . . . . . . . . . . .
Texas . . . . . . . . . . . . . . . .
Utah . . . . . . . . . . . . . . . . .
Vermont . . . . . . . . . . . . . .
Virginia . . . . . . . . . . . . . .
Washington . . . . . . . . . . .
West Virginia . . . . . . . . .
Wisconsin . . . . . . . . . . . .
Wyoming . . . . . . . . . . . . .
Total . . . . . . . . . . . . . . .
12
;
3
175
25
17
8
8
47
12
4
63
21
11
18
6
12
11
33
69
49
19
3
27
3
10
1
4
68
11
120
19
3
72
13
18
90
10
9
5
2
11
67
10
23
18
5
19
4
1,286
0.9
0.1
0.7
0.2
13.6
1.9
1.3
0.6
0.6
3.7
0.9
0.3
0.3
4.9
1.6
0.9
.05
0,9
0.9
2.6
5.4
3.8
1.5
0.2
2.1
0.2
0.8
0.1
0.3
5.3
0.9
9.3
1.5
0.2
5.6
1.0
1.4
7.0
0.8
0.7
0.4
0.2
0.9
5.2
0.8
0.3
1.8
1.4
0.4
1.5
0,3
100
24
51
34
46
1
13
22
36
37
10
25
41
42
8
15
27
19
38
26
28
11
5
9
16
47
12
48
31
52
43
6
29
2
17
49
4
23
20
3
32
35
39
50
30
7
33
44
14
21
40
18
45
SOURCE: U.S. Department of Agriculture, Animal and Plant Health Inspection
Service, Anirrra/  kVe/fare:List  off?egisteredfacillfies, Fiscal Year19S5.
mice used in testing and testing-related research
merit the same coverage as other warm-blooded
animals, and if inhumane treatment of such ani-
reals that are not part of interstate commerce is
as much a burden on oraffects commerce as much
as the animals that are part of such commerce
this disparity assumes greater legislative and reg-
ulatory significance.
Table 13-summarizes annual registration and
reporting activity as recorded by APHIS for fiscal
years 1978-83. The total number of licensees and
registrants covered by the act-all classes of reg-
ulated parties, from dealers through intermedi-
ate handlers-decreased slightly, and the total at
the close of fiscal year 1983 remained smaller than
in 1978. Increases in the number of RRFs over the
preceding year occurred in 4 of the 6 years. The
number of registered research facilities classified
as “inactive” by APHIS (i.e., reporting no use of
regulated animals for 2 consecutive years) has risen
steadily but it remains below 7 percent of the to-
tal. As a class, RRFs rose from 15.8 percent of the
total in fiscal 1978 to 19.3 percent in fiscal year
1983, due mainly to a simultaneous decrease in
the number of licensed dealers.
APHIS indicated in its 1981 and 1982 Annual En-
forcement Reports that the failure of qualified re-
search facilities to register and report was a sig-
nificant enforcement problem and stated that it
“currently had no effective system for detecting
research facilities that use laboratory animals with-
out being registered.” During 1981, one research
facility was prosecuted for failure to register, re-
sulting in registration and entry of a cease and de-
sist order by an administrative law judge (41).
Three cases were filed against registrants who had
failed to report in 1981; in one case, a fine of $1,000
was assessed, the first time a research facility had
been fined for failure to report (41,42).
A number of reports are late or not filed by ac-
tively registered research facilities either through
inattention, ignorance of the law, lack of penal-
ties with sufficient deterrent value, some incom-
patibility between the calendar or fiscal years of
facilities and the established Federal fiscal year for
reporting, the inability of APHIS to analyze and
compile all reports to meet the congressionally
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Table 13-3.—Licensing, Registration, and Reporting Activity of Registered Research Facilities
Under the Animal Welfare Act, Fiscal Years 1978.83
1978 1979 1980 1981 1982 1983
Total licensees/registrants . . . . . . . . . . . . . . . . . . . . . .........6,902 6,389 6,585 6,492 6,297 6,447
Licensed dealers . . . . . . . . . . . . . . . . . . . . . ...............4,501 3,982 3,886 3,664 3,439 3,490
Exhibitors:
Licensed . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 924 978 1,101 1,168 1,237 1,266
Registered . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 313 239 170 130 106 101
intermediate handlers/carriers . . . . . . . . . . . . . . . . . . . . . . . . . 66 139 274 312 339 346
Registered Research Facilities (RRFs)
Active . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ..........1,057 1,051 1,092 1,169 1,113 1,166
Inactive a . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35 — 62 49 63 78
New RRFs added . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . — — 71 43 70
RRFs asproportion of total percent) . . . . . . . . . . . . . . . . . . . . 16
—
17 18 19 19 19
Reports received from RRFs . . . . . . . . . . . . . . . . . . . . . . . .. ..1,092 NA 1,061 1,111 968 1,127
Active . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . , ............1,072 1,061 857 919 885 1,005
Negative c . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . — 169 138 143 73 73
Late or no report filedd. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20 NA 66 49* 10 49
aMean~  “O ~eporfed  US* Of regulated anirnalS  for two cOnsecUtlVe Years.
bEXCludeSrepoflS frofrl Federal factiitles.
CM*anS no US* Of regulated animals during r*pOrtinfJ  Year.
dMeanS
 no Annual Repo~  re~el”ed bY@C*rnber  1 of reportlngyearfor inclusion inApHls’Anlf’rlal welfareErlfOrC*nl*nt Report tO Congress for that year
*LXtrepoflingYe~rforwhich  lateornoffllngscould becalculared frorninforrnatlon given in AnnUal  AnimalWdfare Enforcement RePort.  Later fiwressuwlied bYApHls.
NA = Not available.
SOURCE: Office of Technology Assessment
established deadline for annual enforcement re-
ports, or some combination of all these factors.
The method used by APHIS for monitoring com-
pliance with the act’s and its own standards is
“regular,unannounced’’ inspections of licensee and
registrant premises. For research facilities, the
most important standard is that adequate veteri-
nary care or, more particularly, “professionally
acceptable standards” of relief of pain and distress
are observed during and after experimentation,
except where administration of anesthetics or pain
relievers would interfere with the purpose of the
experiment. Major inspections are characterized
as:
l
l
l
l
recurring compliance inspections, per-
formed to “spot-check” active licensees and
registrants for continued compliance with
established standards;
inspections to investigate complaints of
noncompliance or substandard treatment;
status searches, undertaken to determine
whether a business (principally potential
dealers) should be licensed; and
inspections to investigate apparent viola-
tions that have come to the attention of in-
spectors (43).
Though a multi-sited facility may be required
to register only as a single entity, obviously all sites
where covered animals are held must be inspected
on a regular basis if standards are to be enforced
adequately. The precise number of sites of animal
use in experimentation in the United States is un-
known; it likely falls between 5,000 and 10,000.
In 1985, GAO completed a study for the Chair-
man of the Subcommittee on Agriculture, Rural
Development and Related Agencies, Senate Com-
mittee on Appropriations, on USDA activities un-
der the Animal Welfare Act. GAO focused on:
l the training and guidance given to USDA’s in-
spectors;
l how USDA schedules its inspections of licen-
sees and registrants and the frequency of
those inspections; and
l the followup action USDA takes when inspec-
tors find unsatisfactory conditions (32).
GAO reviewed animal welfare inspection activi-
ties at the APHIS area offices in California, Iowa,
Kansas, Missouri, New York, and Texas. These
offices accounted for 45 percent of the 19,473 re-
curring compliance inspections made in fiscal year
1982.
290 l Alternatives to Animal Use in Research, Testing, and Education
Regarding the training and guidance of inspec-
tors, GAO found that 57 out of 73 inspectors had
attended formal training courses. However, 43 of
the 57 had received no training in recent years.
The last training course for the 17 inspectors in
Texas was given in 1979.
Although USDA personnel and planning docu-
ments state that four inspections a year per site
is desirable, GAO found that the 3,379 sites in the
six States were inspected, on the average, 1.7 times
during fiscal year 1983. In California and New York,
each site averaged 0.7 inspections per year. Be-
tween 6.4 percent (in Kansas) and 51.7 percent
(in California) of the registered facilities in a given
State were not inspected at all during fiscal year
1983.
When looking at followup action taken by USDA
for unsatisfactory conditions, GAO reviewed in-
spection reports of 114 sites where major deficien-
cies were found. In general, GAO found that the
APHIS offices complied with the Service’s policy
and met the timeframe goals for the various steps
in the process. Only 17 of the 114 sites did not fol-
low the prescribed procedure.
While conducting the review, GAO noted some
additional matters affecting the APHIS Animal Wel-
fare Program. First, there was no specified pro-
gram or procedure to oversee the quality of in-
spections. Three of the six States surveyed did not
have any program for monitoring inspection qual-
ity. Second, GAO found inconsistencies in the re-
porting of inspections. Finally, GAO found that
funding of inspections for 1983 had been based
on 1982 work levels rather than on estimates of
current potential workloads and the severity of
expected problems.
USDA is subject to the provisions of the Free-
dom of Information Act (FOIA) (public Law 90-23),
a Federal law that generally requires most Fed-
eral agencies to release to interested persons in-
formation in its possession, unless it is classified
or meets one of the other exceptions established
by Congress and interpreted by the courts. Con-
gress, concerned about the potential for “harass-
ment” of research facilities through the use and
publication of their required inspection forms and
reports, specified in the final sentence of Section
25 of the 1966 Animal Welfare Act that USDA could
not release any such information (except to other
agencies) “unless and until it [was] made public
by an appropriate’’ congressional committee (Pub-
lic Law 89-544).
Requests for information under FOIA have in-
creased steadily since fiscal year 1979. Humane
groups have usually made about half the petitions
for information. In fiscal 1978, they accounted for
53 of 98 requests —54 percent (40). For fiscal years
1981-83, the proportions were 50,53, and 52 per-
cent (41,42,43). The highest numbers of documents
released were in fiscal year 1981 and calendar year
1984, which coincided with renewed lobbying for
amendments to strengthen the Animal Welfare Act
or for new legislation increasing the Federal reg-
ulatory presence in research. No data are avail-
able on the proportion of requests for research
facility records for prior years, but 1984 records
show that 58 percent of total requests concerned
research facilities, 62 percent of all documents re-
leased affected research, and 50 percent of all reg-
ulated parties affected were registered research
facilities. The Animal Welfare Institute, a Wash-
ington, DC, organization interested in the act ap-
plication to research, entered most of the requests
affecting such institutions  (19). Documents most
often requested are copies of inspection reports,
reporting forms, records, and forms used to ap-
ply for licenses or registrations (43).
Litigation
No cases can be found where a Federal court
has had to interpret the provisions of the Animal
Welfare Act requiring humane care and treatment
of research animals. Though some State courts
have considered the act’s provisions when inter-
preting the effect of other laws (see ch. 14), their
decisions cannot affect the constitutionality of a
Federal law’s application under the Federal Con-
stitution. In the only case where the U S. Supreme
Court considered any of the act’s provisions, “ex-
emplary” language in the 1970 amendments ex-
tending judicial enforcement powers to the Fed-
eral district courts was cited to sustain review
jurisdiction asserted under another, similar pro-
vision in Federal law (14),
Three Federal appeals courts have had occasion
to examine the language of the act, though none
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of the cases involved registered research facilities
(11,21,27). One case is nevertheless germane be-
cause it is the only time the courts have had to
examine the language and the intent of Congress
in passing the act, In a 1976 decision denying a
professional dog-and-pony-show owner’s claim
that he was not covered by the act, the U .S. Court
of Appeals for the District of Columbia indicated
the likelihood of a favorable judicial response to
attacks on the act and of a liberal interpretation
of the legislation. Quoting from the House report,
the Court stated that (11):
As the evolution of the Animal Welfare Act
manifests, Congress has chosen a cautious ap-
proach to regulation in this area, increasing gov-
ernmental intervention as the national interest
seemed to warrant. . . . From the small beginning
in 1966--confined to a few animals, and only
when they were devoted to research purposes—
the present legislation further, though still mod-
estly, “implement[s] a statutory mandate that
small helpless creatures deserve the care and pro-
tection of a strong and enlightened public.” We
perceive nothing in the Constitution outlawing
this commendable “effort to demonstrate Ameri-
ca’s humanity to lesser creatures. ”
The U.S. Supreme Court refused to review the de-
cision (11). Thus, the case’s value rests in using
it to support the notion that the highest court re-
fused to disturb a lower court’s decision uphold-
ing the reasonableness of Congress’ effort to pro-
tect animals from inhumane treatment, including
in research. The D.C. Federal appeals court has
cited provisions of the act on three other occasions,
once in support of judicial review of the delegated
powers of the Secretary of Agriculture (29) and
twice without comment (1,28).
At the district court level (the Federal system’s
usual courts of first resort, or ‘(trial” courts), sev-
eral cases have been brought in which the act’s
provisions have been raised (3,5,9, 10), but no court
has fully considered or decided any case invoking
the act against a research facility.
A review of reported and unreported cases in-
volving the Animal Welfare Act indicates that what -
ever case law has been developed bears little rela-
tion to the act’s regulation of research activities.
This can be traced to a single major factor. Con-
gress–very deliberately, it appears, fearing harass-
ment of research facilities—gave no party other
than APHIS any statutory right to enforce the act
or regulations promulgated pursuant to it. The de-
gree of circumspection toward research evident
in Congress’ consideration of the act and its amend-
ments must be seen as an obstacle to private en-
forcement of its standards through the courts,
since at least one Federal court has held that hu-
mane groups have standing to sue on behalf of
animals under another law enacted for humane
objectives, the Marine Mammal Protection Act (2).
Lack of standing—i.e., proof to a court that a claim-
ant’s stake in the accomplishment of the policy ob-
jectives of a statute is significant and the effect
on the claimant’s interests is real if those objec-
tives are frustrated (see ch. 14)—makes it impossi-
ble to attain enforcement of laws from the bench.
The Health Research Extension Act
of 1985
In 1985, Congress amended the Public Health
Service Act (Public Law 78-184) by enacting the
Health Research Extension Act of 1985 (Public Law
99-158), which contained provisions for the care
and treatment of animals in research funded by
the Public Health Service (PHS), including the Na-
tional Institutes of Health (NIH). The act provided
statutory authority for and recognition of certain
elements of the PHS Policy on Humane Care and
Use of Laboratory Animals by Awardee Institutions
(see app. C).
The act also contained provisions for the devel-
opment of alternative research methods. Thus, the
concept of alternatives to animal use was explicitly
described for the first time in Federal law in 1985.
(The concept of alternatives first appeared in Fed-
eral law earlier in 1985, in fact. Public Law 99-
129, The Health Professions Educational Assistance
Amendments of 1985, also mentions the develop-
ment of curriculum for veterinary students on
alternatives to the use of animals. It is described
in ch. 12.)
Care and Treatment of
Animals in Research
The act requires that each entity receiving PHS
support for research with animals establish a com-
mittee to monitor care and treatment of animals
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used in research. These committees shall consist
of at least three members, of which one must be
a veterinarian and one an individual having no asso-
ciation with the institution. The act thus specifies
more modest requirements for the committees
than does the PHS policy. The PHS policy requires
a minimum of five committee members, and the
veterinarian must have training or experience in
laboratory-animal science or medicine.
The animal care committees are responsible for:
1) reviewing at least semiannually the care and
treatment of animals in all animal study areas and
facilities for compliance with NIH guidelines, 2)
keeping appropriate records of such reviews, and
3) certifying to NIH that such reviews have been
conducted. In requiring a minimum of two inspec-
tions per year, the law is more stringent than the
PHS policy, which requires at least one per year.
The act requires applicants for NIH funds to file
assurances with NIH indicating both that the ap-
plicant will meet the NIH guidelines for the care
and treatment of animals and that the applicant’s
institution has an animal care committee. Appli-
cants must also assure NIH of the availability of
instruction at their institutions in the humane prac-
tices of animal care and in research methods that
minimize the use of animals and limit animal dis-
tress. All applications for NIH funds must include
a statement of the reasons for using animals in
the research. If NIH determines that a research
entity is not meeting the guidelines, and if no ac-
tion is taken after notification of the noncompli-
ance, the act provides that the NIH Director shall
suspend or revoke funding.
Research on Alternatives
The act directs NIH to establish a plan for re-
search into methods of biomedical and behavioral
experimentation that do not require the use of ani-
mals, that reduce the number of animals used, or
that produce less pain and distress than methods
currently in use. NIH is further directed to develop
plans for evaluating the validity and reliability of
such methods, proceeding with development of
methods found to be valid and reliable, and train-
ing scientists in the use of such methods. The law
instructs NIH to disseminate information to investi-
gators about alternative methods that are found
to be valid and reliable, and to establish an internal
coordinating committee (made up of the directors
of each NIH institute) to assist in developing the
NIH plan, which must be prepared by October 1,
1986. With the creation in 1985 of the Biological
Models and Materials Resources Section (see ch.
12), NIH appears poised to respond to this legisla-
tive mandate.
Other Federal Laws and Regulations
Beyond the Federal laws and regulations that
either directly require or have been interpreted
to require the use of certain animals in testing or
research and guidelines adopted pursuant to gen-
eral statutory authority, several other Federal laws
and regulations establish duties for research fa-
cilities concerning the acquisition and general care
of animals used for experimentation.
Good Laboratory Practices
In the 1970s, concern at the Food and Drug
Administration (FDA) about faulty toxicological
data based on animals, generated both internally
and externally (18), led to the promulgation of reg-
ulations requiring all regulated parties conduct-
ing nonclinical laboratory studies that test for
safety or effectiveness to conduct, keep records
about, and permit audits on all such tests in a speci-
fied manner. In 1978, FDA adopted Good Labora-
tory Practices (GLP) rules (43 FR 59986) and be-
gan a laboratory audit and inspection program.
In 1984, FDA published a notice proposing some
changes in these regulations primarily to stream-
line recordkeeping, data storage and retrieval, and
reporting practice (49 FR 43530). Further action
may occur in early 1986,
Drawing on the FDA experience and mindful of
its responsibility to collect and analyze substantial
amounts of testing data for approval of new chem-
icals and registration of pesticides, the Environ-
mental Protection Agency (EPA) defined its own
approach to GLPs (44FR 27362). In 1978, EPA exe-
cuted a Memorandum of Understanding to permit
FDA to inspect toxicity testing labs and audit pes-
ticide data submitted in support of registration ap-
plications (43 FR 14124). After much considera-
tion—and the discovery by FDA of the submission
of hundreds of fraudulent test results by one in-
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dependent laboratory (22)–in 1983 EPA issued its
own final GLP rules for its toxic substances con-
trol (48 FR 53922) and pesticides (48 FR 53946)
programs.
The GLPs for FDA and EPA are similar. Both ad-
dress all areas of laboratory operations, delineating
requirements for the establishment of a Quality
Assurance Unit to conduct periodic internal inspec-
tions and keep records for audit and reporting pur-
poses; Standard Operating procedures (SOPS) for
all aspects of each study and for all phases of lab-
oratory maintenance; a formal mechanism for eval-
uation and approval of study protocols and their
amendments; and inclusion in reports of data in
sufficient detail to support conclusions drawn from
them. FDA performs four kinds of inspections in
US. toxicology labs (8):
l
l
l
l
GLP compliance, including examination of
an ongoing study as well as a completed study
(once every 2 years);
data audit as needed, to verify that informa-
tion submitted to the agency accurately re-
flects the raw data;
directed, when prompted by questionable
data, an informer’s tip, etc.; and
followup, to observe for correction of pre-
viously discovered deficiencies.
Inspections are conducted by investigators, who
visit each facility and are given access to all parts
of the premises where covered studies are per-
formed and to all pertinent personnel and docu-
mentation. The Final Report and a more detailed
Establishment Inspection Report are prepared af-
ter an audit is concluded; both can be obtained
under FOIA. One (or more) of three sanctions can
be imposed in cases of noncompliance: refusal to
consider a study in support of an application; dis-
qualification of the testing facility; or, in cases of
alleged fraud, recommendation for criminal prose-
cution.
Provisions relating to care and housing of test
animals are identical in both agencies’ GLP rules.
Both regulations provide that, where animals are
housed, “facilities shall exist for the collection and
disposal of all animal waste and refuse or for safe
sanitary storage of waste before removal from the
testing facility. Disposal facilities shall be so pro-
vided and operated as to minimize vermin infesta-
tion, odors, disease hazards, and environmental
contamination. ” Finally, each GLP has a full sec-
tion on animal care, specifying SOPS for housing,
feeding, handling, and care, with additional stand-
ards on separation, disease control and treatment,
identification, sanitation, feed and water inspec-
tion, bedding, and pest control (21 CFR 1984 ed.
58.43,58.45,58.49, 58.90; 40 CFR 1984ed. 792.17,
792.43, 792.45, 792.90).
One chemical-industry representative summa-
rized the benefits and problems of GLPs as follows:
l Benefits:
1) promotion of good science through good
documentation;
2) credibility–’’clean bill of health”; and
3) self-assurance through knowledge-reduc-
ing chances of mistakes due to ignorance
or use of shortcuts.
l Problems:
1) duplication—possibility of six distinct au-
dits in the animal care operation—FDA,
EPA, USDA/APHIS, American Association
for the Accreditation of Laboratory Animal
Care (if accredited), State, and internal Qual-
ity Assurance Unit;
2) adversarial climate—”guilty until proven in-
nocent”;
3) confidentiality and accessibility—inadvert-
ent disclosure of confidential business in-
formation or compromise of client con-
fidentiality;
4) time and cost—in larger facilities, single
audits may occupy several hours per day
for several weeks (7).
Noting that the GLP compliance record has been
good, the commentator suggests that some dupli-
cation can be avoided by instituting a self-audit
compliance program, using the Guide for the Care
and Use of Laboratory Animals of the National In-
stitutes of Health (47).
If consideration is given to broadening USDA’s
enforcement of the Animal Welfare Act to reach
more testing facilities that may not now be cov-
ered—either by extending coverage to include ro-
dents beyond only hamsters and guinea pigs or by
increasing covered facilities compliance duties—
the problems of cost and duplication assume more
significance. One indication of the cost of increas-
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ing an animal facility’s compliance duties comes
from a study commissioned by EPA to estimate
the compliance costs for its new GLPs. That study
concluded that additional costs to industrial lab-
oratories would be $15 million ($80,000 per lab-
oratory for 185 laboratories) (48 FR 53946).
Military Research and Training
In 1973, Congress prohibited the use of dogs for
research and development of chemical or biologi-
cal weapons (public Law 93-365). At that time, Sen-
ate and House conferees stated that they did not
support the use of dogs for research on chemical
or biological agents whose only function was to
destroy life. They believed it essential, however,
that research to improve and save human and ani-
mal lives be continued, including establishing im-
munologic levels, occupational safety hazard levels,
and other “vital medical research designed to im-
prove and save lives.”
Continued concern about this issue prompted
a request for a GAO investigation of the U.S. Army’s
Edgewood Arsenal (Edgewood, NJ). The Comptrol-
ler General reported that the Army had complied
with the restriction in fiscal year 1975 and, fur-
ther, that compliance would continue. He re-
sponded to congressional concern about APHIS’s
lack of jurisdiction to inspect Federal facilities with
the finding that, although dogs being used in toxic
exposure research were treated well during ex-
perimental procedures, their housing facilities
were deficient and needed physical improvements.
He stated that legislation would be required to ac-
complish that purpose (33). Meanwhile, to imple-
ment the new restrictions, the Secretary of De-
fense issued three policy documents, in 1976 (44),
1982 (46), and 1984 (44), defining the types of in-
vestigations in which animals could be used.
In 1983, publicity about the use of dogs and pigs
at the Uniformed Services University of Health Sci-
ences (Bethesda, MD) to train military surgeons
to treat wounds led to prohibitions on the expend-
iture of Department of Defense (DOD) funds in
fiscal years 1984 and 1985 (Public Law 98-473) for
the training of surgical personnel in treating
weapon-produced wounds in dogs and cats (26).
The Assistant Secretary of Defense for Health Af-
fairs issued a memorandum in 1984 that explained
the reach of the new limitation and superseded
old policy directives (45):
. . . effective October 1, 1983, dogs or cats will
not be purchased or otherwise used for the pur-
pose of training Department of Defense students
or other personnel in surgical or other medical
treatment of wounds produced by any type of
weapon. In addition, the standards of such train-
ing with respect to the treatment of animals shall
adhere to the Federal Animal Welfare Law and
to those prevailing in the civilian medical com-
munity.
Current DOD policies and their effect on intra-
mural and extramural defense research are ex-
amined in more detail in appendix B.
Animal welfare groups have expressed dissatis-
faction about substitution of other animals for dogs
and cats in ballistics training, and pressure on Con-
gress to prohibit animals’ use in this type of re-
search is expected to continue (15).
Endangered Species, Public Health,
and Import Legislation
Research facilities that plan to import, take, or
otherwise use nonhuman primates or other ani-
mals protected by national or international laws
and agreements must comply with provisions
found in several laws. Besides prohibiting or con-
trolling acquisition of some types of animals, these
laws and agreements generally require, at a mini-
mum, a permit or authorization from one or more
Federal agencies. Relevant legislation includes:
l
l
l
l
l
Section 7 of the Endangered Species Act of
1973, as amended (16 U.S.C. 1531 et seq.), and
regulations administered by the Research Di-
vision of the Fish and Wildlife Service [50 CFR
10-24];
Public Health Service Act regulations govern-
ing importation of nonhuman primates, both
to control the spread of animal-borne disease
(42 U.S.C. 264; 42 CFR 71) and for use in pro-
ducing and testing viral vaccines (42 U.S.C.
262; 21 CFR 620 et seq.);
the Airline Deregulation Act of 1978 and the
Tariff Schedules of the Civil Aeronautics Board;
Convention on International Trade in Endan-
gered Species of Wild Fauna and Flora Treaty
of 1973 [see app, E); and
certificates of need for importing rhesus mon-
keys (a 1955 agreement between the United
States and India, resulting in the Indian Rhe-
sus Monkey Certification Program).
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AGENCY GUIDELINES AND ACTIVITIES
Besides providing general assurances to USDA
that intramural research activities involving warm-
blooded animals meet the general requirements
of the Animal Welfare Act, various Federal agen-
cies have adopted general animal use guidelines
or have taken steps to review relevant intramural
and extramural policies. Most policies are confined
to measures governing humane care and treatment
of animals in testing and research-establishment
of standards, review, and enforcement. Some pol-
icies mention the actual conduct of experimen-
tation.
The Public Health Service Policy
Pursuant to a delegation of authority from the
Secretary of the Department of Health and Human
Services (DHHS), NIH is responsible for implement-
ing the public Health Service Policy on Humane
Care and Use of Laboratory Animals by Awardee
Institutions (PHS Manual, chs. 1 through 43). Each
institution that receives Federal support from PHS
for research involving live vertebrate animals is
subject to the policy, including agencies of the PHS
itself (NIH; FDA; the Alcohol, Drug Abuse, and Men-
tal Health Administration; the Centers for Disease
Control; and the Health Resources and Services
Administration). Provisions of the PHS policy, re-
vised in 1985, are discussed in detail in chapter
15 and the policy is reproduced in appendix C.
Interagency Activities
Governmentwide Standards
Representatives from 14 Federal entities3 in-
volved in animal use sit on the Interagency Re-
search Animal Committee (IRAC) formed in rec-
ognition of the need for an interagency committee
knowledgeable about the use, care, and welfare
of research animals.
3USDA, Department of Defense, DHHS, Department of Energy, De-
partment of State, Departmentof the Interior, EPA, the National Aero-
nautics and Space Administration, the National Science Foundation,
and the Veterans’ Administration. Components of the Public Heahh
Service within DHHS  that are represented on the committee include
the Alcohol, Drug Abuse, and Mental Health Administration; the
Centers for Disease Control; FDA; NIH; and the Office of Interna-
tional Health.
Staffed and sponsored by NIH, IRAC was estab-
lished by the Assistant Secretary of Health in 1983
as an outgrowth of the Interagency Primate Steer-
ing Committee that had been established within
NIH in 1974 to assure both short- and long-term
supplies of primates critical to biomedical research,
testing, and vaccine development programs (48).
Along with regular meetings to discuss current
issues and needs, the Committee has undertaken
two principal projects to date: serving in an advi-
sory capacity to U.S. observers to the Council of
Europe, which considered a draft convention on
laboratory-animal use (see app. E), and writing the
“Principles for the Utilization and Care of Ver-
tebrate Animals Used in Testing, Research, and
Training” (see box A). Developed and issued at the
request of the Executive Office of Science and Tech-
nology Policy, the principles are intended to serve
as a model for Federal agencies developing spe-
cific policies on the use of animals. The IRAC prin-
ciples incorporate nine distinct injunctions on
proper care and treatment of research animals,
based primarily on similar principles promulgated
by the Council for International Organizations of
Medical Science (see app. E).
These statements on establishment, review, and
enforcement of standards of humane care and
treatment are part of the NIH Guide for the Care
and Use of Laboratory Animals and are explicitly
endorsed in the PHS Policy on Humane Care and
Use of Laboratory Animals by Awardee Institu-
tions (47).
Memorandum of Understanding
In 1983, APHIS, NIH, and FDA executed a Memo-
randum of Understanding and agreed to exchange
information on animal welfare concerns and com-
pliance with policies. Each has appointed liaison
officers to serve on a standing committee to meet
at least annually. Specifically, APHIS, NIH, and FDA
have agreed to:
l
l
share information contained in the registry/
inventory/listing of establishments that fall un-
der the purview of each;
send to one another, each quarter, a listing
of establishments that have been inspected
or site-visited, to be used to avoid redundant
evaluations;
share information on significant adverse find- l
ings concerning animal care and welfare re-
vealed by inspections or site visits and on fol-
lowup actions taken;
inform each other of evidence of serious non- l
compliance with required standards or pol-
with PHS policies) in establishments that fall
under the authority of each agency;
request from each other comments and ad-
vice on regulatory or policy proposals involv-
ing animal care and welfare under consider-
ation; and
provide to each other resource persons for
scientific seminars, speeches, and workshops.
icies for care and use of laboratory animals The agreement remains in effect indefinitely, may
(including defective assurances of compliance be modified by mutual consent, and may be ter-
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minated by any agency on 90-day advance writ- fiscal year 1983 (see ch. 3). In addition, extramural
ten notice to the other two agencies (37). research is conducted by many of these depart-
ments, Two departments, Commerce and Trans-
Specific Agency Activities portation, conduct almost all research extramurally
and so have no specific policy regulating animal
Six departments and four agencies within the use other than the PHS policy (1 7,23). For a detailed
Federal Government do intramural research in- discussion of the regulation of animal use within
volving animals. At least 1.6 million animals were Federal departments and agencies, see appendix B.
used by these branches for such research during
CRITICISMS OF THE PRESENT SYSTEM OF FEDERAL REGULATION
The operation of the Animal Welfare Act, as ap-
plied to research, has been criticized since its pas-
sage. In addition to obvious shortcomings—lack
of coverage for actual research practices and in-
adequate resources for enforcement-critics have
questioned the presumption that researchers know
best how to care for experimental animals (20,49)
and the choice of APHIS as the primary enforce-
ment agency (16,24). Complex recordkeeping re-
quirements imposed on APHIS inspectors and
other field enforcement staff have been decried;
the process of noting, investigating, and evaluat-
ing violations for prosecution, and the attendant
rights of suspected violators that can result in de-
lay in disposition of cases, are viewed by some as
too cumbersome and bureaucratic (20). Some ques-
tion the expertise and the will of APHIS, pointing
out its traditional reluctance to accept broader
responsibilities under the act. Indeed, USDA re-
mains opposed to its further extension (34,37). A
1982 review of the APHIS reporting system by the
Humane Society of the United States concluded
that the present system, as it is administered (24):
. . . fails to achieve its primary statutory objec-
tive: it does not provide APHIS with information
sufficient to demonstrate that researchers have
used pain-relieving drugs “appropriately” and in
accordance with “professionally acceptable stand-
ards.’’ The chief reasons for this failing are: 1) reg-
ulations and guidelines do not define “pain” or
“distress, ” 2) regulations and guidelines do not
adequately define “routine procedures, ” and 3)
regulations and guidelines do not require mean-
ingful explanations for the withholding of pain-
relieving drugs in procedures acknowledged to
cause pain.
The Reporting System, as presently adminis-
tered, for the same reasons also fails to achieve
a secondary—but nonetheless important —objec-
tive: it does not generate reliable and meaningful
information to the public about the use of ani-
mals in research.
Humane groups have used the Freedom of Infor-
mation Act with increasing frequency to obtain
copies of inspection and annual reports in attempts
to demonstrate their claims that the system does
not work. Members of the research community
opposed to the act extension defend existing prac-
tices as adequate (16,34)37).
Could the Secretary of Agriculture require greater
proof that “professionally acceptable” standards
of care are being followed, require more detailed
explanations of the use and withholding of anes-
thetics and pain relievers, and more effectively au-
dit annual reports? The law permits such greater
discretion. Several competing factors, however,
are worth noting. First, consistent with Congress’
enumerated powers to spend and to regulate inter-
state commerce, the objectives for the regulation
of research are more limited than is often admit-
ted by the critics. The remarks of congressional
sponsors of the first bills, in the record of debates
on the 1966 conference report, recognize that only
a fraction of research animals would be covered
(30) and that the new act was “nothing more than
a very small first step toward the elimination of
cruelty, mistreatment, and abuse of laboratory ani-
mals .“ The absolute power that remained with the
experimenter to determine the nature of experi-
mentation prompted the remark that “animals that
are under research or experimentation for sev-
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eral years will have absolutely no protection under
this law” (31). Subsequent amendments added
more specific requirements but left the intra-
research exemption undisturbed, retaining a post-
hoc, audit-style enforcement system.
Second, creating an agency whose sole purpose
is to regulate experimentation, or infusing more
authority and funds into APHIS, are options that
Congress has not chosen to exercise, even in the
face of a lukewarm commitment to enforcement
by existing executive agencies. Third, these choices
have not been made because a consensus on the
preferable mode and extent of control has never
been apparent. Some regulation advocates, it ap-
pears, will settle for some degree of tinkering with
the act; others will not rest until research on ani-
mals is done away with (27). Those differences have
strong roots and are likely to persist.
There are important statutory and regulatory
considerations regarding any attempt to modify
existing law in order to effect replacements, re-
ductions, or refinements of animal use. Statutory
changes would reflect judgments on:
l
l
l
l
l
l
whether the jurisdiction of enforcing agen-
cies should be expanded to enforcement of
adequate care, treatment, and use standards
during actual conduct of experimentation;
whether the scheme of regulation of ex-
perimentation should be scaled to a higher
level of compliance responsibility, as is now
the case for dealers and exhibitors;
whether penalties for violations of research
standards should be enacted that are commen-
surate with those assessed against other reg-
ulated parties;
whether voluntary assurances or simple cer-
tifications of compliance are adequate;
whether coverage of existing classes of ani-
mals is statutorily adequate to achieve even
existing policy objectives; and
whether proposed changes take into account
the operation of other, overlapping laws that
have different policy objectives.
Regulatory changes would involve judgments of:
l whether existing enforcement agencies are
appropriate (and willing) to continue to fulfill
current responsibilities and assume others;
l
l
l
whether enforcement agencies should be
given increased discretion in formulating and
enforcing professionally acceptable standards
of care, handling, treatment, and use of re-
search animals;
whether additional requirements for research
regulation will be susceptible to consistent
interpretation by inspection and enforcement
agents in the field, in light of existing avail-
ability of training resources and aids for field
inspectors; and
whether efficient assignment of funds and en-
forcement resources on a state-to-state basis
is likely to occur.
In addition, statutory or regulatory change would
reflect a judgment of:
l
l
l
whether funds authorized and appropriated
will be adequate in relation to contemplated
enforcement duties;
whether regulated research institutions have
sufficient financial resources and institutional
and independent veterinary resources to ef-
fect meaningful compliance with a strength-
ened law, while avoiding any compromise of
research or testing objectives; and
whether strengthening existing laws will pro-
mote resolution of or enhance differences be-
tween the research and animal welfare com-
munities.
Finally, the Animal Welfare Act is often criti-
cized—inappropriately—for excluding mice and
rats from its coverage. In fact, the act, as amended
in 1970, covers all warm-blooded animals that the
Secretary of Agriculture determines are being used
or intended for use in research or for another
named purpose. The Secretary does not appear
to have the discretion to determine whether or
not mice and rats are warm-blooded animals, only
whether or not they are used in research. No
amendment to the act is therefore necessary to
bring mice and rats under its scope. The exclu-
sion of mice and rats (and birds) from the defini-
tion of “animal” by USDA regulation in 1977 (9 CFR
1.1 (n),(o)) appears to frustrate the intent of Con-
gress and to be beyond the Secretary of Agricul-
ture’s statutory authority (6).
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SUMMARY AND
The Animal Welfare Act and its amendments rep-
resent a cautious and deliberate attempt by Con-
gress to improve care and treatment of research
animals. Initially, the act was designed to regulate
interstate traffic in dogs and cats used for research,
with the goal of halting the use of stolen pets. This
was accomplished by requiring Federal licenses
for dealers, requiring research facilities to regis-
ter, and instituting inspection and recordkeeping
requirements for both. Enforcement responsibil-
ity was vested in the Animal and Plant Health In-
spection Service of the U.S. Department of Agri-
culture, an agency not aligned with traditional,
nonagricultural research interests. Three times
the act was amended; twice the amendments ex-
tended interstate regulation to exhibition, trans-
portation, and auction sales of covered animals
(which, as enforced, now includes dogs, cats, rab-
bits, hamsters, guinea pigs, and nonhuman pri-
mates), The oversight of animal use by commit-
tees at every research facility was mandated in
the most recent amendments.
A legislative reluctance to invade the actual con-
duct of research is clear. The Secretary of Agri-
culture is forbidden to enact any regulation that
could be so construed. The closest the law comes
is to require the Secretary to establish and enforce
standards for care and treatment of experimental
animals outside the laboratory door, and to require
covered research facilities to certify that profes-
sionally acceptable standards of care, treatment,
and use are being followed in the laboratory, in-
cluding “appropriate” use of anesthetics and pain
relievers, except when their use would interfere
with experimental objectives. In addition, large
classes of experimental animals—principally mice
and rats—are not covered by the act as it is cur-
rently enforced by the Department of Agriculture,
and the law’s provisions remain weighted toward
traffic in pet species. Since interstate regulation
constitutionally requires some connection to inter-
state commerce, research institutions that use ani-
CONCLUSIONS
reals protected by the act but that receive no Fed-
eral funds and that maintain their own breeding
colonies cannot be regulated. To date, there has
been no significant judicial test of the provisions
regulating research.
The Health Research Extension Act of 1985
amended the Public Health Service Act with pro-
visions for the care and treatment of animals in
PHS-funded research. The 1985 act also contained
provisions for the development of alternatives to
research methods using animals.
In addition to the Animal Welfare Act and the
Health Research Extension Act of 1985, there is
regulation of the use of laboratory animals at the
Federal agency level. The Interagency Research
Animal Committee was formed to provide a knowl-
edgeable source about all vertebrate animal use
in testing, research, and training within the Fed-
eral Government. It has developed the U.S. Gov-
ernment’s “Principles for the Utilization and Care
of Vertebrate Animals Used in Testing, Research,
and Training” at the request of the Executive Of-
fice of Science and Technology Policy. The IRAC
principles are endorsed by the Public Health Serv-
ice, are part of the widely used NIH Guide for the
Care and Use of Laboratory Animals, and are used
by some Federal agencies in their own policies on
animal use.
Six Federal departments and four Federal agen-
cies conduct animal experimentation within Fed-
eral facilities (see app. B). Only the Departments
of Commerce and Transportation, which use few
animals, have no specific guidelines. The other en-
tities all have some type of policy for such in-
tramural research. In general, the more research
conducted by an agency, the more extensive are
its animal care guidelines. In addition, departments
in which animal treatment has been targeted by
animal welfare groups or spotlighted by the me-
dia tend to have more substantive guidelines.
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Chapter 14
State Regulation of Animal Use
States have enacted a bewildering array of laws
governing animals-their control, their ownership
and disposition as human property, the respon-
sibilities and liabilities of their owners, and the
duty of care that is owed animals, including free-
dom from unnecessary and unjustified suffering.
State laws in the last category are the most ven-
erable; many predate any congressional action
on the subject. These laws take several general
forms, including the regulation of animal use in
experimentation and the delegation of authority
to local governments to regulate animal use and
treatment (33). With Federal entry into the field,
the potential for conflict and duplication arises.
This chapter summarizes State laws affecting
the use of research animals and examines the po-
tential for conflict or duplication with current
Federal law. The analysis is restricted to laws with
some bearing on the conduct of research and
where some potential for conflict or duplication
may exist. Examples of types of local laws or ordi-
nances are cited to illustrate the contexts in which
local law has affected research, but no attempt
is made to describe such legislation independent
of the operation of State law.
ANTICRUELTY LAWS
At common law, animals were entitled to no in-
trinsic right of protection, reflecting the prevail-
ing belief that they were mere human instrumen-
talities. Two classes of animals existed, domestic
and wild, with domestic animals considered the
property of their owners and legally protected
only as possessions. An owner could treat an ani-
mal in any manner, as long as no public nuisance
was created. Abuse of an animal owned by another
created liability in the abuser only for resulting
damage to the economic value of the animal (2,4).
This means that any legal right or duty owed
to animals by humans must have a statutory ba-
sis (33). Every U.S. jurisdiction has in place a stat-
ute prohibiting cruel treatment of some types of
animals. These statutes generally apply criminal
penalties (usually lower class misdemeanors) and
civil sanctions for specified violations (74). Most
of the original State anticruelty statutes were
enacted prior to the turn of the century and have
common, continental roots as offshoots of gen-
eral societal concern for humane treatment. The
first such statute, known as an “override, over-
drive” law because it outlawed riding or driving
farm animals beyond reasonable limits, was passed
in the Massachusetts Bay Colony in 1641. It pro-
vided that “No man shall exercise any Tyranny
or Cruelty towards any Brut Creatures which are
usually kept for the use of man” (19).
The principal social goals promoted by the im-
position of criminal or economic penalties for
cruel or inhumane treatment of animals are three-
fold (3,33):
l protecting the interests of society and pro-
moting morality by deterring conduct con-
sidered wanton or offensive, such as willful
mistreatment of animals;
l protecting the interests of animals and pre-
venting neglect by establishing enforceable
minimum standards of care for animals; and
l protecting the economic interests of animal
owners by shielding animals against treat-
ment that invades or damages the owner’s
economic interest (including companionship
and enjoyment).
Most anticruelty statutes serve the first two goals
by prohibiting and punishing active cruelty to ani-
mals (beating, burning, castrating, shooting, pour-
ing acid on hooves, or overworking) and, in some
cases, passive cruelty occasioned by neglect, such
as failure to provide basic necessities (food, water,
shelter, or appropriate care) (36). Since most State
anticruelty statutes combine elements of both ac-
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tive and passive cruelty, these concepts are dis-
cussed under this single rubric. Special duties of
care, such as those imposed in some States on ani-
mal carriers, pet stores, and others, generally do
not affect research facilities (39).
Genera] Provisions
State anticruelty statutes often incorporate pro-
hibitions on both active cruelty and failure to
meet a generally described duty of care. Under
these laws, several elements must be proved to
sustain a conviction and penalty:
l
l
l
l
l
The mistreated animal must come under the
statute’s coverage.
The person charged with infliction or neglect
must similarly be subject to the reach of the
law, as must the conduct complained of.
The act complained of must not be the sub-
ject of any exceptions to the statute.
There must be no statutory defenses that can
be sustained against the act complained of.
The prescribed level of human knowledge or
intent must be present if required by stat-
ute. Most States, however, do not require cul-
pability to be proven (33).
Culpability depends on the presence of a speci-
fied state of mind at the time of the commission
of the act. Except for statutes that create liabil-
ity without culpability, conduct must generally
fall into one of the following categories to result
in the commission of an offense:
l Intentional, Knowing or Willful The in-
dividual must be conscious of his or her con-
duct, intend his or her voluntary actions or
failure to act, and know or should know the
actual consequences.
l Recklessly Negligent: This lesser level ap-
plies to an individual who is aware of and
consciously disregards a substantial and un-
justified risk to another interest (the animal’s
interest in avoiding cruel treatment).
l Negligent: This lowest level of culpability,
also known as criminal negligence, applies to
an individual who fails to perceive a substan-
tial and unjustified risk incurred by his or
her action or inaction. The standard applied
in cases of criminal negligence is proof of a
gross deviation from the standard of care ob-
served by a reasonable person in similar cir-
cumstances.
Many statutes incorporate more than one level
of culpability (33,36).
The other type of criminal statute, often com-
bined with those that prohibit specified acts of
cruelty, deals with nonfeasance or omissions.
These laws establish a minimum duty of care
toward an animal by making it a crime to fail to
meet that duty in some specified way. Their ob-
jective is general care of covered animals, rather
than protection from immediate harm. If no de-
gree of culpability is required, defenses applica-
ble under active statutes are not available. None-
theless, if words like “willfully,” “intentionally,”
or “knowingly” are used, then the appropriate de-
gree of culpability must be proved. The most com-
prehensive “duty-of-care” statute is Virginia’s Ani-
mal Welfare Act, which requires all companion-
animal owners to provide adequate food, water,
shelter, and space, as well as humane care and
treatment and veterinary care necessary to pre-
vent suffering. The maximum penalty upon con-
viction is a fine of $100 (117).
The variability of the basic elements of anti-
cruelty statutes is demonstrated by a recent re-
view by the Animal Welfare Institute of laws in
the 50 States, the District of Columbia, Puerto
Rico, Guam, the Virgin Islands, and the Canal
Zone. The Institute found the following:
l
l
l
Definition of “Animal”: Twenty-nine anti-
cruelty laws protect “any animal,” including
all living creatures except humans. Nineteen
others provide no definition at all, and others
apply the word to domestic animals, captive
animals, or warm-blooded creatures.
Culpability Thirty-two jurisdictions have
prohibitions on specified types of cruelty
with no qualifying phrases—i.e., no require-
ment for proof of a particular state of mind
on the part of the person charged. The other
23 have one or more of the qualifying phrases
described above.
Food, Water, and Shelter Statutory prohi-
bitions against failure to provide for basic ani-
mal survival vary in both definition and inter-
pretation. Thirty-two jurisdictions have laws
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l
l
l
l
requiring food and water, with no qualify-
ing phrases. Twenty-three others qualify the
duty of care to provide food and water with
some requirement to prove at least a high de-
gree of neglect; the word used most often as
a qualifier here is “unnecessarily. ”
Other Living Conditions: Requirements for
adequate exercise or space, light, ventilation,
and clean living conditions are found in some
statutes. Eight jurisdictions require fresh air.
Exercise or adequate space is required by 11.
One requires sufficient light, and two laws
mention clean living conditions.
Abandonment General anticruelty statutes
in 42 jurisdictions prohibit the abandonment
of animals. In several cases, abandonment is
restricted to willful, cruel, or intentional
abandonment, to abandoning animals to die,
to abandoning disabled animals, or to aban-
doning domestic animals.
Humane Transport: Thirty-eight jurisdic-
tions incorporate provisions prohibiting cruel
or inhumane transport of various classes of
animals. Minnesota’s statute is most specific,
applying to “any live animal” and defining in
detail requirements for humane transport.
In most jurisdictions, however, laws govern-
ing humane transportation are much more
general, often consisting of no more than a
single section incorporating undefined or
vaguely defined terms.
Poisoning: Twenty-four jurisdictions pro-
hibit or restrict the use of poison to inflict
injury or death on an animal. Some statutes
are modified with terms such as “needlessly,”
and others are found outside general anti-
cruelty law, intended to apply primarily to
livestock or other animals held and kept for
specific purposes, usually related to their eco-
nomic value in a given activity, such as rac-
ing or hunting (74).
Some statutes acknowledge the potential appli-
cation of general anticruelty statutes to research
facilities. Twenty-three jurisdictions specifically
exclude experimental animals from the reach of
criminal anticruelty statutes; 25 others make no
mention of any possible relation (89) (see table 14-
1). Interpretation of these statutes is discussed
later in this chapter.
Table 14.1 .—Laws on Research and Animal Cruelty,
by Jurisdiction
Research No mention
State/jurisdiction exemption in law Other
Alabama. . . . . . . . . . . . . .
Alaska . . . . . . . . . . . . . . .
Arizona. . . . . . . . . . . . . . .
Arkansas . . . . . . . . . . . . .
California. . . . . . . . . . . . .
Colorado . . . . . . . . . . . . .
Connecticut . . . . . . . . . .
Delaware . . . . . . . . . . . . .
District of Columbia , . .
Florida . . . . . . . . . . . . . . .
Georgia . . . . . . . . . . . . . .
Hawaii . . . . . . . . . . . . . . .
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aExempts “veterinary practices.”
bExpre55[y  intends  for animals used for “scientific or medical aCtMty”  to be PrO-
tactad from “intentional cruelty” but exempts “normal human activities to which
the infliction of pain to an animal is purely incidental and unavoidable. ”
cprohibits entry or search to enforce the law  “where SC)eIWC  research is behw
conducted by or under the supervision of graduates of reputable scientific
schools or where biological products are being produced for the care or preven-
tion ot disease. ”
SOURCE: National Association for Biomedical Researchj State  Laws Concerrr-
ing  the  Use of Animals in Research (Washington, DC: Foundation for
Biomedical Research, 1985).
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Most of the laws that do address the issue ex-
empt “scientific experiments” or “investigations”
entirely. In Alaska, one defense to prosecution is
that the defendant’s conduct “conformed to ac-
cepted veterinary practice [or] was part of scien-
tific research governed by accepted standards”
(l). Maine allows proof of “accepted veterinary
practice or bona fide experimentation for scien-
tific research” as an affirmative defense to a
charge of cruelty as well, so long as the animal’s
destruction, if required, is not “unnecessarily
cruel unless directly necessary to the veterinary
purpose” (89). Florida’s 59-year-old law states that
cruelty “shall be held to include every act, omis-
sion, or neglect whereby unnecessary or unjustifi-
able pain or suffering is caused, except when
done in the interest of medical science” (34). Geor-
gia is more direct in establishing a connection be-
tween the exemption and the interest protected
by it: “The killing or injuring of an animal for hu-
mane purposes or in the furtherance of medical
or scientific research is justifiable” (53). Others
contain specific provisos that the statutes not be
construed to prohibit or interfere with scientific
research, if done by qualified persons in a hu-
mane manner (18)30). The majority simply exempt
“acceptable veterinary practices” and “bona fide
experiments” or research “governed by accepted
standards” (89).
Three other anticruelty statutes, all amended
within the last 3 years, are equivocal. The Indi-
ana Code was amended in 1983 to exempt “veteri-
nary practices” from the general anticruelty stat-
ute (63). In Pennsylvania, neither an exemption
nor a provision interpreting the statute as exclud-
ing scientific use is included in the law. The gen-
eral grant of authority to police or humane soci-
ety agents to enter premises for the purpose of
seizing and destroying exploited animals prohibits
entry or search “where scientific research work
is being conducted by or under the supervision
of graduates of reputable scientific schools or
where biological products are being produced for
the care or prevention of disease” (97).
The Maryland General Assembly, in a 1984
amendment, expressed its intention that “all ani-
mals . . . under private, local, state, or federally
funded scientific or medical activity . . . be pro-
tected from intentional cruelty” but provided that
no person is to be held liable for criminal prose-
cution due to “normal human activities to which
the infliction of pain to an animal is purely in-
cidental and unavoidable.” Authorized enforce-
ment officers otherwise permitted to take posses-
sion of animals to protect them from neglect or
cruelty cannot do so without prior review and
recommendation from the Division of Veterinary
Medicine in the Department of Health and Men-
tal Hygiene. Reports to the State’s attorney for
the county in which the facility is located must
be made by the Division within 48 hours of re-
ceipt of a complaint (75).
Of greatest concern to those engaged in test-
ing and research are older, general anticruelty
statutes that prohibit cruelty to all animals with-
out requiring proof of a culpable state of mind.
Many of these statutes do not generally exempt
scientific inquiry from the prohibitions, and those
statutes that attempt to do so often fail to define
“animal” or “science” or contain vague definitions
of the terms. Virtually none of the statutes sur-
veyed attempts to define what activities consti-
tute scientific research, nor do they establish sep-
arate classifications for experimental animals.
Enforcement
Like Congress, State legislatures delegate en-
forcement to the executive branch of govern-
ment, which is authorized to promulgate regula-
tions and enforce them under authority of an
enactment. The exercise of the police power to
control and protect animals has been sustained
in a variety of areas, including controlling migra-
tion of animals into a State, requiring registration
and licensing of animals, controlling contagious
and infectious diseases borne by animals, and
compensating private parties for the destruction
of animals in furtherance of anticruelty laws (33).
Because criminal penalties are imposed for vio-
lations of anticruelty statutes, primary enforce-
ment responsibility generally rests with “duly con-
stituted” law enforcement authorities-police and
sheriff’s departments. Most State legislatures,
however, recognize the difficulty of ensuring en-
forcement of anticruelty statutes on the local level
and have also delegated limited police powers to
private, not-for-profit organizations, principally
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humane societies or societies for the prevention
of cruelty to animals (74). These limited grants
of authority are most frequently extended to sei-
zure of animals found to be cruelly treated, ne-
glected, or abandoned, in violation of an applica-
ble State law. In some States, officers or agents
of these groups possess specific powers for inter-
vention, inspection, or the procurement of war-
rants or summonses or the ability to be deputized
by local law enforcement officials for such pur-
poses. In New York, for example, lawfully ap-
pointed agents of the American Society for the
Prevention of Cruelty to Animals (ASPCA) have
been judicially recognized as “peace officers” and
are therefore authorized to issue summonses for
violations of anticruelty laws. Another New York
State case allowed the ASPCA to seize without a
warrant and impound animals held in violation
of cruelty statutes.
In States where no powers are specified or im-
plied, societies formed for this purpose have de-
veloped investigative programs on which State or
local law enforcement officers rely for prelimi-
nary investigative activities. There appears to be
some movement away from statutory grants of
authority to nongovernmental agencies for this
purpose. Several States have repealed prior grants
and others have left undisturbed laws with no
mention of them. Beyond enforcement through
specific grants of police power, many anticruelty
groups initiate criminal investigations by filing
complaints or resorting to civil actions against
agencies or facilities to enjoin alleged
animals (33,36).
Constitutionality
cruelty to
Several State anticruelty statutes have been at-
tacked on grounds that they are unconstitution-
ally vague, either because the statute allegedly
fails to give a person of ordinary intelligence fair
notice that a contemplated act is forbidden or be-
cause the statute as drafted encourages arbitrary
arrests and convictions. In almost all instances,
both active cruelty and duty-of-care provisions
have survived constitutional challenges based on
vagueness, even though their breadth and lack
of definition and specificity makes them suscep-
tible to such attacks (9,62).
Cruel Acts
An Arizona statute outlawing cockfighting was
found to be unconstitutionally vague in its use of
the terms “animal” and “needless suffering,” and
two convictions were overturned (104). Disparate
results were reached in cases brought for con-
victions for the same activity in Kansas and Ha-
waii (86,105); the court was able to sustain the
statute in the latter case because statutory defi-
nitions of “animals” and “cruelty” helped over-
come problems of vagueness. These cases are in-
structive for another reason. When convictions
have been thrown out, it is because courts have
been unwilling to interpret general statutes to for-
bid cockfights in the absence of legislative action
making these previously acceptable acts illegal.
Duty of Care
Courts have applied the same general princi-
ples of construction used in constitutional chal-
lenges to anticruelty statutes in upholding their
components governing minimum husbandry or
humane treatment standards. High courts in at
least two States have sustained legislative estab-
lishment of broad standards of care, but judicial
interpretations of the application of those stand-
ards varies. For example, a Texas court found,
without explanation, that the duty-of-care statute
“sufficiently informs an accused of the nature and
cause of the accusation against him and that it
is not unconstitutionally indefinite. ” Idaho’s Su-
preme Court upheld the legislature’s intent to
establish broad standards of care, suggesting that
“proper care” is that degree of care that a pru-
dent person would use under similar circum-
stances. Virginia’s statute attempts to define the
terms ‘(adequate feed” and “adequate water,” but
ultimately the standard adopted is a “reasonable
level of nutrition,” though it adds nothing to the
law’s specificity. Thus, the duty charged to any-
one responsible for animal care is speculative,
though the duty implicitly requires knowledge of
the animal’s requirements (33).
Review of the available case law indicates that
courts are reluctant to accept constitutional at-
tacks even against vague and undefined anti-
cruelty statutes, preferring to limit themselves to
measuring defendants’ conduct against general
statutory provisions on a case-by-case basis.
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Judicial Interpretation of
Applicability of Anticruelty
Statutes to Research
Historically, those interested in protecting lab-
oratory animals from cruelty have used general
anticruelty statutes against research facilities or
individual researchers, but (at least until 1981) to
little effect. In 1914, for example, the Women’s
SPCA sued six faculty members at a Pennsylvania
medical school for “wanton cruelty,” but no con-
viction resulted (33).
Two recent cases give some indication how a
modern State court might respond to a confron-
tation between anticruelty and research interests.
The Taub Decision
The most celebrated and controversial case
in this area is Maryland v. Taub, Montgomery
County police investigated conditions at a labora-
tory that was performing stroke research on non-
human primates that was funded by the National
Institutes of Health (NIH). The investigation re-
sulted in seizure of the primate colony. In Janu-
ary 1982, the county’s State’s attorney filed 17
charges against the investigator, Edward Taub,
charging him with violation of Maryland Code,
Article 27, Section 59 (1957, 1976 Repl. Vol.), with
respect to each of 17 primates. Following a trial
in district court, the defendant was found guilty
of failing to provide necessary veterinary care for
6 animals and acquitted of all other charges. On
appeal to the circuit court, a jury hearing the case
de novo found Taub guilty of one charge of fail-
ing to provide necessary veterinary care for 1
monkey, known as “Nero” (76).
Taub appealed to the Maryland Court of Ap-
peals, asserting that the law was unconstitution-
al because the Federal Animal Welfare Act pre-
empted State jurisdiction in the area of federally
funded research, and attacking several of the trial
court’s evidentiary rulings. The Maryland high
court reversed the circuit court’s decision and
remanded the case with instructions to dismiss
the charges (32). Tracing the legislative history
of the Maryland statute from 1890 to its last re-
vision in 1976, the court concluded that the leg-
islature had not intended the statute to apply to
this type of research activity under a Federal pro-
gram, basing its ruling on three points:
l
l
l
The legislative intent was interpreted as ex-
empting from punishment acts not involving
“unnecessary” or “unjustifiable” pain, given
exceptions for “customary and normal veteri-
nary and agricultural husbandry practices”
and the last sentence of Section 59, which
states:
It is the intention of the General Assembly
that all animals shall be protected from in-
tentional cruelty, but that no person shall be
liable for normal human activities to which
the infliction of pain to an animal is purely
incidental and unavoidable.
The court imputed to the assembly “aware-
ness” of the Federal Animal Welfare Act,
which constituted a “comprehensive plan for
the protection of animals used in research
facilities, while at the same time recognizing
and preserving the validity of use of animals
in research.”
Taub’s laboratory was subject to detailed reg-
ulations of the U.S. Department of Agricul-
ture (USDA), which set forth specifications
for humane handling, care, treatment, trans-
portation, and veterinary care. With respect
to the latter, the court noted that Federal law
recognized and preserved the validity of ani-
mal research. The court also noted the ap-
plication of NIH’s grant requirements to the
defendant’s project (32).
The Maryland statute neither generally ex-
empted scientific research from the reach of its
anticruelty law nor regulated experimentation
separately, as some others do. On 1984, the Mary-
land General Assembly enacted a law that made
the anticruelty statute’s application to research
activities less ambiguous.) The Maryland court’s
disposition of the case illustrates a judicial reluc-
tance to find cruelty in an activity of some rec-
ognized social utility. Its value as a bellwether for
other States is limited, however, for several rea-
sons. First, although the case may be cited by
other defendants as a helpful precedent, it is law
only in Maryland. Second, the holding in this case
may be limited to its particular facts. At the trial
that resulted in conviction, a substantial amount
of testimony was heard on the issue of adequate
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veterinary care in research involving intentional
injury to the research subjects. The court’s opin-
ion did not fully address this issue. Third, the
court relied heavily on its presumption that the
General Assembly of Maryland had been aware
of the Federal Animal Welfare Act when it last
amended the statute, 8 years earlier. Many of the
two dozen or so general anticruelty laws that
contain no research exemption have not been
amended since the 1966 passage of the Animal
Welfare Act.
The Preemption Question
The Taub decision is also relevant to the ques-
tion of research coverage by general anticruelty
statutes because of what the case did not decide.
On appeal, Taub asserted that his conviction was
invalid for five main reasons, three of which ad-
dressed themselves to actions occurring in or
taken by the trial court (sufficiency of evidence,
permitting medical experts to define the term
“veterinary care)” and denial of a fair trial due
to introduction of evidence of Nero’s physical con-
dition more than a month after he had been seized).
But Taub also contended that the Maryland stat-
ute was unconstitutionally vague, because the def-
inition of “animal” was excessively broad and be-
cause it was unclear as to what was ‘(the most
humane method reasonably available” and what
were included or excluded from “normal human
activities to which the infliction of pain to an ani-
mal is purely incidental and unavoidable.” In addi-
tion, he claimed that his prosecution was barred
by the Supremacy Clause of the Federal Consti-
tution and that the reach of Maryland’s general
statute was therefore preempted by congressional
passage of the Federal Animal Welfare Act (10).
Thus, the court was presented with two con-
stitutional questions of considerable importance
to the continued enforceability of general anti-
cruelty statutes. First, do the old, nonspecific for-
mulations of cruelty provide sufficient notice of
what conduct is prohibited, under what circum-
stances, and how violation of the law can be
avoided? Second, has Congress so occupied the
field of research regulation that enforcement of
a similar ”State law would violate the principle that
the Federal Constitution and reasonable Federal
laws enacted under it are the supreme law of the
land? The Animal Legal Defense Fund (ALDF), for-
merly known as Attorneys for Animal Rights, Inc.,
a nonprofit professional legal group interested in
better laws protecting animals, joined the State
attorney general as a friend of the court in
defending the appeal and briefing the constitu-
tional issues raised by Taub’s challenges (11,66).
Whether a State law is preempted by a Federal
law is a matter of statutory interpretation by a
State or Federal court. (Jurisdiction is concurrent
where these questions arise, since both the State
and the Federal Government have a stake in the
outcome of the question.) Court decisions touch-
ing on this question over the years have estab-
lished two general requirements for Federal
preemption of a State statute. First, the Federal
Government must have the authority to preempt
the State’s enactment. Second, Congress must
have intended to preempt State law (115).
Preemptive authority is found where Congress
legitimately exercises an enumerated power, such
as the constitutional power to regulate interstate
commerce (79,100,112,118). A Federal law may
also be preemptive when, supported by applica-
tion of the “Necessary and Proper Clause” (111),
it gives effect to an enumerated power, even
though the means used is not expressly enumer-
ated in the Constitution (68). In either of those
circumstances, if the law is found to have a ra-
tional basis for regulation and effectuation of an
enumerated power, it is capable of preempting
a State law (90). A Federal law does not have
preemptive capability, however, if Congress uses
its enumerated powers alone to go beyond its
areas of enumerated concerns to achieve a result
that a State could also achieve by the exercise of
its reserved power.
Congress may exercise an enumerated power
to achieve an end extraneous to the effectuation
of that power. Thus, for example, Congress may
exercise its spending power to encourage an ex-
traneous goal such as humane treatment for re-
search animals. As a general principle, however,
if an enumerated power is used to affect an area
not within the Federal “circle” of interests, it can-
not compel the States to accept that exercise. In
such cases, concurrent jurisdiction exists (16)68)
110). The ALDF brief relied on this principle in
its assertion that, while Congress’ power to appro-
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priate funds for the general good may be used
to require Federally funded research facilities to
comply with Federal standards of animal care, this
does not preempt similar State laws. Thus, the
grantee of Federal funds maybe bound to adhere
to any conditions of the grant, but the State can-
not be and is not so bound except to the extent
that the State itself accepts Federal research
funds. ALDF argued that denial of preemptive ca-
pability would promote valuable public policy by
“preserving to the people of Maryland the right
to determine what constitutes cruelty” (66).
Once a Federal law is shown to be constitution-
ally capable of preemption, it must be demon-
strated against a generally applicable presump-
tion in favor of State laws that Congress either
explicitly or by inference intended for the Fed-
eral law to supersede conflicting State enactments
(57,98). Determining legislative intent can some-
times be difficult, especially when Congress avails
itself of more than one enumerated power, against
which different constitutional standards must be
applied (28). When the State law involves the ex-
ercise of its traditional police powers—to protect
the welfare of its citizens—preemption will occur
only when there is proof that such was the Fed-
eral law’s clear purpose (35). If there is insuffi-
cient evidence that Congress intended to totally
occupy the field regulated by the respective laws,
there must be sufficient conflict between them
for the State law to stand as “an obstacle to ac-
complishment and execution of the full purposes
and objectives of Congress” (57).
Both the State and ALDF argued, first, that ex-
ercise of a traditional police power was involved
and, second, that Section 2145(b) of the Animal
Welfare Act made it sufficiently clear that Con-
gress intended to establish a cooperative enforce-
ment scheme rather than a conflicting one, so that
no conflict or obstacle to attainment of Federal
objectives was presented (11,66). (Section 2145(b)
of the act authorizes USDA to cooperate with
State and local governments carrying out “any
State, local, or municipal legislation or ordinance
on the same subject.”) Taub, on the other hand,
pressed the argument that the State law was in
conflict with, and an obstacle to, the congressional
objective of minimizing disruption of research
(10). In any case, the court decided that the mat-
ter may be disposed of by the conclusion that the
Maryland statute simply is inapplicable to Dr.
Taub (32).
The decision was not at all surprising, given the
publicity about the case over 2 years (8,73,88).
Reaction was also predictable. One professional
society’s newsletter concluded that the Maryland
court had “wisely recognized” the fact that the
“ultimate goal [of biomedical research] is improve-
ment of the human condition” and claimed that
the decision provided an “important legal prece-
dent that affirms the propriety of the use of ani-
mals in biomedical research” (31), One of the at-
torneys on the ALDF brief called the court’s
decision “opaque)” observing that “one manifesta-
tion of the court’s confused reasoning is that at-
torneys and commentators cannot agree on the
grounds for the decision” (122). Writing in the
New England Journal of Medicine, an attorney-
professor who reviewed the decision and the re-
sulting commentary reached this sober conclu-
sion (27):
It is now necessary for the Congress to con-
sider whether or not it wishes to address this
question and to remove the uncertainty in the
law by making it clear that the Animal Welfare
Act is intended to be a comprehensive, exclusive
system of control over the use of animals in
experimental facilities and activities in interstate
and foreign commerce and under the National
Institutes of Health research programs, Without
such clarification, investigators and operators of
facilities face the possibility of local criminal
prosecution, seizure of animals, injunctions to
close facilities, and cessation of animal investi-
gations. It should be understood, however, that
this Federal mandate, if accepted, means that the
administrative system for monitoring, including
on-site inspection, must be adequate to insure
continued compliance with national standards
for humane treatment. Otherwise, state-level or-
ganizations with a sincere and reasonable con-
cern about the care of animals will be justified
in demanding local enforcement and surveillance
of biomedical research programs involving lab-
oratory animals.
Winkler v. Colorado
Only one other State court case addresses the
question of preemption by the Animal Welfare
Act. In Winkler v. Colorado, that State’s supreme
court considered a preemptive challenge to Colo-
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rado regulations prohibiting the importation of
pets for resale from States with less stringent
licensing laws and regulations covering commer-
cial pet dealers. The court found preemptive capa-
bility, holding that Congress used an enumerated
power to effectuate an enumerated power: regu-
lating interstate commerce, The challenge to the
State law was not sustained, however; the court
found that the act not only “clearly did not indi-
cate preemptive intent, but rather, expressly en-
dorsed state-federal cooperation” (119).
Criticisms
Despite the fact that it set the stage for future
collisions between research and animal interests,
the Taub case is not particularly valuable for re-
solving such conflicts, since the court avoided con-
stitutional questions in reaching its decision. The
decision suggests that when a court is confronted
with a difficult case involving sharply contrasting
but supportable interests and obscure legal prin-
ciples whose potential impact on a decision far
outweighs their understandability in application,
it will go to extraordinary lengths to avoid that
decision. It is a natural and conservative reaction
for a judge to decline an invitation to make law
that prejudices an existing enforcement system,
however imperfect, when the legislature has
shown no inclination to do so itself. The mixture
of enumerated powers supporting the Animal
Welfare Act, coupled with evidence that Congress
did not intend to preempt the field of research
regulation, are probably sufficient to avoid
preemption. That result, however, cannot be pre-
dicted with any confidence.
Animal welfare advocates criticize general anti-
cruelty laws as being ineffective in protecting
animals from harm (19,29,124). The statutes’
vagueness and the frequent requirement for some
degree of culpability both exact high standards
of proof and subject statutes to a greater risk of
ineffectiveness. Other criticisms are that general
anticruelty statutes fail to anticipate and prevent
cruelty or neglect, instead taking effect only when
a sustainable complaint is entered. Enforcement
of these statutes is generally entrusted to local
law enforcement agencies, which for a number
of reasons typically assign them a comparatively
low priority. State regulations and local proce-
dures for investigating and building a criminal
case against a violator are complex, involving com-
plicated rules governing warrants and searches.
Fines are low, as a rule, and criminal violations
comparatively hard to prove. When convictions
are obtained, fines assessed against violators are
generally collected by the State, though humane
societies or SPCAs with limited enforcement au-
thority must spend their own funds to investigate
and prove cases (33,36).
Recent Initiatives in
Anticruelty Laws
Critics of current anticruelty statutes, who have
pressed to extend the laws’ reach to research
activities, have not met with a great deal of suc-
cess. They insist that two basic changes must be
made if anticruelty laws are to be enforced mean-
ingfully: First, animal welfare specialists must be
trained and used; second, those trained specialists
must be given increased enforcement authority
(81). One situation hailed as a model is Massachu-
setts’ creation of a private right-f-action and its
delegation to the Massachusetts SPCA and, more
recently, to the Animal Rescue League, of author-
ity to act as agents of the Commissioner of Health
in enforcing the State’s anticruelty laws.
The private right-f-action allows citizens to
bring civil suits to enjoin violations, reap statu-
tory damages, and collect court costs and attor-
neys’ fees if successful. Massachusetts SPCA of-
ficers are commissioned as special State police
officers and given training by the police academy
and the Massachusetts SPCA. They have arrest
and prosecution authority for violations. Inspec-
tions are conducted when a problem becomes ap-
parent. The officers can use selective enforcement
procedures that focus on serious violations, which
conserves time, money, and personnel while in-
creasing the law’s deterrent effect (77). Supporters
of this model argue that efficient enforcement of
the type contemplated by it would curtail animal
abuse, including abuse occurring in laboratories.
Skeptics point to the obvious increase in cost en-
tailed by such qualification and training require-
ments, and they wonder if the research commu-
nity would accept enforcement of anticruelty
provisions by its chief antagonists (19).
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Legislatures that have revised their anticruelty
statutes within the last several years are mind-
ful of the problems in applying and enforcing
older laws. Virginia, for example, totally revised
its Animal Welfare Act. Enforcement powers, du-
ties, and training and skill requirements for “ani-
mal wardens” were increased, and local humane
societies were granted limited warrant, search,
and arrest powers (117). Florida, while not con-
sidering any animal welfare amendments per se,
upgraded the maximum fine for active cruelty to
animals from $1,000 to $5,000, and the fine for
confinement without food, water, or exercise or
for abandonment from $500 to $5)000 (58). The
Michigan Humane Society has drafted a model
anticruelty bill, as well as publishing a compre-
hensive guide to enforcement of the existing
Michigan statute and supplements for use in Illi-
nois and New York (69,70,71). (A model statute
is a law proposed for State adoption by a group
of experts, frequently a national conference of
legal scholars, though advocacy groups are in-
creasingly likely to offer model laws incorporat-
ing their positions. Although model statutes are
intended to promote uniformity among the States,
a State adopting such a law will often modify it
to some extent to meet its own needs, or it may
only adopt a portion of the model statute.) The
Michigan guide and its supplements detail the
process of investigating suspected cruel conduct
and building a case against the suspected violator.
Another model anticruelty statute (26) includes
provisions regulating research animals by divid-
ing covered animals into three classes, with treat-
ment depending on their classification. Class A
animals are chimpanzees, gorillas, and dolphins.
An experiment that causes a significant amount
of pain to a Class A animal would be prohibited
unless it is performed in a licensed research fa-
cility, it causes less suffering than any alternative
experiment that would provide the same scien-
tific information at a reasonable cost, and it is
limited to gaining information about human or
animal disease, injury, or mental disorder. In addi-
tion, weapons research on Class A animals would
be banned unless the experiments dealt directly
with counteracting the health effects of weapons.
Furthermore, behavioral research with this group
would be prohibited unless justified by health-
related reasons.
Class B animals are all other mammals. The
model statute prohibits scientific experiments that
cause suffering to Class B animals unless the same
restrictions that apply to Class A animals are met.
Behavorial research is not prohibited, however.
Class C consists of any other vertebrate. Only
two restrictions would apply to experiments caus-
ing pain to Class C creatures: The research facil-
ity would have to be licensed, and the experiment
would have to produce less pain than any other
reasonably priced experiment that would produce
the same information.
This model statute provides both criminal penal-
ties and civil damages for violations. The crimi-
nal provisions would be enforced by law enforce-
ment officers and the others by any interested
party (see discussion of private enforcement in-
terests in the next section). Recordkeeping by fa-
cilities is required, and the records could be in-
spected at any time. Required entries include the
number and types of animals used, the conditions
under which animals were kept, and a descrip-
tion of the purpose and design of the experiment.
Proponents contend that adoption of this statute
would provide clear standards of research-animal
care, resulting in less abuse. Critics cite the diffi-
culty of classifying species so as to satisfy every-
one and the inconsistency of arbitrarily excluding
behavorial research for Class A animals (12,19).
RIGHT TO TAKE LEGAL ACTION ON AN ANIMAL’S BEHALF
Past Trends contexts, such a right is exercised by bringing
against the enforcement agency a legal action
There are two ways a State could allow legaI seeking a court order directing the agency to en-
action on an animal’s behalf. First, an anticruelty force the law. Second, a legislature or court could
statute could provide private citizens with a right confer upon private citizens “standing to sue” on
to compel enforcement of the law. In nonanimal an animal’s behalf, such as by allowing citizens
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to act as legal guardians of an animal’s welfare.
The requirement of standing is satisfied either if
it is conferred by statute or if a court holds that
the plaintiff has a legally protectable and tangi-
ble interest at stake in the litigation.
One State trial court was called on in 1982 to
decide whether the Animal Welfare Act or either
or both of two Connecticut laws confer upon a
private citizen a right to compel enforcement of
the statutes against, and the right to seek damages
from, a research entity on behalf of an animal.
In Friends of Animals, Inc. v. U.S. Surgical Cor-
poration, the plaintiffs filed a complaint alleging
that the defendant’s use of dogs in teaching its
technical field representatives how to use surgi-
cal staplers violated both the Animal Welfare Act
and the State’s general anticruelty law. The Con-
necticut anticruelty law is a general misdemeanor
statute with no qualifiers and contains no re-
search exemption. (Similar attempts by this group
to get a Federal hearing on these charges are de-
scribed in ch. 13. For a complete chronology of
the lawsuits between these parties and a more
detailed examination of the attempted use of the
act and the State’s anticruelty laws against a re-
search enterprise, see the case study at the end
of this chapter.)
The group, claiming for its members “a personal
stake and an intense interest in the prevention
of cruelty to animals)” asserted a private right of
action against the company to enforce the laws
and recover damages. The defendant moved to
strike the complaint for failure to state a claim
on which relief could be granted, a pleading that,
under Connecticut rules of procedure, automat-
ically tests the legal sufficiency of the complaint.
The court struck the anticruelty counts, finding
no legislative intent to create a private right of
action and noting that the plaintiff introduced no
legal authority in support of its contention that
such a right existed.
To support the alleged right under the Animal
Welfare Act, the plaintiff claimed the act was anal-
ogous to the Marine Mammal Protection Act (5).
(A Federal court had previously interpreted the
latter to support a private right to sue, as dis-
cussed in ch. 13.) The Connecticut court rejected
this analogy. Citing a judicial-review provision in
the latter statute that is not found in the Animal
Welfare Act, the absence of any proof that the
Congress intended to create a private right to en-
force the Animal Welfare Act, and the absence
of supporting case law, the judge struck the bal-
ance of the Friends of Animals complaint, leav-
ing no issues for trial before the court (45).
Recent Initiatives to Create Legally
Enforceable Rights for Animals
Support is growing in the animal welfare com-
munity for establishing independent and legally
enforceable rights for animals, on the theory that
effective enforcement of animal interests will
never occur as long as they are balanced against,
and almost always outweighed by, competing hu-
man or social considerations. This reflects a gen-
eral historical progression toward treating ani-
mals as intrinsically valuable and away from
treating them as mere chattels or personal prop-
erty (7)29).
Interest in this concept is fed by the success of
animal welfare groups in expanding the reach of
statutes like the Marine Mammal Protection Act
by winning the right to sue on behalf of protected
animals, at least in a limited sense (5,120). Accept-
ance of other statutes with similar objectives, such
as the Endangered Species Act, has led to a widen-
ing circle of protected and judicially enforceable
interests for animals (22,29). Conferring standing
to sue on animals would allow humans to sue on
an animal’s behalf (or on behalf of a class of
animals) to protect the interests of the animal.
Groups such as the Animal Welfare Institute have
used their judicially conferred standing to sue the
Federal Government and others under the Endan-
gered Species Act, for example, on behalf of in-
terests they believe are not being protected suffi-
ciently (29).
Standing proposals have led naturally to other
interest-protecting roles for those seeking to pro-
tect animals’ rights. In particular, application of
the familiar principles of guardianship is sought.
Under guardianship principles, the legislative
status of animals, especially companion species,
would be changed from property to possessors
of specified rights, while the definition of a guard-
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ian would be amended to include a person who
“has elected to take responsibility for the care
and well-being” of an animal. Thus, guardianship
would commence on adoption or purchase. Legal
guardians could be appointed by courts to assume
duties as custodians and conservators of a lab-
oratory animal’s rights, including the right to sue.
The relationship could be terminated by judicial
removal for malfeasance or nonfeasance and would
terminate on the animal’s death or the guardian’s
incapacity. The guardian’s ability to protect and
enforce the animal’s interests, by lawsuit if nec-
essary, would afford animals better protection,
it is argued (109).
As discussed, courts have thus far been unwill-
ing to confer standing on human plaintiffs in the
absence of a specific statutory grant. In the U.S.
Surgical case, the Connecticut Superior Court
found no sustainable private right to enforce ei-
ther the Animal Welfare Act or the State’s anti-
cruelty statute. Even if courts were less conserv-
ative about granting standing, and even if the
burden required for standing of showing actual
injury were not as rigorous, the interest being af-
fected still must be cognizable at law. Using the
Endangered Species Act as an analogy, what would
be required at a minimum is conferring the right
to judicial review on “any person” affected by an
action taken under the law containing the right
of review. Thus, the likelihood of legislative, fol-
lowed by judicial, acceptance of even some mini-
mal version of animal standing is probably not
imminent. Acceptance of novel interpretations of
otherwise familiar concepts of guardianship to
cover animals is likely to be even farther off.
As frustrated as animal advocates have been in
their efforts to secure enforcement of laws pro-
tecting animals, they show no sign of abating. Sev-
eral such cases, instituted or pending at the Fed-
eral level, are examined in chapter 13, and the
case study at the end of this chapter discusses
a series of cases, involving the same parties, that
explores a variety of unsuccessful theories. Re-
cently, Actors and Others for Animals and the
Fund for Animals sued the Los Angeles County
Board of Supervisors, alleging their failure to en-
force the county’s pound release ordinances,
which require certification of humane treatment
of animals by institutions seeking to purchase
pound animals (108). Common-law theories, such
as nuisance, have been used in these suits, and
environmental statutes have been enlisted as well.
In 1984, a California Superior Court dismissed
a suit brought by a coalition of animal welfare
groups, citing provisions of the California Envi-
ronmental Quality Act, to include an evaluation
of laboratory-animal use in an environmental im-
pact report for a new, $46 million science build-
ing at the University of California at Berkeley (20).
REGULATION OF RESEARCH
Past Trends
Apart from regulating agricultural and other
economically oriented uses of animals, some
States regulate the use of animals for research
l
purposes. Twenty-one jurisdictions regulate re-
search specifically, either in the context of gen-
eral registration, licensure or inspection laws, or
l
independently:
Four States allow or require regulation of re-
search facilities: California (15,17), Michigan l
(84), Tennessee (107), and Virginia (117).
Seven States and the District of Columbia re-
quire licensing or registration for a research
facility to receive pound animals: D.C. (30),
Illinois (61), Iowa (65), Minnesota (87), Ohio
(95), Oklahoma (96), South Dakota (103), and
Utah (116).
Two States extend an exemption from their
animal cruelty statutes only to research ap-
proved or licensed by the State: New Jersey
(92) and New York (93).
Two States require licenses to use dogs or
cats in research: Connecticut (24) and Mas-
sachusetts (77).
Five States exempt all research facilities or
federally licensed facilities from State licens-
ing programs: Colorado (23), Kansas (67),
North Carolina (94), Pennsylvania (97), and
Rhode Island (99).
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Most State statutes deal with the procurement
of animals for research. For example, the Michi-
gan statute makes it unlawful to sell animals to
an unlicensed research facility (84). Dogs used in
research must be marked. Animals cannot be sold
to research facilities at a public auction or by
weight, and when an animal is purchased for re-
search, a bill of sale signed by the seller must be
retained. A facility failure to abide by those rules
could result in revocation of its required license
(85). Conditions in animal holding facilities are also
common concerns in these laws. New York facil-
ities must treat research animals kindly and hu-
manely and must feed and house them properly
(93). Animals held in California facilities must re-
ceive satisfactory food, shelter, and sanitation
(15,17).
State legislatures have been as reluctant as Con-
gress to go behind the laboratory door. Califor-
nia law provides that the Department of Health
Services is required to promulgate rules for the
control and humane use of animals in specified
types of research (17). The New York statute spec-
ifies that:
.
. . . commensurate with experimental needs and
with the physiologic function under study, all
tests, experiments, and investigations involving
pain shall be performed under adequate anesthe-
sia (93).
Under that statute, the Commissioner of Health
has promulgated regulations applicable to re-
search in the State university system to require
ethical review of experimental procedures by the
degree of pain and suffering caused the animal
involved.
Some of the statutes extend their requirements
only to the use of companion animals. Massachu-
setts requires a license prior to experimentation
on dogs and cats (77), and Connecticut requires
a license for research on dogs only (24). Institu-
tions in Illinois, Iowa, or Oklahoma that plan to
use live dogs or cats may apply for a license to
obtain animals from a pound (61)65,96); in Ohio,
to receive impounded dogs institutions must be
certified by the Ohio Public Health Council as be-
ing engaged in teaching or research (95).
State research-regulation laws enacted since the
passage of the Animal Welfare Act are mindful
of the potential for duplication. California specif-
ically exempts some laboratories from its licen-
sure law, such as those regulated by the National
Institutes of Health (17). Facilities in Kansas hold-
ing a current Federal registration under the Ani-
mal Welfare Act are exempt from State law (67),
as are federally regulated facilities in North Caro-
lina and Rhode Island (94)99). Facilities in Penn-
sylvania that have undergone a Federal inspec-
tion within the past year are exempt from regular
inspections by Commonwealth animal wardens
(97).
With the exception of Massachusetts and Kansas,
inspection and enforcement authorities are State-
level agencies. The California statute prohibits
delegation of this authority to anyone other than
an employee of the Department of Health Serv-
ices (17). Conversely, Kansas law allows the Com-
missioner of Health to appoint county and city
health commissioners as authorized representa-
tives for inspection purposes (67). In Massachu-
setts, research institutions must apply to the Com-
missioner of Licenses for a license to “employ dogs
or cats in scientific investigation, experiment or
instruction or for the testing of drugs or medi-
cines,” The Commissioner must investigate the ap-
plicant prior to licensure to determine whether
the public interest is served by granting a license
and that the licensee “is a fit and proper institu-
tion to receive such license. ” Licenses are revo-
cable, after notice and hearing, and must be re-
newed annually. Knowing violators are subject
to a fine of up to $100 for each discovered viola-
tion of the statute. Local courts are authorized
to enjoin violations “or to take such other actions
as equity and justice require” in enforcing the
licensing law. The Commissioner is given a gen-
eral grant of rulemaking and inspection author-
ity, and visitation and inspection powers may be
delegated by regulation to the Massachusetts
SPCA and the Animal Rescue League of Boston,
“as agents of the commissioner” (77).
Recent Initiatives in
Research Regulation
Proposals to enactor modify licensing statutes
suggest such changes as increasing control over
the research process; requiring stricter standards
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of treatment and care; increasing recordkeeping
and inspection functions; streamlining investiga-
tion, complaint, and prosecution procedures; and
providing additional enforcement resources. Other
than these proposals, not many other initiatives
have been put forward to prevent or reduce ex-
perimental-animal suffering. The model statute
discussed above has not generated a great deal
of interest (26). Bills routinely introduced in the
legislatures of more populous States require per-
centage reductions in funds spent on animal re-
search, require consideration and adoption of
alternatives to animal use, or attack the legitimacy
of animal usage in some other way. But none has
yet been taken seriously. Nevertheless, House Bill
742 in Massachusetts would mandate a 5 percent
annual reduction per institution in the number
of animals used in that State’s research labora-
tories.
POUND RELEASE LAWS
Past Trends
All States have statutes that provide for the sei-
zure, holding, and humane destruction of un-
owned or unclaimed stray animals (74). These
laws, which are most complex and aggressive in
their application to dogs and cats, attempt to bal-
ance the need for protection of the public’s health
and safety from unmanaged animals against the
rights and duties of private animal ownership,
whether for aesthetic or commercial purposes.
To serve the interests of public protection and
welfare, most States provide for the release to re-
search institutions of unowned or unclaimed ani-
mals, usually dogs and cats, under certain circum-
stances or when specified conditions are met,
such as obtaining a license. Such statutes gener-
ally provide for a suitable holding period after
collection or seizure, so that owners have an op-
portunity to claim their animals, and specify pro-
cedures to be followed by owners, holding facilities,
and claiming institutions. Many municipalities also
have laws either requiring or authorizing the re-
lease of “random-source” animals to research in-
stitutions. Definitions of what types of institutions
qualify to claim random-source animals, and at
what level of “scientific research,” vary widely.
As noted, there is little agreement on what legiti-
mate scientific research is. Sometimes this is left
to authorities responsible for regulating research,
independent of general anticruelty laws, and
some types of educational research activities are
proscribed (33,36). These laws are summarized
in table 14-2.
The authority of States to release unclaimed ani-
mals to appropriate research facilities has never
been successfully challenged. In 1959, for exam-
ple, the Supreme Judicial Court of Massachusetts
declined to rule that such a scheme impaired any
rights of petitioning humane societies or pet
owners, or that it called for an unconstitutional
expenditure of public funds or property (78). The
force of the court’s ruling was rendered moot by
the recent passage in Massachusetts of a law, dis-
cussed below, prohibiting the release or importa-
tion of pound animals for research purposes.
Currently, nine States (Connecticut, Hawaii,
Maine, Massachusetts, New Hampshire, New Jer-
sey, Pennsylvania, Rhode Island, and Vermont)
prohibit the release of dogs and cats from pounds
for research purposes (89). The most far-reaching
of these laws was passed by Massachusetts in
1983 and went into effect in October 1984. Be-
sides repealing the State’s old pound release stat-
ute and eliminating all pertinent references in
general pound law, the new statute prohibits the
release by “dog officers” or municipalities of any
animal to any “business or institution licensed or
registered as a research facility or animal dealer
with the United States Department of Agricul-
ture.” A research ‘(institution” is defined as (77):
. . . any institution operated by the United States
or by the Commonwealth or a political subdivi-
sion thereof, or any school or college of medi-
cine, public health, dentistry, pharmacy, veteri-
nary medicine or agriculture, medical diagnostic
laboratory or biological laboratory, hospital or
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Table 14.2.—Laws on Pound Animal Use,
by Jurisdiction
-
Alabama ., . . . . . . . . . . . . . . . . . . . . . . . . X . . . .
Alaska . . . . . . . . . . . . . . . . . . . . . . . . . . . . X . . . .
Arizona . . . . . . . . . . . . . . . . . . . . . . X . . . . . . . . .
Arkansas . . . . . . . . . . . . . . . . . . . . . . . . . . X . . . .
California . . . . . . . . . . . . . . . . . . . . X . . . . . . . . .
Colorado . . . . . . . . . . . . . . . . . . . . . . . . . . X . . . .
Connecticut . . . . . . . . X . . . . . . . . . . . . . . . . . . .
Delaware . . . . . . . . . . . . . . . . . . . . . . . . . . X . . . .
District of Columbia. . . . . . X . . . . . . . . . . . . . .
Florida . . . . . . . . . . . . . . . . . . . . . . . . . . . . X . . . .
Georgia . . . . . . . . . . . . . . . . . . . . . . . . . . . X .,..
Hawaii . . . . . . . . . . . . . X . . . . . . . . . . . . . . . . . . .
Idaho . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X . . . .
Illinois . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X
Indiana . . . . . . . . . . . . . . . . . . . . . . . . . . . X . . . .
Iowa. . . . . . . . . . . . . . . . . . . . X . . . . . . . . . . . . . .
Kansas . . . . . . . . . . . . . . . . . . . . . . . . . . . X . . . .
Kentucky . . . . . . . . . . . . . . . . . . . . . . . . . . X . . . .
Louisiana . . . . . . . . . . . . . . . . . . . . . . . . . X . . . .
Maine . . . . . . . . . . . . . X . . . . . . . . . . . . . . . . . . .
Maryland . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X
Massachusetts . . . . . . X . . . . . . . . . . . . . . . . . . .
Michigan . . . . . . . . . . . . . . . . . . . . . X . . . . . . . . .
Minnesota . . . . . . . . . . . . . . . X . . . . . . . . . . . . . .
Mississippi . . . . . . . . . . . . . . . . . . . . . . . . X . . . .
Missouri . . . . . . . . . . . . . . . . . . . . . . . . . . X . . . .
Montana . . . . . . . . . . . . . . . . . . . . . . . . . . X . . . .
Nebraska . . . . . . . . . . . . . . . . . . . . . . . . . . X . . . .
Nevada . . . . . . . . . . . . . . . . . . . . . . . . . . . X . . . .
New Hampshire . . . . . X . . . . . . . . . . . . . . . . . . .
New Jersey . . . . . . . . X . . . . . . . . . . . . . . . . . . .
New Mexico . . . . . . . . . . . . . . . . . . . . . . . X . . . .
New York . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X
North Carolina . . . . . . . . . . . . . . . . X . . . . . . . . .
North Dakota . . . . . . . . . . . . . . . . . . . . . . X . . . .
Ohio. . . . . . . . . . . . . . . . . . . . . . . . . X . . . . . . . . .
Oklahoma . . . . . . . . . . . . . . . X . . . . . . . . . . . . . .
Oregon . . . . . . . . . . . . . . . . . . . . . . . . . . . X . . . .
Pennsylvania . . . . . . . X . . . . . . . . . . . . . . . . . . .
Rhode Island . . . . . . . X . . . . . . . . . . . . . . . . . . .
South Carolina . . . . . . . . . . . . . . . . . . . . . X . . . .
South Dakota . . . . . . . . . . . . X . . . . . . . . . . . . . .
Tennessee . . . . . . . . . . . . . . . . . . . X . . . . . . . . .
Texas . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X . . . .
Utah . . . . . . . . . . . . . . . . . . . . X . . . . . . . . . . . . . .
Vermont . . . . . . . . . . . X . . . . . . . . . . . . . . . . . . .
Virginia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . X
Washington . . . . . . . . . . . . . . . . . . . . . . . X . . . .
West Virginia . . . . . . . . . . . . . . . . . . . . . . X . . . .
Wisconsin . . . . . . . . . . . . . . . . . . . . X . . . . . . . . .
Wyoming . . . . . . . . . . . . . . . . . . . . . . . . . . X . . . .
SOURCE: National Association for Biomedical Research,State  Laws Corrcern-
ingthe L4eofAn/mals  in &search (Washington, DC: Foundation for
Biomedical Research, 19S5).
other educational or scientific establishment
within the Commonwealth above the rank of sec-
ondary school, which, in connection with any of
its activities) investigates or gives instruction con-
cerning the structure or functions of living or-
ganisms or the causes, prevention, control or
cure of diseases or abnormal conditions of hu-
man beings or animals.
Effective October 1, 1986, Section 9 of the law
will forbid the importation of similar animals into
the Commonwealth for research purposes:
. . . no person, institution, animal dealer or their
authorized agents shall transport, or cause to be
transported, any animal obtained from any mu-
nicipal or public pound, public agency, or dog
officer acting individually or in an official capac-
ity into the commonwealth for purposes of re-
search) experimentation, testing, instruction or
demonstration.
Under the provisions o Section 9, any instltution
obtaining animals before the deadline must have
filed a report with the Department of Public Health
“detailing its plans for discontinuation of the use
of such animals. ”
The impact of recent laws forbidding the acqui-
sition of unclaimed animals for research is un-
certain. Research community representatives in
Massachusetts have claimed that the new laws,
when fully in effect, will add perhaps $6 million
to the annual price of research conducted in the
Commonwealth (80,82). The added cost to tax-
payers of humanely destroying animals that re-
main unclaimed at pounds must also be consid-
ered, although it could be argued that taxpayers
bear the cost of sacrificing animals in research
as well, however indirectly (81). The effects of the
new Massachusetts laws merit close observation.
Recent Initiatives in
Pound Release Laws
The success of those who wish to repeal pound
release laws or to prohibit the use of stray and
abandoned companion animals in research by
some other means has been spotty. Most of the
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laws permitting the use of pound animals in re-
search were passed in the decade following World
War II, when the need for inexpensive research
models began to mount, and the vast majority of
jurisdictions still permit it. As table 14-2 shows,
6 jurisdictions require release of impounded ani-
mals for research purposes, 7 permit it, 29 nei-
ther expressly require nor forbid release, and 9
prohibit the practice. Most delegate that author-
ity to local animal control officers and authorities
(89). Release repeals have succeeded in larger
areas, which are perceived to have the resources
for less-convenient means of disposition of un-
wanted animals. Smaller jurisdictions without
those resources are faced with animal and dis-
ease control problems that are as persistent as
ever. Thus, a senate committee in Florida re-
ported a bill in 1984 that required more-humane
methods of euthanasia for strays but rejected a
proposal to prohibit city and county shelters from
sending excess animals to the University of Florida
for experimental purposes (114), Similarly, the Hu-
mane Society in Larimer County, CO, voted unani-
mously in May 1983 to sell animals to Colorado
State University for veterinary research in order
to raise funds.
Pound release laws, whether mandatory or per-
missive, have come under close scrutiny in the
last 10 years at both the State and local level. A
25-year-oldd law in New York requiring the release
of pound animals to State-run research institu-
tions was repealed in 1979 (21). A bill defeated
in the Wisconsin Senate by a vote of 2-97 would
have amended the current law requiring pounds
and shelters to release unclaimed dogs to State-
accredited institutions, upon proper requisition,
for research purposes (33,121).
A running legislative battle has been taking
place in the California Assembly for several years.
Two major bills dominated the legislative agenda
in 1983 and 1984, but neither received approval.
Senate Bill No. 883, defeated in 1984 in an assem-
bly committee, would have repealed current re-
quirements for pound signs warning owners and
others that animals could be used in research and
would have generally prohibited the release by
local pounds and shelters of live dogs, cats, and
other animals for the purpose of experimentation,
testing, demonstration, or research (14). Assem-
bly Bill No. 1735, left pending in the 1984 assem-
bly session, would have modified the same law
by permitting persons leaving strays to stipulate
that the animal not be used for research purposes.
Further, it would have extended the mandatory
holding period for potential research animals and
prohibited release of any pound animal to a re-
search facility prior to a determination that the
facility meets specified standards of humane ani-
mal care (13). (California law currently provides,
in a regulation-of-research statute, that the De-
partment of Health Services may not make any
rule “compelling the delivery of animals for the
purpose of research, demonstration, diagnosis, or
experimentation,” thus leaving the policy to the
discretion of local jurisdictions (17).)
Substantial recent activity has occurred at the
local level, as well. For 3 years, the City of Los
Angeles has prohibited the release of cats or dogs
for research (60). In 1984, commissioners in Jack-
son County, MI, refused to prohibit the release
of pound animals to research institutions and
educational facilities. Advocates of the measure
subsequently failed in their drive to have the is-
sue placed on a referendum ballot (102). In 1983,
the Society for Humane Ethics and Principles peti-
tioned the Board of Supervisors for Maricopa
County, AZ, to adopt a policy prohibiting the sale
of impounded animals to research facilities, fol-
lowing the State legislature’s rejection of the so-
ciety’s proposal for a State law with identical re-
strictions (72)83). The board adopted the proposal
and the policy has been sustained by an opinion
issued by the State attorney general in 1984 (25).
In 1985, 11 influential animal welfare organi-
zations joined in an effort to prevent all use of
pound and shelter animals for scientific purposes.
The new National Coalition to Protect Our Pets
(Pro-Pets), which includes both humane societies
and antivivisection groups, seeks legislation
toward this end (64).
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ANIMAL USE IN EDUCATION
Past Trends
Of all areas of State and local law dealing with
the humane treatment of experimental animals,
the realm of education is probably the most ne-
glected. Statutes that refer to humane treatment
in grammar and secondary schools usually con-
tain very general terms, leaving the interpreta-
tion for instructional and curricular requirements
to local school authorities.
Twenty-one States, in codes governing public
instruction, list requirements for teaching stu-
dents about the value of animals. These require-
ments vary widely and correspond to legislative
perceptions of both the morality and utility of hu-
mane treatment. Some States, such as Pennsyl-
vania and Wyoming, require a certain amount of
time per week or other designated instruction
period to be devoted to “kindness to” or “humane
treatment of” animals. Others require such in-
struction, in more general terms, on designated
days of the year—”bird, flower, and arbor day”
in Tennessee, “arbor and bird day” in Wisconsin,
“bird” day in Utah, and “conservation” day in New
York. New York, however, also requires general-
instruction programs in “moral and humane edu-
cation” and “protection of wildlife and humane
care of domestic animals, ” while Wisconsin man-
dates such programs regarding “kindness to and
the habits, usefulness and importance of animals
and birds, and the best methods of protecting,
preserving and caring for all animal and bird life.”
California, besides requiring each teacher to “im-
press upon the minds of the pupils the principles
of morality . . . including kindness toward domes-
tic pets and the humane treatment of living crea-
tures,” requires public elementary and second-
ary schools to house and care for live animals in
a ‘(humane and safe” manner and prohibits kill-
ing or injuring, including anesthetizing, live verte-
brates. Illinois and Massachusetts prohibit any “ex-
periment upon any living animal for the purpose
of demonstration in any study” in a public school.
Further, dogs and cats may not be killed for vivi-
section, nor can any animal provided by or killed
in the presence of a pupil be so used. Dissection
of dead animals is limited to classrooms before
students “engaged in the study to be illustrated
thereby” (74).
Interest is increasing in laws restricting the use
of at least some animals in experimentation be-
low the undergraduate level. Recently introduced
Kansas Senate Bill No. 529 forbids any school prin-
cipal, administrator, or teacher from allowing any
live vertebrate animal in a school or sponsored
activity to be used as part of a scientific experi-
ment or procedure in which the normal health
of the animal is interfered with or in which fear,
pain, suffering, or distress is caused. Covered ex-
periments and procedures include, but are not
limited to:
. . . surgery, anesthetization, and the inducement
by any means of painful, lethal, stressful, or
pathological conditions through techniques that
include but are not limited to:
(a) administration of drugs;
(b) exposure to pathogens, ionizing radiation,
carcinogens, or to toxic, hazardous or pol-
luting substances;
(c) deprivation; and
(dielectric shock or other distressing stimuli.
Dissection of dead animals would be permitted
if confined to classrooms, and the bill requires
that its provisions not be construed to prohibit
“biological instruction involving the maintenance
and study of living organisms or the vocational
instruction in the practice of animal husbandry.”
Finally, the bill requires live animals in schools
to be housed and cared for in a humane and safe
manner, assigning personal responsibility to the
teacher or other adult supervisor of a project or
study. Violations would be punished as Class A
misdemeanors.
A bill introduced in Florida seeks to set State
policy regarding experimentation with live ani-
mals. The bill prohibits biological experiments on
living subjects other than lower orders of life or
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anatomical specimens purchased from biological
supply houses. Further, it permits only noninter-
ventional observation of vertebrate animals (59).
A similar bill was introduced in the New York As-
sembly in 1983 (58).
Only one case has tested the application of a
State’s general anticruelty statute to secondary
school experimentation. For a science fair project,
a New Jersey high school student intentionally in-
flicted two chickens with cancer and later killed
them for dissection. The court first found that
the State’s general exemption for scientific re-
search was unavailable to the student, since he
was not a licensed institution. The plaintiff, the
New Jersey SPCA, argued that experiments such
as this one were needless and unnecessary. Adopt-
ing an expansive view of what constitutes scien-
tific activity, the court found that the experiment
did not violate the New Jersey anticruelty stat-
ute, for several reasons, including:
l the student had received proper supervision
and normal protocols had been employed;
l there were general benefits to society in per-
mitting such experimentation; and
l the chickens were given proper care during
the term of the experiment, and it was un-
clear whether the chickens were in pain dur-
ing the experiment (91).
Recent Initiatives in Education
Measures continue to be introduced that re-
strict the use of some types of animals for exper-
imentation, teaching, or demonstration purposes
and that prohibit painful or invasive procedures
of any kind, as outlined above (56). An extreme
example is Massachusetts House Bill No. 742,
which would eliminate the use of animals for
demonstration purposes at medical schools.
There appears to be growing interest among
professional and humane oriented organizations
in establishing standards for animal use in teach-
ing and promoting science to the young that also
encourage humane attitudes. The Scientists’ Cen-
ter for Animal Welfare (Bethesda, MD), for exam-
ple, has targeted science fairs (see ch. 9) as can-
didates for making students more sensitive to the
needs of animals.
SUMMARY AND CONCLUSIONS
Unlike the Federal Animal Welfare Act, most
State anticruelty statutes were enacted prior to
the turn of the century, and they have been in-
terpreted as protecting the interests of society,
the animal owner, and the animal, in roughly that
order. Most forbid both active cruelty (torture,
“overriding”) and failure to satisfy some specific
(food, water, shelter) or nonspecific (“necessary
sustenance”) duty of care owed to animals. Many
incorporate vague or undefined terms, require
some proof of state of mind (culpability) to sus-
tain a conviction, and are subject to a variety of
defenses. Enforcement of most aspects of these
statutes is usually delegated to local police and
to humane societies. The members of humane so-
cieties are generally not trained to build crimi-
nal cases skillfully, they lack the enforcement
tools to do so, and they are underfunded for the
task.
The application of these statutes to the conduct
of research is unclear, since many State anti-
cruelty laws are general in nature and contain
no specific exemption for research activity. The
only case that offered the ideal forum for resolv-
ing conflicting research and animal protection in-
terests at the Federal and State level—and for
deciding whether Congress intended to occupy
the field of laboratory-animal regulation or, rather,
to establish a cooperative system of protection—
was decided without addressing these issues.
Another State court found no preemptive intent
in Congress’ passage of the Animal Welfare Act.
It seems clear enough that the act is intended to
complement, or at least operate concurrently,
with State efforts at research regulation, but
courts’ reluctance to render broad decisions in
cases on animals and the mixture of constitutional
principles represented in the act make prediction
of outcome difficult in any given case.
Twenty States and the District of Columbia reg-
ulate research to some extent. Like the Federal
act, however, most address themselves to pro-
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curement and treatment of animals after experi-
mentation, rather than to specific standards of
care to be observed before and during research.
These laws concern themselves primarily with
dogs and cats, and some merely require or en-
courage licensing or some other type of certifi-
cation to enable research facilities to obtain pound
animals. Several States have passed regulatory
laws that complement the Federal act, in the sense
that they exempt facilities from compliance with
certain responsibilities if they fulfill similar re-
quirements under Federal law, regulations, or
guidelines.
All States have laws providing for the control
and disposition of stray and abandoned dogs and
cats. Beginning in the late 1940s, States began
adopting laws requiring or permitting research
facilities to purchase strays from pounds and
shelters. These laws have been the targets of re-
peal efforts.
All 50 States and the District of Columbia allow
some form of pound animal use for research and
training. To date, 9 States prohibit in-State pro-
curement (although not importation from out-of-
State) of pound animals for research and train-
ing. Of these, Massachusetts will in October 1986
prohibit the use of any animal obtained from a
pound.
Twenty-one States have some provision in their
codes requiring the teaching of “kindness” or “hu-
manity” toward, or the “value” of, animals. A few
place some restrictions on animal use in gram-
mar and secondary schools.
Advocates of laboratory-animal protection crit-
icize current State and local efforts to assure ani-
mals’ humane treatment for several reasons, the
main ones being that compliance schemes are
overly complex and bureaucratic, that training
and resources are inadequate, and that existing
laws are not specific enough in their standards
for care, treatment, and use. One model statute
would regulate research use more closely by
establishing classes of eligible research animals,
based on comparative intelligence, with specific
proofs to be met before animals in any class could
be used in experiments.
Interest is growing in establishing direct, legally
enforceable rights for animals. Some protection
groups have endeavored to protect laboratory ani-
mals by seeking enforcement of anticruelty stat-
utes or suing those they see damaging animals’
interests. They have had virtually no success.
Some have advocated conferring standing to sue
on animals by applying the traditional concepts
of guardianship to them.
Reviewing recent trends in each of these fields
of law, it appears certain that animal welfare and
humane groups will continue to press their case
for reform on all fronts. Thus, it is likely that re-
search and animal welfare interests will continue
to collide in all three branches of Government at
the State and local levels. Though some bills have
been introduced that seek to reduce animal use
in experimentation, promote other models, or
eliminate the use of animals entirely, they have
not been given serious consideration.
CASE STUDY:
FRIENDS OF ANIMALS, INC. v. U.S. SURGICAL CORPORATION
Every year, the United States Surgical Com- fact that one of the dealers who supplied them
pany used approximately 900 dogs to train sales with dogs has been convicted of animal cruelty
representatives in the proper use of their [sur- and of receiving stolen animals (101).
gical] staple guns–a tool that is rapidly replacing
conventional stitching of wounds or operation
cuts. The representatives are chosen primarily
for their sales ability and thus may have little or
no medical knowledge. Before being sent out on
the road, they must pass through a six-week
training course. The company is now the focus
for animal welfare protest in Connecticut. Their
position has not been improved by allegations
of animal abuse in a newspaper expose or the
Thus was summarized a dispute between Friends
of Animals, Inc., a major animal welfare organiza-
tion, and US. Surgical Corporation, a large, pri-
vate manufacturing interest using dogs to train
its own personnel and customers in the use of
its products. Behind local newspaper headlines
on the case was a running legal battle involving
several distinct lawsuits in Federal as well as State
courts. Regardless of the positions or motives of
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the litigants, the cases in which they are parties
provide an interesting view of the perceived roles
that existing Federal and State animal welfare
laws play when such disputes arise.
The Parties
Friends of Animals, Inc.
Friends of Animals, Inc. (FOA), is a not-for-
profit, charitable organization incorporated under
the laws of New York, with registered agents in
a number of other States. FOA claims some 100,000
members nationwide, more than 5,000 of whom
live in Connecticut, where these FOA complaints
were filed. FOA is active in defense of all animals’
right to humane treatment—politically, as well as
legally. In the suits, FOA alleged that among its
members are “individuals who are owners of dogs
and . . . who have an intense interest in the prop-
er administration and enforcement” of animal
welfare laws (37).
U.S. Surgical Corporation
Headquartered in Norwalk, CT, U.S. Surgical
Corporation is the leading producer of surgical
stapling devices used for surgical tissue repair and
wound closure. It has been in business for some
18 years and total sales in 1982 were $146 mil-
lion. Its surgical products, marketed under the
trade name AUTO-SUTURE, are sold in over 40
countries. U.S. Surgical has international subsidi-
aries in seven European countries and Australia,
and the company employs about 1,900 people,
two-thirds of whom work in Connecticut. Though
it receives no Federal funding to support its prod-
uct research or development, the company is sub-
ject to inspection and licensure by the Animal and
Plant Health Inspection Service (APHIS) as a “re-
search facility” under the Federal Animal Welfare
Act, by the Drug Enforcement Administration
under the Controlled Substances Act, and by the
Departments of Health and Consumer Protection
in Connecticut, which regulate the use and dis-
posal of dogs in research (106,123). U.S. Surgical’s
president has expressed concern about the amend-
ment of the Federal Animal Welfare Act that
would require the company to appoint nonaffili-
ated persons to internal animal care review com-
mittees that have access to confidential business
information (113).
The Controversy
U.S. Surgical’s use of dogs purchased from lo-
cal animal dealers to provide live-tissue training
for its sales staff, also known as technical field
representatives, in the use of surgical stapling
equipment at the Norwalk teaching facility first
came to the public’s attention with the publica-
tion of a newspaper article in November 1981.
That article contained a variety of allegations
about the company’s practices:
l
l
l
l
l
l
l
“Sales personnel with no medical experience
and surgeons destroyed at least 900 dogs at
the Norwalk laboratory between October 1,
1980, and September 30, 1981. Additional
hundreds of dogs are operated on each year
for sales demonstration purposes by the com-
pany’s traveling sales staff and at regional and
national sales meetings.”
Anesthesia was “routinely administered to
the dogs by persons with no medical train-
ing, including the sales staff.”
U.S. Surgical “failed to comply, for three con-
secutive years, with federal laws that [re-
quired it] to register with the U.S. Depart-
ment of Agriculture.”
In at least one case, the personnel perform-
ing live-tissue training demonstrated the
strength of the staple closure by lifting a dog
by the clamp enclosing the abdominal fascia
and by attempting to sunder the stapled cut.
Some dogs appeared to be inadequately anes-
thetized, “jumping, jerking, writhing, and moan-
ing” or showing other apparent signs of pain
or distress during demonstrations, and others
died prematurely, apparently from overdoses
of barbiturates used for anesthesia.
USDA officials quoted in the article were of
the opinion that use of dogs for this purpose
was a legal research activity although they
“questioned the validity of sacrificing animals,
especially in such large numbers, for this type
of commercial purpose. ”
One of the federally licensed dealers from
whom the company had acquired dogs had
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been “convicted in local court [in New Jer-
sey] of receiving stolen dogs, animal cruelty,
failing to keep proper records and failing to
provide animals with adequate shelter from
the cold” (54).
US. Surgical contended that its salespeople are
given hands-on, live-tissue training in the use of
its surgical stapling equipment, principally to “en-
able [them] to provide technical assistance in the
operating room the first few times a surgeon uses
the stapling instrumentation on a human patient.”
U.S. Surgical’s technical field representatives also
act as instructors, under the supervision of pro-
fessors of surgery, in the laboratory portion of
surgical-stapling seminars at postgraduate teach-
ing hospitals. The company provides an “intense,
five-week training program” for these purposes,
consisting of instruction in “anatomy, physiology,
surgical terminology, aseptic surgical techniques,
surgical gowning, gloving, and scrubbing, and
operating room protocol, ” in addition to super-
vised live-tissue training. Refresher courses on
new surgical-stapling procedures are given to all
sales staff at least once each year (106).
U.S. Surgical responded to major charges con-
tained in the 1981 article as follows:
l
l
l
In all, 974 dogs were acquired and used dur-
ing the period mentioned, but only for ‘(teach-
ing regarding technical application and use
of surgical instrumentation in well-accepted
surgical procedures,” and not for demonstra-
tion purposes. The company asserts that only
foam wound and organ models are used for
sales demonstration purposes.
All anesthetic procedures are initiated and
supervised by two “laboratory technicians
trained in animal care and handling and who
have been previously employed in animal lab-
oratories responsible for both survival and
nonsurvival animal research work.”
The company “complied in good faith” with
Animal Welfare Act requirements. U.S. Surgi-
cal first applied for registration of its Stam-
ford, CT, facility on June 4, 1976; it was first
visited by USDA-APHIS inspectors in Febru-
ary 1979, and informed that it was not reg-
istered under the act. An inspection was con-
ducted under ‘(license-pending” status. The
l
l
l
l
company reapplied for registration on Feb-
ruary 20, 1979, and Registration No. 16-28
was issued on March 27, 1979.
“The strength of the staples is tested to dem-
onstrate their benefit when used in human
clinical surgery; however, the methods de-
scribed lifting dogs by the staples and at-
tempting to pull incisions apart by hand] are
not employed. ”
Although ‘(the level of sedation may vary dur-
ing the program, ” due to periodic adminis-
tration of regulated doses to maintain un-
consciousness without overdose, “the animal
never regains consciousness or experiences
discomfort.” U.S. Surgical also stated that
multiple teaching procedures are performed
on single dogs in one session, “minimizing the
need to use even more dogs and maximizing
the teaching benefit provided by the animal.”
Expressing no specific opinion about the
statements made by the quoted USDA-APHIS
inspector as to the utility of using dogs for
this purpose, U.S. Surgical noted that they
had been contacted by a USDA veterinarian
who would be writing to substantiate its need
to use live animals.
Dogs used in live-tissue training were ac-
quired only from federally licensed dealers,
their identification tags were checked and
recorded, and their condition was evaluated
prior to acceptance. If, as was stated in the
article, the New Jersey dealer had had its Fed-
eral license revoked, then reinstated when
violations had been corrected, the dealer
“must be considered an acceptable source by
the USDA” (123).
The Lawsuits
Friends of Animals filed its first lawsuit against
U.S. Surgical in Federal court in Connecticut on
December 29, 1981, a little less than 2 months af-
ter the newspaper article had appeared (37). Al-
leging that the defendant company, registered as
a research facility as defined in the Federal Ani-
mal Welfare Act, had killed 974 dogs to demon-
strate its surgical equipment, FOA contended that
the demonstrations:
l were “at times, performed without the prop-
er administration of anesthesia”;
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l did not constitute “experimentation and/or
research, as permitted by . . . the Animal Wel-
fare Act”; and
. violated the Connecticut anticruelty statute.
The FOA complaint also contended that simi-
lar demonstrations performed from 1977 through
1979, when the company was not registered un-
der the act, were not permitted experiments or
research and violated the State anticruelty stat-
ute. FOA petitioned the court for a jury trial; un-
specified compensatory damages; $5 million in pu-
nitive damages; interests, costs, and attorney’s
fees; and “other equitable relief .“ On February 8,
1982, U.S. Surgical filed a motion, under Rule 12
of the Federal Rules of Civil Procedure, to dismiss
the suit because the plaintiff had failed to state
a claim on which the court could base any war-
ranted relief (38). Two days later, FOA filed a sep-
arate suit in the Superior Court of Connecticut,
alleging the same facts, complaining of the same
acts by the company, and requesting the same
relief (41). On February 12, 1982, FOA filed a mo-
tion for voluntary dismissal without prejudice of
the action filed in the Federal court, under Rule
41(a)(l)(i) of the Federal Rules of Civil Procedure,
asserting that the Federal court lacked jurisdic-
tion over the subject-matter of the suit (39). The
court concurred and dismissed the suit without
prejudice (40).
FOA amended the State court complaint on
April 6, 1982, adding three additional counts to
the original two (42). The third count alleged that
the surgical-stapling demonstrations performed
on anesthetized dogs from 1977 through 1981 vio-
lated Connecticut Statute 22a-15, which contains
a general declaration of policy on environmental
preservation. Counts Four and Five complained
that the demonstrations constituted a nuisance
and violated the provisions of the Animal Welfare
Act. Thus, in addition to asserting that the com-
pany’s complained-f activity violated Federal and
State animal welfare laws, FOA contended that
it amounted to a compensable common-law nui-
sance and also violated Connecticut’s stated pol-
icies concerning protection of the public trust in
natural resources.
US. Surgical countered with motions to strike
the first two counts, on April 12, 1982, and the
last three counts added by amendment, on May
19, 1982. In its memoranda in support of the mo-
tions, the company responded to the allegations
as follows:
l
l
l
l
l
l
The Connecticut anticruelty statute, being a
criminal statute, created no private right of
action to seek or compel enforcement of its
provisions. According to U.S. Surgical, the
law was not enacted to specially benefit a par-
ticular class and no evidence of legislative in-
tent to create a private right of action could
be found. The company claimed that such a
right would be inconsistent with the statu-
tory scheme of criminal and administrative
enforcement erected by the legislature to
protect both animals in general and dogs
used in research.
FOA lacked standing to sue, both on behalf
of its members and on its own behalf, since
the alleged injury was neither direct nor “dis-
tinct from a general interest shared with the
public at large.”
Punitive damages could not be awarded to
FOA since no allegation was made that the
defendant’s acts were committed to inten-
tionally and wantonly violate FOA’s rights or
showed a reckless indifference to the rights
of FOA.
The Connecticut statute articulating the
state’s interest in natural resources as a “pub-
lic trust” provided no basis for FOA’s chal-
lenge to U.S. Surgical’s use of dogs, for three
reasons. First, it authorizes no private right
of action. Second, the State’s declared policy
of protecting the public trust in natural re-
sources does not apply to defendant’s use of
dogs. Third, the environmental statute does
not supersede other State laws governing the
use of dogs in research.
FOA lacked standing to sue on grounds of
nuisance, having suffered no direct and dis-
tinct injury of an interest in real property.
The Federal Animal Welfare Act created no
private right of action in favor of FOA, for
the same reasons stated in US. Surgical’s re-
sponse to the first count (43,44).
FOA filed an opposition to U.S. Surgical’s mo-
tion to strike on June 10, 1982, and the court
heard oral arguments on the motion on Novem-
ber 3, 1982 (106).
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The superior court entered a decision granting
the company’s motion to strike all five counts of
FOA’s complaint (45). With regard to the alleged
violation of Connecticut’s anticruelty law, the
court construed the criminal-penalty law strictly
and found no evidence of intent to create a pri-
vate right to enforce its provisions. Although the
Court did find legislative intent to create a pri-
vate right to seek injunctive relief against pollu-
tion, under the Connecticut Environmental Pro-
tection Act, it rejected FOA’s contention that dogs
were covered by the statute.
The court also rejected FOA’s charge that U.S.
Surgical’s destruction of dogs for surgical pur-
poses constituted a common-law nuisance be-
cause FOA both “failed to set forth allegations that
established a public nuisance” and based its claim
for recovery “upon its peculiar and particular sen-
sitivities and not upon its rights as a member of
the general public.” Additionally, the court re-
jected FOA’s claim that the Federal Animal Wel-
fare Act created a private right of enforcement
similar to that created by the Marine Mammal
Protection Act. Finally, the court agreed with U.S.
Surgical that FOA could not collect punitive dam-
ages unless it pleaded and proved that the com-
pany had shown ‘(a reckless indifference to the
rights of others or an intentional and wanton vio-
lation of those rights” (45).
On December 21, 1982, before judgment had
been entered on the motion to strike, FOA filed
an amended complaint in Connecticut superior
court, alleging again that U.S. Surgical’s use of
dogs for surgical demonstrations was reckless,
wanton, sometimes without proper anesthetiza-
tion, and constituted a public nuisance (46). FOA
also claimed that the company’s use of dogs vio-
lated a New Jersey anticruelty statute, The revised
complaint added a new party to the proceedings:
Pierre Quintana, a resident of Wilton, CT, who
alleged that his springer spaniel, “George,” was
“stolen by agents or servants or employees of the
U.S. Surgical Corporation and converted to said
owner’s use. ” FOA asked for a trial by jury and
the same relief as earlier. U.S. Surgical, unaware
that a substitute complaint had been filed, the fol-
lowing day filed a motion for early entry of judg-
ment on the motion to strike (47,106).
While the action in State court continued, FOA
refiled its case in Federal District Court on De-
cember 29, 1982, again asserting an interest on
behalf of its members in “legally sufficient en-
forcement of the Animal Welfare Act” (48). Reiter-
ating the allegations of the company’s use of dogs
in 1981, FOA renewed its contention that proper
anesthetics were not used. It further alleged that
U.S. Surgical had purchased live dogs from un-
licensed dealers, in violation of the act, and that
the company’s surgery on live animals did not
constitute experimentation and/or research as
permitted by the act and was performed with
“reckless indifference to the lives and well-being”
of the animals.
Almost 4 months later, FOA moved for leave
to amend the renewed complaint, and the motion
was granted (49). In its amended complaint, filed
on April 13, 1983, FOA charged that Rudolph
Varana, a federally licensed animal dealer doing
business as Varana Rabbit Farms, had committed
“criminal acts”—i.e., received a stolen golden
retriever, for which he was convicted under New
Jersey Law—”as agent and servant for the U.S.
Surgical Corporation . . . in direct violation of 7
U.S.C. 2131(3) which states that one of the pur-
poses of the Animal Welfare Act is ‘to protect the
owners of animals from the theft of their animals
by preventing the sale or use of animals which
have been stolen ’.” FOA contended that the com-
pany knew or should have known of ‘(its agent”
Varana’s “criminal acts” but continued to pur-
chase dogs from him. As a result of Varana’s
“criminal acts” and US. Surgical’s own negligence,
FOA claimed that it had “been required to expend
substantial amounts of money, [had] diverted sub-
stantial corporate resources, and [had] been
forced to restructure [its] activities in order to in-
vestigate the criminal activities of said Rudolph
Varana , . . and address the violations of the Ani-
mal Welfare Act and regulations enacted thereof
[sic] by the U.S. Surgical Corporation.” (FOA did
not state that the golden retriever had been ac-
quired and used by US. Surgical.)
Meanwhile, the company filed a request to re-
vise the substituted complaint in the State court
action, asserting that the second count of the sub-
stituted complaint reiterated allegations of pub-
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lic nuisance that had already been stricken by the
Court (50). Failure by FOA to object to the request
resulted in the request being granted on May 9,
1983, leaving intact the counts concerning the
claimed violation of the New Jersey anticruelty
statute and the alleged theft of Quintana’s dog
(106).
On December 9, 1983, FOA’s lawyer moved to
withdraw as counsel in the Federal case. The re-
quest was granted in March 1984. On August 23,
1984, FOA’s new attorney filed a motion to dis-
miss the Federal complaint with prejudice, and
moved to withdraw the State complaint and to
set aside a judgment of dismissal entered in that
case. Both motions were granted and the lawsuits
were dismissed, not to be filed again (51,52,106).
A newspaper story a week before the dismissal
and withdrawal motions were filed by FOA re-
ported that prior counsel had instituted suit
against FOA for nonpayment of legal fees in the
U.S. Surgical cases and others filed on FOA’s be-
half (6).
Discussion of the Case
Almost 3 years of legal sparring over an animal
welfare controversy, conducted in both Federal
and State courts, came to no substantive conclu-
sion on the real issues in disagreement. There was
no examination by a judge or a jury of the evi-
dence to determine whether U.S. Surgical’s use
of anesthetized dogs to train its personnel in the
use of surgical-stapling equipment on human pa-
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tients was cruel or unjustified. FOA’s attempts to
invoke Federal and State animal use, anticruelty,
animal theft, and even environmental statutes to
“punish” or control behavior it deemed cruel or
unjustified accomplished little more than the con-
sumption of substantial amounts of time and ju-
dicial resources.
This result can be attributed to a number of
factors, chief among which is a demonstrated
reluctance on the part of judges to permit private
enforcement of laws entrusted by legislation to
administrative and law-enforcement agencies,
Whether FOA decided to abandon its prosecution
of U.S. Surgical as a result of disagreements with
initial counsel or a realization of the unlikelihood
of a victory on the merits is an open question.
Statements attributed to FOA representatives in
published press accounts could support both of
those reasons (6,55).
Connecticut regulates the use of live compan-
ion animals (dogs) in research; its general anti-
cruelty statutes make no mention as to whether
its provisions also apply to the conduct of re-
search. The same situation exists in 24 other
States, If the complex and wholly inconclusive le-
gal maneuvering in Friends of Animals, Inc. v. US.
Surgical Corporation is indicative of what might
occur in similar circumstances in other jurisdic-
tions, it is unrealistic to expect a result that settles
anything or satisfies any party with an ideologi-
cal interest in the treatment of laboratory animals
and the human benefits of animal research.
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Chapter 15
Institutional and
Self-Regulation
of Animal Use
The public fears and distrusts science. Regulation-any regulation—ma-y in the end make
them fear it less. But scientists themselves have a duty, I believe, not just to argue their
own case but to argue it in a manner acceptable to society as a whole. . . . [Fear] must be
allayed if at all by scientists and doctors themselves, making their own case and making it
intelligibly in public.
Baroness Mary Warnock
Girton College, Cambridge
Br. Med. J. 291: 187-190, 1985
What’s happening in I+ Washington is a red herring. The issue of the use of animals in re-
search won ‘t be resolved on Capitol Hill. The real action is right here on your front door
step.
William M. Samuels
American Physiological Society
Address given at the University of South Florida Medical Center
March 21, 1984
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chapter 15
Institutional and Self-Regulation
of Animal Use
The most important check on the proper treat-
ment of animals is the conscience of the individ-
ual investigator (23). A person’s view about ani-
mal welfare is influenced by many forces; some
of the most formidable include exposure to pro-
fessional peers, mentors, and formal course work
on animal care or the ethics of animal experimen-
tation.
Beyond individual conscience, the most visible
means of self-regulation is institutional commit-
tee review of animal care and use. The use of ani-
mals is also overseen by the peer review of scien -
tific colleagues and others outside of the research
facility—an important part of the grants adminis-
tration process.
In addition, most scientists are members of one
or more professional associations, some of which
have codes of ethics for research with animal sub-
jects. These statements of principles can serve to
inspire ethical behavior and alert researchers to
ethical issues raised by their work. Codes can some-
times provide advice on specific cases and sanc-
tions for violations (reviewed in ref. 21).
REVIEW OF ANIMAL CARE AND USE
All research supported by the Public Health Serv-
ice (PHS), including that of the National Institutes
of Health (NIH), is subject to the provisions of the
PHS Policy on Humane Care and Use of Labora-
tory Animals by Awardee Institutions (revision ef-
fective Dec. 31, 1985) (44). Each institution so
funded must submit an acceptable assurance to
NIH’s Office for Protection from Research Risks
(OPRR) that commits the facility to active promo-
tion of compliance with the policy and the NIH
Guide for the Care and Use of Laboratory Animals
(42).
The NIH peer-review system can be construed
as external rather than self-regulation (46). Site
visits to determine compliance can occur, and fund-
ing can be terminated for lack of compliance with
contractual assurances, as happened in the Taub
case (see ch. 14). In the broadest sense, however,
NIH is fully dependent on grant recipients for ef-
fective policing of its provisions.
The enactment in 1985 of Public Law 99-158 (see
ch. 13) provided statutory authority and recogni-
tion for some provisions of the PHS policy, requir-
ing, for example, all entities conducting research
with PHS funds to organize and operate institu-
tional animal care and use committees. Also in
1985, amendments to the Animal Welfare Act (see
ch. 13) extended the mandate for institutional com-
mittee oversight to research facilities covered by
the Animal Welfare Act and to Federal research
facilities.
NIH Assurance Review
To test the operation of written assurances of
compliance with the PHS policy regarding humane
care and treatment of experimental animals by in-
vestigators in the field, and perhaps in response
to congressional and public pressure, the NIH Of-
fice of Extramural Research and Training in 1983
conducted site visits to 10 grantee facilities (43).
These institutions were chosen from a stratified
sample of the more than 800 awardees with gen-
eral assurances on file at the NIH Office for Pro-
tection from Research Risks.
The 10 institutions were distributed among those
receiving more than $10 million in annual support
from NIH (3 institutions), between $5 million and
$10 million (3 institutions), and less than $5 mil-
lion (4 institutions). The sample was further de-
fined by selecting institutions from each of those
categories with valid written assurances on file
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but lacking accreditation by the American Asso-
ciation for Accreditation of Laboratory Animal
Care (AAALAC). Awardee institutions were noti-
fied of the prospective visits by publication of the
selection criteria and the site names (43), and the
NIH chairperson notified the appropriate institu-
tional representative(s) at least 1 month prior to
the scheduled visit.
Site-visit team size depended on the size of the
institution and the complexity of its physical facil-
ities. At a minimum, teams consisted of a veterinar-
ian, a biological scientist engaged in research using
animals, and an NIH scientist/administrator. In
addition, non-Federal consultants were included
“with a view towards ensuring impartiality and
enhancing expertise” (43). Between June and Sep-
tember 1983, the 10 site visits were conducted to
receive information and impressions in order to
answer the following questions:
l
l
l
Is NIH’s current assurance system adequate
for promoting the proper care and use of ani-
mals involved in federally funded biomedical
research?
If it is adequate, how can it be further im-
proved?
If it is not adequate, what alternatives should
be considered?
The NIH site visits were generally criticized
within the animal welfare community on three
grounds:
l
l
l
10 institutions may not represent a sizable
enough sample to generate sufficiently repre-
sentative data on which to base policy;
the l-month advance notification to the in-
stitutions to be visited may have skewed the
findings; and
too few smaller institutions were visited, since
the majority of NIH-funded recipients fall into
the unaccredited, less-than-$5-million category.
Despite these potential shortcomings, information
generated by the 10 site visits led NIH to draw con-
clusions and make recommendations about the
PHS policy regarding laboratory-animal welfare,
In early 1984, NIH reported on the site visits (43).
Based on the finding of these visits, two general
conclusions were reached:
l Reliance upon voluntary compliance with PHS
policy and recommendations in the NIH Guide
l
is a realistic approach to fostering proper care
and use of laboratory animals in biomedical
research. There is no reason to believe that
regular NIH inspections are needed or would
be more effective than the traditional assur-
ance process.
The present assurance system should be
strengthened by modifying the 1979 PHS pol-
icy on animal welfare to promote more con-
scientious involvement by both NIH and its
awardee institutions.
In addition, the report stated that “no incidents
of animal abuse were observed” (43).
From the findings of the site-visit teams, a series
of recommendations concerning the adequacy of
the current policy and its enforcement were made.
The site-visit report recommended that NIH:
l
l
l
l
l
undertake a program for helping institutional
officials, scientists, and responsible veterinar-
ians “understand fully their responsibilities”
for policy implementation;
expand the policy to include ‘(more specific
information regarding responsibilities of the
institution that receives funds for research
involving the use of animals, ” including new
and more specific assurances to be negotiated
with institutions receiving funds “carefully
and promptly”;
modify the policy to define more precisely in-
stitutional responsibilities, “particularly the
role of the animal welfare committee,” to which
the appointment of a nonscientist and a per-
son unaffiliated with the institution should be
given serious consideration;
conduct or sponsor a survey to assess whether
the number of veterinarians trained in labora-
tory-animal science is sufficient to meet the
needs of institutions conducting biomedical
research involving animals; and
conduct further assessments of the assurance
process, including visiting more awardee in-
stitutions receiving total annual support of less
than $5 million, since that category of institu-
tions is the largest with assurance statements
on file (43).
In response to the above recommendations and
criticisms, five additional institutions receiving less
than $5 million were visited in 1984. Using the same
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protocol as before, visits were made to a stratified
sample of institutions without AAALAC accredita-
tion during the months of July and August 1984.
The site-visit teams consisted of a representative
of the NIH Office of Extramural Research and
Training, a scientist or administrator from OPRR,
and two non-Federal consultants (a veterinarian
experienced in laboratory-animal medicine and a
biomedical scientist currently conducting research
requiring laboratory animals) (44).
The conclusions following these additional visits
are almost identical to the earlier ones. The teams
noted that the small institutions were capable of
both meeting the responsibilities of the 1979 PHS
policy and assuming additional responsibilities in
response to changes made in the 1985 PHS policy.
The site visitors did find, however, that these in-
stitutions needed to improve the advisory and over-
sight roles of their institutional animal care and
use committees (IACUCs) and upgrade their veteri-
nary oversight (44).
Public Health Service Policy
In mid-1985, the Department of Health and Hu-
man Services (DHHS) released its new PHS Policy
on Humane Care and Use of Laboratory Animals
by Awardee Institutions (44) to replace the 1979
PHS Extramural Animal Welfare Policy (41). (For
the full text of the new policy, see app. C.) This
new policy is a result of the proposed PHS policy
(43), the conclusions from the 15 site visits t. ani-
mal care facilities by NIH, and 340 written and oral
comments on the proposed policy. It took effect
December 31, 1985, for all potential grantees of
PHS wishing to use animals in experimentation.
This policy has many of the same features as
the 1979 version. It applies to all PHS-supported
activities involving animals in the United States.
Animal is defined as “any live, vertebrate animal
used or intended for use in research, research
training, experimentation or biological testing or
for related purposes.” The public Health Service
includes the Alcohol, Drug Abuse, and Mental
Health Administration; the Centers for Disease
Control; the Food and Drug Administration; the
Health Resources and Services Administration; and
the National Institutes of Health. The policy relies
on the NIH Guide for the Care and Use of Labora-
tory Animals for the standards for animal care and
treatment. Finally, the PHS policy is based on a
set of overall principles governing animal experi-
mentation. The 1979 policy was based on 12 prin-
ciples on the use of animals. The new policy im-
plements and supplements the “Principles for the
Utilization and Care of Vertebrate Animals Used
in Testing, Research, and Training” (50 FR 20864)
prepared by the U.S. Interagency Research Ani-
mal Committee (see ch. 13, box A). The principles
contained in these two documents are very similar.
Two major requirements form the core of the
PHS policy-the institutional animal welfare assur-
ance to NIH and an institutional animal care and
use committee, Each institution wishing to obtain
PHS funding for a research project involving ani-
mals must have on file with NIH’s Office for Pro-
tection from Research Risks a written assurance
setting forth compliance with this policy. The as-
surance must describe in detail the institution’s
program for the care and use of animals in PHS-
supported activities including:
l
l
l
l
l
l
l
a list of every branch and major component
of the institution;
the lines of authority and responsibility for
administering the program (each institution
must identify an official who is ultimately re-
sponsible for the institution’s animal program);
the qualifications, authority, and responsibility
of the veterinarian who will participate in the
program;
the membership list of the IACUC;
the procedures that the IACUC will follow to
implement this policy;
the health-care practices for personnel who
work with laboratory animals or their facil-
ities; and
the gross square footage of each animal facil-
ity (including satellite facilities), the species
housed therein, and the average daily inven-
tory, by species, of animals in each facility.
In addition, each assurance must categorize the
evaluation of its program and facilities as either
accredited by AAALAC or as evaluated by the in-
stitution itself. The second category requires that
the IACUC assess its own program every year and
maintain records on the nature and extent of the
institution’s adherence to the NIH Guide and the
PHS policy. This report must also contain justifi-
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cations for any departures from the policy. Defi-
ciencies in an institution’s program or facilities
must be reported to NIH and the institution must
adhere to an approved time frame for correction
of the deficiencies.
The animal care and use committee required by
the new PHS policy is specifically structured to
consist of at least five members including:
. . . one Doctor of Veterinary Medicine with train-
ing or experience in laboratory animal medicine,
one practicing scientist experienced in research
involving animals, one member whose primary
concerns are in a nonscientific area, and one in-
dividual who is not affiliated with the institution
in anyway other than as a member of the IACUC.
New duties of this committee include reviewing
the institution’s program for animal care and use
and inspecting the facilities (including satellites)
at least annually. The policy also authorizes the
IACUC to suspend any activity involving animals
that is found to not be in compliance with the
policy.
A new power of the IACUC is to “review and
approve, require modifications in (to secure ap-
proval), or withhold approval of those sections of
PHS applications or proposals related to the care
and use of animals.” The policy gives a detailed
plan for the administrative structure to handle this
task, along with certain specific animal care re-
quirements that must be met by each proposal (e.g.,
minimization of discomfort of animals). Each ap-
plication or proposal submitted to PHS must ver-
ify that the IACUC has approved those sections
of the proposal related to the care and use of lab-
oratory animals. It should be submitted along with
the application but may be sent directly to the ex-
ecutive secretary of the initial review group within
60 days of the original submission. Figure 15-1 is
the example NIH provides of an acceptable verifi-
cation letter for a proposal. The letter must be
signed either by the institutional official who signed
the institution’s Animal Welfare Assurance or by
another individual authorized by the institution
to provide verification of IACUC approval.
The PHS policy is implemented by the NIH’s Of-
fice for Protection from Research Risks, which is
responsible for approving, disapproving, or with-
drawing approval of institutional assurances. It
also has the power to evaluate allegations of non-
compliance with the policy and to conduct site visits
to selected institutions to check for proper imple-
mentation of the policy.
The new PHS policy differs from the 1979 ver-
sion in the following ways:
l
l
l
l
l
l
Institutions are required to designate clear
lines of authority and responsibility for those
involved in animal care and use in PHS-sup-
ported projects, including an institutional of-
ficer responsible for the entire program.
The role and responsibilities of the IACUC
have been upgraded. The requirements of spe-
cific types of committee members (e.g., a mem-
ber unaffiliated with the institution or a mem-
ber in a nonscientific area) are new, as is the
policy that these committees review and ap-
prove those sections of research applications
for PHS funding that relate to the care and
use of animals before they are actually funded.
If an institution is not AAALAC-accredited,
stringent standards for self -assurances apply
and more information about animal facilities
must be made available to NIH.
Following the policy is mandatory, as opposed
to the earlier “commitment to comply.”
Recordkeeping requirements for institutions
are explicitly addressed. Records of IACUC
meeting deliberations, assurance forms, ac-
crediting body determinations, and so forth
must be maintained for 3 years and made
accessible for inspection to PHS officials.
OPRR has power to “evaluate allegations of
noncompliance with the policy [and]. . . con-
duct site visits to selected institutions.”
In general, the Public Health Service now has
a much more structured animal welfare policy that
specifically designates what individual institutions
must do in order to achieve satisfactory compli-
ance. The old policy had many of the same struc-
tures (e.g., institutional committees and assurances)
but in a form that allowed different degrees of in-
stitutional animal care and treatment responsibil-
ity. The new policy defines a minimum standard
animal care and use policy for an institution that
wishes to obtain PHS funding. In 1979, OPRR re-
leased a sample assurance that was two pages long
and only required a few specifics from the insti-
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Figure 15.1 –Exampie of Acceptable Verification for Grant Submission to NIH
[Date]
Division of Research Grants
National Institutes of Health
5333 Westbard Avenue
Westwood Building, Room 240
Bethesda, Maryland 20205
Dear Sir:
The following application submitted to the Public Health Service was reviewed and approved by this institution’s Animal Care
and Use Committee on [insert date of approval]:
Title of application:
Name of principal investigator:
Name of institution:
This institution has an Animal Welfare Assurance on file with the Office for Protection from Research Risks. The Assurance
number is [insert old assurance number until a new assurance number is assigned].
As a condition of approval, this institution’s Animal Care and Use Committee required the following modifications to the above
referenced application:
This information is required when the modifications are not reflected in the original grant application or con-
tract proposal.]
[Signature]
[Title]
SOURCE: Adapted from US. Department of Health and Human Services, Public Health Service, National Institutes of Health, “Laboratow  Animal Welfare,” N/H Guide
for Grarrts  and Contracts 14(8): June 25, 1985.
tution. The new sample assurance, released in
1985, is seven pages long, including two tables (one
on membership of the IACUC and one summariz-
ing the institution’s individual animal facilities, their
square footage, the species within, and the aver-
age daily inventory of species), and requires spe-
cific detailed data on the institution’s animal wel-
fare program.
REVIEW BY COMMITTEE
Recourse to committees to sort through a thicket
of value questions occasioned by advances in bio-
medicine, and in particular biomedical research,
is not unique to the area of research with animals.
For example, there has been a recent explosion
of interest in the formation of hospital ethics com-
mittees to develop policies and consult in individ-
ual cases. According to one newspaper account,
“quietly and without fanfare, hundreds of Amer-
ican hospitals are organizing internal ethics com-
mittees that are coming to play crucial roles . . .
involving life and death decisions for thousands
of patients” (24).
Concern in this country about the objects of re-
search—and the link between animal and human
subjects—has been evident for decades. A recently
published historical account describes nonthera-
peutic research into the cause of syphilis conducted
at the beginning of the century and reviews the
reaction to the use of orphans and hospital patients
who had not given their consent. The result was
a nearly 20-year campaign against “human vivisec-
tion” conducted by antivivisectionists who saw the
use of human beings without their consent in non-
therapeutic research as the logical outcome of a
science built on animal suffering: “To whomsoever,
in the cause of Science, the agony of a dying rab-
bit is of no consequence, it is likely that the old
or worthless man which in the cause of learning
may well be sacrificed” (22). A number of State
and Federal legislative initiatives proposed 60 to
70 years ago regarding animal research were
amended to regulate “human vivisection” as well.
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Some egregious violations of human rights in the
name of medical research occurred earlier in this
century. The experiments conducted on prisoners
of war during World War II that were revealed
at Nuremberg are the most notorious and well-
known examples; the trials resulted in a code of
ethics to guide future research. Haunted by the
specter of patently unethical and scientifically
unsound research conducted by Nazi physicians,
some commentators began to complain that it was
not only in wartime that the rights of human sub-
jects had been overlooked. In an influential series
of articles by an American physician (12) and a
British physiologist (28), hundreds of experiments
published in major medical journals were re-
viewed, revealing many instances in which re-
search subjects were abused or misinformed. In
addition, there was concern that certain segments
of the population-blacks, the poor, women, or
the elderly —were bearing a disproportionate
share of the burden of being research subjects.
In response to such revelations about the exploi-
tation of vulnerable populations, a number of in-
ANIMAL CARE AND
Roles and Responsibilities
One commentator has summarized the poten-
tial functions for animal care and use committees
as (26):
l
l
l
l
l
l
l
l
l
to ensure compliance with local, State, and
Federal laws and regulations on animal care
and use;
to inspect animal care facilities;
to review protocols for animal welfare issues;
to assess the qualifications of investigators;
to oversee student use of animals;
to advise on institutional needs, costs of ani-
mals, and animal procurement policies;
to control allocation of animals within the in-
stitution;
to act as a resource on animal welfare issues
and to educate the university community and
the community at large on animal welfare is-
sues; and
to serve as a community complaint forum.
stitutional review boards (IRBs) were setup in the
mid-1960s under Federal regulations to oversee
research with human subjects. of all the commit-
tees formed to respond to value questions raised
by medical practice and biomedical and behavioral
research, IRBs have the most obvious parallels to
animal care and use committees. Many of the ques-
tions raised now about committees on animals—
whether they can both protect animal subjects and
abet the scientific enterprise, whether they func-
tion to minimize pain and suffering in experiments,
or are mere window dressings for public relations
purposes—have been addressed in 15 years of ex-
perience with committees on human subjects, This
experience includes not only the establishment of
IRBs within institutions and oversight of the proc-
ess through the general assurance process moni-
tored by OPRR (31), but also frequent conferences,
a spate of academic literature, and the publication
of a journal devoted exclusively to the human-
subjects review process, which includes case
studies reviewing problematic protocols.
USE COMMITTEES
Each IACUC may be mandated to perform all
or some of the above responsibilities. Some com-
mittees oversee the care of all the research ani-
mals housed in an institution, This may include
ensuring compliance with local, State, and Federal
regulations; inspecting facilities; and advising on
matters of care and feeding, design of facilities,
and resource allocation. Some of the most diffi-
cult problems in this regard have been encoun-
tered in large institutions with farflung, decen-
tralized facilities that may house only a few animals
for use by individual researchers or small groups
of students. Small, satellite facilities can present
problems in ventilation, sanitation, care, and over-
sight during weekends and holidays (25). Some
universities have countered this problem by cen-
tralizing a procurement system, so that the pur-
chase of an animal by a researcher anywhere in
the university triggers oversight mechanisms (32).
At a minimum, the IACUC must comply with the
PHS policy committee requirements,
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According to NIH, approximately 26 percent of
existing animal care and use committees review
research protocols (25). Under the new PHS pol-
icy, all IACUCS will be required to approve all sec-
tions of each research protocol that involves ani-
mals. Some committees have established a system
of expedited review where only protocols that raise
questions regarding pain and suffering are con-
sidered by the full committee. More innocuous
projects are reviewed perfunctorily by smaller sub-
committees. Rating scales have been established
for expedited reviews. One suggestion of such a
scale has five categories, detailing a range of de-
gree of harm inflicted on animals. This proposal,
already in place in some form in a number of insti-
tutions, is designed to provide a calculus so that
“ethical risks” can be weighed against ‘(the benefit
in terms of improvement of animal or human
health or other societal good” (27). Other commit-
tees have a bifurcated review, with parallel proc-
esses for considering animal care and ethical is-
sues (32).
In a broad sense, animal welfare concerns are
by definition inextricably intertwined with scien-
tific issues. The threshold question of the validity
of an animal model approach and the possible avail-
ability of alternatives is followed closely by ques-
tions of the efficiency of animal use. Is the smallest
number of animals of an appropriate species be-
ing used? Would a more sophisticated statistical
methodology assure this is the case? Are genetic
variables manipulated to the extent necessary? Will
the data generated by the experiment be under-
stood and of use to other scientists? Does the re-
search answer an important question and has the
researcher made sure it does not unintentionally
duplicate already published work? Is the research-
er qualified to undertake the project? These are
among the questions that raise twin concerns of
scientific and ethical appropriateness.
The dual nature of the scientific and care review
issues were the focus of remarks by one commit-
tee proponent (20):
Concern for the reduction or elimination of pain
is inseparable from consideration of the poten-
tial scientific value or the benefits to humankind
to be derived from the work. . . Decisions about,
for example, the species and number of animals
to be used, or the necessity for particular inva-
sive procedures, simply cannot be made intelli-
gently without reference to the scientific value
of the work; or without an understanding of the
scientific discipline represented in the proposal.
Research of inferior quality should not be done
on any species, regardless of how humanely it
is done. Concern for humane treatment of ani-
mals is not only consistent with good science, but
augments its quality by assuring us of well-main-
tained and nourished animals that are behavior-
ally comfortable.
Many people feel that the IACUC is not qualified
to judge the science or ‘(scientific merit” of an ex-
periment. Yet, it maybe impossible to discuss ani-
mal care and use issues without some discussion
of the science involved. How does an IACUC draw
the line between discussing and approving the ani-
mal care and use issues and the scientific merit,
feasibility, and potential scientific gain of a par-
ticular experiment? Depending on the member-
ship of a particular committee or the institution
itself, science issues may or may not be addressed
in the approval process. This may lead to an in-
consistent system: A proposal that might be modi-
fied in one IACUC could be approved in a differ-
ent committee depending on whether only animal
care and use issues were addressed.
In addition to the above functions, animal care
and use committees can also play an educational
role. The process by which investigators justify
their research can bean educational one and the
committee can also be used to teach the research
community as a whole. The availability of alterna-
tives, ways to avoid unintentional duplication, and
amelioration of pain are all subjects the commit-
tee can discuss. Some committees also monitor ani-
mal welfare legislation and advise institutional offi-
cials about pending State and Federal initiatives.
Financial and Procedural Issues
A number of questions about how committees
operate involve “housekeeping” details that, as a
practical matter, may be as important as substan-
tive concerns. The operation of the committee in
terms of recordkeeping and voting has important
implications. Whether it operates on a consensus
or majority vote may determine how much influ-
ence unaffiliated members have. In addition, some
committees have provisions for investigators to
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appeal adverse findings; the rights of investiga-
tors in this regard, as well as the legal posture of
the committee (and individual members), are still
open to question. Other concerns include the com-
mittee’s ability to monitor current research and
to establish procedures ensuring that its advice
is followed.
There is a paucity of data on operating costs for
animal care and use committees for several rea-
sons. Service on committees is part of the general
responsibilities of salaried faculty or institutional
officials. Additional overhead costs of office space,
support staff, and recordkeeping are also often
factored into general budgets. One cost estimate
comes from Colorado State University, where the
animal research committee costs about $24,000
per year to run, which was 0.43 percent of the
university’s biomedical research budget (35). In
smaller institutions, requirements for more active
committees would likely be a great administrative
and financial burden, especially with a review proc-
ess entailing prospective review of all protocols
submitted for funding.
The parallel between the institutional review
boards and IACUCs is the strongest when discuss-
ing procedural matters. The lessons learned by
individual institutions in setting up, funding, find-
ing administrative staff support, and structuring
IRBs can help IACUCs avoid similar problems.
Membership
Much of the debate about the value of animal
care and use committees has focused on who
should be on them. One commentator, writing
about the use of hospital ethics committees to ad-
vise on decisions about seriously ill newborns,
maintained (10):
. . . when it comes to matters of life and death,
our society prefers procedure to substance. In-
stead of asking, “What is the right thing to do?”
we ask, ‘Who should decide?” The attractiveness
of such committees probably derives in large
measure from their potential for transmuting a
hard question (Who shall live?) into a more tract-
able one (Who shall sit on the committee?).
For animal care and use committees, however, the
question may not be quite so tractable after all.
Practicing Research Scientists
Until the recent changes in the PHS policy, which
now requires a diverse group of individuals on the
IACUC, many institutional committees consisted
primarily of practicing research scientists involved
with animal research. Their contribution to an
IACUC is important because of their knowledge
on animal models, research protocols and proce-
dures, and the use of animals in research. These
members make sure that the views of the major
users of animals are represented. At the same time,
they have a conflict of interest with some of the
goals of the IACUC since their jobs and livelihood
are involved with research on animals. Ensuring
their objectivity, therefore, is important.
Veterinarians
Having a veterinarian on the committee is es-
sential since in many cases that person is respon-
sible for the institution’s animals. The PHS policy
requires that each IACUC have one Doctor of
Veterinary Medicine with training or experience
in laboratory-animal science and medicine. The
veterinarian must implement the institution’s ani-
mal care and use program on a daily basis. The
role of this person on an IACUC is to be the pro-
fessional-level link between the committee and the
daily operation of the institutional program.
Veterinarians for institutions doing animal re-
search have come from all fields of veterinary medi-
cine. In the late 1950S) veterinarians began to enter
the specialty known as laboratory-animal medi-
cine. To date, approximately 700 full-time veteri-
narians are certified in this field (out of a total of
about 45,000 nationwide). The two organizations
accrediting practitioners of laboratory-animal
medicine are the American Society of Laboratory
Animal Practitioners and the American College of
Laboratory Animal Medicine. These veterinarians,
along with any others with experience in labora-
tory-animal science and medicine, fulfill the PHS
requirement on IACUC membership. For small in-
stitutions with only a few projects with animals,
it can be difficult and costly to obtain a part-time
laboratory-animal veterinarian as there are so few
of them.
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Unaffiliated Members
Most proposals for institutional animal review
committees require that one or more persons not
affiliated with the research entity (e.g., members
of the local community) be included. This would
be someone who is primarily responsible for rep-
resenting community concerns regarding the wel-
fare of animal subjects. This person can bring
objectivity to the committee because there is no
financial tie between the person and the institu-
tion and therefore no conflict of interest. The PHS
policy requires one such unaffiliated member.
(This person might also fill the nonscientific spot
described below, but need not.) An unaffiliated
member could well be a research scientist at a
different institution.
The unaffiliated members who have generated
the most controversy are representatives of the
animal welfare and animal rights community.
Scientists have feared that the involvement of such
people might delay or derail research projects.
There have also been concerns about confiden-
tiality and unwarranted disclosure of research
ideas in progress, a fear exacerbated in the com-
mercial setting. On the other hand, not unlike in-
dividuals with strongly held views opposing capi-
tal punishment (who may be challenged during
the jury selection process for a capital case), some
animal welfare advocates have refused to cooper-
ate with these committees at all.
This leads to another problem: How to certify
the bona fides of such a committee member? Is
membership in a local humane society sufficient
or must it be a particular activist group? Some in-
stitutions may have difficulty finding members of
the general community, let alone animal welfare
advocates, who are willing to expend the consid-
erable time necessary to participate in the proc-
ess. Animal welfare proponents have complained
that the fact they are generally not remunerated
for such activities (whereas other committee mem-
bers maybe devoting salaried time to the commit-
tee) tends to greatly discourage their participation.
(This has generally not been a problem in the hu-
man subjects area, however.) Paying unaffiliated
members, which some schemes have proposed,
would present a “Catch 22” situation: Payment
would “affiliate” them with the institution and
therefore disqualify them. Even with all these pos-
sible problems, many committees have been very
successful at opening their deliberations to un-
affiliated members.
Nonscientific Members
The presence of nonscientifically trained peo-
ple on the IACUC has rankled some scientists;
others have speculated that the need to translate
research questions for nonspecialists “may well
necessitate [the investigator’s] use of a new vocabu-
lary and new patterns of thought, especially if he
is compelled to provide moral justifications for his
use of animals” (34,37). Against the wishes of many
scientists, the PHS policy requires that one mem-
ber of the IACUC be from a nonscientific area.
Although nonscientific members are often spo-
ken of as lay members, often they are simply pro-
fessionals with different backgrounds. Lawyers,
members of the clergy, and philosophers with
training in bioethics have all been suggested as able
to bring relevant outlooks to bear. On occasion,
committees may also rely on specialists on an ad
hoc basis to review particular projects. A profes-
sional statistician, for example, might be consulted
in a determination of the appropriate number of
animals to be used in a particular protocol.
Animal Care Staff
Many committees include an animal technician
or a member of the technical staff who provide
the daily service, health care, and personal care
of the laboratory animals. Animal technicians,
well trained in animal health care, animal mainte-
nance, and facility design, can represent the view
of the animal care facility on the committee. Ani-
mal care committees with technical staff find these
members helpful with issues of protocol review
(including whether the protocol can be done within
the facility), space allocation, and management is-
sues. On some committees, animal technicians act
as full voting members of the IACUC; in others,
they act as ad hoc advisory members without vot-
ing privileges.
Institutional Representatives
Representatives of the institutional administra-
tion are often members of animal care and use
committees because of the insights they may have
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into the overall management of the institution, in-
cluding the financial constraints under which it
operates. Management personnel can often pro-
vide information on the physical plant that may
bear on care and husbandry issues. For the com-
mittees to have clout, it is necessary to have a rep-
resentative of the office of the president, dean,
or provost.
Monitoring the Monitors
How can the successful functioning of animal
care and use committees be determined? Some of
the committee functions just described translate
into fairly accessible benchmarks. The composi-
tion of the committees, the number of protocols
reviewed, and the types of experiments given full
review are all factors that can be examined. Yet
even this relatively “hard” data can belie more elu-
sive factors at work. For example, as in the area
of human subjects review, often the process by
which a committee approves a protocol is one of
negotiation, during which an investigator may
justify or change the number of animals, or spe-
cies, or methods of experimental manipulation—
a process that would not be reflected in a “yes”
or “no” vote.
Since the review process itself is one that is dif-
ficult to study, site visits have been relied on to
examine committee functioning. In addition to ex-
amining minutes of meetings, the composition of
the committee, and number and types of protocols
approved, site visits can afford the opportunity
to interview scientists, committee members, and
institutional officials and, perhaps, to sit in on a
committee meeting.
THE AAALAC PROCESS
The American Association for Accreditation of
Laboratory Animal Care is a voluntary organiza-
tion that accredits institutions that conduct ani-
mal research. According to the group (2):
. . . [the association] was organized in 1965 to con-
duct a voluntary program for the accreditation
of laboratory animal care facilities and programs.
The accreditation program is concerned with en-
couraging high standards for the care and use
of laboratoy animals including appropriate vet-
erinary care, controlling variables that might ad-
versely affect animal research, and protecting the
health of animal research workers.
AAALAC is governed by a Board of Trustees com-
posed of representatives of 27 professional orga-
nizations in education and research, including the
American Association for Laboratory Animal
Science, American Veterinary Medical Association,
Pharmaceutical Manufacturers Association, and
American Association for the Advancement of Sci-
ence. A 16-member Council on Accreditation is ap-
pointed by the board to make recommendations.
All the Council members have D.V.M. or Ph.D.
degrees and are actively involved in laboratory-
animal medicine or biomedical science. As of 1985,
a total of 483 institutions had received AAALAC
accreditation (see app. D) (3). Table 15-1 summa-
rizes the types of facilities that have received ac-
creditation.
To become AAALAC-accredited, a facility must
pay a nonrefundable application fee prior to the
Table 15.1.–Oistribution of AAALAC-Accredited
Facilities by Category
Type of facility Percent of total
Veterans’ Administration medical centers . . . 15
Commercial laboratories . . . . . . . . . . . . . . . . . . 14
Medical schools. . . . . . . . . . . . . . . . . . . . . . . . . . 13
Pharmaceutical manufacturers . . . . . . . . . . . . . 9
Nonprofit research laboratories . . . . . . . . . . . . 9
Government laboratories . . . . . . . . . . . . . . . . . . 8
Hospitals. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8
Universities (facilities serving an entire
campus) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6
Combined facilities for health schools . . . . . . 4
Dental schools . . . . . . . . . . . . . . . . . . . . . . . . . . . 4
Laboratory animal breeders . . . . . . . . . . . . . . . . 3
Colleges of pharmacy. . . . . . . . . . . . . . . . . . . . . 3
Veterinary schools. . . . . . . . . . . . . . . . . . . . . . . . 1
Colleges of biological science . . . . . . . . . . . . . 1
Colleges of arts . . . . . . . . . . . . . . . . . . . . . . . . . . 1
Universities (programs serving only a
portion of a campus) . . . . . . . . . . . . . . . . . . . . 1
College of engineering . . . . . . . . . . . . . . . . . . . . 1
Total. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 100
SOURCE: American Association for Accreditation of Laboratory Animal Care,
AAALAC  Act/v/t/es Report, vol. 13, New Lenox,  IL, Apr. 1, 19S5.
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first site visit. Current application fees range from
$1,050 to $1,650, depending on the size of the fa-
cility, and annual fees range from $600 to $900.
AAALAC uses the NIH Guide for the Care and Use
of Laboratory Animals as its primary standard for
evaluating facilities and programs. In addition, the
association recommends these sources about lab-
oratory animal care:
l
l
l
l
l
“Report of the AVMA Panel on Euthanasia”
(19) and subsequent revisions.
NIH Guidelines for the Laboratory Use of
Chemical Carcinogens (45).
Biological Safety Manual for Research Involv-
ing Oncogenic Viruses (40).
Classification of Etiologic Agents on the Basis
of Hazard (39) and subsequent revisions.
Laboratory animal management and stand-
ards documents developed by committees of
the Institute of Laboratory Animal Resources
(3).
The accreditation procedure involves 11 steps.
First, an application is requested from AAALAC.
The completed application for accreditation is
returned to AAALAC, which reviews it and deter-
mines whether the applicant is eligible to seek ac-
creditation. After the application fee is paid, the
Chairman of the AAALAC Council on Accredita-
tion selects the site-visit team. Normally, this con-
sists of one member of the council and one con-
sultant. The institution is notified of the date and
time of the visit and the names of the site visitors
and is asked to have assembled materials ready.
The site-visit team inspects the laboratory-animal
care facility and evaluates all aspects of the ani-
mal care program with respect to AAALAC stand-
ards. Copies of the report are forwarded to two
members of the council, who evaluate it for com-
pleteness and clarity. The final site visit report is
then reviewed by the council during its next sched-
uled council meeting, and the accreditation sta-
tus of the applicant is determined. The Board of
Trustees confirms the action of the council. Finally,
the applicant institution is provided with a letter
summarizing the conclusions of the council (3).
After the initial site visit, an institution can be
awarded full accreditation, provisional accredita-
tion, or accreditation can be withheld. For accred-
ited institutions, AAALAC reinspects facilities once
every 3 years and can either decide to continue
accreditation, provide a probationary accredita-
tion while deficiencies are corrected, or revoke
accreditation. Sixty-six percent (483 out of731) of
the institutions applying for accreditation since
1965 have received it.
Although AAALAC is a private, voluntary orga-
nization, its decisions carry great weight because
the PHS recognizes AAALAC accreditation as a
demonstration of institutional compliance with
PHS policies. Moreover, the NIH Guide for the Care
and Use of Laboratory Animals is the benchmark
AAALAC uses in assessing the adequacy of lab-
oratory facilities, sanitation, veterinary care, ani-
mal husbandry, and such basic but important de-
tails such as cage size. Approximately 25 percent
of the close to 1,000 institutions with approved
assurances on file with NIH are AAALAC-accredited.
POLICIES OF SCIENTIFIC AND PROFESSIONAL SOCIETIES
A number of scientific societies and professional ture (l). It states, in part: “The AALAS is committed
organizations associated with science and research to the principles of humane care and treatment
have generated policies on the standards of con- of laboratory animals and endorses membership
duct expected of their members in the care or use compliance with established scientific and legal
of animals. Some of these are simple statements standards .“
of support for research use and for humane care
The AALAS policy statement also contains someof research animals in accordance with Federal
and State laws and the NIH Guide. For example, of the strong language that has only recently be-
the American Association for Laboratory Animal gun to appear in statements of scientific and profes-
Science (AALAS), an organization that emphasizes sional organizations:
improved animal care and personnel training (13), Many of the factors that affect both animal and
has issued a four-paragraph statement of this na- human life can only be studied in intact animal
38-750 0 - 86 - 12
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systems by systematically manipulating specific
research variables. Given an incomplete knowl-
edge of biological systems, it is inconceivable that
animal experimentation can be replaced, in the
foreseeable future, by mechanical models or
other incomplete biological systems.
Several organizations have developed more com-
prehensive policies. These statements of princi-
ple have tended to evolve from early concern with
solely humane animal care to a concentration on
the humane care and use of animals.
Ethical standards and policies may be developed
in a variety of ways. Some are prepared by com-
mittees or boards composed of members from
different areas of research within a given discipline
(e.g., American psychological Association), from
many countries (e.g., International Association for
the Study of Pain), from several disciplines (e.g.,
Federation of American Societies for Experimental
Biology), from the faculties and communities asso-
ciated with a university (e.g., University of South-
ern California), or from within industry (e.g., Smith
Kline &French Laboratories). Guidelines may also
be issued by a professional society as part of the
requirements for publication of research reports
in a society’s journal (e.g., Society for the Study
of Reproduction).
The comprehensive statements of well-estab-
lished organizations are examined here to provide
insight into both the development and the pro-
mulgation of policies affecting large numbers of
research investigators and their experimental sub-
jects. The guidelines of the societies and associa-
tions reviewed by OTA share certain common ele-
ments, in that they all support or require:
l
Ž
l
l
l
humane care and use of animals in accordance
with relevant laws and the NIH guidelines;
use of minimum numbers of animals of an
appropriate species;
limitations of the time and/or degree of allow-
able pain or discomfort during chronic exper-
iments;
use of proper types and amounts of analgesics
or anesthesias or of euthanasia to prevent or
terminate excessive pain during acute exper-
iments; and
assurance that all animal experiments are con-
ducted by or under the supervision of qual-
ified personnel.
Beyond these common elements, most policy state-
ments contain principles tailored to the specific
research interests of each organization’s members.
The Animal Care Guidelines of the Animal Behavior
Society, for example, offer instruction on the ob-
servation of natural populations (9):
Observation of free-living animals in their nat-
ural habitat may involve disruption, particularly
if feeding, trapping, or marking is involved. While
field studies may further scientific knowledge and
advance awareness of human responsibility towards
animal life, the investigator should always weigh
any potential gain in knowledge against the ad-
verse consequences of disruption for the animals
used as subjects and also for other animals in the
ecosystem.
American Psychological Association
The American Psychological Association (APA)
was founded in 1892 to advance the understanding
of basic behavioral principles and to contribute
to the improvement of human health and welfare.
Today, there are approximately 61,700 members
of the APA in research, education, and clinical prac-
tice. Policies adopted in 1979, entitled Principles
for the Care and Use of Animals, were designed
to be posted in all facilities and included several
additions to the common elements listed previ-
ously. They read, in part (5):
All research conducted by members of the
American Psychological Association or published
in its journals must conform to these Principles.
Investigators are strongly urged to consult with
the Committee on Animal Research and Experi-
mentation at any stage preparatory to or during
a research project for advice about the appropri-
ateness of research procedures or ethical issues
related to experiments involving animals.
Apparent violations of these Principles shall be
reported immediately to the facility supervisor
whose signature appears below.
All persons in each laboratory, classroom, or
applied facility shall indicate by signature and date
. . . that they have read these Principles.
Although the issues of ethics and responsibility
were briefly addressed in the 1979 Principles, the
APA soon felt that a more complete statement was
needed. The principles were extensively revised
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and issued in 1985 as the Guidelines for Ethical
Conduct in the Care and Use of Animals (6).
The most comprehensive document of its type,
the APA Guidelines is a detailed statement cover-
ing all aspects of animal care and use—personnel,
facilities, acquisition of animals, care and housing,
experimental design and procedures, field re-
search, educational use of animals, and disposi-
tion and disposal of animals. The importance of
the use of sound ethical judgment is reiterated
throughout, and the new guidelines are to be
signed by a supervisor and an administrative offi-
cial and posted wherever animals are maintained
or used.
The APA statement is distinguished by both the
number and diversity of its requirements, In addi-
tion to supporting the principles previously men-
tioned, it states that “considerations limited to the
time, convenience, or expense of a procedure do
not justify violations of any of the principles.” When
violations are not resolved at the local level, they
“should be referred to the APA Committee on
Ethics, which is empowered to impose sanctions.”
The possible nature of such sanctions remains
undefined.
The APA Guidelines state: “Psychologists should
ensure that all individuals who use animals under
their supervision receive explicit instruction in ex-
perimental methods and in the care, maintenance,
and handling of the species being studied .“ All re-
search should be justifiable, with “a reasonable
expectation” that the research will:
l increase knowledge of the processes under-
lying the evolution, development, control, or
biological significance of behavior;
. increase understanding of the species under
study in the research; or
l provide results that benefit the health or wel-
fare of humans or other animals.
These contributions “should be of sufficient po-
tential significance as to outweigh any harm or
distress to the animals used.” Moreover, “when
appropriate, animals intended for use in the lab-
oratory should be bred for that purpose.”
The APA stands virtually alone among scientific
societies in offering guidance in the educational
use of animals:
When animals are used solely for educational
rather than research purposes, the consideration
of possible benefits accruing from their use vs.
the cost in terms of animal distress should take
into account the fact that some procedures which
can be justified for research purposes cannot be
justified for educational purposes.
The Guidelines further urge that alternatives to
the use of animals be investigated and that alter-
natives to euthanasia, such as animal sharing and
return of wild-trapped animals in the field, be con-
sidered. Following euthanasia, “no animal shall be
discarded until its death is verified.” Investigators
are invited to seek assistance from the APA on rele-
vant issues, and a list of references on the ethics
of animal research is mentioned as available. The
association supports the formation of institutional
animal care and use committees (including repre-
sentatives from the local community) to assist in
the resolution of questions within individual insti-
tutions, but it recognizes that “laws and regulations
notwithstanding, an animal’s immediate protection
depends upon the scientist’s own conscience.”
American Physiological Society
The minutes of the 1913 meeting of the Council
of the American Physiological Society (APS) con-
tain the first written statement by a U.S. scientific
society in support of the prevention of cruelty to
research animals. Although it did not receive much
attention at that time, the statement later led to
the development of the NIH Guide (33). The present
APS policy statement, revised in 1980 as Guiding
Principles in the Care and Use of Animals (30), is
sent to each member to be signed and posted.
In addition to the principles they have in com-
mon with other societies, the APS Guiding Princi-
ples require that “animal experiments are to be
undertaken only for the purpose of advancing
knowledge” and that “consideration should be
given to the appropriateness of experimental pro-
cedures.”
“Only animals that are lawfully acquired shall
be used, ’’and, when muscle relaxants or paralytics
are employed, ‘(they should not be used alone for
surgical restraint, rout] in conjunction with drugs
known to produce adequate analgesia.” In 1984,
this provision concerning relaxants and paralytic
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became the object of a proposed revision, stating
that they:
. . . must only be used after administration of a
general anesthetic, adequate to cause uncon-
sciousness, so that when the muscle relaxant is
given, the animal is already unconscious. The ani-
mal must then be kept unconscious until complete
recovery from paralysis occurs. The only excep-
tion to this guideline would be in unusual cases
where the use of an anesthetic would defeat the
purpose of experiment and data cannot be ob-
tained by any other humane procedure.
The revision was proposed in 1984 by the APS Ani-
mal Care and Experimentation Committee and is
presently under consideration by APS members
for comment on its impact on the design of their
research.
Federation of American Societies
for Experimental Biology
The Federation of American Societies for Exper-
imental Biology (FASEB) is composed of six constituent
societies (APS, the American Society of Biological
Chemists, the American Society for Pharmacology
and Experimental Therapeutics, the American So-
ciety of Pathologists, the American Institute of
Nutritionists, and the American Association of Im-
munologists) and one affiliated society (the Amer-
ican Society for Cell Biology). As such, FASEB rep-
resents more than 28,000 research investigators
and clinicians.
The organization adopted a policy on animal ex-
perimentation in 1913 that in 1984 it reaffirmed,
while endorsing the APS Guiding Priniciples and
issuing a policy statement on the appropriate use
of animals for scientific experimentation and edu-
cation (16). The latter document urges ‘(appropri-
ate safeguards to preclude inadvertent use of pet
animals,” supports the “wide application of accred-
itation procedures for animal experimental facil-
ities)” and resolves “that continuing collection of
appropriate data on the conditions and number
of animals used in scientific research and educa-
tion is necessary for development of legislative or
administrative remedies in the field. ”
International Association for
the Study of Pain
The International Association for the Study of
Pain publishes the journal Pain, which first ap-
peared in 1975, In its first issue, the journal ex-
pressed its ‘(one proper duty; to pursue knowledge
for the alleviation of suffering in man and animals
without any deviation in which we justify the pas-
sive observation or intentional production of
suffering” (48). Pain refuses “to publish any reports
where the animal was unable to indicate or arrest
the onset of suffering” (48). In 1980, the associa-
tion’s Committee for Research and Ethical Issues
published Ethical Standards for Investigations of
Experimental Pain in Animals (15). These urge the
acceptance of “a general attitude in which the ani-
mal is regarded not as an object for exploitation,
but as a living individual” and offer a list of guide-
lines “concerned with the importance of the inves-
tigation, the severity and the duration of the pain.”
The statement speaks to the need for justification
and review by colleagues, ethologists, and lay-
persons. In addition, it:
l
l
l
l
states that “if possible, the investigator should
try the pain stimulus on himself”;
urges careful assessment of the animal’s “devi-
ation from normal behavior” during the ex-
periment;
requires that by escape or avoidance, the ani-
mal “be able to control the effects of acute
experimental pain” and be treated for chronic
pain or “allowed to self -administer analgesic
agents or procedures, as long as this will not
interfere with the aim of the investigation”;
and
urges researchers to “choose a species which
is as low as possible in the phylogenic order .“
In 1983, the committee issued Ethical Guidelines
for Investigations of Experimental Pain in Con-
scious Animals (50), containing two salient revi-
sions from the 1980 document, First, when sub-
mitting a manuscript to Pain, authors are “required
to show” that they have followed the ethical guide-
lines that are published in every issue. Second,
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“studies of pain in animals paralyzed with a neu-
romuscular blocking agent should not be per-
formed without a general anesthetic or an appro-
priate surgical procedure that eliminates sensory
awareness .“
Society for Neuroscience
After more than 2 years of revision, review, and
commentary by members of the Society for Neuro-
science (17), an Ad Hoc Committee on Animals in
Research published its Guidelines for the Use of
Animals in Neuroscience Research in 1984 (14).
In addition to the requirements in common with
other societies, these Guidelines place particular
emphasis on good experimental design and state
that “advances in experimental methods, more ef-
ficient use of animals, within-subject designs, and
modern statistical techniques all provide possible
ways to minimize the numbers of animals used
in research. ”
The Guidelines show particular concern about
prolonged immobilization or restraint, suggesting
that “reasonable periods of rest and readjustment
should be included in the experimental schedule
unless these would be absolutely inconsistent with
valid scientific objectives ,“ R is noteworthy that
although the policy statement was formulated to
deal with research using warm-blooded verte-
brates, it includes a statement concerning inver-
tebrates:
As a general principle. . . ethical issues involved
in the use of any species, whether vertebrate or
invertebrate, are best considered in relation to
the complexity of that species’ nervous system
and its apparent awareness of the environment,
rather than physical appearance or evolutionary
proximity to humans.
In this inclusion of invertebrates into its Guide-
lines, the Society for Neuroscience is unique among
scientific organizations. This policy likely reflects
an enhanced awareness in neurobiology of the de-
gree of sophistication exhibited by some inver-
tebrate nervous systems.
Society for the Study
of Reproduction
The Society for the Study of Reproduction (SSR)
publishes its Guiding Principles for the Care and
Use of Research Animals in each issue of its jour-
nal, Biology of Reproduction, as part of the instruc-
tions to authors. Investigators are urged to give
consideration to, among other things, “the use of
in vitro models.”
An investigator wishing to present data at the
annual meeting of the SSR must first make a decla-
ration regarding the use of animals in generating
those data. The researcher is required to attest
with his or her signature (see fig. 15-2) that the
research described in the abstract is in strict ac-
cord with the guiding principles for experimental
procedures endorsed by the society. Written affir-
mations of this nature are becoming increasingly
common among scientific societies; the American
Physiological Society, the Society for Neuroscience,
and the International Association for the Study of
Pain are among the groups with prerequisites of
signed statements of humane treatment of exper-
imental subjects for abstract presentations.
American College of Physicians
In a 1983 position paper entitled Animal Re-
search, the American College of Physicians (ACP)
stated that “scientists and animal welfare advocates
share a belief that safeguards are necessary to en-
sure humane treatment of animals used in scien-
tific research and testing” and that other issues
needing to be addressed include “development of
alternative testing methods” and “mechanisms to
ensure that. . . treatment, care, and experimental
methods limit animal pain and suffering.”
ACP suggests that appropriate safeguards “may
require the establishment of procedures not un-
like human subjects protection review” and “rec-
ognizes the importance of standards that promote
the conduct of quality research and ensure the
humane care of healthy animals for research activ-
ities” (4).
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Figure 15-2.– Declaration Required for the Presentation of Data at the
Annual Meeting of the Society for the Study of Reproduction, July 1985
Abstract for
SOCIETY FOR THE
STUDY OF
R E P R O D U C T I O N
I have read and understand the Society’s Guiding Principles for the Care and Humane
Treatment of Research Animals and affirm that the research described in the above abstract
is in strict accord with these principles.
Presenter’s signature
Telephone No. (Area Code) No.
SOURCE: Society for the Study of Reproduction, Champaign, IL.
American Pharmaceutical
Association
In 1981, the Policy Committee on Scientific Af-
fairs of the American Pharmaceutical Association
offered a number of recommendations on the use
of animals in drug research (36). These included:
provision for adequate regulation, controls,
and enforcement directed toward the pro-
curement, transportation, housing, care, and
treatment of animals;
encouragement of further development of
alternative methods; and
opposition of legislation penalizing properly
controlled and conducted animal research and
testing.
In what stands as one of the most strongly worded
statements of support for the use of alternative
methods from any scientific organization, the pol-
icy committee also observed that:
. . . the use of animals for research, testing, con-
trol and production purposes is all inherently
quite expensive when compared to other proce-
dures, such as microbiological, chemical, in-
strumentation and tissue culture. Moreover, both
the speed and accuracy of analytical tests and the
yields of biological production are much superior
when these alternate methods can be employed
in place of animal procedures. As a result, there
has been a continuing shift away from the use
of animals and in favor of alternate procedures
as the latter have been developed and have been
demonstrated to be acceptable substitutes.
American Veterinary Medical
Association
In 1982, the American Veterinary Medical Asso-
ciation (AVMA) approved the AVMA Animal Wel-
fare Guiding Principles (7), which states that
veterinarians must consider certain ethical, philo-
sophical, and moral values relating to the welfare
of animals. Among these considerations are the
encouragement of humane care and proper stew-
ardship, implementation of relevant laws and reg-
ulations, support of research to illuminate animal
welfare issues, and identification of individuals
qualified to speak to these issues as a continuing
education resource. In 1983, an AVMA Animal Wel-
fare Positions report recommended the voluntary
establishment of standards of excellence for ani-
mal care and use (8). This report includes a num-
ber of recommendations on animal welfare issues
outside of research use, such as ownership of ex-
otic animals, declawing of domestic cats, and ear-
trimming and tail-docking of dogs.
Association of American
Veterinary Medical Colleges
In A Policy on Standards and Procedures Related
to the Use and Care of Animals in Veterinary Med-
ical Education and Research, the Association of
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American Veterinary Medical Colleges recom- continual monitoring of animal use and policies.
mended use of the NIH Guide and pursuit of It urges that “administrators. . . voluntarily estab-
AAALAC accreditation by all its member institu- lish standards of excellence for animal care and
tions (1 1). It also supports education in ethical con- use programs rather than relying upon external
siderations, use of alternatives where feasible, and enforcement agencies.”
STATEMENTS OF INSTITUTIONAL POLICY
In addition to scientific and professional socie-
ties, several universities have formulated policies
regarding animal use in research and education.
Three such statements are reviewed here for pur-
poses of illustration.
University of Southern California
In 1984, the University of Southern California
published Policies Governing the Use of Live Ver-
tebrate Animals, which contains a “Code of Ethics
for the Use of Animals in Research and Teaching”
adopted by the university’s Animal Ethics Review
Board. The code contains guidelines on avoidance
of unnecessary pain or distress, searching for alter-
natives for all LD5O studies, prohibition of pro-
longed physical restraint or deprivation studies,
the use of euthanasia and anesthesia, and consid-
eration of alternatives to animal use. It further
states that “this University shall expect each In-
vestigator to consider alternatives to the use of
animals in research or teaching before present-
ing a protocol for the use of live animals. The signed
protocol should contain a statement to that effect .“
All protocols must be approved by the Animal
Ethics Review Board. Principles governing the use
of live animals for teaching are similar to those
for research animals (47).
University of Wisconsin
The University of Wisconsin system began re-
quiring in 1981 that all animals used for teaching
and research on all of its campuses be used and
cared for according to the NIH Guide, regardless
of the species or source of funds used to conduct
the teaching or research. The university at that
time took a second extraordinary step and required
the certification of all investigators, technicians,
graduate students, or staff who supervise, use, or
care for animals. On the main campus in Madi-
son, for example, approximately 1)400 persons
have been certified to date through instruction
and examination (49).
Wisconsin Regional Primate
Research Center
In 1982, the Director of the Wisconsin Regional
Primate Research Center (WRPRC) published a Pol-
icy Statement on Principles for the Ethical Uses
of Animals at the Wisconsin Regional Primate Re-
search Center (18). This statement deals with the
issues of respect for animals, care, choice of alter-
natives, use of animals in education, personnel
training, appointment of animal rights advocates
to oversight groups, and the use of good ethical
judgment in evaluating the significance of proposed
research. It is official WRPRC policy that “all ani-
mals under its control are recognized as creatures
of great intrinsic value, remarkable complexity,
and inherent dignity. ”
In a section of the Policy dealing with the unique
value of nonhuman animals as models, research-
ers are charged to make the following choices
when designing experiments:
l
l
l
When the research question can be meaning-
fully pursued using nonanimal or in vitro
models, the researcher must choose these
alternatives.
When animal experimentation is required, the
researcher must seek the least traumatic tech-
niques feasible, minimize the intensity and du-
ration of any distress, and minimize the num-
ber of subjects.
Nonhuman primates shouId be used only in
projects for-which they are the most suitable
animal model.
All research at the WRPRC must have a “rea-
sonable expectation that the experiment will con-
tribute significantly to knowledge that may even-
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tually lead to improvements in the health and
welfare of humans or nonhuman animals” and the
expected benefits must “clearly outweigh any pain
and suffering experienced by the. . . animals. ’’Con-
sideration of time or expense alone may never
justify violation of the principles. Sanctions for vio-
lation of the Policy include dismissal in accordance
with due process and university regulations.
School of Veterinary Medicine,
Purdue University
Purdue University’s School of Veterinary Medi-
cine drafted a Policy Statement on the Utilization
of Animals in 1985 (38). The statement makes clear
that the school “cannot fulfill its teaching, research,
and service missions without the utilization of ani-
mals .“ Purdue’s policy spells out the sources of ani-
mals for veterinary medical research and edu-
cation:
Animals must be legally acquired, and properly
housed, fed, cleaned, and cared for to insure their
comfort and well-being.
The instructional programs require that pre-
ventive medicine, curative medicine, and surgery
be practiced in a sequence involving, first, ani-
mals owned and maintained by the School and
second, animals owned by the general populace
who seek professional health services.
STATEMENTS OF CORPORATE POLICY
Industrial testing and research laboratories often
have standard operating procedures in writing re-
garding animal care and use. One of the most com-
prehensive policy statements on animal welfare
comes from the Research and Development Divi-
sion of Smith Kline&French Laboratories of Phil-
adelphia, PA. In its Policies and Procedures for the
Conservation and Humane Treatment of Experi-
mental Animals, Smith Kline & French adopted
the following initiatives (29):
l Animal studies of a seemingly unwarranted
nature, but that are required to meet regula-
tions set by external agencies, will be reported
to the Director of Laboratory Animal Science.
SUMMARY AND
In mid-1985, the Public Health Service of the De-
partment of Health and Human Services released
a new policy on humane care and use of labora-
tory animals for all awardee institutions. The pol-
icy requires self-regulation of animal welfare by
all institutions using animals in research and ob-
taining PHS funds. It is based on a PHS 1979 policy
l
l
l
l
Animal tests required by regulatory author-
ities in certain countries, but generally not by
others, will be reported to the Director of Lab-
oratory Animal Science,
In vitro test methods developed to replace in
vivo studies are to be documented so that other
areas may consider potential applications.
Mistreatment of animals is a serious violation
of policy and may be grounds for dismissal.
A series of Animal Welfare Achievement
Awards will recognize and encourage a max-
imum effort toward conserving animals and
developing in vitro techniques.
CONCLUSIONS
and on information obtained during 15 site visits
by NIH to awardee institutions with general as-
surances on file with NIH. The new policy is more
stringent and structured than the old one. It
revolves around the institutional assurance to NIH
and the institutional animal care and use commit -
tee. To obtain assured status with NIH, an institu-
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tion must either be AAALAC-accredited or fulfill
the steps outlined in the policy for self-assurance
status.
In 1985, Congress gave the force of Federal law
to some of the provisions of the PHS policy and,
in separate action, mandated the establishment of
institutional animal care and use committees at
all research facilities covered by the Animal Wel-
fare Act as well as at Federal facilities (see ch. 13).
Taken together, the new PHS policy and Federal
statutes bring the overwhelming majority of ani-
mal users in the United States under the oversight
of institutional animal care and use committees.
Researchers who use animals, their institutional
colleagues, their peers in science, laboratory-
animal veterinarians, and local community mem-
bers are today viewed as the appropriate arbiters
of what constitutes acceptable care and use of ani-
mals. The PHS policy charges these individuals with
membership on institutional animal care and use
committees at each site where animals are involved
in PHS-funded research. Each IACUC shall have
broad oversight authority of the animal welfare
program at the institution and approve all portions
of research protocols involving animals for proper
animal care and treatment.
The functions of animal care and use commit-
tees may include:
l
l
l
l
l
l
l
l
l
ensuring compliance with local, State, and Fed-
eral laws and regulations on animal care and
use;
inspecting animal care facilities;
reviewing protocols for animal welfare issues;
assessing the qualifications of investigators;
overseeing student use of animals;
advising on institutional needs, costs of ani-
mals, and animal procurement policies;
controlling allocation of animals within the
institution;
serving as a resource on animal welfare is-
sues and as an educator of the university com-
munity and the community at large on ani-
mal welfare issues; and
acting as a community complaint forum.
The concept of review by committee is not
unique to the use of animals in experimentation.
In fact, institutional review boards and human-
subjects committees have overseen research using
humans for a decade or more. Current thinking
about animal care and use committees is modeled
after experience with IRBs.
A voluntary private organization, the American
Association for Accreditation of Laboratory Ani-
mal Care, functions as a respected agent of cer-
tification of an individual laboratory’s standards
of care. As of April 1985, a total of 483 institutions
using animals had received AAALAC accreditation
after passing an inspection based on the NIH Guide
for the Care and Use of Laboratory Animals.
Several scientific and professional societies,
universities, and corporations have promulgated
statements of policy concerning their members’
and employees’ standards of conduct in the care
and/or use of animals. An organization’s policy
statement usually reflects its characteristic inter-
ests. Some policies are brief enough to cover only
one column of a page, while others (e.g., Amer-
ican Psychological Association) take many pages
and go into great detail. These policies generally
require:
l humane care and use of animals,
. use of a minimum number of animals,
l alleviation of pain and suffering, and
. supervision of animal use by qualified per-
sonnel.
At least eight of the organizations and institu-
tions whose policies were reviewed by OTA sup-
port the concept of animal care and use commit-
tees. Twelve of the fifteen organizations reviewed
specifically support or require consideration of
the use of alternatives to animals in research, and
three specify the maximum use of available statis-
tical methodology.
Several statements of policy require signed state-
ments attesting to humane animal care prior to
the publication and/or presentation of papers. only
three policy statements, those of the American Psy-
chological Association, the Wisconsin Regional Pri-
mate Research Center, and Smith Kline & French
Laboratories, directly mention any sanctions against
violators of their guidelines. As a rule, there are
neither enforcement provisions accompanying the
stated policies and principles of scientific and
professional societies nor any apparent penalties
for the violation of these policies. For these rea-
sons, the practical significance of certain of these
statements of principle is open to question.
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Chapter 16
Regulation of Animal Use
in Selected Foreign Countries
One of the tests of a civilized society is its treatment of animals.
Scientific Procedures on Living Animals, (Command 9521
British Home Office
May 1985
We have come to the conclusion that the status of the dog in Western Sociey is such that
it is desirable to minimize its use in the laboratory. Some SO percent of Canadian house-
holds include a dog. These pets are regarded by most owners in an anthropomorphic way
as being full members of the family. Clearly, such people are very receptive to emotional
appeals to ban the use of animals-especially dogs like theirs-for research. Thus, it will
probably be necessary to phase out the significant use of dogs if a major battle over the use
of animals for research is to be avoided.
J.C. Russell and D.C. Secord
University of Alberta, Edrnonton
Perspect. Biol. Med. 28:374-381, 1985
Possibly the most important feature of any legislation on behalf of laboratory animals is
the acknowledgment that the ultimate responsibility for their welfare rests with society and
not with the research community.
Anne Doncaster
Mississauga, Ontario
“Experiments on Animals—Review of
the Scientific Literature, ” June 1982
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Regulation of Animal Use
in Selected Foreign Countries
The protections afforded animals vary greatly
among countries, from almost complete disregard
of animal welfare to the many cultural and legal
protections provided in Western Europe and Can-
ada. These protections are currently the subject
of heated debate in many countries, particularly
where animal protection is already significant. In
1985, for example, Switzerland’s voters rejected
a referendum that would have virtually banned
the use of animals for experimental purposes. The
use of the LD5O in safety testing continues to be
given careful scrutiny by Government and scien-
tific organizations in Switzerland (73,76, 77) and
the United Kingdom (4,67,69).
Actions taken in other countries are relevant to
U.S. policies for several reasons. First, steps taken
by trading partners can lead to political and eco-
nomic pressures to take similar actions. Second,
decreased use of animals abroad, particularly by
multinational corporations, can lead to an in-
creased use in the United States. Finally, the ex-
periences of other countries can serve as instruc-
tive models, both for policies and for their effects.
This chapter describes the laws of Australia, Can-
ada, Denmark, the Federal Republic of Germany,
Japan, the Netherlands, Norway, Sweden, Swit-
zerland, and the United Kingdom. The most com-
mon provisions are prohibitions against painful
experiments without anesthesia unless anesthe-
sia would frustrate the purpose of the experiment;
requirements for licensing or permitting of facil-
ities, investigators, or experiments; limitations on
animal use for education; and requirements for
internal or external review of experiments by
interdisciplinary committees. Two of the more
unusual provisions are the protection of crusta-
ceans (Norway) and of native nonvertebrates (the
Netherlands).
The impact of these laws on the welfare of ani-
mals is affected by several factors other than the
substantive requirements of the laws, including
societal attitudes toward animals; training of scien-
tists and technicians, both in techniques and in
ethics; the composition and procedures of review-
ing committees; and the vigor of animal welfare
advocates. This chapter discusses the substantive
and procedural aspects of these various laws and,
where information was available, criticisms and
comments on the effectiveness of the systems.
In addition to the array of national laws, there
are international agreements—both in effect and
proposed–that affect animal welfare. Among
these, the Convention on International Trade in
Endangered Species, bans on trade in primates,
the Draft Convention of the Council of Europe,
and the guidelines of the Council for International
Organizations of Medical Sciences, are discussed
in appendix E.
AUSTRALIA
In Australia, as in the United States, animal wel- Of the States, New South Wales has the most
fare is primarily a State concern. Each State has extensive laws. Its Prevention of Cruelty to Ani-
its own legislation and regulations for animal ex- mals Act, passed in 1901 and amended many times,
perimentation. At the Federal level, a select com- prohibits activities such as inflicting umecessary
mittee of the Australian Senate is in the early stages pain; killing, mutilating, or poisoning; and failing
of an 18-month examination of animal welfare, and to provided proper food, drink, shelter, or exer-
in 1985 the National Health and Medical Research cise. Experimentation is permitted only in the most
Council revised its Code of Practice for experimen- humane manner available and pain must be al-
tal animals (41a). leviated. The most recent amendments, in 1979,
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primarily served to make the act more specific.
Two levels of cruelty were defined and penalties
specified—aggravated cruelty, resulting in death
or severe injury or disease (fined at about $1,400
and/or 1 to 2 years imprisonment), and simple cru-
elty, resulting in pain or distress (fined at about
$700 and/or 6 months) (2).
In addition to the act’s prohibitions, it requires
that those performing surgery have certain scien-
tific credentials or a license. Recognizing that
credentials alone do not prevent cruelty, the Min-
ister for Local Government has the power to re-
quire those performing surgery as licensees to re-
port the details of a procedure (1).
In 1985, the New South Wales Parliament passed
legislation establishing an Animal Research Review
Panel to oversee licensing of research institutions
and animal suppliers. Each institution is required
to establish its own review committee (56). These
requirements make the laws of New South Wales
quite similar in their comprehensiveness and ap-
proach to the laws existing in Western Europe.
CANADA
As in the United States and Australia, the Prov-
inces have primary authority over animal use; na-
tional action is not taken unless there are inter-
provincial or national concerns. Although Canada
has no national legislation pertaining specifically
to protecting laboratory animals, it has a compre-
hensive voluntary national system.
Three Provinces have legislation affecting lab-
oratory animal use: Two deal primarily with
procurement of unclaimed pound animals (8,9,10),
while Ontario has a more comprehensive Animals
for Research Act, amended in 1979 (6) and ac-
companied by regulations (i’). Many provisions of
the Ontario law parallel the voluntary national
program.
Although Canada is rather proud of its volun-
tary program, some Canadian animal protectionists
are not satisfied. Vandalism and threats against
an official have occurred at the University of Brit-
ish Columbia in Vancouver, the Clarke Institute
of Psychiatry in Toronto has been firebombed, and
protesters have campaigned against the use of
pound animals at Dalhousie University (55).
Many years ago, scientists at the University of
Alberta went further than their counterparts in
other Provinces in protecting animal welfare. They
employed a research veterinarian who upgraded
their facilities to levels as high as animal hospitals
and clinics, added various precautions against the
use of stolen dogs, and established open commu-
nication with the press and the local community.
Another policy, certainly welcomed by dog en-
thusiasts, has been the gradual replacement of the
dog with the small Yucatan pig for many kinds of
experiments. Some Alberta researchers feel that
animal protectionists have not been active in Al-
berta because of these initiatives (55).
Canada’s voluntary national program is run by
the Canadian Council on Animal Care (CCAC). The
first step toward the creation of the CCAC was
taken in 1963, when the Canadian Medical Re-
search Council requested the National Research
Council (of Canada) to investigate the procurement
of experimental animals, the facilities for their care,
and control of experiments. This request followed
on the heels of the inauguration of the Canadian
Society for Animal Care (which became the Cana-
dian Association for Laboratory Animal Science,
an organization similar to the American Associa-
tion for Laboratory Animal Science).
After completing its investigation, the National
Research Council recommended that institutions
voluntarily assess and control animal experimen-
tation through:
l
l
l
animal care committees that would monitor
care and use of experimental animals and en-
sure compliance with uniform standards;
Provincial advisory boards to deal with pro-
curement matters; and
a national, independent advisory body to estab-
lish guiding principles and oversee their appli-
cation and to advise Provincial governments.
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These recommendations led to the formation of
the CCAC in 1968 as a committee of the Associa-
tion of Universities and Colleges of Canada (AUCC).
CCAC is independent of governmental and direct
university control and is funded by the Medical
Research Council and the National Research Coun-
cil. Its 20 members are drawn from various sec-
tors: 8 from national associations of higher edu-
cation (including the AUCC), 5 from departments
of the Federal Government, 4 from national agen-
cies providing research grants, 2 from the Cana-
dian Federation of Humane Societies, and 1 from
the Pharmaceutical Manufacturers Association of
Canada. The members of the CCAC also partici-
pate informally in curriculum committees for in-
stitutions that educate animal care attendants and
technicians and, together with the Canadian Asso-
ciation for Laboratory Animal Science, certify lab-
oratory animal personnel at five skill levels (28,
50)51)52).
The CCAC has two executive officers: the Ex-
ecutive Director, responsible for standards and
overall operation; and the Director of the Assess-
ment Program, responsible for compliance with
the voluntary program. They organize the CCAC’s
activities around the Guide to the Care and Use
of Experimental Animals, a two-volume publica-
tion much like the Guide for the Care and Use of
Laboratory Anhnals issued by the U.S. National
Institutes of Health (NIH). The CCAC’s Guide, pro-
vided at no charge to every researcher using ani-
mals, details standards for the care and use of ani-
mals in experiments for government, university,
and pharmaceutical research institutions.
The most important requirement of the Guide
is that a local institutional Animal Care Commit-
tee (ACC) be set up. Volume I lists the following
general requirements for a facility’s committee:
l
l
l
It must consist of senior scientific personnel
experienced with laboratory animals. An ex-
perienced veterinarian or a biological scien-
tist should be a member of the ACC or retained
as a consultant.
It must be kept informed of all activities in-
volving animals.
It must establish procedures to ensure that
in any experiment likely to result in pain, the
animal is anesthetized or given analgesics ex-
cept when it would interfere with the ex-
periment.
l It is responsible for all training and qualifica-
tions of personnel who care for animals.
l If its members believe required procedures
are not being followed and unnecessary pain
is being experienced, it has the power to stop
the procedure and to destroy the animal hu-
manely if necessary to alleviate distress (11).
In 1983, an addendum to Volume I, The Use of
Animals in Psychology, provided additional guide-
lines to those engaged in psychological research
(13). Volume II of the Guide, published in 1984,
provides information on selection, acquisition, use,
and care of 22 distinct classes of laboratory ani-
mals (14).
In addition to the Guide, CCAC has also published
Ethics of Animal Experimentation, a set of princi-
ples for “all those utilizing vertebrates in the con-
duct of research, teaching, or testing. ’’These stress
the
l
l
l
l
l
l
l
l
l
importance of:
exhausting all alternative methods before ani-
mal use is considered;
using the best methods on the smallest num-
ber of appropriate animals required to obtain
valid information;
having a reasonable expectation that the study
will contribute significantly to knowledge that
may eventually improve the health or welfare
of humans or animals;
avoiding unnecessary pain and duress, both
in intensity and duration;
humanely destroying animals when severe
pain cannot be alleviated;
seeking humane end points;
withholding food or water on a short-term
basis only;
avoiding physical restraints; and
using anesthetics or analgesics for surgery or
traumatic procedures (burning, freezing, frac-
turing) (12).
CCAC publications that do not necessarily promote
animal welfare, but that are useful to experi-
menters, include Canadian Suppliers of Labora-
tory Animals (a detailed list of suppliers, with spe-
cies, producers, and locations) and annual editions
of Research Animals in Canada (comprehensive
information, by species, on laboratory-animal re-
sources available to researchers) (15).
Compliance with the various guides and princi-
ples and the functioning of the local ACCS are over-
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seen by assessment panels chosen by the CCAC.
The typical panel consists of three scientists, one
representative appointed by the Canadian Feder-
ation of Humane Societies, and the Director of
Assessments, acting ex officio. Panelists are se-
lected, to the extent possible, for the fields of re-
search at the institution to be assessed.
Institutions, contacted in advance, complete a
questionnaire describing the local ACC, the re-
search facilities, the animals used, and the person-
nel, After the facility has been inspected (for as
long as 4 days in large institutions), the panel dis-
cusses its general findings with the ACC and
reports in confidence to the principal official of
the institution. If the panel is dissatisfied, a followup
visit may be scheduled. Major assessments occur
approximately every 2 years; minor ones, or re-
assessments, occur less frequently (15,23).
Identified problems that are widespread are
solved at the national level. For example, inap-
propriate use of certain animals as models, poor
surgical or anesthesia techniques, dated equip-
ment, and poor husbandry led the CCAC’s ad hoc
Education Committee to issue the Syllabus of the
Basic Principles of Laboratory Animal Science in
1983 (16). Several Canadian universities have used
the syllabus in short courses in basic laboratory-
animal science, and one university proposed that
such courses be mandatory for graduate students
who may use animals during research (27).
Although there are no penalties in law or regu-
lation for violating CCAC standards, an incentive
for compliance has been provided by the Health
Protection Branch of the Department of National
Health and Welfare since 1975. It includes in its
contracts with private sector institutions a require-
ment that the CCAC Guide be followed. All gov-
ernmental departments with contracts involving
animal experimentation have now adopted simi-
lar provisions, and a finding of noncompliance is
grounds for terminating a contract (28,51).
Responding to increasing criticism from some
quarters about CCAC's reliance on researchers to
police themselves and to more frequent demands
for Provincial legislation controlling research ani-
mal use, Canada’s Minister of State for Science and
Technology requested a review of CCAC’s effec-
tiveness in 1981. A special committee formed to
conduct the review found that the CCAC has had
considerable influence in eliminating those prob-
lems that led to its establishment and that it works
effectively to produce further improvements. The
site inspections involving the humane society and
the facility upgrading were found to have resulted
in Canadian animal care facilities now being among
the best in the world (28).
JAPAN
The protections afforded animals in Japan are
like those of Europe in their requirements for
anesthetics and euthanasia, as well as in their
concern, in particular, about dogs and cats. An
interesting facet of the Japanese laws is that they
combine the protection of animals with the respon-
sibility of those possessing animals to protect other
humans from them.
The principal law governing animal control and
treatment in Japan (33) went into effect in 1974.
Its purposes are to prevent cruelty to animals; to
provide for appropriate treatment, taking natu-
ral habits into account; to engender a feeling of
love for animals among people, thereby contrib-
uting to the development of respect for life and
sentiments of friendship and peace; and to pro-
tect humans from any hazards to themselves or
their property that could result from possession
by others of domestic or laboratory animals. The
law establishes a fine of up to $1,400 for violations
of the law or of standards implementing it (32,
33,34).
The law protects all mammals and birds, but it
is apparently intended to apply to other species
as well. It establishes several responsibilities rele-
vant to research:
l Those possessing animals are responsible for
their maintenance, health, safety, and control,
l Where an animal is used for education, ex-
perimental research, manufacture of biotics,
or other scientific purposes, the animal is to
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suffer the minimum pain possible within the
limits imposed by these purposes.
If an animal will not recover from a scientific
procedure, the person who used the animal
must immediately dispose of the animal by a
method that causes it the minimum pain
possible.
These responsibilities do not apply to education
and research in livestock husbandry or breeding
or to experiments for the purpose of observing
animal’s roles in an ecosystem (37).
The Prime Minister has issued three standards
in implementing this law: Standards for the Keep-
ing and Custody of Dogs and Cats (1975); Stand-
ards Relating to the Keeping and Custody of Ani-
mals for Exhibition, etc. (1976); and Standards
Concerning the Raising, Custody, etc. of Animals
in Experimental Use (1980) (37), The first two estab-
lish general requirements for adequate food,
water, shelter, exercise, care, safety, and disease
control for animal owners, custodians, and exhib-
itors. As the title indicates, the first standard ap-
plies to dogs and cats; the most recent standard
covers other mammals, birds, and reptiles. En-
forcement guidance for local authorities was also
provided in 1980 (37), and a licensing system was
established for facilities conducting experiments
(35).
The law establishes a decentralized system for
general administration and enforcement. Local
authorities at various levels—prefectures, cities,
towns, villages, and wards—pass ordinances and
establish custody and disposition programs. Prefec-
tures, the largest units, can levy fees for custodial
programs and can enlist the aid of animal protec-
tion societies. Such programs can also be granted
subsidies by Cabinet Order (38).
An Animal Protection Council created by the Cab-
inet in 1974 (36) aids the Prime Minister at his re-
quest. Though the 15-member Council is advisory,
the Prime Minister must consult with it before
establishing, enlarging, or abolishing standards.
The Council, together with the Government and
the Japanese Science Council, recommended in
1980 that the Government establish guidelines for
animal experimentation (39). The guidelines de-
veloped are quite like the NIH’s Guide for the Care
and Use of Laboratory Animals; they cover stand-
ards for housing, husbandry, veterinary care, han-
dling during and after experimental procedures,
anesthetics, euthanasia, and disposal (63).
In addition to these several publications on how
to use animals, the Government has also published
detailed information on licensed and regulated fa-
cilities, including statistics on experimental-animal
use (75). According to this publication, mice ac-
counted for 78 percent of total animal usage in
1980, while rats accounted for a little less than
17 percent. The total number of animals used has
been declining from a peak in 1970 (13.6 million),
though the use of hamsters, dogs, cats, and pri-
mates has increased (30).
WESTERN EUROPE
Throughout Western Europe, animals have legis-
lative protections. The first such protections were
anticruelty laws, many of which were passed in
the late 19th century. Most anticruelty laws had
only limited application to experiments, but in the
last several decades, additional laws were passed
to protect experimental animals, primarily from
pain. This section describes the laws of seven of
the more active countries. Table 16-1 compares
the major provisions of these laws.
Denmark
The philosophy in Denmark, as in other Scan-
dinavian countries, is that animal experiments are
prohibited unless specifically allowed. This belief
was first expressed by statute in 1953 (19). With
amendments in 1977 (18), Denmark gave author-
ity for all experiments involving animals to an Ani-
mal Experiment Board at the Ministry of Justice.
This board has seven members who are doctors
Table 16-1.—Natlonal Laws for the Protection of Animals in Selected European Countries
Federal Republic
Provisions Denmark of Germany Netherlands Norway Sweden Switzerland United Kingdom
Species protected. . . . Vertebrates
Distinctions among species Should use lowest
rank; dogs, cats,
rabbits purpose-bred
Alternatives must be used
i f  a v a i l a b l e Yes
Anesthetics, analgesics, or
approval required for
painful experiments Except for minor or
transient pain
E d u c a t i o n a l  u s e s Higher education,
technique
Ban on animal use for more
than one painful experiment. All dogs, cats,
monkeys; most
experiments
License/permit for dealers,
facilities, and investigators .All facilities, head
investigators
Review of experiments ., Most experiments need
approval by national
Board
Administration Centralized,
government/
All animals
Better to use
invertebrates or cold-
blooded vertebrates
Yes
If pain, suffering, or
injury likely
High school and above
No multiple surgeries
on vertebrates
Dealers, facilities,
investigators
Not needed; proposed
that facility’s animal
welfare officer review
States enforce and
administer (proposed
nongovernment board; that facilities have
licensee is animal welfare
responsible officer)
Animal welfare representation ...3 nominees to Being considered
national Board
Reporting Annual report In-house
recordkeeping
Vertebrates, native Vertebrates,
species crustaceans
Vertebrates better Monkeys, dogs, cats
protected better protected
Vertebrates Yes
If injury or pain likely If pain is possible
(unless Board
approves)
University and Professional training
vocational
Rarely reused because Only one experiment
of pain requirements allowed per animal
Dealers (dogs and cats), Investigators or facilities
facilities licensed
Head of institute Investigator or facility
reviews (licensee) review
Central enforcement Central coordination,
and reporting: some functions
Vertebrates Vertebrates Vertebrates
Should use lowest Should use lowest rank
rank; all purpose-bred
Alternatives promoted
Surgery on mammals
unless committee
approves
Allowed, but restricted
Rarely reused because
of pain requirements
Breeders, facilities
Notification/application;
tiered system
Central coordination
with oversight by
administration by delegated to licensees facility head and
institute committee
Not required, but Not required On all committees;
facility reports are being reconsidered
public
Annual report Annual report Government
recordkeeping
SOURCE Office of Technology Assessment
Yes
Slight pain or anxiety;
if too painful, must
forgo
Not allowed
Only reused if pain
was slight
Breeders, facilities
2 State committees
review
Central coordination,
administered by
States
Members of national
commission
In-house
recordkeeping
Primates, dogs, cats,
equidae preferred; no
stray dogs
Alternatives encouraged
Statute does not specify,
but certificate may
require
Some demonstration; not
for practicing
If anesthetized or
because of pain
requirements
Facilities registered,
investigators licensed
Home Office and
Advisory Committee
Centralized, shared by
Head Office, Advisory
Committee, Royal
Society
Advisory Committee
Annual report
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or veterinarians. Members are nominated by vari-
ous groups—two by the Medical, Agricultural, and
Veterinarian Scientific Councils; one by the Pub-
lic Health Authority; one by the Council for Indus-
try; and three by associations for the protection
of animals.
Because there are fewer than 300 experimenters,
most of whom are clustered in a handful of facil-
ities, the Board is able to oversee all experiments.
A permit must be obtained from the Board for most
experiments, and its decisions cannot be appealed.
The only exceptions to the requirement for ap-
proval are nutrition studies that will cause condi-
tions similar to what might occur naturally, and
experiments that cause only transient and minor
pain, as in the taking of blood samples or skin bi-
opsies, but even these procedures are subject to
the statute’s other requirements. In a change from
the earlier statute, Government institutes must ob-
tain permits for experiments, although licensing
of individual investigators in certain positions and
of facilities is still automatic. Those having permis-
sion to conduct experiments may delegate this au-
thority to others, but they remain responsible for
the experiment.
There are two other important changes in stat-
utory law. First, the use of animals in experiments
is forbidden if alternative methods, such as cell,
tissue, or organ cultures, could achieve the same
results. Second, in the area of education, animals
may only be used in universities and other institu-
tions of higher learning, and then only to train peo-
ple in experimental techniques. One troublesome
provision, carried over from the 1953 act, is that
animals of the lowest possible “rank” must be used.
One can infer from the special protections given
dogs, cats, and monkeys that these are the high-
est species, but the statute does not specify how
rank is to be determined. A recent ordinance re-
quires that as of January 1, 1986, all dogs, cats,
and rabbits be purpose-bred. The Animal Experi-
ment Board is also studying the need for the LD5O
test, with decisions expected no earlier than mid-
1986 (40).
The law requires the use of as few animals as
possible and the prevention and alleviation of pain,
Invasive (surgical) procedures and physically and
chemically induced insults that might cause pain
must be performed under anesthesia. The animal
involved must be killed before recovery unless the
experimenter can assume that pain will not en-
dure or unless the procedures require that the ani-
mal be kept alive. If the latter, the animal must
be given pain relievers and special care. If it sur-
vives in an abnormal state, any suffering that re-
sults must be relieved to the extent possible. The
abnormal condition must be corrected as soon as
possible, or the animal must be destroyed hu-
manely. If dogs, cats, and monkeys are not killed
at the conclusion of experiments, reasons must
be given; the exact details of destruction and dis-
posal must be included (40), This is similar in ef-
fect to those statutes requiring that an animal be
used in no more than one painful experiment.
Licensees must keep records and file a detailed
annual report on numbers and species of animals
used; type of euthanasia performed on dogs, cats,
horses, ungulates, and nonhuman primates; and
purposes of experiments. Since 1979, the Board
has required reporting that is unique. Research
institutions must distinguish between the total
numbers used in experiments (Category A), and
those used as controls and sacrificed for harvest-
ing organs or some other purpose only indirectly
related to the performance of an experiment (Cat-
egory B). Categories are further subdivided to re-
flect the risk of pain and suffering:
l procedures of short duration performed not
under anesthetic (Category A-l);
l procedures of longer duration, when the ani-
mal is not sacrificed while still anesthetized
(Category A-2);
l procedures performed under anesthetic,
when the procedure is of short (Category A-
3-a) or long (Category A-3-b) duration;
l procedures to produce or test substances per-
formed without anesthetic and not included
in the following two categories (Category A-4);
l procedures involving the induction of patho-
gens or infection (Category A-5); and
l procedures involving the injection of other
matter (Category A-6).
There has been a steady growth in the number
of licensees in Denmark, from 159 in 1970, to 276
in 1983, some of which is due to broadening scope
of licensing requirements. Animal use has been
fairly steady, but Category A uses have grown.
Mice and rats accounted for 91 percent of all po-
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tentially painful experimental animal use in Den-
mark in 1983. Of those two species, 66 percent
were used for toxicological testing. Nonhuman pri-
mates and companion animals (dogs and cats) were
used in less than 0.25 percent of the total experi-
ments. Most dogs and cats were used in longer
term procedures under anesthetic, from which
they recovered. In painful procedures, primates
were used most often in long-term procedures un-
der anesthetic, but 56 percent were used for pur-
poses exempt from the law (40), that is, nutrition
studies or experiments involving only minor or
transient pain.
Federal Republic of Germany
West Germany’s animal protection laws have
been evolving since 1883, at which time anesthetics
were required, if possible; experiments using ani-
mals could be done by trained persons only; the
number of animals and amount of distress were
to be minimized; and greater protection was af-
forded “higher” animals. Amendments in 1933 re-
tained these requirements and added a licensing
requirement for institutions using animals. In the
1972 Animal Protection Act, licenses were also re-
quired for individual scientists for each study (19).
The Parliament is considering new legislation
that would create an ethics commission of scien-
tists and animal protectionists that would review
detailed applications for each project involving ani-
mals, require that each laboratory appoint an ani-
mal welfare officer, and require that the Govern-
ment identify alternatives and promote their use.
Finally, Parliament is also considering a special tax,
probably 5 to 25 percent of costs, on animal ex-
periments as a means of providing additional in-
centive to use alternatives (26,29).
Although the law is national, it is administered
by the States (Lander). In enforcing the law, States
can use sanctions ranging from stopping an ex-
periment and seizing the animals or revoking a
permit, to imposing penalties of about $3,800 and
up to 2 years’ imprisonment (24).
The basic goal of the law is that no one shall be
permitted to cause pain, suffering, or injury to ani-
mals without acceptable reasons. Other provisions
require that vertebrates not be used when inver-
tebrates would suffice and that warm-blooded ver-
tebrates not be used when cold-blooded ones
would do. Further, experiments should be limited
to the number absolutely necessary.
Those desiring a permit must be affiliated with
a university or otherwise conducting research, and
they must provide detailed information to the per-
mitting authorities in the Lander documenting that:
l
l
l
l
l
the desired results cannot be obtained by more
humane methods;
the experiment is necessary for the preven-
tion, diagnosis, or cure of diseases in humans
or other animals or serves scientific purposes;
the director and deputy director of the ex-
periment are reliable;
the necessary equipment, facilities, supplies,
and personnel are available; and
proper care and medical treatment will be
provided.
Permits may be restricted or revoked if require-
ments are not met by a specified time or if permit
restrictions or regulations are not complied with.
The permit contains the name of the director of
the experiment and a deputy.
Unlike Denmark and other countries discussed
in this chapter, educational uses are permitted at
the high school level and a permit is not required.
However, such activities must be reported to the
authorities before they take place. Other experi-
ments that do not require permits are those that
fulfill governmental requirements and those used
for diagnostic purposes.
Several restrictions pertain to pain. An animal
should not endure pain, suffering, or harm if avoid-
able, Experiments on vertebrates may be per-
formed only under anesthetic unless it is incom-
patible with the purpose of the research or the
pain connected with the operation is less than the
damage inflicted by anesthesia. A painful opera-
tion or treatment may be performed on an un-
anesthetized animal only once unless the purpose
of the experiment cannot otherwise be achieved;
the animal may be used for another experiment
only if the second experiment does not involve pain,
suffering, or harm. After an experiment, certain
species must be presented immediately to a veter-
inarian, others to the experimenter, and killed pain-
lessly if the animal can live only in great pain.
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Animal experiments may be performed only by
persons with the required professional knowledge
in veterinary medicine, medicine, or biology. Sur-
gery may only be performed by a certified veter-
inarian.
Detailed standards governing housing, care, and
treatment of live vertebrates in experiments were
published in 1977. The Federal Government has
published a number of monographs and guidances
for the use of the States and regulated facilities
in interpreting the act in a variety of circumstances
(25). In 1983, the German Veterinary Society is-
sued codex experiendi providing advice and sug-
gestions to investigators on the ethical use of ex-
perimental animals (26).
There are specific reporting requirements for
regulated experiments. Each experiment for which
permission was required must have a report on
file that describes the purpose of the experiment,
the number and types of animals used, and the
nature and performance of the experiment. The
reports must be signed both by experimenters and
the director and retained for 3 years. ownership
histories must be kept for dogs and cats. Though
no official national statistics are kept, the Minis-
try of Food, Agriculture, and Forestry estimates
that approximately 7 million animals were used
in experiments in West Germany in 1984 (71).
Netherlands
The Netherlands places a great deal of responsi-
bility for animals’ welfare on the head of the facil-
ity in which experiments are conducted. This over-
sight is coordinated by the Veterinary Chief
Inspectorate of the Ministry of Public Health, who
in 1984 began a major project in cooperation with
five animal welfare organizations to identify po-
tential alternatives to the use of animals in testing
vaccines, serums, and other diagnostic methods.
This report, and other initiatives, are expected to
increase research on alternatives (53).
Like most other West European countries, the
Netherlands has had a general statute that pro-
tects animals from cruelty since the late 19th cen-
tury. It prohibits causing pain, suffering, or injury
to an animal, or withholding proper care without
reasonable cause. It provides criminal penalties
for violations, but it has not been necessary to use
them for animal experiments (21). A law govern-
ing trade in livestock confines trade in dogs and
cats to licensed dealers, thus protecting pets (43),
and an ordinance taking effect in 1986 requires
that dogs, cats, and rabbits be purpose-bred (31).
Finally, the Netherlands has a “protection of na-
ture” law, which protects some invertebrate
species—such as Helixpomatia, the Roman snail—
and all native amphibians (42,44).
The Law for Experimental Animals, passed in
1976, established a comprehensive system for reg-
ulation of animal experimentation, including the
filing of annual reports by all animal facilities with
the Ministry of public Health (45). The law is based
on general guidelines issued by the International
Committee for Laboratory Animals, and became
the Council of Europe’s model for the Draft Con-
vention on protection of laboratory animals (see
app. E).
The law requires justification for all animal ex-
periments on vertebrates that are likely to be in-
jurious or cause significant pain or other distress.
Experiments must benefit human or animal health
or food, or science, and must be approved by the
head of the institute where they are to be done.
Statistics on registered experiments compiled by
the Dutch Government indicate that from 1978
to 1983 about 20 percent of the experiments were
related to the production of serums, vaccines, and
other biological products; about 30 percent were
related to toxicological and pharmaceutical re-
search; less than 10 percent were related to the
diagnosis of pregnancy or disease; and about 30
percent were related to the solution of a scientific
problem (and the vast majority of these were re-
lated to medical research). Less than 2 percent
were for training and education. These statistics
also indicate that about one-third of the experi-
ments were done because of legal requirements,
and less than 10 percent were toxicity tests.
As do many other countries, the Netherlands
does not permit painful experiments on vertebrates
when alternatives are available, and requires
anesthetics for more than negligible pain except
where their use would frustrate the purpose of
the experiment. Where severe and prolonged pain
will likely result from the procedure, the animal
must be humanely killed without recovering from
anesthesia (45). Statistics for 1978-83 indicate that
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some 20 to 30 percent of experiments do not re-
quire anesthetics (though the figure is steadily de-
creasing); that more than 10 percent of the ani-
mals are killed without treatment to obtain organs
or blood; that about 10 percent of the operations
end in euthanasia or slight pain; and that the great-
est number of experiments producing significant
pain are those involving pathogens, immunization,
or toxic substances.
The Government entrusts most of the responsi-
bility for administering the law to the head of the
research enterprise to whom licenses are issued.
The director of research need not be an expert,
but he or she is responsible for appointing experts
to ensure that:
l
l
l
l
animal technicians involved in licensed exper-
iments are qualified and accredited up to the
level established by the Ministry;
those engaged in animal experimentation co-
operate in matters affecting the welfare of the
subjects;
research workers are qualified to perform as-
signed tasks; and
the welfare of experimental animals is super-
vised by a qualified veterinary surgeon or
equivalent professional.
From January 1986, licensed institutions are re-
quired to have an institutional ethics committee
composed of persons of several disciplines, includ-
ing ethics, who oversee all experiments (31).
Licensed institutions must keep records on ex-
periments and care. They are further required to
report research activities, including data on num-
bers of animals used by type and purpose. The
information is available to the public.
The law also provides for establishment of a cen-
tral veterinary inspectorate under the Ministry of
Public Health, responsible for:
l registering research facilities, as of 1984 (22);
l periodically inspecting facilities conducting re-
search;
. issuing regulations and guidelines governing
laboratory animal housing; and
l regulating sources (breeders and suppliers)
of laboratory animals.
In addition, the law also authorizes the appoint-
ment of an advisory committee of persons skilled
in animal experimentation, laboratory-animal
science, and animal welfare to advise the Minis-
try. This committee includes two representatives
of animal welfare organizations. The committee
participates in the drafting of regulations and other
aspects of implementing the 1976 law.
The Ministry of Public Health is the central en-
forcement agency for the 1976 law. It has the pow-
er to issue detailed regulations on laboratory-ani-
mal treatment and presides over them using teams
of veterinary inspectors who supervise and ad-
vise research institutions. The director of the re-
search facility is also expected to enforce stand-
ards of care and treatment.
Regulations require that investigators and tech-
nicians complete training in laboratory-animal
principles and techniques (22), including a 20-day
course that emphasizes animal well-being and the
social and ethical aspects of animal use (53). A 4-
year program for training animal technicians is
also available.
Data compiled from the 1983 annual reports in-
dicate that there are 71 licensed institutes (con-
taining 387 distinct research departments); 2,118
investigators working directly with animals; 2,541
persons involved in animal care management; and
4,683 students taking classes involving animal ex-
periments.
Indications of the commitment to protecting ani-
mals are the use of experimental review commit-
tees in 17 percent of the departments surveyed
and the fact that in 19 of 71 establishments, meth-
ods had been introduced to replace animals in ex-
periments, reduce the use of animals, or refine
procedures (54). Furthermore, there has been a
steady decline in the use of experimental animals
over the reporting years, from 1.6 million in 1978
to 1.3 million in 1983. Of these, mice account for
about 56 percent and rats, about 26 percent.
Norway
Norway requires more of people in their be-
havior toward animals than most other countries.
The Welfare of Animals Act, passed in 1974 and
in effect since 1977, even goes as far as requiring
people encountering a domestic animal or tame
reindeer in pain to come to its assistance or to call
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the appropriate authority, and the act forbids the
display of animals other than fish (46,47).
The act applies to vertebrates and crustaceans;
it provides that animals shall be treated well and
that due regard shall be given to their natural in-
stincts and needs so that they are not in danger
of being caused unnecessary suffering. Adequate
care must be provided and many procedures can
only be performed by a veterinarian or other
highly qualified professional. Anesthetics must be
used when there is reason to believe that a proce-
dure may cause considerable suffering unless it
would interfere with the purpose of the experi-
ment, but such an experiment would require spe-
cial permission from the National Experimental
Animal Board. Experiments must be planned and
carried out to avoid any unnecessary suffering,
sometimes necessitating pilot studies. Destruction
without delay is required where suffering after
recovery will occur. Animals used in painful pro-
cedures without anesthetic may not be reused in
further experiments.
The provisions of the act most applicable to re-
search are its prohibitions on the use of live ani-
mals for educational purposes, except as a neces-
sary part of professional training. It also requires
permission to carry out biological tests on animals.
The purpose must be to diagnose animal or hu-
man disease, test a hypothesis, produce or con-
trol a product, or test medicines or other sub-
stances for effects. Such tests must not inflict
greater suffering than is strictly necessary to
achieve the purpose, and licensees are permitted
to acquire and use local and general anesthetics
for this purpose. Inspection authority is broad, and
anyone “willfully or negligently” violating the act
or authorized regulations is guilty of a misde-
meanor, carrying penalties of a fine or imprison-
ment up to 6 months for the first offense, and up
to a 1 year for subsequent offenses (47).
The Experimental Animal Board, first appointed
under the statute by the Minister of Agriculture
in 1976, has primary authority. Its five members
issue and administer regulations on obtaining per-
mission for experimentation on protected animals.
In 1985, the regulations were amended to pro-
vide that no experiment on a live animal can be
carried out without the written consent of the in-
stitute’s or organization’s license holder. Copies
of executed consent forms must be filed with the
Board (20).
Sweden
Sweden’s approach to experimental use of ani-
mals has much in common, both in substance and
procedure, with that of the other countries of
Western Europe surveyed here. For example, ex-
periments involving pain or suffering receive
greater scrutiny, anesthesia during painful exper-
iments is generally required, and licenses are is-
sued to facilities in which experiments are con-
ducted. Its more unusual features are the close
working relationships among scientists, techni-
cians, and laypeople (most often animal welfare
advocates) at all levels of review and the complex
system of ethical review, which divides responsi-
bilities among many organizations and committees.
The review procedures, which have evolved over
many years, are being reevaluated by the Govern-
ment. Matters being reconsidered include the ex-
tensive use of Iaypeople (who often disagree with
other reviewers); the use of small subcommittees
(which sometimes disagree with full committees);
and the limited review given to experiments that
cause little or no pain (which leaves their aim un-
examined) (57). Sweden’s active animal welfare rep-
resentatives can be expected to vigorously oppose
any changes that would decrease their input in
the review process or that might reduce the pro-
tections provided to animals (17).
The first law pertaining to experimental use of
animals, passed in 1944 (58), prohibited cruel treat-
ment and governed care and transport of classes
of animals. Painful experiments on animals were
generally prohibited and experiments could be per-
formed only in licensed institutions by persons
with established qualifications for conducting such
research (64). Furthermore, anesthetic was re-
quired where more than minor pain was produced,
except where its use would frustrate the study’s
purpose (58).
Several ordinances and amendments were pub-
lished between 1978 and 1982 (59,60,61). They
added both substantive and procedural require-
ments, Experiments involving pain, suffering, or
anxiety now have to be licensed by the National
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Board of Agriculture (unless conducted by the Gov-
ernment). Vertebrates were ranked hierarchically,
ranging from mammals to birds to reptiles to frogs
to fish. The use of warm-blooded vertebrates in
education at or below the secondary level became
subject to approval, regardless of whether pain
or suffering would occur. Animals used in labora-
tories now must be bred for that purpose, and dogs,
cats, and rabbits must be marked and various
records kept showing their origin. Most responsi-
bility for the conduct of experiments is placed on
individual licensees and heads of licensed insti-
tutions.
Several changes were also made in how experi-
ments were to be reviewed. These changes were
based on a voluntary system that began at the
University of Uppsala. A Laboratory Animals
Board, established by the National Medical Re-
search Council in 1965, was called on in 1972 to
help the Council review grant applications. Draw-
ing from the considerable expertise of Karl-Johan
Obrink, a professor of physiology at the Univer-
sity of Uppsala’s medical school, and of Lars Wass,
a representative of the National Board of Univer-
sities, guidelines were developed for both the orga-
nization and operation of an ethics committee.
In response to the Board’s request for a system
through which the Council Administration could
determine automatically whether a grant appli-
cation involving the use of animals ought to be re-
ferred for ethical review, Obrink and Wass pro-
posed a scale of expected discomfort. Experiments
causing little or no discomfort received little, if any,
review, with other experiments receiving scrutiny
in proportion to the pain they would cause. (This
is not so different from other European systems—
pain normally triggers review, and the reviewers
would most likely take the degree of expected pain
into account.) Other key provisions of the guide-
lines include:
l
l
l
Members of the committee would be within
easy reach of anyone planning animal work,
even if the committee were large.
The committee would be composed of animal
technicians and laypeople, as well as re-
searchers.
The day-to-day work of the committee would
be performed by ad hoc subcommittees,
formed after submission of an investigator’s
‘ o
l
l
proposal to a member of the parent com-
mittee.
Experimentation could begin immediately
upon approval of an experiment by the sub-
committee.
To protect an investigator’s privacy, the com-
mittee and subcommittees would be volun-
tary only and would have no legal or adminis-
trative authority.
Discussion between investigators and subcom-
mittee members would promote increased
awareness of research ethics.
The prototype committee consisted of 30 indi-
viduals, mostly investigators. Meetings were held
frequently and applications were reviewed in full
committee, with investigators present to discuss
experiments and answer questions.
With the election of a new National Government
in 1976, the Minister of Agriculture decided that
the Uppsala system, with minor modifications,
should be introduced throughout the country and
incorporated into the National Board of Agricul-
ture’s regular system of experimental control. It
was in place by 1979.
As the laws have become more comprehensive,
their administration has become more complex.
The National Board of Agriculture has the broadest
range of responsibilities. In addition to its involve-
ment with the ethical committees and the Board
for Laboratory Animals, it oversees government
laboratories that use animals, approves plans for
new facilities for animals, conducts inspections,
oversees breeding and transportation of animals,
provides a variety of forms needed for review and
recordkeeping, and keeps journals of experiments
that have been approved (59,60).
The 1979 laws gave certain enforcement and
administrative functions to the County Public
Health Committee, with consultation and direc-
tion with the National Board of Agriculture. Oper-
ating somewhat independently of the National
Board of Agriculture is the Swedish Laboratory
Animals Board (referred to as CFN in Sweden). It
has members nominated by Government (includ-
ing the National Board of Agriculture), universi-
ties, the Swedish Medical Research Council, and
the Swedish Natural Science Research Council. The
Board, most recently the subject of a 1982 statute,
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is now charged with promoting cooperation be-
tween scientists, technicians, and animal welfare
organizations; planning for long-term improve-
ments in conditions for laboratory animals; pro-
moting the development of alternatives, which it
also funds; reviewing the work of ethical commit-
tees; and working toward the efficient use of ani-
mals by promoting cooperation among animal
users (58).
The 1982 statute also required the establishment
of six ethical committees, one in each university
region. The requirements were based on the pro-
totype committee developed in Uppsala. These
committees, overseen by the National Board of
Agriculture, advise and consult on individual ex-
periments and report to their County’s Public
Health Committee. They have equal numbers of
scientists, animal technicians, and laypeople.
The Central Veterinary Board of the National
Board of Agriculture solicits nominees for review
committees from each of six Regional Boards of
Higher Education (that consist of university and
political officials) and major animal welfare groups.
Nominees are of three kinds: researchers, techni-
cians, and laypeople. The animal welfare organi-
zations nominate laypeople only. From the nomi-
nations submitted, the Board appoints six regional
ethical committees, designating a chair and vice
chair; six regional subcommittees for secret proj-
ects; and one special committee for military re-
search. The special military-research group and
the regional subcommittees for secret research
were created to protect national defense interests
and pharmaceutical trade secrets.
Although full committees meet at least twice an-
nually, day-today application review is conducted
by subcommittees, consisting of equal numbers
of researchers, technicians, and laypeople. The
technicians and laypeople are chosen from man-
datory rotation lists, to avoid exclusion of any rep-
resented interest, and each subcommittee must
have at least three members.
The applicant completes a one-page form, stat-
ing the objective of the research project; describ-
ing the experiment, with an emphasis on the use
and disposition of the animals and the number of
animals of different species that will be used; and
describing what the investigator plans to do to al-
leviate and abbreviate suffering. When the sub-
committee meets with the applicant, it may sug-
gest improvements in the description of the pro-
cedure, modifications to the procedure itself, or
a reduction in the number of animals used. If the
subcommittee agrees to the applicant’s proposal,
it forwards a signed form to the central au-
thority.
If an applicant or a subcommittee member dis-
agrees with the decision of a subcommittee, the
application is referred to the full committee, which
can call a session to review appeals. All subcom-
mittee decisions are discussed by the full commit-
tee at its regular meetings. A permit, valid for up
to 3 years, is all that iS needed to begin work. Re-
review is required only if an investigator plans to
conduct experiments more severe than those for
which approval was granted.
Precise data on numbers of animals used for vari-
ous kinds of procedures are not available. Report-
ing is only done in conjunction with the applica-
tion process, although certain records must be
submitted and others must be kept.
The time required to obtain a decision varies
from region to region. Two contributing factors
have been identified: difficulty in scheduling meet-
ings, and some applicants’ inability to use simple
language, thus requiring extra time for clarifica-
tion. To help remedy the lag problem, the 1982
ordinance required a subcommittee to reach a de-
cision within 3 weeks of receipt of the application.
The 1982 ordinance also abolished the require-
ment that experiments be grouped into the tra-
ditional discomfort categories, thus eliminating
needless discussion. Obrink, the architect of the
voluntary review mechanisms, has expressed worry
over the system’s potential, with increasing regu-
latory emphasis, to become bureaucratized to the
point where it sacrifices the objectives of ethical
review for the sake of control (5,48,49).
Switzerland
Switzerland has probably gone further to pro-
tect animals than any other country and recently
came to the brink of going even further. In 1985,
Swiss voters were presented with a constitutional
amendment that read: “The vivisection of verte-
brates as well as all cruel animal experimentation
shall be forbidden in Switzerland. ” The proposal
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was rejected by a two-to-one margin. This law
would have had a major impact on the three large
pharmaceutical firms with facilities in Switzerland.
Another, less restrictive referendum is being read-
ied for Swiss voters, but may be 4 years away from
a vote (74).
The Swiss antivivisection movement has become
particularly active, if not violent in recent years.
Research facilities have been broken into, scien-
tists sued, and untrue or overstated stories publi-
cized (for example, that vaccines had no part in
fighting infectious diseases) (72).
Swiss scientists have not fought controls, and
some have pointed out the benefits to good sci-
ence—more attention is given to planning and
scientists have greater incentives to keep abreast.
Of course, there are also disadvantages to sci-
ence—senior scientists must spend time answer-
ing simple questions and there can be delays of
4 to 6 weeks for licensing an experiment.
An indication of the importance of animal wel-
fare to the Swiss is the fact that animal protection
is addressed in the Constitution, which recognizes
the necessity for and utility of humane treatment
of animals. Controls on animal experimentation
in Switzerland are found in the Federal Law of
1978 Regarding the Protection of Animals (as
amended by the Ordinance of 1981 Regarding the
Protection of Animals).
In response to antivivisectionist pressures, ad-
ditional guidelines were developed in 1981 by the
Swiss Academies of Medical Sciences and of
Sciences. These have been adopted by government,
industry, and academia. Under the guidelines, a
permanent committee was set up to review ani-
mal experiments, and stringent requirements were
set up for experiments involving severe pain—if
the experiment cannot be modified to reduce pain,
it must be forgone. Under the statute, any experi-
ment that could cause pain to a protected animal
or that would adversely affect its well-being must
be licensed, whether conducted by government
or by private institutions. Even where pain is not
significant, licensing authorities must be satisfied
that the expected benefits of the proposed experi-
ment outweigh the adverse effects on experimental
animals. Furthermore, animals that have suffered
more than minor pain or anxiety may not be re-
used (62).
Licenses are issued to individual investigators
for each experiment or series of related experi-
ments. Licenses to perform experiments are issued
by the cantons, or Swiss States. Special commis-
sions must determine whether all legal require-
ments and qualifications are met before a license
is issued. Thus, the commission must verify, in each
instance, whether the proposed experiment:
l
l
l
l
is essential in order to achieve the objective
of the experiment, or whether alternative ap-
proaches are possible;
is sound from a methodological point of view;
can be performed with a lower order of spe-
cies than the one proposed; and
can be modified to reduce the number of ani-
reals to be used.
The conditions under which experimental animals
are to be kept and used are specified in the law,
setting standards for accommodations of differ-
ing species, by size and weight, and prescribing
care. Animal caretakers must demonstrate their
competency by passing a Federal examination.
Records of licensed experiments must be kept for
a minimum of 2 years after the experiment ends,
and they must be available for inspection by local
authorities (77).
Most licensed experiments in Switzerland are
conducted by large pharmaceutical companies (74),
with some work done by Government and univer-
sities. In addition, a few private institutes do test-
ing and research, The experiments’ purposes fall
into four major categories: research and develop-
ment (87 percent); production and quality assur-
ance (12 percent); teaching (1 percent); and diag-
nostics (less than 1 percent).
According to the Swiss Government, the three
pharmaceutical companies used 36 percent fewer
animals in 1983 than in 1976; the decrease between
1981 and 1983 averaged 23 percent for all spe-
cies, with the largest categorical decreases occur-
ring in the use of mice (26 percent) and rabbits
(25 percent). The authorities believe this indicates
a general trend toward reduced animal use, since
the firms involved account for about two-thirds
of all experimental-animal use; one governmental
representative has said the decline was hastened
by the implementation of the 1981 ordinance (77).
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United Kingdom
The United Kingdom has been a pioneer in the
protection of experimental animals. The Cruelty
to Animals Act, passed in 1876 (68), was the most
protective statute of its kind for many decades.
Although the act has not been amended, the pro-
tections afforded animals have continued to ex-
pand through administrative actions of the Home
office and by voluntary actions by institutions and
individuals (69).
As in other parts of Western Europe, animal wel-
fare advocates have been actively campaigning for
more protective laws, Unlike many other coun-
tries, some of these groups have also made major
scientific contributions to the development of alter-
natives. The most active of these scientifically, the
Fund for the Replacement of Animals in Medical
Experiments, was recently given over $200,000
by the Government to fund research on alter-
natives.
Contributing to the debate over how the act
should be changed, the British Veterinary Asso-
ciation, the Committee for the Reform of Animal
Experimentation, and the Fund for the Replace-
ment of Animals in Medical Experiments made rec-
ommendations that became the basis for a 1983
White Paper by the Home Office. Several items
in that paper provoked considerable debate, lead-
ing to the 1985 White Paper Scientific Procedures
on Live Animals (70). This was presented by the
Home Office to the Parliament in May 1985 and
recommends substantial amendments to the 1876
Act, some of which would codify current prac-
tice. The 1876 act (as it is currently practiced) and
the proposed legislation are summarized and com-
pared in table 16-2.
Other acts that bear on these activities include
the Dogs Act of 1906 and the Theft Act of 1968
(as amended by the Criminal Theft Act of 1977),
which address the problem of stolen pets. Experi-
ments regulated by the Cruelty to Animals Act are
excluded specifically from the reaches of the Pro-
tection of Animals Act of 1911, the Protection of
Animals (Scotland) Act of 1912, the Protection of
Animals (Anesthetics) Act of 1954 (65), and the
Protection of Animals (Anesthetics) Act of 1964
(66).
A basic philosophy of the act is that experiments
should be permitted if they lead to new knowl-
edge, but the use of animals to develop manual
skills is not permitted. (Demonstrations—another
educational use—are permitted, however, if the
animal is anesthetized and does not recover.) In
permitting the development of new knowledge,
the authorities, as in many other countries, will
not try to predict which experiments will result
in useful knowledge or practical applications.
Control over experiments occurs in three ways:
through the granting of licenses to experimenters,
through the registration of facilities where exper-
iments take place, and through the appointment
of government inspectors. Although responsibil-
ity rests with the Home Office, assistance is pro-
vided by an Advisory Committee with represen-
tation by animal welfare organizations. In addition,
many institutions have established their own in-
formal review procedures (3).
The Secretary of State approves and registers
every place for the performance of experiments
or for the purpose of instruction, imposes condi-
tions on licenses, and revokes licenses for cause.
The Secretary may require reports, appoint inspec-
tors, and require inspections. Most licenses are
issued with one or more certificates. Certificates
may be given for the period and series of experi-
ments the persons signing the certificate may think
expedient. There are six kinds of certificates, based
on species use, pain, and the use of anesthetic,
A practical approach to the assessment of pain,
suggested by a Royal Commission appointed in
1906, is that it would be unreasonable to impose
greater restrictions on the infliction of pain for
the advancement of knowledge than those imposed
by public opinion in the pursuit of sport, in carry-
ing out such operations as castration and spaying,
or in the destruction of rabbits, rats, and other
vermin (41).
The United Kingdom is able to compile detailed,
accurate statistics on animal use through its report-
ing requirements as well as the through the issu-
ance of licenses and certificates. Each licensee (ex-
cept those who have no experiments to report for
a given year) must submit an annual report for
as many of each of the following reporting cate-
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Table 16-2.—Comparison of the United Kingdom’s Cruelty to Animals Act of 1876 and Proposed Amendments
Provision Current law Proposed amendments
Animals
protected
Permissible
purposes
Licensing
system
Severity
Assessors
Registering
facilities
Fees
Source of
animals
Reuse of
animals
Killing of
animals when
procedure
ends
Use of animals
to attain
manual skill
Use of
alternatives
Use for
education
and training
Advisory
Committee
Codes of
practice
Offenses and
penalties
Records
All living vertebrates; additional
protection for nonhuman primates,
dogs, cats, and equidae
Advance new discovery of
knowledge or lead to longer life,
less suffering
Any person Home Secretary allows:
difficult to alter issued license;
restrictions must be specified
No statutory limit on pain, but may
be limited in certificates; pain may
be severe or enduring, not both
No mechanism to assess integrity or
competence for personal license
Most facilities for experiments are
registered; most breeders and
suppliers are not
None
Only stray dogs protected
(Dog Act)
Only anesthetized animals must be
killed
Only if animal is in severe pain or
was anesthetized
Not permitted unless decerebrated
Encouraged but not required
Only anesthetized animals that
killed before recovery for
university lectures
are
Not required, but has existed since
1912, with lay members since 1979
Voluntary codes are often used
Experimenting without a license; 6
months and $3,000
All licensees keep records of
All living vertebrates, fetuses of mammals, embryonic or larval
young of other species at specified stages, (would also add
authority over breeding of animals with potentially disabling
genetic defects; would allow the Home Secretary to protect
invertebrates; would require justification of all species choices)
Adopts permissible purposes of European Convention (Article
2) (see app. E), encompassing many procedures rather than
experiments (e.g., production of serums, maintaining tumors
or pathogens); Secretary must balance the severity (pain)
against the purpose
Personal license would only allow specified techniques and
species; project license for each experiment, specifying
purpose of work, species, number of animals, techniques;
Secretary must answer to Parliament for balance of severity
and purpose (Secretary must publish guidelines for the
decision criteria)
An animal in severe pain or distress would have to be killed
immediately and painlessly; severity would encompass pain,
distress, suffering, morbidity, and mortality and would be
tailored to each project license; would require licensees to
minimize severity wherever possible; would broaden
inspector’s power to kill humanely
Senior licensee with personal knowledge of applicant and
applicant’s abilities would certify applicant’s competence;
Home Office would continue to issue license
All facilities would be registered; Secretary would have power
to set standards for staffing, care, and accommodation;
facilities would name person responsible for day-to-day care
and outside veterinarian must be called for problems;
breeders and suppliers would register
Registered facilities, based on number of procedures
All animals purpose-bred in registered establishments (except
for farm animals and animals taken from the wild);
recordkeeping on source and disposal
Reuse would require Secretary’s permission, and only if the
animal has returned to normal
Not required to kill animals at the end of a procedure; if
certified fit, surviving wild animals may be returned to the
wild, farm animals to a farm, and certain domestic animals
may be offered to private homes
Secretary would authorize for special, specific skills such as
microsurgery on anesthetized animals
License would not be issued until Secretary was convinced
that alternatives were not suitable and that no further
refinements or reductions could be made
Would be extended to allow other nonrecovery training for
approved professional courses; would permit recovery if
animal suffers only trivial pain or distress under exceptional
circumstances, decerebration would become a licensed
procedure and no longer permitted in schools
Would require Animal Procedures Committee, with lay members
(including animal welfare advocates), doctors, veterinarians,
and biologists; no more than half of the Committee would be
licensees; would advise Secretary on procedures, standards,
trends, licensing, and revisions of the law
Secretary would issue guidelines and codes of practice on
animal husbandry and would give guidance on recognizing
and alleviating stress and pain
Performing, aiding, or abetting performance of a procedure without
authority; providing false information; disclosing information
obtained in confidence; 2 years and an unlimited fine
Same
experiments
SOURCE: Office of Technology Assessment.
Ch. 16—Regulation of Animal Use in Selected Foreign Countries l 375
gories as apply. (The number of distinct entry codes l toxicity tests [6];
for each list subclassification is given in brackets.) l experiments in response to domestic or for-
l
l
Ž
l
l
anesthetic (none, for part of experiment, or
entire experiment) [3];
types of vertebrates (mammals—rodents, rab-
bits, primates, carnivores, ungulates, and
others—birds, reptiles, amphibians, and fish)
[16];
neoplasia [4];
infection and immunology [41;
primary purpose (to study body function or
structure, to develop or study the various
products or chemicals, to develop transplant
techniques) [15];
eign legislation [14]; and
l use of particular painful techniques (such as
eye irritation) [141.
These annual reports are compiled in detailed
reports. Several tables from the 1984 report are
included here. Table 16-3 shows the frequency
with which various species are used in the United
Kingdom, table 16-4 shows the primary purpose
of the experiments, and table 16-5 shows the reg-
istered institutions performing experiments. These
tables represent only highlights of the consider-
able data available.
Table 16-3.—Experiments by Species of Animal, 1977=84, United Kingdom
Species of animal (thousands of experimental animals used)
Year Mouse Rat Guinea pig Other rodent Rabbit Primate Cat Dog
1977 . . . . . . . . . 3,234.9 1,073.0 187.7 38.7 191.8 9.0 8.5 14.3
1978 . . . . . . . . . 3,168.5 1,062.6 193.4 39.4 199.2 7.2 7.9 13.7
1979 . . . . . . . . . 2,901.3 994.8 165.7 37.2 187.0 6.4 7.5 12.0
1980 . . . . . . . . . 2,780.7 957.9 188.6 36.4 181.5 5.2 6.8 11.5
1981 . . . . . . . . . 2,616.9 908.6 159.1 35.0 176.0 6.2 8.0 13.5
1982 . . . . . . . . . 2,442.7 932.3 154.7 36.8 165.0 7.3 13.1
1983 . . . . . . . . . 2,070.2 878.4 144.7 36.2 160.0 5.6 7.5 13.9
1984 . . . . . . . . . 1,903.8 888.0 141.7 36.5 156.0 6.0 6.4 14.4
Other Horse, donkey, Other Other Reptile or
carnivore or crossbred ungulate mammal Bird amphibian Fish Total a
1977 . . . . . . . . . 2.2 0.5 31.9 3.0 344.3 7.2 157.5 5,385.6b
1978 . . . . . . . . . 2.7 0.6 36,0 2.6 314.3 6.6 140.6 5,195.4
1979 . . . . . . . . . 2.2 0.6 36.5 2.4 241.4 7.6 117.4 4,719.9
1980 . . . . . . . . . 1.3 0.5 33.4 2.6 211.6 7.8 175.5 4,579.5
1981 . . . . . . . . . 2.3 0.4 35.4 1.8 194.2 8.6 178.9 4,344.8
1982 . . . . . . . . . 1.9 0.5 33.6 2.7 251.8 7.8 165.8 4,221.8
1983 . . . . . . . . . 1.8 0.6 36.4 3.0 132.6 18.2 115.2 3,624.2
1984 . . . . . . . . . 1.7 0.6 33,1 2.7 155.0 8.1 143.2 3,497.3
%olumns  do not add up to total due to rounding.
blncludes 81.3 thousand experimental animals that could not be classified.
SOURCE: U.K. Home Office, Secreta~  of State, Statlstks  of Experiments on Living  Anima/s:  Great  Britain, 19S4  (London: Her Majesty’s Stationery Office, 1985).
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Table 16-4.—Primary Purpose of Experiments, 1977-84, United Kingdom
(thousands of experimental animals used)
To select,
develop, or
study the use,
etc., of medical, To select, develop, or study the use, hazards, or safety of
To study normal dental, and
or abnormal veterinary To develop
body structure products and transplant
Year or function appliances techniques
1977 . . . . . 1,266.0 2,932.6 22.5
1978 . . . . . 1,164.8 2,925.7 16.2
1979 . . . . . 1,051.7 2,680.8 25.4
1980 . . . . . 909.3 2,680.1 14.7
1981 . . . . . 1,119.2 2,403.0 14.6
1982 . . . . . 997.0 2,373.0 15.2
1983 . . . . . 875.2 2,039.9 12.6
1984 . . . . . 824.8 1,915.7 15.0
Herbicides or
Plant pesticides, substances Substances Substances
including modifying plant used in used in the
fungicides growth industry household
35.8 20.3 81.6 18.8
50.4 18.8 88.0 14.9
34.1 24.0 75.3 18.5
40.1 17.5 80.4 13.8
30.6 12.9 69.2 14.3
33.0 15.1 66.2 13.9
35.4 17.9 59.1 17.2
46.7 18.1 64.5 12,9
Cosmetics and
toiletries
24.6
28.2
30.5
31.3
24.4
18.9
18.0
17.5
To select, develop, or study the use, hazards, or safety of
Plants or General
Tobacco and animals and environmental To demonstrate Other More than
Food additives its substitutes their toxins pollutants known facts purposes one purpose Totala
1977 . . . . . 39.3 15.2 4.2 60.4 2.7 676.8 83.4 5,385.6 b
1978 . . . . . 42.5 2.7 2.7 70.4 2.6 709.8 57.6 5,195.4
1979 . . . . . 27.7 4.6 3.3 33.6 1.8 600.5 108,1 4,719.9
1960 . . . . . 21.3 1.9 3.3 40.9 1.7 635.9 87.2 4,579.5
1981 . . . . . 20.2 2.3 2.7 45.8 1.9 519.4 64.3 4,344.8
1982 . . . . . 20.1 3.2 5.9 27.3 1.6 562.5 68.9 4,221.8
1983 . . . . . 14.1 2.7 4.8 34,4 1.6 444.9 46.4 3,624,2
1984 . . . . . 12.0 2.2 5.8 31.8 1.1 453.1 76.0 3,497.3
%Iurrms may not add up due to rounding.
blncludes 81.3 thouaand experimental animals that could fiOt be classified.
SOURCE: U.K. Home Office, Secretary of State, Statistics of Experiments on Ming Animals:  Great  Britain, 1984 (London: Her Majesty’s Stationew  Office, 1985).
Table 16-5.-Experiments by Type of Registered Facility, 197744, United Kingdom
1977 1978 1979 1982 1963 1984
Type of registered place a (thousands of experimental animals used)
Public health Iaboratoriesb . . . . 37.8 41.8 120.6 106.7 117.0 106.4 78.4 63.7
Universities (including
medical schools). . . . . . . . . . . 875.5 927.4 975.9 895.3 847.6 813.6 785.9 772.7
Polytechnics . . . . . . . . . . . . . . . . 32.9 46.7 38.4 37.7 34.9 29.5 36.9 29.8
Quasi-autonomous
nongovernmental
organizations. . . . . . . . . . . . . . 316.4 280.6 255.7 274.6 242.8 268.9 239.5 209.3
National health service
hospitals (excluding
medical schools). . . . . . . . . . . 180.5 157.4 147.7 159.4 154.3 144.2 132.2 134.4
Government departments . . . . 323.9 273.5 163.7 169.8 174.0 154.0 101.9 103.2
Nonprofitmaking
organizations, . . . . . . . . . . . . . 858.3 779.5 614.0 546.9 507.0 512.3 396.2 340.3
Commercial concerns . . . . . . . . 2,760.4 2,688.6 2,403.8 2,389.0 2,267.2 2,192.9 1,853.1 1,843.9
Total c . . . . . . . . . . . . . . . . . . . . . . 5,385.6 d 5,195.4 4,719.9 4,579.5 4,344.8 4,221.8 3,624.2 3,497.3
aRaor&j  on the bssis  of the registered pl~e that the licensees regard ss their main place of work at the time the returna were issued. A liCenSee  maY have commenced
experiments at more than one registered place during the year.
bThe  differences betw~n 1978 and 1979 are partly because some establishments were reclassified from one  type of registered place to another.
c~lumns  may not add up due to rounding.
dlncludes 813 thousand experimental animals that could not  * classified.
SOURCE: U.K. Home Office, Secretaw  of State, Statistics of Experiments on Living  Animals: Great Britain,  1984 (London: Her Majesty’s Stationery Office, 1985).
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SUMMARY AND CONCLUSIONS
Most of the countries examined for this assess-
ment have laws far more protective of experi-
mental animals than those in the United States.
Despite these protections, animal welfare advo-
cates have been applying considerable pressure
for even stronger laws, and many countries,
including Australia, Switzerland, West German}’,
and the United Kingdom, are considering major
changes.
Many of the laws have similar requirements.
Almost all require anesthetics or analgesics for
painful experiments unless these would frustrate
the purpose of the experiment. Switzerland goes
so far as to require that certain experiments be
forgone because they are too painful. Some coun-
tries balance the importance of the experiment
and the level of pain it would cause before giving
approval.
Several countries require euthanasia after a pain-
ful experiment is finished; some require destruc-
tion of an animal even when it is no longer in pain,
rather than allowing it to be reused, Euthanasia
requirements sometimes apply only to certain ani-
mals, such as dogs, cats, and monkeys. These spe-
cies are also preferred in other ways, such as re-
quiring that lower animals be substituted for them
wherever possible.
Many countries encourage the use of alterna-
tives, and Denmark, West Germany, the Nether-
lands, Norway, and Sweden require that non-
animal alternatives be used if they are available.
Sweden and the United Kingdom have provided
funding for the development of alternatives, and
West Germany is considering doing so. Many coun-
tries restrict educational uses of animals to profes-
sional or vocational training, and Switzerland pro-
hibits even this.
All West European countries reviewed for this
assessment require that facilities that use experi-
mental animals be licensed. Some also license
dealers, breeders, or experimenters. Many also
require that individual experiments be approved,
some by Government authorities, some by com-
mittees. Such committees, except in Sweden and
the United Kingdom, do not require lay represent-
atives, although Switzerland and Denmark have
such representatives on national advisory boards.
The use of ethics committees within the facilities
that use animals is growing; their use is presently
most well developed in Canada and Sweden,
The experiences of these selected countries can
serve as useful models for various protections that
are being considered in the United States. How-
ever, in trying to apply them, it is necessary to con-
sider the size of a country, and perhaps more im-
portantly, those cultural considerations that affect
compliance with the laws.
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Appendix A
Testing Guidelines
Testing Guidelines
Testing guidelines are developed for a variety of rea-
sons: to allow results of various test substances or spe-
cies to be easily compared, to encourage the use of cer-
tain protocols so that testing need not be repeated, and
to facilitate the work of those who design and carry
out tests. Many organizations have developed testing
guidelines. Three such compilations have been selected
for discussion.
FDA Guidelines Involving
Whole Animal Testing
To the extent possible, the Food and Drug Adminis-
tration (FDA) makes its animal testing guidelines con-
sistent throughout the agency and consistent with those
of other agencies and organizations. However, special
uses of products require special testing, and guidance
is available from agency staff to help manufacturers
meet those requirements. In this table, tests that gen-
erally can be considered common or standard toxico-
logical tests usually used throughout the agency are
grouped together. Those that are more specific for
evaluation of the safety of certain products are identi-
fied with the FDA Center responsible for regulating
that product.
I. Agency-wide
A. General Toxicity
1. Acute oral—rodent, nonrodent
2. Acute dermal—rodent, nonrodent
3. Acute inhalation—rodent
4. Subchronic oral—rodent, nonrodent
5. Chronic oral—rodent, nonrodent
6. Carcinogenicity —rodent
7. Combined chronic/carcinogenicity —rodent
B. Specific Effects
1. Dermal sensitization—guinea pig
2. Dermal irritation—rabbit
3. Eye irritation—rabbit
4. Teratogenicity—rodent, rabbit
5. Reproduction—rodent
6. Absorption, distribution, metabolism,
elimination—rodent, nonrodent
7. Neural-behavioral—rodent, rabbit
H. Center-oriented
A. Human Drugs
1. Subchronic inhalation—rodent, nonrodent
2. Subchronic dermal—rodent, nonrodent
3. Vaginal and rectal administration—rodent,
nonrodent
4. Immunotoxicity—rodent
B. Food Additives/Color Additives
I. Immunotoxicity—rodent
2. Protein quality—rodent
3. Vitamin D assay—rodent
C. Biologics
1. All biologics administered by injection
a. Safety—guinea pigs, mice
b. pyrogenicity–rabbits
2. Vaccines
a. Safety—mice, suckling mice,
chimpanzees, monkeys, guinea pigs,
rabbits
b. Potency–guinea pigs, mice, monkeys
c. Hypersensitivity-guinea pigs
d. Toxicity—mice
3. Antitoxins
a. Potency—guinea pigs, mice
4. Toxins
a. Potency—mice
5. Toxoids
a. Potency—mice
6. Immune globulins
a. Potency—guinea pigs
7. Tuberculin
a. Safety—guinea pigs
b. Potency—mice
D. Devices
1. Corneal metabolism—rabbit
2. Biomaterial implant—rabbit, primate, cat
3. U.S.P. intracutaneous—rabbit
E. Cosmetics
1. Primary skin irritation and corrosivity -
rabbit
2. Phototoxicity—nude mouse, rabbit, guinea
pig
F. New Veterinary Drugs
1.
2.
3.
4,
5.
6.
7.
8.
Safety, efficacy—target species
Drug tolerance—target species
Reproduction studies—target species
Tissue irritation—target species
Combination drug—target species
Drug disposition—target species
Route of administration—target species
Intramammary infusion-dairy cows, goats
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OECD Guidelines Involving
Whole Animal Testing
The Organization for Economic Cooperation and De-
velopment (OECD) guidelines have wide acceptance in
the United States and abroad because of the Mutual
Acceptance of Data Decision (l). Under the terms of
this decision, member countries of OECD must accept
data generated in other countries if done so according
to these guidelines. Animal tests contained in the guide-
lines are listed below.
1. Effects on Biotic Systems
202 Daphnia, acute immobilization test and re-
production test
203 Fish, acute toxicity test
204 Fish, prolonged toxicity test: 14 day study
205 Avian dietary toxicity test
206 Avian reproduction test
2. Degradation and Accumulation
305A Bioaccumulation:
Test
305B Bioaccumulation:
305C Bioaccumulation:
Bioconcentration
305D Bioaccumulation:
305E Bioaccumulation:
3. Health Effects
Sequential Static Fish
Semi-static Fish Test
Test for the Degree of
in Fish
Static Fish Test
Flow-through Fish Test
Short-Term Toxicology
401 Acute oral toxicity
402 Acute dermal toxicity
403 Acute inhalation toxicity
404 Acute dermal irritation/corrosion
405 Acute eye irritation/corrosion
406 Skin sensitization
407 Repeated dose oral toxicity—rodent: 14/28
day
408 Subchronic oral toxicity–rodent: 90 day
409 Subchronic oral toxicity—nonrodent: 90 day
410 Repeated dose dermal toxicity: 14/28 day
411 Subchronic dermal toxicity: 90 day
412 Repeated dose inhalation toxicity: 14/28 day
413 Subchronic inhalation toxicity: 90 day
414 Teratogenicity
415 One-generation reproduction toxicity study
416 Two-generation reproduction toxicity study
417 Toxicokinetics
418 Acute delayed neurotoxicity of
organophosphorous substances
419 Subchronic delayed neurotoxicity of
organophosphorous substances: 90 day
Long-Term Toxicology
451 Carcinogenicity studies
452 Chronic toxicity studies
453 Combined chronic toxicity/carcinogenicity
studies
Genetic Toxicology
474 Genetic toxicity: micronucleus test
475 In vivo mammalian bone marrow
cytogenetic test—chromosomal analysis
478 Rodent dominant lethal test
Pesticide Assessment Guidelines
Involving Whole-Animal Testing
The Office of Pesticide Programs of the Environmen-
tal Protection Agency (EPA) has developed guidelines
for testing required under the Federal Insecticide, Fun-
gicide, and Rodenticide Act. These Pesticide Assessment
Guidelines contain standards for conducting acceptable
tests, guidelines for the evaluation and reporting of data,
guidelines as to when additional testing might be re-
quired, and examples of acceptable protocols (2). Simi-
lar guidelines have been developed by EPA’s Office of
Toxic Substances (OTS) for testing required under the
Toxic Substances Control Act (3).
Subdivision E: Hazard Evaluation: Wildlife and
Aquatic Organisms
Series 70: General Information and Requirements
Series 71: Avian and Mammalian Testing
71-1 Avian single-dose oral LD5O test
71-2 Avian dietary LC5O test
71-3 Wild mammal toxicity test
71-4 Avian reproduction test
71-5 Simulated and actual field tests for mammals
and birds
Series 72: Aquatic Organism Testing
72-1 Acute toxicity test for freshwater fish
72-2 Acute toxicity test for freshwater aquatic
invertebrates
72-3 Acute toxicity test for estuarine and marine
organisms
72-4 Fish early life-stage and aquatic invertebrate
life-cycle studies
72-5 Life-cycle tests of fish
72-6 Aquatic organism accumulation tests
72-7 Simulated or actual field testing for aquatic
organisms
Subdivision F: Hazard Evaluation: Humans
and Domestic Animals
Series 80: Overview, Definition, and Genera]
Requirements
Series 81: Acute Toxicity and Irritation Studies
81-1 Acute oral toxicity study
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81-2 Acute dermal toxicity study
81-3 Acute inhalation toxicity study
81-4 Primary eye irritation study
81-5 Primary dermal irritation study
81-6 Dermal sensitization study
81-7 Acute delayed neurotoxicity of
Series
82-1
82-2
82-3
82-4
82-5
Series
83-1
83-2
83-3
83-4
83-5
Series
84-1
84-2
Series
85-1
85-2
organophosphorous substances
82: Subchronic Testing
Subchronic oral toxicity (rodent and
nonrodent): 90 day study
Repeated dose dermal toxicity: 21 day study
Subchronic dermal toxicity: 90 day study
Subchronic inhalation toxicity: 90 day study
Subchronic neurotoxicity: 90 day study
83: Chronic and Long-Term Studies
Chronic toxicity studies
Oncogenicity studies
Teratogenicity study
Reproductive and fertility effects
Combined chronic toxicity/oncogenicity
studies
84: Mutagenicity
Purpose and general recommendations for
mutagenicity testing
Mutagenicity tests (described in very general
terms, with reference to the OTS guidelines)
85: Special Studies
Metabolism study
Domestic animal safety testing
Subdivision G: Product Performance
Series 95: Efficacy of Invertebrate Control Agents
95-1 Genera] considerations
95-8 Livestock, poultry, fur and wool-bearing ani-
mal treatments
95-9 Treatments to control pests of humans and
pets
Series 96: Efficacy of Vertebrate Control Agents
96-1
96-2
96-3
96-4
96-5
96-6
96-7
96-8
96-9
General considerations
Fish control agents
Aquatic amphibian control agents
Terrestrial amphibian and reptilian control
agents
Avian toxicants
Avian repellents
Avian frightening agents
Mole toxicants
Bat toxicants and repellents
96-10 Commensal rodenticides
96-11 Rodenticides in orchards
96-12 Rodenticides on farm and rangelands
96-13 Rodent fumigants
96-14 Rodent repellents on tree seeds
96-15 Rodent repellents on cables
96-16 Rodent reproductive inhibitors
96-17 Mammalian predacides
96-18 Domestic dog and cat repellents
96-19 Browsing animal repellents
96-30 Methods and protocols
Subdivision M: Biorational Pesticides
(This subdivision duplicates many of the provisions
of other subdivisions, and is therefore not described
in detail. )
Series 150: Overview, Definitions, and General
Provisions
Series 152: Toxicology Guidelines
Subseries 152A: Toxicology Guidelines
Subseries 152B: Toxicology Guidelines for
Microbial Pest Control Agents
Series 154: Nontarget Organism Hazard Guidelines
Subseries 154A: Nontarget Organism Hazard
Guidelines for Biochemical
Agents
Subseries 154B: Nontarget Organism Hazard
Guidelines for Microbial Agents
Series 157: Experimental Use Permit Guidelines
Subdivision N: Environmental Fate
Series 165: Accumulation Studies
165-4 Laboratory Studies of Pesticide
Accumulation in Fish
165-5 Field Accumulation Studies of Aquatic
Nontarget Organisms
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Appendix B
Regulation of Animal Use within
Federal Departments and Agencies
Six Federal departments and four Federal agencies
conduct animal experimentation within Federal facil-
ities, or “intramurally. ” Of those, only the Departments
of Commerce and Transportation, which use few ani-
mals, have no specific guidelines. A seventh Federal
department, the Department of Energy (DOE), conducts
no intramural animal experimentation, but has a pol-
icy on animal experimentation for its extramural con-
tracted work. The other entities all have some type of
policy for intramural use of animals.
Effective December 1986, each Federal research fa-
cility will be required to establish an animal care and
use committee with composition and function as de-
scribed in the 1985 amendments to the Animal Welfare
Act (see ch. 13). Each Federal committee will report
to the head of the Federal entity conducting the animal
experimentation.
Several generalizations can be drawn about the guide-
lines of the Federal entities conducting intramural ani-
mal experimentation. Most policies on proper animal
care and treatment include:
l
l
l
l
l
l
l
adherence to the Animal Welfare Act and to the
Guide for the Care and Use of Laboratory Animals
of the National Institutes of Health (NIH) (26) as well
as the Public Health Service (PHS) Policy on Hu-
mane Care and Use of Laboratory Animals by
Awardee Institutions (see app. C);
an animal care and use committee with at least
three members (the attending veterinarian and two
scientists within the agency);
an attending veterinarian responsible for maintain-
ing the proper animal care standards;
some prior review of protocols and animal species
use, usually accomplished by an animal care and
use committee;
no real mechanism for enforcement of the policy,
with the primary responsibility for maintaining the
proper standards and adhering to agency guide-
lines lying with the individual investigator;
a minimal number of site inspections and no real
oversight mechanism; and
a policy calling for using as few animals as possi-
ble and encouraging the use of alternative meth-
ods wherever feasible.
Some agency policies are noteworthy for additional
provisions intended to promote high standards of ani-
mal care and use:
• NIH requires all animal research committees to in-
clude one member sensitive to bioethical issues and
l
l
l
l
not employed in the same NIH bureau, institute,
or division. This person must be a Federal Govern-
ment employee and so may or may not be a lay-
person. These committees have explicit responsi-
bilities and a detailed administrative structure in
which to carry out duties.
The Ames Research Center of the National Aero-
nautics and Space Administration (NASA) has dem-
onstrated the successful participation of lay com-
mittee members in the consideration of animal
welfare issues: 40 percent of the committee are
laypeople, a format set up at NASA’s instigation.
Since 1971, the Veterans’ Administration (VA) has
required that all facilities using animals seek and ob-
tain accreditation by the American Association for
Accreditation of Laboratory Animal Care (AAALAC).
The VA has a contract with AAALAC covering all
its research facilities, thus prohibiting failure of
accreditation of any constituent facility solely for
financial reasons. The Department of Energy also
requires the facilities of its extramural contractors
to be AAALAC-accredited.
The Department of Defense (DOD) has a policy and
committee distinct from its general animal policy
to ensure proper care and use of nonhuman primates.
The policies at the Food and Drug Administration
(FDA) and the Department of the Interior give a
great deal of flexibility to the research centers to
allow specific policies tailored to the needs and de-
mands of each animal facility. Although this may
have many advantages, it may make the mainte-
nance and monitoring of a standard of care through-
out the agency difficult.
Department of Agriculture
Regulation of animal use in research within the U.S.
Department of Agriculture (USDA) involves adherence
to the Animal Welfare Act and to the NIH Guide (26).
Much of the animal research performed by USDA in-
volves farm animals, which are largely excluded from
these policies. The system of compliance involves peri-
odic checking of intramural research facilities. For ex-
tramural research, no enforcement occurs; hence the
system is largely voluntary and self-regulating (15).
Department of Defense
The general policy on animal use in all Department
of Defense programs is contained in DOD Directive No.
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3216.1, issued by the Deputy Secretary of Defense in
1982. This statement sets policy on the humane treat-
ment and appropriate care of animals used in research
and the responsibilities of different DOD personnel to
carry out the directive. In general, it follows the Ani-
mal Welfare Act and the NIH Guide, along with attempt-
ing to incorporate alternatives to animal use in the form
of replacement, reduction, and refinement. Other, spe-
cial policies treat the general use of nonhuman primates
and prohibit the use of dogs, cats, and nonhuman pri-
mates for developing nuclear weapons. The directive
also requires that all proposals or designs for animal
experiments undergo appropriate animal welfare re-
view to confirm: “I) the need to perform the experi-
ment or demonstration; 2) the adequacy of the design
of the experiment or demonstration; and 3) compliance
with established policy on the use of animals” (20).
Army Regulation 70-18 (a Joint Service regulation)
implements the directive’s policies uniformly for all
DOD components. The authority for enforcing this reg-
ulation is conferred to the Secretary of the Army, who
is required to develop and issue, in consultation with
the other DOD components, regulations implementing
the directive. Army Regulation 70-18 states that all DOD
facilities using animals should seek AAALAC accredi-
tation. Also, it sets up a long chain of responsibilities
for establishing and policing animal welfare policies.
The regulation states that the Under Secretary of De-
fense for Research and Engineering will:” 1) issue pol-
icies and procedural guidance under DOD directive
3216.1, 2) allocate nonhuman primate resources, and
3) designate a veterinarian as the DOD representative
to IRAC [Interagency Research Animal Committee]” (21).
The Surgeon General of each DOD component involved
in animal research must supervise animal use and im-
plement this regulation in each component, establish
a joint working group to identify and conserve non-
human primate resources, and establish and provide
representatives to a joint technical working group that
periodically reviews the care and use of animals in DOD
programs. Finally, the local commander of a facility
must ensure that:
all programs involving animals conform to the
guidelines cited in Army Regulation 70-18;
local animal care and use, procurement, and trans-
portation policies and procedures comply with the
regulation;
animals used or intended to be used will experi-
ence no unnecessary pain, suffering, or stress, and
their use will meet valid DOD requirements;
alternatives to animal species will be used if they
produce scientifically satisfactory results; and
dogs, cats, or nonhuman primates are not used in
research conducted to develop nuclear, biological,
or chemical weapons (21).
Thus, the powers and responsibilities for carrying out
DOD animal welfare policies are decentralized. DOD
does not do any inspections of its facilities. The facil-
ities are required to submit annual reports to USDA
under the regulations implementing the Animal Wel-
fare Act.
The Army regulation builds the institutional review
structure around the local animal care committee. Lo-
cal commanders must form a committee to oversee the
care and use of animals in their facilities. The committ-
tee must have at least three members, including at least
one person not involved in the proposed project and
one veterinarian. The committee reviews: 1) all aspects
of animal care to ensure that established policies, stand-
ards, and regulations are complied with; and 2) all
research protocols and proposals for proper animal wel-
fare policies and good animal experimentation stand-
ards. Sufficient information to do this animal care and
treatment review must be presented with all research
proposals. In addition, proposals that involve experi-
mentation on nonhuman primates are reviewed sepa-
rately by the proper DOD component office (21).
As with other departments in the Federal Govern-
ment, DOD contracts with outside investigators for
some of its research. The DOD extramural animal re-
search policy requires that the same standards outlined
in Army Regulation 70-18 be followed by contractors
in order to receive DOD funds. Assurance is obtained
by written statements from the recipient animal care
committee or other responsible official. An assurance
is also required that the proposal or protocol has been
reviewed and approved by the local animal care and
use committee or by the attending veterinarian (21).
Enforcement of these policies for extramural research
is more difficult than the intramural policy, since in-
vestigators and administrators are not directly respon-
sible to the military line of command.
In addition to DOD-wide policies issued by the Office
of the Secretary, a recommendation is pending in the
Army Medical Research and Development Command
that an Advisory Committee on Animal Welfare be ap-
pointed, including non-DOD representatives, to meet
periodically about concerns related to the use of ani-
mals for research and training purposes (7).
In 1983, the Air Force commissioned an outside re-
view panel to study animal use in its Aerospace Medi-
cal Division. The panel looked at Brooks Air Force Base
(San Antonio, TX) and Wright -Patterson Air Force Base
(Dayton, OH), which together account for 95 percent
of the service’s animal use. The panel found the cur-
rent policy in place to be satisfactory and was (17):
... impressed with the thoroughness and genuine con-
cern of all those involved to ensure that appropriate
measures are taken to effect proper care and use of
animals. Furthermore, there was a clear emphasis on
selection of alternatives to animal use where feasible.
Excellent progress was shown in the use of simulation
models for a variety of radiation and toxicological
studies.
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The panel did note that the system of care and treat-
ment policies was too informal and based on the cur-
rent personnel; it was unconvinced the system would
remain in place if staff were transferred. The Aero-
space Medical Division of the Air Force drafted a Sup-
plement to Army Regulation 70-18 to implement some
of the review panel’s recommendations. The most sub-
stantial change deals with the animal care and use com-
mittee membership (21):
The local commander will appoint at least one lay
person from the local community who has no direct
Department of Defense connections to serve as a mem-
ber of the Committee. This lay member should not be
a veterinarian or research scientist who works with
animals; however, a background in sciences would be
helpful. The Committee may have permanent or ad hoc
membership. Its specific purpose is to review all pro-
tocols, experimental designs, or lesson plans that in-
volve the use of animals and assure compliance with
[DOD policy].
The Air Force Supplement to Army Regulation 70-18
also requires that each organization using animals sub-
mit not just the Annual Report of Research Facility of
USDA’s Animal and Plant Health Inspection Service
(APHIS), but also an Annual Animal Use Report, listing
all species used, the inventory at the beginning of the
year, additions and losses to the facility, the ending in-
ventory, the utilization of the animals, the different ex-
perimental situations, and the projected use of animals
for the next fiscal year (18).
Department of Energy
The Department of Energy has no intramural re-
search facilities and so contracts for all its research.
The division involved with animals is the Office of
Health and Environmental Research (OHER); programs
involving research with animals represented less than
15 percent of OHER’s total research budget for fiscal
year 1985 (5), Proposals for OHER-funded research are
subjected to outside peer review for scientific merit. An
OHER research committee from the Office’s four divi-
sions has final approval before funding a research
proposal.
The OHER policy for animal use by its extramural
contractors places the prime responsibility for the main-
tenance of animal facilities and for animal care on the
contractor. OHER contract research facilities are bound
by law to comply with the Animal Welfare Act and its
regulatory policies, and OHER personnel maintain close
liaison to assure such compliance. In addition, the IRAC
principles are part of the OHER policy statement, along
with the requirement to maintain AAALAC accredita-
tion (5),
To enforce these policies, one OHER staff member
has responsibility for monitoring animal research pro-
grams for compliance. This staff member must main-
tain contact with the research facilities to assure ac-
creditation and to affirm, at least yearly, that it is being
maintained. Site visits with at least one noncontract
veterinarian who is an expert in laboratory-animal care
may be conducted to evaluate the care and treatment
of experimental animals (5,6).
Department of Health and
Human Services
Food and Drug Administration
The Food and Drug Administration has recently
played a major role in attempting to address animal
welfare issues. In 1983, the agency took two steps in
this direction by sponsoring an acute studies workshop
and by establishing an Agency Steering Committee on
Animal Welfare Issues.
The workshop helped clarify FDA’s position on its
need for toxicity data, especially from the LD50 test.
The points emerging from the workshop were that:
FDA had no regulations mandating use of the LD5O
test;
the requirement by Federal agencies for LD5O data
from regulated parties was much less than per-
ceived by the public;
government and industry agreed that there are bet-
ter determinants of acute toxicity than the LD5O
test and that they supported developing valid alter-
natives to the use of animals for testing chemicals;
U.S. Government agencies are cooperating with
other countries through organizations like the
Organization for Economic Cooperation and De-
velopment; and
improvements in the way animals are used for tox -
icity testing can and should be made administra-
tively rather than through legislation (1,22).
The steering committee, which in part grew out of
the acute studies workshop, found several FDA refer-
ences to the LD5O that could be misinterpreted as re-
quirements to perform the test, and one involving three
antitumor antibiotics where the requirement still ex-
isted (in contrast to the workshop findings). Its 1984
report states that, in all these instances (except for the
antitumor antibiotics), regulations and guidelines are
being rewritten to resolve any misunderstandings.
They will then reflect the position of FDA that “the use
of this test should be avoided except for those rare sit-
uations where no alternative exists. ” In the case of the
antitumor antibiotics, FDA is considering eliminating
the requirement (23).
Addressing five specific considerations, all part of its
investigation of agency testing guidelines and practices
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to answer questions raised at the acute studies work-
shop, the steering committee concluded that:
l
l
l
l
l
FDA practices and procedures are designed to ob-
tain the maximum amount of data from the mini-
mum number of animals;
despite general references to the use of LD5O tests,
FDA has no requirements for LD5O data obtained
by using the classical, statistically precise test, ex-
cept for batch release toxicity tests of three anti-
tumor antibiotics;
there are many alternative tests being studied and
developed throughout FDA;
practices and procedures for assuring humane
care and treatment of animals are agency-wide;
and
FDA has a number of regular channels of commu-
nication to industry, consumers, and the private
sector in general and efforts to improve commu-
nication channels will continue (23).
The steering committee recommended workshops
on acute toxicity studies throughout the agency, on the
use of in vitro alternatives by various centers, and on
agency and PHS practices and procedures for the care
and handling of animals. The recommendations also
called for the establishment of an agency-wide animal
welfare committee (23). FDA is now setting up two in-
house workshops to address the first two topics (l).
Furthermore, it has established a Research Animal
Council to see that the recommendations of the report
are carried out, to consider animal research issues at
FDA in a broad context, and to serve as an oversight
committee for individual FDA centers. FDA’s Research
Animal Council began meeting quarterly in 1984 and
will report to the Commissioner; its membership in-
cludes one representative from each of the centers
within FDA (3).
FDA policies on humane animal care and treatment
require compliance with the Animal Welfare Act as well
as with other standards for humane care and use of
animals. The steering committee report found that all
centers have acceptable procedures, but that they var-
ied in specific details. The centers conduct different
amounts of research and testing; some have more for-
mal procedures than others and stronger veterinary
staff capabilities. Accreditation by AAALAC is sought
on a voluntary basis, and two of FDA animal facilities,
the National Center for Toxicological Research (NCTR)
and the Center for Drugs and Biologics of the Office
of Biologics Research and Review, are fully accredited
(23).
The policies and procedures in place at the National
Center for Toxicological Research (Jefferson, AR) are
a good example of FDA system for addressing animal
welfare issues, since NCTR is the primary animal re-
search facility within FDA (24):
The policy of NCTR management is to use labora-
tory animals under practical and reasonable conditions
of humane treatment, in carefully planned experiments
with in vitro methodologies balanced against minimally
required test species numbers in in vivo bioassays, and
via procedures set forth in national standards and
guidelines.
The Director of NCTR has primary responsibility for
assuring compliance with the policy but delegates some
aspects of that control. The duties of the Senior Scien-
tists in NCTR’s Office of Research include technical over-
view of animal use, strain selection, genetic quality con-
trol, state-of -the-art reviews, and recommendations for
adopting new concepts in animal care and control. The
Director of the Division of Animal Husbandry is respon-
sible for breeding-colony operations, animal produc-
tion and laboratory-animal care in NCTR’s various hold-
ing areas, and quarantine procedures (25). The animal
care committee has adopted an “Animal Use Form for
Experimental Protocols” and requires every investiga-
tor using animals to provide the committee with detailed
information for evaluation (23). Finally, the Director
has set up ad hoc committees of in-house personnel
to evaluate specific areas of animal care, such as change
in feed for the facility (1,24).
The FDA policy on extramural research requires ad-
herence by awardee institutions to the PHS policy and
procedures (23):
This includes (1) having in place a program of animal
care which meets federal and Department standards,
(2) providing, through AAALAC accreditation or de-
fined self-assessment procedures, assurance of institu-
tional conformance, and (3) maintaining an animal
research committee to provide oversight of the insti-
tution’s animal program, facilities and associated
activities.
National Institutes of Health
NIH has a specific animal care and use program for
intramural research and for research within NIH-
controlled space (25). The NIH policy requires individ-
ual investigators to adhere to the NIH Guide. In addi-
tion, each bureau, institute, or division (BID) is encour-
aged to pursue accreditation of its animal facilities by
either AAALAC or any other NIH-approved accrediting
body (at present AAALAC is the sole body) and to re-
port its accreditation status each year to the Deputy
Director, who ensures compliance with the policy by
each BID.
The NIH policy delegates responsibility to five differ-
ent authorities, including two types of committees. The
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first is the local BID Animal Research Committee (ARC).
This committee must have at least five Federal Govern-
ment employees; the BID Scientific Director is respon-
sible for annual appointments of the chairperson and
members and for carrying out the committee’s recom-
mendations. Included among the five ARC members
must be the attending veterinarian on the BID staff,
a tenured investigator representing laboratories and
divisions that use animals, and “a person who is sensi-
tive to bioethical issues, does not possess an advanced
degree in one of the life sciences, and is an employee
from outside that BID” (26).
The NIH policy gives the BID ARCS many specific
responsibilities beyond the general duties of many such
committees. As with other local animal care commit-
tees, each ARC is required to make recommendations
on animal care matters to its Scientific Director and
to review proposals and protocols for humane stand-
ards of animal care. It is also supposed to advise indi-
viduals on the BID’s policies and oversee their imple-
mentation within the facility, The major specific duties
of the ARC are:
l
l
l
l
l
to hold quarterly meetings at which a majority of
the ARC members are present;
to maintain a file of all minutes, memorandums,
waivers, and project review documents;
to perform site visits of each facility within the BID
at least annually to assess compliance, and to sub-
mit written reports on these inspections to the
Scientific Director;
to develop a plan for attaining accreditation of the
animal facilities or for pursuing accreditation
standards; and
to prepare an annual report for the NIH Deputy
Director for Intramural Research addressing prob-
lems and accomplishments related to attaining ac-
creditation.
Individual investigators are responsible for submit-
ting appropriate information needed for ARC review
of a proposal, advising the ARC chairperson of any sig-
nificant deviations from procedures described in the
most recent project review, and ensuring that all per-
sonnel working directly with animals have been trained
in the proper care and use of that species. Thus, the
system puts much of the burden for proper animal care
during an experiment on each investigator.
The second authority set up by the NIH intramural
policy was the NIH Animal Research Committee
(NIHARC). Committee members are appointed annu-
ally by the Deputy Director for Intramural Research
and must include a veterinarian, the chairperson from
each BID ARC, and a nonaffiliated member. NIHARC
holds quarterly meetings, advises the Deputy Director
on animal care and use at NIH, discusses issues referred
from the BID ARCS, develops and coordinates training
programs for NIH employees on animal care and use,
and prepares NIH’s Annual Report of Research Facility
for USDA.
Department of the Interior
The Department of the Interior does more than 95
percent of its research in-house. All research and de-
velopment facilities must comply with both the Ani-
mal Welfare Act and with the Department Research
and Development Policy Procedures Handbook (27),
which calls for an approved animal welfare plan. The
National Wildlife Health Laboratory (NWHL) must pro-
vide assistance upon request in the development, im-
plementation, and maintenance of each program. Due
to the diversity of the research programs and the
uniqueness of the species involved, each facility is al-
lowed to develop an animal welfare plan peculiar to
its own needs as long as it is approved by NWHL.
Each division plan must discuss:
l
l
l
l
l
l
l
persons responsible for compliance;
reporting and recordkeeping procedures for ani-
mals used;
all components of the Animal Welfare Act and the
Department animal health and husbandry stand-
ards that cannot be complied with, due either to
the general design of anticipated studies or the
unique natural requirements of the species in-
volved;
quarantine procedures for exotic species;
personnel health monitoring and disease preven-
tion programs;
a schedule for periodic onsite evaluations by the
NWHL Veterinary Medical Officer; and
procedures for handling carcasses following un-
expected mortalities (27).
The NWHL Veterinary Medical Officer oversees en-
forcement of these policies.
Consumer Product Safety
Commission
The Consumer product Safety Commission (CPSC),
as part of its mission to enforce the labeling require-
ments of the Federal Hazardous Substances Act (FHSA)
(see ch. 7), conducts its own oral acute toxicity studies
to determine the toxic potential of regulated substances.
If the demand for testing exceeds the capacity of the
CPSC’s Health Sciences Laboratory Division, the agency
contracts with FDA’s NCTR (13).
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In addition to requiring its own personnel, contract-
ing agencies, and regulated parties to observe the re-
quirements of the Animal Welfare Act and the NIH
Guide in performing required safety tests on animals,
CPSC has published an Animal Testing Policy, “which
is intended to reduce the number of animals tested to
determine hazards associated with household products
and to reduce any pain that might be associated with
such testing” (49 FR 22522). The policy states that CPSC
itself and manufacturers of substances covered by the
FHSA “should wherever possible utilize existing alter-
natives to conducting animal testing [including] prior
human experience, literature sources which record
prior animal testing or limited human tests, and expert
opinion. ”
Citing the provision in FHSA regulations that gives
preference to studies based on humans over those with
animals, the policy states that CPSC “resorts to animal
testing only when the other information sources have
been exhausted. ” It also states that:
l
l
l
“limit” tests for acute toxicity studies, rather than
the “classic” LD5O, are performed when necessary,
requiring fewer animals;
eye irritancy testing is not performed if the test
substance is a known skin irritant; and
agency-required Draize (eye irritation) tests are
modified to eliminate the need for restraining test
rabbits, allowing them full mobility and access to
food and water (49 FR 22522).
Environmental Protection Agency
The guidelines and policies that the Environmental
Protection Agency (EPA) follows governing humane
treatment and appropriate veterinary care for labora-
tory animals involve AAALAC accreditation for its two
major laboratories, adherence to the NIH Guide, and
adherence to the Animal Welfare Act. In addition, EPA
has an intra-agency committee that oversees animal re-
search issues. There is no separate policy for extramural
research; NIH Guide principles and requisites are en-
forced in such cases by a signed statement from the
investigator that the proper animal care is being ob-
served (16).
The EPA facility at Research Triangle Park, NC, has
an animal care committee that oversees and carries out
an institutional review of animal care and welfare is-
sues. The committee is composed of representatives
of the different research divisions within that facility
along with the attending veterinarian. Its 8 to 10 mem-
bers, who meet approximately once a month and keep
records of their proceedings, are responsible for ani-
mal care issues only, and do not conduct scientific re-
views of research proposals, Scientific review is done
separately before proposals reach the committee. The
overall responsibilities for the committee are to:
l oversee the functioning of the animal care facility,
l plan improvements for the facility and carry them
out ,
• set policy for humane treatment of animals,
l set policy for sharing facility resources,
l address any day-to-day animal care problems
brought to its attention, and
l review proposals for appropriate animal use and
care (2).
In addition, the committee can recommend experi-
mental changes to improve animal care and treatment
and has the authority to interrupt or terminate an ex-
periment if it finds any instances of inhumane treat-
ment or inappropriate care of the animals, a step that
has been taken at least once since the committee was
established (2).
The committee does not monitor experiments while
in progress or handle the day-to-day activities of the
animal care facility. These powers are delegated to the
attending veterinarian (who is under contract with EPA
to work at the facility 3 days a week) and a staff of ap-
proximately 20 (2).
National Aeronautics and Space
Administration
The overall National Aeronautics and Space Admin-
istration policy on animal research is based on the Ani-
mal Welfare Act, the NIH Guide, and the IRAC princi-
ples. All NASA facilities, all users of NASA facilities,
aircraft, or spacecraft, and all NASA contractors using
animals are subject to this policy. The overriding phi-
losophy of the policy is based on three principles:
l
l
l
Animals will be used only to answer valid ques-
tions that improve the health, welfare, or general
medical and scientific knowledge of humans.
Experimental animals must not be subject to avoid-
able discomfort or distress.
Experiments requiring the use of invasive proce-
dures without benefit of anesthetic agents demand
strong justification and attention to possible alter-
natives (12).
Although the NASA policy exists today as only a pro-
posed NASA Management Instruction (NMI), it is already
being implemented. For example, the NMI establishes
an Animal Care and Use Committee (ACUC) in each
facility with animals (12); the committee includes a
research veterinarian, a biomedical scientist, a non-
scientist, and a person not affiliated with NASA. It is
responsible for overseeing the animal care facility,
establishing specific guidelines, reviewing proposals,
and making recommendations for approval or dis-
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approval of funding (9). The committee must ask the
following questions for each experiment (12):
l Will the minimum possible number of animals be
used?
l Is the use of animals necessary in this experiment?
l Are provisions for care of these animals adequate?
Different compliance with these policies is needed
for intramural versus extramural research. For NASA
facilities, ACUC reports are required to be sent to the
Director of the Life Sciences Division at NASA head-
quarters reviewing facility procedures. AAALAC accred-
itation is required for all NASA installations. Currently
all facilities are moving toward AAALAC accreditation
but have not yet obtained it (12). For extramural re-
search, the institution must submit a written assurance
that its animal care policies are equivalent to the NASA
policy. (AAALAC accreditation is one way of showing
compliance. ) Noncompliance will result in termination
of the research by the ACUC and possibly sanctions
after review by the Director of the Life Sciences Divi-
sion (19).
The Ames Research Center (Moffett Field, CA), NASA’s
primary center for nonhuman research, illustrates the
implementation of NASA policy. The Ames Research
Center has established the Animal Users Guide for
Ames-sponsored laboratory experiments using animals.
This guide sets up two entities to ensure that all legal
requirements are met: The animal care facility is re-
sponsible for housing and maintaining the animals prop-
erly, and the animal care and use committee must mon-
itor all animal care and experimentation progress at
the center. In addition, the guide states (28):
EVERY RESEARCH SCIENTIST AND ALL RESEARCH
PERSONNEL, CONTRACTORS, AND GRANTEES ARE
RESPONSIBLE FOR OBSERVING THE LEGAL REQUIRE-
MENTS CONCERNING LABORATORY ANIMALS.
The Ames committee reports to the center’s Direc-
tor of Life Sciences and is responsible for:
l reviewing the use of animals in proposed and on-
going experiments;
l reviewing all animal experimentation performed
by contractors or grantees;
l serving as an advisory committee on all questions
of animal care and use, and as a forum for resolv-
ing differences that may occur; and
l reviewing animal-related inventions and devices
(28).
At present, the Ames committee has 10 members—4
non-NASA, non-life-sciences laypersons; 1 veterinarian;
1 scientist-veterinarian; 1 engineer; 2 scientists; and 1
science manager. In addition, 2 veterinarians accred-
ited in Laboratory Animal Medicine are advisors. The
lay members include an attorney, a professor of relig-
ion (ethics), the chairman of the Department of Educa-
tion at a local college, and the public relations director
of the Santa Clara Valley Humane Society. This is one
of the few such committees in the country with a 40
percent lay membership. According to the Acting Di-
rector of Life Sciences at Ames Research Center, “the
out -of -house members have contributed materially to
the [committee].” Two of the lay members head sub-
committees that are reviewing and updating the Ani-
mal Users Guide and committee charter and develop-
ing an animal user’s orientation program (14).
National Science Foundation
A summary of the animal care requirements of the
National Science Foundation (NSF) is found in Section
713 of the NSF Grant Policy Manual (30) and included
in the NSF document “Grant General Conditions, ” that
is sent to each grantee when an award is made. Any
grantee performing research on warm-blooded animals
must comply with the Animal Welfare Act and its reg-
ulations and follow the NIH Guide. NSF has no formal
inspection system to check on compliance with these
policies, as that is judged to be the responsibility of
USDA/APHIS (8). The result is a voluntary adherence
system by NSF grantees,
Beginning in 1986, NSF imposed two new require-
ments on grant applicants and grantees who perform
research on vertebrate animals:
l Each proposal must be reviewed by an institutional
animal care and use committee.
l Each proposal must be accompanied by a statement
from the grantee that assures the grantee’s com-
pliance with the PHS policy.
Grant proposals submitted to NSF thus face three sep-
arate reviews-one by the grantee’s institutional com-
mittee, one by outside reviewers, and one by NSF staff.
Although these are primarily scientific in nature,
reviewers are asked to comment on animal welfare is-
sues. If a proposal involves the use of animals, suffi-
cient information must be provided to allow evalua-
tion of the appropriateness of experimental protocols
with respect to the choice of species, the number of
animals to be used, and any necessary exposure of ani-
mals to discomfort, pain, or injury (29). With this infor-
mation, the reviewers are asked to (29):
. . . comment if you have any concerns regarding the
violation of animal welfare laws or guidelines, the ex-
posure of animals to unnecessary pain or mistreatment,
or the use of excessive numbers of animals. If the spe-
cies being used is not the one most appropriate, or if
alternative or adjunct methods could be used to elimi-
nate or reduce the need for animal experimentation,
please comment.
Veterans’ Administration
The Veterans’ Administration is unique in its policies
governing humane treatment and appropriate veteri-
— .
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nary care for laboratory animals because it has required
all its facilities using animals to seek and obtain AAALAC
accreditation (see ch. 15). This policy was originated
in 1971, and 81 out of 174 VA facilities (as of Apr. 1,
198.5) had some level of AAALAC accreditation. Not all
VA constituents apply for accreditation, since some do
not engage in animal research. In fact, the VA has a
contract with AAALAC covering all its research facil-
ities that prohibits failure of accreditation of any con-
stituent facility solely for financial reasons (10).
In addition to requiring adherence to the PHS policy,
the VA has a lengthy research review process with a
strong committee structure. At the local research fa-
cility, each research and development committee has
a subcommittee for animal studies that oversees all such
research. The membership varies, though it includes
at least one member of the research and development
committee, a Veterinary Medical Officer (VA employee),
and two to four investigators who are involved in
studies using animals. Thus, there are no laypersons
or persons not affiliated with the research facility on
the subcommittee. Except for the veterinarian, who
serves indefinitely, members serve 3-year terms (31).
The subcommittee has three primary functions:
l
l
l
to approve the use or uses made of animal sub-
jects in all research studies as they relate to animal
welfare laws, regulations, and policies;
to review all animal studies for need, adequacy,
and availability of essential animal research facil-
ity support; for the appropriateness, quality, and
availability of the animal models; for the humane-
ness and appropriateness of procedures and con-
ditions surrounding animal subjects before and
throughout the study; and
to evaluate, at least annually, the animal research
facility and recommend appropriate actions to cor-
rect deficiencies noted (11).
Proposals are reviewed again at a regional VA office
by two committees, first for veterinary medical review
(appropriate use and care of animals) and then for scien-
tific merit (10). The animal welfare review is done by
a Veterinary Medical Panel of specialists chosen for
their experience, knowledge, and research in labora-
tory-animal science and medicine. This panel attempts
“to assure that proposals include sound, acceptable ani-
mal medicine and husbandry practices in animal re-
search facilities that are operated in conformance with
all pertinent animal welfare laws, regulations, and pol-
icies” (11). Specifically, the panel conducts reviews:
l to ascertain the description of the animal model;
l to ascertain the biological and medical definition
of the animal model;
• to ascertain the environmental and experimental-
animal-related factors;
l to determine if there is evidence of adequate ex-
perience with the proposed technology of manipu-
lations, monitoring, or measuring;
l to determine if use of intact animals is required
or if animal parts could be obtained from or shared
with other investigators who have scientifically
compatible studies;
l to determine if painful procedures are involved
and whether these can be avoided or if their con-
trol has been satisfactorily planned; and
l to relate the budget of the experiment to the ani-
mal costs and to the animal maintenance needs (11).
In 1984, the VA required that all research proposals
have an appendix with a detailed discussion of animal
protocols, the number of animals to be used, and why
the specific choice of organism was made. This appen-
dix is signed by three people from the local facility–
the researcher, the animal committee chairperson, and
the research and development chairperson—to guar-
antee that the procedures are carried out.
The enforcement of the VA’s animal research pol-
icies rests with the committee structure and is over-
seen by the Chief Veterinary Medical Officer for the
VA, whose duties include making sure all Federal and
State animal research laws are observed and that the
individual facilities have the funds to continue to re-
main AAALAC-accredited. In addition, the VA began
in fiscal year 1984 strict enforcement of the comple-
tion of the Annual Reports of Animal Research Facil-
ities for APHIS by every VA facility, whether the facil-
ity used animals in research the preceding year or not
(lo).
At the local VA facilities, the attending veterinarian
has authority for veterinary medical matters. This per-
son must monitor the housing, general treatment, and
care of the experimental animals while the experiment
is in progress as often as needed. If inhumane treat-
ment or inappropriate care is found, the veterinarian
and animal subcommittee do not have the authority
to interrupt or terminate an experiment. The subcom-
mittee would make a recommendation to the research
and development committee and to the Associate Chief
of Staff for Research and Development, who may make
a decision or a recommendation to the Director (4). This
means there is some enforcement of the proper ani-
mal care standards at each local VA facility on a day-to-
day basis.
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Appendix C
Public Health Service Policy on
Humane Care and Use of Laboratory
Animals by Awardee Institutions
The following is reprinted from U.S. Department of
Health and Human Services, Public Health Service, Na-
tional Institutes of Health, “Laboratory Animal Wel-
fare, ” NIH Guide for Grants and Contracts 14(8), June
2.5, 1985.
Introduction
It is the policy of the Public Health Service (PHS) to
require institutions to establish and maintain proper
measures to ensure the appropriate care and use of
all animals involved in research, research training and
biological testing activities (hereinafter referred to as
activities) supported by the PHS. The PHS endorses
the “U.S. Government Principles for the Utilization and
Care of Vertebrate Animals Used in Testing, Research
and Training” developed by the Interagency Research
Animal Committee (IRAC). This policy is intended to
implement and supplement those Principles.
Applicability
This policy is applicable to all PHS-approved activities
involving animals, whether the activities are performed
at an awardee institution or any other institution and
conducted in the United States, the Commonwealth
of Puerto Rico, or any territory or possession of the
United States. Institutions in foreign countries receiv-
ing PHS support for activities involving animals shall
comply with this policy, or provide evidence to the
PHS that acceptable standards for humane care and
use of the animals in PHS-supported activities will be
met, No PHS support for an activity involving animals
will be provided to an individual unless that individ-
ual is affiliated with or sponsored by an institution
which can and does assume responsibility for compli-
ance with this policy for PHS-supported activities, or
unless the individual makes other arrangements with
the PHS. This policy does not affect applicable state
or local laws or regulations which impose more strin-
gent standards for the care and use of laboratory ani-
mals. All institutions are required to comply, as appli-
cable, with the Animal Welfare Act, and other Federal
statutes and regulations relating to animals.
A.
B.
c.
D.
E.
F.
G.
H.
Definitions
Animal
Any live, vertebrate animal used or intended for
use in research, research training, experimenta-
tion or biological testing or for related purposes.
Animal Facility
Any and all buildings, rooms, areas, enclosures,
or vehicles, including satellite facilities, used for
animal confinement, transport, maintenance, breed-
ing or experiments inclusive of surgical manipula-
tion. A satellite facility is any containment outside
of a core facility or centrally designated or man-
aged area in which animals are housed for more
than 24 hours.
Animal Welfare Act
Public Law 89-544, 1966, as amended, (P.L. 91-
579 and P.L. 94-279) 7 U.S.C. 2131 et seq. Imple-
menting regulations are published in the Code of
Federal Regulations (CFR), Title 9, Subchapter A,
Parts 1, 2, 3 and 4, and are administered by the
U.S. Department of Agriculture.
Animal Welfare Assurance or Assurance
The documentation from an awardee or a pro-
spective awardee institution assuring institutional
compliance with this policy.
Guide
Guide for the Care and Use of Laboratory Ani-
mals, DHEW, NIH Pub. No, 78-23, 1978 edition or
succeeding revised editions.
Institution
Any public or private organization, business, or
agency (including components of Federal, state and
local governments).
Institutional Official
An individual who has the authority to sign the
institution’s Assurance, making a commitment on
behalf of the institution that the requirements of
this policy will be met.
Public Health Service
The Public Health Service includes the Alcohol,
Drug Abuse, and Mental Health Administration, the
Centers for Disease Control, the Food and Drug
Administration, the Health Resources and Services
Administration, and the National Institutes of
Health.
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I. Quorum
A majority of the members of the Institutional
Animal Care and Use Committee.
Implementation by Awardee
Institutions
A. Animal Welfare Assurance
No activity involving animals will be supported
by the PHS until the institution conducting the ac-
tivity has provided a written Assurance acceptable
to the PHS, setting forth compliance with this pol-
icy for PHS-supported activities. Assurances shall
be submitted to the Office for Protection from Re-
search Risks (OPRR), Office of the Director, Na-
tional Institutes of Health, 9000 Rockville Pike,
Building 31, Room 4B09, Bethesda, Maryland 20205.
The Assurance shall be typed on the institution’s
letterhead and signed by an institutional official.
OPRR will provide the applicant institution with
necessary instructions and an example of an ac-
ceptable Assurance. All Assurances submitted to
the PHS in accordance with this policy will be
evaluated by OPRR to determine the adequacy of
the institution’s proposed program for the care and
use of animals in PHS-supported activities. On the
basis of this evaluation OPRR may approve or dis-
approve the Assurance, or negotiate an approva-
ble Assurance with the institution. Approval of an
Assurance will be for a specified period of time (no
longer than five years) after which time the insti-
tution must submit a new Assurance to OPRR.
OPRR may limit the period during which any par-
ticular approved Assurance shall remain effective
or otherwise condition, restrict, or withdraw ap-
proval. Without an applicable PHS approved Assur-
ance no PHS-supported activity involving animals
at the institution will be permitted to continue.
1. Institutional Program for Animal
Care and Use
The Assurance shall fully describe the insti-
tution’s program for the care and use of animals
in PHS-supported activities. The PHS requires in-
stitutions to use the Guide for the Care and Use
of Laboratory Animals (Guide) as a basis for de-
veloping and implementing an institutional pro-
gram for activities involving animals. The pro-
gram description must include the following:
a, a list of every branch and major component
of the institution, as well as a list of every
branch and major component of any other in-
stitution which is to be included under the As-
surance;
b. the lines of authority and responsibility for ad-
ministering the program and ensuring com-
pliance with this policy;
c. the qualifications, authority and responsibil-
ity of the veterinarian(s) who will participate
in the program;
d. the membership list of the Institutional Ani-
mal Care and Use Committee (IACUC) es-
tablished in accordance with the require-
ments set forth in IV.A.3.;
e. the procedures which the IACUC will follow
to fulfill the requirements set forth in IV. B.;
f. the health program for personnel who work
in laboratory animal facilities or have frequent
contact with animals;
g. the gross square footage of each animal facil-
ity (including satellite facilities), the species
housed therein and the average daily inven-
tory, by species, of animals in each facility;
and
h. any other pertinent information requested by
OPRR.
2. Institutional Status
Each institution must assure that its program
and facilities are in one of the following cate-
gories:
• Category l—Accredited by the American Asso-
ciation for the Accreditation of Laboratory
Animal Care (AAALAC). All of the institution’s
programs and facilities (including satellite fa-
cilities) for activities involving animals have
been evaluated and accredited by AAALAC,
or other accrediting body recognized by PHS.2
l Category 2—Evaluated by the Institution. All
of the institution’s programs and facilities (in-
cluding satellite facilities) for activities involv-
ing animals have been evaluated by the IACUC
and will be reevaluated by the IACUC at least
once each year. The IACUC shall use the Guide
for the Care and Use of Laboratory Animals
as a basis for evaluating the institution’s pro-
gram and facilities. A report of the IACUC
evaluation shall be submitted to the institu-
tional official and updated on an annual ba-
sis.3 The initial report shall be submitted to
IThe  name Institutional Animal Care and Use Committee ([ AC UC) M used
in this policv is intended as a generic term for a committee whose function
is to ensure that the care and use of animals in PHS-supported  activities is
appropriate and humane in accordance with this policy. Howe\,er,  each in.
stitution  may identify the committee by whatever name it chooses. Member-
ship and responsibilities of the IACLJC are set forth in IL’.A,3 and It’  B.
‘As of the issuance date of this policy the only accrediting body recognized
by PHS  is the American Association for Accreditation of Laboratory)’ .Animal
Care (AAA1.AC).
3The IACUC  may, at its discretion, determine the best means of conduct-
ing an evaluation of the institution’s programs and facilities. The IACUC  may
invite ad hoc consultants to conduct or assist in conducting the evaluation.
However, the 1.4CL1C remains responsible for the evaluation and report.
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OPRR with the Assurance. Annual reports of
the IACUC evaluation shall be maintained by
the institution and made available to OPRR
upon request. The report must contain a
description of the nature and extent of the in-
stitution’s adherence to the Guide and this pol-
icy.4 The report must identify specifically any
departures from provisions of the Guide and
this policy, and state the reasons for each
departure, If program or facility deficiencies
are noted, the report must contain a reason-
able and specific plan and schedule for cor-
recting each deficiency. The report must dis-
tinguish significant deficiencies from minor
deficiencies. A significant deficiency is one
which, in the judgment of the IACUC and the
institutional official, is or may be a threat to
the health or safety of the animals. Failure of
the IACUC to conduct an annual evaluation
and submit the required report to the institu-
tional official may result in PHS withdrawal
of its approval of the Assurance.
3. Institutional Animal Care and Use Committee
(IACUC)
a. Each institution shall appoint an Institutional
Animal Care and Use Committee (IACUC),
qualified through the experience and exper-
tise of its members to oversee the institution’s
animal program, facilities and procedures.
b. The Assurance must include the names, posi-
tion titles and credentials of the IACUC chair-
person and the members. The committee shall
consist of not less than five members, and shall
include at least:
(1) one Doctor of Veterinary Medicine, with
training or experience in laboratory animal
science and medicine, who has direct or
delegated program responsibility for activ-
ities involving animals at the institution;
(2) one practicing scientist experienced in re-
search involving animals;
(3) One member whose primary concerns are
in a nonscientific area (for example, ethi-
cist, lawyer, member of the clergy); and
(4) one individual who is not affiliated with the
institution in any way other than as a mem-
ber of the IACUC, and is not a member of
the immediate family of a person who is af-
filiated with the institution.
c. An individual who meets the requirements of
more than one of the categories detailed in
—.————
41f  some of the institution’s facilities are accredited b}r AAAI,AC  or other
accrediting body recognized by PHS,  the report should” identify those facil-
ities and need not contain any further information about e~,aluation  of those
facilities
IV. A.3.b. (1)-(4) may fulfill more than one re-
quirement, However, no committee may con-
sist of less than five members,
B. Functions of the Institutional Animal Care and Use
Committee
As an agent of the institution the IACUC shall,
with respect to PHS-supported activities:
1. review at least annually the institution’s program
for humane care and use of animals;
2. inspect at least annually all of the institution’s
animal facilities, including satellite facilities;
3. review concerns involving the care and use of
animals at the institution;
4. make recommendations to the institutional offi-
cial regarding any aspect of the institution’s ani-
mal program, facilities or personnel training;
5. review and approve, require modifications in (to
6
7.
secure approval) or withhold approval of those
sections of PHS applications or proposals related
to the care and use of animals as specified in
IV.C.;
review and approve, require modifications in (to
secure approval), or withhold approval of pro-
posed significant changes regarding the use of
animals in ongoing activities; and
be authorized to suspend an activity involving
animals in accord with specifications set forth
in IV.C.5.
C. Review of PHS Applications and Proposals
I. In order to approve applications and proposals
or proposed significant changes in ongoing activ-
ities, the IACUC shall conduct a review of those
sections related to the care and use of animals
and determine that the proposed activities are
in accord with this policy. In making this deter-
mination, the IACUC shall confirm that the activ-
ity will be conducted in accord with the Animal
Welfare Act insofar as it applies to the activity,
and that the activity is consistent with the Guide
unless acceptable justification for a departure is
presented. Further, the IACUC shall determine
that the activity conforms with the institution’s
Assurance and meets the following requirements:
a. Procedures with animals will avoid or mini-
mize discomfort, distress and pain to the ani-
mals, consistent with sound research design.
b. Procedures that may cause more than momen-
tary or slight pain or distress to the animals
will be performed with appropriate sedation,
analgesia, or anesthesia, unless the procedure
is justified for scientific reasons in writing by
the investigator.
c. Animals that would otherwise experience se-
vere or chronic pain or distress that cannot
be relieved will be painlessly sacrificed at the
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end of the procedure or, if appropriate, dur-
ing the procedure.
d. The living conditions of animals will be appro-
priate for their species and contribute to their
health and comfort. The housing, feeding and
nonmedical care of the animals will be di-
rected by a veterinarian or other scientist
trained and experienced in the proper care,
handling and use of the species being main-
tained or studied.
e. Medical care for animals will be available and
provided as necessary by a qualified veteri-
narian.
f. Personnel conducting procedures on the spe-
cies being maintained or studied will be appro-
priately qualified and trained in those pro-
cedures.
g. Methods of euthanasia used will be consistent
with the recommendations of the American
Veterinary Medical Association (AVMA) Panel
on Euthanasia,s unless a deviation is justified
for scientific reasons in writing by the inves-
tigator.
2. Prior to the review, each IACUC member shall
be provided with a list of applications and pro-
posals to be reviewed, Those sections of appli-
cations and proposals that relate to the care and
use of animals shall be available to all IACUC
members, and any member of the IACUC may
upon request obtain full committee review of
those sections, If full committee review is not re-
quested, at least one member of the IACUC, des-
ignated by the chairperson and qualified to con-
duct the review, shall review those sections and
have the authority to approve, require modifi-
cations in (to secure approval) or request full
committee review of those sections. If full com-
mittee review is requested, approval of those sec-
tions may be granted only after review at a con-
vened meeting of a quorum of the IACUC and
with the approval vote of a majority of the quo-
rum present. No member may participate in the
IACUC review or approval of an application or
proposal in which the member has a conflicting
interest (e.g., is personally involved in the
project), except to provide information requested
by the IACUC; nor may a member who has a
conflicting interest contribute to the constitution
of a quorum.
3. The IACUC may invite consultants to assist in the
review of complex issues. Consultants may not
‘Journal of the American Veterinary Medical Association (JAVMA),  1978,
Vol. 173, No. 1, pp.  59-72, or succeeding revised editions.
approve or withhold approval of an application
or proposal or vote with the IACUC.
4. The IACUC shall notify investigators and the in-
stitution in writing of its decision to approve or
withhold approval of those sections of applica-
tions or proposals related to the care and use
of animals, or of modifications required to se-
cure IACUC approval. If the IACUC decides to
withhold approval of an application or proposal,
it shall include in its written notification a state-
ment of the reasons for its decision and give the
investigator an opportunity to respond in per-
son or in writing.
5. The IACUC shall conduct continuing review of
applications and proposals covered by this pol-
icy at appropriate intervals as determined by the
IACUC, but not less than once every three years.
6. The IACUC may suspend an activity that it pre-
viously approved if it determines that the activ-
ity is not being conducted in accordance with
applicable provisions of the Animal Welfare Act,
the Guide, the institution’s Assurance, or
IV. C.l.a.-g. The IACUC may suspend an activity
only after review of the matter at a convened
meeting of a quorum of the IACUC and with the
suspension vote of a majority of the quorum
present.
7. If the IACUC suspends an activity involving ani-
mals, the institutional official in consultation with
the IACUC shall review the reasons for suspen-
sion, take appropriate corrective action and re-
port that action with a full explanation to OPRR.
8. Applications and proposals that have been ap-
proved by the IACUC maybe subject to further
appropriate review and approval by officials of
the institution. However, those officials may not
approve those sections of an application or pro-
posal related to the care and use of animals if
they have not been approved by the IACUC.
D. Information Required in Applications and Propos-
als Submitted to PHS
1. All Institutions
Applications and proposals submitted to PHS
that involve the care and use of animals shall
contain the following information:
a. identification of the species and approximate
number of animals to be used;
b. rationale for involving animals, and for the
appropriateness of the species and numbers
to be used;
c. a complete description of the proposed use of
the animals;
d. assurance that discomfort and injury to ani-
mals will be limited to that which is unavoid-
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able in the conduct of scientifically valuable
research, and that analgesic, anesthetic, and
tranquilizing drugs will be used where indi-
cated and appropriate to minimize discomfort
and pain to animals; and
e. a description of any euthanasia method to he
used.
2. Institutions That Have an Approved Assurance
Applications or proposals covered by this pol-
icy from institutions which have an approved As-
surance on file with OPRR shall include verifi-
cation of approval by the IACUC of those sections
related to the care and use of animals, With the
authorization of PHS, such verification may be
filed at a time not to exceed 60 days after sub-
mission of applications or proposals.6
If verification of IACUC approval is submitted
subsequent to the submission of the application
or proposal, the verification shall state the
modifications, if any, required by the IACUC.
The verification shall be signed by an individual
authorized by the institution, but need not be
signed b-y the institutional official who signed the
Assurance.
3. Institutions That Do Not Have an Approved As-
surance
Applications and proposals involving animals
from institutions that do not have an approved
Assurance on file with OPRR shall contain a dec-
laration that the institution will establish an IA-
CUC and submit an Assurance upon request by
OPRR. After OPRR has requested the Assurance,
the institution shall establish an IACUC as re-
quired by IV.A.3. and the IACUC shall review
those sections of the application or proposal as
required by IV.c. The institution shall then sub-
mit to OPRR the Assurance and verification of
IACUC approval. The verification shall state the
modifications, if any, required by the IACUC.
The verification shall be signed by an individual
authorized by the institution, but need not be
signed by the institutional official who signed the
Assurance.
E. Recordkeeping
1. The awardee institution shall maintain:
a. an Assurance approved by the PHS;
b. minutes of IACUC meetings, including records
of attendance, activities of the committee, and
committee deliberations;
6(lnt Il further notwe PHS  hereh\,  authorizes all institutions with approked
Assuraores  to file \ ~r]ftration  of 1,4(;{  1(’  appro~ al either  along with the ap.
plicatwn  or proposal or within f-XI da}s  of submission of the application or
proposal From time to time P}iS  w ill rem  aluate  this hl,]nket authorization
An}’  deriwn  to withdra}~  this authorization will  take place on]?  after  ample
Opporfllnlt}’  IS pr”ol ided for romment  by the Put)]ic
c.
d,
e.
records of applications, proposals and pro-
posed significant changes in the care and use
of animals and whether IACUC approval was
given or withheld;
records of any IACUC reports and recommen-
dations as forwarded to the institutional offi-
cial; and
records of accrediting body determinations.
2. All records shall be maintained for at least three
years; records that relate directly to applications,
proposals, and proposed significant changes in
ongoing activities reviewed and approved by the
IACUC shall be maintained for the duration of
the activity and for an additional three years af-
ter the completion of the activity. All records
shall be accessible for inspection and copying by
authorized OPRR or other PHS representatives
at reasonable times and in a reasonable manner.
F. Reporting Requirements
1. On or before each anniversary of approval of its
Assurance, the institution shall report in writ-
ing to OPRR:
a. any change in the institution’s program or fa-
cilities which would place the institution in a
different category than specified in its Assur-
ance (see IV.A.2.);
b. any change in the description of the institu-
tion’s program for animal care and use as re-
quired by IV. A.l.a.-h.;
c. any changes in IACUC membership; and
d. if the institution’s program and facilities are
in Category 2 (see  IV.A.2.), verification that the
IACUC has conducted an annual evaluation of
the institution’s program and facilities and sub-
mitted the evaluation to the institutional
official.
2. Institutions that have no changes to report as
specified in IV.F. 1.a.-c. shall submit a letter to
OPRR stating that there are no changes.
3. Institutions shall provide OPRR promptly with
a full explanation of the circumstances and ac-
tions taken with respect to:
a. any serious or continuing noncompliance with
this policy;
b. any serious deviation from the provisions of
the Guide; or
c. any suspension of an activity by the IACUC.
Implementation by PHS
A. Responsibilities of OPRR
OPRR is responsible for the general administra-
tion and coordination of this policy and will:
I. request and negotiate, approve or disapprove,
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and, as necessary, withdraw approval of As-
surances;
2. distribute to executive secretaries of initial re-
view and technical evaluation groups, and to PHS
awarding units, lists of institutions that have an
approved Assurance;
3. advise awarding units and awardee institutions
concerning the implementation of this policy;
4. evaluate allegations of noncompliance with this
policy;
5. have the authority to review and approve or dis-
approve waivers to this policy (see V.D.); and
6. conduct site visits to selected institutions.
B. Responsibilities of PHS Awarding Units
PHS awarding units may not make an award for
an activity involving animals unless the institution
submitting the application or proposal is on the list
of institutions that have an approved Assurance on
file with OPRR, and the institution has provided
verification of approval by the IACUC of those sec-
tions of the application or proposal related to the
care and use of animals in PHS-supported activi-
ties. If an institution is not listed, the awarding unit
will ask OPRR to negotiate an Assurance with the
institution before an award is made. No award shall
be made until the Assurance has been submitted
by the institution, approved by OPRR, and the in-
stitution has provided verification of approval by
the IACUC of those sections of the application or
proposal related to the care and use of animals in
PHS-supported activities.
C. Conduct of Special Reviews/Site Visits
Each awardee institution is subject to review at
anytime by PHS staff and advisors, which may in-
clude a site visit, in order to assess the adequacy
of the institution’s compliance with this policy.
D. Waiver
Institutions may request a waiver of a provision
or provisions of this policy by submitting a request
to OPRR. No waiver will be granted unless suffi-
cient justification is provided and the waiver is ap-
proved in writing by OPRR.
Appendix
Laboratory-Animal Facilities Fully
Accredited by the American Association
for Accreditation of Laboratory Animal Care
As of April 1, 1985, there were 483 facilities listed
as fully accredited by the American Association for
Accreditation of Laboratory Animal Care (AAALAC)
(New Lenox, IL). Institutions are categorized as univer-
sities, medical schools, combined facilities for health
sciences, veterinary schools, dental schools, colleges
of pharmacy, colleges of biological science, colleges of
arts, colleges of engineering, Veterans’ Administration
medical centers, pharmaceutical manufacturers, gov-
ernment laboratories, commercial laboratories, hos-
pitals, nonprofit research laboratories, or laboratory
animal breeders. The following list of AAALAC-accred-
ited facilities numbers 538, as some institutions are
listed in more than one category. (Facilities receiving
accreditation since April 1, 1985, are not listed.)
Universities
(Programs serving an entire campus)
Alabama:
University of Alabama, University
University of Alabama at Birmingham and the
Veterans’ Administration Medical Center,
Birmingham
Arkansas:
University of Arkansas at Little Rock, Little
Rock
California:
University of California-Davis, Davis
University of California-San Diego, San Diego
University of California at Los Angeles, Los
Angeles
University of Southern California, Los Angeles
Georgia:
Medical College of Georgia, Augusta
Illinois:
University of Illinois at the Medical Center and
the Veterans’ Administration Medical Center,
Chicago
Kansas:
University of Kansas-Lawrence, Lawrence
Massachusetts:
Massachusetts Institute of Technology,
Cambridge
Michigan:
University of Michigan, Ann Arbor, Dearborn,
and Flint
Wayne State University, Detroit
Missouri:
University of Missouri-Kansas City, Kansas City
Montana:
University of Montana, Missoula
Nebraska:
University of Nebraska at Omaha, Omaha
New York:
St. John’s University, Jamaica
State University of New York at Buffalo, Buffalo
Rockefeller University, New York
North Carolina:
Duke University, Durham
Oklahoma:
Oral Roberts University, Tulsa
Rhode Island:
Brown University, Providence
South Carolina:
University of South Carolina, Columbia
Tennessee:
Oak Ridge Associated Universities, Oak Ridge
Vanderbilt University, Nashville
Utah:
University of Utah, Salt Lake City
Virginia:
Virginia Commonwealth University, Richmond
University of Virginia, Charlottesville
Washington:
University of Washington, Seattle
Universities (Programs serving
only a portion of a campus)
California:
Divisions of Animal Resources, University of
California, Berkeley
Georgia:
Yerkes Regional Primate Research Center,
Emory University, Atlanta
Ohio:
Laboratory Animal Center, The Ohio State
University, Columbus
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Medical Schools
Arizona:,
Arizona Medical Center, University of Arizona,
Tucson
Arkansas:
Medical Center, University of Arkansas, Little
Rock
California:
California College of Medicine, University of
California, Irvine
School of Medicine, University of California at
Los Angeles, Los Angeles
School of Medicine, University of California at
San Diego, San Diego
Charles R. Drew Postgraduate Medical School,
Los Angeles
School of Medicine, Loma Linda University,
Loma Linda
Colorado:
Medical School, University of Colorado, Denver
Connecticut:
School of Medicine, University of Connecticut
Health Center, Farmington
School of Medicine, Yale University, New Haven
District of Columbia:
School of Medicine, Georgetown University
College of Medicine, Howard University
Florida:
College of Medicine, University of Florida,
Gainesville
Medical Center, University of South Florida,
Tampa
Illinois:
Chicago College of Osteopathic Medicine,
Chicago
The Chicago Medical School/University of Health
Services, North Chicago
College of Medicine-Rockford, University of
Illinois, Rockford
Stritch School of Medicine, Loyola University,
Maywood
School of Medicine, Southern Illinois University,
Springfield
Iowa:
College of Osteopathic Medicine and Surgery,
Des Moines
Kentucky:
Medical Center, University of Kentucky,
Lexington
School of Medicine, University of Louisville,
Louisville
Louisiana:
School of Medicine, Tulane University, New
Orleans
Delta Regional Primate Research Center, Tulane
University, Covington
Maryland:
School of Medicine, University of Maryland at
Baltimore, Baltimore
School of Medicine, Uniformed Services
University of the Health Sciences, Bethesda
Massachusetts:
Medical School, Harvard University, Boston
Medical Center, University of Massachusetts,
Worcester
School of Medicine, Tufts-New England Medical
Center, Boston
Michigan:
Medical Center, University of Michigan, Ann
Arbor
Medical School, Wayne State University, Detroit
Minnesota:
School of Medicine, University of Minnesota-
Duluth, Duluth
Medical School, University of Minnesota,
Minneapolis
Missouri:
The University of Health Sciences, Kansas City
Kirksville College of Osteopathic Medicine,
Kirksville
School of Medicine, University of Missouri,
Columbia
Nebraska:
College of Medicine, University of Nebraska,
Omaha
New Hampshire:
Dartmouth Medical School, Hanover
New Jersey:
Medical School, College of Medicine and
Dentistry of New Jersey, Newark
New Mexico:
School of Medicine, University of New Mexico,
Albuquerque
New York:
Albany Medical College of Union University,
Albany
Albert Einstein College of Medicine, Bronx
College of Physicians and Surgeons, Columbia
University, New York
Medical College, Cornell University, New York
Mount Sinai Medical Center, New York
Downstate Medical Center, State University of
New York, Brooklyn
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School of Medicine, University of Rochester,
Rochester
North Carolina:
School of Medicine, University of North
Carolina, Chapel Hill
Bowman Gray School of Medicine, Wake Forest
College, Winston-Salem
Ohio:
Medical College of Ohio, Toledo
College of Medicine, University of Cincinnati,
Cincinnati
College of Medicine, Northeastern Ohio
Universities, Rootstown
Department of Animal Laboratories, Hospitals,
and College of Medicine, The Ohio State
University, Columbia
Oregon:
Oregon Health Sciences University, Portland
Pennsylvania:
School of Medicine, Hahnemann University,
Philadelphia
Milton S. Hershey Medical Center, Pennsylvania
State University, Hershey
Jefferson Medical College, Thomas Jefferson
University, Philadelphia
School of Medicine, University of Pittsburgh,
Pittsburgh
Puerto Rico:
Medical Sciences Campus, University of Puerto
Rico, San Juan
South Carolina:
School of Medicine, University of South
Carolina, Columbia
Tennessee:
Meharry Medical College, Nashville
Texas:
Texas College of Osteopathic Medicine, North
Texas State University, Ft. Worth
Medical School, University of Texas at Houston,
Houston
Utah:
College of Medicine, University of Utah, Salt
Lake City
Vermont:
College of Medicine, University of Vermont,
Burlington
Virginia:
Medical College of Virginia, Virginia
Commonwealth University, Richmond
Medical Center, University of Virginia,
Charlottesville
Eastern Virginia Medical School, Norfolk
Washington:
School of Medicine, University of Washington,
Seattle
Wisconsin:
Medical College of Wisconsin, Milwaukee
Medical School, University of Wisconsin,
Madison
Combined Facilities for Health Sciences
Connecticut:
University of Connecticut Health Center,
Farmington
District of Columbia:
Georgetown University Medical Center
School of Medicine and Health Sciences, George
Washington University
Florida:
University of Florida, J. Hillis Miller Health
Center and the Veterans’ Administration
Medical Center, Gainesville
Illinois:
Life Sciences Vivarium, Southern Illinois
University, Carbondale
Indiana:
Lobund Laboratory, University of Notre Dame,
Notre Dame
Kansas:
University of Kansas-Lawrence, Lawrence
Louisiana:
Medical Center, Louisiana State University, New
Orleans
Maryland:
Johns Hopkins Medical Institutions, Baltimore
Massachusetts:
Boston University School of Medicine and
Graduate School of Dentistry, Boston
Harvard University Medical School, Dental
School, School of Public Health, Animal
Research Center, and the New England
Regional Primate Research Center, Southboro
Tufts-New England Medical Center, Boston
Minnesota:
Health Sciences, University of Minnesota,
Minneapolis
Missouri:
John M. Dalton Research Center, Graduate
School, University of Missouri, Columbia
New Jersey:
College of Medicine and Dentistry of New
Jersey, Newark
New York:
Health Sciences Center, State University of New
York at Stony Brook, Stony Brook
School of Medicine and Dentistry, University of
Rochester, Rochester
North Carolina:
School of Medicine and School of Dentistry,
University of North Carolina, Chapel Hill
—404 . Altematives to Animal Use in Research, Testing, and Education
Oklahoma:
University of Oklahoma Health Sciences Center
at Oklahoma City, Oklahoma City
Texas:
University of Texas Health Science Center, San
Antonio
Virginia:
School of Basic Sciences, Virginia
Commonwealth University, Richmond
West Virginia:
West Virginia University Medical Center,
Morgantown
Wisconsin:
University of Wisconsin, Madison
Graduate School, University of Wisconsin,
Madison
Veterinary Schools
California:
School of Veterinary Medicine, University of
California-Davis, Davis
Florida:
College of Veterinary Medicine, University of
Florida, Gainesville
Louisiana:
School of Veterinary Medicine, Louisiana State
University, Baton Rouge
Massachusetts:
School of Veterinary Medicine, Tufts-New
England Medical Center, Boston
New York:
New York State College of Veterinary Medicine,
Cornell University, Ithaca
Tennessee:
College of Veterinary Medicine, University of
Tennessee, Knoxville
Wisconsin:
School of Veterinary Medicine, University of
Wisconsin, Madison
Dental Schools
California:
School of Dentistry, University of California at
Los Angeles, Los Angeles
Connecticut:
Dental School, University of Connecticut Health
Center, Farmington
District of Columbia:
School of Dentistry, Georgetown University
Florida:
College of Dentistry, University of Florida,
Gainesville
Illinois:
Dental School, University of Illinois at the
Medical Center, Chicago
School of Dentistry,
Maywood
Indiana:
School of Dentistry,
Indianapolis
Maryland:
School of Dentistry,
Baltimore
Massachusetts:
School of Dentistry,
Loyola University,
Indiana University,
University of Maryland,
Harvard University, Boston
School of Dental Medicine, Tufts-New England
Medical Center, Boston
Michigan:
School of Dentistry, University of Michigan,
Ann Arbor
Minnesota:
School of Dentistry, University of Minnesota,
Minneapolis
New Jersey:
School of Dentistry, Fairleigh Dickinson
University, Hackensack
Dental School, College of Medicine and
Dentistry of New Jersey, Newark
New York:
School of Dentistry, University of Rochester,
Rochester
North Carolina:
School of Dentistry, University of North
Carolina, Chapel Hill
Ohio:
College of Dentistry, The Ohio State University,
Columbus
Oregon:
School of Dentistry, Oregon Health Sciences
University, Portland
Washington:
School of Dentistry, University of Washington,
Seattle
Colleges of pharmacy
Florida:
College of Pharmacy, University of Florida,
Gainesville
Indiana:
School of Pharmacy and Pharmaceutical
Sciences, Purdue University, Lafayette
Kansas:
School of Pharmacy, University of Kansas-
Lawrence, Lawrence
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Massachusetts:
Massachusetts College of Pharmacy and Allied
Health Sciences, Boston
Michigan:
College of Pharmacy, University of Michigan,
Ann Arbor
Minnesota:
College of pharmacy, University of Minnesota,
Minneapolis
Nebraska:
School of Pharmacy,
Omaha
New Mexico:
College of Pharmacy,
Albuquerque
Ohio:
College of Pharmacy,
Columbus
South Carolina:
College of Pharmacy,
Carolina, Columbia
Virginia:
University of Nebraska,
University of New Mexico,
The Ohio State University,
University of South
School of Pharmacy, Virginia Commonwealth
University, Richmond
Washington:
School of Pharmacy, University of Washington,
Seattle
College of Pharmacy, Washington State
University, Pullman
Wisconsin:
School of Pharmacy, University of Wisconsin,
Madison
Colleges of Biological Science
California:
College of Biological Sciences and Scripps
Oceanography, University of California-San
Diego, San Diego
Pomona College, Claremont
South Carolina:
College of Humanities and Social Sciences,
University of South Carolina, Columbia
College of Science and Mathematics, University
of South Carolina, Columbia
Utah:
College of Science, University of Utah, Salt Lake
City
College of Social and Behavioral Science,
University of Utah, Salt Lake City
Washington:
College of Biological and Laboratory Animal
Resource Center, Washington State
University, Pullman
Colleges of Arts
Alabama:
College of Arts and Sciences, University of
Alabama, University
Tennessee:
College of Liberal Arts, University of Tennessee,
Knoxville
Virginia:
School of Arts and Sciences, Virginia
Commonwealth University, Richmond
College of Arts and Science,
Virginia, Charlottesville
Washington:
College of Arts and Science,
Washington, Seattle
College of Arts, Washington
Pullman
College of Engineering
New York:
University of
University of
State University,
Biomedical Engineering Laboratory, Rensselaer
Polytechnic Institute, Troy
Veterans’ Administration Medical
Centers
Alabama:
Birmingham
Arizona:
Tucson
Phoenix
Arkansas:
Little Rock
North Little Rock
California:
Fresno
Loma Linda
Long Beach
Martinez
San Diego
San Francisco
Sepulveda
West Los Angeles
Colorado:
Denver
Connecticut:
West Haven
Delaware:
Wilmington
District of Columbia:
Washington
Florida:
Gainesville
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Tampa
Miami
Lake City
Bay Pines
Georgia:
Decatur
Augusta
Illinois:
Chicago (2)
North Chicago
Hines
Indiana:
Indianapolis
Iowa:
Iowa City
Des Moines
Kentucky:
Lexington
Louisiana:
New Orleans
Shreveport
Maryland:
Perry Point
Baltimore
Massachusetts:
Bedford
Boston
Brockton
West Roxbury
Michigan:
Allen Park
Ann Arbor
Minnesota:
Minneapolis
Mississippi:
Jackson
Missouri:
Kansas City
Columbia
St. Louis
Nebraska:
Omaha
New Mexico:
Albuquerque
New Jersey:
East Orange
New York:
Albany
Brooklyn
Buffalo
Castle Point
New York
Northport
Syracuse
North Carolina:
Asheville
Durham
Ohio:
Cleveland
Cincinnati
Dayton
Oklahoma:
Oklahoma City
Oregon:
Portland
Pennsylvania:
Coatesville
Philadelphia
Puerto Rico:
San Juan
South Carolina:
Charleston
Tennessee:
Memphis
Nashville
Texas:
Dallas
Houston
San Antonio
Utah:
Salt Lake City
Virginia:
Richmond
Washington:
Seattle
Tacoma
West Virginia:
Huntington
Wisconsin:
Madison
Wood
Vermont:
White River Junction
pharmaceutical Manufacturers
California:
Hyland Division, Travenol Laboratories,
Glendale
Quidel, La Jolla
Connecticut:
Boehringer Ingelheim Ltd., Ridgefield
Miles Laboratories, Inc., West Haven
Medical Research Laboratory, Charles Pfizer &
Co., Inc., Groton
Delaware:
Stuart Pharmaceuticals, Division of ICI
Americas, Inc., Wilmington
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Illinois:
Abbott Laboratories, North Chicago
American Critical Care, American Hospital
Supply Corporation, McGaw Park
Division of Biological Research, G.D. Searle &
Co., Chicago
Travenol Laboratories, Inc., Morton Grove
Indiana:
Bristol-Myers Company, Evansville
Eli Lilly and Company, Indianapolis and
Greenfield
Miles Laboratories, Inc., Elkhart
Michigan:
The Upjohn Company, Kalamazoo
Warner-Lambert/Parke-Davis, Ann Arbor and
Detroit
Minnesota:
Riker/3M, St. Paul
Missouri:
Mallinckrodt, Inc., St. Louis
Marion Laboratories, Inc., Kansas City
Mississippi:
Travenol Laboratories, Inc., Cleveland
New Jersey:
Berlex Laboratories, Inc., Cedar Knolls
Biological Research Division, Bristol-Myers
Products, Inc., Hillside
Pharmaceuticals Division, Ciba-Geigy, Inc.,
Summit
Hoechst-Roussel Pharmaceuticals, Inc.,
Somerville
Ethicon Research Foundation, Somerville
Hoffman-La Roche, Inc., Nutley
Johnson & Johnson Baby Products Company,
Skillman
Johnson & Johnson Research Foundation, New
Brunswick
Merck Institute for Therapeutic Research,
Merck Sharp & Dohme Research
Laboratories, Rahway
Merck Sharp & Dohme Research Laboratories,
Branchburg Farm, Somerville
Ortho Pharmaceutical Corporation, Raritan
Sandoz Inc., East Hanover
Biological Research Division, Schering Corp.,
Bloomfield
Toxicology and Pathology Division, Schering
Corp., Lafayette
Squibb Institute for Medical Research, E.R.
Squibb & Sons, Inc., Princeton and New
Brunswick
Wallace Laboratories, Carter Wallace, Inc.,
Cranbury
New York:
American Cyanamid Company, Lederle
Laboratories, Pearl River
Bristol-Myers Company, Buffalo
Norwich-Eaton Pharmaceuticals, Norwich
Pennwalt Corporation, Rochester
Revlon Health Care Group, Tuckahoe
North Carolina:
Becton Dickinson and Company Research
Center, Research Triangle Park and Durham
Wellcome Research Laboratories, Burroughs-
Wellcome, Co., Research Triangle Park
Ohio:
Merrell Research Center, Merrell Dow
Pharmaceuticals, Cincinnati
Pennsylvania:
McNeil Pharmaceutical, Inc., Spring House
Merck Institute for Therapeutic Research,
Merck Sharp & Dohme Research
Laboratories, West Point
Veterinary Services and Veterinary Pathology,
Merck Sharp & Dohme, West Point
William H. Rorer, Inc., Fort Washington
Research and Development Divison-
Pharmaceuticals, Smith Kline & French
Laboratories, Philadelphia
Wyeth Laboratories, Radnor
Virginia:
A.H. Robins Research Laboratories, A.H. Robins,
Co., Richmond
France:
Searle Recherche et Developpement, G.D. Searle
and Company, Valbonne
Government Laboratories
Alabama:
U.S Army Aeromedical Research Laboratory,
Fort Rucker
Arizona:
National Center for Toxicological Research,
Jefferson
California:
Health Protection Systems/Laboratory Services
Program, California Department of Health,
Berkeley
Letterman Army Institute of Research, Animal
Resources Division, Presidio of San Francisco,
San Francisco
Colorado:
Fitzsimons Army Medical Center, Aurora
Connecticut:
Naval Submarine Medical Research Laboratory,
Naval Submarine Medical Center, Groton
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District of Columbia:
Armed Forces Institute of Pathology,
Washington
Florida:
Naval Aerospace Medical Research Laboratory,
Naval Aerospace Medical Institute, Pensacola
John F. Kennedy Space Center, John F.
Kennedy Space Center
Georgia:
Centers for Disease Control, Atlanta
Hawaii:
Tripler Army Medical Center, Honolulu
Illinois:
Argonne National Laboratory, Argonne
Naval Dental Research Institute, Great Lakes
Naval Base, Great Lakes
Iowa:
National Animal Disease Center, U.S.
Department of Agriculture, Ames
Louisiana:
Naval Biodynamics Laboratory, New Orleans
Maryland:
Bureau of Biologics, Food and Drug
Administration, Bethesda
Frederick Cancer Research Facility, National
Cancer Institute, Frederick
Medical Laboratory Veterinary, Medicine
Service, Department of Pathology, Ft. Meade
Gerontology Research Center, National Institute
on Aging, National Institutes of Health,
Baltimore
Veterinary Resources Branch, National Institutes
of Health, Bethesda
U.S. Army Environmental Hygiene Agency,
Edgewood
U.S. Army Medical Research Institute of
Chemical Defense, Aberdeen Proving Ground
U.S. Army Medical Research Institute of
Infectious Diseases, Fort Detrick, Frederick
Massachusetts:
Human Nutrition Research Center at Tufts
University, Boston
U.S. Army Research Institute of Environmental
Medicine, Natick
Mississippi:
USAF Medical Center Keesler, Keesler Air Force
Base
Montana:
National Institute of Allergy and Infectious
Disease, National Institutes of Health,
Hamilton
New Mexico:
Los Alamos National Laboratory, University of
California, Los Alamos
New York:
Brookhaven National Laboratory, Upton
Food and Drug Research Laboratories, Inc.,
Waverly
North Carolina:
National Institute of Environmental Health
Sciences, National Institutes of Health,
Research Triangle Park
United States Environmental Protection Agency,
Research Triangle Park
Ohio:
National Institute for Occupational Safety and
Health, Cincinnati
United States Environmental Protection Agency,
Cincinnati
USAF 6570th Aerospace Medical Research
Laboratories, Wright-Patterson AFB
Oklahoma:
Civil Aeromedical Institute, FAA Aeronautical
Center, Oklahoma City
Oregon:
Oregon Regional Primate Research Center,
Beaverton
Pennsylvania:
Naval Air Development Center, Warminster
Tennessee:
Oak Ridge National Laboratory, Biology Division,
Oak Ridge
Texas:
William Beaumont Army Medical Center (U.S.
Army), El Paso
Brooke Army Medical Center, Department of
Pathology and Laboratory Services, Fort Sam
Houston
Texas Research Institute of Mental Sciences,
Houston
USAF School of Aerospace Medicine, Brooks
AFB
Washington:
Madigan Army Medical Center, Tacoma
Commercial Laboratories
Arizona:
Armour Research Center, Armour-Dial
Company, Scottsdale
Arkansas:
INTOX Laboratories, Inc., Little Rock
California:
American Pharmaseal Laboratories, Irwindale
Bio-Devices Laboratories, Inc., Orange
Chevron Environmental Health Center,
Richmond
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Edwards Laboratories, Santa Ana
McGaw Laboratories, Irvine
Science Applications, Inc., La Jolla
North American Science Associates of
California, Irvine
Shell Development Company, Modesto
Stauffer Chemical Company, Mountain View
Connecticut:
United States Surgical Corporation, Norwalk
Stauffer Chemical Company, Farmington
Delaware:
Haskell Laboratory for Toxicology and
Industrial Medicine, Newark
Florida:
Life Sciences, Inc., St. Petersburg
Sherwood Medical Laboratories, Inc., DeLand
Georgia:
American McGaw, Milledgeville
Illinois:
American Biogenics Corporation, Decatur
Kendall Company Health Research Center,
Barrington
Quaker Oats Company, Barrington
Kansas:
Mobay Chemical Corporation, Stilwell
BAVET Division of hliles Laboratories, Inc.,
Shawnee Missions
Maryland:
BioCon, Inc., Rockville
Biotech Research Laboratories, Inc., Rockville
Borriston Laboratories, Inc., Temple Hills
Gillette Capital Corporation, Rockville
Laboratory Animal Services, Inc., Rockville
Litton Bionetics, Inc., Bethesda
Microbiological Associates, Bethesda
Tegeris Laboratories, Inc., Laurel
Massachusetts:
Arthur D. Little, Inc., Cambridge
Bioassay Systems Corporation, Woburn
Biotek, Inc., Woburn
EG & G Mason Research Institute, Inc.,
Worcester
SISA Laboratories Inc., Cambridge
Michigan:
Toxicology Research Laboratory, The Dow
Chemical Company, Midland
Dow Corning Corporation, Midland
General Motors Research Laboratories, Warren
International Research and Development
Corporation, Mattawan
Toxicity Research Laboratories, Ltd., Muskegon
Minnesota:
Medtronic, Inc., Coon Rapids
Missouri:
Environmental Health Laboratory, Monsanto
Company, St. Louis
New Jersey:
Biodynamics, Inc., East Millstone
Colgate Palmolive Research Center, Piscataway
Cyanamid Foundation for Agricultural
Development, Princeton
Exxon Biomedical Sciences, Inc., East Millstone
FMC Corporation Toxicology Laboratory,
Somerville
FMC Corporation, Princeton
Lever Brothers Company, Edgewater
Mobil Oil Corporation, Princeton
Revlon Research Center, Inc., Edison
New York:
Eastman Kodak Company, Rochester
Ohio:
Ben Venue Laboratories, Inc., Bedford
Hill Top Research, Inc., Miamiville
North American Science Associates, Inc.,
Northwood
Procter and Gamble Company, Cincinnati
Toilet Goods Division, Procter and Gamble
Company, Cincinnati
Springborn Institute for Bioresearch, Inc.,
Spencerville
WIL Research Laboratories, Inc., Ashland
Pennsylvania:
Biosearch, Inc. Philadelphia
M.B. Research Laboratories, Inc., Spinnertown
Pharmakon Research International, Inc.,
Waverly
Rohm and Haas Company, Spring House
Texas:
Alcon Laboratories, Fort Worth
Health and Environmental Sciences, Dow
Chemical, U. S. A., Lake Jackson
STILLMEADOW, Inc., Houston
Virginia:
Flow Laboratories, Inc., McLean
Hazelton Laboratories America, Inc., Vienna
Meloy Laboratories, Inc., Springfield
Washington:
Genetics Systems Corp., Seattle
Hollister-Stier, Division of Miles Laboratories,
Inc., Spokane
Oncogen, Seattle
Wisconsin:
Hazelton Laboratories America, Inc., Madison
Canada:
Bio-Research Laboratories, Ltd., Senneville,
Quebec
38-750 0 - 86 - 14
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Hospitals
Arizona:
Barrow Neurological Institute, St. Joseph’s
Hospital and Medical Center, Phoenix
California:
Children’s Hospital of San Francisco, San
Francisco
Sutter Hospitals Medical Research Foundation,
Sutter Community Hospitals, Sacramento
Colorado:
Denver General Hospital, Denver
National Jewish Hospital, Denver
District of Columbia:
Research Foundation of the Washington
Hospital Center
Research Foundation of Children’s Hospital,
Children’s Hospital
Florida:
Mount Sinai Medical Center, Miami Beach
Illinois:
Evanston Hospital Association, Evanston
Michael Reese Hospital and Medical Center,
Chicago
Louisiana:
Southern Baptist Hospital, New Orleans
U.S. Public Health Service Hospital, Carville
Maryland:
Maryland Psychiatric Research Center,
Catonsville
Massachusetts:
Beth Israel Hospital, Boston
New England Deaconess Hospital, Boston
St. Vincent Healthcare System, Inc., Worcester
New England Medical Center Hospitals, Tufts-
New England Medical Center, Boston
Michigan:
Henry Ford Hospital, Detroit
Sinai Hospital of Detroit, Detroit
Wayne County General Hospital, Westland
Minnesota:
Saint Paul-Ramsey Medical Center, St. Paul
New Jersey:
Newark Beth Israel Medical Center, Newark
New York:
Beth Israel Medical Center, New York
Hospital for Special Surgery, New York
Montefiore Hospital and Medical Center, Bronx
Nassau Hospital, Mineola
Nassau County Medical Center, East Meadow
St. Luke’s-Roosevelt Institute for Health
Sciences, New York
St. Vincent’s Hospital and Medical Center of NY,
New York
Ohio:
Akron City Hospital, Akron
Children’s Hospital Research Foundation,
Children’s Hospital, Columbus
Children’s Hospital Research Foundation,
Children’s Hospital Medical Center, Cincinnati
Cleveland Research Institute, Cleveland
Pennsylvania:
Albert Einstein Medical Center, Northern
Division, Philadelphia
Graduate Hospital, Philadelphia
Lehigh Valley Hospital Center, Allentown
Skin and Cancer Hospital of Philadelphia,
Philadelphia
Joseph Stokes, Jr. Research Institute of the
Children’s Hospital of Philadelphia
Rhode Island:
Miriam Hospital, Providence
Tennessee:
St. Jude Children’s Research Hospital, Memphis
University of Tennessee Memorial Hospital and
Research Center, Knoxville
Texas:
Scott and White Memorial Hospital, Temple
Nonprofit Research Laboratories
California:
Cedar-Sinai Medical Research Institute, Los
Angeles
Huntington Institute of Applied Medical
Research, Pasadena
Lawrence Berkeley Laboratory, Berkeley
Palo Alto Medical Research Foundation, Palo
Alto
Research and Education Institute, Inc., Harbor-
UCLA Medical Center, Torrance
SRI International, Menlo Park
Whittier Institute for Diabetes and
Endocrinology, La Jolla
Connecticut:
John B. Pierce Foundation Laboratory, New
Haven
Florida:
Miami Heart Institute, Miami Beach
Illinois:
American Dental Association Research Institute,
Chicago
Life Sciences Division, IIT Research Institute,
Chicago
Kansas:
Menninger Foundation, Topeka
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Louisiana:
Division of Research, Alton Ochsner Medical
Foundation, New Orleans
USL New Iberia Research Center, New Iberia
Maine:
Jackson Laboratory, Bar Harbor
Maryland:
American Type Culture Collection, Rockville
Massachusetts:
Worcester Foundation for Experimental Biology,
Inc., Shrewsbury
Center for Blood Research, Inc., Boston
Dana-Farber Cancer Institute, Boston
Forsyth Dental Center, Boston
Eunice Kennedy Shriver Center for Mental
Retardation, Waltham
Michigan:
Michigan Cancer Foundation, Detroit
Missouri:
Midwest Research Institute, Kansas City
Nebraska:
Eppley Institute for Research in Cancer, Omaha
New Mexico:
Lovelace Biomedical and Environmental
Research Institute, Inc., Albuquerque
iNew Jersey:
Institute for Medical Research, Camden
New York:
American Health Foundation, Naylor Dana
Institute for Disease Prevention, Valhalla
Cold Spring Harbor Laboratory, Cold Spring
Harbor
Memorial Sloan-Kettering Cancer Center, New
York
New York Blood Center, New York
Trudeau Institute, Inc., Saranac Lake
North Carolina:
Chemical Industry Institute for Toxicology,
Research Triangle Park
Research Triangle Institute, Research Triangle
Park
Ohio:
Battelle Memorial Institute, Columbus
Cleveland Clinic Foundation, Cleveland
Oklahoma:
Oklahoma Medical Research Foundation,
Oklahoma City
Pennsylvania:
Bushy Run Research Center, Export
Federated Medical Resources, Honey Brook
Institute for Cancer Research, Philadelphia
Texas:
Southwest Foundation for Research and
Education, San Antonio
Southwest Research Institute, San Antonio
University of Texas Cancer Center, Houston
Veterinary Resources Division, Science Park,
The University of Texas Cancer Center,
Bastrop
Utah:
University of Utah Research Institute, Salt Lake
City
Washington:
Battelle, Pacific Northwest Laboratories,
Richland
Bob Hope International Heart Research
Institute, Seattle
Fred Hutchinson Cancer Research Center,
Seattle
Pacific Northwest Research Foundation, Seattle
Virginia Mason Research Center, Seattle
Laboratory-Animal Breeders
Indiana:
Engle Laboratory Animals, Inc., Farmersburg
Harlan Sprague Dawley, Inc., Indianapolis
Laboratory Supply Company, Indianapolis
Maryland:
M.A. Bioproducts, Inc., Walkersville
Massachusetts:
Charles River Breeding Laboratories, Inc.,
Wilmington
Michigan:
Charles River-Portage, Portage
New Jersey:
Carom Research Institute, Inc., Wayne
Charles River Lakeview, Newfield
H.A.R.E. Rabbits for Research, Marland
Breeding Farms, Hewitt
New York:
Carworth Division, The Charles River Breeding
Laboratories Inc., Kingston
Charles River Research Primates Corporation,
Port Washington
Taconic Farms, Inc., Germantown
Tennessee:
Cumberland View Farms, Clinton
Virginia:
Hazelton Research Primates, Reston
Hazelton Research Animals, Inc., Vienna
Canada:
Charles River Canada Incorporated, St.
Constant, Quebec
Appendix E
International Agreements
Governing Animal Use
Convention on International Trade
in Endangered Species
In 1973, the Convention on International Trade in
Endangered Species of Fauna and Flora (CITES) was
signed by 61 nations. It has since been ratified by a
total of 81 separate nations and has been enforced in
the United States since 1977 (10,11).
In addition to protecting animals from extinction,
the Convention specifies in seven different places that
the Management Authority must be “satisfied that any
living specimen will be so transported and cared for
as to minimize the risk of injury, damage to health or
cruel treatment. ” CITES is administered on an inter-
national basis by the International Union for the Con-
servation of Nature and Natural Resources headquar-
tered in Gland, Switzerland. Endangered plants and
animals are listed in three Appendixes to the Conven-
tion, according to level of endangerment. For purposes
of monitoring, all primates have been included in Ap-
pendix 11 (“Threatened”) except chimpanzees, which
are classified as “Endangered. ” Under CITES provi-
sions, the effect of the Appendix 11 classification has
been to require export permits for all listed primates.
The U.S. agency responsible for administration of
CITES provisions is the Research Division of the Fish
and Wildlife Service, Department of the Interior, which
has additional responsibilities regarding international
trade in endangered or threatened species under Sec-
tion 7 of the Endangered Species Act of 1973. (For a
brief discussion of how this act affects experimenta-
tion in the United States, see ch. 13.) Current CITES
Appendixes listings, by species of wildlife and family
of plants, can be found in part 23 of title 50 of the
Code of Federal Regulations; lists of endangered and
threatened wildlife species and plant families affected
by the Endangered Species Act are found in part 17.
The Convention’s importance to research is twofold.
First, it has limited trade in nonhuman primates and
a few other species favored at one time or another
in experiments (1). Second, continued review of the
Convention by signatories has served as a forum for
discussion of protection of laboratory animals. CITES
signatories meet periodically in conferences, convened
under CITES provisions, to discuss the required clas-
sification of species according to the terms of the Con-
vention. Under regulations promulgated by the Fish
and Wildlife Service (50 CFR 23.31-,39), members of
the public must be given notice of the U.S. negotiat-
ing position at CITES conferences and an opportunity
to provide information and comments on the proposed
agenda, including at least one public meeting. Humane
groups have used these meetings to raise the issue of
humane treatment of laboratory-animal species in re-
lation to the Convention’s articles (12). Recently, for
example, CITES delegates were petitioned to ratify
proposed interpretations of the Convention to reach
that very question. The petition was ruled outside the
terms of the Convention (9).
Bans on Exporting Primates
From time to time, nations with indigenous popula-
tions of nonhuman primates that have been in demand
for various types of traditional research have consid-
ered or implemented prohibitions on their export, ei-
ther to protect dwindling populations or because of
high mortality rates suffered in transit. India ordered
such a ban in 1955, for the latter reason. Because rhe-
sus monkeys were in demand for testing polio vaccines
at the time, India agreed to reopen trade with the
United States on condition that the Surgeon General
sign a certificate of need for each order of monkeys,
with assurances that they be used humanely and only
for medical research and vaccine production. The ban
was reimposed by the Indian Government when it was
revealed that military experiments, specifically pro-
hibited under the agreement, were being done with
some of the monkeys. Other countries have consid-
ered similar bans or have imposed ceilings on exports.
Bans were enacted in Malaysia and Bolivia in 1984, and
a U.S. dealer was ousted from Bangladesh in 1979 for
selling Rhesus monkeys for military research (5). Some
commentators have been critical of U.S. estimates of
need for nonhuman primates in research, finding them
overstated, and have faulted the research community
for attempts to circumvent export bans (13).
Draft Convention of the
Council of Europe
The Council of Europe, headquartered in Stras-
bourg, France, and with 21 member countries, was
organized in 1949 to work for greater European unity,
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to improve the conditions of life and develop humane
values in Europe, and to uphold the principles of par-
liamentary democracy (6).
Historically, the Council has been concerned about
the treatment of animals. It has drafted Conventions
on the protection of animals in international transport
(1968), on those kept for farming purposes (1976), on
slaughter (1979), and on conservation of European
wildlife and natural habitats (1979). In 1971, the Coun-
cil adopted Recommendation 621, which contained
three relevant proposals:
l
l
l
Establish a-documentation and information cen-
ter on alternatives to animal use in testing and ex-
perimentation.
Establish tissue banks for research.
Establishment of an Ad Hoc Committee of Experts
to study the problems rising out of the abuse of
live animals for experimental industrial purposes,
The Committee was given the task of drafting in-
ternational legislation setting out the conditions
under which, and the scientific grounds on which,
experiments on live animals may be authorized
(15).
The Ad Hoc Committee of Experts for the Protec-
tion of Animals began its work on the Draft Conven-
tion in 1978. In 1983, the committee presented a Draft
Convention, guidelines for care and treatment, and a
guidance note on data collection to the Council of Min-
isters plenary sessions and seven working party meet-
ings under three successive chairmen. The commit-
tee was composed of experts from member countries.
Observers from the United States and Europe, includ-
ing representatives from several nongovernmental
organizations (World Society for the Protection of Ani-
mals, Federation of Veterinarians of the European Eco-
nomic Community, European Federation of Pharma-
ceutical Industries’ Associations, and the International
Council for Laboratory Animal Science) were admitted
to the committee’s meetings (2,14).
The form of the Draft Convention follows an earlier
one on the treatment of farm animals. Its preamble,
restating the general objective of European unity in
the context of protection of experimental animals,
balances the need of “man in his quest for knowledge,
health and safety . . . to use animals where there is a
reasonable expectation that the result will be to ex-
tend knowledge or be to the overall benefit of man
or animal, just as he uses them for food, clothing and
as beasts of burden” against the “moral obligation to
respect all animals and to exercise due consideration
for their capacity for suffering and memory.” As stated
in the preamble, the general objective of the Conven-
tion is ‘(to limit wherever practicable the use of ani-
mals for experimental and other scientific purposes,
in particular by seeking alternative methods to replace
the use of animals” (2).
Prospects for final ratification of the Draft Conven-
tion remain unclear. Twice in 1983 the Council’s as-
sembly failed to achieve the required two-thirds vote
on the committee’s report to urge the Committee of
Ministers to adopt it as soon as possible. Reported
accounts stated that some delegates did not believe
the Convention goes far enough in controlling animal
experimentation. The assembly, however, rejected
amendments that would have outlawed the use of ex-
perimental animals (8).
The Convention itself is
are summarized below.
General Principles
divided into 10 parts, which
Article 1 applies the Convention “to any animal be-
ing used or intended for use in any experimental or
other scientific procedure where that procedure may
cause pain, suffering, distress, or lasting harm. It does
not apply to any nonexperimental agricultural or clin-
ical veterinary practice. ” “Animal” means, “unless
otherwise qualified . . . any live non-human vertebrate,
including free-living larval and/or reproducing larval
forms, but excluding other foetal or embryonic forms. ”
‘(Procedure” is defined to include:
. . . any experimental or other scientific use of an ani-
mal which may cause it pain, suffering, distress or last-
ing harm, including any course of action intended to,
or  liable to, result in the birth of an animal in any such
condition, but excluding the least painful methods ac-
cepted in modern practice (i.e., “humane” methods) of
killing or marking an animal; a procedure starts when
the animal is first prepared for use and ends when no
further observations are to be made for that procedure;
the elimination of pain, suffering, distress or lasting
harm by the successful use of anesthesia or analgesia
or other methods does not place the use of an animal
outside the scope of this definition.
Article 2 provides that a defined procedure can be
performed on an animal for only one or more of the
following purposes, subject to other restrictions con-
tained in the Convention:
the avoidance or prevention of disease, ill health
or other abnormality, or their effects, in humans,
vertebrate or invertebrate animals, or plants,
including the production and the quality, efficacy,
and safety testing of drugs, substances, or products;
the diagnosis or treatment of disease, ill health or
other abnormality, or their effects, in humans,
vertebrate or invertebrate animals, or plants;
the assessment, detection, regulation or modifi-
cation of physiological conditions in humans, ver-
tebrate and invertebrate animals, or plants;
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l the prolongation or saving of life of humans, ver-
tebrate or invertebrate animals or plants;
l the protection of the environment;
Ž the production and quality control of foodstuffs;
l the breeding of vertebrate or invertebrate animals;
. scientific research;
l education and training; or
l forensic inquiries.
Article 3 requires all member nations “to take all nec-
essary steps to give effect to [its] provisions . . . and
to ensure an effective system of control and supervi-
sion” within 5 years of the Convention’s approval for
ratification.
Article 4 stipulates that ratification by a member
country does not bar it from adopting stricter meas-
ures to control experimental animal use.
General Care and Accommodation
Article 5 requires any animal to be used in a proce-
dure to be provided with “accommodation, an envi-
ronment, at least a minimum freedom of movement,
food, water, and care all appropriate to its health and
well-being. Any restriction on the extent to which an
animal can satisfy its physiological and ethnological
needs shall be limited as far as practicable.” Envi-
ronmental conditions must be checked daily and as
needed to prevent avoidable suffering.
Conduct of Procedure
Article 6 requires that procedures not be performed
where “another scientifically satisfactory method, not
entailing the use of an animal, is reasonably and prac-
ticably available,” and asks member nations to “encour-
age, if possible, scientific research into the development
of methods which could provide the same informa-
tion as that obtained in procedures.”
Article 7 requires careful consideration of choice of
species in procedures and that choices be explained,
where required, to the responsible authority. Proce-
dures should use the minimum number of animals,
cause the least pain, suffering, distress, or lasting harm
consistent with providing satisfactory results.
Article 8 requires all procedures to be performed
under general or local anesthetic or by other meth-
ods designed to eliminate to the extent practicable
pain, suffering, distress, or lasting harm unless the
methods are judged to be more distressing than the
procedure or are incompatible with the aim of the pro-
cedure.
Article 9 requires specific authorization of the au-
thority where an animal may experience severe pain
that is likely to endure. Authorization must be refused
if the authority judges that the procedure is not of ex -
ceptional importance for meeting the essential needs
of humans or animals, including the solution of scien-
tific problems.
Article 10 declares that an animal under procedure
remains subject to the provisions of article 5, except
where those provisions are incompatible with the ob-
ject of the procedure.
Article 11 provides for a decision at the end of proce-
dures whether the animal shall be kept alive or killed
by a humane method, subject to the condition that it
shall not be kept alive if, even though it has been re-
stored to normal health in all other respects, it is likely
to remain in lasting pain or distress. Such decisions
must be made by a veterinarian or a person responsi-
ble for the procedure. If an animal is not to be kept
alive it should be killed by a humane method as soon
as possible. Finally, the article provides that no ani-
mal be used in more than one painful procedure un-
less the second procedure is one in which the animal
is subject throughout to general anesthesia, from
which it is not allowed to recover, or the further pro-
cedure will involve minor interventions only.
Article 12 permits experimental animals to be set
free as part of the procedure provided that the maxi-
mum practicable care has been taken to safeguard the
animal’s well-being. Procedures that involve setting the
animal free are not permitted solely for educational
or training purposes.
Authorization
Article 13 provides that procedures authorized by
article 2 may be performed only by authorized per-
sons or persons under their direct responsibility, or
if the project is authorized by the legislation of a mem-
ber country. Only persons deemed competent by the
responsible authority may be so authorized.
Breeding or Supplying Establishments
The four articles contained in this part establish
principles for breeders and suppliers of experimental
animals, who would be required to:
l
l
l
l
register and comply with article 5 (article 14);
specify a competent person in charge with author-
ity to administer or arrange for suitable care (ar-
ticle 15);
keep detailed records on breeding, shipment, and
transfer, to be maintained at least 3 years from
the date of last entry (article 16); and
mark humanely for identification dogs and cats
and maintain complete records to promote their
identification (article 17).
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User Establishments
Under the provisions of the seven articles in this
part, users (i.e., experimental facilities) would be re-
quired to:
register with national authorities and comply with
article 5 (article 18);
provide equipment and facilities appropriate for
species used and to ensure that the procedures
are performed as effectively as practicable with
the minimum number of animals and the mini-
mum degree of pain, suffering, distress, or last-
ing harm (article 19);
identify persons administratively responsible for
care and equipment, provide sufficiently trained
staff, and make adequate arrangements for veteri-
nary advice and treatment (article 20);
use only animals supplied by registered breeders
or suppliers, subject to national exceptions (arti-
cle 21);
use only mice, rats, guinea pigs, golden hamsters,
rabbits, dogs, cats, or quail originating in or ac-
quired directly from registered breeding establish-
ments, subject to national exemptions (member
countries would add species to the list, particu-
larly primates, as soon as there is a reasonable
prospect of a sufficient supply of purpose-bred
animals; straying domestic animals cannot be used
and exemptions are not permitted) (article 22);
conduct procedures outside their establishments
only where authorized by the national authority
(article 23); and
keep records adequate to meet the requirements
of article 27 and, in addition, to show the num-
ber and species of all animals acquired, from
whom acquired, and date of arrival, and to make
such records available for inspections by the re-
sponsible authority (article 24).
Education and Training
Article 25 specifies that professional and training
procedures must be approved by responsible author-
ities before being used and must be carried out by or
under the supervision of a qualified person. Proce-
dures are not permitted at or below the secondary
level except when it is specifically directed to prepar-
ing for a career involving treatment or care of ani-
mals and the procedures entail no severe or enduring
pain or suffering. Only the minimum measures abso-
lutely necessary for the purpose are permitted, and
only if their objective cannot be achieved by audio-
visual or any other suitable methods. Article 26 re-
quires that persons who carry out, take part in, or take
care of animals used for procedures, including super-
visors, must have adequate education and training.
Statistical Information
Article 27 requires each agreeing nation to collect
and make public, where lawful, statistical information
on animals in experimentation, including:
l numbers and kinds of animals used;
. numbers of animals, by categories, used in pro-
cedures directly concerned with medicine and in
teaching and learning;
. numbers of animals, by categories, used in pro-
cedures for the protection of humans and their
environment; and
l numbers of animals, by categories, used in pro-
cedures required by legislation.
Article 28 specifies that, subject to its own secrecy
laws, each nation must submit information annually
in the form set out in Appendix B to the Secretary Gen-
eral of the Council, who is required to publish it. Each
nation is invited to send the name and address of the
corresponding authority, to be included in the Secre-
tary General’s compilation of statistics.
Recognition of International
Procedures
Article 29 binds agreeing nations to share informa-
tion on results of procedures and to provide mutual
assistance in order to avoid unnecessary repetition of
procedures for the purposes of satisfying national leg-
islation on health and safety.
Final Provisions
Articles 30 through 36 specify the manner and con-
ditions under which the Convention will become rati-
fied and effective (i.e., 6 months after four member
states express their consent to be bound and, for any
ratifying or acceding state after that, 6 months after
written ratification or accession), and reserve a mem-
ber state’s right to reservation, partial application, or
denunciation (2).
Appendix A of the Draft Convention
Appendix A, Guidelines on Accommodation and Care
of Animals, contains detailed specifications for physi-
cal facilities, holding-room environments and environ-
mental control, and care. Though the specifications
are comprehensive, article 5 does refer to them as
“suggested” (3).
Appendix B of the Draft Convention
Appendix B consists of Statistical Tables and Guid-
ance Notes for Their Completion in Fulfillment of the
Requirements in Articles 27 and 28 of the Draft Euro-
pean Convention for the Protection of Vertebrate Ani-
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reals Used for Experimental and Other Scientific Pur-
poses. The appendix would require submission by
agreeing nations of experimental-animal data, re-
ported to the Secretary General for each calendar year
under the general classifications established by the
referenced articles. The method of data collection is
left to each member nation (4).
Guidelines of the Council for
International Organizations of
Medical Sciences
Through the World Health Organization (WHO),
headquartered in Geneva, Switzerland, more than 150
nations exchange information and share resources for
laboratory-animal science training, technical informa-
tion, consultative support, and other activities.
In 1985, in the culmination of a 3-year effort initi-
ated in 1982, the Council for International Organiza-
tions of Medical Sciences (CIOMS), an international
nongovernmental organization representative of many
branches of medicine and cognate disciplines that was
established under the auspices of WHO and UNESCO
in 1949, issued  International Guiding Principles for Bio-
medical Research Involving Animals (7).
Modeled after the Tokyo revision of the Declaration
of Helsinki by the World Medical Association in 1975
and CIOMS’s Proposed International Guidelines for
Biomedical Research Involving Human Subjects, issued
in 1982, the CIOMS International Guiding Principles
are intended to provide a conceptual and ethical frame-
work for whatever regulatory measure each country
chooses to adopt with respect to animal use (7).
The International Guiding Principles enumerate 11
basic principles, as follows (7):
1.
II.
111,
IV,
The advancement of biological knowledge and
the development of improved means for the pro-
tection of the health and well-being both of man
and of animals require recourse to experimen-
tation on intact live animals of a wide variety of
species.
Methods such as mathematical models, computer
simulation and in vitro biological systems should
be used wherever appropriate.
Animal experiments should be undertaken only
after due consideration of their relevance for hu-
man or animal health and the advancement of
biological knowledge.
The animals selected for an experiment should
be of an appropriate species and quality, and the
minimum number required, to obtain scientifi-
cally valid results.
V. Investigators and other personnel should never
fail to treat animals as sentient, and should re-
VI.
VII.
VIII.
IX.
x.
XI<
gard their proper care and use and the avoidance
or minimization of discomfort, distress, or pain
as ethical imperatives.
Investigators should assume that procedures that
would cause pain in human beings cause pain in
other vertebrate species although more needs to
be known about the perception of pain in
animals.
Procedures with animals that may cause more
than momentary or minimal pain or distress should
be performed with appropriate sedation, analge-
sia, or anesthesia in accordance with accepted
veterinary practice. Surgical or other painful pro-
cedures should not be performed on unanesthe -
tized animals paralysed by chemical agents.
Where waivers are required in relation to the
provisions of article VII, the decisions should not
rest solely with the investigators directly con-
cerned but should be made, with due regard to
the provisions of articles IV, V, and VI, by a suita-
bly constituted review body. Such waivers should
not be made solely for the purposes of teaching
or demonstration.
At the end of, or when appropriate during, an
experiment, animals that would otherwise suf-
fer severe or chronic pain, distress, discomfort,
or disablement that cannot be relieved should be
painlessly killed.
The best possible living conditions should be
maintained for animals kept for biomedical pur-
poses. Normally the care of animals should be
under the supervision of veterinarians having ex-
perience in laboratory animal science. In any
case, veterinary care should be available as re-
quired.
It is the responsibility of the director of an in-
stitute or department using animals to ensure
that investigators and personnel have appropri-
ate qualifications or experience for conducting
procedures on animals. Adequate opportunities
shall be provided for in-service training, includ-
ing the proper and humane concern for the ani-
mals under their care.
Additional special provisions accompany the basic
principles. These deal with sources of supply of ani-
mal subjects; transport conditions; housing, including
space allocation, hygienic standards, and protection
against vermin; environmental conditions, including
temperature, humidity, lighting, and social interaction;
nutrition appropriate to the species; provision of
veterinary care; and the keeping of records (7).
The CIOMS statement also urges that the develop-
ment and use of alternatives be actively encouraged.
Specifically mentioned are nonbiological methods—
such as the study of structure-activity relationships or
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computer modeling—and biological methods, includ-
ing the use of micro-organisms, in vitro preparations,
and sometimes animal embryos (7).
Organization for Economic
Cooperation and Development
The Organization for Economic Cooperation and De-
velopment (OECD) is a group of nations whose mem-
bership accounts for two-thirds of the world’s chemi-
cal production, including the United States, Canada,
Japan, and most of the countries of Western Europe.
It also embraces six organizations that have a major
role in international efforts to regulate chemicals (6).
In 1979-80, an international group of experts con-
vened under the OECD’s Special Program on the Con-
trol of Chemicals drafted and recommended for the
Council’s approval OECD Principles of Good Labora-
tory Practice. The Council approved the document in
1981 (OECD, Guidelines for Testing of Chemicals,
C(81)30 (Final), Annex 2).
Though the main purpose for adopting the Princi-
@es was to promote international harmonization of
chemical-testing practices and thereby help safeguard
the integrity of test results required under health and
environmental safety laws, the document is patterned
very much after good laboratory practice regulations
adopted in 1978 by the U.S. Food and Drug Adminis-
tration (see ch. 13). Following the Principles’ general
command would certainly have an impact on use of
test animals, but they do not contain the same detailed
language on animal care, management, and housing
that domestic regulations do, nor are any sanctions
to be levied for failure to observe them.
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Appendix H
Glossary of Acronyms and Terms
Glossary of Acronyms
AAALAC —American Association for Accreditation
of Laboratory Animal Care
AALAS —American Association for Laboratory
Animal Science
AAMC —Association of American Medical
Colleges
AAVMC –Association of American Veterinary
Medical Colleges
ACC –Animal Care Committee (Canada)
ACP —American College of Physicians
ACUC —Animal Care and Use Committee
ADAMHA–Alcohol, Drug Abuse, and Mental
Health Administration (PHS, DHHS)
AFAAR —American Fund for Alternatives to
Animal Research
ALD —Approximate Lethal Dose
ALDF –Animal Legal Defense Fund
AMD —Aerospace Medical Division (U.S. Air
Force)
APA —American Psychological Association
APHIS —Animal’ and Plant Health Inspection
Service (USDA)
APS –American Physiological Society
ARC —Animal Research Committee
ASPCA —American Society for the Prevention of
Cruelty to Animals
AUCC —Association of Universities and Colleges
of Canada
AVMA —American Veterinary Medical
Association
BID –bureau, institute, or division (NIH)
BIOSIS —Biosciences Information Service
CAAT -Center for Alternatives to Animal
Testing (The Johns Hopkins University)
CALAS -Canadian Association for Laboratory
Animal Science
CBO -Congressional Budget Office (U.S.
Congress)
CCAC —Canadian Council on Animal Care
CDC --Centers for Disease Control (PHS,
DHHS)
CERCLA —Comprehensive Environment Response,
Compensation, and Liability Act
CFHS —Canadian Federation of Humane
Societies
CFR -Code of Federal Regulations
CIIT --Chemical Industry Institute of
Toxicology
CIOMS
CITES
CPSC
CTFA
CT&T
DHEW
DHHS
DOD
DOE
DOT
EPA
EWST
FAA
FASEB
FDA
FIFRA
FOA
FOIA
FR
FRAME
FTC
GAO
GLP
IACUC
ILAR
IRAC
IRB
ISEF
LADB
LC5O
LD5O
LSRO
MRI
NAL
--Council of International Organizations
of Medical Sciences
--Convention on International Trade in
Endangered Species
—U.S. Consumer Product Safety
Commission
—Cosmetic, Toiletry, and Fragrance
Association
-Chemical Times and Trends
—U.S. Department of Health, Education,
and Welfare (see DHHS)
—U.S. Department of Health and Human
Services
—U.S. Department of Defense
—U.S. Department of Energy
—U.S. Department of Transportation
—U.S. Environmental Protection Agency
—Ethics and Values in Science and
Technology (NSF program)
—U.S. Federal Aviation Administration
—Federation of American Societies for
Experimental Biology
–Food and Drug Administration (PHS,
DHHS)
—Federal Insecticide, Fungicide, and
Rodenticide Act
—Friends of Animals, Inc.
—Freedom of Information Act
—Federal Register
—Fund for Replacement of Animals in
Medical Experiments
—U.S. Federal Trade Commission
-General Accounting Office (U.S.
Congress)
—Good Laboratory Practices
—Institutional Animal Care and Use
Committee
—Institute for Laboratory Animal
Resources (NRC)
—Interagency Research Animal
Committee
—Institutional Review Board
–International Science and Engineering
Fair
—Laboratory Animal Data Bank
—median lethal concentration
—median lethal dose
–Life Sciences Research Office (FASEB)
—magnetic resonance imaging
—National Agricultural Library
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NAS
NASA
NBS
NCI
NCTR
NIDA
NIEHS
NIH
NIHARC
NIMH
NIOSH
NLM
NRC
NSF
NTIS
NTP
NWHL
OECD
OHER
ONR
OPRR
OSHA
OSTP
OTA
OTS
PHS
PMA
PRI
QSAR
RCRA
R&D
RRF
RTECS
—National Academy of Sciences
—National Aeronautics and Space
Administration
—National Bureau of Standards
(Department of Commerce)
–National Cancer Institute (NIH)
—National Center for Toxicological
Research (FDA)
—National Institute on Drug Abuse
(ADAMHA)
–National Institute of Environmental
Health Sciences (NIH)
–National Institutes of Health (PHS,
DHHS)
—National Institutes of Health Animal
Research Committee
–National Institute of Mental Health
(ADAMHA)
—National Institute for Occupational
Safety and Health (CDC)
–National Library of Medicine (NIH)
—National Research Council
—National Science Foundation
—National Technical Information Service
(Department of Commerce)
–National Toxicology Program (NIEHS)
—National Wildlife Health Laboratory
—Organization for Economic Cooperation
and Development
-Office of Health and Environmental
Research (DOE)
–Office of Naval Research (Navy)
—Office for Protection from Research
Risks (NIH)
-Occupational Safety and Health
Administration (U.S. Department of
Labor)
-Office of Science and Technology
Policy (Executive Office of the
President)
-Office of Technology Assessment (U.S.
Congress)
–Office of Toxic Substances (EPA)
–U.S. Public Health Service (DHHS)
—Pharmaceutical Manufacturers’
Association
—Primate Research Institute (University
of New Mexico)
-quantitative structure-activity
relationships
–Resource Conservation and Recovery
Act
—research and development
–Registered Research Facility
—Registry of Toxic Effects of Chemical
Substances (NIOSH)
SBIR –Small Business Innovation Research
(program)
SPCA –Society for the Prevention of Cruelty to
Animals
SSR —Society for the Study of Reproduction
TDB –Toxicology Data Bank (NLM)
TSCA —Toxic Substances Control Act
UNEP —United Nations Environment Program
UNESCO —United Nations Educational, Scientific,
and Cultural Organization
USDA —U.S. Department of Agriculture
VA —U.S. Veterans’ Administration
WHO —World Health Organization
WRPRC —Wisconsin Regional Primate
Center
Glossary of Terms
Research
Acute Toxicity Test: Tests that are used to detect the
toxic effects of single or multiple exposures to a sub-
stance occurring within 24 hours. These are fre-
quently the first tests performed to determine the
toxic characteristics of a given substance. One of the
most common acute toxicity tests is the LD5O test.
Alternatives to Animal Use: For purposes of this
assessment, OTA has chosen to define ‘(alternatives”
as encompassing any subjects, protocols, or technol-
ogies that replace the use of laboratory animals al-
together; reduce the number of animals required;
or refine existing procedures or techniques so as to
minimize the level of stress endured by the animal.
These technologies involve the continued, but modi-
fied, use of animals; use of living systems; use of chem-
ical and physical systems; and use of computers.
American Association for Accreditation of Labo-
ratory Animal Care (AAALAC): A voluntary private
organization that, by April 1985, provided accredi-
tation for 483 institutions. AAALAC accreditation is
based on the provisions of the NIH Guide for the Care
and Use of Laboratory Animals, and is recognized
by the PHS.
Ames Test: The most commonly used test for mutage-
nicity, it tests “reverse mutation” by exposing an al-
ready mutated strain of micro-organism to potential
mutagens. If the mutation is reversed the micro-
organisms regain their ability to produce the amino
acid histidine and will proliferate in a histidine-
deficient culture medium. However, when used alone
the Ames test does not seem to be as predictive of
human carcinogenicity as are animal tests.
Analgesic: An agent that relieves pain without caus-
ing loss of consciousness.
Anesthetic: An agent that causes loss of the sensation
of pain, usually without loss of consciousness. Anes-
thetics may be classified as topical, local, or general.
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Animal: For purposes of this assessment, animal is de-
fined as any nonhuman member of five classes of
vertebrates: mammals, birds, reptiles, amphibians,
and fish. Within this group, two kinds of animals can
be distinguished, warm-blooded animals (mammals
and birds) and cold-blooded animals (reptiles, am-
phibians, and fish). Under this definition, inver-
tebrates are not considered to be animals.
Animal Care and Use Committee (ACUC): An institu-
tional committee that oversees housing and routine
care of animals. The committee may also review
research proposals. The committee’s membership
generally includes the institution’s attending veter-
inarian, a representative of the institution’s admin-
istration, users of research animals, and one or more
nonscientist and lay members.
Animal and Plant Health Inspection Service
(APHIS): A branch of USDA that, among other duties,
is charged with the enforcement of the Animal Wel-
fare Act. Enforcement of the act is directed through
four regional offices and is carried out by 286 APHIS
Veterinary Medical Officers (inspectors) who spend
about 6 percent of their time inspecting over 1,200
research facilities (many of which have multiple sites).
Animal Use The use of animals for research purposes.
Three aspects of animal use are dealt with in this
assessment: in behavioral and biomedical research;
in testing products for toxicity; and in the education
of students at all levels. This assessment does not
cover animal use for food and fiber; animal use to
obtain biological products; or animal use for sport,
entertainment, or companionship.
Animal Welfare Act: This act, passed in 1966 and
amended in 1970, 1976, and 1985, was originally an
endeavor to stop traffic in stolen animals that were
being shipped across State lines and sold to research
laboratories. Amendments to the act have expanded
its scope to include housing, feeding, transportation,
and other aspects of animal care. However, the act
bars regulation of the conduct of research and test-
ing by USDA. Animals covered by the act, as cur-
rently enforced, are dogs, cats, hamsters, rabbits,
guinea pigs, nonhuman primates, and marine mam-
mals. The Animal Welfare Act is enforced by APHIS.
Animal Welfare Enforcement Report: Annual re-
port submitted to Congress by APHIS, based on data
collected from the Annual Report of Research Facil-
ity forms.
Animal Welfare Groups: There are a number of
groups concerned with animal rights and animal
welfare-e. g., the ASPCA, FOA, and AFAAR. These
groups cover a broad spectrum of ethical concerns
about animal use, they may question the objectives
as well as the means of research, but they generally
find common ground in the principle of humane
treatment of animals.
Annual Report of Research Facility: This is required
under the regulations stemming from the Animal
Welfare Act. Research facilities must submit these
annual reports, detailing animal use, to APHIS for
evaluation. (Elementary and secondary schools are
exempt, as are facilities using exempt species.) APHIS
presents data collected from these reports to Con-
gress in its annual Animal Welfare Enforcement
Report.
Anticruelty Statutes: Laws passed by States that pro-
hibit active cruelty, and in some cases passive cru-
elty (neglect), to animals. Some of these laws acknowl-
edge the potential application of anticruelty statutes
to research animals, but most of them exempt “scien-
tific experiments” entirely. Twenty States and the
District of Columbia regulate research to some ex-
tent. Twenty-one States have some provisions in their
codes requiring the teaching of “kindness” to or the
“value” of animals, and a few place restrictions on
animal experimentation in secondary schools.
Behavioral Research: Research into the movements
and sensations by which living things interact with
their environment, with the purpose of better under-
standing human behavior. A further goal of behav-
ioral research is the better understanding of animal
species of economic or intrinsic interest to humans.
Behavioral research differs from biomedical research
in that it is difficult to study behavioral phenomena
in isolation; therefore continued, but modified, use of
animals holds most promise for this area of research.
Biological Model A surrogate or substitute for a proc-
ess or organ of interest to an investigator. Animals
or alternatives can serve as biological models.
Biological Testing: The repetitive use of a standard
biological test situation or protocol employing differ-
ent chemicals or different test parameters. Such test
protocols are more stereotyped than those used in
research, and may be more amenable to the institu-
tion of a computerized data retrieval system.
Biomedical Research: A branch of research devoted
to the understanding of life processes and the appli-
cation of this knowledge to serve humans. A major
user of animals, biomedical research affects human
health and the health care industry. It is instrumen-
tal in the development of medical products such as
drugs and medical devices, and in the development
of services such as surgical and diagnostic techniques.
Biomedical research covers abroad spectrum of dis-
ciplines, such as anatomy, biochemistry, biology,
endocrinology, genetics, immunology, nutrition, on-
cology, and toxicology.
Carcinogen: An agent or process that significantly in-
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creases the incidence of abnormal, invasive, or un-
controlled cell growth in a population. Carcinogens
fall into three classes: chemicals, viruses, and ioniz-
ing radiation. A variety of screening assays have been
developed to detect chemical carcinogens, including
the Salmonella-mediated mutagenesis assay (Ames
test), the sister chromatid exchange assay, and tradi-
tional laboratory animal toxicity tests.
Cell Culture: Growth in the laboratory of cells isolated
from multicellular organisms. Each culture is usually
of one type. Cell culture may provide a promising
alternative to animal experimentation, for example
in the testing of mutagenicity, and may also become
a useful adjunct in repeated dose toxicity testing.
Center for Alternatives to Animal Testing (CAAT):
Established by the Johns Hopkins University in 1981
to search for alternatives to animal use, CAAT puts
out publications and supports intramural and extra-
mural research. The Center is sponsored by the CTFA
and corporate donors as well as consumer and in-
dustrial groups.
Chick Embryo Chorioallantoic Membrane Assay:
A test used to determine the irritancy of a substance.
A test sample is placed on the chorioallantoic mem-
brane formed on top of a chick embryo. The mem-
brane is then evaluated for response to the test sub-
stance and the embryo is discarded. This test may
be a promising alternative to the Draize Test.
Chronic Toxicity Test: Repeated dose toxicity test
with exposure to a test substance lasting at least 1
year, or the lifetime of the test species.
Comprehensive Environment Response, Com-
pensation, and Liability Act (CERCLA): Known
as “Superfund,” CERCLA authorizes the Federal Gov-
ernment to cleanup or otherwise respond to the re-
lease of hazardous wastes or other pollutants that
endanger public welfare.
Crossover Test: A useful laboratory or clinical method
whereby an animal serves as its own control by first
receiving a drug or a placebo and then receiving the
reverse. This kind of test has potential applications
in anesthesiology, endocrinology, radiology, and vari-
ous other fields.
Computer Simulation: The use of specially devised
computer programs to simulate cells, tissues, fluids,
organs, and organ systems for research purposes; to
develop mathematical models and algorithms for use
in toxicity testing; and to simulate experiments tradi-
tionally done with animals, for educational purposes.
Data Sources: Can provide an alternative to animal
testing by disseminating information generated from
prior use of animals. The TDB and RTECS are two
such sources, as was the LADB.
Descriptive Toxicology A branch of toxicology deal-
ing with phenomena above the molecular level. De-
scriptive toxicology relies heavily on the techniques
of pathology, statistics, and pharmacology to dem-
onstrate the relationship between cause and effect—
e.g., that certain substances cause liver cancer in cer-
tain species within a certain time. It is most often
used in regulatory schemes requiring testing.
Distress: Usually the product of pain, anxiety, or fear.
However, distress can also occur in the absence of
pain. For example, an animal struggling in a restraint
device may be free from pain, but maybe in distress.
Distress can be eased with tranquilizers.
Draize Eye Irritancy Test: A test that involves plac-
ing a single dose of a test substance into one eye of
four to six rabbits (the other eye remains untreated)
and observing its irritating effects. A promising alter-
native to this test is the chick embryo chorioallan-
toic membrane assay.
Education: The aspect of education dealt within this
assessment is the use of animals and alternatives in
the teaching of life sciences to secondary school stu-
dents, university students, health professionals and
preprofessionals, and research scientists.
Federal Environmental Acts: A number of these
have been passed to protect human health and the
environment from the adverse effects of toxic sub-
stances, and to regulate the release of such sub-
stances into the environment. Among these acts are
FIFRA, TSCA, the Clean Air Act, the Clean Water Act,
RCRA, CERCLA, and the Consumer Product Safety
Act, Animal testing provides much of the data needed
for the enforcement of these acts.
Federal Government Use of Animals for Research
Six Cabinet departments and four Federal agencies
conduct intramural research and testing involving
animals. They are: USDA, Department of Commerce,
DHHS, DOD, Department of the Interior, DOT, CPSC,
EPA, NASA, and the VA.
Federal Insecticide, Fungicide, and Rodenticide
Act (FIFRA): Designed to protect the human envi-
ronment from the adverse effects of pesticides and
their use, FIFRA regulates various aspects of pesti-
cide use by means of registration, labeling, and the
setting of maximum residue levels. It also established
procedures for safe application, storage, and disposal
of pesticides.
Good Laboratory Practices (GLP): Rules adopted by
FDA in 1978 requiring that all regulated parties con-
ducting nonclinical laboratory studies keep records
and permit audits of such studies. The GLP rules
also contain specific provisions for animal housing,
feeding, and care, In 1983, EPA issued similar GLP
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rules for its toxic substances and pesticides research
programs.
Guidelines for Animal Care and Use: Various or-
ganizations outside the Federal Government have
adopted their own guidelines-e.g., the APA’s Guide-
lines for Ethical Conduct in the Care and Use of Ani-
mals, which is the most comprehensive and has been
endorsed by FASEB; the APS’s Guiding Principles in
the Care and Use of Animals; and the AVMA’s Ani-
mal Welfare Guiding Principles. For Federal guide-
lines, see Interagency Research Animal Committee,
NIH Guide for the Care and Use of Laboratory Ani-
mals, and PHS Policy.
Hepatotoxicity: The quality of exerting a destructive
or poisonous effect upon the liver.
Homology The correspondence among organisms of
structures and functions derived from a common
evolutionary origin (e g., a common gene structure).
Immunoscintigraphy The use of external radioimag-
ing techniques to locate tumors and to identify cer-
tain noncancerous diseases.
Institute for Laboratory Animal Resources (ILAR):
A component of the National Research Council, ILAR
performs periodic surveys on the use of laboratory
animals.
Interagency Research Animal Committee (IRAC):
This committee was formed by 14 Federal entities
in recognition of a need for an interagency body
knowledgeable about the welfare of research ani-
mals. IRAC meets regularly to discuss research needs
and has written principles for the Utilization and Care
of Vertebrate Animals Used in Testing, Research and
Training. These Principles, which incorporate nine
injunctions on animal welfare, are intended to serve
as a model for Federal agencies in developing pol-
icies on animal use.
Invertebrate Any nonplant organism without a spinal
column-e. g., worms, insects, and crustaceans. In-
vertebrates account for 90 percent of the Earth’s non-
plant species. For the purposes of this assessment,
invertebrates are not considered to be animals.
In vitro: Literally, in glass; pertaining to a biological
process or reaction taking place in an artificial envi-
ronment, usually a laboratory. Human and animal
cells, tissues, and organs can be cultured in vitro.
In vitro testing may hold some promising alterna-
tives to animal testing-e.g., in testing for eye irrita-
tion and mutagenicity.
In vivo: Literally, in the living; pertaining to a biologi-
cal process or reaction taking place in a living cell
or organism.
Laboratory Animal Data Bank (LADB): Founded by
NCI and NLM in the late 1970s, the LADB was sup-
posed to provide a computer-based registry of re-
search and testing data. However, the data were
limited and consequently LADB had few users. It was
terminated in 1981 because of lack of funding. It ex-
ists today only as an archival reference,
LC50:An acute toxicity test used to screen substances
for their relative toxicity. LC50 is calculated to be the
lethal concentration for half of the animals exposed
to a test substance. Exposure may be by breathing
vapor or immersion in liquid (e.g., fish in water).
LD50: An acute toxicity test used to screen substances
for their relative toxicity. LD50 is calculated to be the
lethal dose for half of the animals exposed to a test
substance. Exposure is often by ingestion.
Mechanistic Toxicology An approach to testing that
focuses on the chemical processes by which a toxic
effect occurs. Mechanistic toxicology testing relies
heavily on physiology, biochemistry, and analytical
chemistry techniques to monitor these processes.
Micro-organism: A minute microscopic or submicro-
scopic living organism, such as bacteria, viruses, and
protozoa.
Mutagen: An agent that induces chemical changes in
genetic material. Chemicals, viruses, and ionizing
radiation can be mutagenic. Most carcinogens are
mutagens, therefore many screening tests to detect
carcinogens are designed to detect the mutagenic
potential of the compound. Some mutagens are not
direct-acting, requiring metabolic activation in the
body before they exert their mutagenic potential.
National Toxicology Program (NTP): NTP was char-
tered in 1978 as a cooperative effort by DHHS. Par-
ticipants in NTP are NIH (through its agencies NCI
and NIEHS), FDA (through NCTR), and CDC (through
NIOSH). The stated goals of NTP include the expan-
sion of toxicological information; expansion of num-
hers of chemicals to be tested; the validation, devel-
opment, and coordination of tests to meet regulatory
needs; and the communication of programs, plans,
and results to the public.
Neurotoxicity: The quality of exerting a destructive
or poisonous effect on nerve tissue.
NIH Guide for the Care and Use of Laboratory Ani-
mals: Revised in 1985, the Guide lays out detailed
standards for animal care, maintenance, and hous-
ing. Its provisions apply to all research supported
by NIH, and it is used by most animal research facil-
ities, both within and outside the Federal Govern-
ment. AAALAC and PHS also use it when assessing
research facilities for accreditation.
Nonliving Systems: Inanimate chemical or physical
systems used in testing.
Oncology: The study of tumors.
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Organ Culture: The attempt to isolate and maintain
animal or human organs in in-vitro culture. Long-
term culture of whole organs is not generally feasi-
ble, but they can be sustained in cultures for short
periods (hours or days).
Pain: Discomfort resulting from injury or disease. Pain
can also be psychosomatic, the product of emotional
stress. Pain can be induced by mechanical, thermal,
electrical, or chemical stimuli, and it can be relieved
by analgesics or anesthetics.
Pharmacokinetic Studies: A branch of toxicity test-
ing that provides information about the mechanics
of absorption.
PHS Policy on Humane Care and Use of Labora-
tory Animals by Awardee Institutions: Revised
in 1985, the Policy applies to PHS-supported activi-
ties involving animals (including those of NIH). It re-
lies on the NIH Guide for the Care and Use of Lab-
oratory Animals, and uses institutional committees
for the assessment of programs and maintenance of
records.
Pound Release Laws: State laws that provide for the
seizure, holding, and humane disposal of stray and
unwanted animals, Most States permit the release
of unowned animals to research institutions that have
met specified conditions. These laws have been
closely scrutinized. In the past 10 years and nine States
have passed laws prohibiting the release of stray ani-
mals to research institutions. The most far-reaching
of these laws takes effect in Massachusetts in 1986.
Also referred to as “pound seizure laws.”
Protocol: The plan of a scientific experiment or treat-
ment.
Reduction Considered an alternative to animals when
fewer animals are used in research and education
through changed practices, sharing of animals, or
better design of experimental protocols.
Refinement: An alternative to animal use by better
use and modification of existing procedures so that
animals are subject to less pain and distress. Exam-
ples of such refinements are the administration of
anesthetics and tranquilizers, humane destruction,
and the use of noninvasive imaging techniques.
Registry of Toxic Effects of Chemical Substances
(RTECS): An annually published compendium, ex-
tracted from the literature, of known toxic and
biological effect of chemical substances. RTECS is
published by NIOSH under the provisions of the Oc-
cupational Safety and Health Act of 1970.
Repeated-Dose Toxicity Test: Repeated or prolonged
exposure to measure the cumulative effects of expo-
sure to a test substance. These tests involve chronic,
subchronic, or short-term exposure to a test sub-
stance.
Replacement: An alternative to animal use, replac-
ing methods using animals with those that do not.
Examples include the use of a placenta instead of a
whole animal for microsurgical training, the use of
cell cultures instead of mice and rats, the use of non-
living systems, and the use of computer programs.
Research: The development of new knowledge and
technologies, often with unpredictable but poten-
tially significant results. Uncertainty, missteps, and
serendipity are inherent in the research process. Re-
search is distinguished from testing by the ways in
which animals are used, and the identity of the in-
vestigators. There are more research procedures
than there are tests, and researchers are more likely
to develop their own procedures.
Research Facility Under the Animal Welfare Act, any
individual, institution, organization, or postsecond -
ary school that uses or intends to use live animals
in research, tests, or experiments. Facilities that re-
ceive no Federal support for experimental work and
that either purchase animals only within their own
State or that maintain their own breeding colonies
are not considered research facilities under the act,
however.
Resource Conservation and Recovery Act (RCRA):
This act was passed to protect public health and the
environment through the regulation of the manage-
ment and handling of hazardous waste and through
the control of solid waste disposal.
Resusci-Dog: A plastic mannequin linked to a com-
puter. The Resusci-Dog can simulate an arterial pulse
and pressure can be applied to its ribcage for cardiac
massage or cardiopulmonary resuscitation.
Sequential Design Test: The comparison of treatment
groups at set stages of experimentation. Further ex-
perimentation at higher doses is undertaken only if
there is no significant difference between the two
groups. This kind of test has potential application
in anesthesiology, endocrinology, nutrition, and
other fields.
Serial Sacrifice: The sequential killing of animals to
examine the occurrence and progress of induced
effects.
Short-Term Toxicity Test: Repeated dose toxicity test
that involves exposure to a test substance over a pe-
riod of 2 to 4 weeks.
Speciesism: A term used by some animal rights activ-
ists, referring to the denial of animal rights as a moral
breach analogous to racism or sexism.
State Environmental Acts: Legislation passed by
States to regulate pesticides, air quality, water, and
waste products. These laws are often the simple
adoption or recodification of existing Federal laws.
Subchronic Toxicity Test: Repeated dose toxicity test
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of intermediate duration, with exposure to a test sub-
stance for 3 to 6 months.
Testing: Standardized procedures that have been dem-
onstrated to predict certain health effects in humans
and animals. Testing involves the frequent repeti-
tion of well-defined procedures with measurement
of standardized biological endpoints. A given test may
be used to test many different substances and may
use many animals. Testing is used to establish the
efficacy, safety, and toxicity of substances and pro-
cedures.
Tissue Culture: The maintenance in vitro of isolated
pieces of a living organism. The various cell types
are still arranged as they were in the original organ-
ism and their differential functions are intact,
Toxic Substances Control Act (TSCA): This act au-
thorizes EPA to regulate substances that present an
unreasonable risk of injury to health or to the envi-
ronment. The act also requires the reporting or de-
velopment of data to assess the risks posed by a given
substance.
Toxicity Testing: The testing of substances for toxic-
ity in order to establish conditions for their safe use.
There are now more than 50,000 chemicals on the
market and 500 to 1,000 new ones are introduced
each year. The Federal agencies with the largest role
in toxicity testing are FDA, EPA, CPSC, and OSHA.
Toxicology Data Bank (TDB): Made public by the
NLM in 1978, the TDB provides toxicity information
on more than 4,000 chemicals and substances. TDB
information is based on conventional published
sources.
Tranquilizer: An agent that quiets, calms, and reduces
anxiety and tension, with some alteration of the level
of consciousness.
T-test: An estimate of the difference between the mean
values of one parameter of two treatments. This can
be a powerful measure when the number of compari-
sons is small, but the potential for error increases
as the number of parameters grows.
Veterinary Medicine: The maintenance and improve-
ment of the health and well-being of animals, par-
ticularly the 30 to 40 different species of animals of
‘economic, ecological, and environmental importance.
Veterinary medicine is closely allied with veterinary.
research.
Veterinary Research: A branch of biomedical re-
search devoted to the understanding of the life proc-
esses of animals and the application of this knowl-
edge to serve animals as well as humans.
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